<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>370</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">370</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Leroueil, P. R.</author><author> Hong, S.</author><author>Mecke, A.</author><author>Baker, J. R., Jr.</author><author>Orr, B. G.</author><author>Banaszak Holl, M. M.</author></authors></contributors><auth-address>Program in Macromolecular Science and Engineering, Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.</auth-address><titles><title>Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?</title><secondary-title>Acc Chem Res</secondary-title><alt-title>Accounts of chemical research</alt-title></titles><alt-periodical><full-title>Accounts of Chemical Research</full-title></alt-periodical><pages>335-42</pages><volume>40</volume><number>5</number><edition>2007/05</edition><keywords><keyword>Cell Membrane/chemistry/*metabolism</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cytosol/chemistry/metabolism</keyword><keyword>Diffusion</keyword><keyword>Dimyristoylphosphatidylcholine/chemistry/metabolism</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Fluorescent Dyes/analysis/chemistry</keyword><keyword>Lipid Bilayers/*chemistry/metabolism</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Models, Biological</keyword><keyword>Models, Molecular</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>*Nanotechnology</keyword><keyword>Particle Size</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0001-4842 (Print)</isbn><accession-num>17474708</accession-num><abstract>Polycationic organic nanoparticles are shown to disrupt model biological membranes and living cell membranes at nanomolar concentrations. The degree of disruption is shown to be related to nanoparticle size and charge, as well as to the phase-fluid, liquid crystalline, or gel-of the biological membrane. Disruption events on model membranes have been directly imaged using scanning probe microscopy, whereas disruption events on living cells have been analyzed using cytosolic enzyme leakage assays, dye diffusion assays, and fluorescence microscopy.</abstract><notes>N01-c027173/phs&#xD;R01-eb005028/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17474708 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>16.214 </custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>708</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">708</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S.E.A</author><author>Williams, S.  </author><author>Napier M.E.</author><author>et al.</author></authors></contributors><titles><title>The Pursuit of a Scalable Nano-Fabrication Platform for Use in Material and Life Science Applications</title><secondary-title>Accounts of Chemical Research</secondary-title></titles><periodical><full-title>Accounts of Chemical Research</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - UNC</custom1><custom4>16.214</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>599</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">599</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Insin, Numpon</author><author>Tracy, Joseph B.</author><author>Lee, Hakho</author><author>Zimmer, John P.</author><author>Westervelt, Robert M.</author><author>Bawendi, Moungi G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and ! Division of Engineering and Applied Sciences and Department of Physics, Harvard University, Cambridge, Massachusetts 02138</auth-address><titles><title>Incorporation of Iron Oxide Nanoparticles and Quantum Dots into Silica Microspheres</title><secondary-title>ACS Nano</secondary-title></titles><pages>197-202</pages><volume>2</volume><number>2</number><edition>2008/07</edition><dates><year>2008</year><pub-dates><date>2008/07</date></pub-dates></dates><isbn>1936-0851</isbn><abstract>ABSTRACT We describe the synthesis of magnetic and fluorescent silica microspheres fabricated by incorporating maghemite (³-Fe2O3) nanoparticles (MPs) and CdSe/CdZnS core/shell quantum dots (QDs) into a silica shell around preformed silica microspheres. The resultant &lt;500 nm microspheres have a narrow size distribution and show uniform incorporation of QDs and MPs into the shell. We have demonstrated manipulation of these microspheres using an external magnetic field with real-time fluorescence microscopy imaging.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700344x</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>560</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">560</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kumar, R.</author><author>Roy, I. </author><author>Ohulchanskyy, T. Y.</author><author>Goswami, L. N.</author><author>Bonoiu, A. C.</author><author>Bergey, E. J.</author><author>Tramposch, K. M.</author><author>Maitra, A. </author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, State University of New York, Buffalo, New York 14260-3000, and ! Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland 21231</auth-address><titles><title>Covalently Dye-Linked, Surface-Controlled, and Bioconjugated Organically Modified Silica Nanoparticles as Targeted Probes for Optical Imaging</title><secondary-title>ACS Nano</secondary-title></titles><pages>449-456</pages><volume>2</volume><number>3</number><edition>2008/03/7</edition><dates><year>2008</year></dates><isbn>1936-0851</isbn><abstract>ABSTRACT In this paper we report the synthesis and characterization of organically modified silica (ORMOSIL) nanoparticles, covalently incorporating the fluorophore rhodamine-B, and surface-functionalized with a variety of active groups. The synthesized nanoparticles are of ultralow size (diameter ~20 nm), highly monodispersed, stable in aqueous suspension, and retain the optical properties of the incorporated fluorophore. The surface of the nanoparticles can be functionalized with a variety of active groups such as hydroxyl, thiol, amine, and carboxyl. The carboxyl groups on the surface were used to conjugate with various bioactive molecules such as transferrin, as well as monoclonal antibodies such as anti-claudin 4 and anti-mesothelin, for targeted delivery to pancreatic cancer cell lines. In vitro experiments have revealed that the cellular uptake of these bioconjugated (targeted) nanoparticles is significantly higher than that of the nonconjugated ones. The ease of surface functionalization and incorporation of a variety of biotargeting molecules, combined with their observed noncytotoxicity, makes these fluorescent ORMOSIL nanoparticles potential candidates as efficient probes for optical bioimaging, both in vitro and in vivo.</abstract><work-type>Journal Article</work-type><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700370b</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1021/nn700370b</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>562</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">562</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Sun, X.</author><author>Nakayama-Ratchford, N.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, California 94305</auth-address><titles><title>Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and Delivery</title><secondary-title>ACS Nano</secondary-title></titles><pages>50-56</pages><volume>1</volume><number>1</number><edition>2007/08/14</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1936-0851</isbn><abstract>ABSTRACT We show that large surface areas exist for supramolecular chemistry on single-walled carbon nanotubes (SWNTs) prefunctionalized noncovalently or covalently by common surfactant or acid-oxidation routes. Water-soluble SWNTs with poly(ethylene glycol) (PEG) functionalization via these routes allow for surprisingly high degrees of À-stacking of aromatic molecules, including a cancer drug (doxorubicin) with ultrahigh loading capacity, a widely used fluorescence molecule (fluorescein), and combinations of molecules. Binding of molecules to nanotubes and their release can be controlled by varying the pH. The strength of À-stacking of aromatic molecules is dependent on nanotube diameter, leading to a method for controlling the release rate of molecules from SWNTs by using nanotube materials with suitable diameter. This work introduces the concept of  functionalization partitioning  of SWNTs, i.e., imparting multiple chemical species, such as PEG, drugs, and fluorescent tags, with different functionalities onto the surface of the same nanotube. Such chemical partitioning should open up new opportunities in chemical, biological, and medical applications of novel nanomaterials.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700040t</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>na</custom4><electronic-resource-num>10.1021/nn700040t</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>550</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">550</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mirkin, C. A.</author></authors></contributors><auth-address>Chemistry Department and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208</auth-address><titles><title>The Power of the Pen: Development of Massively Parallel Dip-Pen Nanolithography</title><secondary-title>ACS Nano</secondary-title></titles><pages>79-83</pages><volume>1</volume><number>2</number><edition>2007/09/27 </edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1936-0851</isbn><abstract>ABSTRACT If one had complete control of the architecture of a surface, in terms of composition and physical structure, one could ask and answer some of the most important scientific questions in a wide variety of fields, including surface science, catalysis, and cellular biology. Unfortunately, there are few tools that allow one to tailor surface architecture with such control, and of those that exist, such as electron- and ion-beam lithographies, most are limited in terms of the environment in which they can operate, the materials that can be patterned, cost, and throughput. Toward this end, important new scanning probe technologies have been developed that have impacted fields such as electronics, optics, and medicine.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700228m</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1021/nn700228m</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>662</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">662</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Young, A. N.</author><author>Master, V. A.</author><author>Paner, G. P.</author><author>Wang, M. D.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, Emory University School of Medicine/Grady Memorial Hospital, 80 Jesse Hill Jr. Drive SE, Atlanta, GA 30303, USA. andrew.n.young@emory.edu</auth-address><titles><title>Renal epithelial neoplasms: diagnostic applications of gene expression profiling</title><secondary-title>Adv Anat Pathol</secondary-title></titles><pages>28-38</pages><volume>15</volume><number>1</number><edition>2007/12/25</edition><keywords><keyword>Carcinoma, Renal Cell/*diagnosis/*genetics</keyword><keyword>DNA, Neoplasm/genetics</keyword><keyword>Gene Expression Profiling/*methods</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*diagnosis/*genetics</keyword><keyword>Neoplasm Staging/methods</keyword><keyword>Neoplasms, Glandular and Epithelial/classification/diagnosis/genetics</keyword><keyword>Prognosis</keyword><keyword>World Health Organization</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1072-4109 (Print)</isbn><accession-num>18156810</accession-num><abstract>Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. RCC is a significant challenge for pathologic diagnosis and clinical management. The primary approach to diagnosis is by light microscopy, using the World Health Organization (WHO) classification system, which defines histopathologic tumor subtypes with distinct clinical behavior and underlying genetic mutations. However, light microscopic diagnosis of RCC subtypes can be difficult due to variable histology, morphologic features shared by tumor subtypes, and a growing frequency of small tumor biopsies with limited morphologic information. In addition to these diagnostic problems, the clinical behavior of RCC is highly variable, and therapeutic response rates are poor. Few clinical assays are available to predict outcome in RCC or correlate behavior with histology. Therefore, novel RCC classification systems based on gene expression should be useful for diagnosis, prognosis, and treatment. Recent microarray studies have shown that renal tumors are characterized by distinct gene expression profiles, which can be used to discover novel diagnostic and prognostic biomarkers. Here, we review clinical features of kidney cancer, the WHO classification system, and the growing role of molecular classification for diagnosis, prognosis, and therapy of this disease.</abstract><notes>Young, Andrew N&#xD;Master, Viraj A&#xD;Paner, Gladell P&#xD;Wang, May D&#xD;Amin, Mahul B&#xD;1U54 CA 119338-02/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Advances in anatomic pathology&#xD;Adv Anat Pathol. 2008 Jan;15(1):28-38.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18156810</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.014</custom4><electronic-resource-num>10.1097/PAP.0b013e3181594720&#xD;00125480-200801000-00003 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>28</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">28</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farokhzad, O. C.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesiology, Peri-operative and Pain Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA 02115, USA. ofarokhzad@partners.org</auth-address><titles><title>Nanomedicine: developing smarter therapeutic and diagnostic modalities</title><secondary-title>Adv Drug Deliv Rev</secondary-title><alt-title>Advanced drug delivery reviews</alt-title></titles><pages>1456-9</pages><volume>58</volume><number>14</number><edition>2006/12</edition><keywords><keyword>Diagnostic Techniques and Procedures/*trends</keyword><keyword>Drug Delivery Systems/*trends</keyword><keyword>Humans</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Therapeutics/*trends</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>17070960</accession-num><abstract>The early impact of nanotechnology on medicine is beginning to get realized, with novel nanoscale therapeutic and diagnostic modalities under development or in clinical practice today. In this commentary the field of &quot;nanomedicine&quot; is briefly reviewed form the perspective of where we were; where we are today; and where we are likely to go tomorrow.</abstract><notes>Journal Article&#xD;Review&#xD;Netherlands</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17070960 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>7.977</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>689</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">689</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, C.</author><author>Lee, J. S.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>Magnetic nanoparticles in MR imaging and drug delivery</title><secondary-title>Adv Drug Deliv Rev</secondary-title></titles><pages>1252-65</pages><volume>60</volume><number>11</number><edition>2008/06/19</edition><dates><year>2008</year><pub-dates><date>Aug 17</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>18558452</accession-num><abstract>Magnetic nanoparticles (MNPs) possess unique magnetic properties and the ability to function at the cellular and molecular level of biological interactions making them an attractive platform as contrast agents for magnetic resonance imaging (MRI) and as carriers for drug delivery. Recent advances in nanotechnology have improved the ability to specifically tailor the features and properties of MNPs for these biomedical applications. To better address specific clinical needs, MNPs with higher magnetic moments, non-fouling surfaces, and increased functionalities are now being developed for applications in the detection, diagnosis, and treatment of malignant tumors, cardiovascular disease, and neurological disease. Through the incorporation of highly specific targeting agents and other functional ligands, such as fluorophores and permeation enhancers, the applicability and efficacy of these MNPs have greatly increased. This review provides a background on applications of MNPs as MR imaging contrast agents and as carriers for drug delivery and an overview of the recent developments in this area of research.</abstract><notes>Sun, Conroy&#xD;Lee, Jerry S H&#xD;Zhang, Miqin&#xD;Netherlands&#xD;Advanced drug delivery reviews&#xD;Adv Drug Deliv Rev. 2008 Aug 17;60(11):1252-65. Epub 2008 Apr 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18558452</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2008</custom3><custom4>7.977</custom4><electronic-resource-num>S0169-409X(08)00101-4 [pii]&#xD;10.1016/j.addr.2008.03.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>87</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">87</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, M.</author><author>Lu, J. J.</author><author>Chen, J.</author><author>Klibanov, A. M.</author></authors></contributors><auth-address>Department of Chemistry and Division of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. mint@mit.edu</auth-address><titles><title>Non-viral siRNA delivery to the lung</title><secondary-title>Adv Drug Deliv Rev</secondary-title></titles><pages>124-33</pages><volume>59</volume><number>2-3</number><edition>2007/04/27</edition><keywords><keyword>Animals</keyword><keyword>Drug Delivery Systems/methods/*trends</keyword><keyword>Gene Silencing</keyword><keyword>Humans</keyword><keyword>Lung/metabolism/pathology</keyword><keyword>Lung Diseases/genetics/*therapy</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage/genetics/pharmacokinetics</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 30</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>17459519</accession-num><abstract>SiRNAs exert their biological effect by guiding the degradation of their cognate mRNA sequence, thereby shutting down the corresponding protein production (gene silencing by RNA interference or RNAi). Due to this property, siRNAs are emerging as promising therapeutic agents for the treatment of inherited and acquired diseases, as well as research tools for the elucidation of gene function in both health and disease. Because of their lethality and prevalence, lung diseases have attracted particular attention as targets of siRNA-mediated cures. In addition, lung is accessible to therapeutic agents via multiple routes, e.g., through the nose and the mouth, thus obviating the need for targeting and making it an appealing target for RNAi-based therapeutic strategies. The clinical success of siRNA-mediated interventions critically depends upon the safety and efficacy of the delivery methods and agents. Delivery of siRNAs relevant to lung diseases has been attempted through multiple routes and using various carriers in animal models. This review focuses on the recent progress in non-viral delivery of siRNAs for the treatment of lung diseases, particularly infectious diseases. The rapid progress will put siRNA-based therapeutics on fast track to the clinic.</abstract><notes>Thomas, Mini&#xD;Lu, James J&#xD;Chen, Jianzhu&#xD;Klibanov, Alexander M&#xD;Ai56267/ai/niaid&#xD;Eb000244/eb/nibib&#xD;P50 ca112967/ca/nci&#xD;U54 ca119349/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;Netherlands&#xD;Advanced drug delivery reviews&#xD;Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):124-33. Epub 2007 Mar 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17459519</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>7.977</custom4><electronic-resource-num>S0169-409X(07)00020-8 [pii]&#xD;10.1016/j.addr.2007.03.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>44</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">44</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Segal, E.</author><author>Perelman, L. A.</author><author>Cunin, F.</author><author>Di Renzo, F.</author><author>Devoisselle, J. M.</author><author>Li, Y. Y.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Segal, E&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Mat Sci &amp; Engn Program, La Jolla, CA 92093 USA&#xD;Inst Charles Gerhardt, CNRS,UMR 5618, UMI, ENSCM, F-34296 Montpellier, France&#xD;Hitachi Chem Res Ctr Inc, Irvine, CA 92617 USA</auth-address><titles><title>Confinement of thermoresponsive hydrogels in nanostructured porous silicon dioxide templates</title><secondary-title>Advanced Functional Materials</secondary-title></titles><pages>1153-1162</pages><volume>17</volume><number>7</number><edition>2007/05</edition><keywords><keyword>linkable pnipaam copolymers</keyword><keyword>volume phase-transition</keyword><keyword>drug-delivery</keyword><keyword>polymer gels</keyword><keyword>scanning microcalorimetry</keyword><keyword>mechanical-properties</keyword><keyword>optical-properties</keyword><keyword>photonic crystals</keyword><keyword>colloidal silica</keyword><keyword>layers</keyword></keywords><dates><year>2007</year><pub-dates><date>May 7</date></pub-dates></dates><isbn>1616-301X</isbn><accession-num>ISI:000246647500015</accession-num><abstract>A thermoresponsive hydrogel, poly(N-isopropylacrylamide) (poly(NIPAM)), is synthesized in situ within an oxidized porous Si template, and the nanocomposite material is characterized. Infiltration of the hydrogel into the interconnecting nanoscale pores of the porous SiO2 host is confirmed by scanning electron microscopy. The optical reflectivity spectrum of the nanocomposite hybrid displays Fabry-Perot fringes characteristic of thin film interference, enabling direct, real-time observation of the volume phase transition of the confined poly(NIPAM) hydrogel. Reversible optical reflectivity changes are observed to correlate with the temperature-dependent volume phase transition of the hydrogel, providing a new means of studying nanoscale confinement of responsive hydrogels. The confined hydrogel displays a swelling and shrinking response to changes in temperature that is significantly faster than that of the bulk hydrogel. The porosity and pore size of the SiO2 template, which are precisely controlled by the electrochemical synthesis parameters, strongly influence the extent and rate of changes in the reflectivity spectrum of the nanocomposite. The observed optical response is ascribed to changes in both the mechanical and the dielectric properties of the nanocomposite.</abstract><notes>170FH&#xD;Times Cited:0&#xD;Cited References Count:51</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246647500015</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>7.496</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>557</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">557</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, S. H.</author><author>Shi, X.</author><author>Van Antwerp, M.</author><author>Cao, Z.</author><author>Swanson, S. D.</author><author>Bi, X.</author><author>Baker, Jr., J. R.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109 (USA); Department of Radiology, Medical School, University of Michigan, Ann Arbor, MI 48109 (USA)</auth-address><titles><title>Dendrimer-Functionalized Iron Oxide Nanoparticles for Specific Targeting and Imaging of Cancer Cells</title><secondary-title>Advanced Functional Materials</secondary-title></titles><pages>3043-3050</pages><volume>17</volume><number>16</number><edition>2007/08/31</edition><keywords><keyword>Dendrimers</keyword><keyword>Iron oxides</keyword><keyword>Layer-by-layer assembly</keyword></keywords><dates><year>2007</year><pub-dates><date>November 2007</date></pub-dates></dates><isbn>1616-3028</isbn><abstract>We demonstrated a unique approach that combines a layer-by-layer (LbL) self-assembly method with dendrimer chemistry to functionalize Fe3O4 nanoparticles (NPs) for specific targeting and imaging of cancer cells. In this approach, positively charged Fe3O4 NPs (8.4 nm in diameter) synthesized by controlled co-precipitation of FeII and FeIII ions were modified with a bilayer composed of polystyrene sulfonate sodium salt and folic acid (FA)- and fluorescein isothiocyanate (FI)-functionalized poly(amidoamine) dendrimers of generation 5 (G5.NH2-FI-FA) through electrostatic LbL assembly, followed by an acetylation reaction to neutralize the remaining surface amine groups of G5 dendrimers. Combined flow cytometry, confocal microscopy, transmission electron microscopy, and magnetic resonance imaging studies show that Fe3O4/PSS/G5.NHAc-FI-FA NPs can specifically target cancer cells overexpressing FA receptors. The present approach to functionalizing Fe3O4 NPs opens a new avenue to fabricating various NPs for numerous biological sensing and therapeutic applications.</abstract><notes>10.1002/adfm.200601139</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adfm.200601139</url></related-urls></urls><custom1>CCNE - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>7.496</custom4><electronic-resource-num>10.1002/adfm.200601139</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>561</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">561</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, W.</author><author>Wilson, R. J.</author><author>Koh, A.</author><author>Fu, A.</author><author>Faranesh, A. Z.</author><author>Earhart, C. M.</author><author>Osterfeld, S. J.</author><author>Han, S. J.</author><author>Xu, L.</author><author>Guccione, S.</author><author>Sinclair, R.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Department of Materials Science and Engineering Stanford University Stanford, CA 94305 (USA); Department of Electrical Engineering Stanford University Stanford, CA 94305 (USA); Department of Mechanical Engineering Stanford University Stanford, CA 94305 (USA); Department of Radiology Stanford University Stanford, CA 94305 (USA)</auth-address><titles><title>High-Moment Antiferromagnetic Nanoparticles with Tunable Magnetic Properties</title><secondary-title>Advanced Materials</secondary-title></titles><pages>1479-1483</pages><volume>20</volume><number>8</number><edition>2008/04/4</edition><keywords><keyword>magnetic nanoparticles</keyword><keyword>nanoimprint lithography</keyword><keyword>ferromagnetic materials</keyword></keywords><dates><year>2008</year></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200703077</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200703077</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>8.191</custom4><electronic-resource-num>10.1002/adma.200703077</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>547</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">547</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huh, Y.M.</author><author>Lee, E.S.</author><author>Lee, J.H.</author><author>Jun, J.W.</author><author>Kim, P.H.</author><author>Yun, C.O.</author><author>Kim, J.H.</author><author>Suh, J.S.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Radiology, College of Medicine, Yonsei University, Seoul 120-752 (Korea); Department of Chemistry, Yonsei University, Seoul 120-749 (Korea); Brain Korea 21 Projects for Medical Science, Institute for Cancer Research, Yonsei Cancer Center, College of Medicine, Yonsei University, Seoul 120-752 (Korea)</auth-address><titles><title>Hybrid Nanoparticles for Magnetic Resonance Imaging of Target-Specific Viral Gene Delivery</title><secondary-title>Advanced Materials</secondary-title></titles><pages>3109-3112</pages><volume>19</volume><number>20</number><edition>2007/10/17</edition><keywords><keyword>Gene delivery</keyword><keyword>Hybrid materials</keyword><keyword>Magnetic nanoparticles</keyword><keyword>Viruses</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1521-4095</isbn><abstract>No abstract.</abstract><notes>10.1002/adma.200701952</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200701952</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.191</custom4><electronic-resource-num>10.1002/adma.200701952</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>549</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">549</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J.</author><author>Hasan, W.</author><author>Lee, M. H.</author><author>Odom, T. W.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208 (USA); Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208 (USA)</auth-address><titles><title>Optical Properties and Magnetic Manipulation of Bimaterial Nanopyramids</title><secondary-title>Advanced Materials</secondary-title></titles><pages>4387-4391</pages><volume>19</volume><number>24</number><edition>2007/12/11</edition><dates><year>2007</year><pub-dates><date>December 2007</date></pub-dates></dates><isbn>1521-4095</isbn><abstract>No abstract.</abstract><notes>10.1002/adma.200701505</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200701505</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.191</custom4><electronic-resource-num>10.1002/adma.200701505 </electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>621</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">621</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J.H.</author><author>von Maltzahn, G.</author><author>Zhang, L.</author><author>Schwartz, M.P.</author><author>Ruoslahti, E.</author><author>Bhatia, S.N.</author><author>Sailor, M.J.</author></authors></contributors><auth-address>Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA); Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA 02139 (USA); Burnham Institute for Medical Research at UCSB University of California, Santa Barbara 1105 Life Sciences Technology Bldg., Santa Barbara, CA 93106 (USA)</auth-address><titles><title>Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging</title><secondary-title>Advanced Materials</secondary-title></titles><pages>1589</pages><volume>20</volume><number>9</number><edition>2008/07</edition><keywords><keyword>Bionanotechnology</keyword><keyword>Iron oxide</keyword><keyword>Nanoparticles</keyword><keyword>Cells</keyword><keyword>Drug delivery</keyword></keywords><dates><year>2008</year></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200890033</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200890033</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>UCSD/ MIT</custom2><custom3>2008</custom3><custom4>8.191</custom4><electronic-resource-num>10.1002/adma.200890033</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>686</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">686</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. H.</author><author>von Maltzahn, G.</author><author>Zhang, L.</author><author>Schwartz, M. P.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA); Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA 02139 (USA); Burnham Institute for Medical Research at UCSB University of California, Santa Barbara 1105 Life Sciences Technology Bldg., Santa Barbara, CA 93106 (USA)</auth-address><titles><title>Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging (Adv. Mater. 9/2008)</title><secondary-title>Advanced Materials</secondary-title></titles><pages>1589</pages><volume>20</volume><number>9</number><edition>2008/05</edition><keywords><keyword>Bionanotechnology</keyword><keyword>Iron oxide</keyword><keyword>Nanoparticles</keyword><keyword>Cells</keyword><keyword>Drug delivery</keyword></keywords><dates><year>2008</year><pub-dates><date>May 5, 2008</date></pub-dates></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200890033</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200890033</url></related-urls></urls><custom1>CNPP - U.C.S.F.</custom1><custom3>2008</custom3><custom4>8.191</custom4><electronic-resource-num>10.1002/adma.200890033</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>685</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">685</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Wang, S. H.</author><author>Swanson, S. D.</author><author>Ge, S.</author><author>Cao, Z.</author><author>Van Antwerp, M. E.</author><author>Landmark, K. J.</author><author>Baker, Jr., J. R.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109 (USA); Department of Radiology, University of Michigan, Ann Arbor, MI 48109 (USA); Department of Physics, University of Michigan, Ann Arbor, MI 48109 (USA)</auth-address><titles><title>Dendrimer-Functionalized Shell-crosslinked Iron Oxide Nanoparticles for In-Vivo Magnetic Resonance Imaging of Tumors</title><secondary-title>Advanced Materials</secondary-title></titles><pages>1671-1678</pages><volume>20</volume><number>9</number><edition>2008/04/11</edition><keywords><keyword>dendrimers</keyword><keyword>functionalization</keyword><keyword>iron oxide</keyword><keyword>magnetic resonance imaging</keyword><keyword>metal nanoparticles</keyword></keywords><dates><year>2008</year></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200702770</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200702770</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>8.191</custom4><electronic-resource-num>10.1002/adma.200702770</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>335</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">335</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Z. L.</author></authors></contributors><auth-address>Wang, ZL&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA</auth-address><titles><title>Nanopiezotronics</title><secondary-title>Advanced Materials</secondary-title></titles><pages>889-892</pages><volume>19</volume><number>6</number><edition>2007/03</edition><keywords><keyword>nanowire</keyword><keyword>arrays</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 19</date></pub-dates></dates><isbn>0935-9648</isbn><accession-num>ISI:000245382100023</accession-num><abstract>This article introduces the fundamental principal nanopiezotronics which utilizes the coupled piezoelectric and semiconducting properties of nanowires and nanobelts for designing and fabricating electronic devices and components, such as field effect transistors and diodes. The physics of nanopiezotronics is based on the principle of a nanowire nanogenerator that converts mechanical energy into electric energy. It is anticipated to have a wide range of applications in electromechanical coupled electronics, sensing, harvesting/recycling energy from the environment, and self-powered nanosystems.</abstract><notes>152SM&#xD;Times Cited:3&#xD;Cited References Count:10</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245382100023</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>8.191</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>269</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">269</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bullitt, E.</author><author>Wolthusen, P. A.</author><author>Brubaker, L.</author><author>Lin, W.</author><author>Zeng, D.</author><author>Van Dyke, T.</author></authors></contributors><auth-address>Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice</title><secondary-title>AJNR Am J Neuroradiol</secondary-title></titles><pages>612-9</pages><volume>27</volume><number>3</number><edition>2006/03/23</edition><keywords><keyword>Animals</keyword><keyword>Animals, Genetically Modified</keyword><keyword>Carcinoma/*blood supply/*diagnosis</keyword><keyword>Choroid Plexus Neoplasms/*blood supply/*diagnosis</keyword><keyword>*Diagnosis, Computer-Assisted</keyword><keyword>*Magnetic Resonance Angiography/methods</keyword><keyword>Mice/genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0195-6108 (Print)</isbn><accession-num>16552004</accession-num><abstract>BACKGROUND AND PURPOSE: The ability to assess tumor malignancy and monitor treatment response noninvasively would be of value to both clinicians and animal investigators. This report describes the MR imaging characteristics of a genetically engineered mouse model of choroid plexus carcinoma (CPC) during tumor growth and progression to malignancy. We assess the ability of vessel tortuosity measurements, as calculated from high-resolution MR angiographic (MRA) images, to detect emerging CPC cancers. METHODS: MR images of 9 healthy mice and of 20 CPC mice with precancerous choroid dysplasia or with cancer over a wide range of sizes were analyzed. Two vessel tortuosity measures and a measure of vessel attenuation (vessel count) were calculated from MRA images. Malignancy assessment was based upon a statistical analysis of vessel tortuosity, by using an equation derived from an earlier study of human brain tumor patients. RESULTS: Choroid dysplasia was correctly judged nonmalignant. On the basis of vessel count, neoangiogenesis could not be detected until cancers were full-blown and had reached a volume of approximately 80 mm3. Vessel tortuosity measurements, however, correctly identified emerging malignancy in lesions larger than 0.3 mm3. CONCLUSION: To the best of our knowledge, this report provides the first description of in vivo, MR imaging characteristics of genetically engineered CPC mice during the progression from dysplasia to cancer. Vessel tortuosity measurements offer promise of correctly defining even tiny tumors as malignant.</abstract><notes>Bullitt, E&#xD;Wolthusen, P A&#xD;Brubaker, L&#xD;Lin, W&#xD;Zeng, D&#xD;Van Dyke, T&#xD;R01 eb000219/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;AJNR. American journal of neuroradiology&#xD;AJNR Am J Neuroradiol. 2006 Mar;27(3):612-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16552004</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>2.279</custom4><electronic-resource-num>27/3/612 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>400</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">400</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Arnold, R. S.</author><author>He, J.</author><author>Remo, A.</author><author>Ritsick, D.</author><author>Yin-Goen, Q.</author><author>Lambeth, J. D.</author><author>Datta, M. W.</author><author>Young, A. N.</author><author>Petros, J. A.</author></authors></contributors><auth-address>Department of Urology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd., Building B, Atlanta, GA 30322, USA.</auth-address><titles><title>Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1</title><secondary-title>Am J Pathol</secondary-title></titles><pages>2021-32</pages><volume>171</volume><number>6</number><edition>2007/12/07</edition><keywords><keyword>Aged</keyword><keyword>Animals</keyword><keyword>Caveolin 1/genetics/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Gene Expression</keyword><keyword>Humans</keyword><keyword>Interleukin-8/genetics/metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>NADH, NADPH Oxidoreductases/antagonists &amp; inhibitors/genetics/*metabolism</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prostate/enzymology/*pathology</keyword><keyword>Prostatic Neoplasms/*enzymology/genetics/*pathology</keyword><keyword>Proto-Oncogene Proteins c-fos/genetics/metabolism</keyword><keyword>RNA, Small Interfering/genetics</keyword><keyword>Reactive Oxygen Species/*metabolism</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0002-9440 (Print)</isbn><accession-num>18055552</accession-num><abstract>Increased cellular reactive oxygen species (ROS) can act as mitogenic signals in addition to damaging DNA and oxidizing lipids and proteins, implicating ROS in cancer development and progression. To analyze the effects of Nox1 expression and its relation to cellular ROS and signal transduction involved in cellular proliferation, Nox1RNAi constructs were transfected into DU145 prostate cancer cells overexpressing Nox1, causing decreased Nox1 message and protein levels in the Nox1RNAi cell lines. Increased ROS and tumor growth in the Nox1-overexpressing DU145 cells were reversed in the presence of the Nox1RNAi. Analysis and comparison of the message levels in the overexpression and RNAi cells demonstrated that Nox1 overexpression leads to changes in message levels of a variety of proteins including c-fos-induced growth factor, interleukin-8, and Cav-1. Finally, we found that Nox1 protein overexpression is an early event in the development of prostate cancer using a National Cancer Institute prostate cancer tissue microarray (CPCTR). Tumor (86%) was significantly more likely to have Nox1 staining than benign prostate tissue (62%) (P = 0.0001). These studies indicate that Nox1 overexpression may function as a reversible signal for cellular proliferation with relevance for a common human tumor.</abstract><notes>Arnold, Rebecca S&#xD;He, Ju&#xD;Remo, Andrea&#xD;Ritsick, Darren&#xD;Yin-Goen, Qiqin&#xD;Lambeth, J David&#xD;Datta, Milton W&#xD;Young, Andrew N&#xD;Petros, John A&#xD;CA098912/CA/United States NCI&#xD;CA96994/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The American journal of pathology&#xD;Am J Pathol. 2007 Dec;171(6):2021-32. Epub 2007 Nov 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18055552</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>5.487</custom4><electronic-resource-num>ajpath.2007.061144 [pii]&#xD;10.2353/ajpath.2007.061144</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>38</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">38</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jarvinen, T. A.</author><author>Ruoslahti, E.</author></authors></contributors><auth-address>Cancer Research Center, Burnham Institute for Medical Research, La Jolla, CA, USA.</auth-address><titles><title>Molecular changes in the vasculature of injured tissues</title><secondary-title>Am J Pathol</secondary-title><alt-title>The American journal of pathology</alt-title></titles><pages>702-11</pages><volume>171</volume><number>2</number><edition>2007/08</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Bacteriophages/genetics</keyword><keyword>CHO Cells</keyword><keyword>Cricetinae</keyword><keyword>Cricetulus</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neovascularization, Pathologic/metabolism/*physiopathology</keyword><keyword>Oligopeptides/genetics/metabolism/*physiology</keyword><keyword>*Peptide Library</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword><keyword>Skin/injuries/metabolism/physiopathology</keyword><keyword>Tendon Injuries/metabolism/physiopathology</keyword><keyword>Transfection/methods</keyword><keyword>Wound Healing/physiology</keyword><keyword>Wounds and Injuries/metabolism/*physiopathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0002-9440 (Print)</isbn><accession-num>17600129</accession-num><abstract>We have explored molecular specialization of the vasculature of regenerating wound tissue in the skin and tendons to identify a different repertoire of markers from that obtained by studying tumor vasculature. We screened a phage-displayed peptide library for peptides that home to wounds in mice and identified two peptides that selectively target phage to skin and tendon wounds: CARSKNKDC (CAR) and CRKDKC (CRK). CAR is homologous to heparin-binding sites in various proteins and binds to cell surface heparan sulfate and heparin. CRK is similar to a segment in thrombospondin type 1 repeat. Intravenously injected CAR and CRK phage, as well as fluorescein-labeled CAR and CRK peptides, selectively accumulated at wound sites, where they partially co-localized with blood vessels. The CAR peptide showed a preference for early stages of wound healing, whereas the CRK favored wounds at later stages of healing. The CAR peptide was internalized into the target cells and delivered the fluorescent label into the cell nuclei. These results identify new molecular markers in wound tissues and show that the expression of these markers in wound vasculature changes as healing progresses. The peptides recognizing these markers may be useful in delivering treatments into regenerating tissues.</abstract><notes>Ca 119335/ca/nci&#xD;Ca 30199/ca/nci&#xD;Ca 82713/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17600129 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>5.487</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>113</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">113</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paner, G. P.</author><author>Srigley, J. R.</author><author>Radhakrishnan, A.</author><author>Cohen, C.</author><author>Skinnider, B. F.</author><author>Tickoo, S. K.</author><author>Young, A. N.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology, Emory University Hospital, 1364 Clifton Road NE, G-167, Atlanta, GA 30322, USA.</auth-address><titles><title>Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution</title><secondary-title>Am J Surg Pathol</secondary-title></titles><pages>13-9</pages><volume>30</volume><number>1</number><edition>2005/12/07</edition><keywords><keyword>Adenocarcinoma, Mucinous/*diagnosis</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Carcinoma/*diagnosis</keyword><keyword>Carcinoma, Papillary/*diagnosis</keyword><keyword>Carcinoma, Renal Cell/*diagnosis</keyword><keyword>Diagnosis, Differential</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Kidney Neoplasms/*diagnosis</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tumor Markers, Biological/*analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0147-5185 (Print)</isbn><accession-num>16330937</accession-num><abstract>Mucinous tubular and spindle cell carcinoma, a rare, recently described distinctive subtype of renal cell carcinoma, may have some morphologic similarities to the more common papillary renal cell carcinoma, particularly the basophilic (type 1) tumors with prominent solid growth pattern. Tumor circumscription, compact tubular architecture, focal papillations, mucin production and foam cells (features seen in both papillary renal cell carcinoma and mucinous tubular and spindle cell carcinoma), as well as spindle cell morphology, have resulted in some cases sent to us in consultation with a question of possible sarcomatoid papillary renal cell carcinoma. In this study, tissue microarrays with triplicate samples each from 27 mucinous tubular and spindle cell carcinomas and 20 papillary renal cell carcinomas were created to simulate experience in renal biopsy specimens. From immunohistochemistry (IHC) data, published in the contemporary literature, a panel consisting of alpha-methylacyl-CoA racemase (AMACR), cytokeratin 7 (CK7), epithelial membrane antigen (EMA), renal cell carcinoma marker (RCC Ma), CD10, high molecular weight cytokeratin (HMWK), and c-kit was designed to test its utility in differential diagnosis. The immunoreactivity in mucinous tubular and spindle cell carcinoma was AMACR 93%, CK7 81%, EMA 95%, RCC Ma 7%, CD10 15%, HMWK 15%, and c-kit 5% and in papillary renal cell carcinoma was AMACR 95%, CK7 65%, EMA 88%, RCC Ma 25%, CD10 80%, HWMK 15%, and c-kit 18%. This largest study to date on IHC of mucinous tubular and spindle cell carcinoma dispels the specificity of AMACR for papillary renal cell carcinoma among the RCC subtypes. The histogenesis of mucinous tubular and spindle cell carcinoma from the distal nephron continues to be debatable, as our study showed the expression of the proximal convoluted tubule-related marker AMACR among these tumors. Thus, in tumors with predominant compact tubular growth and focal papillary architectures, careful attention to the presence of a low-grade spindle cell population may be helpful in the distinction of mucinous tubular and spindle cell carcinoma, as the key immunohistochemical stains for papillary renal cell carcinoma are also expressed in this subtype of renal cell carcinoma.</abstract><notes>Paner, Gladell P&#xD;Srigley, John R&#xD;Radhakrishnan, Anuradha&#xD;Cohen, Cynthia&#xD;Skinnider, Brian F&#xD;Tickoo, Satish K&#xD;Young, Andrew N&#xD;Amin, Mahul B&#xD;Comparative Study&#xD;United States&#xD;The American journal of surgical pathology&#xD;Am J Surg Pathol. 2006 Jan;30(1):13-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16330937</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>4.181</custom4><electronic-resource-num>00000478-200601000-00003 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>114</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">114</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tickoo, S. K.</author><author>dePeralta-Venturina, M. N.</author><author>Harik, L. R.</author><author>Worcester, H. D.</author><author>Salama, M. E.</author><author>Young, A. N.</author><author>Moch, H.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. tickoos@mskcc.org</auth-address><titles><title>Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia</title><secondary-title>Am J Surg Pathol</secondary-title></titles><pages>141-53</pages><volume>30</volume><number>2</number><edition>2006/01/26</edition><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Carcinoma, Renal Cell/*complications/metabolism/*pathology</keyword><keyword>Diagnosis, Differential</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Kidney Failure, Chronic/*complications/metabolism/*pathology</keyword><keyword>Kidney Neoplasms/*complications/metabolism/*pathology</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Tumor Markers, Biological/analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0147-5185 (Print)</isbn><accession-num>16434887</accession-num><abstract>Most (up to 71%) of renal cell neoplasms occurring in patients with end-stage renal disease (ESRD), particularly with acquired cystic disease of the kidney (ACDK), have been reported to be papillary renal cell carcinoma (RCC). Our initial experience with tumors in such a setting indicated that many tumors were histologically difficult to classify into the known subtypes of RCC or had features that were different from those in sporadically occurring RCCs. In this study on 66 ESRD kidneys (52 of which showed features of ACDK) removed because tumors were detected in them, we found two major groups of RCC. Overall, there were 261 grossly identified tumors in these kidneys, and many additional tumors were observed on microscopic evaluation in some. Of the two major groups of RCCs, one consisted of tumors similar to those seen in sporadic settings (ie, clear-cell, papillary, and chromophobe RCC), and these formed the dominant mass in 12 (18%), 10 (15%), and 5 (8%) of the 66 kidneys, respectively. The other group consisted of two subtypes of RCC that appear quite unique to ESRD. The more common tumor that we have designated as &quot;acquired cystic disease-associated RCC&quot; was seen as the dominant mass in 24 (36%) of 66 of the kidneys, and it formed the most common tumor type among the smaller nondominant masses, as well. It was characterized by a typical microcystic architecture, eosinophilic cytoplasm with Fuhrman&apos;s grade 3 nuclei, and frequent association with intratumoral oxalate crystals. Additionally, these tumors frequently, but usually focally, exhibited papillary architecture, and clear cytoplasm. These tumors occurred only in kidneys with ACDK, and not in noncystic ESRD. The other category was &quot;clear-cell papillary RCC of the end-stage kidneys,&quot; present as the dominant mass in 15 (23%) of the 66 kidneys and occurring in both the ACDK and noncystic ESRD. These predominantly cystic tumors showed prominent papillary architecture with purely clear-cell cytology. Immunohistochemical studies in tumors with histology similar to the known subtypes of sporadic RCC showed immunoprofiles similar to that reported in sporadically occurring tumors. The two subtypes of RCC unique to ESRD had distinctive immunoprofiles supporting their separate morphologic subcategorization. Only the acquired cystic disease-associated RCC showed lymph node metastases in 2 cases and sarcomatoid features in 2 more cases. One of the latter 2 died with widespread metastatic disease within 34 months of nephrectomy. Thus, a broad spectrum of renal cell tumors exist in ESRD, only some of which resemble the sporadic RCCs. Acquired cystic disease-associated RCC is the commonest tumor subtype in ESRD, and biologically it appears to be more aggressive than the other tumor subtypes in ESRD.</abstract><notes>Tickoo, Satish K&#xD;dePeralta-Venturina, Mariza N&#xD;Harik, Lara R&#xD;Worcester, Heath D&#xD;Salama, Mohamed E&#xD;Young, Andrew N&#xD;Moch, Holger&#xD;Amin, Mahul B&#xD;United States&#xD;The American journal of surgical pathology&#xD;Am J Surg Pathol. 2006 Feb;30(2):141-53.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16434887</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>4.181</custom4><electronic-resource-num>00000478-200602000-00001 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>484</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">484</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Blair, S. L.</author><author>Wang-Rodriguez, J.</author><author>Cortes-Mateos, M. J.</author><author>Messmer, D.</author><author>Sandoval, S.</author><author>Messmer, B.</author><author>Trogler, W.</author><author>Kummel, A.</author></authors></contributors><auth-address>Department of Surgery and Pathology, University of California San Diego, La Jolla, California 92093-0987, USA. slblair@ucsd.edu</auth-address><titles><title>Enhanced touch preps improve the ease of interpretation of intraoperative breast cancer margins</title><secondary-title>Am Surg</secondary-title></titles><pages>973-6</pages><volume>73</volume><number>10</number><edition>2007/11/07</edition><keywords><keyword>Antibodies, Monoclonal</keyword><keyword>Breast Neoplasms/*surgery</keyword><keyword>Cadherins/analysis</keyword><keyword>Carcinoma in Situ/pathology</keyword><keyword>Carcinoma, Ductal, Breast/*pathology</keyword><keyword>*Cytological Techniques</keyword><keyword>Female</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Intraoperative Period</keyword><keyword>Mastectomy, Segmental/*standards</keyword><keyword>Paraffin Embedding</keyword><keyword>Prospective Studies</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0003-1348 (Print)</isbn><accession-num>17983060</accession-num><abstract>Positive margins and the resulting multiple operations are a major problem for breast conservation therapy. Accurate assessment of intraoperative tumor margins can limit multiple re-excision procedures. Intraoperative touch preparations have been used in the past but can be difficult to interpret without an experienced cytopathologist. The objective of this study is to examine the reliability of enhanced intraoperative touch preps (EIOTP) compared with final pathologic margins. We prospectively performed EIOTP on 20 tumors in women undergoing breast conservation therapy. Six margins and the main tumor were touched onto poly-L-lysine coated slides. The slides were stained with anti MUC1 and anti-E-cadherin antibodies, and Hoechst nuclear stain. A parallel set of slides were stained with hematoxylin and eosin for comparison. The EIOTP results were compared with pathologic interpretation of paraffin embedded permanent sections. A total of 120 margins underwent EIOTP in 20 patients. We found a sensitivity equal to 80 per cent, specificity 100 per cent, positive predictive value 100 per cent, and negative predictive value 99 per cent. EIOTP in conjunction with MUC-1 and E-cadherin by immunofluorescence is a sensitive and highly specific mechanism to identify cancer cells at breast tissue margins. The immunofluorescence stains may help the pathologist to identify cancer cells in fresh breast tissue and limit breast re-excisions in the future.</abstract><notes>Blair, Sarah L&#xD;Wang-Rodriguez, Jessica&#xD;Cortes-Mateos, Maria Jose&#xD;Messmer, Davorka&#xD;Sandoval, Sergio&#xD;Messmer, Bradley&#xD;Trogler, William&#xD;Kummel, Andrew&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The American surgeon&#xD;Am Surg. 2007 Oct;73(10):973-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983060</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>1.261</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>102</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">102</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agrawal, A.</author><author>Zhang, C.</author><author>Byassee, T.</author><author>Tripp, R. A.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle Suite 2001, Atlanta, GA 30322, USA.</auth-address><titles><title>Counting single native biomolecules and intact viruses with color-coded nanoparticles</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>1061-70</pages><volume>78</volume><number>4</number><edition>2006/02/16</edition><keywords><keyword>Base Sequence</keyword><keyword>Binding Sites</keyword><keyword>*Color</keyword><keyword>DNA Probes</keyword><keyword>Fluorescence</keyword><keyword>*Nanoparticles</keyword><keyword>Viruses/*isolation &amp; purification</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>16478096</accession-num><abstract>Nanometer-sized particles such as semiconductor quantum dots and energy-transfer nanoparticles have novel optical properties such as tunable light emission, signal brightness, and multicolor excitation that are not available from traditional organic dyes and fluorescent proteins. Here we report the use of color-coded nanoparticles and dual-color fluorescence coincidence for real-time detection of single native biomolecules and viruses in a microfluidic channel. Using green and red nanoparticles to simultaneously recognize two binding sites on a single target, we demonstrate that individual molecules of genes, proteins, and intact viruses can be detected and identified in complex mixtures without target amplification or probe/target separation. Real-time coincidence analysis of single-photon events allows rapid detection of bound targets and efficient discrimination of excess unbound probes. Quantitative studies indicate that the counting results are remarkably precise when the total numbers of counted molecules are more than 10. The use of bioconjugated nanoparticle probes for single-molecule detection is expected to have important applications in ultrasensitive molecular diagnostics, bioterrorism agent detection, and real-time imaging and tracking of single-molecule processes inside living cells.</abstract><notes>Agrawal, Amit&#xD;Zhang, Chunyang&#xD;Byassee, Tyler&#xD;Tripp, Ralph A&#xD;Nie, Shuming&#xD;P20 gm 072069/gm/nigms&#xD;R01 ca 108468-01/ca/nci&#xD;R01 gm 60562/gm/nigms&#xD;U01 hl 080711/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2006 Feb 15;78(4):1061-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16478096</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac051801t</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>464</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">464</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hill, H. D.</author><author>Vega, R. A.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Nonenzymatic detection of bacterial genomic DNA using the bio bar code assay</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>9218-23</pages><volume>79</volume><number>23</number><edition>2007/10/12</edition><keywords><keyword>*Automatic Data Processing</keyword><keyword>Bacillus subtilis/genetics</keyword><keyword>Base Sequence</keyword><keyword>DNA Probes</keyword><keyword>DNA, Bacterial/*analysis</keyword><keyword>*Genome, Bacterial</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17927207</accession-num><abstract>The detection of bacterial genomic DNA through a nonenzymatic nanomaterials-based amplification method, the bio bar code assay, is reported. The assay utilizes oligonucleotide-functionalized magnetic microparticles to capture the target of interest from the sample. A critical step in the new assay involves the use of blocking oligonucleotides during heat denaturation of the double-stranded DNA. These blockers bind to specific regions of the target DNA upon cooling and prevent the duplex DNA from rehybridizing, which allows the particle probes to bind. Following target isolation using the magnetic particles, oligonucleotide-functionalized gold nanoparticles act as target recognition agents. The oligonucleotides on the nanoparticle (bar codes) act as amplification surrogates. The bar codes are then detected using the Scanometric method. The limit of detection for this assay was determined to be 2.5 fM, and this is the first demonstration of a bar code-type assay for the detection of double-stranded, genomic DNA.</abstract><notes>Hill, Haley D&#xD;Vega, Rafael A&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Dec 1;79(23):9218-23. Epub 2007 Oct 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17927207</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac701626y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>465</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">465</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hurst, S. J.</author><author>Han, M. S.</author><author>Lytton-Jean, A. K.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Screening the sequence selectivity of DNA-binding molecules using a gold nanoparticle-based colorimetric approach</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>7201-5</pages><volume>79</volume><number>18</number><edition>2007/08/19</edition><keywords><keyword>Base Sequence</keyword><keyword>Binding Sites</keyword><keyword>Colorimetry</keyword><keyword>DNA/*analysis/chemistry/metabolism</keyword><keyword>Gold/*chemistry</keyword><keyword>Molecular Sequence Data</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 15</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17696406</accession-num><abstract>We have developed a novel competition assay that uses a gold nanoparticle (Au NP)-based, high-throughput colorimetric approach to screen the sequence selectivity of DNA-binding molecules. This assay hinges on the observation that the melting behavior of DNA-functionalized Au NP aggregates is sensitive to the concentration of the DNA-binding molecule in solution. When short, oligomeric hairpin DNA sequences were added to a reaction solution consisting of DNA-functionalized Au NP aggregates and DNA-binding molecules, these molecules may either bind to the Au NP aggregate interconnects or the hairpin stems based on their relative affinity for each. This relative affinity can be measured as a change in the melting temperature (Tm) of the DNA-modified Au NP aggregates in solution. As a proof of concept, we evaluated the selectivity of 4&apos;,6-diamidino-2-phenylindone (an AT-specific binder), ethidium bromide (a nonspecific binder), and chromomycin A (a GC-specific binder) for six sequences of hairpin DNA having different numbers of AT pairs in a five-base pair variable stem region. Our assay accurately and easily confirmed the known trends in selectivity for the DNA binders in question without the use of complicated instrumentation. This novel assay will be useful in assessing large libraries of potential drug candidates that work by binding DNA to form a drug/DNA complex.</abstract><notes>Hurst, Sarah J&#xD;Han, Min Su&#xD;Lytton-Jean, Abigail K R&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Sep 15;79(18):7201-5. Epub 2007 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17696406</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac071253e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>668</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">668</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, S. J.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Self-sealed vertical polymeric nanoporous-junctions for high-throughput nanofluidic applications</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>3507-11</pages><volume>80</volume><number>9</number><edition>2008/04/03</edition><keywords><keyword>Dimethylpolysiloxanes/*chemistry</keyword><keyword>Fluorocarbon Polymers/chemistry</keyword><keyword>Microfluidic Analytical Techniques/instrumentation/*methods</keyword><keyword>Nanotechnology/instrumentation/*methods</keyword><keyword>Proteins/chemistry</keyword><keyword>Silicones/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18380489</accession-num><abstract>We developed a reliable but simple integration method of polymeric nanostructure in a poly(dimethylsiloxane) (PDMS)-based microfluidic channel, for nanofluidic applications. The Nafion polymer junction was creased by infiltrating polymer solution between the gaps created by mechanical cutting, without any photolithography or etching processes. The PDMS can seal itself with the heterogeneous polymeric nanoporous material between the PDMS/PDMS gap due to its flexibility without any (covalent) bonding between PDMS and the polymer materials. Thus, one can easily integrate the nanoporous-junction into a PDMS microchip in a leak-free manner with excellent repeatability. We demonstrated nanofluidic preconcentration of proteins (beta-phycoerythrin) using the device. Because the polymeric junction spans across the entire microchannel height, the preconcentration was achieved with high-pressure field or even in large channels, with the dimensions of 1000 microm width x 100 microm depth.</abstract><notes>Kim, Sung Jae&#xD;Han, Jongyoon&#xD;CA119402/CA/United States NCI&#xD;EB005743/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 May 1;80(9):3507-11. Epub 2008 Apr 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18380489</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac800157q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>349</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">349</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. H.</author><author>Chung, S.</author><author>Kim, S. J.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Electrical Engineering and Computer Science, and Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139.</auth-address><titles><title>Poly(dimethylsiloxane)-Based Protein Preconcentration Using a Nanogap Generated by Junction Gap Breakdown</title><secondary-title>Anal Chem</secondary-title><alt-title>Analytical chemistry</alt-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>6868-73</pages><volume>79</volume><number>17</number><edition>2007/09</edition><dates><year>2007</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17628080</accession-num><abstract>Simple and efficient sample concentration tools are the key to the application of proteomics in a biological system. In this paper, we developed a method to realize a nanofluidic preconcentrator on a poly(dimethylsiloxane) (PDMS)-based microfluidic channel. The originality of our preconcentration device is the simple nanogap formation using the junction gap breakdown phenomenon between two PDMS microchannels, without using any photolithography and etching techniques. From the dc current measurement, we confirm that the nanogap formed between two microchannel junctions with approximately 80 nm depth. Using this device, we achieve the concentration volume of beta-phycoerythrin protein as high as 70 pL, which is 120-fold larger than that from our previous reports, with a concentration factor as high as 104 within 1 h. Also we show the availability of protein preconcentration under several different buffers (phosphate, acetate) at several different pH values (pH 5 to pH 9).</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17628080 </url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>5.646</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>612</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">612</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, S.</author><author>Szegedi, S.</author><author>Goluch, E.</author><author>Liu, C.</author></authors></contributors><auth-address>Micro and Nanotechnology Laboratory, University of Illinois at Urbana-Champaign 208 North Wright Street, Urbana, Illinois 61801, USA.</auth-address><titles><title>Dip pen nanolithography functionalized electrical gaps for multiplexed DNA detection</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5899-904</pages><volume>80</volume><number>15</number><edition>2008/07/03</edition><dates><year>2008</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18593193</accession-num><abstract>Nanoparticle-based, silver-enhanced DNA electrical detection shows great promise for point-of-care diagnostics. In this paper, we demonstrate that the dip pen nanolithography (DPN) method can be used to precisely functionalize multiple electrical gaps for multiplexed DNA detection. With the use of the DPN technique, capture ssDNAs are written inside 5 microm x 10 microm electrical gaps on substrates. The DPN functionalized electrical gaps can specifically hybridize to target ssDNAs in solution. Successful hybridization of the capture-target DNA complex is detected by the use of gold nanoparticles carrying ssDNA, which also hybridize to the target ssDNA, followed by silver enhancement. The drop of resistance across the gaps due to the formation of metal nanoparticle-DNA complexes is measured over time and compared against characteristics of control gaps, which are either left unfunctionalized or functionalized with noncomplementary capture ssDNA. This technique has potential for high-density multiplexed DNA assay chips. Multiplex detection of two different target ssDNAs in solution using DPN functionalized electrical gaps on the same chip is demonstrated. The lowest detection limit is 10 pM.</abstract><notes>Li, Shifeng&#xD;Szegedi, Sandra&#xD;Goluch, Edgar&#xD;Liu, Chang&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 Aug 1;80(15):5899-904. Epub 2008 Jul 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18593193</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac800445p</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>136</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">136</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lytton-Jean, A. K.</author><author>Han, M. S.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Microarray detection of duplex and triplex DNA binders with DNA-modified gold nanoparticles</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>6037-41</pages><volume>79</volume><number>15</number><edition>2007/07/07</edition><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17614366</accession-num><abstract>We have designed a chip-based assay, using microarray technology, for determining the relative binding affinities of duplex and triplex DNA binders. This assay combines the high discrimination capabilities afforded by DNA-modified Au nanoparticles with the high-throughput capabilities of DNA microarrays. The detection and screening of duplex DNA binders are important because these molecules, in many cases, are potential anticancer agents as well as toxins. Triplex DNA binders are also promising drug candidates. These molecules, in conjunction with triplex-forming oligonucleotides, could potentially be used to achieve control of gene expression by interfering with transcription factors that bind to DNA. Therefore, the ability to screen for these molecules in a high-throughput fashion could dramatically improve the drug screening process. The assay reported here provides excellent discrimination between strong, intermediate, and weak duplex and triplex DNA binders in a high-throughput fashion.</abstract><notes>Lytton-Jean, Abigail K R&#xD;Han, Min Su&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Aug 1;79(15):6037-41. Epub 2007 Jul 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17614366</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac070635h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>104</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">104</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sathe, T. R.</author><author>Agrawal, A.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5627-32</pages><volume>78</volume><number>16</number><edition>2006/08/16</edition><keywords><keyword>Ferric Compounds</keyword><keyword>*Magnetics</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>*Microspheres</keyword><keyword>Porosity</keyword><keyword>*Quantum Dots</keyword><keyword>*Semiconductors</keyword><keyword>Silicon Dioxide</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>16906704</accession-num><abstract>Mesoporous beads are promising materials for embedding functional nanoparticles because of their nanometer-sized pores and large surface areas. Here we report the development of silica microbeads embedded with both semiconductor quantum dots (QD) and iron oxide (Fe3O4) nanocrystals as a new class of dual-function carriers for optical encoding and magnetic separation. The embedding (doping) process is carried out by either simultaneous or sequential addition of quantum dots and iron oxide (Fe3O4) nanocrystals in solution. The doping process is fast and quantitative, but the incorporated iron oxide strongly attenuates the signal intensity of QD fluorescence. We find that this attenuation is not due to conventional fluorescence quenching but is caused by the broad optical absorption spectrum of mixed-valence Fe3O4. For improved biocompatibility and reduced nonspecific binding, the encoded beads are further coated with amphiphilic polymers such as octylamine poly(acrylic acid). The results indicate that the polymer-coated beads are well suited for target capturing and enrichment, yielding magnetic separation efficiencies higher than 99%. By combining the multiplexing capability of QDs with the superparamagnetic properties of iron oxide nanocrystals, this class of encoded beads is expected to find broad applications in high-throughput and multiplexed biomolecular assays.</abstract><notes>Sathe, Tushar R&#xD;Agrawal, Amit&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468-01/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2006 Aug 15;78(16):5627-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16906704</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac0610309</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>40</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">40</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, M. P.</author><author>Alvarez, S. D.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Biochem &amp; Chem, 9500 Gilman Dr,Dept 0358, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Biochem &amp; Chem, La Jolla, CA 92093 USA</auth-address><titles><title>Porous SiO2 interferometric biosensor for quantitative determination of protein interactions: Binding of protein a to immunoglobulins derived from different species</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>327-334</pages><volume>79</volume><number>1</number><edition>2007/01</edition><keywords><keyword>surface-plasmon resonance</keyword><keyword>fourier-transform spectroscopy</keyword><keyword>optical biosensor</keyword><keyword>grating couplers</keyword><keyword>silicon microcavities</keyword><keyword>staphylococcus-aureus</keyword><keyword>ligand-binding</keyword><keyword>mass-transport</keyword><keyword>rate constants</keyword><keyword>acoustic-wave</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 1</date></pub-dates></dates><isbn>0003-2700</isbn><accession-num>ISI:000243143300048</accession-num><abstract>Determination of kinetic and thermodynamic protein binding constants using interferometry from a porous Si Fabry-Perot layer is presented. A protein A capture probe is adsorbed within the pores of an oxidized porous Si matrix, and binding of immunoglobulin G (IgG) antibodies derived from different species is investigated. The relative protein A/IgG binding affinity is human &gt; rabbit &gt; goat, in agreement with literature values. The equilibrium binding constant (K-a) for human IgG binding to surface-immobilized protein A is determined to be (3.0 +/- 0.5) x 10(7) M-1 using an equilibrium Langmuir model. Kinetic rate constants are calculated to be k(d) = (2.1 +/- 0.2) x 10(-4) s(-1) and k(a) = (1.2 +/- 0.4) x 10(4) M-1 s(-1) using nonlinear least-squares analysis, yielding an equilibrium binding constant of K-a = (5.5 +/- 1.5) x 10(7) M-1. Both steady-state and time-dependent measurements yield equilibrium binding constants that are consistent with literature values. Kinetic rate constants determined through nonlinear least-squares analysis are also in agreement with protein A/IgG binding on a surface. Dosing with a high concentration of analyte leads to deviations from ideal binding behavior, interpreted in terms of restricted analyte diffusion within the porous SiO2 matrix. It is shown that the diffusion limitations can be minimized if the kinetic measurements are performed at low analyte concentrations or under conditions in which the protein A capture probe is not saturated with analyte. Potential limitations of the use of porous SiO2 interferometers for quantitative determination of protein binding constants are discussed.</abstract><notes>121FK&#xD;Times Cited:2&#xD;Cited References Count:57</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000243143300048</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>5.646</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>671</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">671</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Son, S.</author><author>Grover, W. H.</author><author>Burg, T. P.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Suspended microchannel resonators for ultralow volume universal detection</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>4757-60</pages><volume>80</volume><number>12</number><edition>2008/05/21</edition><keywords><keyword>Chemistry, Analytical/*instrumentation/*methods</keyword><keyword>Computers</keyword><keyword>Solutions</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18489125</accession-num><abstract>Universal detectors that maintain high sensitivity as the detection volume is reduced to the subnanoliter scale can enhance the utility of miniaturized total analysis systems (mu-TAS). Here the unique scaling properties of the suspended microchannel resonator (SMR) are exploited to show universal detection in a 10 pL analysis volume with a density detection limit of approximately 1 microg/cm (3) (10 Hz bandwidth) and a dynamic range of 6 decades. Analytes with low UV extinction coefficients such as polyethylene glycol (PEG) 8 kDa, glucose, and glycine are measured with molar detection limits of 0.66, 13.5, and 31.6 microM, respectively. To demonstrate the potential for real-time monitoring, gel filtration chromatography was used to separate different molecular weights of PEG as the SMR acquired a chromatogram by measuring the eluate density. This work suggests that the SMR could offer a simple and sensitive universal detector for various separation systems from liquid chromatography to capillary electrophoresis. Moreover, since the SMR is itself a microfluidic channel, it can be directly integrated into mu-TAS without compromising overall performance.</abstract><notes>Son, Sungmin&#xD;Grover, William H&#xD;Burg, Thomas P&#xD;Manalis, Scott R&#xD;EB003403/EB/United States NIBIB&#xD;P50-GM68762/GM/United States NIGMS&#xD;R21 EB003403-02/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 Jun 15;80(12):4757-60. Epub 2008 May 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18489125</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac800307a</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>247</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">247</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sui, G.</author><author>Wang, J.</author><author>Lee, C. C.</author><author>Lu, W.</author><author>Lee, S. P.</author><author>Leyton, J. V.</author><author>Wu, A. M.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging and Department of Molecular &amp; Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, California 90095, USA.</auth-address><titles><title>Solution-phase surface modification in intact poly(dimethylsiloxane) microfluidic channels</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5543-51</pages><volume>78</volume><number>15</number><edition>2006/08/02</edition><keywords><keyword>Amines/chemistry</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line, Tumor</keyword><keyword>DNA/analysis</keyword><keyword>Dimethylpolysiloxanes/*chemistry</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide/*chemistry</keyword><keyword>Immunoassay</keyword><keyword>Microfluidic Analytical Techniques/instrumentation/*methods</keyword><keyword>Molecular Structure</keyword><keyword>Oxidation-Reduction</keyword><keyword>Peptides/analysis</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Proteins/analysis</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Silicones/*chemistry</keyword><keyword>Solutions/chemistry</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>16878894</accession-num><abstract>An improved approach composed of an oxidation reaction in acidic H2O2 solution and a sequential silanization reaction using neat silane reagents for surface modification of poly(dimethylsiloxane) (PDMS) substrates was developed. This solution-phase approach is simple and convenient for some routine analytical applications in chemistry and biology laboratories and is designed for intact PDMS-based microfluidic devices, with no device postassembly required. Using this improved approach, two different functional groups, poly(ethylene glycol) (PEG) and amine (NH2), were introduced onto PDMS surfaces for passivation of nonspecific protein absorption and attachment of biomolecules, respectively. X-ray electron spectroscopy and temporal contact angle experiments were employed to monitor functional group transformation and dynamic characteristics of the PEG-grafted PDMS substrates; fluorescent protein solutions were introduced into the PEG-grafted PDMS microchannels to test their protein repelling characteristics. These analytical data indicate that the PEG-grafted PDMS surfaces exhibit improved short-term surface dynamics and robust long-term stability. The amino-grafted PDMS microchannels are also relatively stable and can be further activated for modifications with peptide, DNA, and protein on the surfaces of microfluidic channels. The resulting biomolecule-grafted PDMS microchannels can be utilized for cell immobilization and incubation, semiquantitative DNA hybridization, and immunoassay.</abstract><notes>Sui, Guodong&#xD;Wang, Jinyi&#xD;Lee, Chung-Cheng&#xD;Lu, Weixing&#xD;Lee, Stephanie P&#xD;Leyton, Jeffrey V&#xD;Wu, Anna M&#xD;Tseng, Hsian-Rong&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2006 Aug 1;78(15):5543-51.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16878894</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac060605z</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>435</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">435</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Taktak, S.</author><author>Sosnovik, D.</author><author>Cima, M. J.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research and Department of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA.</auth-address><titles><title>Multiparameter magnetic relaxation switch assays</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>8863-9</pages><volume>79</volume><number>23</number><edition>2007/11/07</edition><keywords><keyword>Magnetic Resonance Imaging</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>*Magnetics</keyword><keyword>*Nanoparticles</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17983206</accession-num><abstract>Magnetic nanoparticles (NPs) can serve as magnetic relaxation switches (MRSw&apos;s), switching from a dispersed to a clustered state, or the reverse, due to the presence of molecular targets, with changes in the spin-spin relaxation time of water (T2). Biotinylated NP probes reacted with an avidin molecular target to form stable NP clusters, which permitted several NMR parameters to be measured as a function of cluster size. Associated with avidin-induced NP cluster formation was an increase in the spin-spin relation rate (1/T2), while the spin-lattice relaxation rate (1/T1)was unaffected. On the basis of the selective effects of NP cluster formation on T2, we developed a T1/T2 interrogation method where NP probe concentration and avidin analyte were unknown and both were determined. A third NMR parameter examined was the replication of T2 measurements, which were used to rapidly determine whether the ratio of avidin to biotinylated NP was optimal or whether additional biotinylated NP was needed. The T1/T2 and T2 replication interrogation methods illustrate how MRSw assays can employ multiple parameters, instead of relying only on T2, to obtain information about the reaction of NPs with molecular targets.</abstract><notes>Taktak, Sonia&#xD;Sosnovik, David&#xD;Cima, Michael J&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;R01-EB004626/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Dec 1;79(23):8863-9. Epub 2007 Nov 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983206</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac701976p</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>477</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">477</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, X.</author><author>Georganopoulou, D. G.</author><author>Hill, H. D.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Homogeneous detection of nucleic acids based upon the light scattering properties of silver-coated nanoparticle probes</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>6650-4</pages><volume>79</volume><number>17</number><edition>2007/08/01</edition><keywords><keyword>DNA/analysis</keyword><keyword>*Light</keyword><keyword>Metal Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nucleic Acids/*analysis</keyword><keyword>Silver/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17663531</accession-num><abstract>Herein we report the development of a simple, rapid, homogeneous, and sensitive detection system for DNA based on the scattering properties of silver-amplified gold nanoparticle probes. The assay uses DNA-functionalized magnetic particle probes that act as scavengers for target DNA, which can be collected via a magnetic field. Once the DNA targets are isolated from the initial sample, they are sandwiched via hybridization by a second set of probes. The latter probes are 13-nm gold nanoparticles modified with a different target complementary DNA. Excess probes are removed through repetitive washing steps. The gold particles are dispersed in solution by dehybridization, corresponding to an assumed 1:1 ratio with the target DNA. Electroless deposition of silver on the surface of the gold probes results in particle growth, which increases their scattering efficiency with time. The scattering efficiency and the extinction signatures of the particle sizes are monitored as a function of time and correlated with target concentration. The limit of detection for this novel assay was determined to be 10 fM.</abstract><notes>Xu, Xiaoyang&#xD;Georganopoulou, Dimitra G&#xD;Hill, Haley D&#xD;Mirkin, Chad A&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Sep 1;79(17):6650-4. Epub 2007 Jul 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17663531</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac070867g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>660</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">660</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, X.</author><author>Zhao, Z.</author><author>Qin, L.</author><author>Wei, W.</author><author>Levine, J. E.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Fluorescence recovery assay for the detection of protein-DNA binding</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5616-21</pages><volume>80</volume><number>14</number><edition>2008/05/24</edition><dates><year>2008</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18498181</accession-num><abstract>We report a novel and straightforward fluorescence recovery assay which enables the detection of protein-DNA interactions and simultaneously determines relative binding affinities of sequence-specific DNA-binding proteins for a variety of DNA sequences in a multiplexed format. The detection of protein-DNA binding is accomplished by monitoring fluorescence recovery during exonuclease digestion of DNA sequences that are modified with fluorophore-quencher pairs. Retardation of fluorescence recovery occurs with binding of the protein to the putative DNA binding element, which arrests exonuclease digestion. The assay detects protein-DNA binding in a homogeneous solution simply, quickly, and reliably without using radioisotopes. Multiplexing is possible by labeling different DNA sequences with spectrally distinct dyes, allowing simultaneous analysis of experimental and control binding reactions in the same mixture.</abstract><notes>Xu, Xiaoyang&#xD;Zhao, Zhen&#xD;Qin, Lidong&#xD;Wei, Wei&#xD;Levine, Jon E&#xD;Mirkin, Chad A&#xD;R01 HD20677/HD/United States NICHD&#xD;U54 HD041859/HD/United States NICHD&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 Jul 15;80(14):5616-21. Epub 2008 May 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18498181</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.646</custom4><electronic-resource-num>10.1021/ac8007016</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>373</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">373</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Bi, X.</author><author>Ganser, T. R.</author><author>Hong, S.</author><author>Myc, L. A.</author><author>Desai, A.</author><author>Holl, M. M.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA.</auth-address><titles><title>HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein</title><secondary-title>Analyst</secondary-title><alt-title>The Analyst</alt-title></titles><pages>842-8</pages><volume>131</volume><number>7</number><edition>2006/06</edition><keywords><keyword>Biocompatible Materials/analysis/chemistry</keyword><keyword>Carrier Proteins/*chemistry</keyword><keyword>Chromatography, Gel/methods</keyword><keyword>Chromatography, High Pressure Liquid/methods</keyword><keyword>Electrophoresis, Polyacrylamide Gel/methods</keyword><keyword>Polyamines/*analysis/chemistry</keyword><keyword>Receptors, Cell Surface/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0003-2654 (Print)</isbn><accession-num>16802031</accession-num><abstract>Poly(amidoamine) (PAMAM) dendrimers of different generations with carboxyl, acetyl, and hydroxyl terminal groups and a folic acid (FA)-dendrimer conjugate were separated and analyzed using reverse-phase high performance liquid chromatography (HPLC). Analysis of both the individual PAMAM derivatives and the separation of mixed generations can be achieved using a linear gradient 0-50% acetonitrile (ACN) (balance water) within 40 min. We also show that PAMAMs with defined acetylation and carboxylation degrees can be analyzed using HPLC. Furthermore, a generation 5 dendrimer-FA conjugate (G5.75Ac-FA4; Ac denotes acetyl) was analyzed and its specific binding with a bovine folic acid binding protein (FBP) was monitored. The HPLC and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) results indicate the formation of three complexes after the binding of G5.75Ac-FA4 with FBP. Dendrimers with FA moieties show much higher specific binding capability with FBP than those without FA moieties. Findings from this study indicate that HPLC is an effective technique not only for characterization and separation of functionalized PAMAM dendrimers and conjugates but also for investigation of the interaction between dendrimers and biomolecules.</abstract><notes>N01-co-97111/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16802031 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2006</custom3><custom4>3.198</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>688</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">688</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, J.</author><author>Gunn, J.</author><author>Dave, S. R.</author><author>Zhang, M.</author><author>Wang, Y. A.</author><author>Gao, X.</author></authors></contributors><auth-address>Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>Ultrasensitive detection and molecular imaging with magnetic nanoparticles</title><secondary-title>Analyst</secondary-title></titles><pages>154-60</pages><volume>133</volume><number>2</number><edition>2008/01/30</edition><keywords><keyword>*Contrast Media</keyword><keyword>*Ferric Compounds</keyword><keyword>Forecasting</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Nanocomposites</keyword><keyword>Nanotechnology</keyword><keyword>Research Design</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0003-2654 (Print)</isbn><accession-num>18227935</accession-num><abstract>Recent advances in nanotechnology have produced a variety of nanoparticles ranging from semiconductor quantum dots (QDs), magnetic nanoparticles (MNPs), metallic nanoparticles, to polymeric nanoparticles. Their unique electronic, magnetic, and optical properties have enabled a broad spectrum of biomedical applications such as ultrasensitive detection, medical imaging, and specific therapeutics. MNPs made from iron oxide, in particular, have attracted extensive interest and have already been used in clinical studies owing to their capability of deep-tissue imaging, non-immunogenesis, and low toxicity. In this Research Highlight article, we attempt to highlight the recent breakthroughs in MNP synthesis based on a non-hydrolytic approach, nanoparticle (NP) surface engineering, their unique structural and magnetic properties, and current applications in ultrasensitive detection and imaging with a special focus on innovative bioassays. We will also discuss our perspectives on future research directions.</abstract><notes>Yang, Jian&#xD;Gunn, Jonathan&#xD;Dave, Shivang R&#xD;Zhang, Miqin&#xD;Wang, Y Andrew&#xD;Gao, Xiaohu&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;The Analyst&#xD;Analyst. 2008 Feb;133(2):154-60. Epub 2007 Sep 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18227935</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2008</custom3><custom4>3.198</custom4><electronic-resource-num>10.1039/b700091j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>86</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">86</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bagalkot, V.</author><author>Farokhzad, O. C.</author><author>Langer, R.</author><author>Jon, S.</author></authors></contributors><auth-address>Department of Life Science, Gwangju Institute of Science and Technology, 1 Oryoung-dong, Buk-gu, Gwangju 500712, South Korea.</auth-address><titles><title>An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>8149-52</pages><volume>45</volume><number>48</number><edition>2006/11/14</edition><keywords><keyword>Antineoplastic Agents/administration &amp; dosage/chemistry</keyword><keyword>Aptamers, Nucleotide/administration &amp; dosage/*chemistry</keyword><keyword>Doxorubicin/*administration &amp; dosage/*chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Leukemia, Plasmacytic/metabolism</keyword><keyword>Microscopy, Confocal</keyword><keyword>Molecular Structure</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17099918</accession-num><notes>Bagalkot, Vaishali&#xD;Farokhzad, Omid C&#xD;Langer, Robert&#xD;Jon, Sangyong&#xD;Eb003647/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8149-52.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17099918</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200602251</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>491</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">491</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barrett, D. G.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and The Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Rapid patterning of cells and cell co-cultures on surfaces with spatial and temporal control through centrifugation</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>7437-9</pages><volume>46</volume><number>39</number><edition>2007/08/21</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Separation/*methods</keyword><keyword>Centrifugation/*methods</keyword><keyword>Coculture Techniques</keyword><keyword>Drosophila melanogaster</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17705322</accession-num><notes>Barrett, Devin G&#xD;Yousaf, Muhammad N&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(39):7437-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17705322</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200701841</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>572</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">572</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Park, S.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and The Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>An electroactive catalytic dynamic substrate that immobilizes and releases patterned ligands, proteins, and cells</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>6267-71</pages><volume>47</volume><number>33</number><edition>2008/06/21</edition><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>18567039</accession-num><notes>Chan, Eugene W L&#xD;Park, Sungjin&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(33):6267-71.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18567039</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>10.031</custom4><electronic-resource-num>10.1002/anie.200800166</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>76</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">76</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Surface-chemistry control to silence gene expression in Drosophila Schneider 2 cells through RNA interference</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>3881-4</pages><volume>46</volume><number>21</number><edition>2007/04/07</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Drosophila/*cytology/*genetics</keyword><keyword>*Gene Expression Regulation</keyword><keyword>*Gene Silencing</keyword><keyword>Gold/chemistry</keyword><keyword>*RNA Interference</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17415732</accession-num><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(21):3881-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17415732</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200604079</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>129</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">129</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Han, M. S.</author><author>Lytton-Jean, A. K.</author><author>Oh, B. K.</author><author>Heo, J.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Evanston, IL, 60208-3113, USA.</auth-address><titles><title>Colorimetric screening of DNA-binding molecules with gold nanoparticle probes</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>1807-10</pages><volume>45</volume><number>11</number><edition>2006/02/17</edition><keywords><keyword>Colorimetry</keyword><keyword>DNA/chemistry/*metabolism</keyword><keyword>Gold/*chemistry/metabolism</keyword><keyword>Models, Biological</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>Oligonucleotide Probes/*chemistry</keyword><keyword>Thionucleotides/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar 3</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16482507</accession-num><notes>Han, Min Su&#xD;Lytton-Jean, Abigail K R&#xD;Oh, Byung-Keun&#xD;Heo, Jungseok&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Mar 3;45(11):1807-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16482507</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200504277</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>22</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">22</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harris, T. J.</author><author>von Maltzahn, G.</author><author>Derfus, A. M.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Proteolytic actuation of nanoparticle self-assembly</title><secondary-title>Angew Chem Int Ed Engl</secondary-title><alt-title>Angewandte Chemie (International ed</alt-title></titles><pages>3161-5</pages><volume>45</volume><number>19</number><edition>2006/05</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Humans</keyword><keyword>Magnetics</keyword><keyword>Matrix Metalloproteinase 2/*antagonists &amp; inhibitors/metabolism</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>*Nanotechnology</keyword><keyword>Particle Size</keyword><keyword>Polyethylene Glycols/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>May 5</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16642514</accession-num><notes>Eb 006324/eb/nibib&#xD;N01-co37117/co/nci&#xD;U54 ca119335/ca/nci&#xD;U54 ca119349/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16642514 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2006</custom3><custom4>10.232</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>316</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">316</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hurst, S. J.</author><author>Payne, E. K.</author><author>Qin, L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Multisegmented one-dimensional nanorods prepared by hard-template synthetic methods</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>2672-92</pages><volume>45</volume><number>17</number><edition>2006/03/30</edition><keywords><keyword>Electrochemistry</keyword><keyword>Electrons</keyword><keyword>Metals/chemistry</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 21</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16570332</accession-num><abstract>In the science and engineering communities, the nanoscience revolution is intensifying. As many types of nanomaterials are becoming more reliably synthesized, they are being used for novel applications in all branches of nanoscience and nanotechnology. Since it is sometimes desirable for single nanomaterials to perform multiple functions simultaneously, multicomponent nanomaterials, such as core-shell, alloyed, and striped nanoparticles, are being more extensively researched. Nanoscientists hope to design multicomponent nanostructures and exploit their inherent multiple functionalities for use in many novel applications. This review highlights recent advances in the synthesis of multisegmented one-dimensional nanorods and nanowires with metal, semiconductor, polymer, molecular, and even gapped components. It also discusses the applications of these multicomponent nanomaterials in magnetism, self-assembly, electronics, biology, catalysis, and optics. Particular emphasis is placed on the new materials and devices achievable using these multicomponent, rather than single-component, nanowire structures.</abstract><notes>Hurst, Sarah J&#xD;Payne, Emma Kathryn&#xD;Qin, Lidong&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Apr 21;45(17):2672-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16570332</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200504025</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>603</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">603</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koh, I.</author><author>Hong, R.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Boston, MA 02129, USA.</auth-address><titles><title>Sensitive NMR sensors detect antibodies to influenza</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>4119-21</pages><volume>47</volume><number>22</number><edition>2008/04/23</edition><keywords><keyword>Antibodies, Viral/*analysis/chemistry</keyword><keyword>Antigen-Antibody Reactions</keyword><keyword>Hemagglutinin Glycoproteins, Influenza Virus/immunology</keyword><keyword>Humans</keyword><keyword>*Magnetics</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Nuclear Magnetic Resonance, Biomolecular/*methods</keyword><keyword>Oligopeptides/immunology</keyword><keyword>Orthomyxoviridae/*immunology</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>18428168</accession-num><notes>Koh, Isaac&#xD;Hong, Rui&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;R01EB0004626/EB/United States NIBIB&#xD;U54A119349/United States PHS&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(22):4119-21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18428168</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200800069</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>320</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">320</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. H.</author><author>Jun, Y. W.</author><author>Yeon, S. I.</author><author>Shin, J. S.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Chemistry, Yonsei University, Seoul 120-749, Korea.</auth-address><titles><title>Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>8160-2</pages><volume>45</volume><number>48</number><edition>2006/11/15</edition><keywords><keyword>Cell Line</keyword><keyword>Fluorescent Dyes/*analysis/chemistry</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Nanoparticles/*analysis/chemistry</keyword><keyword>Nanotechnology</keyword><keyword>Neuroblastoma/*diagnosis</keyword><keyword>Silicon Dioxide/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17103471</accession-num><notes>Lee, Jae-Hyun&#xD;Jun, Young-Wook&#xD;Yeon, Soo-In&#xD;Shin, Jeon-Soo&#xD;Cheon, Jinwoo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8160-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17103471</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200603052</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>222</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">222</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Winters, M.</author><author>Holodniy, M.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>siRNA delivery into human T cells and primary cells with carbon-nanotube transporters</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>2023-7</pages><volume>46</volume><number>12</number><edition>2007/02/10</edition><keywords><keyword>Antigens, CD4/metabolism</keyword><keyword>*Biosensing Techniques</keyword><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Leukemia, T-Cell, Acute/genetics</keyword><keyword>Nanotubes, Carbon/*chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage/pharmacology</keyword><keyword>Receptors, CCR5/metabolism</keyword><keyword>Receptors, CXCR4/*antagonists &amp; inhibitors/genetics/metabolism</keyword><keyword>T-Lymphocytes/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17290476</accession-num><notes>Liu, Zhuang&#xD;Winters, Mark&#xD;Holodniy, Mark&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(12):2023-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17290476</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200604295</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>72</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">72</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Kim, J. S.</author><author>Taylor, K. M.</author><author>An, H.</author><author>Lin, W.</author><author>Tarrant, T.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Hybrid silica nanoparticles for multimodal imaging</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>3680-2</pages><volume>46</volume><number>20</number><edition>2007/04/07</edition><keywords><keyword>Gadolinium/chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry</keyword><keyword>Particle Size</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Silicon Dioxide/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17415734</accession-num><notes>Rieter, William J&#xD;Kim, Jason S&#xD;Taylor, Kathryn M L&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Tarrant, Teresa&#xD;Lin, Wenbin&#xD;P20 rr020764/rr/ncrr&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(20):3680-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17415734</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200604738</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>642</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">642</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tong, R.</author><author>Cheng, J.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.</auth-address><titles><title>Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>4830-4</pages><volume>47</volume><number>26</number><edition>2008/05/21</edition><keywords><keyword>Antineoplastic Agents, Phytogenic/chemistry</keyword><keyword>Drug Carriers/*chemical synthesis</keyword><keyword>Models, Chemical</keyword><keyword>Molecular Structure</keyword><keyword>*Nanoparticles</keyword><keyword>Paclitaxel/*chemistry</keyword><keyword>Polyesters/*chemistry</keyword><keyword>Polymers/*chemistry</keyword></keywords><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>18491339</accession-num><notes>Tong, Rong&#xD;Cheng, Jianjun&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(26):4830-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18491339</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>10.031</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200800491</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>249</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">249</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, J.</author><author>Sui, G.</author><author>Mocharla, V. P.</author><author>Lin, R. J.</author><author>Phelps, M. E.</author><author>Kolb, H. C.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Integrated microfluidics for parallel screening of an in situ click chemistry library</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>5276-81</pages><volume>45</volume><number>32</number><edition>2006/08/24</edition><keywords><keyword>Combinatorial Chemistry Techniques/*instrumentation/*methods</keyword><keyword>Ligands</keyword><keyword>Microfluidics/*instrumentation</keyword><keyword>Molecular Structure</keyword><keyword>Proteins/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 11</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16927322</accession-num><notes>Wang, Jinyi&#xD;Sui, Guodong&#xD;Mocharla, Vani P&#xD;Lin, Rachel J&#xD;Phelps, Michael E&#xD;Kolb, Hartmuth C&#xD;Tseng, Hsian-Rong&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Aug 11;45(32):5276-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16927322</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200601677</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>132</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">132</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, X.</author><author>Han, M. S.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>A gold-nanoparticle-based real-time colorimetric screening method for endonuclease activity and inhibition</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>3468-70</pages><volume>46</volume><number>19</number><edition>2007/03/28</edition><keywords><keyword>Base Sequence</keyword><keyword>*Biosensing Techniques</keyword><keyword>Endonucleases/*analysis/antagonists &amp; inhibitors/metabolism</keyword><keyword>Gold/*chemistry/diagnostic use</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligonucleotide Probes/*chemistry</keyword><keyword>Spectrophotometry, Ultraviolet</keyword></keywords><dates><year>2007</year></dates><isbn>1433-7851 (Print)</isbn><accession-num>17385814</accession-num><notes>Xu, Xiaoyang&#xD;Han, Min Su&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(19):3468-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17385814</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200605249</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>238</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">238</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yao, H.</author><author>Zhang, Y.</author><author>Xiao, F.</author><author>Xia, Z.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Biophysics, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Quantum dot/bioluminescence resonance energy transfer based highly sensitive detection of proteases</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>4346-9</pages><volume>46</volume><number>23</number><edition>2007/05/01</edition><keywords><keyword>Enzyme Activation</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>Luminescent Measurements/*methods</keyword><keyword>Matrix Metalloproteinases/*analysis/*chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2007</year></dates><isbn>1433-7851 (Print)</isbn><accession-num>17465433</accession-num><notes>Yao, Hequan&#xD;Zhang, Yan&#xD;Xiao, Fei&#xD;Xia, Zuyong&#xD;Rao, Jianghong&#xD;1u54ai19367-01/ai/niaid&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(23):4346-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17465433</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200700280</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>240</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">240</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, Y.</author><author>So, M. K.</author><author>Loening, A. M.</author><author>Yao, H.</author><author>Gambhir, S. S.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>HaloTag protein-mediated site-specific conjugation of bioluminescent proteins to quantum dots</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><pages>4936-40</pages><volume>45</volume><number>30</number><edition>2006/06/30</edition><keywords><keyword>Hydrolases/*chemistry/genetics/metabolism</keyword><keyword>Kinetics</keyword><keyword>Luciferases, Renilla/*chemistry/genetics/metabolism</keyword><keyword>Luminescent Measurements</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Nanotechnology</keyword><keyword>*Protein Engineering</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 24</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16807952</accession-num><notes>Zhang, Yan&#xD;So, Min-Kyung&#xD;Loening, Andreas M&#xD;Yao, Hequan&#xD;Gambhir, Sanjiv S&#xD;Rao, Jianghong&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Jul 24;45(30):4936-40.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16807952</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200601197</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>106</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">106</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Ruan, G.</author><author>Rhyner, M. N.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Engineering luminescent quantum dots for in vivo molecular and cellular imaging</title><secondary-title>Ann Biomed Eng</secondary-title></titles><pages>3-14</pages><volume>34</volume><number>1</number><edition>2006/02/02</edition><keywords><keyword>Animals</keyword><keyword>Fluorescence Resonance Energy Transfer/methods</keyword><keyword>Humans</keyword><keyword>Luminescent Agents/*chemistry/classification/pharmacology</keyword><keyword>Luminescent Measurements</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Molecular Probes/*chemistry/classification/pharmacology</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0090-6964 (Print)</isbn><accession-num>16450199</accession-num><abstract>Semiconductor quantum dots are luminescent nanoparticles that are under intensive development for use as a new class of optical imaging contrast agents. Their novel properties such as optical tunability, improved photostability, and multicolor light emission have opened new opportunities for imaging living cells and in vivo animal models at unprecedented sensitivity and spatial resolution. Combined with biomolecular engineering strategies for tailoring the particle surfaces at the molecular level, bio-conjugated quantum dot probes are well suited for imaging single-molecule dynamics in living cells, for monitoring protein-protein interactions within specific intracellular locations, and for detecting diseased sites and organs in deep tissue. In this article, we describe the engineering principles for preparing high-quality quantum dots and for conjugating the dots to biomolecular ligands. We also discuss recent advances in using quantum dots for in vivo molecular and cellular imaging.</abstract><notes>Smith, Andrew M&#xD;Ruan, Gang&#xD;Rhyner, Matthew N&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468/ca/nci&#xD;R01 gm058173/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Annals of biomedical engineering&#xD;Ann Biomed Eng. 2006 Jan;34(1):3-14. Epub 2006 Feb 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16450199</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.346</custom4><electronic-resource-num>10.1007/s10439-005-9000-9</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>125</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">125</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stokes, T. H.</author><author>Moffitt, R. A.</author><author>Phan, J. H.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Department of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0535, USA.</auth-address><titles><title>chip artifact CORRECTion (caCORRECT): a bioinformatics system for quality assurance of genomics and proteomics array data</title><secondary-title>Ann Biomed Eng</secondary-title></titles><pages>1068-80</pages><volume>35</volume><number>6</number><edition>2007/04/27</edition><keywords><keyword>*Algorithms</keyword><keyword>*Artifacts</keyword><keyword>Computational Biology/*methods</keyword><keyword>Genomics/*methods</keyword><keyword>Oligonucleotide Array Sequence Analysis/*methods</keyword><keyword>Quality Control</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>*Software</keyword><keyword>Software Design</keyword><keyword>*User-Computer Interface</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0090-6964 (Print)</isbn><accession-num>17458699</accession-num><abstract>Quality assurance of high throughput &quot;-omics&quot; data is a major concern for biomedical discovery and translational medicine, and is considered a top priority in bioinformatics and systems biology. Here, we report a web-based bioinformatics tool called caCORRECT for chip artifact detection, analysis, and CORRECTion, which removes systematic artifactual noises that are commonly observed in microarray gene expression data. Despite the development of major databases such as GEO arrayExpress, caArray, and the SMD to manage and distribute microarray data to the public, reproducibility has been questioned in many cases, including high-profile papers and datasets. Based on both archived and synthetic data, we have designed the caCORRECT to have several advanced features: (1) to uncover significant, correctable artifacts that affect reproducibility of experiments; (2) to improve the integrity and quality of public archives by removing artifacts; (3) to provide a universal quality score to aid users in their selection of suitable microarray data; and (4) to improve the true-positive rate of biomarker selection verified by test data. These features are expected to improve the reproducibility of Microarray study. caCORRECT is freely available at: http://caCORRECT.bme.gatech.edu.</abstract><notes>Stokes, Todd H&#xD;Moffitt, Richard A&#xD;Phan, John H&#xD;Wang, May D&#xD;P20gm072069/gm/nigms&#xD;R01ca108468/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Annals of biomedical engineering&#xD;Ann Biomed Eng. 2007 Jun;35(6):1068-80. Epub 2007 Apr 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17458699</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>2.346</custom4><electronic-resource-num>10.1007/s10439-007-9313-y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>283</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">283</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Juliano, R. L.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. arjay@med.unc.edu</auth-address><titles><title>Intracellular delivery of oligonucleotide conjugates and dendrimer complexes</title><secondary-title>Ann N Y Acad Sci</secondary-title></titles><pages>18-26</pages><volume>1082</volume><edition>2006/12/06</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Dendrimers/*pharmacokinetics/therapeutic use</keyword><keyword>Drug Carriers/*chemistry/pharmacokinetics</keyword><keyword>Gene Expression Regulation/drug effects</keyword><keyword>Humans</keyword><keyword>Macromolecular Substances/chemistry/pharmacokinetics/therapeutic use</keyword><keyword>Oligonucleotides/*administration &amp; dosage</keyword><keyword>Oligonucleotides, Antisense/administration &amp; dosage</keyword><keyword>Particle Size</keyword><keyword>Peptides/*pharmacokinetics/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0077-8923 (Print)</isbn><accession-num>17145920</accession-num><abstract>Enhancing the delivery of antisense and siRNA molecules to cells and tissues is a key issue for oligonucleotide therapeutics. Cell-penetrating peptides (CPPs) have the ability to convey linked &quot;cargo&quot; molecules into the cytosol; thus we have explored the use of CPPs as delivery agents for oligonucleotides. We have extensively evaluated CPP-oligonucleotide conjugates, and have recently begun to explore the use of CPP-dendrimer-oligonucleotide complexes. We have found that CPP-antisense oligonucleotide conjugates can be taken up by cells and can effectively modify gene expression in cell culture and in tissues. Although not as potent in cell culture as cationic lipid delivery agents, CPP-oligonucleotide conjugates offer the advantage of being molecules rather than particles, and may have substantial advantages over particle-based delivery in the in vivo setting.</abstract><notes>Juliano, R L&#xD;United States&#xD;Annals of the New York Academy of Sciences&#xD;Ann N Y Acad Sci. 2006 Oct;1082:18-26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17145920</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>1.93</custom4><electronic-resource-num>1082/1/18 [pii]&#xD;10.1196/annals.1348.011</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>174</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">174</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lanza, G.</author><author>Winter, P.</author><author>Cyrus, T.</author><author>Caruthers, S.</author><author>Marsh, J.</author><author>Hughes, M.</author><author>Wickline, S.</author></authors></contributors><auth-address>Med and Biomed Engineering, School of Medicine, Washington University St. Louis, 4003 Kingshighway Bldg., St. Louis, MO 63130, USA. greg@cvu.wustl.edu</auth-address><titles><title>Nanomedicine opportunities in cardiology</title><secondary-title>Ann N Y Acad Sci</secondary-title></titles><pages>451-65</pages><volume>1080</volume><edition>2006/11/30</edition><keywords><keyword>*Cardiology</keyword><keyword>Fluorocarbons</keyword><keyword>Humans</keyword><keyword>*Nanomedicine</keyword><keyword>Nanoparticles</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0077-8923 (Print)</isbn><accession-num>17132801</accession-num><abstract>Despite myriad advances, cardiovascular-related diseases continue to remain our greatest health problem. In more than half of patients with atherosclerotic disease, their first presentation to medical attention becomes their last. Patients often survive their first cardiac event through acute revascularization and placement of drug-eluting stents (DES), but only select coronary lesions are amenable to DES placement, resulting in the use of bare metal or no stent, both of which lack the benefit of antirestenotic therapy. In other patients, transient ischemic attacks (TIAs) and stroke constitute the initial presentation of disease. In these patients, the diagnostic and therapeutic options are woefully inadequate. Nanomedicine offers options to each of these challenges. Antiangiogenic paramagnetic nanoparticles may be used to serially assess the severity of atherosclerotic disease in asymptomatic, high-risk patients by detecting the development of plaque neovasculature, which reflects the underlying lesion activity and vulnerability to rupture. The nanoparticles can locally deliver antiangiogenic therapy, which may acutely retard plaque progression, allowing aggressive statin therapy to become effective. Moreover, these agents may be useful as a quantitative marker to guide atherosclerotic management in an asymptomatic patient. In those cases proceeding to the catheterization laboratory for revascularization, nanoparticles incorporating antirestenotic drugs can be delivered directly into the wall of lesions not amenable to DES placement. Targeted nanoparticles could help ensure that antirestenotic drugs are available for all lesions. Moreover, displacement of antiproliferative agents from the intimal surface into the vascular wall is likely to improve rehealing of the endothelium, improving postprocedural management of these patients.</abstract><notes>Lanza, Gregory&#xD;Winter, Patrick&#xD;Cyrus, Tillmann&#xD;Caruthers, Shelton&#xD;Marsh, Jon&#xD;Hughes, Michael&#xD;Wickline, Samuel&#xD;Eb 01704/eb/nibib&#xD;Hl 42950/hl/nhlbi&#xD;Hl 59865/hl/nhlbi&#xD;Hl 78631/hl/nhlbi&#xD;N01 co 37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Annals of the New York Academy of Sciences&#xD;Ann N Y Acad Sci. 2006 Oct;1080:451-65.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17132801</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>1.93</custom4><electronic-resource-num>1080/1/451 [pii]&#xD;10.1196/annals.1380.034</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>118</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">118</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nie, S.</author><author>Xing, Y.</author><author>Kim, G. J.</author><author>Simons, J. W.</author></authors></contributors><auth-address>Department of Biomedical Engineering and the Winship Cancer Institute, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30322, USA. snie@emory.edu</auth-address><titles><title>Nanotechnology applications in cancer</title><secondary-title>Annu Rev Biomed Eng</secondary-title></titles><pages>257-88</pages><volume>9</volume><edition>2007/04/19</edition><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1523-9829 (Print)</isbn><accession-num>17439359</accession-num><abstract>Cancer nanotechnology is an interdisciplinary area of research in science, engineering, and medicine with broad applications for molecular imaging, molecular diagnosis, and targeted therapy. The basic rationale is that nanometer-sized particles, such as semiconductor quantum dots and iron oxide nanocrystals, have optical, magnetic, or structural properties that are not available from molecules or bulk solids. When linked with tumor targeting ligands such as monoclonal antibodies, peptides, or small molecules, these nanoparticles can be used to target tumor antigens (biomarkers) as well as tumor vasculatures with high affinity and specificity. In the mesoscopic size range of 5-100 nm diameter, nanoparticles also have large surface areas and functional groups for conjugating to multiple diagnostic (e.g., optical, radioisotopic, or magnetic) and therapeutic (e.g., anticancer) agents. Recent advances have led to bioaffinity nanoparticle probes for molecular and cellular imaging, targeted nanoparticle drugs for cancer therapy, and integrated nanodevices for early cancer detection and screening. These developments raise exciting opportunities for personalized oncology in which genetic and protein biomarkers are used to diagnose and treat cancer based on the molecular profiles of individual patients.</abstract><notes>Nie, Shuming&#xD;Xing, Yun&#xD;Kim, Gloria J&#xD;Simons, Jonathan W&#xD;P20gm072069/gm/nigms&#xD;R01 ca108468-01/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Annual review of biomedical engineering&#xD;Annu Rev Biomed Eng. 2007;9:257-88.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17439359</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>10.533</custom4><electronic-resource-num>10.1146/annurev.bioeng.9.060906.152025</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>450</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">450</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Heath, J. R.</author><author>Davis, M. E.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA. heath@caltech.edu</auth-address><titles><title>Nanotechnology and cancer</title><secondary-title>Annu Rev Med</secondary-title></titles><pages>251-65</pages><volume>59</volume><edition>2007/10/17</edition><keywords><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Nanoparticles</keyword><keyword>*Nanotechnology</keyword><keyword>Neoplasms/*diagnosis/*therapy</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0066-4219 (Print)</isbn><accession-num>17937588</accession-num><abstract>The biological picture of cancer is rapidly advancing from models built from phenomenological descriptions to network models derived from systems biology, which can capture the evolving pathophysiology of the disease at the molecular level. The translation of this (still academic) picture into a clinically relevant framework can be enabling for the war on cancer, but it is a scientific and technological challenge. In this review, we discuss emerging in vitro diagnostic technologies and therapeutic approaches that are being developed to handle this challenge. Our discussion of in vitro diagnostics is guided by the theme of making large numbers of measurements accurately, sensitively, and at very low cost. We discuss diagnostic approaches based on microfluidics and nanotechnology. We then review the current state of the art of nanoparticle-based therapeutics that have reached the clinic. The goal of the presentation is to identify nanotherapeutic strategies that are designed to increase efficacy while simultaneously minimizing the toxic side effects commonly associated with cancer chemotherapies.</abstract><notes>Heath, James R&#xD;Davis, Mark E&#xD;Review&#xD;United States&#xD;Annual review of medicine&#xD;Annu Rev Med. 2008;59:251-65.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17937588</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>13.415</custom4><electronic-resource-num>10.1146/annurev.med.59.061506.185523</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>134</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">134</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Willets, K. A.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208-3113, USA. kallie@northwestern.edu</auth-address><titles><title>Localized surface plasmon resonance spectroscopy and sensing</title><secondary-title>Annu Rev Phys Chem</secondary-title></titles><pages>267-97</pages><volume>58</volume><edition>2006/10/28</edition><keywords><keyword>Nanostructures/chemistry/ultrastructure</keyword><keyword>Spectrum Analysis</keyword><keyword>Surface Plasmon Resonance/*instrumentation/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0066-426X (Print)</isbn><accession-num>17067281</accession-num><abstract>Localized surface plasmon resonance (LSPR) spectroscopy of metallic nanoparticles is a powerful technique for chemical and biological sensing experiments. Moreover, the LSPR is responsible for the electromagnetic-field enhancement that leads to surface-enhanced Raman scattering (SERS) and other surface-enhanced spectroscopic processes. This review describes recent fundamental spectroscopic studies that reveal key relationships governing the LSPR spectral location and its sensitivity to the local environment, including nanoparticle shape and size. We also describe studies on the distance dependence of the enhanced electromagnetic field and the relationship between the plasmon resonance and the Raman excitation energy. Lastly, we introduce a new form of LSPR spectroscopy, involving the coupling between nanoparticle plasmon resonances and adsorbate molecular resonances. The results from these fundamental studies guide the design of new sensing experiments, illustrated through applications in which researchers use both LSPR wavelength-shift sensing and SERS to detect molecules of chemical and biological relevance.</abstract><notes>Willets, Katherine A&#xD;Van Duyne, Richard P&#xD;4r33 dk 066990-02/dk/niddk&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Annual review of physical chemistry&#xD;Annu Rev Phys Chem. 2007;58:267-97.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17067281</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>11.25</custom4><electronic-resource-num>10.1146/annurev.physchem.58.032806.104607</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>591</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">591</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gurard-Levin, Zachary A.</author><author>Mrksich, Milan</author></authors></contributors><titles><title>Combining Self-Assembled Monolayers and Mass Spectrometry for Applications in Biochips</title><secondary-title>Annual Review of Analytical Chemistry</secondary-title></titles><pages>767-800</pages><volume>1</volume><number>1</number><edition>2008/07</edition><dates><year>2008</year></dates><abstract>Biochip arrays have enabled the massively parallel analysis of genomic DNA and hold great promise for application to the analysis of proteins, carbohydrates, and small molecules. Surface chemistry plays an intrinsic role in the preparation and analysis of biochips by providing functional groups for immobilization of ligands, providing an environment that maintains activity of the immobilized molecules, controlling nonspecific interactions of analytes with the surface, and enabling detection methods. This review describes recent advances in surface chemistry that enable quantitative assays of a broad range of biochemical activities. The discussion emphasizes the use of self-assembled monolayers of alkanethiolates on gold as a structurally well-defined and synthetically flexible platform for controlling the immobilization and activity of molecules in an array. The review also surveys recent methods of performing label-free assays, and emphasizes the use of matrix-assisted laser desorption/ionization mass spectrometry to directly observe molecules attached to the self-assembled monolayers.</abstract><urls><related-urls><url>http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.anchem.1.031207.112903</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>doi:10.1146/annurev.anchem.1.031207.112903</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>507</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">507</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Myc, A.</author><author>Douce, T. B.</author><author>Ahuja, N.</author><author>Kotlyar, A.</author><author>Kukowska-Latallo, J.</author><author>Thomas, T. P.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, BSRB, Ann Arbor, Michigan 48109, USA. myca@umich.edu</auth-address><titles><title>Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates</title><secondary-title>Anticancer Drugs</secondary-title></titles><pages>143-9</pages><volume>19</volume><number>2</number><edition>2008/01/08</edition><keywords><keyword>Antimetabolites, Antineoplastic/chemistry/*pharmacology</keyword><keyword>Carrier Proteins/genetics/metabolism</keyword><keyword>Cell Proliferation/*drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Coculture Techniques</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Screening Assays, Antitumor/methods</keyword><keyword>Flow Cytometry</keyword><keyword>Folic Acid/chemistry/metabolism</keyword><keyword>Green Fluorescent Proteins/genetics/metabolism</keyword><keyword>Humans</keyword><keyword>KB Cells</keyword><keyword>Luminescent Proteins/genetics/metabolism</keyword><keyword>Methotrexate/chemistry/*pharmacology</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Plasmids/chemistry/genetics</keyword><keyword>Polyamines/*chemistry/metabolism</keyword><keyword>Receptors, Cell Surface/genetics/metabolism</keyword><keyword>Transfection</keyword><keyword>Tumor Stem Cell Assay/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0959-4973 (Print)</isbn><accession-num>18176110</accession-num><abstract>Our previous studies have demonstrated the in-vitro and in-vivo targeting of a generation-5 (G5) dendrimer-based multifunctional conjugate, which used folic acid (FA) as the targeting agent and methotrexate (MTX) as the chemotherapeutic drug. For the synthesized G5-FA-MTX nanodevice conjugate to be clinically applicable as a cancer therapeutic drug, it is important that the compound elicits cytotoxicity specifically and consistently. The aim of this work was to evaluate four independently synthesized batches of G5-FA-MTX conjugates for their cytotoxic potential and specificity. For determination of specificity, we have used a unique &apos;coculture&apos; assay in which FA receptor-positive and FA receptor-negative cells were cultured together and have examined the preferential killing of the former. The results of our study show the batch-to-batch consistency and specificity of the G5-FA-MTX nanodevice in the preferential killing of FA receptor-positive cells. The coculture assay shows the consistency of the four different G5-FA-MTX conjugate lots in the specific killing of targeted cells. Further in-vivo studies are, however, necessary to prove the clinical potential of this targeted therapeutic nanodevice.</abstract><notes>Myc, Andrzej&#xD;Douce, Thomas B&#xD;Ahuja, Niharika&#xD;Kotlyar, Alina&#xD;Kukowska-Latallo, Jolanta&#xD;Thomas, Thommey P&#xD;Baker, James R Jr&#xD;1 R01 CA119409/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Anti-cancer drugs&#xD;Anticancer Drugs. 2008 Feb;19(2):143-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18176110</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>2.357</custom4><electronic-resource-num>10.1097/CAD.0b013e3282f28842&#xD;00001813-200802000-00005 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">3</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Nagakura, C.</author><author>Maitra, A.</author><author>Moossa, A. R.</author><author>Katsuoka, K.</author><author>Hoffman, R. M.</author><author>Bouvet, M.</author></authors></contributors><auth-address>AntiCancer, Inc., 7917 Ostrow Street, San Diego, California, USA.</auth-address><titles><title>Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer</title><secondary-title>Anticancer Res</secondary-title><alt-title>Anticancer research</alt-title></titles><pages>3237-42</pages><volume>26</volume><number>5A</number><edition>2006/05</edition><keywords><keyword>Animals</keyword><keyword>Antimetabolites, Antineoplastic/therapeutic use</keyword><keyword>Deoxycytidine/analogs &amp; derivatives/therapeutic use</keyword><keyword>Green Fluorescent Proteins/genetics/*metabolism</keyword><keyword>Humans</keyword><keyword>Intermediate Filament Proteins/genetics/metabolism</keyword><keyword>Liver Neoplasms/blood supply/drug therapy/*pathology/secondary</keyword><keyword>Luminescent Proteins/genetics/*metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neovascularization, Pathologic/metabolism/*pathology/prevention &amp; control</keyword><keyword>Nerve Tissue Proteins/genetics/metabolism</keyword><keyword>Pancreatic Neoplasms/blood supply/drug therapy/*pathology</keyword><keyword>Transfection</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>0250-7005 (Print)</isbn><accession-num>17094435</accession-num><abstract>As previously shown, the stem cell marker nestin is expressed in nascent blood vessels in transgenic nestin-driven green fluorescent protein (ND-GFP) nude mice. This mouse model was recently utilized to evaluate angiogenesis in primary tumors in an orthotopic model of pancreatic cancer. In the present study, nascent angiogenesis of pancreatic cancer liver metastasis in the ND-GFP transgenic nude mice after splenic injection of low-passage xPA-1 human pancreatic cancer cells expressing red fluorescent protein (RFP) was visualized by dual-color fluorescence imaging. ND-GFP was highly expressed in proliferating endothelial cells and nascent blood vessels in the growing liver metastasis. Immunohistochemical staining showed that CD31 co-localized in ND-GFP-expressing nascent blood vessels. The density of nascent blood vessels in the tumor was readily quantitated. Gemcitabine significantly decreased the mean nascent blood vessel density in the pancreatic liver metastases. In conclusion, the dual-color model of the ND-GFP nude mouse with RFP-expressing pancreatic cancer liver metastases, enabled the simultaneous visualization and quantitation of nascent angiogenesis and its response to angiogenesis inhibitors. This model will be useful for understanding the mechanism of angiogenesis of pancreatic cancer liver metastasis and for the discovery of effective new inhibitors of this process.</abstract><notes>Ca099258/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Greece</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17094435 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.479</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>83</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">83</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, Y.</author><author>Hayashi, K.</author><author>Amoh, Y.</author><author>Tsuji, K.</author><author>Yamauchi, K.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111, USA.</auth-address><titles><title>The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer</title><secondary-title>Anticancer Res</secondary-title></titles><pages>713-8</pages><volume>27</volume><number>2</number><edition>2007/05/01</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents, Phytogenic/*pharmacology</keyword><keyword>Camptothecin/*analogs &amp; derivatives/pharmacology</keyword><keyword>Colonic Neoplasms/*blood supply/*drug therapy/genetics/metabolism</keyword><keyword>Female</keyword><keyword>Green Fluorescent Proteins/biosynthesis/genetics</keyword><keyword>HCT116 Cells</keyword><keyword>Humans</keyword><keyword>Intermediate Filament Proteins/biosynthesis/genetics</keyword><keyword>Luminescent Proteins/biosynthesis/genetics</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Neovascularization, Pathologic/drug therapy/genetics/metabolism</keyword><keyword>Nerve Tissue Proteins/biosynthesis/genetics</keyword><keyword>Recombinant Fusion Proteins/biosynthesis/genetics</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>0250-7005 (Print)</isbn><accession-num>17465193</accession-num><abstract>Recent studies have shown the expression of a stem cell marker protein, nestin, in nascent blood vessels in nestin-driven green fluorescent protein (ND-GFP) transgenic nude mice. In the present study, we visualized tumor angiogenesis and evaluated the antiangiogenic efficacy of CPT-11 in ND-GFP nude mice using dual-color fluorescence imaging. We orthotopically implanted ND-GFP nude mice with the human cancer cell line HCT-116 expressing red fluorescent protein (RFP). The mice were treated with CPT-11 at 40 mg/kg on days 7, 10, 14. Tumor angiogenesis was imaged and visualized by dual-color fluorescence imaging on day 17, three days after the last CPT-11 treatment. Tumor volume and the mean nascent blood vessel density were determined and compared to the control mice. The growing tumor had high expressions of nestin in the nascent blood vessels. The nascent blood vessels showed co-localization of the endothelial-cell-specific marker CD-31 under immunohistochemical staining. The nascent blood vessels were highly visible and their density was determined. ND-GFP nude mice that were administered CPT-11 showed significant reduction in the mean nascent blood vessel density and tumor volume. The dual-color model of ND-GFP transgenic nude mice orthotopically implanted with HCT-116 expressing RFP proved to be effective in visualizing and quantitating tumor growth and tumor angiogenesis. The results showed that CPT-11 is an effective inhibitor of angiogenesis and provided strong implications for wider clinical application of CPT-11 for colon cancer.</abstract><notes>Ji, Yong&#xD;Hayashi, Katsuhiro&#xD;Amoh, Yasuyuki&#xD;Tsuji, Kazuhiko&#xD;Yamauchi, Kensuke&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Greece&#xD;Anticancer research&#xD;Anticancer Res. 2007 Mar-Apr;27(2):713-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17465193</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.479</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>663</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">663</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Y.</author><author>Newaz, A. K. M.</author><author>Wu, J.</author><author>Solin, S. A.</author><author>Kavasseri, V. R.</author><author>Jin, N.</author><author>Ahmed, I. S.</author><author>Adesida, I.</author></authors></contributors><titles><title>Extraordinary electroconductance in metal-semiconductor hybrid structures</title><secondary-title>Applied Physics Letters</secondary-title></titles><pages>262106</pages><volume>92</volume><number>26</number><edition>2008/07</edition><keywords><keyword>electrical conductivity</keyword><keyword>electron field emission</keyword><keyword>gallium arsenide</keyword><keyword>III-V semiconductors</keyword><keyword>junction gate field effect transistors</keyword><keyword>metallic thin films</keyword><keyword>Schottky gate field effect transistors</keyword><keyword>semiconductor epitaxial layers</keyword><keyword>semiconductor-metal boundaries</keyword><keyword>thermionic electron emission</keyword><keyword>titanium</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 2</date></pub-dates></dates><abstract>We report the phenomenon of extraordinary electroconductance in microscopic metal-semiconductor hybrid structures fabricated from GaAs epitaxial layer and a Ti thin film shunt. Four-lead Van der Pauw structures show a gain of 5.2% in electroconductance under +2.5  kV/cm with zero shunt bias. The increase in the sample conductance results from the thermionic field emission of electrons and the geometrical amplification. A model provides good agreement with the experimental data and clearly demonstrates the geometry dependence of the field effect in extraordinary electroconductance (EEC). The differences between EEC devices and field effect transistors, such as junction field effect transistor (FET) and Schottky barrier gate FET, are discussed. </abstract><urls><related-urls><url>http://link.aip.org/link/?APL/92/262106/1</url><url>http://dx.doi.org/10.1063/1.2955503</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>3.596</custom4><electronic-resource-num>DOI:10.1063/1.2955503</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>333</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">333</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, J.</author><author>Yang, G.</author><author>Lee, Y. Z.</author><author>Chang, S.</author><author>Lu, J. P.</author><author>Zhou, O.</author></authors></contributors><auth-address>Zhang, J&#xD;Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Phys &amp; Astron, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Curr Appl &amp; Mat Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Multiplexing radiography using a carbon nanotube based x-ray source</title><secondary-title>Applied Physics Letters</secondary-title></titles><pages>-</pages><volume>89</volume><number>6</number><edition>2006/08</edition><keywords><keyword>computed-tomography</keyword><keyword>tool</keyword><keyword>technology</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 7</date></pub-dates></dates><isbn>0003-6951</isbn><accession-num>ISI:000239690800121</accession-num><abstract>Speed and temporal resolution are critical for tomographic imaging of objects in rapid motion. Current x-ray scanners record images sequentially in the time domain. The serial approach limits their performance and demands increasingly high x-ray peak power and gantry speed. We have developed a multipixel carbon nanotube based field emission x-ray source that produces spatially and temporally modulated radiations. Using this device we show the feasibility of multiplexing radiography that enables simultaneous collection of multiple projection images using frequency multiplexing. A drastic increase of the speed and reduction of the x-ray peak power are achieved without compromising the imaging quality. (c) 2006 American Institute of Physics.</abstract><notes>072RN&#xD;Times Cited:0&#xD;Cited References Count:21</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000239690800121</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>3.977</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>480</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">480</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cyrus, T.</author><author>Zhang, H.</author><author>Allen, J. S.</author><author>Williams, T. A.</author><author>Hu, G.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University School of Medicine, Saint Louis, Mo. 63108, USA. tcyrus@im.wustl.edu</auth-address><titles><title>Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury</title><secondary-title>Arterioscler Thromb Vasc Biol</secondary-title></titles><pages>820-6</pages><volume>28</volume><number>5</number><edition>2008/02/23</edition><keywords><keyword>Angioplasty, Balloon/*adverse effects</keyword><keyword>Animals</keyword><keyword>Anti-Bacterial Agents/*administration &amp; dosage/pharmacology</keyword><keyword>Constriction, Pathologic/drug therapy/pathology/*prevention &amp; control</keyword><keyword>Drug-Eluting Stents</keyword><keyword>Endothelium, Vascular/drug effects/pathology</keyword><keyword>Femoral Artery/drug effects/pathology</keyword><keyword>Integrin alphaVbeta3/*administration &amp; dosage</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Male</keyword><keyword>Nanomedicine/methods</keyword><keyword>Nanoparticles/administration &amp; dosage/*therapeutic use</keyword><keyword>Rabbits</keyword><keyword>Sirolimus/*administration &amp; dosage/pharmacology</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1524-4636 (Electronic)</isbn><accession-num>18292395</accession-num><abstract>BACKGROUND: Drug eluting stents prevent vascular restenosis but can delay endothelial healing. A rabbit femoral artery model of stenosis formation after vascular injury was used to study the effect of intramural delivery of alpha(v)beta(3)-integrin-targeted rapamycin nanoparticles on vascular stenosis and endothelial healing responses. METHODS AND RESULTS: Femoral arteries of 48 atherosclerotic rabbits underwent balloon stretch injury and were locally treated with either (1) alpha(v)beta(3)-targeted rapamycin nanoparticles, (2) alpha(v)beta(3)-targeted nanoparticles without rapamycin, (3) nontargeted rapamycin nanoparticles, or (4) saline. Intramural binding of integrin-targeted paramagnetic nanoparticles was confirmed with MR molecular imaging (1.5 T). MR angiograms were indistinguishable between targeted and control arteries at baseline, but 2 weeks later they showed qualitatively less luminal plaque in the targeted rapamycin treated segments compared with contralateral control vessels. In a first cohort of 19 animals (38 vessel segments), microscopic morphometric analysis of the rapamycin-treated segments revealed a 52% decrease in the neointima/media ratio (P&lt;0.05) compared to control. No differences (P&gt;0.05) were observed among balloon injured vessel segments treated with alpha(v)beta(3)-targeted nanoparticles without rapamycin, nontargeted nanoparticles with rapamycin, or saline. In a second cohort of 29 animals, endothelial healing followed a parallel pattern over 4 weeks in the vessels treated with alpha(v)beta(3)-targeted rapamycin nanoparticles and the 3 control groups. CONCLUSIONS: Local intramural delivery of alpha(v)beta(3)-targeted rapamycin nanoparticles inhibited stenosis without delaying endothelial healing after balloon injury.</abstract><notes>Cyrus, Tillmann&#xD;Zhang, Huiying&#xD;Allen, John S&#xD;Williams, Todd A&#xD;Hu, Grace&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;EB-01704/EB/United States NIBIB&#xD;HL-73646/HL/United States NHLBI&#xD;HL-78631/HL/United States NHLBI&#xD;N01-CO-37007/CO/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Arteriosclerosis, thrombosis, and vascular biology&#xD;Arterioscler Thromb Vasc Biol. 2008 May;28(5):820-6. Epub 2008 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18292395</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>7.221</custom4><electronic-resource-num>ATVBAHA.107.156281 [pii]&#xD;10.1161/ATVBAHA.107.156281</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>168</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">168</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wickline, S. A.</author><author>Neubauer, A. M.</author><author>Winter, P.</author><author>Caruthers, S.</author><author>Lanza, G.</author></authors></contributors><auth-address>Department of Medicine, Washington University, St Louis, MO, USA. wicklines@aol.com</auth-address><titles><title>Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology</title><secondary-title>Arterioscler Thromb Vasc Biol</secondary-title></titles><pages>435-41</pages><volume>26</volume><number>3</number><edition>2005/12/24</edition><keywords><keyword>Animals</keyword><keyword>Atherosclerosis/*diagnosis/physiopathology/*therapy</keyword><keyword>Drug Delivery Systems/trends</keyword><keyword>Humans</keyword><keyword>Nanotechnology/*trends</keyword><keyword>Thrombosis/*diagnosis/physiopathology/*therapy</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1524-4636 (Electronic)</isbn><accession-num>16373609</accession-num><abstract>The role of nanotechnology in cardiovascular diagnosis is expanding rapidly. The goal of this brief review is to illustrate selected examples of nanosystems that have been applied to the arenas of atherosclerosis, thrombosis, and vascular biology. The technologies for producing targeted nanosystems are multifarious and reflect end uses in many cases. The results to date indicate rapid growth of interest and capability in the field. The future of cardiovascular diagnosis already is being impacted by nanosystems that can both diagnose pathology and treat it with targeted delivery systems.</abstract><notes>Wickline, Samuel A&#xD;Neubauer, Anne M&#xD;Winter, Patrick&#xD;Caruthers, Shelton&#xD;Lanza, Gregory&#xD;Review&#xD;United States&#xD;Arteriosclerosis, thrombosis, and vascular biology&#xD;Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):435-41. Epub 2005 Dec 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16373609</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>7.221</custom4><electronic-resource-num>01.ATV.0000201069.47550.8b [pii]&#xD;10.1161/01.ATV.0000201069.47550.8b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>173</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">173</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Neubauer, A. M.</author><author>Caruthers, S. D.</author><author>Harris, T. D.</author><author>Robertson, J. D.</author><author>Williams, T. A.</author><author>Schmieder, A. H.</author><author>Hu, G.</author><author>Allen, J. S.</author><author>Lacy, E. K.</author><author>Zhang, H.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.</auth-address><titles><title>Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis</title><secondary-title>Arterioscler Thromb Vasc Biol</secondary-title></titles><pages>2103-9</pages><volume>26</volume><number>9</number><edition>2006/07/11</edition><keywords><keyword>Angiogenesis Inhibitors/*administration &amp; dosage/pharmacology</keyword><keyword>Animals</keyword><keyword>Aorta, Abdominal/pathology</keyword><keyword>Atherosclerosis/complications/diagnosis/*metabolism</keyword><keyword>Cyclohexanes</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Endothelium, Vascular/*metabolism</keyword><keyword>Fatty Acids, Unsaturated/*administration &amp; dosage/pharmacology</keyword><keyword>Hyperlipidemias/blood</keyword><keyword>Integrin alphaVbeta3/*metabolism</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>*Nanostructures</keyword><keyword>Neovascularization, Pathologic/etiology/*prevention &amp; control</keyword><keyword>Rabbits</keyword><keyword>Sesquiterpenes</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1524-4636 (Electronic)</isbn><accession-num>16825592</accession-num><abstract>OBJECTIVE: Angiogenic expansion of the vasa vasorum is a well-known feature of progressive atherosclerosis, suggesting that antiangiogenic therapies may stabilize or regress plaques. Alpha(v)beta3 integrin-targeted paramagnetic nanoparticles were prepared for noninvasive assessment of angiogenesis in early atherosclerosis, for site-specific delivery of antiangiogenic drug, and for quantitative follow-up of response. METHODS AND RESULTS: Expression of alpha(v)beta3 integrin by vasa vasorum was imaged at 1.5 T in cholesterol-fed rabbit aortas using integrin-targeted paramagnetic nanoparticles that incorporated fumagillin at 0 microg/kg or 30 microg/kg. Both formulations produced similar MRI signal enhancement (16.7%+/-1.1%) when integrated across all aortic slices from the renal arteries to the diaphragm. Seven days after this single treatment, integrin-targeted paramagnetic nanoparticles were readministered and showed decreased MRI enhancement among fumagillin-treated rabbits (2.9%+/-1.6%) but not in untreated rabbits (18.1%+/-2.1%). In a third group of rabbits, nontargeted fumagillin nanoparticles did not alter vascular alpha(v)beta3-integrin expression (12.4%+/-0.9%; P&gt;0.05) versus the no-drug control. In a second study focused on microscopic changes, fewer microvessels in the fumagillin-treated rabbit aorta were counted compared with control rabbits. CONCLUSIONS: This study illustrates the potential of combined molecular imaging and drug delivery with targeted nanoparticles to noninvasively define atherosclerotic burden, to deliver effective targeted drug at a fraction of previous levels, and to quantify local response to treatment.</abstract><notes>Winter, Patrick M&#xD;Neubauer, Anne M&#xD;Caruthers, Shelton D&#xD;Harris, Thomas D&#xD;Robertson, J David&#xD;Williams, Todd A&#xD;Schmieder, Anne H&#xD;Hu, Grace&#xD;Allen, John S&#xD;Lacy, Elizabeth K&#xD;Zhang, Huiying&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-73646/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Arteriosclerosis, thrombosis, and vascular biology&#xD;Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2103-9. Epub 2006 Jul 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16825592</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>7.221</custom4><electronic-resource-num>01.ATV.0000235724.11299.76 [pii]&#xD;10.1161/01.ATV.0000235724.11299.76</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>111</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">111</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zabirnyk, O.</author><author>Yezhelyev, M.</author><author>Seleverstov, O.</author></authors></contributors><auth-address>Institute of Anatomy, University of Leipzig, Leipzig, Germany.</auth-address><titles><title>Nanoparticles as a novel class of autophagy activators</title><secondary-title>Autophagy</secondary-title></titles><pages>278-81</pages><volume>3</volume><number>3</number><edition>2007/03/14</edition><keywords><keyword>Animals</keyword><keyword>*Autophagy</keyword><keyword>Cell Line</keyword><keyword>Drug Delivery Systems</keyword><keyword>Environment</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>*Nanoparticles/administration &amp; dosage/chemistry</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1554-8627 (Print)</isbn><accession-num>17351332</accession-num><abstract>Nano-sized objects exist as engineered tools as well as natural or anthropogenic environmental factors. Recent progress in the field of nanotechnology allows for a deeper understanding of their impact on organisms. Recently, we showed that the size-dependent cell interaction with quantum dots is autophagy-mediated. The potential role of other endo- and exogenous nanoparticles in terms of autophagy is discussed here. Their physical properties should be taken into consideration while constructing delivery systems. Furthermore, we propose several models of targeted nanoparticles delivery. Autophagy can be considered as an additional mechanism providing intracellular selectivity for introduced nanoparticles.</abstract><notes>Zabirnyk, Olga&#xD;Yezhelyev, Maksym&#xD;Seleverstov, Oleksandr&#xD;United States&#xD;Autophagy&#xD;Autophagy. 2007 May-Jun;3(3):278-81. Epub 2007 May 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17351332</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>4.657</custom4><electronic-resource-num>3916 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>652</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">652</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Waters, E. A.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Dept. of Cardiology, Washington University Medical School, Campus Box 8215, Cortex Building, Suite 101, 4320 Forest Park Ave., Saint Louis, MO, 63108, USA.</auth-address><titles><title>Contrast agents for MRI</title><secondary-title>Basic Res Cardiol</secondary-title></titles><pages>114-21</pages><volume>103</volume><number>2</number><edition>2008/03/08</edition><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0300-8428 (Print)</isbn><accession-num>18324367</accession-num><abstract>Molecular imaging is a rapidly growing field with the potential to revolutionize cardiovascular medicine by shifting diagnostic focus from functional abnormalities which occur late in a disease process to the biochemical events which precipitate the earliest stages of disease. MRI is a modality well suited to this task as it allows a variety of contrast mechanisms for detection of epitopes of interest, as well as high-resolution anatomical localization and functional information. In this review, we discuss the widerange of available molecular MRI contrast agents and their application to diseases such as atherosclerosis, thrombus imaging, and stem cell tracking, along with opportunities for molecularly targeted drug delivery.</abstract><notes>Waters, Emily A&#xD;Wickline, Samuel A&#xD;Germany&#xD;Basic research in cardiology&#xD;Basic Res Cardiol. 2008 Mar;103(2):114-21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18324367</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>4.333</custom4><electronic-resource-num>10.1007/s00395-008-0711-6</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>237</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">237</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, C.</author><author>Xing, B.</author><author>Rao, J.</author></authors></contributors><auth-address>Biophysics, Cancer Biology, and Molecular Imaging Programs, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.</auth-address><titles><title>A self-assembled quantum dot probe for detecting beta-lactamase activity</title><secondary-title>Biochem Biophys Res Commun</secondary-title></titles><pages>931-5</pages><volume>344</volume><number>3</number><edition>2006/04/25</edition><keywords><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>*Fluorescent Dyes</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>*Quantum Dots</keyword><keyword>Staining and Labeling/methods</keyword><keyword>beta-Lactamases/*analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 9</date></pub-dates></dates><isbn>0006-291X (Print)</isbn><accession-num>16631595</accession-num><abstract>This communication describes a quantum dot probe that can be activated by a reporter enzyme, beta-lactamase. Our design is based on the principle of fluorescence resonance energy transfer (FRET). A biotinylated beta-lactamase substrate was labeled with a carbocyanine dye, Cy5, and immobilized on the surface of quantum dots through the binding of biotin to streptavidin pre-coated on the quantum dots. In assembling this nanoprobe, we have found that both the distance between substrates and the quantum dot surface, and the density of substrates are important for its function. The fluorescence emission from quantum dots can be efficiently quenched (up to 95%) by Cy5 due to FRET. Our final quantum dot probe, assembled with QD605 and 1:1 mixture of biotin and a Cy5-labeled lactam, can be activated by 32microg/mL of beta-lactamase with 4-fold increase in the fluorescence emission.</abstract><notes>Xu, Chenjie&#xD;Xing, Bengang&#xD;Rao, Jianghong&#xD;R21 eb 003803/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biochemical and biophysical research communications&#xD;Biochem Biophys Res Commun. 2006 Jun 9;344(3):931-5. Epub 2006 Apr 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16631595</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>2.855</custom4><electronic-resource-num>S0006-291X(06)00792-3 [pii]&#xD;10.1016/j.bbrc.2006.03.225</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>661</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">661</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yao, C.</author><author>Qin, Z.</author><author>Works, K. N.</author><author>Austin, G. E.</author><author>Young, A. N.</author></authors></contributors><auth-address>Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Decatur, GA 30033, USA.</auth-address><titles><title>C/EBP and C-Myb sites are important for the functional activity of the human myeloperoxidase upstream enhancer</title><secondary-title>Biochem Biophys Res Commun</secondary-title></titles><pages>309-14</pages><volume>371</volume><number>2</number><edition>2008/04/26</edition><keywords><keyword>Binding Sites</keyword><keyword>CCAAT-Enhancer-Binding Proteins/chemistry/genetics/*metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Deoxyribonuclease I/chemistry</keyword><keyword>*Enhancer Elements (Genetics)</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Genes, Reporter</keyword><keyword>Humans</keyword><keyword>Peroxidase/*genetics</keyword><keyword>Protein Footprinting</keyword><keyword>Proto-Oncogene Proteins c-myb/chemistry/genetics/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun 27</date></pub-dates></dates><isbn>1090-2104 (Electronic)</isbn><accession-num>18435917</accession-num><abstract>Myeloperoxidase (MPO), an enzyme active against bacterial and fungal infections, is expressed specifically in myeloblasts and promyelocytes and minimal in other cell types. We recently identified and partially characterized an upstream enhancer located between -4100 and -3844 bp of the MPO gene. We showed that an AML1 site contributes to enhancer activity and specificity. We now demonstrate three additional footprints within the MPO enhancer and provide evidence that C/EBP and c-Myb sites contribute to its functional, tissue-specific activity. This distal enhancer appears to play an important role in the control of MPO transcription during differentiation of myeloid cells.</abstract><notes>Yao, Congjun&#xD;Qin, Zhenyu&#xD;Works, Kimberly N&#xD;Austin, Garth E&#xD;Young, Andrew N&#xD;United States&#xD;Biochemical and biophysical research communications&#xD;Biochem Biophys Res Commun. 2008 Jun 27;371(2):309-14. Epub 2008 Apr 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18435917</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>2.855</custom4><electronic-resource-num>S0006-291X(08)00744-4 [pii]&#xD;10.1016/j.bbrc.2008.04.065</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>504</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">504</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, J.</author><author>Wu, J.</author><author>Valencia, C. A.</author><author>Liu, R.</author></authors></contributors><auth-address>School of Pharmacy and Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Fibronectin type III domain based monobody with high avidity</title><secondary-title>Biochemistry</secondary-title></titles><pages>12656-64</pages><volume>46</volume><number>44</number><edition>2007/10/13</edition><keywords><keyword>Antibodies, Monoclonal/*chemistry/*isolation &amp; purification/metabolism</keyword><keyword>*Antibody Affinity</keyword><keyword>Dimerization</keyword><keyword>Fibronectins/*chemistry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/genetics/*immunology</keyword><keyword>K562 Cells</keyword><keyword>Peptide Hydrolases/metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Denaturation</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Recombinant Fusion Proteins/chemistry/isolation &amp; purification/metabolism</keyword><keyword>Substrate Specificity</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 6</date></pub-dates></dates><isbn>0006-2960 (Print)</isbn><accession-num>17929945</accession-num><abstract>Significant efforts have been made to improve the target-binding strength of numerous affinity molecules that are widely used in biomedical research and clinical applications. While many antibody-like fragments have been successfully optimized through affinity maturation, the process is time-consuming and restricted by the stability, solubility, and expression level of the protein sequences. To generate a fibronectin type III domain (FN3) based monobody that binds to the tumor-related biomarkers with exceptional high strength and stability, we developed a multivalent strategy by fusing an alphavbeta3-binding FN3 monobody with a short COMP pentamerization domain through a linker that facilitates appropriate display of multivalent FN3 domains. The fusion protein was highly expressed in the soluble fraction of Escherichia coli and efficiently self-assembled into a pentameric molecule that could be readily purified. Compared to the monomeric form, the pentameric monobody bound to alphavbeta3 integrin much more tightly with significantly slower off-rate, while still maintaining its excellent specificity toward alphavbeta3 when tested by using purified integrins and integrin-expressing cell lines. The multivalent strategy we describe here could be applied to engineer other FN3 monobodies to acquire significantly improved targeting-binding strengths.</abstract><notes>Duan, Jinzhu&#xD;Wu, Jinsong&#xD;Valencia, C Alexander&#xD;Liu, Rihe&#xD;U54 CA119343/CA/United States NCI&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Biochemistry&#xD;Biochemistry. 2007 Nov 6;46(44):12656-64. Epub 2007 Oct 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17929945</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.368</custom4><electronic-resource-num>10.1021/bi701215e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>496</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">496</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Garrett, S. C.</author><author>Hodgson, L.</author><author>Rybin, A.</author><author>Toutchkine, A.</author><author>Hahn, K. M.</author><author>Lawrence, D. S.</author><author>Bresnick, A. R.</author></authors></contributors><auth-address>Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.</auth-address><titles><title>A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics</title><secondary-title>Biochemistry</secondary-title></titles><pages>986-96</pages><volume>47</volume><number>3</number><edition>2007/12/25</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Calcium/chemistry/*metabolism/pharmacology</keyword><keyword>Cell Movement/drug effects</keyword><keyword>Cell-Free System</keyword><keyword>Circular Dichroism</keyword><keyword>Cysteine/chemistry</keyword><keyword>Egtazic Acid/chemistry</keyword><keyword>Fibroblasts/drug effects/*metabolism</keyword><keyword>Fluorescence Polarization</keyword><keyword>Humans</keyword><keyword>Iodoacetamide/chemistry</keyword><keyword>Lysophospholipids/pharmacology</keyword><keyword>Mice</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Nonmuscle Myosin Type IIA/chemistry/metabolism</keyword><keyword>Phenothiazines/chemistry/pharmacology</keyword><keyword>Protein Binding/drug effects</keyword><keyword>Protein Conformation/drug effects</keyword><keyword>Pyrimidinones/chemistry</keyword><keyword>Recombinant Proteins/antagonists &amp; inhibitors/chemistry/metabolism</keyword><keyword>S100 Proteins/*antagonists &amp; inhibitors/chemistry/*metabolism</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Trifluoperazine/chemistry/pharmacology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>0006-2960 (Print)</isbn><accession-num>18154362</accession-num><abstract>S100A4, a member of the S100 family of Ca2+-binding proteins, displays elevated expression in malignant human tumors compared with benign tumors, and increased expression correlates strongly with poor patient survival. S100A4 has a direct role in metastatic progression, likely due to the modulation of actomyosin cytoskeletal dynamics, which results in increased cellular motility. We developed a fluorescent biosensor (Mero-S100A4) that reports on the Ca2+-bound, activated form of S100A4. Direct attachment of a novel solvatochromatic reporter dye to S100A4 results in a sensor that, upon activation, undergoes a 3-fold enhancement in fluorescence, thus providing a sensitive assay for use in vitro and in vivo. In cells, localized activation of S100A4 at the cell periphery is observed during random migration and following stimulation with lysophosphatidic acid, a known activator of cell motility and proliferation. Additionally, a screen against a library of FDA-approved drugs with the biosensor identified an array of phenothiazines as inhibitors of myosin-II associated S100A4 function. These data demonstrate the utility of the new biosensor both for drug discovery and for probing the cellular dynamics controlled by the S100A4 metastasis factor.</abstract><notes>Garrett, Sarah C&#xD;Hodgson, Louis&#xD;Rybin, Andrew&#xD;Toutchkine, Alexei&#xD;Hahn, Klaus M&#xD;Lawrence, David S&#xD;Bresnick, Anne R&#xD;CA095019/CA/United States NCI&#xD;GM057464/GM/United States NIGMS&#xD;GM069945/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Biochemistry&#xD;Biochemistry. 2008 Jan 22;47(3):986-96. Epub 2007 Dec 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18154362</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.368</custom4><electronic-resource-num>10.1021/bi7021624</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>592</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">592</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gurard-Levin, Zachary A.</author><author>Mrksich, Milan</author></authors></contributors><auth-address>Department of Chemistry and Howard Hughes Medical Institute, The University of Chicago, 929 East 57th Street, Chicago, Illinois 60521</auth-address><titles><title>The Activity of HDAC8 Depends on Local and Distal Sequences of Its Peptide Substrates</title><secondary-title>Biochemistry</secondary-title></titles><pages>6242-6250</pages><volume>47</volume><number>23</number><edition>2008/07</edition><dates><year>2008</year></dates><isbn>0006-2960</isbn><abstract>Abstract: This paper introduces a flexible assay for characterizing the activities of the histone deacetylase enzymes. The approach combines mass spectrometry with self-assembled monolayers that present acetylated peptides and enables a label-free and one-step assay of this biochemical activity. The assay was used to characterize the activity of HDAC8 toward peptides taken from the N-terminal tail of the H4 histone and reveals that a distal region of the peptide substrate interacts with the deacetylase at an exosite and contributes to the activity of the substrate. Specifically, a peptide corresponding to residues 8 19 of H4 and having lysine 12 acetylated is an active substrate, but removal of the KRHR (residues 16 19) sequence abolishes activity. Mutation of glycine 11 to arginine in the peptide lacking the KRHR sequence restores activity, demonstrating that both local and distal sequences act synergistically to regulate the activity of the HDAC. Assays with peptides bearing multiply acetylated residues, but in which each acetyl group is isotopically labeled, permit studies of the processive deacetylation of peptides. Peptide substrates having an extended sequence that includes K20 were used to demonstrate that methylation of this residue directly affects HDAC8 activity at K12. This work provides a mechanistic basis for the regulation of HDAC activities by distal sequences and may contribute to studies aimed at evaluating the role of the histone code in regulating gene expression.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/bi800053v</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.368</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>467</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">467</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Macdonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, 2205 Tech Drive, Evanston, IL 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>Natural lipid extracts and biomembrane-mimicking lipid compositions are disposed to form nonlamellar phases, and they release DNA from lipoplexes most efficiently</title><secondary-title>Biochim Biophys Acta-Biomembranes</secondary-title></titles><periodical><full-title>Biochim Biophys Acta-Biomembranes</full-title></periodical><pages>2373-82</pages><volume>1768</volume><number>10</number><edition>2007/06/15</edition><keywords><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>DNA/*administration &amp; dosage/chemistry</keyword><keyword>Electrostatics</keyword><keyword>Fluorometry</keyword><keyword>Lipids/*chemistry</keyword><keyword>Liposomes/chemistry</keyword><keyword>Membrane Lipids/*chemistry</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0006-3002 (Print)</isbn><accession-num>17559800</accession-num><abstract>A viewpoint now emerging is that a critical factor in lipid-mediated transfection (lipofection) is the structural evolution of lipoplexes upon interacting and mixing with cellular lipids. Here we report our finding that lipid mixtures mimicking biomembrane lipid compositions are superior to pure anionic liposomes in their ability to release DNA from lipoplexes (cationic lipid/DNA complexes), even though they have a much lower negative charge density (and thus lower capacity to neutralize the positive charge of the lipoplex lipids). Flow fluorometry revealed that the portion of DNA released after a 30-min incubation of the cationic O-ethylphosphatidylcholine lipoplexes with the anionic phosphatidylserine or phosphatidylglycerol was 19% and 37%, respectively, whereas a mixture mimicking biomembranes (MM: phosphatidylcholine/phosphatidylethanolamine/phosphatidylserine /cholesterol 45:20:20:15 w/w) and polar lipid extract from bovine liver released 62% and 74%, respectively, of the DNA content. A possible reason for this superior power in releasing DNA by the natural lipid mixtures was suggested by structural experiments: while pure anionic lipids typically form lamellae, the natural lipid mixtures exhibited a surprising predilection to form nonlamellar phases. Thus, the MM mixture arranged into lamellar arrays at physiological temperature, but began to convert to the hexagonal phase at a slightly higher temperature, approximately 40-45 degrees C. A propensity to form nonlamellar phases (hexagonal, cubic, micellar) at close to physiological temperatures was also found with the lipid extracts from natural tissues (from bovine liver, brain, and heart). This result reveals that electrostatic interactions are only one of the factors involved in lipid-mediated DNA delivery. The tendency of lipid bilayers to form nonlamellar phases has been described in terms of bilayer &quot;frustration&quot; which imposes a nonzero intrinsic curvature of the two opposing monolayers. Because the stored curvature elastic energy in a &quot;frustrated&quot; bilayer seems to be comparable to the binding energy between cationic lipid and DNA, the balance between these two energies could play a significant role in the lipoplex-membrane interactions and DNA release energetics.</abstract><notes>Koynova, Rumiana&#xD;Macdonald, Robert C&#xD;GM52329/GM/United States NIGMS&#xD;GM57305/GM/United States NIGMS&#xD;R01 GM052329-09/GM/United States NIGMS&#xD;R01 GM057305-05/GM/United States NIGMS&#xD;RR08630/RR/United States NCRR&#xD;U54CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Biochimica et biophysica acta&#xD;Biochim Biophys Acta. 2007 Oct;1768(10):2373-82. Epub 2007 May 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17559800</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.640</custom4><electronic-resource-num>S0005-2736(07)00157-5 [pii]&#xD;10.1016/j.bbamem.2007.04.026</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>150</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">150</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Tarahovsky, Y. S.</author><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology Northwestern University 2205 Tech Drive, Evanston, IL 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA</title><secondary-title>Biochim Biophys Acta-Biomembranes</secondary-title></titles><periodical><full-title>Biochim Biophys Acta-Biomembranes</full-title></periodical><pages>375-86</pages><volume>1768</volume><number>2</number><edition>2006/12/13</edition><keywords><keyword>Cell Membrane/*metabolism</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Cytoplasm/metabolism</keyword><keyword>DNA/chemistry/*metabolism</keyword><keyword>Endoplasmic Reticulum/metabolism</keyword><keyword>Endothelium, Vascular/cytology/*metabolism</keyword><keyword>Humans</keyword><keyword>*Liposomes</keyword><keyword>Microscopy, Electron</keyword><keyword>Mitochondria/metabolism</keyword><keyword>Oleic Acids/*metabolism</keyword><keyword>Phosphatidylcholines/*metabolism</keyword><keyword>Transfection</keyword><keyword>Umbilical Arteries/cytology/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0006-3002 (Print)</isbn><accession-num>17156744</accession-num><abstract>Lipoplexes containing a mixture of cationic phospholipids dioleoylethylphosphatidylcholine (EDOPC) and dilauroylethylphosphatidylcholine (EDLPC) are known to be far more efficient agents in transfection of cultured primary endothelial cells than are lipoplexes containing either lipid alone. The large magnitude of the synergy permits comparison of the physical and physico-chemical properties of lipoplexes that have very different transfection efficiencies, but minor chemical differences. Here we report that the superior transfection efficiency of the EDLPC/EDOPC lipoplexes correlates with higher surface activity, higher affinity to interact and mix with negatively charged membrane-mimicking liposomes, and with considerably more efficient DNA release relative to the EDOPC lipoplexes. Observations on cultured cells agree with the results obtained with model systems; confocal microscopy of transfected human umbilical artery endothelial cells (HUAEC) demonstrated more extensive DNA release into the cytoplasm and nucleoplasm for the EDLPC/EDOPC lipoplexes than for EDOPC lipoplexes; electron microscopy of cells fixed and embedded directly on the culture dish revealed contact of EDLPC/EDOPC lipoplexes with various cellular membranes, including those of the endoplasmic reticulum, mitochondria and nucleus. The sequence of events outlining efficient lipofection is discussed based on the presented data.</abstract><notes>Koynova, Rumiana&#xD;Tarahovsky, Yury S&#xD;Wang, Li&#xD;MacDonald, Robert C&#xD;Gm52329/gm/nigms&#xD;Gm57305/gm/nigms&#xD;R01 gm052329-06/gm/nigms&#xD;R01 gm057305-03a1/gm/nigms&#xD;Rr08630/rr/ncrr&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Biochimica et biophysica acta&#xD;Biochim Biophys Acta. 2007 Feb;1768(2):375-86. Epub 2006 Nov 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17156744</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>3.640</custom4><electronic-resource-num>S0005-2736(06)00400-7 [pii]&#xD;10.1016/j.bbamem.2006.10.016</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>721</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">721</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tenchov, B.G.</author><author>Wang, L.</author><author>Koynova, R.D.</author><author>MacDonald R.C.</author></authors></contributors><titles><title>Modulation of a Membrane Lipid Phase Transition: A Predictive Measure for Lipofection Efficiency</title><secondary-title>Biochim Biophys Acta-Biomembranes</secondary-title></titles><periodical><full-title>Biochim Biophys Acta-Biomembranes</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.640</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>18</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">18</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Derfus, A. M.</author><author>Chen, A. A.</author><author>Min, D. H.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Department of Bioengineering, University of California at San Diego, La Jolla, California 92093, Burnham Institute for Medical Research, La Jolla, California 92037, Health Sciences and Technology/Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.</auth-address><titles><title>Targeted Quantum Dot Conjugates for siRNA Delivery</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><edition>2007/07</edition><dates><year>2007</year><pub-dates><date>Jul 14</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17630789</accession-num><abstract>Treatment of human diseases such as cancer generally involves the sequential use of diagnostic tools and therapeutic modalities. Multifunctional platforms combining therapeutic and diagnostic imaging functions in a single vehicle promise to change this paradigm. in particular, nanoparticle-based multifunctional platforms offer the potential to improve the pharmacokinetics of drug formulations, while providing attachment sites for diagnostic imaging and disease targeting features. We have applied these principles to the delivery of small interfering RNA (siRNA) therapeutics, where systemic delivery is hampered by rapid excretion and nontargeted tissue distribution. Using a PEGlyated quantum dot (QD) core as a scaffold, siRNA and tumor-homing peptides (F3) were conjugated to functional groups on the particle&apos;s surface. We found that the homing peptide was required for targeted internalization by tumor cells, and that siRNA cargo could be coattached without affecting the function of the peptide. Using an EGFP model system, the role of conjugation chemistry was investigated, with siRNA attached to the particle by disulfide cross-linkers showing greater silencing efficiency than when attached by a nonreducible thioether linkage. Since each particle contains a limited number of attachment sites, we further explored the tradeoff between number of F3 peptides and the number of siRNA per particle, leading to an optimized formulation. Delivery of these F3/siRNA-QDs to EGFP-transfected HeLa cells and release from their endosomal entrapment led to significant knockdown of EGFP signal. By designing the siRNA sequence against a therapeutic target (e.g., oncogene) instead of EGFP, this technology may be ultimately adapted to simultaneously treat and image metastatic cancer.</abstract><notes>Journal article</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17630789 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>Yes- UCSD and MIT</custom2><custom3>2007</custom3><custom4>4.384</custom4><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>466</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">466</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Karfeld, L. S.</author><author>Bull, S. R.</author><author>Davis, N. E.</author><author>Meade, T. J.</author><author>Barron, A. E.</author></authors></contributors><auth-address>Department of Chemical and Biological Engineering and Feinberg School of Medicine, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Use of a genetically engineered protein for the design of a multivalent MRI contrast agent</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1697-700</pages><volume>18</volume><number>6</number><edition>2007/10/12</edition><keywords><keyword>Chelating Agents/chemistry</keyword><keyword>Contrast Media/*chemistry/*metabolism/pharmacology</keyword><keyword>Gold/chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Sequence Data</keyword><keyword>Molecular Structure</keyword><keyword>Polymers/chemistry</keyword><keyword>*Protein Engineering</keyword><keyword>Water/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17927227</accession-num><abstract>The majority of clinically used contrast agents (CAs) for magnetic resonance imaging have low relaxivities and thus require high concentrations for signal enhancement. Research has turned to multivalent, macromolecular CAs to increase CA efficiency. However, previously developed macromolecular CAs do not provide high relaxivities, have limited biocompatibility, and/or do not have a structure that is readily modifiable to tailor to particular applications. We report a new family of multivalent, biomacromolecular, genetically engineered protein polymer-based CAs; the protein backbone contains evenly spaced lysines that are derivatized with gadolinium (Gd(III)) chelators. The protein&apos;s length and repeating amino acid sequence are genetically specified. We reproducibly obtained conjugates with an average of 8-9 Gd(III) chelators per protein. These multivalent CAs reproducibly provide a high relaxivity of 7.3 mM (-1) s (-1) per Gd(III) and 62.6 mM (-1) s (-1) per molecule. Furthermore, they can be incorporated into biomaterial hydrogels via chemical cross-linking of the remaining free lysines, and provide a dramatic contrast enhancement. Thus, these protein polymer CAs could be a useful tool for following the evolution of tissue engineering scaffolds.</abstract><notes>Karfeld, Lindsay S&#xD;Bull, Steve R&#xD;Davis, Nicolynn E&#xD;Meade, Thomas J&#xD;Barron, Annelise E&#xD;1 R01 EB003806/EB/United States NIBIB&#xD;1 R01 EB005866/EB/United States NIBIB&#xD;2 T32 GM008449/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Nov-Dec;18(6):1697-700. Epub 2007 Oct 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17927227</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc700149u</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>436</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">436</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, G. Y.</author><author>Josephson, L.</author><author>Langer, R.</author><author>Cima, M. J.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Magnetic relaxation switch detection of human chorionic gonadotrophin</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>2024-8</pages><volume>18</volume><number>6</number><edition>2007/09/26</edition><keywords><keyword>Chorionic Gonadotropin/*analysis/*chemistry</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>*Magnetics</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Particle Size</keyword><keyword>Solutions</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17892270</accession-num><abstract>Functionalized nanoparticle contrast agents, also known as magnetic relaxation switches (MRS), were prepared to detect protein A and the beta subunit of human chorionic gonadotrophin (hCG-beta). Antibodies were attached to cross-linked iron oxide (CLIO) nanoparticles using standard peptide chemistry. Protein A was used as a simple model analyte, as it is naturally multivalent and can bind multiple CLIO-IgG simultaneously. The addition of PA to CLIO-IgG resulted in transverse relaxation time (T2) shortening compared to a blank control as seen by NMR relaxometry measurements. Analyte-induced aggregation was confirmed by light scattering particle size analysis. A two-particle system was designed to measure hCG-beta, as it is not multivalent and requires conjugation of a matched pair of monoclonal antibodies to CLIO (referred to as C95 and C97). Measurement of hCG-beta is important, as elevated serum levels are associated with malignancies including testicular and ovarian cancers. The addition of hCG-beta to C95 and C97 resulted in T2 shortening with a linear dynamic concentration range of 0.1 to 1 molecules of analyte per nanoparticle. Similar data were obtained for the hCG dimer. Observations with higher stoichiometric ratios of analyte to nanoparticle and increased nanoparticle valency were also made. This method can potentially be adapted to detect other biomarkers in solution.</abstract><notes>Kim, Grace Y&#xD;Josephson, Lee&#xD;Langer, Robert&#xD;Cima, Michael J&#xD;5 U54 CA119349-12/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Nov-Dec;18(6):2024-8. Epub 2007 Sep 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17892270</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc070110w</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>73</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">73</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, J. S.</author><author>Valencia, C. A.</author><author>Liu, R.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry and School of Pharmacy and Carolina Center for Genome Sciences, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Highly-efficient purification of native polyhistidine-tagged proteins by multivalent NTA-modified magnetic nanoparticles</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>333-41</pages><volume>18</volume><number>2</number><edition>2007/02/22</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Chelating Agents</keyword><keyword>Chromatography, Affinity</keyword><keyword>Endostatins/chemistry/isolation &amp; purification</keyword><keyword>Histidine/*chemistry</keyword><keyword>Humans</keyword><keyword>Kidney/metabolism</keyword><keyword>*Magnetics</keyword><keyword>Mice</keyword><keyword>*Nanoparticles</keyword><keyword>Nickel/*chemistry</keyword><keyword>Nitrilotriacetic Acid/*chemistry</keyword><keyword>Nuclear Proteins/chemistry/isolation &amp; purification</keyword><keyword>Proteins/*chemistry/isolation &amp; purification</keyword><keyword>Ubiquitin/metabolism</keyword><keyword>Ubiquitin Thiolesterase/chemistry/isolation &amp; purification</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17311440</accession-num><abstract>A new bis-nitrilotriacetic acid (NTA) chelate with catechol anchor was synthesized and immobilized on superparamagnetic iron oxide nanoparticles. When loaded with Ni(II), these bis-NTA-immobilized nanoparticles were shown to bind polyhistidine (His x 6-tagged) fusion proteins in their native, folded conformations that commercial microbeads failed to bind under identical conditions. Control experiments with a mono-NTA chelate immobilized on iron oxide nanoparticles indicate a similarly high affinity for His x 6-tagged native proteins, suggesting that the high density of the mono-NTA chelate presented by the nanoparticles allows the binding of the His x 6-tag to more than one Ni-NTA moiety on the surface. This study shows that the multivalency strategy can be utilized to enhance the binding of His x 6-tagged proteins in their native, folded conformations. We further demonstrated the selective purification of His x 6-tagged proteins from crude cell lysates by using the Ni(II)-loaded iron oxide nanoparticles. The present platform is capable of efficient purification of His x 6-tagged proteins that are expressed at low levels in mammalian cells. This work thus presents a novel nanoparticle-based high-capacity protein purification system with shorter incubation times, proportionally large washes, and significantly smaller elution volumes compared to commercially available microbeads.</abstract><notes>Kim, Jason S&#xD;Valencia, C Alexander&#xD;Liu, Rihe&#xD;Lin, Wenbin&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Mar-Apr;18(2):333-41. Epub 2007 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17311440</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc060195l</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>674</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">674</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, C. Y.</author><author>Ma, X. Y.</author><author>Zhang, J. F.</author><author>Corwin, F. D.</author><author>Sim, J. H.</author><author>Zhang, E. Y.</author><author>Dorn, H. C.</author><author>Gibson, H. W.</author><author>Fatouros, P. P.</author><author>Wang, C. R.</author><author>Fang, X. H.</author></authors></contributors><auth-address>Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China.</auth-address><titles><title>Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>651-5</pages><volume>19</volume><number>3</number><edition>2008/02/08</edition><keywords><keyword>Antibodies/*chemistry</keyword><keyword>Biotin/chemistry</keyword><keyword>Chemistry, Physical</keyword><keyword>Contrast Media/*chemical synthesis</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Green Fluorescent Proteins/immunology</keyword><keyword>Indicators and Reagents</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Conformation</keyword><keyword>Molecular Weight</keyword><keyword>Serum Albumin, Bovine/chemistry</keyword><keyword>Solubility</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Streptavidin/chemistry</keyword><keyword>Water</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>18254583</accession-num><abstract>Water-soluble gadofullerides exhibited high efficiency as magnetic resonance imaging (MRI) contrast agents. In this paper, we report the conjugation of the newly synthesized gadofulleride, Gd@C82O6(OH) 16(-)(NHCH2CH2COOH)8, with the antibody of green fluorescence protein (anti-GFP), as a model for &quot;tumor targeted&quot; imaging agents based on endohedral metallofullerenes. In this model system, the activity of the anti-GFP conjugate can be conveniently detected by green fluorescence protein (GFP), leading to in vitro experiments more direct and facile than those of tumor antibodies. Objective-type total internal reflection fluorescence microscopy revealed that each gadofulleride aggregate conjugated on average five anti-GFPs, and the activity of anti-GFPs was preserved after conjugation. In addition, the gadofulleride/antibody conjugate exhibited higher water proton relaxivity (12.0 mM (-1) s (-1)) than the parent gadofulleride aggregate (8.1 mM (-1) s (-1)) in phosphate buffered saline at 0.35 T, as also confirmed by T1-weighted images of phantoms. These observations clearly indicate that the synthesized gadofulleride/antibody conjugate not only has targeting potential, but also exhibits higher efficiency as an MRI contrast agent.</abstract><notes>Shu, Chun-Ying&#xD;Ma, Xin-Yong&#xD;Zhang, Jian-Fei&#xD;Corwin, Frank D&#xD;Sim, Jae Hyun&#xD;Zhang, Er-Yun&#xD;Dorn, Harry C&#xD;Gibson, Harry W&#xD;Fatouros, Panos P&#xD;Wang, Chun-Ru&#xD;Fang, Xiao-Hong&#xD;1 RO1 CA119371/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Mar;19(3):651-5. Epub 2008 Feb 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18254583</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc7002742</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>375</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">375</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shukla, R.</author><author>Thomas, T. P.</author><author>Peters, J. L.</author><author>Desai, A. M.</author><author>Kukowska-Latallo, J.</author><author>Patri, A. K.</author><author>Kotlyar, A.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, 48109, USA.</auth-address><titles><title>HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb</title><secondary-title>Bioconjug Chem</secondary-title><alt-title>Bioconjugate chemistry</alt-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1109-15</pages><volume>17</volume><number>5</number><edition>2006/09</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/chemistry/*metabolism</keyword><keyword>Biocompatible Materials/chemistry/metabolism</keyword><keyword>Cell Line</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/chemistry/metabolism</keyword><keyword>Humans</keyword><keyword>Materials Testing</keyword><keyword>Mice</keyword><keyword>Mice, SCID</keyword><keyword>Molecular Structure</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Polyamines/chemistry/*metabolism</keyword><keyword>Receptor, erbB-2/chemistry/immunology/*metabolism</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>16984117</accession-num><abstract>In the present study, we report the synthesis and human growth factor receptor-2 (HER2) specific tumor targeting properties of a dendrimer conjugated to anti-HER2 mAb (monoclonal antibody) conjugate. The polyamidoamine (PAMAM) dendrimer generation five (G5) was labeled with alexaFluor 488 and conjugated to anti-HER2 mAb. The binding and internalization of the antibody-conjugated dendrimer to HER2-expressing cells was evaluated by flow cytometry and confocal microscopy. Uniquely, the conjugate demonstrated cellular uptake and internalization in HER2-expressing cells as compared to free antibody. The time course of internalization and blocking experiments with free antibody suggest that the rapid and efficient cellular internalization of the dendrimer-antibody conjugate was achieved without alterations in specificity of targeting. Animal studies demonstrated that the conjugate targets HER2-expressing tumors.</abstract><notes>N01-cm-97065-32/cm/nci&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16984117 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>4.384</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>92</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">92</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, E. Y.</author><author>Josephson, L.</author><author>Kelly, K. A.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129-2060, USA.</auth-address><titles><title>Development of nanoparticle libraries for biosensing</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>109-13</pages><volume>17</volume><number>1</number><edition>2006/01/19</edition><keywords><keyword>Amines/chemistry</keyword><keyword>Anhydrides/chemistry</keyword><keyword>*Biosensing Techniques</keyword><keyword>Carboxylic Acids/chemistry</keyword><keyword>Epoxy Compounds/chemistry</keyword><keyword>Hydroxides/chemistry</keyword><keyword>*Magnetics</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>16417258</accession-num><abstract>Magnetic and magnetofluorescent nanoparticles have become important materials for biological applications especially for sensing, separation, and imaging. To achieve target specificity, these nanomaterials are often covalently modified with binding proteins such as antibodies or proteins. Here we report on the creation of nanoparticle libraries that achieve specificity through multivalent modification with small molecules. We explore different synthetic routes to attach small molecules with anhydride, amine, hydroxyl carboxyl, thiol, and epoxy handles. We show that the derived nanomaterials have unique biological functions, possess different behaviors in cell screens, and can be used as substrates for biological screens.</abstract><notes>Sun, Eric Yi&#xD;Josephson, Lee&#xD;Kelly, Kim A&#xD;Weissleder, Ralph&#xD;P01 ca69246/ca/nci&#xD;P50 ca86355/ca/nci&#xD;R24 ca92782/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2006 Jan-Feb;17(1):109-13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16417258</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc050290e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>648</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">648</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>von Maltzahn, Geoffrey</author><author>Ren, Yin</author><author>Park, Ji-Ho</author><author>Min, Dal-Hee</author><author>Kotamraju, Venkata Ramana</author><author>Jayakumar, Jayanthi</author><author>Fogal, Valentina</author><author>Sailor, Michael J.</author><author>Ruoslahti, Erkki</author><author>Bhatia, Sangeeta N.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, Cancer Research Center, Burnham Institute for Medical Research, La Jolla, California, Vascular Mapping Center, Burnham Institute for Medical Research at University of California Santa Barbara, Santa Barbara, California, Materials Science and Engineering Program, Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, and Electrical Engineering and Computer Science, MIT/Brigham &amp; Women s Hospital, Boston, Massachusetts</auth-address><titles><title>In Vivo Tumor Cell Targeting with “Click” Nanoparticles</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><volume>accepted</volume><edition>2008/07/09 </edition><dates><year>2008</year></dates><isbn>1043-1802</isbn><abstract>Abstract: The in vivo fate of nanomaterials strongly determines their biomedical efficacy. Accordingly, much effort has been invested into the development of library screening methods to select targeting ligands for a diversity of sites in vivo. Still, broad application of chemical and biological screens to the in vivo targeting of nanomaterials requires ligand attachment chemistries that are generalizable, efficient, covalent, orthogonal to diverse biochemical libraries, applicable under aqueous conditions, and stable in in vivo environments. To date, the copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition or  click  reaction has shown considerable promise as a method for developing targeted nanomaterials in vitro. Here, we investigate the utility of  click  chemistry for the in vivo targeting of inorganic nanoparticles to tumors. We find that  click  chemistry allows cyclic LyP-1 targeting peptides to be specifically linked to azido-nanoparticles and to direct their binding to p32-expressing tumor cells in vitro. Moreover,  click  nanoparticles are able to stably circulate for hours in vivo following intravenous administration (&gt;5 h circulation time), extravasate into tumors, and penetrate the tumor interstitium to specifically bind p32-expressing cells in tumors. In the future, in vivo use of  click  nanomaterials should expedite the progression from ligand discovery to in vivo evaluation and diversify approaches toward multifunctional nanoparticle development.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/bc800077y</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>UCSD/ MIT</custom2><custom3>2008</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc800077y </electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>656</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">656</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wood, K. C.</author><author>Azarin, S. M.</author><author>Arap, W.</author><author>Pasqualini, R.</author><author>Langer, R.</author><author>Hammond, P. T.</author></authors></contributors><auth-address>Department of Chemical Engineering, Biological Engineering Division, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>403-5</pages><volume>19</volume><number>2</number><edition>2008/01/15</edition><keywords><keyword>*Gene Transfer Techniques</keyword><keyword>Peptides/*administration &amp; dosage</keyword><keyword>Polymers/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>18189340</accession-num><abstract>Before gene therapy can be used in clinical settings, safe and efficient DNA delivery systems must be developed to overcome a range of extra- and intracellular transport barriers. As a step toward the development of a modular, multifunctional gene delivery system to overcome these diverse barriers, we have developed a family of linear-dendritic &quot;hybrid&quot; polymers which contain functionalities for tissue targeting, minimization of nonspecific interactions, endosomal buffering, and DNA binding. Here, we demonstrate the rapid three-step, room-temperature, aqueous synthesis of hybrid polymers, as well as the functionalization of these polymers with a peptide targeting ligand that specifically binds to glucose-regulated protein-78 kDa (GRP-78), a clinically relevant tumor antigen identified in human cancer patients. These polymer systems can condense plasmid DNA into small nanoparticle structures (&lt;210 nm) and transfect cells expressing GRP-78 with efficiencies that exceed that of branched polyethylenimine (bPEI), one of the best commercially available polymers for in vitro transfections. The synthetic approach described here may be useful for the rapid synthesis and optimization of polymer gene delivery systems bearing a range of diverse functional domains, and the specific GRP-78-targeted systems developed in this study may potentially have clinical applications in cancer gene therapy.</abstract><notes>Wood, Kris C&#xD;Azarin, Samira M&#xD;Arap, Wadih&#xD;Pasqualini, Renata&#xD;Langer, Robert&#xD;Hammond, Paula T&#xD;R01-EB00244/EB/United States NIBIB&#xD;R21-EB004122/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Feb;19(2):403-5. Epub 2008 Jan 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18189340</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc700408r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>693</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">693</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, G.</author><author>Yong, K. T.</author><author>Roy, I.</author><author>Mahajan, S. D.</author><author>Ding, H.</author><author>Schwartz, S. A.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute For Lasers, Photonics And Biophotonics, The State University of New York, Buffalo, New York 14260-3000, USA.</auth-address><titles><title>Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1179-85</pages><volume>19</volume><number>6</number><edition>2008/05/14</edition><keywords><keyword>Biosensing Techniques/*instrumentation</keyword><keyword>Blood-Brain Barrier/*metabolism</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Time Factors</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>18473444</accession-num><abstract>We report here, what we believe to be the first time, the successful transport of bioconjugated quantum rods (QRs) across an in vitro blood-brain barrier (BBB) model via a receptor-mediated transport, as well as the use of QR multiplexing technique to compare simultaneously the transmigration efficiency of different biomolecules across the BBB. The migration rate of bioconjugated QRs crossing the in vitro BBB was found to be concentration- and time-dependent. This work illustrates a nanoparticle-based platform that will not only allow a direct visualization of the transmigration ability of various kinds of biomolecules across the BBB, but also facilitate the development of novel diagnostic and therapeutic nanoprobes for early diagnosis and therapy of various disorders of the brain following systemic administration.</abstract><notes>Xu, Gaixia&#xD;Yong, Ken-Tye&#xD;Roy, Indrajit&#xD;Mahajan, Supriya D&#xD;Ding, Hong&#xD;Schwartz, Stanley A&#xD;Prasad, Paras N&#xD;R01CA119397/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Jun;19(6):1179-85. Epub 2008 May 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18473444</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>4.384</custom4><electronic-resource-num>10.1021/bc700477u</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>81</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">81</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bashir, A.</author><author>Liu, Y. T.</author><author>Raphael, B.</author><author>Carson, D.</author><author>Bafna, V.</author></authors></contributors><auth-address>Bioinformatics Program, University of California, San Dego, Department of Computer Science and Engineering, University of California, San Dego, Moores Cancer Center, University of California, San Diego, Department of Computer Science &amp; Center for Computational Molecular Biology, Brown University.</auth-address><titles><title>Optimization of primer design for the detection of variable genomic lesions in cancer</title><secondary-title>Bioinformatics</secondary-title></titles><edition>2007/09/04</edition><dates><year>2007</year><pub-dates><date>Aug 30</date></pub-dates></dates><isbn>1460-2059 (Electronic)</isbn><accession-num>17766270</accession-num><abstract>Primer approximation multiplex PCR (PAMP) is a new experimental protocol for efficiently assaying structural variation in genomes. PAMP is particularly suited to cancer genomes where the precise breakpoints of alterations such as deletions or translocations vary between patients. The design of PCR primer sets for PAMP is challenging because a large number of primer pairs are required to detect alterations in the hundreds of kilobases range that can occur in cancer. These sets of primers must achieve high coverage of the region of interest, while avoiding primer dimers and satisfying the physicochemical constraints of good PCR primers. We describe a natural formulation of these constraints as a combinatorial optimization problem. We show that the PAMP primer design problem is NP-hard, and design algorithms based on simulated annealing and integer programming, that provide good solutions to this problem in practice. The algorithms are applied to a test region around the known CDKN2A deletion, which show excellent results even in a 1:49 mixture of mutated:wild-type cells. We use these test results to help set design parameters for larger problems. We can achieve near-optimal designs for regions close to 1Mb.</abstract><notes>Journal article&#xD;Bioinformatics. 2007 Aug 30;.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17766270</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>5.039</custom4><electronic-resource-num>btm390 [pii]&#xD;10.1093/bioinformatics/btm390</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>558</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">558</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Majoros, I. J.</author><author>Thomas, T.P.</author><author>Candido, K. A.</author><author>Islam, M. T.</author><author>Woehler, S.</author><author>Mehta, C. B.</author><author>Kotlyar, A.</author><author>Cao, Z.</author><author>Kukowska-Latallo, J. F.</author><author>Baker, J.R. Jr. </author></authors></contributors><titles><title>Dendrimer-based nanomedicine: engineered nanodevice synthesis, characterization, and biological testing.</title><secondary-title>Biokémia</secondary-title></titles><pages>9-16</pages><volume>31</volume><edition>2007</edition><dates><year>2007</year></dates><work-type>Journal Article</work-type><urls></urls><custom1>CCNE - U. of Michigan Med.</custom1><custom3>2007</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Cerignoli, F.</author><author>Dawson, M. I.</author><author>Magrini, A.</author><author>Rosato, N.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037, USA. mbottini@burnham.org</auth-address><titles><title>Full-length single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots as multivalent intracellular fluorescent nanoprobes</title><secondary-title>Biomacromolecules</secondary-title><alt-title>Biomacromolecules</alt-title></titles><pages>2259-63</pages><volume>7</volume><number>8</number><edition>2006/08</edition><keywords><keyword>Adsorption</keyword><keyword>Antigens, CD3/metabolism</keyword><keyword>Biological Transport</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Endocytosis</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Lysosomes/metabolism</keyword><keyword>Molecular Probes/chemistry</keyword><keyword>*Nanotechnology/methods</keyword><keyword>Nanotubes, Carbon/*chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>Streptavidin/*chemistry</keyword><keyword>Viruses/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>16903668</accession-num><abstract>We report the formation of a supramolecular luminescent nanoassembly composed of individual or small ropes of full-length, single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots. The supramolecular luminescent nanoassembly was stably dispersed under physiological conditions and was readily visible by both optical and confocal fluorescent microscopies. Jurkat T leukemia cells were able to internalize the nanoassembly by multivalent CD3 receptor-mediated endocytosis (adsorption by cell). Once internalized by cells, the nanoassembly was found to be transported to lysosomes. These properties should make this supramolecular luminescent nanoassembly an excellent building block for the construction of intracellular polyvalent nanoprobes, mimicking natural viral delivery entities with enhanced loading capacity compared to small molecules.</abstract><notes>U54 ca119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16903668 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>3.664</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>371</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">371</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Majoros, I. J.</author><author>Myc, A.</author><author>Thomas, T.</author><author>Mehta, C. B.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, 200 Zina Pitcher Place, 4027 Kresge II., Ann Arbor, 48109-0533, USA. majoros@umich.edu</auth-address><titles><title>PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality</title><secondary-title>Biomacromolecules</secondary-title><alt-title>Biomacromolecules</alt-title></titles><pages>572-9</pages><volume>7</volume><number>2</number><edition>2006/02</edition><keywords><keyword>*Antineoplastic Agents/chemical synthesis/chemistry/pharmacology</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>*Dendrimers/chemical synthesis/chemistry/pharmacology</keyword><keyword>*Drug Carriers/chemical synthesis/chemistry/pharmacology</keyword><keyword>Drug Design</keyword><keyword>Drug Screening Assays, Antitumor</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescein-5-isothiocyanate/chemistry</keyword><keyword>Folic Acid/chemistry</keyword><keyword>Humans</keyword><keyword>KB Cells</keyword><keyword>Molecular Conformation</keyword><keyword>Molecular Weight</keyword><keyword>Paclitaxel/chemistry</keyword><keyword>*Polyamines/chemical synthesis/chemistry/pharmacology</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>16471932</accession-num><abstract>Poly(amidoamine) (PAMAM) dendrimer-based multifunctional cancer therapeutic conjugates have been designed and synthesized. The primary amino groups on the surface of the generation 5 (G5) PAMAM dendrimer were neutralized through partial acetylation, providing enhanced solubility of the dendrimer (in conjugation of FITC (fluorescein isothiocyanate)) and preventing nonspecific targeting interactions (in vitro and in vivo) during delivery. The functional molecules fluorescein isothiocyanate (FITC, an imaging agent), folic acid (FA, targets overexpressed folate receptors on specific cancer cells), and paclitaxel (taxol, a chemotherapeutic drug) were conjugated to the remaining nonacetylated primary amino groups. The appropriate control dendrimer conjugates have been synthesized as well. Characterization of the G5 PAMAM dendrimer and its nanosize conjugates, including the molecular weight and number of primary amine groups, has been determined by multiple analytical methods such as gel permeation chromatography (GPC), nuclear magnetic resonance spectroscopy (NMR), potentiometric titration, high-performance liquid chromatography (HPLC), and UV spectroscopy. These multifunctional dendrimer conjugates have been tested in vitro for targeted delivery of chemotherapeutic and imaging agents to specific cancer cells. We present here the synthesis, characterization, and functionality of these dendrimer conjugates.</abstract><notes>N01-cm-97065-32/cm/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16471932 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2006</custom3><custom4>3.664</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>372</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">372</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Myc, A.</author><author>Majoros, I. J.</author><author>Thomas, T. P.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan 48109, USA.</auth-address><titles><title>Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells</title><secondary-title>Biomacromolecules</secondary-title><alt-title>Biomacromolecules</alt-title></titles><pages>13-8</pages><volume>8</volume><number>1</number><edition>2007/03</edition><keywords><keyword>*Apoptosis</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chromatography, Gel</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Dendrimers/*chemistry</keyword><keyword>Drug Delivery Systems</keyword><keyword>Electrochemistry</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Humans</keyword><keyword>Hydrolysis</keyword><keyword>Jurkat Cells</keyword><keyword>Models, Chemical</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Nanotechnology/methods</keyword><keyword>Neoplasms/metabolism/*pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>17206782</accession-num><abstract>Our previous studies have demonstrated the applicability of poly(amidoamine) (PAMAM) dendrimers as a platform for the targeted delivery of chemotherapeutic drugs both in vitro and in vivo. To monitor the rate and extent of cell-killing caused by the delivered chemotherapeutic drug, we wished to analyze the degree of apoptosis in targeted cells on a real-time basis. As the apoptosis-regulating caspases are activated during the apoptotic process, several caspase-hydrolyzable, fluorescence resonance energy transfer (FRET)-based substrates have been marketed for the detection of apoptosis. However, the applicability of these agents is limited because of their nonspecificity and the consequent high background fluorescence in tissues. Here we show the synthesis, characterization, and in vitro targeting of an engineered PAMAM nanodevice in which folic acid (FA) is conjugated as the targeting molecule and a caspase-specific FRET-based agent (PhiPhiLux G1D2) is conjugated as the apoptosis-detecting agent. This conjugate specifically targets FA-receptor-positive, KB cells. In these cells, the apoptosis-inducing agent staurosporine caused a 5-fold increase in the cellular fluorescence. These results show, for the first time, the potential applicability of a targeted apoptosis-measuring nanodevice, which could be used for simultaneously monitoring the apoptotic potential of a delivered drug.</abstract><notes>N01-cm-97065-32/cm/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17206782 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>3.664</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>508</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">508</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, Z.</author><author>Zheng, S.</author><author>Harrison, W. J.</author><author>Harder, J.</author><author>Wen, X.</author><author>Gelovani, J. G.</author><author>Qiao, A.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.</auth-address><titles><title>Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging</title><secondary-title>Biomacromolecules</secondary-title></titles><pages>3422-8</pages><volume>8</volume><number>11</number><edition>2007/10/26</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chelating Agents/chemistry</keyword><keyword>Cross-Linking Reagents/*chemistry</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>*Micelles</keyword><keyword>Molecular Structure</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Pentetic Acid/chemistry</keyword><keyword>Polymers/*chemistry/pharmacology</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>17958440</accession-num><abstract>We report the synthesis of PEG-coated, core-cross-linked polymeric micelles (CCPMs) derived from an amine-terminated amphiphilic block copolymer, poly(PEG-methacrylate)-b-poly(triethoxysilyl propylmethacrylate). The block copolymer self-assembled to form micellar nanoparticles, and a Cy-7-like near-infrared fluorescence (NIRF) dye was entrapped in the core bearing reactive ethoxysilane functional groups through a subsequent sol-gel process. The fluorescent signal of CCPMs on the molar basis was 16-fold brighter than that of Cy7. With an average diameter of 24 +/- 8.9 nm, CCPMs exhibited a prolonged blood half-life (t1/2,alpha = 1.25 h; t1/2,beta = 46.18 h) and moderate uptake by the mononuclear phagocytic system. Significant accumulation of CCPMs in human breast tumor xenografts allowed noninvasive monitoring of the uptake kinetics with both NIRF optical and gamma imaging techniques. Our data suggest that Cy7-entrapped CCPM nanoparticles are suitable for NIRF imaging of solid tumors and have potential applications in the imaging of tumor-associated molecular markers.</abstract><notes>Yang, Zhi&#xD;Zheng, Shiying&#xD;Harrison, William J&#xD;Harder, John&#xD;Wen, Xiaoxia&#xD;Gelovani, Juri G&#xD;Qiao, Alex&#xD;Li, Chun&#xD;CA 16672/CA/United States NCI&#xD;R01 CA 119387/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biomacromolecules&#xD;Biomacromolecules. 2007 Nov;8(11):3422-8. Epub 2007 Oct 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17958440</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2008</custom3><custom4>3.664</custom4><electronic-resource-num>10.1021/bm7005399</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>25</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">25</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheng, J.</author><author>Teply, B. A.</author><author>Sherifi, I.</author><author>Sung, J.</author><author>Luther, G.</author><author>Gu, F. X.</author><author>Levy-Nissenbaum, E.</author><author>Radovic-Moreno, A. F.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.</auth-address><titles><title>Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery</title><secondary-title>Biomaterials</secondary-title><alt-title>Biomaterials</alt-title></titles><pages>869-76</pages><volume>28</volume><number>5</number><edition>2007/02</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Lactic Acid/*chemistry</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Models, Chemical</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Polyglycolic Acid/*chemistry</keyword><keyword>Polymers/*chemistry</keyword><keyword>Prostatic Neoplasms/drug therapy</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>17055572</accession-num><abstract>Nanoparticle (NP) size has been shown to significantly affect the biodistribution of targeted and non-targeted NPs in an organ specific manner. Herein we have developed NPs from carboxy-terminated poly(d,L-lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-b-PEG-COOH) polymer and studied the effects of altering the following formulation parameters on the size of NPs: (1) polymer concentration, (2) drug loading, (3) water miscibility of solvent, and (4) the ratio of water to solvent. We found that NP mean volumetric size correlates linearly with polymer concentration for NPs between 70 and 250 nm in diameter (linear coefficient=0.99 for NPs formulated with solvents studied). NPs with desirable size, drug loading, and polydispersity were conjugated to the A10 RNA aptamer (Apt) that binds to the prostate specific membrane antigen (PSMA), and NP and NP-Apt biodistribution was evaluated in a LNCaP (PSMA+) xenograft mouse model of prostate cancer. The surface functionalization of NPs with the A10 PSMA Apt significantly enhanced delivery of NPs to tumors vs. equivalent NPs lacking the A10 PSMA Apt (a 3.77-fold increase at 24h; NP-Apt 0.83%+/-0.21% vs. NP 0.22%+/-0.07% of injected dose per gram of tissue; mean+/-SD, n=4, p=0.002). The ability to control NP size together with targeted delivery may result in favorable biodistribution and development of clinically relevant targeted therapies.</abstract><notes>Ca 119349/ca/nci&#xD;Eb 003647/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17055572 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>5.196</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>622</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">622</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Partlow, K. C.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Medicine, Washington University in St. Louis, School of Medicine, Campus Box 8215, 660 South Euclid Avenue, St. Louis, MO 63110, USA.</auth-address><titles><title>Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery</title><secondary-title>Biomaterials</secondary-title></titles><pages>3367-75</pages><volume>29</volume><number>23</number><edition>2008/05/20</edition><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>18485474</accession-num><abstract>The ability to specifically deliver therapeutic agents to selected cell types while minimizing systemic toxicity is a principal goal of nanoparticle-based drug delivery approaches. Numerous cellular portals exist for cargo uptake and transport, but after targeting, intact nanoparticles typically are internalized via endocytosis prior to drug release. However, in this work, we show that certain classes of nanoparticles, namely lipid-coated liquid perfluorocarbon emulsions, undergo unique interactions with cells to deliver lipophilic substances to target cells without the need for entire nanoparticle internalization. To define the delivery mechanisms, fluorescently-labeled nanoparticles complexed with alphav beta 3-integrin targeting ligands were incubated with alphav beta 3-integrin expressing cells (C32 melanoma) under selected inhibitory conditions that revealed specific nanoparticle-to-cell interactions. We observed that the predominant mechanism of lipophilic delivery entailed direct delivery of lipophilic substances to the target cell plasma membrane via lipid mixing and subsequent intracellular trafficking through lipid raft-dependent processes. We suggest that local drug delivery to selected cell types could be facilitated by employing targeted nanoparticles designed specifically to utilize alternative membrane transport mechanisms.</abstract><notes>Partlow, Kathryn C&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;CO-37007/CO/United States NCI&#xD;HL-073646/HL/United States NHLBI&#xD;HL-078631/HL/United States NHLBI&#xD;U54-CA-119342/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2008 Aug;29(23):3367-75. Epub 2008 May 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18485474</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>5.196</custom4><electronic-resource-num>S0142-9612(08)00265-2 [pii]&#xD;10.1016/j.biomaterials.2008.04.030</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>641</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">641</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Teply, B. A.</author><author>Tong, R.</author><author>Jeong, S. Y.</author><author>Luther, G.</author><author>Sherifi, I.</author><author>Yim, C. H.</author><author>Khademhosseini, A.</author><author>Farokhzad, O. C.</author><author>Langer, R. S.</author><author>Cheng, J.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules</title><secondary-title>Biomaterials</secondary-title></titles><pages>1216-23</pages><volume>29</volume><number>9</number><edition>2007/12/18</edition><keywords><keyword>Administration, Oral</keyword><keyword>Animals</keyword><keyword>*Biocompatible Materials</keyword><keyword>Biological Availability</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Insulin/administration &amp; dosage/pharmacokinetics</keyword><keyword>*Lactic Acid</keyword><keyword>*Magnetics</keyword><keyword>Materials Testing</keyword><keyword>Mice</keyword><keyword>Particle Size</keyword><keyword>*Polyglycolic Acid</keyword><keyword>*Polymers</keyword><keyword>Proteins/*administration &amp; dosage/*pharmacokinetics</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>18082254</accession-num><abstract>Protein drugs have low bioavailability after oral administration, which is due in part to fast transit of the drugs or drug delivery vehicles through the gastrointestinal tract. Increasing the time that the drugs spend in the intestine after dosing would allow for greater absorption and increased bioavailability. We developed a formulation strategy that can be used to prolong intestinal retention of drug delivery vehicles without substantial alterations to current polymeric encapsulation strategies. A model drug, insulin, was encapsulated in negatively charged poly(lactic-co-glycolic acid) (PLGA) microparticles, and the microparticles were subsequently mixed with positively charged micromagnets, whose size will prevent them from being absorbed. Stable complexes formed through electrostatic interaction. The complexes were effectively immobilized in vitro in a model of the mouse small intestine by application of an external magnetic field. Mice that were gavaged with radio-labeled complexes and fitted with a magnetic belt retained 32.5% of the (125)I-insulin in the small intestine compared with 5.4% for the control group 6h after administration (p=0.005). Furthermore, mice similarly gavaged with complexes encapsulating insulin (120 Units/kg) exhibited long-term glucose reduction in the groups with magnetic belts. The corresponding bioavailability of insulin was 5.11% compared with 0.87% for the control group (p=0.007).</abstract><notes>Teply, Benjamin A&#xD;Tong, Rong&#xD;Jeong, Seok Y&#xD;Luther, Gaurav&#xD;Sherifi, Ines&#xD;Yim, Christopher H&#xD;Khademhosseini, Ali&#xD;Farokhzad, Omid C&#xD;Langer, Robert S&#xD;Cheng, Jianjun&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2008 Mar;29(9):1216-23. Epub 2007 Dec 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18082254</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom2>MIT/ Siteman</custom2><custom3>2008</custom3><custom4>5.196</custom4><electronic-resource-num>S0142-9612(07)00953-2 [pii]&#xD;10.1016/j.biomaterials.2007.11.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>107</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">107</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, L.</author><author>Zhao, G.</author><author>Olivares-Navarrete, R.</author><author>Bell, B. F.</author><author>Wieland, M.</author><author>Cochran, D. L.</author><author>Schwartz, Z.</author><author>Boyan, B. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, 315 Ferst Drive NW, Georgia 30332, USA.</auth-address><titles><title>Integrin beta1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D3</title><secondary-title>Biomaterials</secondary-title></titles><pages>3716-25</pages><volume>27</volume><number>20</number><edition>2006/03/30</edition><keywords><keyword>Animals</keyword><keyword>Antibodies/metabolism</keyword><keyword>Antigens, CD29/genetics/*metabolism</keyword><keyword>Bone Density Conservation Agents/*metabolism</keyword><keyword>Calcitriol/*metabolism</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Line</keyword><keyword>Dinoprostone/genetics/metabolism</keyword><keyword>*Gene Silencing</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Osteoblasts/cytology/*physiology</keyword><keyword>Osteoprotegerin/genetics/metabolism</keyword><keyword>RNA, Small Interfering/metabolism</keyword><keyword>Surface Properties</keyword><keyword>Titanium/metabolism</keyword><keyword>Transforming Growth Factor beta1/genetics/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>16569430</accession-num><abstract>Surface microroughness increases osteoblast differentiation and enhances responses of osteoblasts to 1,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3]. The observations that beta1 integrin expression is increased in osteoblasts grown on Ti substrates with rough microarchitecture, and that it is regulated by 1alpha,25(OH)2D3 in a surface-dependent manner, suggest that beta1 may play a role in mediating osteoblast response. To test this hypothesis, we silenced beta1 expression in MG63 human osteoblast-like cells using small interfering RNA (siRNA) and examined the responses of the beta1-silenced osteoblasts to surface microtopography and 1alpha,25(OH)2D3. To better understand the role of beta1, MG63 cells were also treated with two different monoclonal antibodies to human beta1 to block ligand binding. beta1-silenced MG63 cells grown on a tissue culture plastic had reduced alkaline phosphatase activity and levels of osteocalcin, transforming growth factor beta1, prostaglandin E2, and osteoprotegerin in comparison with control cells. Moreover, beta1-silencing inhibited the effects of surface roughness on these parameters and partially inhibited effects of 1alpha,25(OH)2D3. Anti beta1 antibody AIIB2 had no significant effect on cell number and osteocalcin, but decreased alkaline phosphatase; MAB2253Z caused dose-dependent decreases in cell number and alkaline phosphatase and an increase in osteocalcin. Effects of 1alpha,25(OH)2D3 on cell number and alkaline phosphatase were reduced and effects on osteocalcin were increased. These findings indicate that beta1 plays a major and complex role in osteoblastic differentiation modulated by either surface microarchitecture or 1alpha,25(OH)2D3. The results also show that beta1 mediates, in part, the synergistic effects of surface roughness and 1alpha,25(OH)2D3.</abstract><notes>Wang, Liping&#xD;Zhao, Ge&#xD;Olivares-Navarrete, Rene&#xD;Bell, Bryan F&#xD;Wieland, Marco&#xD;Cochran, David L&#xD;Schwartz, Zvi&#xD;Boyan, Barbara D&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2006 Jul;27(20):3716-25. Epub 2006 Mar 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16569430</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>5.196</custom4><electronic-resource-num>S0142-9612(06)00158-X [pii]&#xD;10.1016/j.biomaterials.2006.02.022</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>260</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">260</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sui, G.</author><author>Lee, C. C.</author><author>Kamei, K.</author><author>Li, H. J.</author><author>Wang, J. Y.</author><author>Wang, J.</author><author>Herschman, H. R.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Department of Molecular Medical Pharmacology and Crump Institute for Molecular Imaging, University of California, Los Angeles, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>A microfluidic platform for sequential ligand labeling and cell binding analysis</title><secondary-title>Biomed Microdevices</secondary-title></titles><pages>301-5</pages><volume>9</volume><number>3</number><edition>2006/12/30</edition><keywords><keyword>Animals</keyword><keyword>Cell Culture Techniques/*instrumentation/methods</keyword><keyword>Cell Membrane/*metabolism</keyword><keyword>Epidermal Growth Factor/*metabolism</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Flow Cytometry/*instrumentation/methods</keyword><keyword>Flow Injection Analysis/instrumentation/methods</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Microfluidic Analytical Techniques/*instrumentation/methods</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Protein Interaction Mapping/*methods</keyword><keyword>Receptor, Epidermal Growth Factor/*metabolism</keyword><keyword>Staining and Labeling/methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1387-2176 (Print)</isbn><accession-num>17195108</accession-num><abstract>Developing biochemical and cell biological assay for screening biomolecules, evaluating their characteristics in biological processes, and determining their pharmacological effects represents a key technology in biomedical research. A PDMS-based integrated microfluidic platform was fabricated and tested for facilitating the labeling of ligand on the nanogram scale and sequential cell binding analysis in a manner that saves both time and reagents. Within this microfluidic platform, ligand labeling, cell immobolization, and optical analysis are performed in a miniaturized, continuous and semi-automated manner. This microfluidic device for ligand labeling and cell analysis is composed of two functional modules: (i) a circular reaction loop for fluorophore-labeling of the ligand and (ii) four parallel-oriented incubation chambers for immobilization of cells, binding of ligand to different cell populations, and optical evaluation of interactions between the labeled ligand and its cell targets. Epidermal growth factor (EGF) as the ligand and different cell lines with various levels of EGF receptor expression have been utilized to test the feasiblity of this microfluidic platform. When compared to studies with traditional Petri dish handling of cells and tissues, or even microwell analyses, experiments with the microfluidic platform described here are much less time consuming, conserve reagents, and are programmable, which makes these platforms a very promising new tool for biological studies.</abstract><notes>Sui, Guodong&#xD;Lee, Cheng-Chung&#xD;Kamei, Ken-Ichiro&#xD;Li, Hua-Jung&#xD;Wang, Jin-Yi&#xD;Wang, Jun&#xD;Herschman, Harvey R&#xD;Tseng, Hsian-Rong&#xD;P50 ca086306:06/ca/nci&#xD;P50 ca092131:04/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biomedical microdevices&#xD;Biomed Microdevices. 2007 Jun;9(3):301-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17195108</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>Caltech/ Stanford</custom2><custom3>2007</custom3><custom4>2.551</custom4><electronic-resource-num>10.1007/s10544-006-9033-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>199</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">199</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barat, B.</author><author>Wu, A. M.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular &amp; Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum</title><secondary-title>Biomol Eng</secondary-title></titles><pages>283-91</pages><volume>24</volume><number>3</number><edition>2007/03/24</edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1389-0344 (Print)</isbn><accession-num>17379573</accession-num><abstract>Due to its strength and specificity, the interaction between avidin and biotin has been used in a variety of scientific and medical applications ranging from immunohistochemistry to drug targeting. The present study describes two methods for biotinylation of proteins secreted from eukaryotic cells using the Escherichia coli biotin protein ligase. In one system the biotin ligase was co-secreted from the cells along with substrate protein enabling extracellular biotinylation of the tagged protein. In the other system, biotin ligase was engineered to be retained in the endoplasmic reticulum (ER) and metabolically biotinylates the secretory protein as it passes through the ER. An engineered antibody fragment, a diabody with specificity for carcinoembryonic antigen (CEA) was fused to the biotin acceptor domain (123 amino acid) of Propionibacterium shermanii. Coexpression of the fusion protein with ER retained biotin ligase showed higher biotinylation efficiency than biotinylation by co-secreted ligase. Biotinylation of the anti-CEA diabody tagged with a short (15 amino acid, Biotin Avitagtrade mark) biotin acceptor peptide was also successful. Utilization of ER retained biotin ligase for biotinylation of protein is an attractive alternative for efficiently producing uniformly biotinylated recombinant proteins for a variety of avidin-biotin technologies.</abstract><notes>Barat, Bhaswati&#xD;Wu, Anna M&#xD;Netherlands&#xD;Biomolecular engineering&#xD;Biomol Eng. 2007 Sep;24(3):283-91. Epub 2007 Feb 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17379573</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>2.568</custom4><electronic-resource-num>S1389-0344(07)00020-2 [pii]&#xD;10.1016/j.bioeng.2007.02.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>579</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">579</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chong, H. S.</author><author>Song, H. A.</author><author>Lim, S.</author><author>Macrenaris, K.</author><author>Ma, X.</author><author>Lee, H.</author><author>Bui, P.</author><author>Meade, T.</author></authors></contributors><auth-address>Chemistry Division, Biological, Chemical, and Physical Sciences Department, Illinois Institute of Technology, 3101 S. Dearborn St., LS 182, Chicago, IL 60616, USA. chong@iit.edu</auth-address><titles><title>A novel cholic acid-based contrast enhancement agent for targeted MRI</title><secondary-title>Bioorg Med Chem Lett</secondary-title></titles><pages>2505-8</pages><volume>18</volume><number>7</number><edition>2008/03/14</edition><keywords><keyword>Chelating Agents/*chemical synthesis</keyword><keyword>Cholic Acid/*chemistry</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Microscopy, Electron, Transmission/methods</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Organometallic Compounds/*chemical synthesis</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 1</date></pub-dates></dates><isbn>1464-3405 (Electronic)</isbn><accession-num>18337094</accession-num><abstract>The novel Gd(III) complexes of heptadentate ligands NE3TA and NE3TA-Bn were prepared, and their relaxivities were measured and favorably compared to the commercially available MRI contrast enhancement agent Gd(DOTA). NE3TA was conjugated with cholic acid (CA) to produce CA-NE3TA. TEM images of Gd(CA-NE3TA) indicate that the complex self-assembles forming nano-sized micelles and displays an over threefold increased relaxivity compared to Gd(DOTA). The new cholic acid-conjugated nanoparticle MR contrast enhancement agent, Gd(CA-NE3TA) possesses great promise for use in targeted MRI.</abstract><notes>Chong, Hyun-Soon&#xD;Song, Hyun A&#xD;Lim, Sooyoun&#xD;Macrenaris, Keith&#xD;Ma, Xiang&#xD;Lee, Haisung&#xD;Bui, Phuong&#xD;Meade, Thomas&#xD;1R01-EB00-5866/EB/United States NIBIB&#xD;K22CA102637/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Bioorganic &amp; medicinal chemistry letters&#xD;Bioorg Med Chem Lett. 2008 Apr 1;18(7):2505-8. Epub 2008 Jan 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18337094</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>2.604</custom4><electronic-resource-num>S0960-894X(08)00059-0 [pii]&#xD;10.1016/j.bmcl.2008.01.044</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>155</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">155</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, L.</author><author>Koynova, R.</author><author>Parikh, H.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois, USA.</auth-address><titles><title>Transfection activity of binary mixtures of cationic o-substituted phosphatidylcholine derivatives: the hydrophobic core strongly modulates physical properties and DNA delivery efficacy</title><secondary-title>Biophys J</secondary-title></titles><pages>3692-706</pages><volume>91</volume><number>10</number><edition>2006/08/29</edition><keywords><keyword>Cations</keyword><keyword>Cell Membrane/chemistry/*metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Complex Mixtures/chemistry</keyword><keyword>DNA/administration &amp; dosage/*chemistry/genetics/*pharmacokinetics</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Endothelial Cells/*metabolism</keyword><keyword>Humans</keyword><keyword>Hydrophobicity</keyword><keyword>Phosphatidylcholines/*chemistry</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov 15</date></pub-dates></dates><isbn>0006-3495 (Print)</isbn><accession-num>16935955</accession-num><abstract>A combination of two cationic lipid derivatives having the same headgroup but tails of different chain lengths has been shown to have considerably different transfection activity than do the separate molecules. Such findings point to the importance of investigating the hydrophobic portions of cationic amphiphiles. Hence, we have synthesized a variety of cationic phosphatidylcholines with unusual hydrophobic moieties and have evaluated their transfection activity and that of their mixtures with the original molecule of this class, dioleoyl-O-ethylphosphatidylcholine (EDOPC). Four distinct relationships between transfection activity and composition of the mixture (plotted as percent of the new compound added to EDOPC) were found, namely: with a maximum or minimum; with a proportional change; or with essentially no change. Relevant physical properties of the lipoplexes were also examined; specifically, membrane fusion (by fluorescence resonance energy transfer between cationic and anionic lipids) and DNA unbinding (measured as accessibility of DNA to ethidium bromide by electrophoresis and by fluorescence resonance energy transfer between DNA and cationic lipid), both after the addition of negatively charged membrane lipids. Fusibility increased with increasing content of second cationic lipid, regardless of the transfection pattern. However, the extent of DNA unbinding after addition of negatively charged membrane lipids did correlate with extent of transfection. The phase behavior of cationic lipids per se as well as that of their mixtures with membrane lipids revealed structural differences that may account for and support the hypothesis that a membrane lipid-triggered, lamellar--&gt;nonlamellar phase transition that facilitates DNA release is critical to efficient transfection by cationic lipids.</abstract><notes>Wang, Li&#xD;Koynova, Rumiana&#xD;Parikh, Harsh&#xD;MacDonald, Robert C&#xD;Gm52329/gm/nigms&#xD;Gm57305/gm/nigms&#xD;Gm74429/gm/nigms&#xD;Rr08630/rr/ncrr&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Biophysical journal&#xD;Biophys J. 2006 Nov 15;91(10):3692-706. Epub 2006 Aug 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16935955</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>4.627</custom4><electronic-resource-num>biophysj.106.092700 [pii]&#xD;10.1529/biophysj.106.092700</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>204</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T. C.</author><author>Shieh, F.</author><author>Lavery, L. A.</author><author>Levy, M.</author><author>Richards-Kortum, R.</author><author>Korgel, B. A.</author><author>Ellington, A. D.</author></authors></contributors><auth-address>Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, United States.</auth-address><titles><title>Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates</title><secondary-title>Biosens Bioelectron</secondary-title></titles><pages>1859-66</pages><volume>21</volume><number>10</number><edition>2006/02/24</edition><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0956-5663 (Print)</isbn><accession-num>16495043</accession-num><abstract>Aptamers that bind to prostate specific membrane antigen (PSMA) were conjugated to luminescent CdSe and CdTe nanocrystals for cell-labeling studies. The aptamer-nanocrystal conjugates showed specific targeting of both fixed and live cells that overexpressed PSMA. More importantly, aptamers were able to label cells dispersed in a collagen gel matrix simulating tissue. The specific binding abilities and synthetic accessibility of aptamers combined with the photostability and small size of semiconductor nanocrystals offers a powerful and general tool for cellular imaging.</abstract><notes>Chu, Ted C&#xD;Shieh, Felice&#xD;Lavery, Laura A&#xD;Levy, Matthew&#xD;Richards-Kortum, Rebecca&#xD;Korgel, Brian A&#xD;Ellington, Andrew D&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2006 Apr 15;21(10):1859-66. Epub 2006 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16495043</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>4.132</custom4><electronic-resource-num>S0956-5663(05)00403-3 [pii]&#xD;10.1016/j.bios.2005.12.015</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>235</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">235</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soper, S. A.</author><author>Brown, K.</author><author>Ellington, A.</author><author>Frazier, B.</author><author>Garcia-Manero, G.</author><author>Gau, V.</author><author>Gutman, S. I.</author><author>Hayes, D. F.</author><author>Korte, B.</author><author>Landers, J. L.</author><author>Larson, D.</author><author>Ligler, F.</author><author>Majumdar, A.</author><author>Mascini, M.</author><author>Nolte, D.</author><author>Rosenzweig, Z.</author><author>Wang, J.</author><author>Wilson, D.</author></authors></contributors><auth-address>Louisiana State University, Baton Rouge, LA 70803, United States. chsope@lsu.edu</auth-address><titles><title>Point-of-care biosensor systems for cancer diagnostics/prognostics</title><secondary-title>Biosens Bioelectron</secondary-title></titles><pages>1932-42</pages><volume>21</volume><number>10</number><edition>2006/02/14</edition><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0956-5663 (Print)</isbn><accession-num>16473506</accession-num><abstract>With the growing number of fatalities resulting from the 100 or so cancer-related diseases, new enabling tools are required to provide extensive molecular profiles of patients to guide the clinician in making viable diagnosis and prognosis. Unfortunately with cancer-related diseases, there is not one molecular marker that can provide sufficient information to assist the clinician in making effective prognoses or even diagnoses. Indeed, large panels of markers must typically be evaluated that cut across several different classes (mutations in certain gene fragments--DNA; over/under-expression of gene activity as monitored by messenger RNAs; the amount of proteins present in serum or circulating tumor cells). The classical biosensor format (dipstick approach for monitoring the presence of a single element) is viewed as a valuable tool in many bioassays, but possesses numerous limitations in cancer due primarily to the single element nature of these sensing platforms. As such, if biosensors are to become valuable tools in the arsenal of the clinician to manage cancer patients, new formats are required. This review seeks to provide an overview of the current thinking on molecular profiling for diagnosis and prognosis of cancers and also, provide insight into the current state-of-the-art in the biosensor field and new strategies that must be considered to bring this important technology into the cancer field.</abstract><notes>Soper, Steven A&#xD;Brown, Kathlynn&#xD;Ellington, Andrew&#xD;Frazier, Bruno&#xD;Garcia-Manero, Guillermo&#xD;Gau, Vincent&#xD;Gutman, Steven I&#xD;Hayes, Daniel F&#xD;Korte, Brenda&#xD;Landers, James L&#xD;Larson, Dale&#xD;Ligler, Frances&#xD;Majumdar, Arun&#xD;Mascini, Marco&#xD;Nolte, David&#xD;Rosenzweig, Zeev&#xD;Wang, Joseph&#xD;Wilson, David&#xD;Review&#xD;England&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2006 Apr 15;21(10):1932-42. Epub 2006 Feb 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16473506</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>4.132</custom4><electronic-resource-num>S0956-5663(06)00012-1 [pii]&#xD;10.1016/j.bios.2006.01.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>512</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, L.</author><author>Yu, H.</author><author>Akhras, M. S.</author><author>Han, S. J.</author><author>Osterfeld, S.</author><author>White, R. L.</author><author>Pourmand, N.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Stanford University, Stanford, CA 94305-4045, USA.</auth-address><titles><title>Giant magnetoresistive biochip for DNA detection and HPV genotyping</title><secondary-title>Biosens Bioelectron</secondary-title></titles><edition>2008/05/07</edition><dates><year>2008</year><pub-dates><date>Apr 8</date></pub-dates></dates><isbn>0956-5663 (Print)</isbn><accession-num>18457945</accession-num><abstract>A giant magnetoresistive (GMR) biochip based on spin valve sensor array and magnetic nanoparticle labels was developed for inexpensive, sensitive and reliable DNA detection. The DNA targets detected in this experiment were PCR products amplified from Human Papillomavirus (HPV) plasmids. The concentrations of the target DNA after PCR were around 10nM in most cases, but concentrations of 10pM were also detectable, which is demonstrated by experiments with synthetic DNA samples. A mild but highly specific surface chemistry was used for probe oligonucleotide immobilization. Double modulation technique was used for signal detection in order to reduce the 1/f noise in the sensor. Twelve assays were performed with an accuracy of approximately 90%. Magnetic signals were consistent with particle coverage data measured with Scanning Electron Microscopy (SEM). More recent research on microfluidics showed the potential of reducing the assay time below one hour. This is the first demonstration of magnetic DNA detection using plasmid-derived samples. This study provides a direct proof that GMR sensors can be used for biomedical applications.</abstract><notes>Journal article&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2008 Apr 8;.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18457945</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>4.132</custom4><electronic-resource-num>S0956-5663(08)00148-6 [pii]&#xD;10.1016/j.bios.2008.03.030</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>82</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">82</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Li, L.</author><author>Katsuoka, K.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, CA 92111, USA.</auth-address><titles><title>GFP-expressing vascularization of Gelfoam as a rapid in vivo assay of angiogenesis stimulators and inhibitors</title><secondary-title>Biotechniques</secondary-title></titles><pages>294, 296, 298</pages><volume>42</volume><number>3</number><edition>2007/03/30</edition><keywords><keyword>Angiogenesis Inducing Agents/*pharmacology</keyword><keyword>Angiogenesis Inhibitors/*pharmacology</keyword><keyword>Animals</keyword><keyword>Gelatin Sponge, Absorbable/*chemistry</keyword><keyword>Green Fluorescent Proteins/*metabolism</keyword><keyword>Humans</keyword><keyword>Liver Neoplasms/pathology/secondary</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplasm Transplantation</keyword><keyword>*Neovascularization, Pathologic</keyword><keyword>Pancreatic Neoplasms/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0736-6205 (Print)</isbn><accession-num>17390535</accession-num><notes>Amoh, Yasuyuki&#xD;Li, Lingna&#xD;Katsuoka, Kensei&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Ca099258/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;BioTechniques&#xD;Biotechniques. 2007 Mar;42(3):294, 296, 298.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17390535</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>2.759</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>452</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">452</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bartlett, D. W.</author><author>Davis, M. E.</author></authors></contributors><auth-address>Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., MC 210-41, Pasadena, California 91125, USA.</auth-address><titles><title>Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles</title><secondary-title>Biotechnol Bioeng</secondary-title></titles><pages>975-85</pages><volume>99</volume><number>4</number><edition>2007/10/12</edition><keywords><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Female</keyword><keyword>Gene Targeting/*methods</keyword><keyword>Gene Therapy/*methods</keyword><keyword>Injections, Intravenous</keyword><keyword>Mice</keyword><keyword>Nanoparticles/*administration &amp; dosage</keyword><keyword>Neuroblastoma/*genetics/pathology/*therapy</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage</keyword><keyword>Transferrin/*genetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1097-0290 (Electronic)</isbn><accession-num>17929316</accession-num><abstract>This study addresses issues of relevance for siRNA nanoparticle delivery by investigating the functional impact of tumor-specific targeting and dosing schedule. The investigations are performed using an experimental system involving a syngeneic mouse cancer model and a theoretical system based on our previously described mathematical model of siRNA delivery and function. A/J mice bearing subcutaneous Neuro2A tumors approximately 100 mm(3) in size were treated by intravenous injection with siRNA-containing nanoparticles formed with cyclodextrin-containing polycations (CDP). Three consecutive daily doses of transferrin (Tf)-targeted nanoparticles carrying 2.5 mg/kg of two different siRNA sequences targeting ribonucleotide reductase subunit M2 (RRM2) slowed tumor growth, whereas non-targeted nanoparticles were significantly less effective when given at the same dose. Furthermore, administration of the three doses on consecutive days or every 3 days did not lead to statistically significant differences in tumor growth delay. Mathematical model calculations of siRNA-mediated target protein knockdown and tumor growth inhibition are used to elucidate possible mechanisms to explain the observed effects and to provide guidelines for designing more effective siRNA-based treatment regimens regardless of delivery methodology and tumor type.</abstract><notes>Bartlett, Derek W&#xD;Davis, Mark E&#xD;CA119347/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Biotechnology and bioengineering&#xD;Biotechnol Bioeng. 2008 Mar 1;99(4):975-85.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17929316</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>3.037</custom4><electronic-resource-num>10.1002/bit.21668</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>446</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">446</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krauland, E. M.</author><author>Peelle, B. R.</author><author>Wittrup, K. D.</author><author>Belcher, A. M.</author></authors></contributors><auth-address>Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.</auth-address><titles><title>Peptide tags for enhanced cellular and protein adhesion to single-crystalline sapphire</title><secondary-title>Biotechnol Bioeng</secondary-title></titles><pages>1009-20</pages><volume>97</volume><number>5</number><edition>2007/01/24</edition><keywords><keyword>Affinity Labels/*chemistry</keyword><keyword>Aluminum Oxide/*chemistry</keyword><keyword>Binding Sites</keyword><keyword>Cell Adhesion/*physiology</keyword><keyword>Cell Culture Techniques/methods</keyword><keyword>Coated Materials, Biocompatible/*chemistry</keyword><keyword>Peptide Library</keyword><keyword>Peptides/*chemistry</keyword><keyword>Protein Binding</keyword><keyword>Saccharomyces cerevisiae/*physiology</keyword><keyword>Saccharomyces cerevisiae Proteins/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0006-3592 (Print)</isbn><accession-num>17238208</accession-num><abstract>In order to facilitate a novel means for coupling proteins to metal oxides, peptides were identified from a dodecamer peptide yeast surface display library that bound a model metal oxide material, the C, A, and R crystalline faces of synthetic sapphire (alpha-Al(2)O(3)). Seven rounds of screening yielded peptides enriched in basic amino acids compared to the naive library. While the C-face had a high background of endogenous yeast cell binding, the A- and R faces displayed clear peptide-mediated cell adhesion. Cell detachment assays showed that cell adhesion strength correlated positively with increasing basicity of expressed peptides. Cell adhesion was also shown to be sensitive to buffer ionic strength as well as incubation with soluble peptide (with half maximal inhibition of cell binding at approximately 5 microM peptide). Next, dodecamer peptides cloned into yeast showed that lysine led to stronger interactions than arginine, and that charge distribution affected adhesion strength. We postulate binding to arise from peptide geometries that permit conformation alignment of the basic amino acids towards the surface so that the charged groups can undergo local electrostatic interactions with the surface oxide. Lastly, peptide K1 (-(GK)(6)) was cloned onto the c-terminus of maltose binding protein (MBP) and the resultant mutant protein showed a half-maximal binding at approximately 10(-7)-10(-6) M, which marked a approximately 500- to 1,000-fold binding improvement to sapphire&apos;s A-face as compared with wild-type MBP. Targeting proteins to metal oxide surfaces with peptide tags may provide a facile one-step alternative coupling chemistry for the formation of protein bioassays and biosensors.</abstract><notes>Krauland, Eric M&#xD;Peelle, Beau R&#xD;Wittrup, K Dane&#xD;Belcher, Angela M&#xD;T32 GM 008334/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biotechnology and bioengineering&#xD;Biotechnol Bioeng. 2007 Aug 1;97(5):1009-20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17238208</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>3.037</custom4><electronic-resource-num>10.1002/bit.21341</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>232</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">232</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shazer, R. L.</author><author>Jain, A.</author><author>Galkin, A. V.</author><author>Cinman, N.</author><author>Nguyen, K. N.</author><author>Natale, R. B.</author><author>Gross, M.</author><author>Green, L.</author><author>Bender, L. I.</author><author>Holden, S.</author><author>Kaplan, L.</author><author>Agus, D. B.</author></authors></contributors><auth-address>Louis Warschaw Prostate Cancer Center, Cedars-Sinai Medical Center, 8631 West Third Street, Los Angeles, CA 90048, USA.</auth-address><titles><title>Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial</title><secondary-title>BJU Int</secondary-title></titles><pages>691-7</pages><volume>97</volume><number>4</number><edition>2006/03/16</edition><keywords><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Middle Aged</keyword><keyword>Pilot Projects</keyword><keyword>Prostate-Specific Antigen/blood</keyword><keyword>Prostatic Neoplasms/blood/*drug therapy/pathology</keyword><keyword>Raloxifene/*therapeutic use</keyword><keyword>Selective Estrogen Receptor Modulators/*therapeutic use</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1464-4096 (Print)</isbn><accession-num>16536755</accession-num><abstract>OBJECTIVES: To determine, in preclinical in vivo animal and in clinical studies, whether raloxifene (a selective oestrogen-receptor (ER) modulator that targets ER-beta and induces apoptosis in vitro in androgen-independent prostate cancer, AIPC cells) affects prostate cell differentiation, proliferation and carcinogenesis, and in the pilot phase II clinical trial, the response rate and duration of patients with AIPC treated with a daily oral dose of raloxifene. PATIENTS, MATERIALS AND METHODS: Tumour proliferation rate in response to raloxifene treatment, and molecular markers of cell cycle and apoptosis, were evaluated in established ER-beta-positive androgen-dependent (AD) CWR22 and AI CWRSA9 human xenograft prostate cancer models. Twenty-one patients with AIPC and evidence of disease progression were enrolled into the clinical trial and given daily oral raloxifene. RESULTS: There was significant growth inhibition by raloxifene in the ADPC and AIPC xenograft models (CWR22 68%, P &lt; 0.010; CWRSA9 64%, P &lt; 0.001), with no tumour regression. There was evidence of G1 arrest by increased p27kip1 expression in the raloxifene-treated group. Eighteen patients comprised the efficacy analysis, as three withdrew before the first evaluation. At the first evaluation, five men had stable disease and continued on the study for a median of five cycles. The longest response was 17 cycles. Drug related toxicity was minimal. CONCLUSION: Raloxifene has activity in xenograft models, slowing disease progression. This translated to possible disease stabilization in patients with AIPC. Further studies are warranted.</abstract><notes>Shazer, Ronald L&#xD;Jain, Anjali&#xD;Galkin, Anna V&#xD;Cinman, Nadya&#xD;Nguyen, Koo N&#xD;Natale, Ronald B&#xD;Gross, Mitchell&#xD;Green, Leland&#xD;Bender, Leon I&#xD;Holden, Stuart&#xD;Kaplan, Leslie&#xD;Agus, David B&#xD;Clinical Trial, Phase II&#xD;England&#xD;BJU international&#xD;BJU Int. 2006 Apr;97(4):691-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16536755</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>2.751</custom4><electronic-resource-num>BJU5974 [pii]&#xD;10.1111/j.1464-410X.2006.05974.x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>213</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">213</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Irish, J. M.</author><author>Anensen, N.</author><author>Hovland, R.</author><author>Skavland, J.</author><author>Borresen-Dale, A. L.</author><author>Bruserud, O.</author><author>Nolan, G. P.</author><author>Gjertsen, B. T.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, Baxter Laboratory of Genetic Pharmacology, Stanford University, Stanford, CA 94035, USA.</auth-address><titles><title>Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53</title><secondary-title>Blood</secondary-title></titles><pages>2589-96</pages><volume>109</volume><number>6</number><edition>2006/11/16</edition><keywords><keyword>Cells, Cultured</keyword><keyword>DNA Damage</keyword><keyword>Electrophoresis, Gel, Two-Dimensional</keyword><keyword>*Gene Expression</keyword><keyword>Gene Expression Profiling</keyword><keyword>*Gene Expression Regulation, Leukemic</keyword><keyword>Humans</keyword><keyword>Leukemia, Myelocytic, Acute/genetics/*metabolism/pathology</keyword><keyword>Mutation/genetics</keyword><keyword>Phosphorylation</keyword><keyword>Protein Isoforms/genetics/metabolism</keyword><keyword>Proto-Oncogene Proteins c-bcl-2/*metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tumor Suppressor Protein p53/genetics/*metabolism</keyword><keyword>Tyrosine/genetics/*metabolism</keyword><keyword>fms-Like Tyrosine Kinase 3/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 15</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>17105820</accession-num><abstract>Loss or mutation of the TP53 tumor suppressor gene is not commonly observed in acute myeloid leukemia (AML), suggesting that there is an alternate route for cell transformation. We investigated the hypothesis that previously observed Bcl-2 family member overexpression suppresses wild-type p53 activity in AML. We demonstrate that wild-type p53 protein is expressed in primary leukemic blasts from patients with de novo AML using 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and phospho-specific flow cytometry. We found that p53 was heterogeneously expressed and phosphorylated in AML patient samples and could accumulate following DNA damage. Overexpression of antiapoptosis protein Bcl-2 in AML cells was directly correlated with p53 expression and phosphorylation on serine residues 15, 46, and 392. Within those patients with the highest levels of Bcl-2 expression, we identified a mutation in FLT3 that duplicated phosphorylation site Y591. The presence of this mutation correlated with greater than normal Bcl-2 expression and with previously observed profiles of potentiated STAT and MAPK signaling. These results support the hypothesis that Flt3-mediated signaling in AML enables accumulation of Bcl-2 and maintains a downstream block to p53 pathway apoptosis. Bcl-2 inhibition might therefore improve the efficacy of existing AML therapies by inactivating this suppression of wild-type p53 activity.</abstract><notes>Irish, Jonathan M&#xD;Anensen, Nina&#xD;Hovland, Randi&#xD;Skavland, Jorn&#xD;Borresen-Dale, Anne-Lise&#xD;Bruserud, Oystein&#xD;Nolan, Garry P&#xD;Gjertsen, Bjorn T&#xD;N01-hv-281831/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2007 Mar 15;109(6):2589-96. Epub 2006 Nov 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17105820</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>10.37</custom4><electronic-resource-num>blood-2006-02-004234 [pii]&#xD;10.1182/blood-2006-02-004234</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>215</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">215</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Irish, J. M.</author><author>Czerwinski, D. K.</author><author>Nolan, G. P.</author><author>Levy, R.</author></authors></contributors><auth-address>Department of Medicine, Oncology Division, Baxter Laboratory for Genetic Pharmacology, Stanford University Medical Center, Stanford, CA 94305-5151, USA.</auth-address><titles><title>Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells</title><secondary-title>Blood</secondary-title></titles><pages>3135-42</pages><volume>108</volume><number>9</number><edition>2006/07/13</edition><keywords><keyword>B-Lymphocytes/*immunology</keyword><keyword>Humans</keyword><keyword>Lymphocytes, Tumor-Infiltrating/*immunology</keyword><keyword>Lymphoma, B-Cell/*immunology</keyword><keyword>Lymphoma, Follicular/*immunology</keyword><keyword>Receptors, Antigen, B-Cell/*immunology</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov 1</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>16835385</accession-num><abstract>The B-cell receptor (BCR) transmits life and death signals throughout B-cell development, and altered BCR signaling may be required for survival of B-lymphoma cells. We used single-cell signaling profiles to compare follicular lymphoma (FL) B cells and nonmalignant host B cells within individual patient biopsies and identified BCR-mediated signaling events specific to lymphoma B cells. Expression of CD20, Bcl-2, and BCR light chain isotype (kappa or lambda) distinguished FL tumor B-cell and nontumor host B-cell subsets within FL patient biopsies. BCR-mediated signaling via phosphorylation of Btk, Syk, Erk1/2, and p38 occurred more rapidly in tumor B cells from FL samples than in infiltrating nontumor B cells, achieved greater levels of per-cell signaling, and sustained this level of signaling for hours longer than nontumor B cells. The timing and magnitude of BCR-mediated signaling in nontumor B cells within an FL sample instead resembled that observed in mature B cells from the peripheral blood of healthy subjects. BCR signaling pathways that are potentiated specifically in lymphoma cells should provide new targets for therapeutic attention.</abstract><notes>Irish, Jonathan M&#xD;Czerwinski, Debra K&#xD;Nolan, Garry P&#xD;Levy, Ronald&#xD;Ca 33399/ca/nci&#xD;Ca 34233/ca/nci&#xD;N01-hv-281831/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2006 Nov 1;108(9):3135-42. Epub 2006 Jul 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16835385</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>10.37</custom4><electronic-resource-num>blood-2006-02-003921 [pii]&#xD;10.1182/blood-2006-02-003921</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>517</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">517</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shachaf, C. M.</author><author>Perez, O. D.</author><author>Youssef, S.</author><author>Fan, A. C.</author><author>Elchuri, S.</author><author>Goldstein, M. J.</author><author>Shirer, A. E.</author><author>Sharpe, O.</author><author>Chen, J.</author><author>Mitchell, D. J.</author><author>Chang, M.</author><author>Nolan, G. P.</author><author>Steinman, L.</author><author>Felsher, D. W.</author></authors></contributors><auth-address>Division of Medical Oncology, Department of Medicine, Stanford University, Stanford, CA 94305-5151, USA.</auth-address><titles><title>Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis</title><secondary-title>Blood</secondary-title></titles><pages>2674-84</pages><volume>110</volume><number>7</number><edition>2007/07/12</edition><keywords><keyword>Animals</keyword><keyword>Cell Survival</keyword><keyword>Cell Transformation, Neoplastic/genetics/metabolism/*pathology</keyword><keyword>Cells, Cultured</keyword><keyword>Flow Cytometry</keyword><keyword>Gene Expression Profiling</keyword><keyword>Glycine/genetics/metabolism</keyword><keyword>Heptanoic Acids/*pharmacology</keyword><keyword>Humans</keyword><keyword>Hydroxymethylglutaryl CoA Reductases/*metabolism</keyword><keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology</keyword><keyword>Lymphoma/*metabolism/pathology/*prevention &amp; control</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Mutation/genetics</keyword><keyword>Oncogene Protein p55(v-myc)/genetics/*metabolism</keyword><keyword>Phosphoproteins/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Precancerous Conditions/pathology</keyword><keyword>Pyrroles/*pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Survival Rate</keyword><keyword>ras Proteins/genetics/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>17622571</accession-num><abstract>Statins are a class of drugs that inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMGcoA) reductase, a critical enzyme in the mevalonate pathway. Several reports document that statins may prevent different human cancers. However, whether or not statins can prevent cancer is controversial due to discordant results. One possible explanation for these conflicting conclusions is that only some tumors or specific statins may be effective. Here, we demonstrate in an in vivo transgenic model in which atorvastatin reverses and prevents the onset of MYC-induced lymphomagenesis, but fails to reverse or prevent tumorigenesis in the presence of constitutively activated K-Ras (G12D). Using phosphoprotein fluorescence-activated cell sorter (FACS) analysis, atorvastatin treatment was found to result in the inactivation of the Ras and ERK1/2 signaling pathways associated with the dephosphorylation and inactivation of MYC. Correspondingly, tumors with a constitutively activated K-Ras (G12D) did not exhibit dephosphorylation of ERK1/2 and MYC. Atorvastatin&apos;s effects on MYC were specific to the inhibition of HMGcoA reductase, as treatment with mevalonate, the product of HMG-CoA reductase activity, abrogated these effects and inhibited the ability of atorvastatin to reverse or suppress tumorigenesis. Also, RNAi directed at HMGcoA reductase was sufficient to abrogate the neoplastic properties of MYC-induced tumors. Thus, atorvastatin, by inhibiting HMGcoA reductase, induces changes in phosphoprotein signaling that in turn prevent MYC-induced lymphomagenesis.</abstract><notes>Shachaf, Catherine M&#xD;Perez, Omar D&#xD;Youssef, Sawsan&#xD;Fan, Alice C&#xD;Elchuri, Sailaja&#xD;Goldstein, Matthew J&#xD;Shirer, Amy E&#xD;Sharpe, Orr&#xD;Chen, Joy&#xD;Mitchell, Dennis J&#xD;Chang, Maria&#xD;Nolan, Garry P&#xD;Steinman, Lawrence&#xD;Felsher, Dean W&#xD;1 R01 CA105102/CA/United States NCI&#xD;1 R01 CA89305-01A1/CA/United States NCI&#xD;3 R01 CA89305-0351/CA/United States NCI&#xD;AI/GF41520-01/AI/United States NIAID&#xD;AI35304/AI/United States NIAID&#xD;AR44565/AR/United States NIAMS&#xD;N01 AR62227/AR/United States NIAMS&#xD;N01 HV281831/HV/United States NHLBI&#xD;P01 AI39646/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2007 Oct 1;110(7):2674-84. Epub 2007 Jul 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17622571</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>10.37</custom4><electronic-resource-num>blood-2006-09-048033 [pii]&#xD;10.1182/blood-2006-09-048033</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>236</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">236</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Van Meter, M. E.</author><author>Diaz-Flores, E.</author><author>Archard, J. A.</author><author>Passegue, E.</author><author>Irish, J. M.</author><author>Kotecha, N.</author><author>Nolan, G. P.</author><author>Shannon, K.</author><author>Braun, B. S.</author></authors></contributors><auth-address>Department of Pediatrics, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.</auth-address><titles><title>K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells</title><secondary-title>Blood</secondary-title></titles><pages>3945-52</pages><volume>109</volume><number>9</number><edition>2006/12/29</edition><keywords><keyword>Animals</keyword><keyword>*Cell Proliferation</keyword><keyword>Extracellular Signal-Regulated MAP Kinases/metabolism</keyword><keyword>Granulocyte-Macrophage Colony-Stimulating Factor/metabolism</keyword><keyword>Hematopoietic Stem Cells/*metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Myeloproliferative Disorders/genetics/*metabolism/pathology</keyword><keyword>*Point Mutation</keyword><keyword>Proto-Oncogene Proteins p21(ras)/*biosynthesis/genetics</keyword><keyword>Ribosomal Protein S6 Kinases/metabolism</keyword><keyword>STAT5 Transcription Factor/metabolism</keyword><keyword>*Signal Transduction/genetics</keyword><keyword>Tumor Stem Cells/*metabolism/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>17192389</accession-num><abstract>Defining how cancer-associated mutations perturb signaling networks in stem/progenitor populations that are integral to tumor formation and maintenance is a fundamental problem with biologic and clinical implications. Point mutations in RAS genes contribute to many cancers, including myeloid malignancies. We investigated the effects of an oncogenic Kras(G12D) allele on phosphorylated signaling molecules in primary c-kit(+) lin(-/low) hematopoietic stem/progenitor cells. Comparison of wild-type and Kras(G12D) c-kit(+) lin(-/low) cells shows that K-Ras(G12D) expression causes hyperproliferation in vivo and results in abnormal levels of phosphorylated STAT5, ERK, and S6 under basal and stimulated conditions. Whereas Kras(G12D) cells demonstrate hyperactive signaling after exposure to granulocyte-macrophage colony-stimulating factor, we unexpectedly observe a paradoxical attenuation of ERK and S6 phosphorylation in response to stem cell factor. These studies provide direct biochemical evidence that cancer stem/progenitor cells remodel signaling networks in response to oncogenic stress and demonstrate that multi-parameter flow cytometry can be used to monitor the effects of targeted therapeutics in vivo. This strategy has broad implications for defining the architecture of signaling networks in primary cancer cells and for implementing stem cell-targeted interventions.</abstract><notes>Van Meter, Margaret E M&#xD;Diaz-Flores, Ernesto&#xD;Archard, Joehleen A&#xD;Passegue, Emmanuelle&#xD;Irish, Jonathan M&#xD;Kotecha, Nikesh&#xD;Nolan, Garry P&#xD;Shannon, Kevin&#xD;Braun, Benjamin S&#xD;K08 ca 103868/ca/nci&#xD;N01 hv 28183/hv/nhlbi&#xD;R01 ca 72614/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2007 May 1;109(9):3945-52. Epub 2006 Dec 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17192389</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>10.37</custom4><electronic-resource-num>blood-2006-09-047530 [pii]&#xD;10.1182/blood-2006-09-047530</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>625</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">625</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Quo, C. F.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Wallace H, Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. gtg801f@mail.gatech.edu</auth-address><titles><title>Quantitative analysis of numerical solvers for oscillatory biomolecular system models</title><secondary-title>BMC Bioinformatics</secondary-title></titles><pages>S17</pages><volume>9 Suppl 6</volume><edition>2008/06/27</edition><keywords><keyword>*Algorithms</keyword><keyword>Biological Clocks/*physiology</keyword><keyword>Computer Simulation</keyword><keyword>*Models, Biological</keyword><keyword>Numerical Analysis, Computer-Assisted</keyword><keyword>Oscillometry/*methods</keyword><keyword>Proteome/*metabolism</keyword><keyword>Signal Transduction/*physiology</keyword></keywords><dates><year>2008</year></dates><isbn>1471-2105 (Electronic)</isbn><accession-num>18541052</accession-num><abstract>BACKGROUND: This article provides guidelines for selecting optimal numerical solvers for biomolecular system models. Because various parameters of the same system could have drastically different ranges from 10(-15) to 10(10), the ODEs can be stiff and ill-conditioned, resulting in non-unique, non-existing, or non-reproducible modeling solutions. Previous studies have not examined in depth how to best select numerical solvers for biomolecular system models, which makes it difficult to experimentally validate the modeling results. To address this problem, we have chosen one of the well-known stiff initial value problems with limit cycle behavior as a test-bed system model. Solving this model, we have illustrated that different answers may result from different numerical solvers. We use MATLAB numerical solvers because they are optimized and widely used by the modeling community. We have also conducted a systematic study of numerical solver performances by using qualitative and quantitative measures such as convergence, accuracy, and computational cost (i.e. in terms of function evaluation, partial derivative, LU decomposition, and &quot;take-off&quot; points). The results show that the modeling solutions can be drastically different using different numerical solvers. Thus, it is important to intelligently select numerical solvers when solving biomolecular system models. RESULTS: The classic Belousov-Zhabotinskii (BZ) reaction is described by the Oregonator model and is used as a case study. We report two guidelines in selecting optimal numerical solver(s) for stiff, complex oscillatory systems: (i) for problems with unknown parameters, ode45 is the optimal choice regardless of the relative error tolerance; (ii) for known stiff problems, both ode113 and ode15s are good choices under strict relative tolerance conditions. CONCLUSIONS: For any given biomolecular model, by building a library of numerical solvers with quantitative performance assessment metric, we show that it is possible to improve reliability of the analytical modeling, which in turn can improve the efficiency and effectiveness of experimental validations of these models. Also, our study can be extended to study a variety of molecular-level system models for human disease diagnosis and therapeutic treatment.</abstract><notes>Quo, Chang F&#xD;Wang, May D&#xD;R01CA108468/CA/United States NCI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMC bioinformatics&#xD;BMC Bioinformatics. 2008 May 28;9 Suppl 6:S17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18541052</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.493</custom4><electronic-resource-num>1471-2105-9-S6-S17 [pii]&#xD;10.1186/1471-2105-9-S6-S17</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>640</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">640</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stokes, T. H.</author><author>Torrance, J. T.</author><author>Li, H.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Department of Electrical and Computer Engineering, Georgia Institute of Technology, Van Leer Building, 777 Atlantic Drive NW, Atlanta, GA 30332, USA. todd.stokes@bme.gatech.edu</auth-address><titles><title>ArrayWiki: an enabling technology for sharing public microarray data repositories and meta-analyses</title><secondary-title>BMC Bioinformatics</secondary-title></titles><pages>S18</pages><volume>9 Suppl 6</volume><edition>2008/06/27</edition><keywords><keyword>*Artificial Intelligence</keyword><keyword>Biotechnology/*methods</keyword><keyword>*Database Management Systems</keyword><keyword>*Databases, Genetic</keyword><keyword>Information Dissemination/*methods</keyword><keyword>Internet</keyword><keyword>*Meta-Analysis as Topic</keyword><keyword>Oligonucleotide Array Sequence Analysis/*methods</keyword></keywords><dates><year>2008</year></dates><isbn>1471-2105 (Electronic)</isbn><accession-num>18541053</accession-num><abstract>BACKGROUND: A survey of microarray databases reveals that most of the repository contents and data models are heterogeneous (i.e., data obtained from different chip manufacturers), and that the repositories provide only basic biological keywords linking to PubMed. As a result, it is difficult to find datasets using research context or analysis parameters information beyond a few keywords. For example, to reduce the &quot;curse-of-dimension&quot; problem in microarray analysis, the number of samples is often increased by merging array data from different datasets. Knowing chip data parameters such as pre-processing steps (e.g., normalization, artefact removal, etc), and knowing any previous biological validation of the dataset is essential due to the heterogeneity of the data. However, most of the microarray repositories do not have meta-data information in the first place, and do not have a a mechanism to add or insert this information. Thus, there is a critical need to create &quot;intelligent&quot; microarray repositories that (1) enable update of meta-data with the raw array data, and (2) provide standardized archiving protocols to minimize bias from the raw data sources. RESULTS: To address the problems discussed, we have developed a community maintained system called ArrayWiki that unites disparate meta-data of microarray meta-experiments from multiple primary sources with four key features. First, ArrayWiki provides a user-friendly knowledge management interface in addition to a programmable interface using standards developed by Wikipedia. Second, ArrayWiki includes automated quality control processes (caCORRECT) and novel visualization methods (BioPNG, Gel Plots), which provide extra information about data quality unavailable in other microarray repositories. Third, it provides a user-curation capability through the familiar Wiki interface. Fourth, ArrayWiki provides users with simple text-based searches across all experiment meta-data, and exposes data to search engine crawlers (Semantic Agents) such as Google to further enhance data discovery. CONCLUSIONS: Microarray data and meta information in ArrayWiki are distributed and visualized using a novel and compact data storage format, BioPNG. Also, they are open to the research community for curation, modification, and contribution. By making a small investment of time to learn the syntax and structure common to all sites running MediaWiki software, domain scientists and practioners can all contribute to make better use of microarray technologies in research and medical practices. ArrayWiki is available at http://www.bio-miblab.org/arraywiki.</abstract><notes>Stokes, Todd H&#xD;Torrance, J T&#xD;Li, Henry&#xD;Wang, May D&#xD;R01CA108468/CA/United States NCI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;BMC bioinformatics&#xD;BMC Bioinformatics. 2008 May 28;9 Suppl 6:S18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18541053</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.493</custom4><electronic-resource-num>1471-2105-9-S6-S18 [pii]&#xD;10.1186/1471-2105-9-S6-S18</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>536</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">536</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lin, S.</author><author>Xie, X.</author><author>Patel, M. R.</author><author>Yang, Y. H.</author><author>Li, Z.</author><author>Cao, F.</author><author>Gheysens, O.</author><author>Zhang, Y.</author><author>Gambhir, S. S.</author><author>Rao, J. H.</author><author>Wu, J. C.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS) and Bio-X Program, Department of Radiology, Stanford University, Stanford, CA 94305, USA. susans1018@gmail.com</auth-address><titles><title>Quantum dot imaging for embryonic stem cells</title><secondary-title>BMC Biotechnol</secondary-title></titles><pages>67</pages><volume>7</volume><edition>2007/10/11</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Embryonic Stem Cells/*cytology</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1472-6750 (Electronic)</isbn><accession-num>17925032</accession-num><abstract>BACKGROUND: Semiconductor quantum dots (QDs) hold increasing potential for cellular imaging both in vitro and in vivo. In this report, we aimed to evaluate in vivo multiplex imaging of mouse embryonic stem (ES) cells labeled with Qtracker delivered quantum dots (QDs). RESULTS: Murine embryonic stem (ES) cells were labeled with six different QDs using Qtracker. ES cell viability, proliferation, and differentiation were not adversely affected by QDs compared with non-labeled control cells (P = NS). Afterward, labeled ES cells were injected subcutaneously onto the backs of athymic nude mice. These labeled ES cells could be imaged with good contrast with one single excitation wavelength. With the same excitation wavelength, the signal intensity, defined as (total signal-background)/exposure time in millisecond was 11 +/- 2 for cells labeled with QD 525, 12 +/- 9 for QD 565, 176 +/- 81 for QD 605, 176 +/- 136 for QD 655, 167 +/- 104 for QD 705, and 1,713 +/- 482 for QD 800. Finally, we have shown that QD 800 offers greater fluorescent intensity than the other QDs tested. CONCLUSION: In summary, this is the first demonstration of in vivo multiplex imaging of mouse ES cells labeled QDs. Upon further improvements, QDs will have a greater potential for tracking stem cells within deep tissues. These results provide a promising tool for imaging stem cell therapy non-invasively in vivo.</abstract><notes>Lin, Shuan&#xD;Xie, Xiaoyan&#xD;Patel, Manishkumar R&#xD;Yang, Yao-Hung&#xD;Li, Zongjin&#xD;Cao, Feng&#xD;Gheysens, Oliver&#xD;Zhang, Yan&#xD;Gambhir, Sanjiv S&#xD;Rao, Jiang Hong&#xD;Wu, Joseph C&#xD;HL074883/HL/United States NHLBI&#xD;HL089027/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMC biotechnology&#xD;BMC Biotechnol. 2007 Oct 9;7:67.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17925032</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>2.747</custom4><electronic-resource-num>1472-6750-7-67 [pii]&#xD;10.1186/1472-6750-7-67</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>518</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">518</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perez, O. D.</author><author>Mitchell, D.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>The Baxter Laboratory for Genetic Pharmacology, Stanford University School of Medicine, Stanford, CA 94305, USA. Omar.Perez@nodalityinc.com</auth-address><titles><title>Differential role of ICAM ligands in determination of human memory T cell differentiation</title><secondary-title>BMC Immunol</secondary-title></titles><pages>2</pages><volume>8</volume><edition>2007/01/20</edition><keywords><keyword>Antigens, CD28/immunology/metabolism</keyword><keyword>Antigens, CD3/immunology/metabolism</keyword><keyword>Antigens, CD45/immunology/metabolism</keyword><keyword>Caspase 3/immunology/metabolism</keyword><keyword>Cell Adhesion Molecules/*immunology</keyword><keyword>Cell Differentiation/*immunology</keyword><keyword>Cells, Cultured</keyword><keyword>Flow Cytometry</keyword><keyword>Humans</keyword><keyword>*Immunologic Memory</keyword><keyword>Ligands</keyword><keyword>Lymphocyte Activation/immunology</keyword><keyword>Lymphocyte Function-Associated Antigen-1/immunology/metabolism</keyword><keyword>T-Lymphocytes/*cytology/*immunology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1471-2172 (Electronic)</isbn><accession-num>17233909</accession-num><abstract>BACKGROUND: Leukocyte Function Antigen-1 (LFA-1) is a primary adhesion molecule that plays important roles in T cell activation, leukocyte recirculation, and trans-endothelial migration. By applying a multivariate intracellular phospho-proteomic analysis, we demonstrate that LFA-1 differentially activates signaling molecules. RESULTS: Signal intensity was dependent on both ICAM ligand and LFA-1 concentration. In the presence of CD3 and CD28 stimulation, ICAM-2 and ICAM-3 decreased TGFbeta1 production more than ICAM-1. In long-term differentiation experiments, stimulation with ICAM-3, CD3, and CD28 generated IFNgamma producing CD4+CD45RO+CD62L-CD11aBrightCD27- cells that had increased expression of intracellular BCL2, displayed distinct chemokine receptor profiles, and exhibited distinct migratory characteristics. Only CD3/CD28 with ICAM-3 generated CD4+CD45RO+CD62L-CD11aBrightCD27- cells that were functionally responsive to chemotaxis and exhibited higher frequencies of cells that signaled to JNK and ERK1/2 upon stimulation with MIP3alpha. Furthermore, these reports identify that the LFA-1 receptor, when presented with multiple ligands, can result in distinct T cell differentiation states and suggest that the combinatorial integration of ICAM ligand interactions with LFA-1 have functional consequences for T cell biology. CONCLUSION: Thus, the ICAM ligands, differentially modulate LFA-1 signaling in T cells and potentiate the development of memory human T cells in vitro. These findings are of importance in a mechanistic understanding of memory cell differentiation and ex vivo generation of memory cell subsets for therapeutic applications.</abstract><notes>Perez, Omar D&#xD;Mitchell, Dennis&#xD;Nolan, Garry P&#xD;A1/GF41520-01/GF/United States NIH&#xD;AI35304/AI/United States NIAID&#xD;AR44565/AR/United States NIAMS&#xD;N01-AR-6-2227/AR/United States NIAMS&#xD;N01-HV-28183I/HV/United States NHLBI&#xD;P01-AI39646/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMC immunology&#xD;BMC Immunol. 2007 Jan 18;8:2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17233909</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>2.673</custom4><electronic-resource-num>1471-2172-8-2 [pii]&#xD;10.1186/1471-2172-8-2</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>220</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">220</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Laux, I.</author><author>Jain, A.</author><author>Singh, S.</author><author>Agus, D. B.</author></authors></contributors><auth-address>Louis Warschaw Prostate Cancer Center, Cedar-Sinai Medical Center, 8631 West Third Street, Suite 1001E, Los Angeles, CA 90048, USA.</auth-address><titles><title>Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies</title><secondary-title>Br J Cancer</secondary-title></titles><pages>85-92</pages><volume>94</volume><number>1</number><edition>2005/11/25</edition><keywords><keyword>Antibodies, Monoclonal/*adverse effects</keyword><keyword>Antineoplastic Agents/*adverse effects</keyword><keyword>Cell Culture Techniques</keyword><keyword>Dimerization</keyword><keyword>Exanthema/*chemically induced/*physiopathology</keyword><keyword>Humans</keyword><keyword>Keratinocytes/physiology</keyword><keyword>Ligands</keyword><keyword>Quinazolines/*adverse effects</keyword><keyword>Receptor, Epidermal Growth Factor/drug effects/*physiology</keyword><keyword>Receptor, erbB-2/drug effects/*physiology</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 16</date></pub-dates></dates><isbn>0007-0920 (Print)</isbn><accession-num>16306877</accession-num><abstract>Skin toxicity, a common drug-related adverse event observed in cancer patients treated with epidermal growth factor receptor (EGFR)-directed therapies is rarely seen with therapies targeting HER2. This study reports the significance of the EGFR and HER2 dimerization status in skin with regard to these dermatologic side effects. We demonstrate the differential effect of HER-directed therapies on the ligand driven activation status of EGFR, HER2 and MAPK in normal human epidermal keratinocytes. EGFR-directed therapies, such as gefitinib and cetuximab, inhibited ligand-induced activation of EGFR and MAPK in human keratinocytes. Pertuzumab, an antibody interfering with functional HER2 heterodimerization, failed to block ligand-induced HER signaling in primary keratinocytes. Using a novel proximity-based dimerization assay (eTagtrade mark) we show that EGFR homodimers are the predominant HER dimer pair in normal primary kertinocytes and in normal skin tissue from 16 patients with solid malignancies. The presence of [p]EGFR and [p]MAPK, but the absence of [p]HER2, demonstrates productive signaling via EGFR but not HER2 in human skin. These data illustrate the importance of the EGFR dimerization partner in human skin and suggests that inhibition of EGFR homodimer signaling rather than EGFR/HER2 heterodimer signaling maybe the key molecular event determining dermatologic toxicity discrepancies observed between EGFR-targeted versus HER2-targeted therapies.</abstract><notes>Laux, I&#xD;Jain, A&#xD;Singh, S&#xD;Agus, D B&#xD;P50 ca92131/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;British journal of cancer&#xD;Br J Cancer. 2006 Jan 16;94(1):85-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16306877</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>4.459</custom4><electronic-resource-num>6602875 [pii]&#xD;10.1038/sj.bjc.6602875</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>701</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">701</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheng, L.</author><author>Anglin, E.</author><author>Cunin, F.</author><author>Kim, D.</author><author>Sailor, M. J.</author><author>Falkenstein, I.</author><author>Tammewar, A.</author><author>Freeman, W. R.</author></authors></contributors><auth-address>Jacobs Retina Center at Shiley Eye Center, UCSD, 9415 Campus Point Drive, La Jolla, CA 92037-0946, USA. cheng@eyecenter.ucsd.edu</auth-address><titles><title>Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle</title><secondary-title>Br J Ophthalmol</secondary-title></titles><pages>705-11</pages><volume>92</volume><number>5</number><edition>2008/04/29</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials</keyword><keyword>*Drug Carriers</keyword><keyword>Electroretinography</keyword><keyword>Fundus Oculi</keyword><keyword>Half-Life</keyword><keyword>Injections</keyword><keyword>Materials Testing</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>*Nanoparticles</keyword><keyword>Ophthalmoscopy</keyword><keyword>Oxidation-Reduction</keyword><keyword>Porosity</keyword><keyword>Rabbits</keyword><keyword>Silicon</keyword><keyword>*Vitreous Body</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1468-2079 (Electronic)</isbn><accession-num>18441177</accession-num><abstract>AIM: To determine the suitability of porous silicon photonic crystals for intraocular drug-delivery. METHODS: A rugate structure was electrochemically etched into a highly doped p-type silicon substrate to create a porous silicon film that was subsequently removed and ultrasonically fractured into particles. To stabilise the particles in aqueous media, the silicon particles were modified by surface alkylation (using thermal hydrosilylation) or by thermal oxidation. Unmodified particles, hydrosilylated particles and oxidised particles were injected into rabbit vitreous. The stability and toxicity of each type of particle were studied by indirect ophthalmoscopy, biomicroscopy, tonometry, electroretinography (ERG) and histology. RESULTS: No toxicity was observed with any type of the particles during a period of &gt;4 months. Surface alkylation led to dramatically increased intravitreal stability and slow degradation. The estimated vitreous half-life increased from 1 week (fresh particles) to 5 weeks (oxidised particles) and to 16 weeks (hydrosilylated particles). CONCLUSION: The porous silicon photonic crystals showed good biocompatibility and may be used as an intraocular drug-delivery system. The intravitreal injectable porous silicon photonic crystals may be engineered to host a variety of therapeutics and achieve controlled drug release over long periods of time to treat chronic vitreoretinal diseases.</abstract><notes>Cheng, L&#xD;Anglin, E&#xD;Cunin, F&#xD;Kim, D&#xD;Sailor, M J&#xD;Falkenstein, I&#xD;Tammewar, A&#xD;Freeman, W R&#xD;U54 CA 119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;The British journal of ophthalmology&#xD;Br J Ophthalmol. 2008 May;92(5):705-11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18441177</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>2.689</custom4><electronic-resource-num>92/5/705 [pii]&#xD;10.1136/bjo.2007.133587</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>651</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">651</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Yang, L.</author><author>Chen, Z. G.</author><author>Shin, D. M.</author></authors></contributors><auth-address>Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.</auth-address><titles><title>Application of nanotechnology in cancer therapy and imaging</title><secondary-title>CA Cancer J Clin</secondary-title></titles><pages>97-110</pages><volume>58</volume><number>2</number><edition>2008/01/30</edition><dates><year>2008</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>0007-9235 (Print)</isbn><accession-num>18227410</accession-num><abstract>Recent developments in nanotechnology have provided researchers with new tools for cancer imaging and treatment. This technology has enabled the development of nanoscale devices that can be conjugated with several functional molecules simultaneously, including tumor-specific ligands, antibodies, anticancer drugs, and imaging probes. Since these nanodevices are 100 to 1,000-fold smaller than cancer cells, they can be easily transferred through leaky blood vessels and interact with targeted tumor-specific proteins both on the surface of and inside cancer cells. Therefore, their application as cancer cell-specific delivery vehicles will be a significant addition to the currently available armory for cancer therapeutics and imaging.</abstract><notes>Wang, Xu&#xD;Yang, Lily&#xD;Chen, Zhuo Georgia&#xD;Shin, Dong M&#xD;P50 CA128613/CA/United States NCI&#xD;R01 CA 112643/CA/United States NCI&#xD;U01 CA 101244/CA/United States NCI&#xD;U54 CA 119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;CA: a cancer journal for clinicians&#xD;CA Cancer J Clin. 2008 Mar-Apr;58(2):97-110. Epub 2008 Jan 28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18227410</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>69.026</custom4><electronic-resource-num>CA.2007.0003 [pii]&#xD;10.3322/CA.2007.0003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>281</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">281</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, H.</author><author>Li, D.</author><author>Chen, L.</author><author>Shimamura, T.</author><author>Kobayashi, S.</author><author>McNamara, K.</author><author>Mahmood, U.</author><author>Mitchell, A.</author><author>Sun, Y.</author><author>Al-Hashem, R.</author><author>Chirieac, L. R.</author><author>Padera, R.</author><author>Bronson, R. T.</author><author>Kim, W.</author><author>Janne, P. A.</author><author>Shapiro, G. I.</author><author>Tenen, D.</author><author>Johnson, B. E.</author><author>Weissleder, R.</author><author>Sharpless, N. E.</author><author>Wong, K. K.</author></authors></contributors><auth-address>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.</auth-address><titles><title>The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies</title><secondary-title>Cancer Cell</secondary-title></titles><pages>485-95</pages><volume>9</volume><number>6</number><edition>2006/05/30</edition><keywords><keyword>Adenocarcinoma/drug therapy/*genetics/pathology</keyword><keyword>Adenocarcinoma, Bronchiolo-Alveolar/drug therapy/genetics/pathology</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/therapeutic use</keyword><keyword>Antineoplastic Agents/*therapeutic use</keyword><keyword>Enzyme Activation</keyword><keyword>Exons</keyword><keyword>Humans</keyword><keyword>Lung/metabolism</keyword><keyword>Lung Neoplasms/drug therapy/*genetics/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Mutation</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Quinazolines/therapeutic use</keyword><keyword>Quinolines/therapeutic use</keyword><keyword>Receptor, Epidermal Growth Factor/antagonists &amp;</keyword><keyword>inhibitors/genetics/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1535-6108 (Print)</isbn><accession-num>16730237</accession-num><abstract>To understand the role of human epidermal growth factor receptor (hEGFR) kinase domain mutations in lung tumorigenesis and response to EGFR-targeted therapies, we generated bitransgenic mice with inducible expression in type II pneumocytes of two common hEGFR mutants seen in human lung cancer. Both bitransgenic lines developed lung adenocarcinoma after sustained hEGFR mutant expression, confirming their oncogenic potential. Maintenance of these lung tumors was dependent on continued expression of the EGFR mutants. Treatment with small molecule inhibitors (erlotinib or HKI-272) as well as prolonged treatment with a humanized anti-hEGFR antibody (cetuximab) led to dramatic tumor regression. These data suggest that persistent EGFR signaling is required for tumor maintenance in human lung adenocarcinomas expressing EGFR mutants.</abstract><notes>Ji, Hongbin&#xD;Li, Danan&#xD;Chen, Liang&#xD;Shimamura, Takeshi&#xD;Kobayashi, Susumu&#xD;McNamara, Kate&#xD;Mahmood, Umar&#xD;Mitchell, Albert&#xD;Sun, Yangping&#xD;Al-Hashem, Ruqayyah&#xD;Chirieac, Lucian R&#xD;Padera, Robert&#xD;Bronson, Roderick T&#xD;Kim, William&#xD;Janne, Pasi A&#xD;Shapiro, Geoffrey I&#xD;Tenen, Daniel&#xD;Johnson, Bruce E&#xD;Weissleder, Ralph&#xD;Sharpless, Norman E&#xD;Wong, Kwok-Kin&#xD;Ag024379/ag/nia&#xD;Ag2400401/ag/nia&#xD;Ca90679/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer cell&#xD;Cancer Cell. 2006 Jun;9(6):485-95. Epub 2006 May 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16730237</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>24.077</custom4><electronic-resource-num>S1535-6108(06)00146-2 [pii]&#xD;10.1016/j.ccr.2006.04.022</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>253</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">253</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lei, Q.</author><author>Jiao, J.</author><author>Xin, L.</author><author>Chang, C. J.</author><author>Wang, S.</author><author>Gao, J.</author><author>Gleave, M. E.</author><author>Witte, O. N.</author><author>Liu, X.</author><author>Wu, H.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California 90095, USA.</auth-address><titles><title>NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss</title><secondary-title>Cancer Cell</secondary-title></titles><pages>367-78</pages><volume>9</volume><number>5</number><edition>2006/05/16</edition><keywords><keyword>Acetylation</keyword><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Down-Regulation/genetics</keyword><keyword>Enzyme Activation</keyword><keyword>Epithelium/metabolism/pathology</keyword><keyword>Gene Expression</keyword><keyword>Histone Deacetylases/metabolism</keyword><keyword>Homeodomain Proteins/*metabolism</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>PTEN Phosphohydrolase/*deficiency/genetics</keyword><keyword>Promoter Regions (Genetics)/genetics</keyword><keyword>Prostatic Neoplasms/genetics/metabolism/*pathology</keyword><keyword>Protein Binding</keyword><keyword>Proto-Oncogene Proteins c-akt/*antagonists &amp; inhibitors/metabolism</keyword><keyword>Proto-Oncogene Proteins c-mdm2</keyword><keyword>Receptors, Androgen/genetics/metabolism</keyword><keyword>Transcription Factors/*metabolism</keyword><keyword>Transplants</keyword><keyword>Tumor Suppressor Protein p53/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1535-6108 (Print)</isbn><accession-num>16697957</accession-num><abstract>We demonstrate that PTEN loss causes reduced NKX3.1 expression in both murine and human prostate cancers. Restoration of Nkx3.1 expression in vivo in Pten null epithelium leads to decreased cell proliferation, increased cell death, and prevention of tumor initiation. Whereas androgen receptor (AR) positively regulates NKX3.1 expression, NKX3.1 negatively modulates AR transcription and consequently the AR-associated signaling events. Consistent with its tumor suppressor functions, NKX3.1 engages cell cycle and cell death machinery via association with HDAC1, leading to increased p53 acetylation and half-life through MDM2-dependent mechanisms. Importantly, overexpression of Nkx3.1 has little effect on Pten wild-type epithelium, suggesting that PTEN plays a predominant role in PTEN-NKX3.1 interplay. Manipulating NKX3.1 expression may serve as a therapeutic strategy for treating PTEN-deficient prostate cancers.</abstract><notes>Lei, Qunying&#xD;Jiao, Jing&#xD;Xin, Li&#xD;Chang, Chun-Ju&#xD;Wang, Shunyou&#xD;Gao, Jing&#xD;Gleave, Martin E&#xD;Witte, Owen N&#xD;Liu, Xin&#xD;Wu, Hong&#xD;P50 ca092131/ca/nci&#xD;R01 ca107166/ca/nci&#xD;U01 ca84128-06/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer cell&#xD;Cancer Cell. 2006 May;9(5):367-78.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16697957</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>24.077</custom4><electronic-resource-num>S1535-6108(06)00118-8 [pii]&#xD;10.1016/j.ccr.2006.03.031</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>352</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">352</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Shenoy, D.</author><author>Little, S.</author><author>Langer, R.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model</title><secondary-title>Cancer Chemother Pharmacol</secondary-title><alt-title>Cancer chemotherapy and pharmacology</alt-title></titles><pages>477-84</pages><volume>59</volume><number>4</number><edition>2007/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Mice</keyword><keyword>*Nanoparticles</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Ovarian Neoplasms/*drug therapy</keyword><keyword>Paclitaxel/*administration &amp; dosage/adverse effects</keyword><keyword>Polyesters/*administration &amp; dosage</keyword><keyword>Polyethylene Glycols</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0344-5704 (Print)</isbn><accession-num>16862429</accession-num><abstract>PURPOSE: The objective of this study was to evaluate the anti-tumor efficacy and lack of systemic toxicity of paclitaxel when administered in pH-sensitive poly(ethylene oxide) (PEO)-modified poly(beta-amino ester) (PbAE) nanoparticles in mice bearing human ovarian adenocarcinoma (SKOV-3) xenograft. METHODS: Paclitaxel-encapsulated PEO-modified PbAE (PEO-PbAE) nanoparticles were prepared by the solvent displacement method. PEO-modified poly(epsilon-caprolactone) (PCL) (PEO-PCL) nanoparticles were used as a non pH-responsive control formulation. Efficacy studies were conducted in SKOV-3 tumor-bearing athymic (Nu/Nu) mice at an equivalent paclitaxel dose of 20 mg/kg with the control and nanoparticle formulations. Safety of the drug when administered in the control and nanoparticle formulation was determined from blood cell counts and changes in body weight of the animals. RESULTS: The formulated paclitaxel-containing PEO-PbAE and PEO-PCL nanoparticles had a particle size in the range of 100-200 nm and a surface charge of + 39.0 and - 30.8 mV, respectively. After intravenous administration of paclitaxel in these formulations, the tumor growth was inhibited significantly. Both of the formulated nanoparticles tested have shown improved therapeutic efficacy as compared to the paclitaxel aqueous solution. Additionally, significantly lower toxicity profile of paclitaxel was observed with PEO-modified nanoparticles as compared to the aqueous solution formulation CONCLUSION: PEO-modified PbAE nanoparticles are a unique pH-sensitive drug delivery system that elicits enhanced efficacy and safety profile in solid tumor therapy.</abstract><notes>R01-ca095522/ca/nci&#xD;R01-ca119617/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16862429 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>2.568</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>354</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">354</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kommareddy, S.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115-5005, USA.</auth-address><titles><title>Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors</title><secondary-title>Cancer Gene Ther</secondary-title><alt-title>Cancer gene therapy</alt-title></titles><pages>488-98</pages><volume>14</volume><number>5</number><edition>2007/05</edition><keywords><keyword>Adenocarcinoma/blood supply/chemistry/therapy</keyword><keyword>Animals</keyword><keyword>Breast Neoplasms/blood supply/chemistry/therapy</keyword><keyword>Capsules/administration &amp; dosage/chemistry</keyword><keyword>Cell Line, Tumor</keyword><keyword>DNA/administration &amp; dosage/chemistry</keyword><keyword>Female</keyword><keyword>Gelatin/chemistry</keyword><keyword>*Gene Therapy</keyword><keyword>*Genetic Vectors/administration &amp; dosage/chemistry</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Inbred Strains</keyword><keyword>*Nanoparticles/administration &amp; dosage/chemistry</keyword><keyword>Neovascularization, Pathologic/*therapy</keyword><keyword>Plasmids/administration &amp; dosage/chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Vascular Endothelial Growth Factor Receptor-1/analysis/*genetics</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0929-1903 (Print)</isbn><accession-num>17363959</accession-num><abstract>This study examined the potential of engineered gelatin-based nanoparticulate vectors for systemic delivery of therapeutic genes to human solid tumor xenografts in vivo. Plasmid DNA encoding for the soluble form of the extracellular domain of vascular endothelial growth factor receptor-1 (VEGF-R1 or sFlt-1) was encapsulated in the control and poly(ethylene glycol) (PEG)-modified gelatin-based nanoparticles. When the plasmid DNA was delivered in PEG-modified thiolated gelatin nanoparticles, highest levels of sFlt-1 expression was observed in vitro in MDA-MB-435 human breast adenocarcinoma cell line. In addition, upon intravenous administration in female Nu/Nu mice bearing orthotopic MDA-MB-435 breast adenocarcinoma xenografts, efficient in vivo expression of sFlt-1 plasmid DNA was confirmed quantitatively by enzyme-linked immunosorbent assay and qualitatively by Western blot analysis. The expressed sFlt-1 was therapeutically active as shown by suppression of tumor growth and microvessel density measurements. The results of this study show that PEG-modified gelatin-based nanovectors can serve as a safe and effective systemically administered gene delivery vehicle for solid tumor.</abstract><notes>Eb-002027/eb/nibib&#xD;R01-ca095522/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17363959 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>3.889</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>584</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">584</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dickerson, E. B.</author><author>Dreaden, E. C.</author><author>Huang, X.</author><author>El-Sayed, I. H.</author><author>Chu, H.</author><author>Pushpanketh, S.</author><author>McDonald, J. F.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>School of Biology, Ovarian Cancer Institute, Georgia Institute of Technology, Atlanta, GA 30332-0400, USA.</auth-address><titles><title>Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice</title><secondary-title>Cancer Lett</secondary-title></titles><edition>2008/06/11</edition><dates><year>2008</year><pub-dates><date>Jun 7</date></pub-dates></dates><isbn>0304-3835 (Print)</isbn><accession-num>18541363</accession-num><abstract>Plasmonic photothermal therapy (PPTT) is a minimally-invasive oncological treatment strategy in which photon energy is selectively administered and converted into heat sufficient to induce cellular hyperthermia. The present work demonstrates the feasibility of in vivo PPTT treatment of deep-tissue malignancies using easily-prepared plasmonic gold nanorods and a small, portable, inexpensive near-infrared (NIR) laser. Dramatic size decreases in squamous cell carcinoma xenografts were observed for direct (P&lt;0.0001) and intravenous (P&lt;0.0008) administration of pegylated gold nanorods in nu/nu mice. Inhibition of average tumor growth for both delivery methods was observed over a 13-day period, with resorption of &gt;57% of the directly-injected tumors and 25% of the intravenously-treated tumors.</abstract><notes>Journal article&#xD;Cancer letters&#xD;Cancer Lett. 2008 Jun 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18541363</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.398</custom4><electronic-resource-num>S0304-3835(08)00325-X [pii]&#xD;10.1016/j.canlet.2008.04.026</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>219</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">219</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kuick, R.</author><author>Misek, D. E.</author><author>Monsma, D. J.</author><author>Webb, C. P.</author><author>Wang, H.</author><author>Peterson, K. J.</author><author>Pisano, M.</author><author>Omenn, G. S.</author><author>Hanash, S. M.</author></authors></contributors><auth-address>Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI, USA.</auth-address><titles><title>Discovery of cancer biomarkers through the use of mouse models</title><secondary-title>Cancer Lett</secondary-title></titles><pages>40-8</pages><volume>249</volume><number>1</number><edition>2007/02/27</edition><keywords><keyword>Animals</keyword><keyword>*Disease Models, Animal</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Neoplasm Proteins/metabolism</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Proteomics</keyword><keyword>RNA, Messenger/metabolism</keyword><keyword>*Tumor Markers, Biological</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 28</date></pub-dates></dates><isbn>0304-3835 (Print)</isbn><accession-num>17320282</accession-num><abstract>Although our understanding of the molecular pathogenesis of common types of cancer has improved considerably, the development of effective strategies for cancer diagnosis and treatment have lagged behind. Mouse models of cancer potentially represent an efficient means for uncovering diagnostic markers as genetic alterations associated with human tumors can be engineered in mice. In addition, defined stages of tumor development, breeding conditions, and blood sampling can all be controlled and standardized to limit heterogeneity. Alternatively human cancer cells can be injected into mice and tumor development monitored in xenotransplants. Mouse-based studies promise to elucidate a repertoire of protein changes that occur in blood and biological fluids during tumor development. This is illustrated in a study in which we have applied a three-dimensional intact protein analysis system (IPAS) to elucidate detectable protein changes in serum from immunodeficient mice with lung xenografts from orthotopically implanted human A549 lung adenocarcinoma cells. With sufficiently detailed protein sequence identifications, the observed protein changes can be attributed to either the host mouse or the human tumor cells. It is noteworthy that the majority of increases identified have corresponded to relatively abundant serum proteins, some of which have previously been reported as increased in the sera of cancer patients. Proteomic studies of mouse models of cancer allow assessment of the range of changes in plasma proteins that occur with tumor development and may lead to the identification of potential cancer markers applicable to humans.</abstract><notes>Kuick, Rork&#xD;Misek, David E&#xD;Monsma, David J&#xD;Webb, Craig P&#xD;Wang, Hong&#xD;Peterson, Kelli J&#xD;Pisano, Michael&#xD;Omenn, Gilbert S&#xD;Hanash, Samir M&#xD;Review&#xD;Ireland&#xD;Cancer letters&#xD;Cancer Lett. 2007 Apr 28;249(1):40-8. Epub 2007 Feb 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17320282</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>3.398</custom4><electronic-resource-num>S0304-3835(06)00700-2 [pii]&#xD;10.1016/j.canlet.2006.12.032</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>298</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">298</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Reddig, P. J.</author><author>Juliano, R. L.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Clinging to life: cell to matrix adhesion and cell survival</title><secondary-title>Cancer Metastasis Rev</secondary-title></titles><pages>425-39</pages><volume>24</volume><number>3</number><edition>2005/11/01</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase</keyword><keyword>Actins/metabolism</keyword><keyword>Animals</keyword><keyword>Anoikis</keyword><keyword>Apoptosis</keyword><keyword>Apoptosis Regulatory Proteins/metabolism</keyword><keyword>*Cell Adhesion</keyword><keyword>Cell Line, Transformed</keyword><keyword>Cell Survival</keyword><keyword>*Cell Transformation, Neoplastic</keyword><keyword>Cytoskeleton/metabolism</keyword><keyword>DNA Damage</keyword><keyword>Extracellular Matrix/metabolism</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases/metabolism</keyword><keyword>Homeostasis</keyword><keyword>Humans</keyword><keyword>Integrins/metabolism</keyword><keyword>Membrane Proteins/metabolism</keyword><keyword>Models, Biological</keyword><keyword>Protein-Serine-Threonine Kinases/metabolism</keyword><keyword>Proto-Oncogene Proteins/metabolism</keyword><keyword>Proto-Oncogene Proteins c-bcl-2/metabolism</keyword><keyword>Signal Transduction</keyword><keyword>bcl-2-Associated X Protein/metabolism</keyword></keywords><dates><year>2005</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0167-7659 (Print)</isbn><accession-num>16258730</accession-num><abstract>Cell to matrix adhesion regulates cellular homeostasis in multiple ways. Integrin attachment to the extracellular matrix mediates this regulation through direct and indirect connections to the actin cytoskeleton, growth factor receptors, and intracellular signal transduction cascades. Disruption of this connection to the extracellular matrix has deleterious effects on cell survival. It leads to a specific type of apoptosis known as anoikis in most non-transformed cell types. Anchorage independent growth is a critical step in the tumorigenic transformation of cells. Thus, breaching the anoikis barrier disrupts the cell&apos;s defenses against transformation. This review examines recent investigations into the molecular mechanisms of anoikis to illustrate current understanding of this important process.</abstract><notes>Reddig, Peter J&#xD;Juliano, Rudy L&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;Netherlands&#xD;Cancer metastasis reviews&#xD;Cancer Metastasis Rev. 2005 Sep;24(3):425-39.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16258730</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>6.115</custom4><electronic-resource-num>10.1007/s10555-005-5134-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>434</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">434</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Arwert, E.</author><author>Hingtgen, S.</author><author>Figueiredo, J. L.</author><author>Bergquist, H.</author><author>Mahmood, U.</author><author>Weissleder, R.</author><author>Shah, K.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.</auth-address><titles><title>Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo</title><secondary-title>Cancer Res</secondary-title></titles><pages>7335-42</pages><volume>67</volume><number>15</number><edition>2007/08/03</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/therapeutic use</keyword><keyword>Blotting, Western</keyword><keyword>Brain Neoplasms/genetics/immunology/*therapy</keyword><keyword>Cell Proliferation</keyword><keyword>Combined Modality Therapy</keyword><keyword>Flow Cytometry</keyword><keyword>*Gene Therapy</keyword><keyword>Genetic Engineering</keyword><keyword>Glioma/genetics/immunology/*therapy</keyword><keyword>Humans</keyword><keyword>Lentivirus/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Small Interfering/*therapeutic use</keyword><keyword>Receptor, Epidermal Growth Factor/antagonists &amp;</keyword><keyword>inhibitors/*genetics/immunology</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17671203</accession-num><abstract>Many altered pathways in cancer cells depend on growth factor receptors. In primary malignant gliomas, the amplification/alteration of the epidermal growth factor receptor (EGFR) has been shown to play a significant role in enhancing glioma burden. In an effort to dissect the role of EGFR expression in glioma progression in vivo and evaluate targeted therapies for gliomas, we have genetically engineered glioma cells to visualize the dynamics of EGFR and targeted therapies in real time in vivo. Using engineered lentiviral vectors bearing fusions between EGFR and its exon 2 to 7 deleted variant (EGFRvIII) with green fluorescent protein (GFP) and Renilla luciferase (Rluc), we show that there is a direct correlation between EGFR expression and glioma cell proliferation in the initial stages of glioma progression. To monitor and evaluate EGFR-targeted therapies, we have engineered (a) short hairpin RNAs (shRNA) and (b) clinically used monoclonal antibody, cetuximab. Using EGFR-GFP-Rluc/firefly luciferase (Fluc)-DsRed2 glioma model, we show that both shRNAs and cetuximab result in a considerable reduction in glioma cell proliferation in culture and glioma burden in vivo that can be monitored in real time at a cellular resolution. This study serves as a template to follow the role of growth factor receptor expression in tumor progression and to image therapeutic efficacy of targeted therapies in cancer.</abstract><notes>Arwert, Esther&#xD;Hingtgen, Shawn&#xD;Figueiredo, Jose-Luiz&#xD;Bergquist, Henry&#xD;Mahmood, Umar&#xD;Weissleder, Ralph&#xD;Shah, Khalid&#xD;CA86355/CA/United States NCI&#xD;P50CA86355/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Aug 1;67(15):7335-42.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17671203</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>7.656</custom4><electronic-resource-num>67/15/7335 [pii]&#xD;10.1158/0008-5472.CAN-07-0077</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bouvet, M.</author><author>Spernyak, J.</author><author>Katz, M. H.</author><author>Mazurchuk, R. V.</author><author>Takimoto, S.</author><author>Bernacki, R.</author><author>Rustum, Y. M.</author><author>Moossa, A. R.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>Department of Surgery, University of California at San Diego, CA 92111, USA.</auth-address><titles><title>High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><pages>9829-33</pages><volume>65</volume><number>21</number><edition>2005/11</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Disease Models, Animal</keyword><keyword>Fluorescent Antibody Technique/methods</keyword><keyword>Humans</keyword><keyword>Luminescent Proteins/*analysis/biosynthesis/genetics</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Pancreatic Neoplasms/*diagnosis/genetics/metabolism</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2005</year><pub-dates><date>Nov 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16267005</accession-num><abstract>We have developed genetically fluorescent orthotopic models of human pancreatic cancer. In these models, noninvasive fluorescent protein imaging (FPI) of internal primary tumors and metastatic deposits has been carried out. Whole-body tumor images are easily and inexpensively obtained using FPI, permitting both detection and quantification of tumor load. In this study, we simultaneously compared single mice with a highly fluorescent, red fluorescent protein-expressing orthotopic pancreatic cancer xenografts with both FPI and high-resolution magnetic resonance imaging (MRI). Images were acquired at multiple time points after tumor implantation in the pancreas. Indwelling pancreatic primary tumors and metastatic foci were detected by both FPI and MRI. Moreover, a strong correlation existed between images taken with these two technologies. FPI permitted rapid, high-throughput imaging without the need for either anesthesia or contrast agents. Both FPI and MRI enabled accurate imaging of tumor growth and metastasis, although MRI enabled tissue structure to be visualized as well. FPI has high resolution and is exceedingly rapid with instant image capture. We suggest a complimentary role for these two imaging modalities.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Comparative Study&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16267005 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.656</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>16</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">16</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bouvet, M.</author><author>Tsuji, K.</author><author>Yang, M.</author><author>Jiang, P.</author><author>Moossa, A. R.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>Department of Surgery, University of California, San Diego, USA.</auth-address><titles><title>In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><pages>11293-7</pages><volume>66</volume><number>23</number><edition>2006/12</edition><keywords><keyword>Animals</keyword><keyword>Colonic Neoplasms/metabolism/*pathology</keyword><keyword>Female</keyword><keyword>Genetic Vectors/genetics</keyword><keyword>Green Fluorescent Proteins/genetics/*metabolism</keyword><keyword>HCT116 Cells</keyword><keyword>Humans</keyword><keyword>Liver Neoplasms/metabolism/*secondary</keyword><keyword>Luminescent Proteins/genetics/*metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Neoplasms, Experimental/metabolism/pathology</keyword><keyword>Retroviridae/genetics</keyword><keyword>Spleen/metabolism/*pathology</keyword><keyword>Transfection</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17145875</accession-num><abstract>The role of host cells in tumor progression and metastasis is critical. Intrasplenic injection of tumor cells has long been known as an effective method of developing liver metastases in nude mice, whereas portal vein (PV) injection of tumor cells can result in rapid death of the tumor cells. Host cells were thought to play a role in these phenomena. We report here that after splenic injection of tumor cells, splenocytes cotraffic with the tumor cells to the liver and facilitate metastatic colony formation. Human colon cancer cells that express green fluorescent protein (GFP) linked to histone H2B in the nucleus and red fluorescent protein (RFP) in the cytoplasm (HCT-116-GFP-RFP) were injected in either the PV or spleen of nude mice and imaged at the subcellular level in vivo. Extensive clasmocytosis (destruction of the cytoplasm) of the cancer cells occurred within 6 hours after PV injection and essentially all the cancer cells died. In contrast, splenic injection of these tumor cells resulted in the aggressive formation of liver and distant metastasis. GFP spleen cells were found in the liver metastases that resulted from intrasplenic injection of the tumor cells in transgenic nude mice ubiquitously expressing GFP. When GFP spleen cells and the RFP cancer cells were coinjected in the PV, liver metastasis resulted that contained GFP spleen cells. These results suggest a novel tumor-host interaction that enables efficient formation of liver metastasis via intrasplenic injection.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103568/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17145875 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.656</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>24</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">24</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Charest, A.</author><author>Wilker, E. W.</author><author>McLaughlin, M. E.</author><author>Lane, K.</author><author>Gowda, R.</author><author>Coven, S.</author><author>McMahon, K.</author><author>Kovach, S.</author><author>Feng, Y.</author><author>Yaffe, M. B.</author><author>Jacks, T.</author><author>Housman, D.</author></authors></contributors><auth-address>Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. charest@mit.edu</auth-address><titles><title>ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><pages>7473-81</pages><volume>66</volume><number>15</number><edition>2006/08</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/*metabolism</keyword><keyword>Animals</keyword><keyword>Astrocytoma/enzymology/metabolism/pathology</keyword><keyword>Brain Neoplasms/enzymology/*metabolism/pathology</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/deficiency/genetics</keyword><keyword>Enzyme Activation</keyword><keyword>Glioblastoma/enzymology/*metabolism/pathology</keyword><keyword>Intracellular Signaling Peptides and Proteins/metabolism</keyword><keyword>Mice</keyword><keyword>Protein Kinases/*metabolism</keyword><keyword>Protein-Tyrosine Kinases/biosynthesis/genetics/*metabolism</keyword><keyword>Protein-Tyrosine-Phosphatase/metabolism</keyword><keyword>Proto-Oncogene Proteins/biosynthesis/genetics/*metabolism</keyword><keyword>Proto-Oncogene Proteins c-akt/metabolism</keyword><keyword>Recombinant Fusion Proteins/biosynthesis/genetics/metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tumor Suppressor Protein p14ARF/deficiency/genetics</keyword><keyword>src Homology Domains</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16885344</accession-num><abstract>Glioblastoma multiforme is the most common and lethal form of primary brain cancer. Diagnosis of this advanced glioma has a poor prognosis due to the ineffectiveness of current therapies. Aberrant expression of receptor tyrosine kinases (RTK) in glioblastoma multiformes is suggestive of their role in initiation and maintenance of these tumors of the central nervous system. In fact, ectopic expression of the orphan RTK ROS is a frequent event in human brain cancers, yet the pathologic significance of this expression remains undetermined. Here, we show that a glioblastoma-associated, ligand-independent rearrangement product of ROS (FIG-ROS) cooperates with loss of the tumor suppressor gene locus Ink4a;Arf to produce glioblastomas in the mouse. We show that this FIG-ROS-mediated tumor formation in vivo parallels the activation of the tyrosine phosphatase SH2 domain-containing phosphatase-2 (SHP-2) and a phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling axis in tumors and tumor-derived cell lines. We have established a fully penetrant preclinical model for adult onset of glioblastoma multiforme in keeping with major genetic events observed in the human disease. These findings provide novel and important insights into the role of ROS and SHP-2 function in solid tumor biology and set the stage for preclinical testing of targeted therapeutic approaches.</abstract><notes>P01 ca 042063/ca/nci&#xD;R01 gm 060594/gm/nigms&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16885344 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>7.656</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>528</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">528</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T. C.</author><author>Marks, J. W., 3rd</author><author>Lavery, L. A.</author><author>Faulkner, S.</author><author>Rosenblum, M. G.</author><author>Ellington, A. D.</author><author>Levy, M.</author></authors></contributors><auth-address>Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas 78712, USA.</auth-address><titles><title>Aptamer:toxin conjugates that specifically target prostate tumor cells</title><secondary-title>Cancer Res</secondary-title></titles><pages>5989-92</pages><volume>66</volume><number>12</number><edition>2006/06/17</edition><keywords><keyword>Antineoplastic Agents, Phytogenic/*administration &amp;</keyword><keyword>dosage/pharmacokinetics</keyword><keyword>Aptamers, Nucleotide/*genetics/pharmacokinetics</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Humans</keyword><keyword>Inhibitory Concentration 50</keyword><keyword>Male</keyword><keyword>Plant Proteins/*administration &amp; dosage/pharmacokinetics</keyword><keyword>Prostate-Specific Antigen/biosynthesis/genetics/metabolism</keyword><keyword>Prostatic Neoplasms/*drug therapy/*genetics/metabolism</keyword><keyword>Ribosome Inactivating Proteins, Type 1</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16778167</accession-num><abstract>We have used RNA aptamer:gelonin conjugates to target and specifically destroy cells overexpressing the known cancer biomarker prostate-specific membrane antigen (PSMA). Aptamer:toxin conjugates have an IC50 of 27 nmol/L and display an increased potency of at least 600-fold relative to cells that do not express PSMA. The aptamer not only promotes uptake into target cells but also decreases the toxicity of gelonin in non-target cells. These results validate the notion that &quot;escort aptamers&quot; may be useful for the treatment of specific tumors expressing unique antigen targets.</abstract><notes>Chu, Ted C&#xD;Marks, John W 3rd&#xD;Lavery, Laura A&#xD;Faulkner, Sarah&#xD;Rosenblum, Michael G&#xD;Ellington, Andrew D&#xD;Levy, Matthew&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Jun 15;66(12):5989-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16778167</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>7.656</custom4><electronic-resource-num>66/12/5989 [pii]&#xD;10.1158/0008-5472.CAN-05-4583</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>432</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">432</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Corsten, M. F.</author><author>Miranda, R.</author><author>Kasmieh, R.</author><author>Krichevsky, A. M.</author><author>Weissleder, R.</author><author>Shah, K.</author></authors></contributors><auth-address>Center for Molecular Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.</auth-address><titles><title>MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas</title><secondary-title>Cancer Res</secondary-title></titles><pages>8994-9000</pages><volume>67</volume><number>19</number><edition>2007/10/03</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/genetics/pathology/*therapy</keyword><keyword>Caspases/metabolism</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Genetic Vectors/genetics</keyword><keyword>Glioblastoma/genetics/pathology/*therapy</keyword><keyword>Humans</keyword><keyword>Lentivirus/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>MicroRNAs/*antagonists &amp; inhibitors</keyword><keyword>Neurons/*physiology</keyword><keyword>Oligonucleotides, Antisense/administration &amp; dosage/*genetics</keyword><keyword>Stem Cells/*physiology</keyword><keyword>TNF-Related Apoptosis-Inducing Ligand/*genetics</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17908999</accession-num><abstract>Despite the development of new glioma therapies that allow for tumor-targeted in situ delivery of cytotoxic drugs, tumor resistance to apoptosis remains a key impediment to effective treatment. Mounting evidence indicates that microRNAs (miRNA) might play a fundamental role in tumorigenesis, controlling cell proliferation and apoptosis. In gliomas, microRNA-21 (miR-21) levels have been reported to be elevated and their knockdown is associated with increased apoptotic activity. We hypothesized that suppression of miR-21 might sensitize gliomas for cytotoxic tumor therapy. With the use of locked nucleic acid (LNA)-antimiR-21 oligonucleotides, bimodal imaging vectors, and neural precursor cells (NPC) expressing a secretable variant of the cytotoxic agent tumor necrosis factor-related apoptosis inducing ligand (S-TRAIL), we show that the combined suppression of miR-21 and NPC-S-TRAIL leads to a synergistic increase in caspase activity and significantly decreased cell viability in human glioma cells in vitro. This phenomenon persists in vivo, as we observed complete eradication of LNA-antimiR-21-treated gliomas subjected to the presence of NPC-S-TRAIL in the murine brain. Our results reveal the efficacy of miR-21 antagonism in murine glioma models and implicate miR-21 as a target for therapeutic intervention. Furthermore, our findings provide the basis for developing combination therapies using miRNA modulation and cytotoxic tumor therapies.</abstract><notes>Corsten, Maarten F&#xD;Miranda, Rafael&#xD;Kasmieh, Randa&#xD;Krichevsky, Anna M&#xD;Weissleder, Ralph&#xD;Shah, Khalid&#xD;P01 CA69246/CA/United States NCI&#xD;P50 CA86355/CA/United States NCI&#xD;R21 CA116141/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Oct 1;67(19):8994-9000.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17908999</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.656</custom4><electronic-resource-num>67/19/8994 [pii]&#xD;10.1158/0008-5472.CAN-07-1045</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>459</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">459</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dimri, M.</author><author>Naramura, M.</author><author>Duan, L.</author><author>Chen, J.</author><author>Ortega-Cava, C.</author><author>Chen, G.</author><author>Goswami, R.</author><author>Fernandes, N.</author><author>Gao, Q.</author><author>Dimri, G. P.</author><author>Band, V.</author><author>Band, H.</author></authors></contributors><auth-address>Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA.</auth-address><titles><title>Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior</title><secondary-title>Cancer Res</secondary-title></titles><pages>4164-72</pages><volume>67</volume><number>9</number><edition>2007/05/08</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/*enzymology/pathology</keyword><keyword>Cell Adhesion/physiology</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cell Transformation, Neoplastic/*metabolism/pathology</keyword><keyword>Collagen</keyword><keyword>Drug Combinations</keyword><keyword>Epithelial Cells/enzymology/pathology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Laminin</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Protein-Tyrosine Kinases/*biosynthesis</keyword><keyword>Proteoglycans</keyword><keyword>Receptor, Epidermal Growth Factor/*biosynthesis</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17483327</accession-num><abstract>Epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is overexpressed in as many as 60% cases of breast and other cancers. EGFR overexpression is a characteristic of highly aggressive molecular subtypes of breast cancer with basal-like and BRCA1 mutant phenotypes distinct from ErbB2-overexpressing breast cancers. Yet, EGFR is substantially weaker compared with ErbB2 in promoting the oncogenic transformation of nontumorigenic human mammary epithelial cells (human MEC), suggesting a role for cooperating oncogenes. Here, we have modeled the co-overexpression of EGFR and a biologically and clinically relevant potential modifier c-Src in two distinct immortal but nontumorigenic human MECs. Using a combination of morphologic analysis and confocal imaging of polarity markers in three-dimensional Matrigel culture together with functional analyses of early oncogenic traits, we show for the first time that EGFR and c-Src co-overexpression but not EGFR or c-Src overexpression alone unleashes an oncogenic signaling program that leads to hyperproliferation and loss of polarity in three-dimensional acinar cultures, marked enhancement of migratory and invasive behavior, and anchorage-independent growth. Our results establish that EGFR overexpression in an appropriate context (modeled here using c-Src overexpression) can initiate oncogenic transformation of nontumorigenic human MECs and provide a suitable in vitro model to interrogate human breast cancer-relevant oncogenic signaling pathways initiated by overexpressed EGFR and to identify modifiers of EGFR-mediated breast oncogenesis.</abstract><notes>Dimri, Manjari&#xD;Naramura, Mayumi&#xD;Duan, Lei&#xD;Chen, Jing&#xD;Ortega-Cava, Cesar&#xD;Chen, Gengsheng&#xD;Goswami, Rasna&#xD;Fernandes, Norvin&#xD;Gao, Qingshen&#xD;Dimri, Goberdhan P&#xD;Band, Vimla&#xD;Band, Hamid&#xD;1U54 CA 119341-01/CA/United States NCI&#xD;CA 76118/CA/United States NCI&#xD;CA 81076/CA/United States NCI&#xD;CA 87986/CA/United States NCI&#xD;CA 94143/CA/United States NCI&#xD;CA 96844/CA/United States NCI&#xD;CA 99163/CA/United States NCI&#xD;CA 99900/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 May 1;67(9):4164-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17483327</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>7.656</custom4><electronic-resource-num>67/9/4164 [pii]&#xD;10.1158/0008-5472.CAN-06-2580</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>246</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">246</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Freeman, D.</author><author>Lesche, R.</author><author>Kertesz, N.</author><author>Wang, S.</author><author>Li, G.</author><author>Gao, J.</author><author>Groszer, M.</author><author>Martinez-Diaz, H.</author><author>Rozengurt, N.</author><author>Thomas, G.</author><author>Liu, X.</author><author>Wu, H.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, University of California at Los Angeles School of Medicine, 650 C.E. Young Drive South, Los Angeles, CA 90095, USA.</auth-address><titles><title>Genetic background controls tumor development in PTEN-deficient mice</title><secondary-title>Cancer Res</secondary-title></titles><pages>6492-6</pages><volume>66</volume><number>13</number><edition>2006/07/05</edition><keywords><keyword>Alleles</keyword><keyword>Animals</keyword><keyword>Female</keyword><keyword>Genes, Tumor Suppressor</keyword><keyword>Germ-Line Mutation</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Knockout</keyword><keyword>Neoplasms, Experimental/*genetics</keyword><keyword>PTEN Phosphohydrolase/*deficiency/genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16818619</accession-num><abstract>PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. Germ line mutations of PTEN have been detected in three rare autosomal-dominant disorders. However, identical mutations in the PTEN gene may lead to different symptoms that have traditionally been described as different disorders, such as Cowden disease, Lhermitte-Duclos disease, and Bannayan-Zonana syndromes. This lack of genotype-phenotype correlation prompted us to directly test the possible effects of genetic background or modifier genes on PTEN-controlled tumorigenesis using genetically engineered mouse models. In this study, we generated two animal models in which either exon 5 (Pten(Delta5)) or promoter to exon 3 (Pten(-)) of the murine Pten gene were deleted and compared phenotypes associated with individual mutations on two genetic backgrounds. We found that the onset and spectrum of tumor formation depend significantly on the genetic background but less on the type of mutation generated. Our results suggest that PTEN plays a critical role in cancer development, and genetic background may influence the onset, the spectrum, and the progression of tumorigenesis caused by Pten mutation.</abstract><notes>Freeman, Dan&#xD;Lesche, Ralf&#xD;Kertesz, Nathalie&#xD;Wang, Shungyou&#xD;Li, Gang&#xD;Gao, Jing&#xD;Groszer, Matthias&#xD;Martinez-Diaz, Hilda&#xD;Rozengurt, Nora&#xD;Thomas, George&#xD;Liu, Xin&#xD;Wu, Hong&#xD;Ca 98013/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Jul 1;66(13):6492-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16818619</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.656</custom4><electronic-resource-num>66/13/6492 [pii]&#xD;10.1158/0008-5472.CAN-05-4143</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>433</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">433</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fulci, G.</author><author>Dmitrieva, N.</author><author>Gianni, D.</author><author>Fontana, E. J.</author><author>Pan, X.</author><author>Lu, Y.</author><author>Kaufman, C. S.</author><author>Kaur, B.</author><author>Lawler, S. E.</author><author>Lee, R. J.</author><author>Marsh, C. B.</author><author>Brat, D. J.</author><author>van Rooijen, N.</author><author>Stemmer-Rachamimov, A. O.</author><author>Hochberg, F. H.</author><author>Weissleder, R.</author><author>Martuza, R. L.</author><author>Chiocca, E. A.</author></authors></contributors><auth-address>Molecular Neuro-oncology Laboratories, Neurosurgery Service, and Center for Molecular Imaging, Massachusetts General Hospital, Charlestown, Massachusetts, USA. gfulci@partners.org</auth-address><titles><title>Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses</title><secondary-title>Cancer Res</secondary-title></titles><pages>9398-406</pages><volume>67</volume><number>19</number><edition>2007/10/03</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/blood/pathology/therapy/*virology</keyword><keyword>Glioma/blood/pathology/therapy/*virology</keyword><keyword>Macrophages/*virology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microglia/pathology</keyword><keyword>Oncolytic Virotherapy/*methods</keyword><keyword>Phagocytosis</keyword><keyword>Rats</keyword><keyword>Rats, Inbred F344</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17909049</accession-num><abstract>Clinical trials have proven oncolytic virotherapy to be safe but not effective. We have shown that oncolytic viruses (OV) injected into intracranial gliomas established in rodents are rapidly cleared, and this is associated with up-regulation of markers (CD68 and CD163) of cells of monocytic lineage (monocytes/microglia/macrophages). However, it is unclear whether these cells directly impede intratumoral persistence of OV through phagocytosis and whether they infiltrate the tumor from the blood or the brain parenchyma. To investigate this, we depleted phagocytes with clodronate liposomes (CL) in vivo through systemic delivery and ex vivo in brain slice models with gliomas. Interestingly, systemic CL depleted over 80% of peripheral CD163+ macrophages in animal spleen and peripheral blood, thereby decreasing intratumoral infiltration of these cells, but CD68+ cells were unchanged. Intratumoral viral titers increased 5-fold. In contrast, ex vivo CL depleted only CD68+ cells from brain slices, and intratumoral viral titers increased 10-fold. These data indicate that phagocytosis by both peripheral CD163+ and brain-resident CD68+ cells infiltrating tumor directly affects viral clearance from tumor. Thus, improved therapeutic efficacy may require modulation of these innate immune cells. In support of this new therapeutic paradigm, we observed intratumoral up-regulation of CD68+ and CD163+ cells following treatment with OV in a patient with glioblastoma.</abstract><notes>Fulci, Giulia&#xD;Dmitrieva, Nina&#xD;Gianni, Davide&#xD;Fontana, Elisabeth J&#xD;Pan, Xiaogang&#xD;Lu, Yanhui&#xD;Kaufman, Claire S&#xD;Kaur, Balveen&#xD;Lawler, Sean E&#xD;Lee, Robert J&#xD;Marsh, Clay B&#xD;Brat, Daniel J&#xD;van Rooijen, Nico&#xD;Stemmer-Rachamimov, Anat O&#xD;Hochberg, Fred H&#xD;Weissleder, Ralph&#xD;Martuza, Robert L&#xD;Chiocca, E Antonio&#xD;CA095673/CA/United States NCI&#xD;NS41571/NS/United States NINDS&#xD;P01 CA69246/CA/United States NCI&#xD;R01 CA85139/CA/United States NCI&#xD;R01 HL63800/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Oct 1;67(19):9398-406.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17909049</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.656</custom4><electronic-resource-num>67/19/9398 [pii]&#xD;10.1158/0008-5472.CAN-07-1063</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>85</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">85</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hayashi, K.</author><author>Jiang, P.</author><author>Yamauchi, K.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Moossa, A. R.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer Inc, San Diego, CA 92111-3604, USA.</auth-address><titles><title>Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels</title><secondary-title>Cancer Res</secondary-title></titles><pages>8223-8</pages><volume>67</volume><number>17</number><edition>2007/09/07</edition><dates><year>2007</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17804736</accession-num><abstract>In the present report, we show real-time imaging of cancer cell trafficking in lymphatic vessels. Cancer cells labeled with both green fluorescent protein (GFP) in the nucleus and red fluorescent protein (RFP) in the cytoplasm or with GFP only or RFP only were injected into the inguinal lymph node of nude mice. The labeled cancer cells trafficked through lymphatic vessels where they were imaged via a skin flap in real time at the cellular level until they entered the axillary lymph node. The bright fluorescence of the cancer cells and the real-time microscopic imaging capability of the Olympus OV100 small-animal imaging system enabled imaging of the trafficking cancer cells in the lymphatics. Using this imaging strategy, two different cancer cell lines, one expressing GFP and the other expressing RFP, were simultaneously injected in the inguinal lymph node. Fluorescence imaging readily distinguished the two color-coded cell lines and their different abilities to survive in the lymphatic system. Using this imaging technology, we also investigated the role of pressure on tumor-cell shedding into lymphatic vessels. Pressure was generated by placing 25- and 250-g weights for 10 s on the bottom surface of a tumor-bearing footpad. Tumor cell fragments, single cells, and emboli shed from the footpad tumor were easily distinguished with the labeled cells and OV100 imaging system. Increasing pressure on the tumor increased the numbers of shed cells, fragments, and emboli. Pressure also deformed the shed emboli, increasing their maximum major axis. Imaging lymphatic trafficking of cancer cells can reveal critical steps of lymph node metastasis.</abstract><notes>Hayashi, Katsuhiro&#xD;Jiang, Ping&#xD;Yamauchi, Kensuke&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Moossa, A R&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Ca099258/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Sep 1;67(17):8223-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17804736</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>7.656</custom4><electronic-resource-num>67/17/8223 [pii]&#xD;10.1158/0008-5472.CAN-07-1237</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>60</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">60</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jiao, J.</author><author>Wang, S.</author><author>Qiao, R.</author><author>Vivanco, I.</author><author>Watson, P. A.</author><author>Sawyers, C. L.</author><author>Wu, H.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, University of California at Los Angeles, Los Angeles, California 90095-1735, USA.</auth-address><titles><title>Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development</title><secondary-title>Cancer Res</secondary-title></titles><pages>6083-91</pages><volume>67</volume><number>13</number><edition>2007/07/10</edition><keywords><keyword>Agar/chemistry</keyword><keyword>Alleles</keyword><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Chromosomes/ultrastructure</keyword><keyword>Female</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Karyotyping</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Mutation</keyword><keyword>PTEN Phosphohydrolase/genetics/*physiology</keyword><keyword>Prostatic Neoplasms/etiology/*metabolism/*pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17616663</accession-num><abstract>PTEN mutations are among the most frequent genetic alterations found in human prostate cancers. Our previous works suggest that although precancerous lesions were found in Pten heterozygous mice, cancer progression and metastasis only happened when both alleles of Pten were deleted. To understand the molecular mechanisms underlying the role of PTEN in prostate cancer control, we generated two pairs of isogenic, androgen receptor (AR)-positive prostate epithelial lines from intact conditional Pten knock-out mice that are either heterozygous (PTEN-P2 and -P8) or homozygous (PTEN-CaP2 and PTEN-CaP8) for Pten deletion. Further characterization of these cells showed that loss of the second allele of Pten leads to increased anchorage-independent growth in vitro and tumorigenesis in vivo without obvious structural or numerical chromosome changes based on SKY karyotyping analysis. Despite no prior exposure to hormone ablation therapy, Pten null cells are tumorigenic in both male and female severe combined immunodeficiency mice. Furthermore, knocking down PTEN can convert the androgen-dependent Myc-CaP cell into androgen independence, suggesting that PTEN intrinsically controls androgen responsiveness, a critical step in the development of hormone refractory prostate cancer. Importantly, knocking down AR by shRNA in Pten null cells reverses androgen-independent growth in vitro and partially inhibited tumorigenesis in vivo, indicating that PTEN-controlled prostate tumorigenesis is AR dependent. These cell lines will serve as useful tools for understanding signaling pathways controlled by PTEN and elucidating the molecular mechanisms involved in hormone refractory prostate cancer formation.</abstract><notes>Jiao, Jing&#xD;Wang, Shunyou&#xD;Qiao, Rong&#xD;Vivanco, Igor&#xD;Watson, Philip A&#xD;Sawyers, Charles L&#xD;Wu, Hong&#xD;P50 ca092131/ca/nci&#xD;R01 ca107166/ca/nci&#xD;U01 ca84128-06/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Jul 1;67(13):6083-91.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17616663</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>7.656</custom4><electronic-resource-num>67/13/6083 [pii]&#xD;10.1158/0008-5472.CAN-06-4202</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>601</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">601</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, K. A.</author><author>Setlur, S. R.</author><author>Ross, R.</author><author>Anbazhagan, R.</author><author>Waterman, P.</author><author>Rubin, M. A.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. kkelly9@partners.org</auth-address><titles><title>Detection of early prostate cancer using a hepsin-targeted imaging agent</title><secondary-title>Cancer Res</secondary-title></titles><pages>2286-91</pages><volume>68</volume><number>7</number><edition>2008/04/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Peptide Library</keyword><keyword>Prostatic Neoplasms/*diagnosis/*enzymology/genetics</keyword><keyword>RNA, Messenger/biosynthesis/genetics</keyword><keyword>Serine Endopeptidases/*analysis/biosynthesis/genetics</keyword><keyword>Transfection</keyword><keyword>Tumor Markers, Biological/*analysis/biosynthesis/genetics</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 1</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>18381435</accession-num><abstract>Early detection and diagnosis of prostate cancer is key to designing effective treatment strategies. Microarrays have resulted in the discovery of hepsin (HPN) as a biomarker for detection of prostate cancer. In this study, we explore the development of HPN imaging probes for detection of prostate cancer. We used phage display to isolate HPN binding peptides with 190 + 2.2 nmol/L affinity in monomeric form and high specificity. The identified peptides were able to detect human prostate cancer on tissue microarrays and in cell-based assays. HPN-targeted imaging agents were synthesized by conjugating multiple peptides to fluorescent nanoparticles to further improve avidity through multivalency and to improve pharmacokinetics. When injected into mouse xenograft models, HPN-targeted nanoparticles bound specifically to HPN-expressing LNCaP xenografts compared with non-HPN-expressing PC3 xenografts. HPN imaging may provide a new method for detection of prostate cancer.</abstract><notes>Kelly, Kimberly A&#xD;Setlur, Sunita R&#xD;Ross, Robert&#xD;Anbazhagan, Rajesh&#xD;Waterman, Peter&#xD;Rubin, Mark A&#xD;Weissleder, Ralph&#xD;P50-CA090381/CA/United States NCI&#xD;P50-CA86355/CA/United States NCI&#xD;R01AG21404/AG/United States NIA&#xD;R24-CA92782/CA/United States NCI&#xD;U54-CA119349/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2008 Apr 1;68(7):2286-91.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18381435</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.656</custom4><electronic-resource-num>68/7/2286 [pii]&#xD;10.1158/0008-5472.CAN-07-1349</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>251</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">251</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Khodavirdi, A. C.</author><author>Song, Z.</author><author>Yang, S.</author><author>Zhong, C.</author><author>Wang, S.</author><author>Wu, H.</author><author>Pritchard, C.</author><author>Nelson, P. S.</author><author>Roy-Burman, P.</author></authors></contributors><auth-address>Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033, USA.</auth-address><titles><title>Increased expression of osteopontin contributes to the progression of prostate cancer</title><secondary-title>Cancer Res</secondary-title></titles><pages>883-8</pages><volume>66</volume><number>2</number><edition>2006/01/21</edition><keywords><keyword>Adenocarcinoma/*genetics/*pathology</keyword><keyword>Animals</keyword><keyword>Chick Embryo</keyword><keyword>Disease Progression</keyword><keyword>*Gene Expression Profiling</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Osteopontin</keyword><keyword>Prostatic Neoplasms/*genetics/pathology</keyword><keyword>Sialoglycoproteins/*biosynthesis/physiology</keyword><keyword>Transduction, Genetic</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16424021</accession-num><abstract>Osteopontin is a secreted glycosylated phosphoprotein known to be involved in numerous physiologic functions and associated with the late stages of various cancers. We used preneoplastic and neoplastic mouse models of prostate cancer to determine the onset of elevated expression of osteopontin in the development of this disease. Osteopontin alterations occurred early in the disease with dysregulated expression observed in lesions of low-grade prostatic intraepithelial neoplasia (PIN). Over time, osteopontin expressing dysplastic cells seemed to increase in number in high-grade PIN and increased further in adenocarcinoma, and in metastasis, almost all of the cancer cells immunohistochemically stained positive for osteopontin overexpression. We examined the biological properties of human prostate cancer cell lines LNCaP and PC-3, in which osteopontin overexpression was achieved via lentiviral gene transduction. Evidence was obtained that osteopontin could contribute to a proliferative advantage in both cell types, although more significantly in LNCaP than PC-3. Osteopontin also influenced their in vitro invasive ability, and again, most strikingly in the weakly oncogenic LNCaP. Furthermore, excess osteopontin induced the LNCaP cells to acquire a strong intravasation potential in vivo in the chicken embryo chorioallantoic membrane assay for blood vessel penetration. These results establish a correlation between an increased gradient of osteopontin expression throughout the stages of murine prostate cancer, beginning from the preneoplastic lesions to distant metastases that suggests a proliferative and invasive advantages to those prostate tumor cells overexpressing osteopontin. Together, these findings support a strategy designed to target osteopontin in the context of prostate cancer therapy.</abstract><notes>Khodavirdi, Ani C&#xD;Song, Zhigang&#xD;Yang, Shangxin&#xD;Zhong, Chen&#xD;Wang, Shunyou&#xD;Wu, Hong&#xD;Pritchard, Colin&#xD;Nelson, Peter S&#xD;Roy-Burman, Pradip&#xD;R0-1 ca 59705/ca/nci&#xD;T32 ai 07078/ai/niaid&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Jan 15;66(2):883-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16424021</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.656</custom4><electronic-resource-num>66/2/883 [pii]&#xD;10.1158/0008-5472.CAN-05-2816</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>605</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">605</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lakshman, M.</author><author>Xu, L.</author><author>Ananthanarayanan, V.</author><author>Cooper, J.</author><author>Takimoto, C. H.</author><author>Helenowski, I.</author><author>Pelling, J. C.</author><author>Bergan, R. C.</author></authors></contributors><auth-address>Division of Hematology/Oncology, Department of Medicine, Northwestern University Medical School and Robert H. Lurie Cancer Center of Northwestern University, Chicago, Illinois, USA.</auth-address><titles><title>Dietary genistein inhibits metastasis of human prostate cancer in mice</title><secondary-title>Cancer Res</secondary-title></titles><pages>2024-32</pages><volume>68</volume><number>6</number><edition>2008/03/15</edition><keywords><keyword>Animals</keyword><keyword>Anticarcinogenic Agents/administration &amp; dosage/blood</keyword><keyword>Cell Growth Processes/drug effects</keyword><keyword>Cell Line, Tumor</keyword><keyword>Diet</keyword><keyword>Enzyme Activation/drug effects</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases/antagonists &amp;</keyword><keyword>inhibitors/biosynthesis</keyword><keyword>Genistein/*administration &amp; dosage/blood</keyword><keyword>Heat-Shock Proteins/antagonists &amp; inhibitors/biosynthesis</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms/*prevention &amp; control/*secondary</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Neoplasm Proteins/antagonists &amp; inhibitors/biosynthesis</keyword><keyword>Prostatic Neoplasms/*drug therapy/metabolism/*pathology</keyword><keyword>Xenograft Model Antitumor Assays</keyword><keyword>p38 Mitogen-Activated Protein Kinases/antagonists &amp;</keyword><keyword>inhibitors/biosynthesis</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 15</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>18339885</accession-num><abstract>Dietary genistein has been linked to lower prostate cancer (PCa) mortality. Metastasis is the ultimate cause of death from PCa. Cell detachment and invasion represent early steps in the metastatic cascade. We had shown that genistein inhibits PCa cell detachment and cell invasion in vitro. Genistein-mediated inhibition of activation of focal adhesion kinase (FAK) and of the p38 mitogen-activated protein kinase (MAPK)-heat shock protein 27 (HSP27) pathway has been shown by us to regulate PCa cell detachment and invasion effects, respectively. To evaluate the antimetastatic potential of genistein, we developed an animal model suited to evaluating antimetastatic drug efficacy. Orthotopically implanted human PC3-M PCa cells formed lung micrometastasis by 4 weeks in &gt;80% of inbred athymic mice. Feeding mice dietary genistein before implantation led to blood concentrations similar to those measured in genistein-consuming men. Genistein decreased metastases by 96%, induced nuclear morphometric changes in PC3-M cells indicative of increased adhesion (i.e., decreased detachment) but did not alter tumor growth. Genistein increased tumor levels of FAK, p38 MAPK, and HSP27 &quot;promotility&quot; proteins. However, the ratio of phosphorylated to total protein trended downward, indicating a failure to increase relative amounts of activated protein. This study describes a murine model of human PCa metastasis well suited for testing antimetastatic drugs. It shows for the first time that dietary concentrations of genistein can inhibit PCa cell metastasis. Increases in promotility proteins support the notion of cellular compensatory responses to antimotility effects induced by therapy. Studies of antimetastatic efficacy in man are warranted and are under way.</abstract><notes>Lakshman, Minalini&#xD;Xu, Li&#xD;Ananthanarayanan, Vijayalakshmi&#xD;Cooper, Joshua&#xD;Takimoto, Chris H&#xD;Helenowski, Irene&#xD;Pelling, Jill C&#xD;Bergan, Raymond C&#xD;CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2008 Mar 15;68(6):2024-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18339885</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.656</custom4><electronic-resource-num>68/6/2024 [pii]&#xD;10.1158/0008-5472.CAN-07-1246</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>15</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">15</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsuji, K.</author><author>Yamauchi, K.</author><author>Yang, M.</author><author>Jiang, P.</author><author>Bouvet, M.</author><author>Endo, H.</author><author>Kanai, Y.</author><author>Yamashita, K.</author><author>Moossa, A. R.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111, USA.</auth-address><titles><title>Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><pages>303-6</pages><volume>66</volume><number>1</number><edition>2006/01</edition><keywords><keyword>Animals</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cell Survival/physiology</keyword><keyword>Colonic Neoplasms/drug therapy/*metabolism/pathology</keyword><keyword>Cyclophosphamide/pharmacology</keyword><keyword>Cytoplasm/metabolism</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>HCT116 Cells</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Liver Neoplasms, Experimental/blood/secondary</keyword><keyword>Luminescent Proteins/metabolism</keyword><keyword>Male</keyword><keyword>Mammary Neoplasms, Experimental/blood/drug therapy/*metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Neoplasm Circulating Cells/drug effects/*metabolism/pathology</keyword><keyword>Portal Vein</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16397243</accession-num><abstract>We used dual-color in vivo cellular imaging to visualize trafficking, nuclear-cytoplasmic dynamics, and the viability of cancer cells after their injection into the portal vein of mice. For these studies, we used dual-color fluorescent cancer cells that express green fluorescent protein (GFP) linked to histone H2B in the nucleus and retroviral red fluorescent protein (RFP) in the cytoplasm. Human HCT-116-GFP-RFP colon cancer and mouse mammary tumor (MMT) cells were HCT-116-GFP-RFP in the portal vein of nude mice. The cells were observed intravitally in the liver at the single-cell level using the Olympus OV100 whole-mouse imaging system. Most HCT-116-GFP-RFP cells remained in sinusoids near peripheral portal veins. Only a small fraction of the cancer cells invaded the lobular area. Extensive clasmocytosis (destruction of the cytoplasm) of the HCT-116-GFP-RFP cells occurred within 6 hours. The number of apoptotic cells rapidly increased within the portal vein within 12 hours of injection. Apoptosis was readily visualized in the dual-color cells by their altered nuclear morphology. The data suggest rapid death of HCT-116-GFP-RFP cells in the portal vein. In contrast, dual-color MMT-GFP-RFP cells injected into the portal vein mostly survived in the liver of nude mice 24 hours after injection. Many surviving MMT-GFP-RFP cells showed invasive figures with cytoplasmic protrusions. The cells grew aggressively and formed colonies in the liver. However, when the host mice were pretreated with cyclophosphamide, the HCT-116-GFP-RFP cells also survived and formed colonies in the liver after portal vein injection. These results suggest that a cyclophosphamide-sensitive host cellular system attacked the HCT-116-GFP-RFP cells but could not effectively kill the MMT-GFP-RFP cells.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16397243 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.656</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>358</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">358</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>van Vlerken, L. E.</author><author>Duan, Z.</author><author>Seiden, M. V.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts, USA.</auth-address><titles><title>Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><pages>4843-50</pages><volume>67</volume><number>10</number><edition>2007/05</edition><keywords><keyword>Antineoplastic Agents, Phytogenic/*administration &amp; dosage</keyword><keyword>Cell Line, Tumor</keyword><keyword>Ceramides/*administration &amp; dosage/*metabolism</keyword><keyword>Drug Resistance, Multiple</keyword><keyword>Drug Resistance, Neoplasm</keyword><keyword>Ethylene Oxide/administration &amp; dosage/chemistry</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Lactones/administration &amp; dosage/chemistry</keyword><keyword>Nanoparticles/*administration &amp; dosage/chemistry</keyword><keyword>Ovarian Neoplasms/*drug therapy/*metabolism</keyword><keyword>Paclitaxel/*administration &amp; dosage</keyword></keywords><dates><year>2007</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17510414</accession-num><abstract>Although multidrug resistance (MDR) is known to develop through a variety of molecular mechanisms within the tumor cell, many tend to converge toward the alteration of apoptotic signaling. The enzyme glucosylceramide synthase (GCS), responsible for bioactivation of the proapoptotic mediator ceramide to a nonfunctional moiety glucosylceramide, is overexpressed in many MDR tumor types and has been implicated in cell survival in the presence of chemotherapy. The purpose of this study was to investigate the therapeutic strategy of coadministering ceramide with paclitaxel, a commonly used chemotherapeutic agent, in an attempt to restore apoptotic signaling and overcome MDR in the human ovarian cancer cell line SKOV3. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) (PEO-PCL) nanoparticles were used to encapsulate and deliver the therapeutic agents for enhanced efficacy. Results show that indeed the cotherapy eradicates the complete population of MDR cancer cells when they are treated at their IC(50) dose of paclitaxel. More interestingly, when the cotherapy was combined with the properties of nanoparticle drug delivery, the MDR cells can be resensitized to a dose of paclitaxel near the IC(50) of non-MDR (drug sensitive) cells, indicating a 100-fold increase in chemosensitization via this approach. Molecular analysis of activity verified the hypothesis that the efficacy of this therapeutic approach is indeed due to a restoration in apoptotic signaling, although the beneficial properties of PEO-PCL nanoparticle delivery seemed to enhance the therapeutic success even further, showing the promising potential for the clinical use of this therapeutic strategy to overcome MDR.</abstract><notes>Ca-095522/ca/nci&#xD;Ca-119617/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17510414 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>7.656</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>381</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">381</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Veiseh, M.</author><author>Gabikian, P.</author><author>Bahrami, S. B.</author><author>Veiseh, O.</author><author>Zhang, M.</author><author>Hackman, R. C.</author><author>Ravanpay, A. C.</author><author>Stroud, M. R.</author><author>Kusuma, Y.</author><author>Hansen, S. J.</author><author>Kwok, D.</author><author>Munoz, N. M.</author><author>Sze, R. W.</author><author>Grady, W. M.</author><author>Greenberg, N. M.</author><author>Ellenbogen, R. G.</author><author>Olson, J. M.</author></authors></contributors><auth-address>Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Avenue N., Seattle, WA 98109, USA.</auth-address><titles><title>Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><pages>6882-8</pages><volume>67</volume><number>14</number><edition>2007/06</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/metabolism</keyword><keyword>Carbocyanines/*chemistry</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Glioma/metabolism</keyword><keyword>Humans</keyword><keyword>Matrix Metalloproteinase 2/metabolism</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Neovascularization, Pathologic</keyword><keyword>Photons</keyword><keyword>Rats</keyword><keyword>Scorpion Venoms/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17638899</accession-num><abstract>Toward the goal of developing an optical imaging contrast agent that will enable surgeons to intraoperatively distinguish cancer foci from adjacent normal tissue, we developed a chlorotoxin:Cy5.5 (CTX:Cy5.5) bioconjugate that emits near-IR fluorescent signal. The probe delineates malignant glioma, medulloblastoma, prostate cancer, intestinal cancer, and sarcoma from adjacent non-neoplastic tissue in mouse models. Metastatic cancer foci as small as a few hundred cells were detected in lymph channels. Specific binding to cancer cells is facilitated by matrix metalloproteinase-2 (MMP-2) as evidenced by reduction of CTX:Cy5.5 binding in vitro and in vivo by a pharmacologic blocker of MMP-2 and induction of CTX:Cy5.5 binding in MCF-7 cells following transfection with a plasmid encoding MMP-2. Mouse studies revealed that CTX:Cy5.5 has favorable biodistribution and toxicity profiles. These studies show that CTX:Cy5.5 has the potential to fundamentally improve intraoperative detection and resection of malignancies.</abstract><notes>Cq 84296/phs&#xD;N01 c0 37007-16/phs&#xD;P30 ca 15704-31/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17638899 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2007</custom3><custom4>7.656</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>262</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">262</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, M. Y.</author><author>Lu, K. V.</author><author>Zhu, S.</author><author>Dia, E. Q.</author><author>Vivanco, I.</author><author>Shackleford, G. M.</author><author>Cavenee, W. K.</author><author>Mellinghoff, I. K.</author><author>Cloughesy, T. F.</author><author>Sawyers, C. L.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Departments of Pathology and Laboratory Medicine, Neurology, Medicine, Molecular and Medical Pharmacology, Henry E. Singleton Brain Tumor Program, and Howard Hughes Medical Institute, David Geffen School of Medicine, University of California at Los Angeles.</auth-address><titles><title>Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells</title><secondary-title>Cancer Res</secondary-title></titles><pages>7864-7869</pages><volume>66</volume><number>16</number><edition>2006/08/17</edition><dates><year>2006</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16912159</accession-num><abstract>The epidermal growth factor receptor (EGFR) is commonly amplified, overexpressed, and mutated in glioblastoma, making it a compelling molecular target for therapy. We have recently shown that coexpression of EGFRvIII and PTEN protein by glioblastoma cells is strongly associated with clinical response to EGFR kinase inhibitor therapy. PTEN loss, by dissociating inhibition of the EGFR from downstream phosphatidylinositol 3-kinase (PI3K) pathway inhibition, seems to act as a resistance factor. Because 40% to 50% of glioblastomas are PTEN deficient, a critical challenge is to identify strategies that promote responsiveness to EGFR kinase inhibitors in patients whose tumors lack PTEN. Here, we show that the mammalian target of rapamycin (mTOR) inhibitor rapamycin enhances the sensitivity of PTEN-deficient tumor cells to the EGFR kinase inhibitor erlotinib. In two isogenic model systems (U87MG glioblastoma cells expressing EGFR, EGFRvIII, and PTEN in relevant combinations, and SF295 glioblastoma cells in which PTEN protein expression has been stably restored), we show that combined EGFR/mTOR kinase inhibition inhibits tumor cell growth and has an additive effect on inhibiting downstream PI3K pathway signaling. We also show that combination therapy provides added benefit in promoting cell death in PTEN-deficient tumor cells. These studies provide strong rationale for combined mTOR/EGFR kinase inhibitor therapy in glioblastoma patients, particularly those with PTEN-deficient tumors. (Cancer Res 2006; 66(16): 7864-9).</abstract><notes>Journal article&#xD;Cancer Res. 2006 Aug 15;66(16):7864-7869.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16912159</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.656</custom4><electronic-resource-num>66/16/7864 [pii]&#xD;10.1158/0008-5472.CAN-04-4392</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yamauchi, K.</author><author>Yang, M.</author><author>Jiang, P.</author><author>Xu, M.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Moossa, A. R.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111, USA.</auth-address><titles><title>Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><pages>4208-14</pages><volume>66</volume><number>8</number><edition>2006/04</edition><keywords><keyword>Animals</keyword><keyword>Carcinoma, Lewis Lung/blood supply/metabolism/pathology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cytoplasm/metabolism</keyword><keyword>Diagnostic Imaging/instrumentation/*methods</keyword><keyword>Fibrosarcoma/blood supply/metabolism/pathology</keyword><keyword>Green Fluorescent Proteins/analysis</keyword><keyword>Humans</keyword><keyword>Luminescent Proteins/analysis</keyword><keyword>Mammary Neoplasms, Experimental/blood supply/metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Circulating Cells/metabolism/*pathology</keyword><keyword>Neoplasms, Experimental/blood supply/metabolism/*pathology</keyword><keyword>Subcellular Fractions/chemistry/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16618743</accession-num><abstract>With the use of dual-color fluorescent cells and a highly sensitive whole-mouse imaging system with both macro-optics and micro-optics, we report here the development of subcellular real-time imaging of cancer cell trafficking in live mice. To observe cytoplasmic and nuclear dynamics in the living mouse, tumor cells were labeled in the nucleus with green fluorescent protein and with red fluorescent protein in the cytoplasm. Dual-color cancer cells were injected by a vascular route in an abdominal skin flap in nude mice. The mice were imaged with an Olympus OV100 whole-mouse imaging system with a sensitive CCD camera and five objective lenses, parcentered and parfocal, enabling imaging from macrocellular to subcellular. We observed the nuclear and cytoplasmic behavior of cancer cells in real time in blood vessels as they moved by various means or adhered to the vessel surface in the abdominal skin flap. During extravasation, real-time dual-color imaging showed that cytoplasmic processes of the cancer cells exited the vessels first, with nuclei following along the cytoplasmic projections. Both cytoplasm and nuclei underwent deformation during extravasation. Different cancer cell lines seemed to strongly vary in their ability to extravasate. With the dual-color cancer cells and the highly sensitive whole-mouse imaging system described here, the subcellular dynamics of cancer metastasis can now be observed in live mice in real time. This imaging technology will enable further understanding of the critical steps of metastasis and provide visible targets for antimetastasis drug development.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16618743 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.656</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>265</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">265</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yoo, L. I.</author><author>Liu, D. W.</author><author>Le Vu, S.</author><author>Bronson, R. T.</author><author>Wu, H.</author><author>Yuan, J.</author></authors></contributors><auth-address>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner</title><secondary-title>Cancer Res</secondary-title></titles><pages>1929-39</pages><volume>66</volume><number>4</number><edition>2006/02/21</edition><keywords><keyword>Animals</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cyclin-Dependent Kinase Inhibitor</keyword><keyword>p21/biosynthesis/deficiency/genetics/metabolism</keyword><keyword>Female</keyword><keyword>Hyperplasia</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Organ Specificity</keyword><keyword>PTEN Phosphohydrolase/*deficiency/genetics</keyword><keyword>Prostate/enzymology/pathology</keyword><keyword>Prostatic Neoplasms/enzymology/pathology</keyword><keyword>Proto-Oncogene Proteins c-akt/metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Up-Regulation</keyword><keyword>Urinary Bladder/enzymology/pathology</keyword><keyword>Urinary Bladder Neoplasms/enzymology/pathology</keyword><keyword>Urogenital Neoplasms/*enzymology/pathology</keyword><keyword>Urothelium/enzymology/pathology</keyword><keyword>Vagina/enzymology/pathology</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16488991</accession-num><abstract>PTEN deficiency predisposes to a subset of human cancers, but the mechanism that underlies such selectivity is unknown. We have generated a mouse line that conditionally deletes Pten in urogenital epithelium. These mice develop carcinomas at high frequency in the prostate but at relatively low frequency in the bladder, despite early and complete penetrance of hyperplasia in both organs. Cell proliferation is initially high in the bladder of newborn Pten-deficient mice but within days is inhibited by p21 induction. In contrast, proliferation remains elevated in Pten-deficient prostate, where p21 is never induced, suggesting that p21 induction is a bladder-specific compensatory mechanism to inhibit proliferation caused by Pten deletion. Furthermore, the AKT/mammalian target of rapamycin growth pathway, which is highly activated in Pten-deficient prostate, is not activated in bladder epithelium. Our results reveal alternative downstream signaling pathways activated by Pten deficiency that lead to tissue-specific susceptibilities to tumorigenesis.</abstract><notes>Yoo, Lina I&#xD;Liu, David W&#xD;Le Vu, Sandrine&#xD;Bronson, Roderick T&#xD;Wu, Hong&#xD;Yuan, Junying&#xD;Ca89434/ca/nci&#xD;R01ca107166/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Feb 15;66(4):1929-39.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16488991</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.656</custom4><electronic-resource-num>66/4/1929 [pii]&#xD;10.1158/0008-5472.CAN-05-1986</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>344</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">344</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Magrini, A.</author><author>Dawson, M. I.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Bottini, M&#xD;Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA&#xD;Burnham Inst Med Res, La Jolla, CA 92037 USA&#xD;Univ Roma Tor Vergata, Dept Environm Occupat &amp; Social Med, I-00133 Rome, Italy</auth-address><titles><title>Non-destructive decoration of full-length multi-walled carbon nanotubes with variable amounts of silica gel nanoparticles</title><secondary-title>Carbon</secondary-title></titles><pages>1301-1303</pages><volume>44</volume><number>7</number><edition>2006/06</edition><keywords><keyword>carbon nanotubes</keyword><keyword>surface treatment</keyword><keyword>adsorption</keyword><keyword>transmission electron microscopy</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0008-6223</isbn><accession-num>ISI:000236689000026</accession-num><notes>031FF&#xD;Times Cited:1&#xD;Cited References Count:9</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000236689000026</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>4.260</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>74</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">74</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, L.</author><author>Marshall, T. W.</author><author>Uetrecht, A. C.</author><author>Schafer, D. A.</author><author>Bear, J. E.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center and Department of Cell and Developmental Biology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge</title><secondary-title>Cell</secondary-title></titles><pages>915-29</pages><volume>128</volume><number>5</number><edition>2007/03/14</edition><keywords><keyword>4-Butyrolactone/*analogs &amp; derivatives/genetics/metabolism</keyword><keyword>Actin Depolymerizing Factors/*metabolism</keyword><keyword>Actin-Related Protein 2-3 Complex/*metabolism</keyword><keyword>Actins/metabolism</keyword><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>*Cell Movement</keyword><keyword>Drosophila</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>Green Fluorescent Proteins/genetics/metabolism</keyword><keyword>Humans</keyword><keyword>Kymography</keyword><keyword>Okadaic Acid/pharmacology</keyword><keyword>Phosphoprotein Phosphatase/metabolism</keyword><keyword>Phosphorylation/drug effects</keyword><keyword>RNA Interference</keyword><keyword>Rats</keyword><keyword>Recombinant Proteins/genetics/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 9</date></pub-dates></dates><isbn>0092-8674 (Print)</isbn><accession-num>17350576</accession-num><abstract>Actin filament formation and turnover within the treadmilling actin filament array at the leading edge of migrating cells are interdependent and coupled, but the mechanisms coordinating these two activities are not understood. We report that Coronin 1B interacts simultaneously with Arp2/3 complex and Slingshot (SSH1L) phosphatase, two regulators of actin filament formation and turnover, respectively. Coronin 1B inhibits filament nucleation by Arp2/3 complex and this inhibition is attenuated by phosphorylation of Coronin 1B at Serine 2, a site targeted by SSH1L. Coronin 1B also directs SSH1L to lamellipodia where SSH1L likely regulates Cofilin activity via dephosphorylation. Accordingly, depleting Coronin 1B increases phospho-Cofilin levels, and alters lamellipodial dynamics and actin filament architecture at the leading edge. We conclude that Coronin 1B&apos;s coordination of filament formation by Arp2/3 complex and filament turnover by Cofilin is required for effective lamellipodial protrusion and cell migration.</abstract><notes>Cai, Liang&#xD;Marshall, Thomas W&#xD;Uetrecht, Andrea C&#xD;Schafer, Dorothy A&#xD;Bear, James E&#xD;1u54 ca 119343/ca/nci&#xD;Ca 16086/ca/nci&#xD;Gm 067222/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cell&#xD;Cell. 2007 Mar 9;128(5):915-29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17350576</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>29.19</custom4><electronic-resource-num>S0092-8674(07)00132-8 [pii]&#xD;10.1016/j.cell.2007.01.031</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>409</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">409</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Leung, A. K.</author><author>Sharp, P. A.</author></authors></contributors><auth-address>Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>microRNAs: a safeguard against turmoil?</title><secondary-title>Cell</secondary-title></titles><pages>581-5</pages><volume>130</volume><number>4</number><edition>2007/08/28</edition><keywords><keyword>Animals</keyword><keyword>Humans</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>Models, Biological</keyword><keyword>*Stress</keyword><keyword>Transcription, Genetic</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 24</date></pub-dates></dates><isbn>0092-8674 (Print)</isbn><accession-num>17719533</accession-num><abstract>Emerging data suggest that microRNAs (miRNAs) are instrumental in a variety of stress responses in addition to their more recognized role in development. Surprisingly, miRNAs, which normally suppress expression of target transcripts, may become activators of expression during stress. This might be partially explained by new interactions of miRNA/Argonaute complexes with RNA-binding proteins that relocate from different subcellular compartments during stress.</abstract><notes>Leung, Anthony K L&#xD;Sharp, Phillip A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cell&#xD;Cell. 2007 Aug 24;130(4):581-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17719533</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>29.19</custom4><electronic-resource-num>S0092-8674(07)01032-X [pii]&#xD;10.1016/j.cell.2007.08.010</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>57</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">57</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shen, W. H.</author><author>Balajee, A. S.</author><author>Wang, J.</author><author>Wu, H.</author><author>Eng, C.</author><author>Pandolfi, P. P.</author><author>Yin, Y.</author></authors></contributors><auth-address>Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.</auth-address><titles><title>Essential role for nuclear PTEN in maintaining chromosomal integrity</title><secondary-title>Cell</secondary-title></titles><pages>157-70</pages><volume>128</volume><number>1</number><edition>2007/01/16</edition><keywords><keyword>Animals</keyword><keyword>Cell Nucleus/*metabolism</keyword><keyword>Centromere/metabolism</keyword><keyword>*Chromosomal Instability</keyword><keyword>Chromosomal Proteins, Non-Histone/metabolism</keyword><keyword>Chromosomes, Mammalian/*metabolism</keyword><keyword>DNA Breaks, Double-Stranded</keyword><keyword>DNA Repair</keyword><keyword>E2F1 Transcription Factor/metabolism</keyword><keyword>Fibroblasts/cytology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mutant Proteins/metabolism</keyword><keyword>PTEN Phosphohydrolase/deficiency/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Transport</keyword><keyword>Rad51 Recombinase/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 12</date></pub-dates></dates><isbn>0092-8674 (Print)</isbn><accession-num>17218262</accession-num><abstract>A broad spectrum of mutations in PTEN, encoding a lipid phosphatase that inactivates the P13-K/AKT pathway, is found associated with primary tumors. Some of these mutations occur outside the phosphatase domain, suggesting that additional activities of PTEN function in tumor suppression. We report a nuclear function for PTEN in controlling chromosomal integrity. Disruption of Pten leads to extensive centromere breakage and chromosomal translocations. PTEN was found localized at centromeres and physically associated with CENP-C, an integral component of the kinetochore. C-terminal PTEN mutants disrupt the association of PTEN with centromeres and cause centromeric instability. Furthermore, Pten null cells exhibit spontaneous DNA double-strand breaks (DSBs). We show that PTEN acts on chromatin and regulates expression of Rad51, which reduces the incidence of spontaneous DSBs. Our results demonstrate that PTEN plays a fundamental role in the maintenance of chromosomal stability through the physical interaction with centromeres and control of DNA repair. We propose that PTEN acts as a guardian of genome integrity.</abstract><notes>Shen, Wen Hong&#xD;Balajee, Adayabalam S&#xD;Wang, Jianli&#xD;Wu, Hong&#xD;Eng, Charis&#xD;Pandolfi, Pier Paolo&#xD;Yin, Yuxin&#xD;R01 ca093677/ca/nci&#xD;R01 ca102447/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Cell&#xD;Cell. 2007 Jan 12;128(1):157-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17218262</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>29.19</custom4><electronic-resource-num>S0092-8674(06)01553-4 [pii]&#xD;10.1016/j.cell.2006.11.042</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>282</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">282</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, H.</author><author>Sharpless, N. E.</author><author>Wong, K. K.</author></authors></contributors><auth-address>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.</auth-address><titles><title>EGFR targeted therapy: view from biological standpoint</title><secondary-title>Cell Cycle</secondary-title></titles><pages>2072-6</pages><volume>5</volume><number>18</number><edition>2006/09/14</edition><keywords><keyword>Adenocarcinoma/genetics/*metabolism/*therapy</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents/pharmacology</keyword><keyword>Carcinoma, Non-Small-Cell Lung/genetics/*metabolism/*therapy</keyword><keyword>Drug Resistance, Neoplasm/*physiology</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>Gene Therapy/methods/trends</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mutation/genetics</keyword><keyword>Receptor, Epidermal Growth Factor/*antagonists &amp;</keyword><keyword>inhibitors/genetics/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1551-4005 (Electronic)</isbn><accession-num>16969107</accession-num><abstract>Activating mutations in the kinase domain of the epidermal growth factor receptor (EGFR) in nonsmall cell lung cancers (NSCLCs) correlate with responsiveness to EGFR kinase inhibitors. In vitro cell culture studies have demonstrated that EGFR kinase domain mutants but not wild type (wt) EGFR are transforming and essential for cancer cell survival. We and others have recently demonstrated that the induction of EGFR kinase domain mutants specifically in murine lung epithelium in vivo led to development of adenocarcinoma with bronchioloalveolar carcinoma (BAC) features. These tumors depend completely on the sustained expression of EGFR kinase domain mutants for tumor maintenance. The murine tumors with EGFR kinase domain mutations are sensitive to EGFR targeted therapy similarly to NSCLC patients whose tumors harbor EGFR mutations. In contrast, initial results suggest that overexpression of wt EGFR in murine lungs does not seem to be transforming. We therefore divide EGFR targeted therapy in NSCLC patients into two parts: &quot;EGFR mutant targeted therapy&quot; and &quot;wt EGFR targeted therapy&quot;. The &quot;EGFR mutant targeted therapy&quot; targets the oncogene essential for tumor initiation and maintenance and is frequently correlated with effective clinical outcome. In contrast, &quot;wt EGFR targeted therapy&quot; likely targets the proto-oncogene product wt EGFR, which is not directly involved in tumor initiation and maintenance, and in these cases, the response has been considerably less dramatic.</abstract><notes>Ji, Hongbin&#xD;Sharpless, Norman E&#xD;Wong, Kwok-Kin&#xD;Ag24004/ag/nia&#xD;Ca90679/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Cell cycle (Georgetown, Tex.)&#xD;Cell Cycle. 2006 Sep;5(18):2072-6. Epub 2006 Sep 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16969107</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>3.214</custom4><electronic-resource-num>3277 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>11</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">11</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jiang, P.</author><author>Yamauchi, K.</author><author>Yang, M.</author><author>Tsuji, K.</author><author>Xu, M.</author><author>Maitra, A.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111, USA.</auth-address><titles><title>Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics</title><secondary-title>Cell Cycle</secondary-title><alt-title>Cell cycle (Georgetown, Tex</alt-title></titles><pages>1198-201</pages><volume>5</volume><number>11</number><edition>2006/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Nucleus/pathology/ultrastructure</keyword><keyword>Cytological Techniques</keyword><keyword>Cytoplasm/pathology/ultrastructure</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Humans</keyword><keyword>Luminescent Proteins/*genetics</keyword><keyword>Neoplasms/*pathology/ultrastructure</keyword><keyword>Transduction, Genetic</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1551-4005 (Electronic)</isbn><accession-num>16760659</accession-num><abstract>Dual-color fluorescent cells with one color fluorescent protein in the nucleus and another color fluorescent protein in the cytoplasm were genetically engineered. The dual-color cancer cells enable real-time nuclear-cytoplasmic dynamics to be visualized in living cells in vivo as well as in vitro. To obtain the dual-color cells, red fluorescent protein (RFP) was expressed in the cytoplasm of a series of human and rodent cancer cells, and green fluorescent protein (GFP) linked to histone H2B was expressed in the nucleus. Nuclear GFP expression enabled visualization of nuclear dynamics, whereas simultaneous cytoplasmic RFP expression enabled visualization of nuclear-cytoplasmic ratios as well as simultaneous cell and nuclear shape changes. Using the Olympus OV100 Whole-Mouse Imaging System, total sub-cellular dynamics can be visualized in the living dual-color cells in real time in the live mouse after cell injection. Highly elongated cancer cells and nuclei in narrow capillaries were visualized where both the nuclei and cytoplasm deform. Both cytoplasm and nuclei were visualized to undergo extreme deformation during extravasation with cytoplasmic processing exiting vessels first and nuclei following along these processes. The dual-color cells described here thus enable the sub-cellular dynamics of cancer cell trafficking to be imaged in the living animal.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16760659 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>3.214</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>486</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">486</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yamauchi, K.</author><author>Yang, M.</author><author>Hayashi, K.</author><author>Jiang, P.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Moossa, A. R.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111-3604, USA.</auth-address><titles><title>Imaging of nucleolar dynamics during the cell cycle of cancer cells in live mice</title><secondary-title>Cell Cycle</secondary-title></titles><pages>2706-8</pages><volume>6</volume><number>21</number><edition>2007/10/04</edition><keywords><keyword>Animals</keyword><keyword>Cell Cycle/*physiology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Nucleolus/*chemistry/*physiology</keyword><keyword>Gene Expression Regulation, Neoplastic/*physiology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Confocal/methods</keyword></keywords><dates><year>2007</year><pub-dates><date>1 November 2007</date></pub-dates></dates><isbn>1551-4005 (Electronic)</isbn><accession-num>17912040</accession-num><abstract>The synthesis and assembly of ribosomal subunits take place in the nucleolus. The nucleolus forms in the nucleus around the repeated ribosomal gene clusters and undergoes cyclic changes during the cell cycle. Although the nucleolus is easily visualized by light microscopy of cells in vitro, the nucleolus has not been imaged in cells in vivo. We report here development of a mouse model to visualize the nucleolus cycle of cancer cells in live mice. HT-1080 human fibrosarcoma cells were labeled in the nucleus with histone H2B-GFP and with retroviral RFP in the cytoplasm. The nucleolus was visualized by contrast to the fluorescence of GFP expressed in the nucleus. HT-1080 dual-color cells were seeded on the surface of a skin-flap of nude mice. The inside surface of the skin-flap was directly imaged with a laser scanning microscope 24 hours after seeding. The nucleoli of the cancer cells were clearly imaged in real-time. The appearance of the nucleoli changed dramatically during the cell cycle. During mitosis, the nucleolus disappeared. After mitosis, the nucleoli decreased in number and increased in size. The nucleolus appears to have a major role in cell cycle regulation. Nucleolar imaging could be used for more precise determination of cancer-cell position in the cell cycle in vivo.</abstract><notes>Yamauchi, Kensuke&#xD;Yang, Meng&#xD;Hayashi, Katsuhiro&#xD;Jiang, Ping&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Moossa, A R&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Comparative Study&#xD;United States&#xD;Cell cycle (Georgetown, Tex.)&#xD;Cell Cycle. 2007 Aug;6(21):2706-8. Epub 2007 Aug 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17912040</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>3.214</custom4><electronic-resource-num>4861 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>369</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">369</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hong, S.</author><author>Leroueil, P. R.</author><author>Majoros, I. J.</author><author>Orr, B. G.</author><author>Baker, J. R., Jr.</author><author>Banaszak Holl, M. M.</author></authors></contributors><auth-address>Program in Macromolecular Science and Engineering, University of Michigan, Ann Arbor, MI 48109, USA.</auth-address><titles><title>The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform</title><secondary-title>Chem Biol</secondary-title><alt-title>Chemistry &amp; biology</alt-title></titles><pages>107-15</pages><volume>14</volume><number>1</number><edition>2007/01</edition><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1074-5521 (Print)</isbn><accession-num>17254956</accession-num><abstract>Dendrimer-based anticancer nanotherapeutics containing approximately 5 folate molecules have shown in vitro and in vivo efficacy in cancer cell targeting. Multivalent interactions have been inferred from observed targeting efficacy, but have not been experimentally proven. This study provides quantitative and systematic evidence for multivalent interactions between these nanodevices and folate-binding protein (FBP). A series of the nanodevices were synthesized by conjugation with different amounts of folate. Dissociation constants (K(D)) between the nanodevices and FBP measured by SPR are dramatically enhanced through multivalency ( approximately 2,500- to 170,000-fold). Qualitative evidence is also provided for a multivalent targeting effect to KB cells using flow cytometry. These data support the hypothesis that multivalent enhancement of K(D), not an enhanced rate of endocytosis, is the key factor resulting in the improved biological targeting by these drug delivery platforms.</abstract><notes>N01-co-27173/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17254956 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>5.718</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>148</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">148</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J.</author><author>Burdette, J. E.</author><author>MacRenaris, K. W.</author><author>Mustafi, D.</author><author>Woodruff, T. K.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Departments of Chemistry, Biochemistry and Molecular, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents</title><secondary-title>Chem Biol</secondary-title></titles><pages>824-34</pages><volume>14</volume><number>7</number><edition>2007/07/28</edition><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1074-5521 (Print)</isbn><accession-num>17656319</accession-num><abstract>A series of contrast agents for magnetic resonance imaging (MRI) aimed at noninvasively determining the hormone receptor status of cancer in vitro was developed. These MRI contrast agents were prepared by conjugating progesterone to clinically used Gd(III) chelates. These agents exhibited higher progesterone receptor binding affinities in the nanomolar range and intracellular accumulation. High logP values of the modified compounds suggested that the lipophilicity of the steroid conjugates may have contributed to membrane permeability. Synchrotron radiation X-ray fluorescence microscopy and magnetic resonance images revealed that the synthesized conjugates showed the greatest cellular accumulation and significant increase in relaxivity in vitro compared to the previously developed steroid-modified agent. Transcriptional assays using the progesterone response element linked to luciferase indicated that the contrast agents entered the cell, interacted with the biological target, and drove specific progesterone-mediated transcription.</abstract><notes>Lee, Jiyoun&#xD;Burdette, Joanna E&#xD;MacRenaris, Keith W&#xD;Mustafi, Devkumar&#xD;Woodruff, Teresa K&#xD;Meade, Thomas J&#xD;1 r01 eb005866-01/eb/nibib&#xD;5 u54 ca90810/ca/nci&#xD;R01 hd044464/hd/nichd&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Chemistry &amp; biology&#xD;Chem Biol. 2007 Jul;14(7):824-34.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17656319</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>5.718</custom4><electronic-resource-num>S1074-5521(07)00211-6 [pii]&#xD;10.1016/j.chembiol.2007.06.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>578</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">578</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, J. S.</author><author>Choi, H. J.</author><author>Jung, D. C.</author><author>Lee, J. H.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Chemistry, Yonsei University, Seoul, 120-749, Korea.</auth-address><titles><title>Nanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid beta self-assembly</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><pages>2197-9</pages><number>19</number><edition>2008/05/09</edition><keywords><keyword>Amyloid beta-Protein/*chemistry/metabolism</keyword><keyword>Cobalt/*chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Magnetics</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Peptide Fragments/*chemistry/metabolism</keyword><keyword>Platinum/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May 21</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>18463738</accession-num><abstract>Co@Pt-Au nanoparticles, which have enhanced magnetism and high stability in aqueous media, are utilized in conjunction with MRI to monitor the structural evolution of Abeta assemblies, especially Abeta protofibrils in the early reversible stages.</abstract><notes>Choi, Jin-Sil&#xD;Choi, Hyuck Jae&#xD;Jung, Dae Chul&#xD;Lee, Joo-Hyuk&#xD;Cheon, Jinwoo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2008 May 21;(19):2197-9. Epub 2008 Apr 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18463738</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.141</custom4><electronic-resource-num>10.1039/b803294g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>580</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">580</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Coti, K. K.</author><author>Wang, Y.</author><author>Lin, W. Y.</author><author>Chen, C. C.</author><author>Tak For Yu, Z.</author><author>Liu, K.</author><author>Shen, C. K.</author><author>Selke, M.</author><author>Yeh, A.</author><author>Lu, W.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA. hrtseng@mednet.ucla.edu wlu@mednet.ucla.edu.</auth-address><titles><title>A dynamic micromixer for arbitrary control of disguised chemical selectivity</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><pages>3426-8</pages><number>29</number><edition>2008/07/18</edition><dates><year>2008</year><pub-dates><date>Aug 7</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>18633511</accession-num><abstract>A new type of dynamic micromixer combining the concepts of parallel multi-lamination and hydrodynamic focusing was developed for arbitrary control of disguised chemical selectivity.</abstract><notes>Coti, Karla K&#xD;Wang, Yanju&#xD;Lin, Wei-Yu&#xD;Chen, Chia-Chun&#xD;Tak For Yu, Zeta&#xD;Liu, Kan&#xD;Shen, Clifton K-F&#xD;Selke, Matthias&#xD;Yeh, Anchi&#xD;Lu, Weixing&#xD;Tseng, Hsian-Rong&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2008 Aug 7;(29):3426-8. Epub 2008 May 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18633511</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>5.141</custom4><electronic-resource-num>10.1039/b804530e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>364</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">364</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, S.</author><author>Pudavar, H. E.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, Department of Chemistry, State University of New York, Buffalo, New York 14260-3000, USA.</auth-address><titles><title>Dye-concentrated organically modified silica nanoparticles as a ratiometric fluorescent pH probe by one- and two-photon excitation</title><secondary-title>Chem Commun (Camb)</secondary-title><alt-title>Chemical communications (Cambridge, England)</alt-title></titles><pages>2071-3</pages><number>19</number><edition>2006/05</edition><keywords><keyword>Coloring Agents</keyword><keyword>Fluorescence</keyword><keyword>*Fluorescent Dyes</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>*Nanostructures</keyword><keyword>Nanotechnology</keyword><keyword>*Photons</keyword><keyword>Radiometry</keyword><keyword>Silicon Dioxide/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2006</year><pub-dates><date>May 21</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>16767279</accession-num><abstract>Basic dye-concentrated nanoparticles (approximately 33 nm in diameter) show fluorescence-based ratiometric pH response, by one- and two-photon excitations, with improved proton sensing ability (pKa approximately 6.4) through nanoscopic intraparticle energy transfer.</abstract><notes>Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16767279 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2006</custom3><custom4>4.521</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>250</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">250</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, J.</author><author>Bunimovich, Y. L.</author><author>Sui, G.</author><author>Savvas, S.</author><author>Guo, Y.</author><author>Heath, J. R.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Department of Molecular Medical Pharmacology and Crump Institute for Molecular Imaging. University of California, Los Angeles, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Electrochemical fabrication of conducting polymer nanowires in an integrated microfluidic system</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><pages>3075-7</pages><number>29</number><edition>2006/07/21</edition><keywords><keyword>Biosensing Techniques</keyword><keyword>*Electric Conductivity</keyword><keyword>*Electrochemistry</keyword><keyword>*Microfluidics</keyword><keyword>*Nanotechnology</keyword><keyword>Polymers/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 7</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>16855690</accession-num><abstract>In this paper, we introduce a new approach for the in situ electrochemical fabrication of an individually addressable array of conducting polymer nanowires (CPNWs) positioned within an integrated microfluidic device and also demonstrate that such an integrated device can be used as a chemical sensor immediately after its construction.</abstract><notes>Wang, Jun&#xD;Bunimovich, Yuri L&#xD;Sui, Guodong&#xD;Savvas, Stavros&#xD;Wang, Jinyi&#xD;Guo, Yaoyao&#xD;Heath, James R&#xD;Tseng, Hsian-Rong&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2006 Aug 7;(29):3075-7. Epub 2006 Jun 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16855690</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>4.521</custom4><electronic-resource-num>10.1039/b604426c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>673</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">673</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zuo, T.</author><author>Walker, K.</author><author>Olmstead, M. M.</author><author>Melin, F.</author><author>Holloway, B. C.</author><author>Echegoyen, L.</author><author>Dorn, H. C.</author><author>Chaur, M. N.</author><author>Chancellor, C. J.</author><author>Beavers, C. M.</author><author>Balch, A. L.</author><author>Athans, A. J.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.</auth-address><titles><title>New egg-shaped fullerenes: non-isolated pentagon structures of Tm3N@C(s)(51 365)-C84 and Gd3N@C(s)(51 365)-C84</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><pages>1067-9</pages><number>9</number><edition>2008/02/23</edition><keywords><keyword>Crystallography, X-Ray</keyword><keyword>Fullerenes/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Nitrogen/*chemistry</keyword><keyword>Thulium/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>18292892</accession-num><abstract>Although there are 51 568 non-IPR and 24 IPR structures for C84, the egg-shaped endohedral fullerenes Tm3N@C(s)(51 365)-C84 and Gd3N@C(s)(51 365)-C84 utilize the same non-IPR cage structure as found initially for Tb3N@C(s)(51 365)-C84.</abstract><notes>Zuo, Tianming&#xD;Walker, Kenneth&#xD;Olmstead, Marilyn M&#xD;Melin, Frederic&#xD;Holloway, Brian C&#xD;Echegoyen, Luis&#xD;Dorn, Harry C&#xD;Chaur, Manuel N&#xD;Chancellor, Christopher J&#xD;Beavers, Christine M&#xD;Balch, Alan L&#xD;Athans, Andreas J&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2008 Mar 7;(9):1067-9. Epub 2008 Jan 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18292892</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>5.141</custom4><electronic-resource-num>10.1039/b716037b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>567</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">567</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Banholzer, M. J.</author><author>Millstone, J. E.</author><author>Qin, L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Rationally designed nanostructures for surface-enhanced Raman spectroscopy</title><secondary-title>Chem Soc Rev</secondary-title></titles><pages>885-97</pages><volume>37</volume><number>5</number><edition>2008/04/30</edition><keywords><keyword>Anisotropy</keyword><keyword>Nanostructures/*analysis/*chemistry</keyword><keyword>Nanotechnology/*trends</keyword><keyword>Particle Size</keyword><keyword>Spectrum Analysis, Raman/*methods</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>0306-0012 (Print)</isbn><accession-num>18443674</accession-num><abstract>Research on surface-enhanced Raman spectroscopy (SERS) is an area of intense interest because the technique allows one to probe small collections of, and in certain cases, individual molecules using relatively straightforward spectroscopic techniques and nanostructured substrates. Researchers in this area have attempted to develop many new technological innovations including high sensitivity chemical and biological detection systems, labeling schemes for authentication and tracking purposes, and dual scanning-probe/spectroscopic techniques that simultaneously provide topographical and spectroscopic information about an underlying surface or nanostructure. However, progress has been hampered by the inability of researchers to fabricate substrates with the high sensitivity, tunability, robustness, and reproducibility necessary for truly practical and successful SERS-based systems. These limitations have been due in part to a relative lack of control over the nanoscale features of Raman substrates that are responsible for the enhancement. With the advent of nanotechnology, new approaches are being developed to overcome these issues and produce substrates with higher sensitivity, stability, and reproducibility. This tutorial review focuses on recent progress in the design and fabrication of substrates for surface-enhanced Raman spectroscopy, with an emphasis on the influence of nanotechnology.</abstract><notes>Banholzer, Matthew J&#xD;Millstone, Jill E&#xD;Qin, Lidong&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Chemical Society reviews&#xD;Chem Soc Rev. 2008 May;37(5):885-97. Epub 2008 Mar 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18443674</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>13.082</custom4><electronic-resource-num>10.1039/b710915f</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>274</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">274</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Euliss, L. E.</author><author>DuPont, J. A.</author><author>Gratton, S.</author><author>DeSimone, J.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Imparting size, shape, and composition control of materials for nanomedicine</title><secondary-title>Chem Soc Rev</secondary-title></titles><pages>1095-104</pages><volume>35</volume><number>11</number><edition>2006/10/24</edition><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0306-0012 (Print)</isbn><accession-num>17057838</accession-num><abstract>This tutorial review presents an overview of strategies for the synthesis and fabrication of organic nanomaterials, specifically those with potential for use in medical applications. Examples include liposomes, micelles, polymer-drug conjugates and dendrimers. Methods of driving shape via&quot;bottom-up&quot; synthetic approaches and thermodynamics and kinetics are discussed. Furthermore, methods of driving shape via&quot;top-down&quot; physical and engineering techniques are also explored. Finally, a novel method (referred to as PRINT) used to produce nanoparticles that are shape-specific, can contain any cargo, and can be easily modified is examined along with its potential future role in nanomedicine.</abstract><notes>Euliss, Larken E&#xD;DuPont, Julie A&#xD;Gratton, Stephanie&#xD;DeSimone, Joseph&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Chemical Society reviews&#xD;Chem Soc Rev. 2006 Nov;35(11):1095-104. Epub 2006 Sep 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17057838</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>13.69</custom4><electronic-resource-num>10.1039/b600913c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>677</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">677</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Angeli, Clairette D.</author><author>Cai, Ting</author><author>Duchamp, James C.</author><author>Reid, Jonathan E.</author><author>Singer, Eric S.</author><author>Gibson, Harry W.</author><author>Dorn, Harry C.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212, and Department of Chemistry, Emory and Henry College, Emory, Virginia 24327</auth-address><titles><title>Purification of Trimetallic Nitride Templated Endohedral Metallofullerenes by a Chemical Reaction of Congeners with Eutectic 9-Methylanthracene</title><secondary-title>Chem. Mater.</secondary-title></titles><pages>4993-4997</pages><volume>20</volume><number>15</number><edition>2008/06/28</edition><dates><year>2008</year></dates><isbn>0897-4756</isbn><abstract>Abstract: The availability of pure samples is a major hurdle in the study of trimetallic nitride templated endohedral metallofullerenes (TNT EMFs). Current HPLC methods of purification are costly, nonrecyclable, and take considerable time. Reported herein is a solvent-free reaction of crude soot extract (empty-cage and Sc or Lu TNT EMFs) in molten 9-methylanthracene that affords almost complete conversion of empty-cage fullerenes to 9-methylanthracene adducts, while leaving TNT EMFs unreacted. After the recovered extract is washed with diethyl ether, the washed extract can then be applied to a silica gel column and subsequently flushed with toluene. To illustrate for Sc3N@C80, the sample was purified to ~60% in a time period of &lt;24 h. Final one-step HPLC purification provided high-purity TNT EMF samples (&gt;99%) in an expeditious and less costly manner.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/cm800795q</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>4.883</custom4><electronic-resource-num>10.1021/cm800795q</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>559</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">559</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, Chun-Ying</author><author>Wang, Chun-Ru</author><author>Zhang, Jian-Fei</author><author>Gibson, Harry W.</author><author>Dorn, Harry C.</author><author>Corwin, Frank D.</author><author>Fatouros, Panos P.</author><author>Dennis, T. John S.</author></authors></contributors><auth-address>Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China, Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060, Department of Radiology, Virginia Commonwealth University, Richmond, Virginia 23298, and Centre for Materials Research, Queen Mary, University of London, London E1 4NS, U.K.</auth-address><titles><title>Organophosphonate Functionalized Gd@C82 as a Magnetic Resonance Imaging Contrast Agent</title><secondary-title>Chem. Mater.</secondary-title></titles><pages>2106-2109</pages><volume>20</volume><number>6</number><edition>2008/02/21 </edition><dates><year>2008</year></dates><isbn>0897-4756</isbn><abstract>Abstract: A new magnetic resonance imaging contrast agent containing organophosphonate functional groups was synthesized in high yield by a simple synthesis procedure. This molecule exhibits much higher longitudinal water proton relaxivity (37.0 mM 1 s 1) than commercial Omniscan (Gd-DTPA BMA, 5.7 mM 1 s 1) at 0.35 T. Notably, the relaxivity is larger than that of carboxylated Gd@C82 (16.0 mM 1 s 1) under the same conditions, indicating that the functional groups have an important role on the image contrast enhancement. In addition, the introduction of phosphonate substituents may provide bone-targeting MRI contrast agents.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/cm7023982</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>4.883</custom4><electronic-resource-num>10.1021/cm7023982 </electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>706</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">706</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, Jian</author><author>Lind, Johan U.</author><author>Trogler, William C.</author></authors></contributors><auth-address>Department of Chemistry &amp; Biochemistry and CalIT2 Nanomedicine Laboratory, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358</auth-address><titles><title>Synthesis of Hollow Silica and Titania Nanospheres</title><secondary-title>Chem. Mater.</secondary-title></titles><pages>2875-2877</pages><volume>20</volume><number>9</number><edition>2008/07</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0897-4756</isbn><abstract>no abstract</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/cm703264y</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>4.883</custom4><electronic-resource-num>10.1021/cm703264y</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>489</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">489</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barrett, D. G.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>A tunable, chemoselective, and moldable biodegradable polyester for cell scaffolds</title><secondary-title>Chembiochem</secondary-title></titles><pages>62-6</pages><volume>9</volume><number>1</number><edition>2007/12/07</edition><keywords><keyword>Aminooxyacetic Acid/chemistry</keyword><keyword>Biocompatible Materials/*chemical synthesis/*metabolism</keyword><keyword>Biodegradation, Environmental</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Ligands</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Polyesters/*chemical synthesis/*metabolism</keyword><keyword>Tissue Scaffolds/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 4</date></pub-dates></dates><isbn>1439-7633 (Electronic)</isbn><accession-num>18058776</accession-num><notes>Barrett, Devin G&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chembiochem : a European journal of chemical biology&#xD;Chembiochem. 2008 Jan 4;9(1):62-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18058776</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.446</custom4><electronic-resource-num>10.1002/cbic.200700550</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>490</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">490</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hoover, D. K.</author><author>Lee, E. J.</author><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, Carolina Center for Genome Science, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Electroactive nanoarrays for biospecific ligand mediated studies of cell adhesion</title><secondary-title>Chembiochem</secondary-title></titles><pages>1920-3</pages><volume>8</volume><number>16</number><edition>2007/10/10</edition><keywords><keyword>3T3 Cells</keyword><keyword>Adsorption</keyword><keyword>Animals</keyword><keyword>Cell Adhesion/drug effects</keyword><keyword>Electrochemistry</keyword><keyword>Fibroblasts/cytology/*drug effects</keyword><keyword>Gold/chemistry</keyword><keyword>Hydroquinones/chemistry</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Molecular Structure</keyword><keyword>Nanostructures/chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Oligopeptides/chemistry/*pharmacology</keyword><keyword>Oxidation-Reduction</keyword><keyword>Particle Size</keyword><keyword>Protein Array Analysis/*methods</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Structure-Activity Relationship</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 5</date></pub-dates></dates><isbn>1439-4227 (Print)</isbn><accession-num>17924378</accession-num><notes>Hoover, Diana K&#xD;Lee, Eun-ju&#xD;Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chembiochem : a European journal of chemical biology&#xD;Chembiochem. 2007 Nov 5;8(16):1920-3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17924378</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.446</custom4><electronic-resource-num>10.1002/cbic.200700421</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>137</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">137</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seferos, D. S.</author><author>Giljohann, D. A.</author><author>Rosi, N. L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Locked nucleic acid-nanoparticle conjugates</title><secondary-title>Chembiochem</secondary-title></titles><pages>1230-2</pages><volume>8</volume><number>11</number><edition>2007/06/15</edition><keywords><keyword>Base Sequence</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligonucleotides, Antisense/*chemistry</keyword><keyword>Proteins/chemistry</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>1439-4227 (Print)</isbn><accession-num>17562553</accession-num><notes>Seferos, Dwight S&#xD;Giljohann, David A&#xD;Rosi, Nathaniel L&#xD;Mirkin, Chad A&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chembiochem : a European journal of chemical biology&#xD;Chembiochem. 2007 Jul 23;8(11):1230-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17562553</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>3.446</custom4><electronic-resource-num>10.1002/cbic.200700262</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>665</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">665</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, L.</author><author>Radovic-Moreno, A. F.</author><author>Alexis, F.</author><author>Gu, F. X.</author><author>Basto, B. A.</author><author>Bagalkot, V.</author><author>Jon, S.</author><author>Langer, R. S.</author><author>Farokhzad, O. C.</author></authors></contributors><titles><title>Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle-Aptamer Bioconjugates</title><secondary-title>ChemMedChem</secondary-title></titles><pages>1268-71</pages><volume>2</volume><number>9</number><edition>2007/06/28</edition><keywords><keyword>antitumor agents</keyword><keyword>conjugation</keyword><keyword>dual drug delivery</keyword><keyword>nanoparticles</keyword><keyword>targeted therapy</keyword></keywords><dates><year>2007</year></dates><abstract>No abstract</abstract><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>2.825</custom4><electronic-resource-num>10.1002/cmdc.200700121 </electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>77</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">77</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Site-selective immobilization of ligands with control of density on electroactive microelectrode arrays</title><secondary-title>Chemphyschem</secondary-title></titles><pages>1469-72</pages><volume>8</volume><number>10</number><edition>2007/06/09</edition><keywords><keyword>Chemistry, Physical</keyword><keyword>Electrochemistry</keyword><keyword>Ligands</keyword><keyword>*Microelectrodes</keyword><keyword>Oxidation-Reduction</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 16</date></pub-dates></dates><isbn>1439-4235 (Print)</isbn><accession-num>17557372</accession-num><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chemphyschem : a European journal of chemical physics and physical chemistry&#xD;Chemphyschem. 2007 Jul 16;8(10):1469-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17557372</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>3.502</custom4><electronic-resource-num>10.1002/cphc.200700303</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>431</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">431</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Sosnovik, D. E.</author><author>Waterman, P.</author><author>Swirski, F. K.</author><author>Pande, A. N.</author><author>Aikawa, E.</author><author>Figueiredo, J. L.</author><author>Pittet, M. J.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.</auth-address><titles><title>Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct</title><secondary-title>Circ Res</secondary-title></titles><pages>1218-25</pages><volume>100</volume><number>8</number><edition>2007/03/24</edition><keywords><keyword>Animals</keyword><keyword>Enzyme Activation/physiology</keyword><keyword>Factor XIII/biosynthesis</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/methods</keyword><keyword>Leukocytes/cytology/enzymology/*radiography</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Inbred CBA</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Myocardial Infarction/enzymology/pathology/*radiography</keyword><keyword>Neutrophil Infiltration/physiology</keyword><keyword>Peptide Hydrolases/*metabolism</keyword><keyword>Tomography, Optical/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 27</date></pub-dates></dates><isbn>1524-4571 (Electronic)</isbn><accession-num>17379832</accession-num><abstract>Inflammatory responses after myocardial infarction profoundly impact tissue repair. Yet, efficient tools to serially and noninvasively assess cellular and molecular functions in postinfarct inflammation are lacking. Here we use multichannel fluorescent molecular tomography (FMT) for spatiotemporal resolution of phagocytic and proteolytic activities mediated by macrophages and neutrophils in murine infarcts. We performed FMT imaging to compare the course of efficient and impaired healing in wild-type and FXIII-/- mice, respectively. Mice subjected to coronary ligation received simultaneous injections with Prosense-680, an activatable fluorescence sensor reporting on cathepsin activity, and CLIO-VT750, a magneto-fluorescent nanoparticle for imaging of phagocyte recruitment. On FMT, Prosense-680 infarct signal was 19-fold higher than background (P&lt;0.05). Protease activity was higher in the infarcted lateral wall than in the remote, uninjured septum on ex vivo fluorescence reflectance imaging (contrast to noise ratio 118+/-24). CLIO-VT750 FMT signal coregistered with contrast enhancement in the hypokinetic infarct on MRI. Microscopic fluorescence signal colocalized with immunoreactive staining for cathepsin, macrophages and neutrophils. Flow cytometry of digested infarcts revealed monocytes/macrophages and neutrophils as the source of the fluorescence signal. Phagocytic activity peaked on day 6, and proteolytic activity peaked on day 4 after myocardial infarction. FMT detected impaired recruitment of phagocytes and protease activity in FXIII-/- mice (P&lt;0.05). FMT is a promising noninvasive molecular imaging approach to characterize infarct healing. Spectrally resolved imaging agents allow for simultaneous assesment of key processes of in vivo cellular functions. Specifically, we show that in vivo FMT detects impaired healing in FXIII-/- mice.</abstract><notes>Nahrendorf, Matthias&#xD;Sosnovik, David E&#xD;Waterman, Peter&#xD;Swirski, Filip K&#xD;Pande, Ashvin N&#xD;Aikawa, Elena&#xD;Figueiredo, Jose-Luiz&#xD;Pittet, Mikael J&#xD;Weissleder, Ralph&#xD;K08 HL079984/HL/United States NHLBI&#xD;R01-HL078641/HL/United States NHLBI&#xD;R24-CA92782/CA/United States NCI&#xD;UO1-HL080731/HL/United States NHLBI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation research&#xD;Circ Res. 2007 Apr 27;100(8):1218-25. Epub 2007 Mar 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17379832</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>9.721</custom4><electronic-resource-num>01.RES.0000265064.46075.31 [pii]&#xD;10.1161/01.RES.0000265064.46075.31</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>412</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">412</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aikawa, E.</author><author>Nahrendorf, M.</author><author>Figueiredo, J. L.</author><author>Swirski, F. K.</author><author>Shtatland, T.</author><author>Kohler, R. H.</author><author>Jaffer, F. A.</author><author>Aikawa, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th St, Room 5420, Charlestown, MA 02129, USA. eaikawa@mgh.harvard.edu</auth-address><titles><title>Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo</title><secondary-title>Circulation</secondary-title></titles><pages>2841-50</pages><volume>116</volume><number>24</number><edition>2007/11/28</edition><keywords><keyword>Animals</keyword><keyword>Apolipoproteins E/*deficiency/genetics</keyword><keyword>Atherosclerosis/pathology/*physiopathology</keyword><keyword>Calcinosis/etiology/pathology</keyword><keyword>Disease Models, Animal</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Inflammation/*etiology/prevention &amp; control</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Osteogenesis/*physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>18040026</accession-num><abstract>BACKGROUND: Arterial calcification is associated with cardiovascular events; however, mechanisms of calcification in atherosclerosis remain obscure. METHODS AND RESULTS: We tested the hypothesis that inflammation promotes osteogenesis in atherosclerotic plaques using in vivo molecular imaging in apolipoprotein E-/- mice (20 to 30 weeks old, n=35). A bisphosphonate-derivatized near-infrared fluorescent imaging agent (excitation 750 nm) visualized osteogenic activity that was otherwise undetectable by x-ray computed tomography. Flow cytometry validated the target specifically in osteoblast-like cells. A spectrally distinct near-infrared fluorescent nanoparticle (excitation 680 nm) was coinjected to simultaneously image macrophages. Fluorescence reflectance mapping demonstrated an association between osteogenic activity and macrophages in aortas of apolipoprotein E-/- mice (R2=0.93). Intravital dual-channel fluorescence microscopy was used to further monitor osteogenic changes in inflamed carotid arteries at 20 and 30 weeks of age and revealed that macrophage burden and osteogenesis concomitantly increased during plaque progression (P&lt;0.01 and P&lt;0.001, respectively) and decreased after statin treatment (P&lt;0.0001 and P&lt;0.05, respectively). Fluorescence microscopy on cryosections colocalized near-infrared fluorescent osteogenic signals with alkaline phosphatase activity, bone-regulating protein expression, and hydroxyapatite nanocrystals as detected by electron microscopy, whereas von Kossa and alizarin red stains showed no evidence of calcification. Real-time reverse-transcription polymerase chain reaction revealed that macrophage-conditioned media increased alkaline phosphatase mRNA expression in vascular smooth muscle cells. CONCLUSIONS: This serial in vivo study demonstrates the real-time association of macrophage burden with osteogenic activity in early-stage atherosclerosis and offers a cellular-resolution tool to identify preclinical microcalcifications.</abstract><notes>Aikawa, Elena&#xD;Nahrendorf, Matthias&#xD;Figueiredo, Jose-Luiz&#xD;Swirski, Filip K&#xD;Shtatland, Timur&#xD;Kohler, Rainer H&#xD;Jaffer, Farouc A&#xD;Aikawa, Masanori&#xD;Weissleder, Ralph&#xD;R0I-HL078641/HL/United States NHLBI&#xD;U0I-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Dec 11;116(24):2841-50. Epub 2007 Nov 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18040026</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.94</custom4><electronic-resource-num>CIRCULATIONAHA.107.732867 [pii]&#xD;10.1161/CIRCULATIONAHA.107.732867</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>429</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">429</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aikawa, E.</author><author>Nahrendorf, M.</author><author>Sosnovik, D.</author><author>Lok, V. M.</author><author>Jaffer, F. A.</author><author>Aikawa, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass 02129, USA. eaikawa@partners.org</auth-address><titles><title>Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease</title><secondary-title>Circulation</secondary-title></titles><pages>377-86</pages><volume>115</volume><number>3</number><edition>2007/01/17</edition><keywords><keyword>Animals</keyword><keyword>Aortic Valve Stenosis/pathology/*physiopathology</keyword><keyword>Apolipoproteins E/genetics/physiology</keyword><keyword>Atherosclerosis/pathology/*physiopathology</keyword><keyword>Calcinosis/pathology/physiopathology</keyword><keyword>Calcium/metabolism</keyword><keyword>Endothelium, Vascular/pathology/physiopathology</keyword><keyword>Enzyme Activation/physiology</keyword><keyword>Fibroblasts/pathology/physiology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Hypercholesterolemia/pathology/physiopathology</keyword><keyword>Macrophage Activation/physiology</keyword><keyword>Macrophages/pathology/physiology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Knockout</keyword><keyword>Osteoblasts/pathology/physiology</keyword><keyword>Osteogenesis/*physiology</keyword><keyword>Peptide Hydrolases/*physiology</keyword><keyword>Predictive Value of Tests</keyword><keyword>Spectroscopy, Near-Infrared/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 23</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17224478</accession-num><abstract>BACKGROUND: Visualizing early changes in valvular cell functions in vivo may predict the future risk and identify therapeutic targets for prevention of aortic valve stenosis. METHODS AND RESULTS: To test the hypotheses that (1) aortic stenosis shares a similar pathogenesis to atherosclerosis and (2) molecular imaging can detect early changes in aortic valve disease, we used in vivo a panel of near-infrared fluorescence imaging agents to map endothelial cells, macrophages, proteolysis, and osteogenesis in aortic valves of hypercholesterolemic apolipoprotein E-deficient mice (30 weeks old, n=30). Apolipoprotein E-deficient mice with no probe injection (n=10) and wild-type mice (n=10) served as controls. Valves of apolipoprotein E-deficient mice contained macrophages, were thicker than wild-type mice (P&lt;0.001), and showed early dysfunction detected by MRI in vivo. Fluorescence imaging detected uptake of macrophage-targeted magnetofluorescent nanoparticles (24 hours after injection) in apolipoprotein E-deficient valves, which was negligible in controls (P&lt;0.01). Valvular macrophages showed proteolytic activity visualized by protease-activatable near-infrared fluorescence probes. Ex vivo magnetic resonance imaging enhanced with vascular cell adhesion molecule-1-targeted nanoparticles detected endothelial activation in valve commissures, the regions of highest mechanical stress. Osteogenic near-infrared fluorescence signals colocalized with alkaline phosphatase activity and expression of osteopontin, osteocalcin, Runx2/Cbfa1, Osterix, and Notch1 despite no evidence of calcium deposits, which suggests ongoing active processes of osteogenesis in inflamed valves. Notably, the aortic wall contained advanced calcification. Quantitative image analysis correlated near-infrared fluorescence signals with immunoreactive vascular cell adhesion molecule-1, macrophages, and cathepsin-B (P&lt;0.001). CONCLUSIONS: Molecular imaging can detect in vivo the key cellular events in early aortic valve disease, including endothelial cell and macrophage activation, proteolytic activity, and osteogenesis.</abstract><notes>Aikawa, Elena&#xD;Nahrendorf, Matthias&#xD;Sosnovik, David&#xD;Lok, Vincent M&#xD;Jaffer, Farouc A&#xD;Aikawa, Masanori&#xD;Weissleder, Ralph&#xD;R01-HL078641/HL/United States NHLBI&#xD;U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Jan 23;115(3):377-86. Epub 2007 Jan 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17224478</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.94</custom4><electronic-resource-num>CIRCULATIONAHA.106.654913 [pii]&#xD;10.1161/CIRCULATIONAHA.106.654913</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>428</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">428</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jaffer, F. A.</author><author>Kim, D. E.</author><author>Quinti, L.</author><author>Tung, C. H.</author><author>Aikawa, E.</author><author>Pande, A. N.</author><author>Kohler, R. H.</author><author>Shi, G. P.</author><author>Libby, P.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, MA 02129, USA. fjaffer@partners.org</auth-address><titles><title>Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor</title><secondary-title>Circulation</secondary-title></titles><pages>2292-8</pages><volume>115</volume><number>17</number><edition>2007/04/11</edition><keywords><keyword>Animals</keyword><keyword>Apolipoproteins E/genetics</keyword><keyword>Carotid Arteries/*enzymology/pathology</keyword><keyword>Carotid Artery Diseases/*metabolism/pathology</keyword><keyword>Cathepsins/*metabolism</keyword><keyword>Elastin/metabolism</keyword><keyword>Enzyme Activation</keyword><keyword>Fluorescein-5-isothiocyanate</keyword><keyword>Fluorescent Dyes</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Macrophages/enzymology/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Mutant Strains</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Peptide Hydrolases</keyword><keyword>Spectroscopy, Near-Infrared/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17420353</accession-num><abstract>BACKGROUND: Cathepsin K (CatK), a potent elastinolytic and collagenolytic cysteine protease, likely participates in the evolution and destabilization of atherosclerotic plaques. To assess better the biology of CatK activity in vivo, we developed a novel near-infrared fluorescence (NIRF) probe for imaging of CatK and evaluated it in mouse and human atherosclerosis. METHODS AND RESULTS: The NIRF imaging agent consists of the CatK peptide substrate GHPGGPQGKC-NH2 linked to an activatable fluorogenic polymer. In vitro, CatK produced a 2- to 14-fold activation of the agent over other cysteine and matrix metalloproteinases (P&lt;0.0001), as well as a &gt;8-fold activation over a control imaging agent (P&lt;0.001). Optical imaging of atheroma revealed &gt;100% NIRF signal increases in apolipoprotein E-/- mice in vivo (n=13; P&lt;0.05, CatK imaging agent versus control agent) and in human carotid endarterectomy specimens ex vivo (n=14; P&lt;0.05). Fluorescence microscopy of plaque sections demonstrated that enzymatically active CatK (positive NIRF signal) localized primarily in the vicinity of CatK-positive macrophages. Augmented NIRF signal (reflecting CatK activity) colocalized with disrupted elastin fibers within the media underlying plaques. CONCLUSIONS: Use of this novel protease-activatable NIRF agent for optical imaging in vivo demonstrated preferential localization of enzymatically active CatK to macrophages, consistent with their known greater elastinolytic capabilities compared with smooth muscle cells. Augmented CatK proteolysis in atheromata further links CatK to vascular remodeling and plaque vulnerability.</abstract><notes>Jaffer, Farouc A&#xD;Kim, Dong-Eog&#xD;Quinti, Luisa&#xD;Tung, Ching-Hsuan&#xD;Aikawa, Elena&#xD;Pande, Ashvin N&#xD;Kohler, Rainer H&#xD;Shi, Guo-Ping&#xD;Libby, Peter&#xD;Weissleder, Ralph&#xD;P50-CA86355/CA/United States NCI&#xD;R01-HL080472/HL/United States NHLBI&#xD;R24-CA92782/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 May 1;115(17):2292-8. Epub 2007 Apr 9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17420353</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.94</custom4><electronic-resource-num>CIRCULATIONAHA.106.660340 [pii]&#xD;10.1161/CIRCULATIONAHA.106.660340</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>426</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">426</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jaffer, F. A.</author><author>Libby, P.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. fjaffer@mgh.harvard.edu</auth-address><titles><title>Molecular imaging of cardiovascular disease</title><secondary-title>Circulation</secondary-title></titles><pages>1052-61</pages><volume>116</volume><number>9</number><edition>2007/08/29</edition><keywords><keyword>Atherosclerosis/pathology/radionuclide imaging</keyword><keyword>Cardiovascular Diseases/pathology/*radionuclide imaging</keyword><keyword>Clinical Trials as Topic</keyword><keyword>Contrast Media/adverse effects</keyword><keyword>Coronary Disease/pathology/radionuclide imaging</keyword><keyword>Humans</keyword><keyword>Macrophages/pathology/radionuclide imaging</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Myocardial Infarction/chemically induced/pathology</keyword><keyword>Positron-Emission Tomography/adverse effects</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Thrombosis/pathology/radionuclide imaging</keyword><keyword>Tomography, Emission-Computed, Single-Photon/adverse effects</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 28</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17724271</accession-num><notes>Jaffer, Farouc A&#xD;Libby, Peter&#xD;Weissleder, Ralph&#xD;R01-HL078641/HL/United States NHLBI&#xD;U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Aug 28;116(9):1052-61.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17724271</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.94</custom4><electronic-resource-num>116/9/1052 [pii]&#xD;10.1161/CIRCULATIONAHA.106.647164</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>410</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">410</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kircher, M. F.</author><author>Grimm, J.</author><author>Swirski, F. K.</author><author>Libby, P.</author><author>Gerszten, R. E.</author><author>Allport, J. R.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Mass, USA.</auth-address><titles><title>Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions</title><secondary-title>Circulation</secondary-title></titles><pages>388-95</pages><volume>117</volume><number>3</number><edition>2008/01/04</edition><keywords><keyword>Adoptive Transfer</keyword><keyword>Animals</keyword><keyword>Apolipoproteins E/deficiency</keyword><keyword>Atherosclerosis/*pathology</keyword><keyword>*Chemotaxis, Leukocyte</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Mice, Transgenic</keyword><keyword>Monocytes/*physiology/transplantation</keyword><keyword>Organometallic Compounds/diagnostic use</keyword><keyword>Oxyquinoline/analogs &amp; derivatives/diagnostic use</keyword><keyword>Tomography, Emission-Computed, Single-Photon/*methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>18172031</accession-num><abstract>BACKGROUND: Monocytes play a key role in atherogenesis, but their participation has been discerned largely via ex vivo analyses of atherosclerotic lesions. We sought to establish a noninvasive technique to determine monocyte trafficking to atherosclerotic lesions in live animals. METHODS AND RESULTS: Using a micro-single-photon emission computed tomography small-animal imaging system and a Food and Drug Administration-approved radiotracer ([indium 111] oxyquinoline, (111)In-oxine), we demonstrate here that monocyte recruitment to atherosclerotic lesions can be visualized in a noninvasive, dynamic, and 3-dimensional fashion in live animals. We show in vivo that monocytes are recruited avidly to plaques within days of adoptive transfer. Using micro-single-photon emission computed tomography imaging as a screening tool, we were able to investigate modulatory effects on monocyte recruitment in live animals. We found that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors rapidly and substantially reduce monocyte recruitment to existing atherosclerotic lesions, as imaged here in vivo. CONCLUSIONS: This novel approach to track monocytes to atherosclerotic plaques in vivo should have broad applications and create new insights into the pathogenesis of atherosclerosis and other inflammatory diseases.</abstract><notes>Kircher, Moritz F&#xD;Grimm, Jan&#xD;Swirski, Filip K&#xD;Libby, Peter&#xD;Gerszten, Robert E&#xD;Allport, Jennifer R&#xD;Weissleder, Ralph&#xD;R24 CA92782/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2008 Jan 22;117(3):388-95. Epub 2008 Jan 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18172031</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.94</custom4><electronic-resource-num>CIRCULATIONAHA.107.719765 [pii]&#xD;10.1161/CIRCULATIONAHA.107.719765</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>36</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">36</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Jaffer, F. A.</author><author>Kelly, K. A.</author><author>Sosnovik, D. E.</author><author>Aikawa, E.</author><author>Libby, P.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.</auth-address><titles><title>Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis</title><secondary-title>Circulation</secondary-title><alt-title>Circulation</alt-title></titles><pages>1504-11</pages><volume>114</volume><number>14</number><edition>2006/10</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Apolipoproteins E/deficiency</keyword><keyword>Atherosclerosis/*drug therapy/*pathology</keyword><keyword>Diagnostic Imaging/methods</keyword><keyword>Down-Regulation/drug effects</keyword><keyword>Drug Monitoring/methods</keyword><keyword>Gene Expression Regulation/drug effects</keyword><keyword>Inflammation/*diagnosis</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Peptides/administration &amp; dosage/pharmacology/therapeutic use</keyword><keyword>Vascular Cell Adhesion Molecule-1/*analysis/drug effects</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 3</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17000904</accession-num><abstract>BACKGROUND: Noninvasive imaging of adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) may identify early stages of inflammation in atherosclerosis. We hypothesized that a novel, second-generation VCAM-1-targeted agent with enhanced affinity had sufficient sensitivity to enable real-time detection of VCAM-1 expression in experimental atherosclerosis in vivo, to quantify pharmacotherapy-induced reductions in VCAM-1 expression, and to identify activated cells in human plaques. METHODS AND RESULTS: In vivo phage display in apolipoprotein E-deficient mice identified a linear peptide affinity ligand, VHPKQHR, homologous to very late antigen-4, a known ligand for VCAM-1. This peptide was developed into a multivalent agent detectable by MRI and optical imaging (denoted VINP-28 for VCAM-1 internalizing nanoparticle 28, with 20 times higher affinity than previously reported for VNP). In vitro, VINP-28 targeted all cell types expressing VCAM-1. In vivo, MRI and optical imaging in apolipoprotein E-deficient mice (n=28) after injection with VINP-28 or saline revealed signal enhancement in the aortic root of mice receiving VINP-28 (P&lt;0.05). VINP-28 colocalized with endothelial cells and other VCAM-1-expressing cells, eg, macrophages, and was spatially distinct compared with untargeted control nanoparticles. Atheromata of atorvastatin-treated mice showed reduced VINP-28 deposition and VCAM-1 expression. VINP-28 enhanced early lesions in juvenile mice and resected human carotid artery plaques. CONCLUSIONS: VINP-28 allows noninvasive imaging of VCAM-1-expressing endothelial cells and macrophages in atherosclerosis and spatial monitoring of anti-VCAM-1 pharmacotherapy in vivo and identifies inflammatory cells in human atheromata. This clinically translatable agent could noninvasively detect inflammation in early, subclinical atherosclerosis.</abstract><notes>P01-ai054904/ai/niaid&#xD;R01-hl078641/hl/nhlbi&#xD;R01-hl36436/hl/nhlbi&#xD;U01-hl080731/hl/nhlbi&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17000904 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>10.94</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>411</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">411</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Zhang, H.</author><author>Hembrador, S.</author><author>Panizzi, P.</author><author>Sosnovik, D. E.</author><author>Aikawa, E.</author><author>Libby, P.</author><author>Swirski, F. K.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.</auth-address><titles><title>Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis</title><secondary-title>Circulation</secondary-title></titles><pages>379-87</pages><volume>117</volume><number>3</number><edition>2007/12/26</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD/analysis</keyword><keyword>Antigens, Differentiation, Myelomonocytic/analysis</keyword><keyword>Apolipoproteins E/deficiency</keyword><keyword>Atherosclerosis/pathology</keyword><keyword>Biological Markers/analysis</keyword><keyword>Copper Radioisotopes/diagnostic use</keyword><keyword>Inflammation/pathology</keyword><keyword>Macrophages/*pathology</keyword><keyword>Mice</keyword><keyword>Microscopy</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Positron-Emission Tomography/*methods/standards</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>18158358</accession-num><abstract>BACKGROUND: Macrophages participate centrally in atherosclerosis, and macrophage markers (eg, CD68, MAC-3) correlate well with lesion severity and therapeutic modulation. On the basis of the avidity of lesional macrophages for polysaccharide-containing supramolecular structures such as nanoparticles, we have developed a new positron emission tomography (PET) agent with optimized pharmacokinetics to allow in vivo imaging at tracer concentrations. METHODS AND RESULTS: A dextranated and DTPA-modified magnetofluorescent 20-nm nanoparticle was labeled with the PET tracer 64Cu (1 mCi/0.1 mg nanoparticles) to yield a PET, magnetic resonance, and optically detectable imaging agent. Peak PET activity 24 hours after intravenous injection into mice deficient in apolipoprotein E with experimental atherosclerosis mapped to areas of high plaque load identified by computed tomography such as the aortic root and arch and correlated with magnetic resonance and optical imaging. Accumulated dose in apolipoprotein E-deficient aortas determined by gamma counting was 260% and in carotids 392% of respective wild-type organs (P&lt;0.05 both). Autoradiography of aortas demonstrated uptake of the agent into macrophage-rich atheromata identified by Oil Red O staining of lipid deposits. The novel nanoagent accumulated predominantly in macrophages as determined by fluorescence microscopy and flow cytometry of cells dissociated from aortas. CONCLUSIONS: This report establishes the capability of a novel trimodality nanoparticle to directly detect macrophages in atherosclerotic plaques. Advantages include improved sensitivity; direct correlation of PET signal with an established biomarker (CD68); ability to readily quantify the PET signal, perform whole-body vascular surveys, and spatially localize and follow the trireporter by microscopy; and clinical translatability of the agent given similarities to magnetic resonance imaging probes in clinical trials.</abstract><notes>Nahrendorf, Matthias&#xD;Zhang, Hanwen&#xD;Hembrador, Sheena&#xD;Panizzi, Peter&#xD;Sosnovik, David E&#xD;Aikawa, Elena&#xD;Libby, Peter&#xD;Swirski, Filip K&#xD;Weissleder, Ralph&#xD;R01-HL078641/HL/United States NHLBI&#xD;R24-CA92782/CA/United States NCI&#xD;U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Circulation&#xD;Circulation. 2008 Jan 22;117(3):379-87. Epub 2007 Dec 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18158358</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.94</custom4><electronic-resource-num>CIRCULATIONAHA.107.741181 [pii]&#xD;10.1161/CIRCULATIONAHA.107.741181</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>425</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">425</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sosnovik, D. E.</author><author>Nahrendorf, M.</author><author>Deliolanis, N.</author><author>Novikov, M.</author><author>Aikawa, E.</author><author>Josephson, L.</author><author>Rosenzweig, A.</author><author>Weissleder, R.</author><author>Ntziachristos, V.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. sosnovik@nmr.mgh.harvard.edu</auth-address><titles><title>Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo</title><secondary-title>Circulation</secondary-title></titles><pages>1384-91</pages><volume>115</volume><number>11</number><edition>2007/03/07</edition><keywords><keyword>Animals</keyword><keyword>Carbocyanines</keyword><keyword>Disease Models, Animal</keyword><keyword>Macrophages/*pathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Myocardial Infarction/immunology/*pathology</keyword><keyword>Myocardium/immunology/*pathology</keyword><keyword>Tomography, Optical/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 20</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17339546</accession-num><abstract>BACKGROUND: Fluorescence imaging of the heart is currently limited to invasive ex vivo or in vitro applications. We hypothesized that the adaptation of advanced transillumination and tomographic techniques would allow noninvasive fluorescence images of the heart to be acquired in vivo and be coregistered with in vivo cardiac magnetic resonance images. METHODS AND RESULTS: The uptake of the magnetofluorescent nanoparticle CLIO-Cy5.5 by macrophages in infarcted myocardium was studied. Ligation of the left coronary artery was performed in 12 mice and sham surgery in 7. The mice were injected, 48 hours after surgery, with 3 to 20 mg of iron per kilogram of CLIO-Cy5.5. Magnetic resonance imaging and fluorescence molecular tomography were performed 48 hours later. An increase in magnetic resonance imaging contrast-to-noise ratio, indicative of myocardial probe accumulation, was seen in the anterolateral walls of the infarcted mice but not in the sham-operated mice (23.0+/-2.7 versus 5.43+/-2.4; P&lt;0.01). Fluorescence intensity over the heart was also significantly greater in the fluorescence molecular tomography images of the infarcted mice (19.1+/-5.2 versus 5.3+/-1.4; P&lt;0.05). The uptake of CLIO-Cy5.5 by macrophages infiltrating the infarcted myocardium was confirmed by fluorescence microscopy and immunohistochemistry. CONCLUSIONS: Noninvasive imaging of myocardial macrophage infiltration has been shown to be possible by both fluorescence tomography and magnetic resonance imaging. This could be of significant value in both the research and clinical settings. The techniques developed could also be used to image other existing fluorescent and magnetofluorescent probes and could significantly expand the role of fluorescence imaging in the heart.</abstract><notes>Sosnovik, David E&#xD;Nahrendorf, Matthias&#xD;Deliolanis, Nikolaos&#xD;Novikov, Mikhail&#xD;Aikawa, Elena&#xD;Josephson, Lee&#xD;Rosenzweig, Anthony&#xD;Weissleder, Ralph&#xD;Ntziachristos, Vasilis&#xD;K08 HL079984/HL/United States NHLBI&#xD;R01EB000750/EB/United States NIBIB&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Mar 20;115(11):1384-91. Epub 2007 Mar 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17339546</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.94</custom4><electronic-resource-num>CIRCULATIONAHA.106.663351 [pii]&#xD;10.1161/CIRCULATIONAHA.106.663351</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>427</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">427</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sosnovik, D. E.</author><author>Nahrendorf, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, 149 13th St, Charlestown, MA 02129, USA. sosnovik@nmr.mgh.harvard.edu</auth-address><titles><title>Molecular magnetic resonance imaging in cardiovascular medicine</title><secondary-title>Circulation</secondary-title></titles><pages>2076-86</pages><volume>115</volume><number>15</number><edition>2007/04/18</edition><keywords><keyword>Animals</keyword><keyword>Biological Markers/analysis</keyword><keyword>Biosensing Techniques</keyword><keyword>Cardiovascular Diseases/*diagnosis</keyword><keyword>Ferrosoferric Oxide/diagnostic use</keyword><keyword>Gadolinium/diagnostic use</keyword><keyword>Humans</keyword><keyword>*Magnetic Resonance Imaging/instrumentation/methods/trends</keyword><keyword>Nanoparticles/diagnostic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 17</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17438163</accession-num><notes>Sosnovik, David E&#xD;Nahrendorf, Matthias&#xD;Weissleder, Ralph&#xD;K08 HL079984/HL/United States NHLBI&#xD;P01CA117969-015904/CA/United States NCI&#xD;R01EB004626/EB/United States NIBIB&#xD;R01HL07864/HL/United States NHLBI&#xD;U01HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Apr 17;115(15):2076-86.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17438163</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.94</custom4><electronic-resource-num>115/15/2076 [pii]&#xD;10.1161/CIRCULATIONAHA.106.658930</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>208</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>deVera, I. E.</author><author>Katz, J. E.</author><author>Agus, D. B.</author></authors></contributors><auth-address>Center for Applied Molecular Medicine at Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.</auth-address><titles><title>Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery</title><secondary-title>Clin Adv Hematol Oncol</secondary-title></titles><pages>541-9</pages><volume>4</volume><number>7</number><edition>2006/12/07</edition><keywords><keyword>Biological Markers/*analysis/blood</keyword><keyword>Human Genome Project</keyword><keyword>Humans</keyword><keyword>Mass Spectrometry/methods</keyword><keyword>Proteomics/*methods</keyword><keyword>Tumor Markers, Biological/analysis/blood</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>(Print)</isbn><accession-num>17147241</accession-num><abstract>The lack of effective surrogates or biomarkers for biologic and disease state is a major hindrance to effective cancer care. Many laboratories have been using mass spectrometry as the means to discover new biomarkers. The success of these efforts relies on effective collaboration between clinicians and mass spectroscopists. This review describes many of the common proteomic experimental methodologies and evaluates the current state of proteomics-based biomarker discovery--starting from sample collection through sample processing and ultimately sample measurement. Guidelines are given for the evaluation of experimental design and for the gauging of result significance. Particular emphasis is placed on those aspects strongly associated with reproducibility from both clinical and laboratory perspectives.</abstract><notes>deVera, Imelda E&#xD;Katz, Jonathan E&#xD;Agus, David B&#xD;United States&#xD;Clinical advances in hematology &amp; oncology : H&amp;O&#xD;Clin Adv Hematol Oncol. 2006 Jul;4(7):541-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17147241</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>na</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>347</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">347</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Banyard, J.</author><author>Bao, L.</author><author>Hofer, M. D.</author><author>Zurakowski, D.</author><author>Spivey, K. A.</author><author>Feldman, A. S.</author><author>Hutchinson, L. M.</author><author>Kuefer, R.</author><author>Rubin, M. A.</author><author>Zetter, B. R.</author></authors></contributors><auth-address>Vascular Biology Program, Department of Surgery, Children&apos;s Hospital, Boston, MA 02115, USA.</auth-address><titles><title>Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>2634-42</pages><volume>13</volume><number>9</number><edition>2007/05</edition><keywords><keyword>Antibodies/immunology</keyword><keyword>Collagen/*analysis/metabolism</keyword><keyword>Disease Progression</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Male</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplasm Recurrence, Local/*diagnosis</keyword><keyword>Neoplasm Staging</keyword><keyword>Prognosis</keyword><keyword>Prostatic Neoplasms/chemistry/*pathology</keyword><keyword>Tumor Markers, Biological/*analysis/metabolism</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>17473194</accession-num><abstract>PURPOSE: We had previously identified a new transmembrane collagen, type XXIII, in metastatic rat prostate carcinoma cells. The purpose of this study was to determine the expression of collagen XXIII in human prostate cancer and investigate its relationship with disease progression. EXPERIMENTAL DESIGN: We investigated collagen XXIII expression in prostate cancer tissue and did a retrospective analysis of association with prostate-specific antigen (PSA)-defined disease recurrence. The presence of collagen XXIII in prostate cancer patient urine was also assessed before and after prostatectomy. RESULTS: Collagen XXIII protein was detected at very low levels in benign prostate tissue and was significantly increased in prostate cancer. Distant metastases exhibited significantly higher collagen XXIII levels compared with either localized prostate cancer or regional (lymph node) metastases. Patients with high collagen XXIII levels had a 2.8-fold higher risk of PSA failure with median time to failure of 8.1 months, compared with low collagen XXIII patients with a median time to failure of 5 years. Multivariate Cox regression showed that the presence of collagen XXIII was significantly associated with time to PSA recurrence, independent of other clinical variables. Collagen XXIII was also detected in prostate cancer patient urine, with reduced levels after prostatectomy, indicating potential as a noninvasive fluid biomarker. CONCLUSIONS: We present the first report demonstrating increased collagen XXIII expression in prostate cancer tissue. We show that collagen XXIII level is a significant independent predictor of PSA-defined disease recurrence, suggesting a potential role as a molecular biomarker of prostate cancer progression and metastasis.</abstract><notes>Ca09381-03/ca/nci&#xD;Ca104973/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;an official journal of the American Association for Cancer Research</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17473194 </url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2007</custom3><custom4>6.250</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>698</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">698</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chang, S. K.</author><author>Rizvi, I.</author><author>Solban, N.</author><author>Hasan, T.</author></authors></contributors><auth-address>Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</auth-address><titles><title>In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>4146-53</pages><volume>14</volume><number>13</number><edition>2008/07/03</edition><keywords><keyword>Animals</keyword><keyword>Calibration</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cytokines/metabolism</keyword><keyword>Fluorescent Dyes/pharmacology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/*instrumentation/*methods</keyword><keyword>Models, Biological</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Photochemotherapy/methods</keyword><keyword>Time Factors</keyword><keyword>Up-Regulation</keyword><keyword>Vascular Endothelial Growth Factor A/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18593993</accession-num><abstract>PURPOSE: Vascular endothelial growth factor (VEGF) expression is a critical component in tumor growth and metastasis. Capabilities to monitor VEGF expression in vivo can potentially serve as a useful tool for diagnosis, prognosis, treatment planning, monitoring, and research. Here, we present the first report of in vivo hyperspectral molecular imaging strategy capable of monitoring treatment-induced changes in VEGF expression. EXPERIMENTAL DESIGN: VEGF was targeted with an anti-VEGF antibody conjugated with a fluorescent dye and was imaged in vivo using a hyperspectral imaging system. The strategy was validated by quantitatively monitoring VEGF levels in three different tumors as well as following photodynamic treatment. Specificity of the molecular imaging strategy was tested using in vivo competition experiments and mathematically using a quantitative pharmacokinetic model. RESULTS: The molecular imaging strategy successfully imaged VEGF levels quantitatively in three different tumors and showed concordance with results from standard ELISA. Changes in tumoral VEGF concentration following photodynamic treatment and Avastin treatment were shown. Immunohistochemistry shows that (a) the VEGF-specific contrast agent labels both proteoglycan-bound and unbound VEGF in the extracellular space and (b) the bound VEGF is released from the extracellular matrix in response to photodynamic therapy. In vivo competition experiments and quantitative pharmacokinetic model-based analysis confirmed the high specificity of the imaging strategy. CONCLUSION: This first report of in vivo quantitative optical molecular imaging-based monitoring of a secreted cytokine in tumors may have implications in providing tools for mechanistic investigations as well as for improved treatment design and merits further investigation.</abstract><notes>Chang, Sung K&#xD;Rizvi, Imran&#xD;Solban, Nicolas&#xD;Hasan, Tayyaba&#xD;P01 CA84203/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Jul 1;14(13):4146-53.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18593993</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>6.250</custom4><electronic-resource-num>14/13/4146 [pii]&#xD;10.1158/1078-0432.CCR-07-4536</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>577</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">577</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cho, K.</author><author>Wang, X.</author><author>Nie, S.</author><author>Chen, Z. G.</author><author>Shin, D. M.</author></authors></contributors><auth-address>Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Therapeutic nanoparticles for drug delivery in cancer</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>1310-6</pages><volume>14</volume><number>5</number><edition>2008/03/05</edition><keywords><keyword>Antineoplastic Agents/*administration &amp; dosage</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Nanomedicine</keyword><keyword>Nanoparticles/*administration &amp; dosage</keyword><keyword>Neoplasms/*drug therapy</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18316549</accession-num><abstract>Cancer nanotherapeutics are rapidly progressing and are being implemented to solve several limitations of conventional drug delivery systems such as nonspecific biodistribution and targeting, lack of water solubility, poor oral bioavailability, and low therapeutic indices. To improve the biodistribution of cancer drugs, nanoparticles have been designed for optimal size and surface characteristics to increase their circulation time in the bloodstream. They are also able to carry their loaded active drugs to cancer cells by selectively using the unique pathophysiology of tumors, such as their enhanced permeability and retention effect and the tumor microenvironment. In addition to this passive targeting mechanism, active targeting strategies using ligands or antibodies directed against selected tumor targets amplify the specificity of these therapeutic nanoparticles. Drug resistance, another obstacle that impedes the efficacy of both molecularly targeted and conventional chemotherapeutic agents, might also be overcome, or at least reduced, using nanoparticles. Nanoparticles have the ability to accumulate in cells without being recognized by P-glycoprotein, one of the main mediators of multidrug resistance, resulting in the increased intracellular concentration of drugs. Multifunctional and multiplex nanoparticles are now being actively investigated and are on the horizon as the next generation of nanoparticles, facilitating personalized and tailored cancer treatment.</abstract><notes>Cho, Kwangjae&#xD;Wang, Xu&#xD;Nie, Shuming&#xD;Chen, Zhuo Georgia&#xD;Shin, Dong M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Mar 1;14(5):1310-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18316549</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>6.250</custom4><electronic-resource-num>14/5/1310 [pii]&#xD;10.1158/1078-0432.CCR-07-1441</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>691</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">691</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cottrell, W. J.</author><author>Paquette, A. D.</author><author>Keymel, K. R.</author><author>Foster, T. H.</author><author>Oseroff, A. R.</author></authors></contributors><auth-address>Department of Imaging Sciences, University of Rochester, Rochester, New York, USA.</auth-address><titles><title>Irradiance-Genetic risk factors of suicidal behaviour acid-photodynamic therapy of superficial basal cell carcinomas</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>4475-83</pages><volume>14</volume><number>14</number><edition>2008/07/17</edition><dates><year>2008</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18628462</accession-num><abstract>PURPOSE: In superficial basal cell carcinomas treated with photodynamic therapy with topical delta-aminolevulinic acid, we examined effects of light irradiance on photodynamic efficiency and pain. The rate of singlet-oxygen production depends on the product of irradiance and photosensitizer and oxygen concentrations. High irradiance and/or photosensitizer levels cause inefficient treatment from oxygen depletion in preclinical models. EXPERIMENTAL DESIGN: Self-sensitized photobleaching of protoporphyrin IX (PpIX) fluorescence was used as a surrogate metric for photodynamic dose. We developed instrumentation measuring fluorescence and reflectance from lesions and margins during treatment at 633 nm with various irradiances. When PpIX was 90% bleached, irradiance was increased to 150 mW/cm(2) until 200 J/cm(2) were delivered. Pain was monitored. RESULTS: In 33 superficial basal cell carcinomas in 26 patients, photobleaching efficiency decreased with increasing irradiance above 20 mW/cm(2), consistent with oxygen depletion. Fluences bleaching PpIX fluorescence 80% (D80) were 5.7 +/- 1.6, 4.5 +/- 0.3, 7.5 +/- 0.8, 7.4 +/- 0.3, 12.4 +/- 0.3, and 28.7 +/- 7.1 J/cm(2), respectively, at 10, 20, 40, 50, 60 and 150 mW/cm(2). At 20-150 mW/cm(2), D80 doses required 2.5-3.5 min; times for the total 200 J/cm(2) were 22.2-25.3 min. No significant pain occurred up to 50 mW/cm(2); pain was not significant when irradiance then increased. Clinical responses were comparable to continuous 150 mW/cm(2) treatment. CONCLUSIONS: Photodynamic therapy with topical delta-aminolevulinic acid using approximately 40 mW/cm(2) at 633 nm is photodynamically efficient with minimum pain. Once PpIX is largely photobleached, higher irradiances allow efficient, rapid delivery of additional light. Optimal fluence at a single low irradiance is yet to be determined.</abstract><notes>Cottrell, William J&#xD;Paquette, Anne D&#xD;Keymel, Kenneth R&#xD;Foster, Thomas H&#xD;Oseroff, Allan R&#xD;CA16056/CA/United States NCI&#xD;P01 CA55719/CA/United States NCI&#xD;T32 HL66988/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Jul 15;14(14):4475-83.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18628462</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>6.250</custom4><electronic-resource-num>14/14/4475 [pii]&#xD;10.1158/1078-0432.CCR-07-5199</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>680</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">680</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Duan, Z.</author><author>Seiden, M. V.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>3193-203</pages><volume>14</volume><number>10</number><edition>2008/05/17</edition><dates><year>2008</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18483388</accession-num><abstract>PURPOSE: To modulate intracellular ceramide levels and lower the apoptotic threshold in multidrug-resistant ovarian adenocarcinoma, we have examined the efficacy and preliminary safety of tamoxifen coadministration with paclitaxel in biodegradable poly(ethylene oxide)-modified poly(epsilon-caprolactone) (PEO-PCL) nanoparticles. EXPERIMENTAL DESIGN: In vitro cytotoxicity and proapoptotic activity of paclitaxel and tamoxifen, either as single agent or in combination, was examined in wild-type (SKOV3) and MDR-1-positive (SKOV3TR) human ovarian adenocarcinoma cells. Subcutaneous SKOV3 and SKOV3TR xenografts were established in female nu/nu mice, and this model was used to evaluate the antitumor efficacy and preliminary safety. Paclitaxel (20 mg/kg) and tamoxifen (70 mg/kg) were administered i.v. either as a single agent or in combination in aqueous solution and in PEO-PCL nanoparticles. RESULTS: In vitro cytotoxicity results showed that administration of paclitaxel and tamoxifen in combination lowered the IC50 of paclitaxel by 10-fold in SKOV3 cells and by &gt;3-fold in SKOV3TR cells. The combination paclitaxel/tamoxifen co-therapy showed even more pronounced effect when administered in nanoparticle formulations. Upon i.v. administration of paclitaxel/tamoxifen combination in PEO-PCL nanoparticle formulations, significant enhancement in antitumor efficacy was observed. Furthermore, the combination paclitaxel/tamoxifen therapy did not induce any acute toxicity as measured by body weight changes, blood cell counts, and hepatotoxicity. CONCLUSIONS: The results of this study show that combination of paclitaxel and tamoxifen in biodegradable PEO-PCL nanoparticles can serve as an effective clinically translatable strategy to overcome multidrug resistance in ovarian cancer.</abstract><notes>Devalapally, Harikrishna&#xD;Duan, Zhenfeng&#xD;Seiden, Michael V&#xD;Amiji, Mansoor M&#xD;R01-CA119617/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 May 15;14(10):3193-203.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18483388</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>6.250</custom4><electronic-resource-num>14/10/3193 [pii]&#xD;10.1158/1078-0432.CCR-07-4973</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>613</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">613</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lin, B.</author><author>Utleg, A. G.</author><author>Gravdal, K.</author><author>White, J. T.</author><author>Halvorsen, O. J.</author><author>Lu, W.</author><author>True, L. D.</author><author>Vessella, R.</author><author>Lange, P. H.</author><author>Nelson, P. S.</author><author>Hood, L.</author><author>Kalland, K. H.</author><author>Akslen, L. A.</author></authors></contributors><auth-address>Zhejiang-California International Nanosystems Institute, Hangzhou, China. bylin@u.washington.edu</auth-address><titles><title>WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>1397-406</pages><volume>14</volume><number>5</number><edition>2008/03/05</edition><keywords><keyword>Adenocarcinoma/genetics/metabolism/pathology</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/immunology/metabolism</keyword><keyword>Blotting, Western</keyword><keyword>Follow-Up Studies</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic/*physiology</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Neoplasm Recurrence, Local/*pathology</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>Prostate-Specific Antigen/metabolism</keyword><keyword>Prostatic Hyperplasia/genetics/metabolism/pathology</keyword><keyword>Prostatic Neoplasms/*genetics/metabolism/pathology</keyword><keyword>Proteins/*genetics</keyword><keyword>RNA, Messenger/genetics/metabolism</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Survival Rate</keyword><keyword>Time Factors</keyword><keyword>Tumor Markers, Biological/genetics/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18316561</accession-num><abstract>PURPOSE: Prostate cancer is the third leading cause of cancer death in the United States, following lung and colorectal cancer. We previously identified WDR19 as a prostate-specific, androgen-regulated gene. Here, we evaluate its utility as a prostate cancer tissue marker for diagnosis and prognostic evaluation. EXPERIMENTAL DESIGN: Real-time quantitative PCR was done on a panel of prostate tissue isolated by laser capture microdissection. After generating antibodies against WDR19, tissue microarrays (TMA) were employed to compare WDR19 expression between normal, benign prostatic hyperplasia, and prostate cancer tissue. RESULTS: Using microarrays and real-time quantitative PCR, we showed that WDR19 mRNA expression was increased in cancer. We further showed that WDR19 protein is localized to cytoplasmic subcellular granules and is expressed exclusively in prostate epithelia. Large-scale immunohistochemical staining using TMAs reveals a significant percentage of increase in intensely staining tissue cores in cancer tissue when compared with normal or benign prostatic hyperplastic tissue. Based on the analysis of a separate TMA for which clinical follow-up information was available, low-intensity WDR19 staining was significantly associated with decreased time to biochemical failure (P = 0.006) and with decreased time to locoregional recurrence (P = 0.050). CONCLUSIONS: WDR19 should be added to the list of prostate cancer tissue markers. The continued expansion of a multiple-marker panel will conceivably increase the sensitivity and specificity of prostate cancer diagnosis and prognosis.</abstract><notes>Lin, Biaoyang&#xD;Utleg, Angelita G&#xD;Gravdal, Karsten&#xD;White, James T&#xD;Halvorsen, Ole J&#xD;Lu, Wei&#xD;True, Lawrence D&#xD;Vessella, Robert&#xD;Lange, Paul H&#xD;Nelson, Peter S&#xD;Hood, Leroy&#xD;Kalland, Karl-Henning&#xD;Akslen, Lars A&#xD;5P50GM076547/GM/United States NIGMS&#xD;5U54CA119347/CA/United States NCI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Mar 1;14(5):1397-406.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18316561</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>6.250</custom4><electronic-resource-num>14/5/1397 [pii]&#xD;10.1158/1078-0432.CCR-07-1535</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>67</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">67</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mellinghoff, I. K.</author><author>Cloughesy, T. F.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Departments of Molecular and Medical Pharmacology, Neurology, and Pathology and Henry E. Singleton Brain Tumor Program, David Geffen School of Medicine, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.</auth-address><titles><title>PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>378-81</pages><volume>13</volume><number>2 Pt 1</number><edition>2007/01/27</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/metabolism</keyword><keyword>Animals</keyword><keyword>Brain Neoplasms/*metabolism</keyword><keyword>Enzyme Inhibitors/*pharmacology</keyword><keyword>Glioblastoma/*metabolism</keyword><keyword>Humans</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms/metabolism</keyword><keyword>PTEN Phosphohydrolase/*physiology</keyword><keyword>Receptor, Epidermal Growth Factor/*antagonists &amp; inhibitors/*physiology</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>17255257</accession-num><abstract>Molecularly targeted therapies are transforming the treatment of cancer. Elucidating the dynamic signaling networks that underlie sensitivity and resistance to these inhibitors is critical for successful clinical application. There is considerable evidence to suggest that constitutively activating mutations in kinases that regulate cellular growth may result in tumor cell &quot;addiction&quot; and favorable response to targeted inhibition. However, there is emerging evidence to suggest that clinical response may also be determined by other changes in the molecular circuitry of cancer cells, such as loss of key tumor-suppressor proteins. Here, we will discuss resistance to epidermal growth factor receptor tyrosine kinase inhibitors in glioblastoma patients that is mediated by loss of the PTEN tumor-suppressor protein.</abstract><notes>Mellinghoff, Ingo K&#xD;Cloughesy, Tim F&#xD;Mischel, Paul S&#xD;Ca 108633/ca/nci&#xD;Ca 119347/ca/nci&#xD;Ns 050151/ns/ninds&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):378-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17255257</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>6.250</custom4><electronic-resource-num>13/2/378 [pii]&#xD;10.1158/1078-0432.CCR-06-1992</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>116</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">116</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nomura, T.</author><author>Huang, W. C.</author><author>Zhau, H. E.</author><author>Wu, D.</author><author>Xie, Z.</author><author>Mimata, H.</author><author>Zayzafoon, M.</author><author>Young, A. N.</author><author>Marshall, F. F.</author><author>Weitzmann, M. N.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis</title><secondary-title>Clin Cancer Res</secondary-title></titles><pages>7294-305</pages><volume>12</volume><number>24</number><edition>2006/12/26</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/metabolism</keyword><keyword>Animals</keyword><keyword>Apoptosis/drug effects</keyword><keyword>Carcinoma, Renal Cell/*metabolism/pathology</keyword><keyword>Cell Adhesion/physiology</keyword><keyword>Cell Movement/drug effects/physiology</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Cyclic AMP Response Element-Binding Protein/*metabolism</keyword><keyword>Cyclic AMP-Dependent Protein Kinases/*metabolism</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Kidney/metabolism</keyword><keyword>Kidney Neoplasms/*metabolism/pathology</keyword><keyword>MAP Kinase Signaling System/physiology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Nude</keyword><keyword>Models, Biological</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Oncogene Protein v-akt/metabolism</keyword><keyword>RNA, Small Interfering/pharmacology</keyword><keyword>Transfection</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Vascular Endothelial Growth Factor A/*metabolism</keyword><keyword>beta 2-Microglobulin/genetics/*physiology</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>17189401</accession-num><abstract>PURPOSE: Beta(2)-microglobulin (beta2M), a soluble protein secreted by cancer and host inflammatory cells, has various biological functions, including antigen presentation. Because aberrant expression of beta2M has been reported in human renal cell carcinoma, we investigated the effects of beta2M overexpression on cancer cell growth and analyzed its molecular signaling pathway. EXPERIMENTAL DESIGN: We established clonal cell lines that overexpressed beta2M in human renal cell carcinoma (SN12C) cells and then examined cell growth in vitro and in vivo and studied the beta2M-mediated downstream cell signaling pathway. RESULTS: Our results showed that beta2M expression positively correlates with (a) in vitro growth on plastic dishes and as Matrigel colonies, (b) cell invasion and migration in Boyden chambers, and (c) vascular endothelial growth factor (VEGF) expression and secretion by cells. We found, in addition, that beta2M mediates its action through increased phosphorylation of cyclic AMP-responsive element-binding protein (CREB) via the protein kinase A-CREB axis, resulting in increased VEGF expression and secretion. In convergence with this signal axis, beta2M overexpression also activated both phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Beta2M overexpression induced accelerated growth of SN12C in mouse subcutis and bone. Interrupting the beta2M signaling pathway using small interfering RNA led to apoptosis with increased activation of caspase-3 and caspase-9 and cleaved poly(ADP-ribose) polymerase. CONCLUSIONS: Our results showed for the first time that the beta2M-protein kinase A-CREB-VEGF signaling axis plays a crucial role in support of renal cell carcinoma growth and progression and reveals a novel therapeutic target.</abstract><notes>Nomura, Takeo&#xD;Huang, Wen-Chin&#xD;Zhau, Haiyen E&#xD;Wu, Daqing&#xD;Xie, Zhihui&#xD;Mimata, Hiromitsu&#xD;Zayzafoon, Majd&#xD;Young, Andrew N&#xD;Marshall, Fray F&#xD;Weitzmann, M Neale&#xD;Chung, Leland W K&#xD;Gm-0702069/gm/nigms&#xD;P01-ca98912/ca/nci&#xD;R01-ca108468/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2006 Dec 15;12(24):7294-305.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17189401</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>6.250</custom4><electronic-resource-num>12/24/7294 [pii]&#xD;10.1158/1078-0432.CCR-06-2060</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">2</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Bouvet, M.</author><author>Li, L.</author><author>Tsuji, K.</author><author>Moossa, A. R.</author><author>Katsuoka, K.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111, USA.</auth-address><titles><title>Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice</title><secondary-title>Clin Exp Metastasis</secondary-title><alt-title>Clinical &amp; experimental metastasis</alt-title></titles><pages>315-22</pages><volume>23</volume><number>7-8</number><edition>2006/12</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD31/analysis</keyword><keyword>Doxorubicin/pharmacology</keyword><keyword>Green Fluorescent Proteins</keyword><keyword>Immunohistochemistry</keyword><keyword>Intermediate Filament Proteins</keyword><keyword>Liver Neoplasms, Experimental/*blood supply/secondary</keyword><keyword>Lung Neoplasms/*blood supply/secondary</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Neovascularization, Pathologic/*diagnosis</keyword><keyword>Nerve Tissue Proteins</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0262-0898 (Print)</isbn><accession-num>17136576</accession-num><abstract>Nestin regulatory-element-driven green fluorescent protein (ND-GFP) transgenic mice highly express GFP in proliferating endothelial cells and nascent blood vessels. In the present study, we visualized angiogenesis in experimental lung and liver metastases by GFP imaging in the ND-GFP transgenic mice. The murine melanoma cell line, B16F10 expressing red fluorescent protein (RFP), was injected i.v. in ND-GFP mice. ND-GFP was highly expressed in proliferating nascent blood vessels in the tumors that developed in the lung after tail vein injection, and in the tumors that developed in the liver after portal vein injection of RFP-expressing melanoma cells. Liver metastasis and angiogenesis were imaged intravitally. Doxorubicin significantly decreased metastatic angiogenesis in the liver. These results demonstrate a new imageable model of angiogenesis in metastasis in the liver and the lung. This new model should enable further understanding of the onset of angiogenesis in metastasis and its effect on metastatic growth. The model will serve as a unique screen for inhibitors of angiogenesis of metastatic tumors. The fact that liver-metastasis angiogenesis can be imaged in the live animal enables real-time studies of the effect of angiogenesis inhibitors.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17136576 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>1.986</custom4><custom7>Dec</custom7><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>666</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">666</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhau, H. E.</author><author>Odero-Marah, V.</author><author>Lue, H. W.</author><author>Nomura, T.</author><author>Wang, R.</author><author>Chu, G.</author><author>Liu, Z. R.</author><author>Zhou, B. P.</author><author>Huang, W. C.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology &amp; Therapeutics Program, Department of Urology, Emory University School of Medicine, 1365B Clifton Road, Suite 5107, Atlanta, GA, 30322, USA, hzhau@emory.edu.</auth-address><titles><title>Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model</title><secondary-title>Clin Exp Metastasis</secondary-title></titles><pages>601-10</pages><volume>25</volume><number>6</number><edition>2008/06/07</edition><dates><year>2008</year><pub-dates><date>Jun 07</date></pub-dates></dates><isbn>0262-0898 (Print)</isbn><accession-num>18535913</accession-num><abstract>Androgen refractory cancer of the prostate (ARCaP) cells contain androgen receptor (AR) and synthesize and secrete prostate specific antigen (PSA). We isolated epithelia-like ARCaP(E) from parental ARCaP cells and induced them to undergo epithelial-mesenchymal transition (EMT) by exposing these cells to soluble factors including TGFbeta1 plus EGF, IGF-1, beta2-microglobulin (beta2-m), or a bone microenvironment. The molecular and behavioral characteristics of the resultant ARCaP(M) were characterized extensively in comparison to the parental ARCaP(E) cells. In addition to expressing mesenchymal biomarkers, ARCaP(M) gained 100% incidence of bone metastasis. ARCaP(M) cells express receptor activator of NF-kappaB ligand (RANKL), which was shown to increase tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts in culture, and when metastatic to bone in vivo. We provide evidence that RANKL expression was promoted by increased cell signaling mediated by the activation of Stat3-Snail-LIV-1. RANKL expressed by ARCaP(M) cells is functional both in vitro and in vivo. The lesson we learned from the ARCaP model of EMT is that activation of a specific cell signaling pathway by soluble factors can lead to increased bone turnover, mediated by enhanced RANKL expression by tumor cells, which is implicated in the high incidence of prostate cancer bone colonization. The ARCaP EMT model is highly attractive for developing new therapeutic agents to treat prostate cancer bone metastasis.</abstract><notes>Zhau, Haiyen E&#xD;Odero-Marah, Valerie&#xD;Lue, Hui-Wen&#xD;Nomura, Takeo&#xD;Wang, Ruoxiang&#xD;Chu, Gina&#xD;Liu, Zhi-Ren&#xD;Zhou, Binhua P&#xD;Huang, Wen-Chin&#xD;Chung, Leland W K&#xD;Netherlands&#xD;Clinical &amp; experimental metastasis&#xD;Clin Exp Metastasis. 2008;25(6):601-10. Epub 2008 Jun 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18535913</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>1.986</custom4><electronic-resource-num>10.1007/s10585-008-9183-1</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>664</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">664</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, L.</author><author>Gu, F. X.</author><author>Chan, J. M.</author><author>Wang, A. Z.</author><author>Langer, R. S.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Chemical Engineering and Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</auth-address><titles><title>Nanoparticles in medicine: therapeutic applications and developments</title><secondary-title>Clin Pharmacol Ther</secondary-title></titles><pages>761-9</pages><volume>83</volume><number>5</number><edition>2007/10/25</edition><keywords><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry/*therapeutic use</keyword><keyword>Nanotechnology/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1532-6535 (Electronic)</isbn><accession-num>17957183</accession-num><abstract>Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.</abstract><notes>Zhang, L&#xD;Gu, F X&#xD;Chan, J M&#xD;Wang, A Z&#xD;Langer, R S&#xD;Farokhzad, O C&#xD;CA119349/CA/United States NCI&#xD;EB003647/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical pharmacology and therapeutics&#xD;Clin Pharmacol Ther. 2008 May;83(5):761-9. Epub 2007 Oct 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17957183</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>8.033</custom4><electronic-resource-num>6100400 [pii]&#xD;10.1038/sj.clpt.6100400</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>714</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">714</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, W.C.</author><author>Havel, J.J.</author><author>Zhau, H.E.</author><author>Qian, W.P.</author><author>Lue, H.W.</author><author>Chu, C.Y.</author><author>Nomura, T.</author><author>Chung, L.W.K.</author></authors></contributors><titles><title>Microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells</title><secondary-title>Clinical Cancer Res</secondary-title></titles><periodical><full-title>Clinical Cancer Res</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>6.250</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>404</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">404</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sharma, P. K.</author><author>Reilly, M. J.</author><author>Jones, D. N.</author><author>Robinson, P. M.</author><author>Bhatia, S. R.</author></authors></contributors><auth-address>Department of Chemical Engineering, 159 Goessmann Laboratory, University of Massachusetts, Amherst, MA 01003-9303, USA.</auth-address><titles><title>The effect of pharmaceuticals on the nanoscale structure of PEO-PPO-PEO micelles</title><secondary-title>Colloids Surf B Biointerfaces</secondary-title></titles><pages>53-60</pages><volume>61</volume><number>1</number><edition>2007/08/31</edition><keywords><keyword>Hydrophobicity</keyword><keyword>Light</keyword><keyword>*Micelles</keyword><keyword>Neutron Diffraction</keyword><keyword>*Pharmaceutical Preparations/administration &amp; dosage</keyword><keyword>Poloxamer/*chemistry</keyword><keyword>Research Design</keyword><keyword>Scattering, Radiation</keyword><keyword>Scattering, Small Angle</keyword><keyword>Solubility</keyword><keyword>Spectrophotometry, Ultraviolet</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>0927-7765 (Print)</isbn><accession-num>17728116</accession-num><abstract>We present results on the effects of various hydrophobic drugs and additives on the micellar structure of Pluronic F127 solutions. Small-angle neutron scattering experiments on 5wt% F127 solutions were used to measure micelle core size (R(1)), micelle corona size (R(2)), intermicellar interaction distance (R(int)), polydispersity (sigma), and aggregation number (N(agg)); dynamic light scattering was used to measure critical micelle concentration (CMC); and ultraviolet spectroscopy was used to measure drug solubility and apparent micelle-water partition coefficient (K(mw)). The core and corona size were found to generally increase in the presence of the drugs, as did R(int). Both sigma and N(agg) were found to decrease in the presence of most of the drugs, and the CMC was found to vary considerably with no clear correlation. A design of experiments (DOE) approach was used to analyze the results and build empirical correlations. All of the parameters from the SANS experiments were found to depend strongly on drug solubility, with a weak dependence on K(mw) in most cases. The aggregation number, however, was found to depend strongly on both K(mw) and solubility. The correlations can be used to roughly predict the structural parameters of F127 micelles for other hydrophobic drugs.</abstract><notes>Sharma, Praveen K&#xD;Reilly, Meghan J&#xD;Jones, Deanna N&#xD;Robinson, Paul M&#xD;Bhatia, Surita R&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Colloids and surfaces. B, Biointerfaces&#xD;Colloids Surf B Biointerfaces. 2008 Jan 15;61(1):53-60. Epub 2007 Jul 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17728116</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>2.109</custom4><electronic-resource-num>S0927-7765(07)00282-2 [pii]&#xD;10.1016/j.colsurfb.2007.07.002</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>177</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">177</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Adair, C.</author><author>Woods, M.</author><author>Zhao, P.</author><author>Pasha, A.</author><author>Winter, P. M.</author><author>Lanza, G. M.</author><author>Athey, P.</author><author>Sherry, A. D.</author><author>Kiefer, G. E.</author></authors></contributors><auth-address>Macrocyclics, 2110 Research Row, STE 425, Dallas, TX 75235, USA.</auth-address><titles><title>Spectral properties of a bifunctional PARACEST europium chelate: an intermediate for targeted imaging applications</title><secondary-title>Contrast Media Mol Imaging</secondary-title></titles><pages>55-8</pages><volume>2</volume><number>1</number><edition>2007/02/28</edition><keywords><keyword>Chelating Agents/chemistry/diagnostic use</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Heterocyclic Compounds, 1-Ring/*chemistry/*diagnostic use</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Organometallic Compounds/*chemistry/*diagnostic use</keyword><keyword>Spectrum Analysis</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1555-4317 (Electronic)</isbn><accession-num>17326038</accession-num><abstract>This report describes a preliminary study to investigate the effect of structural variations in a bifunctional ligand being developed for targeted PARACEST applications. Utilizing Eu-DOTA-4AmCE as the functional PARACEST core, a nitro-aromatic functionality was incorporated to provide the point for conjugation. This intermediate possesses a coordinated water proton signal at 57 ppm which upon saturation produces a 22% decrease in bulk water signal intensity using 10 mM agent. Curve fitting analysis of the CEST spectrum to an exchange model based upon modified Bloch equations gave an estimate of 687 +/- 100 micros for the bound water lifetime (tau(m)). Although substantially longer than the 382 micros observed for the parent chelate structure, this water exchange rate remains in the necessary window to produce a significant CEST effect. These findings demonstrate the need to recognize the influence of bifunctional linkers on water exchange rates in lanthanide complexes of this type and the potential for using this functionality as a means of fine-tuning PARACEST performance.</abstract><notes>Adair, Christopher&#xD;Woods, Mark&#xD;Zhao, Piyu&#xD;Pasha, Azhar&#xD;Winter, Patrick M&#xD;Lanza, Gregory M&#xD;Athey, Phillip&#xD;Sherry, A Dean&#xD;Kiefer, Garry E&#xD;United States&#xD;Contrast media &amp; molecular imaging&#xD;Contrast Media Mol Imaging. 2007 Jan;2(1):55-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17326038</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>1.478</custom4><electronic-resource-num>10.1002/cmmi.125</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>345</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">345</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aslam, M.</author><author>Schultz, E. A.</author><author>Sun, T.</author><author>Meade, T.</author><author>Dravid, V. P.</author></authors></contributors><auth-address>Dravid, VP&#xD;Northwestern Univ, Feinberg Sch Med, Dept Mat Sci &amp; Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Feinberg Sch Med, Dept Mat Sci &amp; Engn, Evanston, IL 60208 USA&#xD;Northwestern Univ, Int Inst Nanotechnol, Feinberg Sch Med, Evanston, IL 60208 USA&#xD;Northwestern Univ, Feinberg Sch Med, Dept Chem, Evanston, IL 60208 USA&#xD;Northwestern Univ, Feinberg Sch Med, Dept Biochem &amp; Mol &amp; Cell Biol, Evanston, IL 60208 USA</auth-address><titles><title>Synthesis of amine-stabilized aqueous colloidal iron oxide nanoparticles</title><secondary-title>Crystal Growth &amp; Design</secondary-title></titles><pages>471-475</pages><volume>7</volume><number>3</number><edition>2007/05</edition><keywords><keyword>magnetic nanocrystals</keyword><keyword>particles</keyword><keyword>size</keyword><keyword>surface</keyword><keyword>molecules</keyword><keyword>fe3o4</keyword><keyword>xps</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1528-7483</isbn><accession-num>ISI:000244701500002</accession-num><abstract>We demonstrate a simple one-step process for the synthesis of iron oxide nanoparticle aqueous colloids using the multifunctional molecule dodecylamine (DDA), which electrostatically complexes with aqueous iron ions (one precursor Fe2+ from FeCl2), reduces them, and subsequently caps the nanoparticles. The iron oxide particles thus synthesized are of the face-centered cubic (FCC) phase with a high degree of monodispersity and an appropriate concentration of the amine-capping molecular layer. The aqueous magnetic nanocrystalline colloids were characterized by TEM, XRD, XPS, TGA/DTA, and FTIR spectroscopy techniques. The relaxivity, stability, and hydrodynamic size of the nanoparticles were investigated for potential application in magnetic resonance imaging (MRI). The magnetic properties were also studied by using a superconducting quantum interference device (SQUID) magnetometer at room temperature. We believe that such a simple one-step synthesis of biocompatible aqueous nanomagnetic colloids will have viable applications in biomedical imaging, diagnostics, and therapeutics.</abstract><notes>143DZ&#xD;Times Cited:0&#xD;Cited References Count:36</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000244701500002</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.046</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>166</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">166</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Cardiovascular Magnetic Resonance Laboratories, Washington University, St. Louis, MO 63110, USA.</auth-address><titles><title>Molecular imaging by MRI</title><secondary-title>Curr Cardiol Rep</secondary-title></titles><pages>65-9</pages><volume>8</volume><number>1</number><edition>2006/03/02</edition><keywords><keyword>Antibiotics, Antineoplastic/administration &amp; dosage</keyword><keyword>Antifibrinolytic Agents/administration &amp; dosage</keyword><keyword>Atherosclerosis/*physiopathology/therapy</keyword><keyword>Contrast Media</keyword><keyword>Doxorubicin/administration &amp; dosage</keyword><keyword>Drug Carriers</keyword><keyword>Fibrin/adverse effects</keyword><keyword>Humans</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Nanostructures</keyword><keyword>Neovascularization, Pathologic/physiopathology/therapy</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1523-3782 (Print)</isbn><accession-num>16507239</accession-num><abstract>The goal of molecular imaging is to detect pathologic biomarkers, which can lead to early recognition of diseases, better therapeutic management, and improved monitoring for recurrence. MRI is a particularly attractive method for molecular imaging applications, due to its noninvasive nature, outstanding signal to noise ratio, high spatial resolution, exceptional tissue contrast, and short imaging times. Site-specific MRI contrast agents have been developed to target biologic processes that occur early in the development of atherosclerotic plaques, including angiogenesis and lipid accumulation, or biosignatures that appear later, such as fibrin and tissue factor resulting from plaque rupture. Moreover, targeted contrast agents can also serve as drug delivery vehicles, combining diagnosis and therapy. If ultimately successful, these emerging molecular imaging agents and techniques will allow early disease recognition and quantification prompting therapeutic intervention before serious sequelae ensue.</abstract><notes>Winter, Patrick M&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Review&#xD;United States&#xD;Current cardiology reports&#xD;Curr Cardiol Rep. 2006 Feb;8(1):65-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16507239</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>?</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>176</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">176</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Consortium for Translational Research in Advanced Imaging and Nanomedicine, Washington University School of Medicine, 4444 Forest Park Avenue, Campus Box 8215, St Louis, MO 63108-2212, USA. scaruthers@cmrl.wustl.edu &lt;scaruthers@cmrl.wustl.edu&gt;</auth-address><titles><title>Nanotechnological applications in medicine</title><secondary-title>Curr Opin Biotechnol</secondary-title></titles><pages>26-30</pages><volume>18</volume><number>1</number><edition>2007/01/27</edition><keywords><keyword>Drug Carriers/chemistry</keyword><keyword>Humans</keyword><keyword>Medicine/*trends</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanostructures/chemistry</keyword><keyword>Nanotechnology/methods/*trends</keyword><keyword>Pharmaceutical Preparations/chemistry</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0958-1669 (Print)</isbn><accession-num>17254762</accession-num><abstract>Nanotechnology-based tools and techniques are rapidly emerging in the fields of medical imaging and targeted drug delivery. Employing constructs such as dendrimers, liposomes, nanoshells, nanotubes, emulsions and quantum dots, these advances lead toward the concept of personalized medicine and the potential for very early, even pre-symptomatic, diagnoses coupled with highly-effective targeted therapy. Highlighting clinically available and preclinical applications, this review explores the opportunities and issues surrounding nanomedicine.</abstract><notes>Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Current opinion in biotechnology&#xD;Curr Opin Biotechnol. 2007 Feb;18(1):26-30. Epub 2007 Jan 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17254762</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>8.32</custom4><electronic-resource-num>S0958-1669(07)00007-9 [pii]&#xD;10.1016/j.copbio.2007.01.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>229</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">229</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rao, J.</author><author>Dragulescu-Andrasi, A.</author><author>Yao, H.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology &amp; Bio-X Program, Cancer Biology Program, Stanford University School of Medicine, 1201 Welch Road, Stanford, California 94305-5484, USA. jrao@stanford.edu &lt;jrao@stanford.edu&gt;</auth-address><titles><title>Fluorescence imaging in vivo: recent advances</title><secondary-title>Curr Opin Biotechnol</secondary-title></titles><pages>17-25</pages><volume>18</volume><number>1</number><edition>2007/01/20</edition><keywords><keyword>Animals</keyword><keyword>*Diagnostic Imaging</keyword><keyword>*Fluorescence</keyword><keyword>Fluorescent Dyes</keyword><keyword>Humans</keyword><keyword>Infrared Rays</keyword><keyword>Nanoparticles</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0958-1669 (Print)</isbn><accession-num>17234399</accession-num><abstract>In vivo fluorescence imaging uses a sensitive camera to detect fluorescence emission from fluorophores in whole-body living small animals. To overcome the photon attenuation in living tissue, fluorophores with long emission at the near-infrared (NIR) region are generally preferred, including widely used small indocarbocyanine dyes. The list of NIR probes continues to grow with the recent addition of fluorescent organic, inorganic and biological nanoparticles. Recent advances in imaging strategies and reporter techniques for in vivo fluorescence imaging include novel approaches to improve the specificity and affinity of the probes and to modulate and amplify the signal at target sites for enhanced sensitivity. Further emerging developments are aiming to achieve high-resolution, multimodality and lifetime-based in vivo fluorescence imaging.</abstract><notes>Rao, Jianghong&#xD;Dragulescu-Andrasi, Anca&#xD;Yao, Hequan&#xD;1u54ca119367-01/ca/nci&#xD;Eb3803/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Current opinion in biotechnology&#xD;Curr Opin Biotechnol. 2007 Feb;18(1):17-25. Epub 2007 Jan 17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17234399</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>8.32</custom4><electronic-resource-num>S0958-1669(07)00004-3 [pii]&#xD;10.1016/j.copbio.2007.01.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>255</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheng, M. M.</author><author>Cuda, G.</author><author>Bunimovich, Y. L.</author><author>Gaspari, M.</author><author>Heath, J. R.</author><author>Hill, H. D.</author><author>Mirkin, C. A.</author><author>Nijdam, A. J.</author><author>Terracciano, R.</author><author>Thundat, T.</author><author>Ferrari, M.</author></authors></contributors><auth-address>Division of Hematology and Oncology, Internal Medicine, The Ohio State University, 473 West 12 Avenue, Columbus OH 43210-1002, USA.</auth-address><titles><title>Nanotechnologies for biomolecular detection and medical diagnostics</title><secondary-title>Curr Opin Chem Biol</secondary-title></titles><pages>11-9</pages><volume>10</volume><number>1</number><edition>2006/01/19</edition><keywords><keyword>Biopolymers/*chemistry</keyword><keyword>Diagnostic Techniques and Procedures/*instrumentation</keyword><keyword>Humans</keyword><keyword>Nanostructures/chemistry</keyword><keyword>Nanotechnology/instrumentation/*methods</keyword><keyword>Protein Array Analysis/instrumentation/methods</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Silicon/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1367-5931 (Print)</isbn><accession-num>16418011</accession-num><abstract>Nanotechnology-based platforms for the high-throughput, multiplexed detection of proteins and nucleic acids in heretofore unattainable abundance ranges promise to bring substantial advances in molecular medicine. The emerging approaches reviewed in this article, with reference to their diagnostic potential, include nanotextured surfaces for proteomics, a two-particle sandwich assay for the biological amplification of low-concentration biomolecular signals, and silicon-based nanostructures for the transduction of molecular binding into electrical and mechanical signals, respectively.</abstract><notes>Cheng, Mark Ming-Cheng&#xD;Cuda, Giovanni&#xD;Bunimovich, Yuri L&#xD;Gaspari, Marco&#xD;Heath, James R&#xD;Hill, Haley D&#xD;Mirkin, Chad A&#xD;Nijdam, A Jasper&#xD;Terracciano, Rosa&#xD;Thundat, Thomas&#xD;Ferrari, Mauro&#xD;N01-co-12400/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Current opinion in chemical biology&#xD;Curr Opin Chem Biol. 2006 Feb;10(1):11-9. Epub 2006 Jan 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16418011</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.588</custom4><electronic-resource-num>S1367-5931(06)00007-X [pii]&#xD;10.1016/j.cbpa.2006.01.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>563</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">563</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T.</author><author>Ebright, J.</author><author>Ellington, A. D.</author></authors></contributors><auth-address>University of Texas at Austin, Department of Chemistry and Biochemistry, Institute for Cell and Molecular Biology, Austin, TX 78712, USA.</auth-address><titles><title>Using aptamers to identify and enter cells</title><secondary-title>Curr Opin Mol Ther</secondary-title></titles><pages>137-44</pages><volume>9</volume><number>2</number><edition>2007/04/27</edition><keywords><keyword>Animals</keyword><keyword>Antigens, Surface/metabolism</keyword><keyword>Aptamers, Nucleotide/*analysis/chemistry/*metabolism</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>RNA, Small Interfering/metabolism</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1464-8431 (Print)</isbn><accession-num>17458167</accession-num><abstract>While nucleic acid binding species (aptamers) have previously been selected against a variety of biomedically important protein targets, the selection of aptamers against complex targets, such as cell surfaces and organisms, is becoming increasingly feasible. A number of aptamers have now been generated that can target specific cell-surface antigens and cell types, including tumor biomarkers and tumor cells. The generation of anti-cell aptamers has important implications for identifying disease-specific biomarkers, generating diagnostics, and developing novel drug delivery strategies.</abstract><notes>Chu, Ted&#xD;Ebright, Jessica&#xD;Ellington, Andrew D&#xD;Review&#xD;England&#xD;Current opinion in molecular therapeutics&#xD;Curr Opin Mol Ther. 2007 Apr;9(2):137-44.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17458167</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>2.526</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>520</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">520</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schulz, K. R.</author><author>Danna, E. A.</author><author>Krutzik, P. O.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>Stanford University, Stanford, California, USA.</auth-address><titles><title>Single-cell phospho-protein analysis by flow cytometry</title><secondary-title>Curr Protoc Immunol</secondary-title></titles><pages>Unit 8 17</pages><volume>Chapter 8</volume><edition>2008/04/25</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1934-368X (Electronic)</isbn><accession-num>18432997</accession-num><abstract>This protocol describes methods for monitoring intracellular phosphorylation-dependent signaling events on a single-cell basis. This approach measures cell signaling by treating cells with exogenous stimuli, fixing cells with formaldehyde, permeabilizing with methanol, and then staining with phospho-specific antibodies. Thus, cell signaling states can be determined as a measure of how cells interact with their environment. This method has applications in clinical research as well as mechanistic studies of basic biology. In clinical research, diagnostic or drug efficacy information can be retrieved by discovering how a disease affects the ability of cells to respond to growth factors. Basic scientists can use this technique to analyze signaling events in cell lines and human or murine primary cells, including rare populations, like B1 cells or stem cells. This technique has broad applications to take standard biochemical analysis into primary cells to garner valuable information about signaling events in physiologic settings.</abstract><notes>Schulz, Kenneth R&#xD;Danna, Erika A&#xD;Krutzik, Peter O&#xD;Nolan, Garry P&#xD;United States&#xD;Current protocols in immunology / edited by John E. Coligan ... [et al.]&#xD;Curr Protoc Immunol. 2007 Aug;Chapter 8:Unit 8.17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18432997</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>na</custom4><electronic-resource-num>10.1002/0471142735.im0817s78</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>482</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">482</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dorvee, J. R.</author><author>Sailor, M. J.</author><author>Miskelly, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego 9500 Gilman Drive, Dept. 0358, La Jolla, CA 92093-0358, USA.</auth-address><titles><title>Digital microfluidics and delivery of molecular payloads with magnetic porous silicon chaperones</title><secondary-title>Dalton Trans</secondary-title></titles><pages>721-30</pages><number>6</number><edition>2008/02/02</edition><keywords><keyword>Electromagnetic Fields</keyword><keyword>Ferric Compounds/*chemistry</keyword><keyword>Magnetics/*instrumentation</keyword><keyword>Microfluidics/*instrumentation/methods</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Porosity</keyword><keyword>Silicon/*chemistry</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 14</date></pub-dates></dates><isbn>1477-9226 (Print)</isbn><accession-num>18239825</accession-num><abstract>Digital microfluidics involves the manipulation of molecules and materials in discrete packages. This paper reviews our work using amphiphilic magnetic microparticles constructed from porous silicon. An individual porous particle can be used to carry a nanomole or smaller quantities of a reagent, and assemblies of the particles can encapsulate and transport microliter droplets of liquid containing inorganic, organic, or biological molecules. The tracking and identification of each particle can be accomplished with spectral labels that are encoded into the particles during their synthesis. When used to chaperone liquid droplets, the labels can identify the separate droplets prior to mixing and also the combined droplets after mixing. Magnetic iron oxide nanoparticles encapsulated in the porous matrix allow the manipulation of the particles or whole droplet assemblies with a magnetic field, and they also allow heating of the particle&apos;s payload by means of an externally applied RF field. Examples of organic, inorganic, and biomolecular addition reactions, catalytic reactions, and thermolysis reactions are described.</abstract><notes>Dorvee, Jason R&#xD;Sailor, Michael J&#xD;Miskelly, Gordon M&#xD;U54 CA 119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Dalton transactions (Cambridge, England : 2003)&#xD;Dalton Trans. 2008 Feb 14;(6):721-30. Epub 2007 Nov 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18239825</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>3.212</custom4><electronic-resource-num>10.1039/b714594b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>635</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">635</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Solomon, A.</author><author>Mian, Y.</author><author>Ortega-Cava, C.</author><author>Liu, V. W.</author><author>Gurumurthy, C. B.</author><author>Naramura, M.</author><author>Band, V.</author><author>Band, H.</author></authors></contributors><auth-address>Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Department of Medicine, Feinberg School of Medicine, USA.</auth-address><titles><title>Upregulation of the let-7 microRNA with precocious development in lin-12/Notch hypermorphic Caenorhabditis elegans mutants</title><secondary-title>Dev Biol</secondary-title></titles><pages>191-9</pages><volume>316</volume><number>2</number><edition>2008/03/13</edition><keywords><keyword>Animals</keyword><keyword>Animals, Genetically Modified</keyword><keyword>Blotting, Northern</keyword><keyword>Caenorhabditis elegans/*genetics/growth &amp; development</keyword><keyword>Gene Expression Regulation, Developmental</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Larva</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>*Mutation</keyword><keyword>Phenotype</keyword><keyword>Receptors, Notch/genetics</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1095-564X (Electronic)</isbn><accession-num>18334253</accession-num><abstract>The lin-12/Notch signaling pathway is conserved from worms to humans and is a master regulator of metazoan development. Here, we demonstrate that lin-12/Notch gain-of-function (gf) animals display precocious alae at the L4 larval stage with a significant increase in let-7 expression levels. Furthermore, lin-12(gf) animals display a precocious and higher level of let-7 gfp transgene expression in seam cells at L3 stage. Interestingly, lin-12(gf) mutant rescued the lethal phenotype of let-7 mutants similar to other known heterochronic mutants. We propose that lin-12/Notch signaling pathway functions in late developmental timing, upstream of or in parallel to the let-7 heterochronic pathway. Importantly, the human microRNA let-7a was also upregulated in various human cell lines in response to Notch 1 activation, suggesting an evolutionarily conserved cross-talk between let-7 and the canonical lin-12/Notch signaling pathway.</abstract><notes>Solomon, Aharon&#xD;Mian, Yousaf&#xD;Ortega-Cava, Cesar&#xD;Liu, Victor Won Tat&#xD;Gurumurthy, Channabasavaiah Basavaraju&#xD;Naramura, Mayumi&#xD;Band, Vimla&#xD;Band, Hamid&#xD;1U54 CA119341-01/CA/United States NCI&#xD;CA116552/CA/United States NCI&#xD;CA76118/CA/United States NCI&#xD;CA81076/CA/United States NCI&#xD;CA87986/CA/United States NCI&#xD;CA94143/CA/United States NCI&#xD;CA96844/CA/United States NCI&#xD;CA99163/CA/United States NCI&#xD;CA99900/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Developmental biology&#xD;Dev Biol. 2008 Apr 15;316(2):191-9. Epub 2008 Jan 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18334253</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.714</custom4><electronic-resource-num>S0012-1606(08)00006-7 [pii]&#xD;10.1016/j.ydbio.2007.12.046</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>703</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">703</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krishnan, R.</author><author>Sullivan, B. D.</author><author>Mifflin, R. L.</author><author>Esener, S. C.</author><author>Heller, M. J.</author></authors></contributors><auth-address>University of California, San Diego, Department of Bioengineering, La Jolla, CA 92093-0412, USA.</auth-address><titles><title>Alternating current electrokinetic separation and detection of DNA nanoparticles in high-conductance solutions</title><secondary-title>Electrophoresis</secondary-title></titles><pages>1765-74</pages><volume>29</volume><number>9</number><edition>2008/04/09</edition><keywords><keyword>Buffers</keyword><keyword>DNA, Single-Stranded/*analysis/chemistry</keyword><keyword>Electric Conductivity</keyword><keyword>Electrophoresis, Microchip/instrumentation/*methods</keyword><keyword>Fluorescent Dyes</keyword><keyword>Microelectrodes</keyword><keyword>Nanoparticles</keyword><keyword>Oligonucleotide Array Sequence Analysis/instrumentation/*methods</keyword><keyword>Oligonucleotides/chemistry</keyword><keyword>Polystyrenes/chemistry</keyword><keyword>Solutions</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>0173-0835 (Print)</isbn><accession-num>18393345</accession-num><abstract>In biomedical research and diagnostics, it is a significant challenge to directly isolate and identify rare cells and potential biomarkers in blood, plasma and other clinical samples. Additionally, the advent of bionanotechnology is leading to numerous drug delivery approaches that involve encapsulation of drugs and imaging agents within nanoparticles, which now will also have to be identified and separated from blood and plasma. Alternating current (AC) electrokinetic techniques such as dielectrophoresis (DEP) offer a particularly attractive mechanism for the separation of cells and nanoparticles. Unfortunately, present DEP techniques require the dilution of blood/plasma, thus making the technology less suitable for clinical sample preparation. Using array devices with microelectrodes over-coated with porous hydrogel layers, AC electric field conditions have been found which allow the separation of DNA nanoparticles to be achieved under high-conductance (ionic strength) conditions. At AC frequencies in the 3000 Hz to 10,000 Hz range and 10 volts peak-to-peak, the separation of 10-microm polystyrene particles into low field regions, and 60-nm DNA-derivatized nanoparticles and 200-nm nanoparticles into high-field regions was carried out in 149 mM 1xPBS buffer (1.68 S/m). These results may allow AC electrokinetic systems to be developed that can be used with clinically relevant samples under physiological conditions.</abstract><notes>Krishnan, Rajaram&#xD;Sullivan, Benjamin D&#xD;Mifflin, Robert L&#xD;Esener, Sadik C&#xD;Heller, Michael J&#xD;U54-CA119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Electrophoresis&#xD;Electrophoresis. 2008 May;29(9):1765-74.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18393345</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>3.609</custom4><electronic-resource-num>10.1002/elps.200800037</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>632</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">632</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C.</author><author>Zhou, G.</author><author>Zhu, Y.</author><author>Su, Y.</author><author>Cheng, T.</author><author>Zhau, H. E.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. shicm1010@yahoo.com.cn</auth-address><titles><title>Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells</title><secondary-title>Eur J Histochem</secondary-title></titles><pages>127-34</pages><volume>52</volume><number>2</number><edition>2008/07/02</edition><dates><year>2008</year><pub-dates><date>Apr-Jun</date></pub-dates></dates><isbn>1121-760X (Print)</isbn><accession-num>18591159</accession-num><abstract>Semiconductor quantum dots (QDs) are bright fluorescent nanoparticles that have been successfully used for the detection of biomarker expression in cells. The objective of the present study is to use this technology in a multiplexing manner to determine at a single cell level the expression of a cell-specific bio-marker, prostate-specific antigen (PSA) expressed by human prostate cancer LNCaP and ARCaP cell lines. Here we compared the sensitivity of immunohistochemistry (IHC) and QD-based detection of AR and PSA expression in these cell lines. Further, we conducted multiplexing QD-based detection of PSA and androgen receptor (AR) expression in LNCaP cells subjecting to androgen (R1881) stimulation. The involvement of AR in PSA regulation in LNCaP cells, at a single cell level, was confirmed by the co-incubation of LNCaP cells in the presence of both R1881 and its receptor antagonist, bicalutamide (Casodex). We showed here the superior quality of QDs, in comparison to IHC, for the detection of AR and PSA in cultured LNCaP and ARCaP cells. Multiplexing QDs technique can be used to detect simultaneously AR and PSA expression induced by R1881 which promoted AR translocation from its cytosolic to the nuclear compartment. We observed AR antagonist, bicalutamide, inhibited AR nuclear translocation and PSA, but not AR expression in LNCaP cells.</abstract><notes>Shi, C&#xD;Zhou, G&#xD;Zhu, Y&#xD;Su, Y&#xD;Cheng, T&#xD;Zhau, H E&#xD;Chung, L W K&#xD;CA108468/CA/United States NCI&#xD;P01 CA098912/CA/United States NCI&#xD;R01 GM60652/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Italy&#xD;European journal of histochemistry : EJH&#xD;Eur J Histochem. 2008 Apr-Jun;52(2):127-34.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18591159</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>4.217</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>26</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">26</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farokhzad, O. C.</author><author>Karp, J. M.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. ofarokhzad@partners.org</auth-address><titles><title>Nanoparticle-aptamer bioconjugates for cancer targeting</title><secondary-title>Expert Opin Drug Deliv</secondary-title><alt-title>Expert opinion on drug delivery</alt-title></titles><pages>311-24</pages><volume>3</volume><number>3</number><edition>2006/05</edition><keywords><keyword>Animals</keyword><keyword>Aptamers, Nucleotide/chemistry/isolation &amp; purification/*therapeutic use</keyword><keyword>Delayed-Action Preparations/chemistry/therapeutic use</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Neoplasms/*drug therapy</keyword><keyword>SELEX Aptamer Technique</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1742-5247 (Print)</isbn><accession-num>16640493</accession-num><abstract>The combination of targeted drug delivery and controlled-release technology may pave the road for more effective yet safer chemotherapeutic options for cancer therapy. Drug-encapsulated polymeric nanoparticle-aptamer bioconjugates represent an emerging technology that can facilitate the delivery of chemotherapeutics to primary and metastatic tumours. Aptamers are short nucleic acid molecules with binding properties and biochemical characteristics that may make them suitable for use as targeting molecules. The goal of this review is to summarise the key components that are required for creating effective cancer targeting nanoparticle-aptamer bioconjugates. The field of controlled release and the structure and properties of aptamers, as well as the criteria for constructing effective conjugates, will be discussed.</abstract><notes>Ca 119349/ca/nci&#xD;Eb003647/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16640493 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>1.424</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>217</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">217</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kenanova, V.</author><author>Wu, A. M.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Tailoring antibodies for radionuclide delivery</title><secondary-title>Expert Opin Drug Deliv</secondary-title></titles><pages>53-70</pages><volume>3</volume><number>1</number><edition>2005/12/24</edition><keywords><keyword>Animals</keyword><keyword>Antibodies/diagnostic use/*therapeutic use</keyword><keyword>Antineoplastic Agents/therapeutic use</keyword><keyword>Humans</keyword><keyword>Immunoglobulin Fragments/diagnostic use/*therapeutic use</keyword><keyword>Neoplasms/immunology/radionuclide imaging/*radiotherapy</keyword><keyword>Radioimmunodetection/methods</keyword><keyword>Radioimmunotherapy/methods</keyword><keyword>Radioisotopes/diagnostic use/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1742-5247 (Print)</isbn><accession-num>16370940</accession-num><abstract>Therapeutic antibodies are well established as an important class of drugs in modern medicine. The exquisite specificity and affinity for a specific target offered by antibodies has also encouraged their development as delivery vehicles for agents such as radionuclides to target tissues, for radioimmunoimaging and radioimmunotherapy. Specifically, in nuclear medicine, radionuclide-conjugated antibody molecules make it possible to image diseased loci with greater sensitivity than other imaging modalities such as magnetic resonance imaging. Furthermore, two radionuclide-conjugated antibodies have recently been approved for the therapy of non-Hodgkin&apos;s lymphoma. However, optimal implementation of antibodies has been limited by the extended circulation persistence that is characteristic of native antibodies, which is responsible for increased background activity in radioimmunoimaging applications and dose-related normal organ toxicities in radioimmunotherapy. In this article the current status of radiolabelled intact antibodies is reviewed, focusing on strategies to improve their pharmacokinetic properties to suit a desired application. Examples from the literature that represent different approaches to accomplishing this task in terms of their successes as well as limitations, and perspectives for the future are discussed.</abstract><notes>Kenanova, Vania&#xD;Wu, Anna M&#xD;Ca 43904/ca/nci&#xD;Ca 86306/ca/nci&#xD;Ca 92131/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Expert opinion on drug delivery&#xD;Expert Opin Drug Deliv. 2006 Jan;3(1):53-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16370940</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>1.424</custom4><electronic-resource-num>10.1517/17425247.3.1.53</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>357</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">357</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>van Vlerken, L. E.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Multi-functional polymeric nanoparticles for tumour-targeted drug delivery</title><secondary-title>Expert Opin Drug Deliv</secondary-title><alt-title>Expert opinion on drug delivery</alt-title></titles><pages>205-16</pages><volume>3</volume><number>2</number><edition>2006/03</edition><keywords><keyword>Animals</keyword><keyword>*Drug Carriers</keyword><keyword>Ferrosoferric Oxide/chemistry</keyword><keyword>Gadolinium/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Humans</keyword><keyword>*Nanostructures</keyword><keyword>Neoplasms/*drug therapy</keyword><keyword>Polymers/administration &amp; dosage/chemistry</keyword><keyword>Quantum Dots</keyword><keyword>Silicon Dioxide/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1742-5247 (Print)</isbn><accession-num>16506948</accession-num><abstract>The use of nanoparticles as drug delivery vehicles for anticancer therapeutics has great potential to revolutionise the future of cancer therapy. As tumour architecture causes nanoparticles to preferentially accumulate at the tumour site, their use as drug delivery vectors results in the localisation of a greater amount of the drug load at the tumour site; thus improving cancer therapy and reducing the harmful nonspecific side effects of chemotherapeutics. In addition, formulation of these nanoparticles with imaging contrast agents provides a very efficient system for cancer diagnostics. Given the exhaustive possibilities available to polymeric nanoparticle chemistry, research has quickly been directed at multi-functional nanoparticles, combining tumour targeting, tumour therapy and tumour imaging in an all-in-one system, providing a useful multi-modal approach in the battle against cancer. This review will discuss the properties of nanoparticles that allow for such multiple functionality, as well as recent scientific advances in the area of multi-functional nanoparticles for cancer therapeutics.</abstract><notes>Journal Article&#xD;Review&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16506948 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2006</custom3><custom4>1.424</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>124</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">124</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, M. D.</author><author>Shin, D. M.</author><author>Simons, J. W.</author><author>Nie, S.</author></authors></contributors><auth-address>Georgia Institute of Technology, Department of Biomedical Engineering, and Emory University, Atlanta, GA 30332, USA. maywang@bme.gatech.edu</auth-address><titles><title>Nanotechnology for targeted cancer therapy</title><secondary-title>Expert Rev Anticancer Ther</secondary-title></titles><pages>833-7</pages><volume>7</volume><number>6</number><edition>2007/06/09</edition><keywords><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Nanostructures</keyword><keyword>*Nanotechnology</keyword><keyword>Neoplasms/diagnosis/*therapy</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1473-7140 (Print)</isbn><accession-num>17555393</accession-num><abstract>Cancer nanotechnology is currently under intense development for applications in cancer imaging, molecular diagnosis and targeted therapy. The basic rationale is that nanometer-sized particles, such as biodegradable micelles, semiconductor quantum dots and iron oxide nanocrystals, have functional or structural properties that are not available from either molecular or macroscopic agents. When linked with biotargeting ligands, such as monoclonal antibodies, peptides or small molecules, these nanoparticles are used to target malignant tumors with high affinity and specificity. In the &apos;mesoscopic&apos; size range of 5-100 nm in diameter, nanoparticles also have large surface areas and functional groups for conjugating to multiple diagnostic (e.g., optical, radioisotopic or magnetic) and therapeutic (e.g., anticancer) agents. Recent advances have led to multifunctional nanoparticle probes for molecular and cellular imaging, nanoparticle drugs for targeted therapy, and integrated nanodevices for early cancer detection and screening. These developments have opened exciting opportunities for personalized oncology in which cancer detection, diagnosis and therapy are tailored to each individual&apos;s molecular profile, and also for predictive oncology, in which genetic/molecular information is used to predict tumor development, progression and clinical outcome.</abstract><notes>Wang, May D&#xD;Shin, Dong M&#xD;Simons, Jonathan W&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468â€“01/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Expert review of anticancer therapy&#xD;Expert Rev Anticancer Ther. 2007 Jun;7(6):833-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17555393</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>1.988</custom4><electronic-resource-num>10.1586/14737140.7.6.833</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>179</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">179</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Cai, K.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Medicine and Biomedical Engineering, C-TRAIN Group, St. Louis, MO 63108, USA. patrick@cvu.wustl.edu</auth-address><titles><title>Emerging nanomedicine opportunities with perfluorocarbon nanoparticles</title><secondary-title>Expert Rev Med Devices</secondary-title></titles><pages>137-45</pages><volume>4</volume><number>2</number><edition>2007/03/16</edition><keywords><keyword>Contrast Media</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Drug Delivery Systems/*trends</keyword><keyword>Fluorocarbons/*diagnostic use/*therapeutic use</keyword><keyword>Forecasting</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanoparticles/*diagnostic use/*therapeutic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1743-4440 (Print)</isbn><accession-num>17359221</accession-num><abstract>Perfluorocarbon (PFC) nanoparticles can serve as a platform technology for molecular imaging and targeted drug-delivery applications. These nanoparticles are approximately 250 nm in diameter and are encapsulated in a phospholipid shell, which provides an ideal surface for the incorporation of targeting ligands, imaging agents and drugs. For molecular imaging, PFC nanoparticles can carry very large payloads of gadolinium to detect pathological biomarkers with magnetic resonance imaging. A variety of different epitopes, including alpha(v)beta(3)-integrin, tissue factor and fibrin, have been imaged using nanoparticles formulated with appropriate antibodies or peptidomimentics as targeting ligands. Lipophilic drugs can also be incorporated into the outer lipid shell of nanoparticles for targeted delivery. Upon binding to the target cell, the drug is exchanged from the particle surfactant monolayer to the cell membrane through a novel process called &apos;contact facilitated drug delivery&apos;. By combining targeted molecular imaging and localized drug delivery, PFC nanoparticles provide diagnosis and therapy with a single agent.</abstract><notes>Winter, Patrick M&#xD;Cai, Kejia&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Co-07121/co/nci&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Expert review of medical devices&#xD;Expert Rev Med Devices. 2007 Mar;4(2):137-45.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17359221</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>1.519</custom4><electronic-resource-num>10.1586/17434440.4.2.137</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>526</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">526</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pitteri, S. J.</author><author>Hanash, S. M.</author></authors></contributors><titles><title>Proteomic approaches for cancer biomarker discovery in plasma</title><secondary-title>Expert Rev Proteomics</secondary-title></titles><pages>589-90</pages><volume>4</volume><number>5</number><edition>2007/10/19</edition><keywords><keyword>Humans</keyword><keyword>Neoplasm Proteins/blood</keyword><keyword>Proteomics/*methods</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</keyword><keyword>Tumor Markers, Biological/*blood</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1744-8387 (Electronic)</isbn><accession-num>17941811</accession-num><notes>Pitteri, Sharon J&#xD;Hanash, Samir M&#xD;Editorial&#xD;England&#xD;Expert review of proteomics&#xD;Expert Rev Proteomics. 2007 Oct;4(5):589-90.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17941811</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>3.650</custom4><electronic-resource-num>10.1586/14789450.4.5.589</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>206</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">206</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>De, A.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS) and Bio-X Program, Department of Radiology, School of Medicine, Stanford University, Stanford, California, USA.</auth-address><titles><title>Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer</title><secondary-title>FASEB J</secondary-title></titles><pages>2017-9</pages><volume>19</volume><number>14</number><edition>2005/10/06</edition><keywords><keyword>Animals</keyword><keyword>Energy Transfer</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Luciferases, Renilla/metabolism</keyword><keyword>Luminescent Measurements/*methods</keyword><keyword>Luminescent Proteins/*chemistry</keyword><keyword>Mice</keyword><keyword>Microscopy, Video</keyword><keyword>*Nanostructures</keyword><keyword>Photons</keyword><keyword>Protein Binding</keyword><keyword>*Protein Interaction Mapping</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Recombinant Fusion Proteins/metabolism</keyword><keyword>Sirolimus/pharmacology</keyword><keyword>Tacrolimus Binding Protein 1A/metabolism</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>16204354</accession-num><abstract>This study demonstrates a significant advancement of imaging of a distance-dependent physical process, known as the bioluminescent resonance energy transfer (BRET2) signal in living subjects, by using a cooled charge-coupled device (CCD) camera. A CCD camera-based spectral imaging strategy enables simultaneous visualization and quantitation of BRET signal from live cells and cells implanted in living mice. We used the BRET2 system, which utilizes Renilla luciferase (hRluc) protein and its substrate DeepBlueC (DBC) as an energy donor and a mutant green fluorescent protein (GFP2) as the acceptor. To accomplish this objective in this proof-of-principle study, the donor and acceptor proteins were fused to FKBP12 and FRB, respectively, which are known to interact only in the presence of the small molecule mediator rapamycin. Mammalian cells expressing these fusion constructs were imaged using a cooled-CCD camera either directly from culture dishes or by implanting them into mice. By comparing the emission photon yields in the presence and absence of rapamycin, the specific BRET signal was determined. The CCD imaging approach of BRET signal is particularly appealing due to its capacity to seamlessly bridge the gap between in vitro and in vivo studies. This work validates BRET as a powerful tool for interrogating and observing protein-protein interactions directly at limited depths in living mice.</abstract><notes>De, Abhijit&#xD;Gambhir, Sanjiv Sam&#xD;5r01 ca82214/ca/nci&#xD;P50 ca114747/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2005 Dec;19(14):2017-9. Epub 2005 Oct 4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16204354</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>6.791</custom4><electronic-resource-num>05-4628fje [pii]&#xD;10.1096/fj.05-4628fje</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>183</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">183</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Partlow, K. C.</author><author>Chen, J.</author><author>Brant, J. A.</author><author>Neubauer, A. M.</author><author>Meyerrose, T. E.</author><author>Creer, M. H.</author><author>Nolta, J. A.</author><author>Caruthers, S. D.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110, USA.</auth-address><titles><title>19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons</title><secondary-title>FASEB J</secondary-title></titles><pages>1647-54</pages><volume>21</volume><number>8</number><edition>2007/02/08</edition><keywords><keyword>Animals</keyword><keyword>Fetal Blood</keyword><keyword>Fluorine</keyword><keyword>Fluorocarbons/*diagnostic use/pharmacokinetics</keyword><keyword>Hematopoietic Stem Cell Transplantation</keyword><keyword>Hematopoietic Stem Cells/*cytology/metabolism</keyword><keyword>Humans</keyword><keyword>Isotopes</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Methods</keyword><keyword>Mice</keyword><keyword>Nanoparticles/diagnostic use</keyword><keyword>Neoplasms, Experimental</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>17284484</accession-num><abstract>MRI has been employed to elucidate the migratory behavior of stem/progenitor cells noninvasively in vivo with traditional proton (1H) imaging of iron oxide nanoparticle-labeled cells. Alternatively, we demonstrate that fluorine (19F) MRI of cells labeled with different types of liquid perfluorocarbon (PFC) nanoparticles produces unique and sensitive cell markers distinct from any tissue background signal. To define the utility for cell tracking, mononuclear cells harvested from human umbilical cord blood were grown under proendothelial conditions and labeled with nanoparticles composed of two distinct PFC cores (perfluorooctylbromide and perfluoro-15-crown-5 ether). The sensitivity for detecting and imaging labeled cells was defined on 11.7T (research) and 1.5T (clinical) scanners. Stem/progenitor cells (CD34+ CD133+ CD31+) readily internalized PFC nanoparticles without aid of adjunctive labeling techniques, and cells remained functional in vivo. PFC-labeled cells exhibited distinct 19F signals and were readily detected after both local and intravenous injection. PFC nanoparticles provide an unequivocal and unique signature for stem/progenitor cells, enable spatial cell localization with 19F MRI, and permit quantification and detection of multiple fluorine signatures via 19F MR spectroscopy. This method should facilitate longitudinal investigation of cellular events in vivo for multiple cell types simultaneously.</abstract><notes>Partlow, Kathryn C&#xD;Chen, Junjie&#xD;Brant, Jason A&#xD;Neubauer, Anne M&#xD;Meyerrose, Todd E&#xD;Creer, Michael H&#xD;Nolta, Jan A&#xD;Caruthers, Shelton D&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Co-37007/co/nci&#xD;Hl-073646/hl/nhlbi&#xD;Hl-078631/hl/nhlbi&#xD;U54-ca-119342/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2007 Jun;21(8):1647-54. Epub 2007 Feb 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17284484</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>6.791</custom4><electronic-resource-num>fj.06-6505com [pii]&#xD;10.1096/fj.06-6505com</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>658</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">658</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xia, N.</author><author>Thodeti, C. K.</author><author>Hunt, T. P.</author><author>Xu, Q.</author><author>Ho, M.</author><author>Whitesides, G. M.</author><author>Westervelt, R.</author><author>Ingber, D. E.</author></authors></contributors><auth-address>Vascular Biology Program, Department of Pathology, Children&apos;s Hospital and Harvard Medical School, Boston, MA 02115, USA.</auth-address><titles><title>Directional control of cell motility through focal adhesion positioning and spatial control of Rac activation</title><secondary-title>FASEB J</secondary-title></titles><pages>1649-59</pages><volume>22</volume><number>6</number><edition>2008/01/09</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>*Cell Movement</keyword><keyword>Cell Surface Extensions/metabolism</keyword><keyword>Extracellular Matrix/metabolism/ultrastructure</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>*Focal Adhesions</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>rac GTP-Binding Proteins/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>18180334</accession-num><abstract>Local physical interactions between cells and extracellular matrix (ECM) influence directional cell motility that is critical for tissue development, wound repair, and cancer metastasis. Here we test the possibility that the precise spatial positioning of focal adhesions governs the direction in which cells spread and move. NIH 3T3 cells were cultured on circular or linear ECM islands, which were created using a microcontact printing technique and were 1 microm wide and of various lengths (1 to 8 microm) and separated by 1 to 4.5 microm wide nonadhesive barrier regions. Cells could be driven proactively to spread and move in particular directions by altering either the interisland spacing or the shape of similar-sized ECM islands. Immunofluorescence microscopy confirmed that focal adhesions assembled preferentially above the ECM islands, with the greatest staining intensity being observed at adhesion sites along the cell periphery. Rac-FRET analysis of living cells revealed that Rac became activated within 2 min after peripheral membrane extensions adhered to new ECM islands, and this activation wave propagated outward in an oriented manner as the cells spread from island to island. A computational model, which incorporates that cells preferentially protrude membrane processes from regions near newly formed focal adhesion contacts, could predict with high accuracy the effects of six different arrangements of micropatterned ECM islands on directional cell spreading. Taken together, these results suggest that physical properties of the ECM may influence directional cell movement by dictating where cells will form new focal adhesions and activate Rac and, hence, govern where new membrane protrusions will form.</abstract><notes>Xia, Nan&#xD;Thodeti, Charles K&#xD;Hunt, Tom P&#xD;Xu, Qiaobing&#xD;Ho, Madelyn&#xD;Whitesides, George M&#xD;Westervelt, Robert&#xD;Ingber, Donald E&#xD;CA45548/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2008 Jun;22(6):1649-59. Epub 2008 Jan 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18180334</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>6.791</custom4><electronic-resource-num>fj.07-090571 [pii]&#xD;10.1096/fj.07-090571</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>203</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">203</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chignard, N.</author><author>Shang, S.</author><author>Wang, H.</author><author>Marrero, J.</author><author>Brechot, C.</author><author>Hanash, S.</author><author>Beretta, L.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.</auth-address><titles><title>Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera</title><secondary-title>Gastroenterology</secondary-title></titles><pages>2010-22</pages><volume>130</volume><number>7</number><edition>2006/06/10</edition><keywords><keyword>Carcinoma, Hepatocellular/genetics/metabolism</keyword><keyword>Electrophoresis, Gel, Two-Dimensional</keyword><keyword>Endoplasmic Reticulum/genetics/metabolism</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunoblotting</keyword><keyword>Liver Neoplasms/metabolism/pathology</keyword><keyword>Male</keyword><keyword>Mass Spectrometry</keyword><keyword>Neoplasm Proteins/genetics/metabolism</keyword><keyword>*Proteomics</keyword><keyword>Reference Values</keyword><keyword>Sampling Studies</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Tumor Markers, Biological/*blood/*metabolism</keyword><keyword>mRNA Cleavage and Polyadenylation Factors/*genetics/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0016-5085 (Print)</isbn><accession-num>16762624</accession-num><abstract>BACKGROUND &amp; AIMS: In the past decade, there has been a rising incidence of hepatocellular carcinoma (HCC) and a progressive increase in HCC-related mortality in the United States and Western Europe. The poor survival of patients with HCC is largely related to the lack of reliable tools for early diagnosis. METHODS: We have applied proteomics tools to the comparative analysis of protein profiles between HCC and adjacent nontumor tissues as a means for discovering novel molecular markers. RESULTS: Forty-seven protein spots that showed reproducible variation were identified by mass spectrometry, corresponding to 23 distinct genes. A positive correlation between transcript and protein level variations was observed for only 7 out of the 23 genes. Proteolytic cleavage accounted for the discrepancies between messenger RNA and protein level changes for 7 genes including calreticulin, PDIA3, PDI, and GRP78. We detected a fragment of each of these 4 endoplasmic reticulum proteins in the culture supernatant of the PLC-PRF5 hepatoma cell line, suggesting that their cleavage leads to release of selected cleaved products in the extracellular compartment. We also detected calreticulin and PDIA3 cleavage products in sera of patients with HCC. A statistically highly significant difference in calreticulin and PDIA3 fragment serum levels between patients with HCC and healthy individuals was observed. Amounts of calreticulin and PDIA3 fragments were also significantly different between patients with HCC and at-risk patients (patients with chronic hepatitis or cirrhosis). CONCLUSIONS: Specific isoforms in general and cleavage products in particular should therefore be further evaluated as new markers for HCC.</abstract><notes>Chignard, Nicolas&#xD;Shang, Sufen&#xD;Wang, Hong&#xD;Marrero, Jorge&#xD;Brechot, Christian&#xD;Hanash, Samir&#xD;Beretta, Laura&#xD;R01 dk066840/dk/niddk&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Gastroenterology&#xD;Gastroenterology. 2006 Jun;130(7):2010-22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16762624</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>12.457</custom4><electronic-resource-num>S0016-5085(06)00737-2 [pii]&#xD;10.1053/j.gastro.2006.02.058</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>285</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">285</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kashatus, D.</author><author>Cogswell, P.</author><author>Baldwin, A. S.</author></authors></contributors><auth-address>Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Expression of the Bcl-3 proto-oncogene suppresses p53 activation</title><secondary-title>Genes Dev</secondary-title></titles><pages>225-35</pages><volume>20</volume><number>2</number><edition>2005/12/31</edition><keywords><keyword>Animals</keyword><keyword>Apoptosis/drug effects</keyword><keyword>Apoptosis Regulatory Proteins/antagonists &amp; inhibitors/metabolism</keyword><keyword>Cell Cycle/drug effects</keyword><keyword>DNA Damage/drug effects</keyword><keyword>Embryo/enzymology/metabolism</keyword><keyword>Fibroblasts/metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Germ-Line Mutation</keyword><keyword>Germinal Center/metabolism</keyword><keyword>Mice</keyword><keyword>NF-kappa B/metabolism</keyword><keyword>Proto-Oncogene Proteins/antagonists &amp;</keyword><keyword>inhibitors/genetics/*metabolism/pharmacology</keyword><keyword>Proto-Oncogene Proteins c-bcl-2/antagonists &amp; inhibitors/metabolism</keyword><keyword>Proto-Oncogene Proteins c-mdm2/metabolism</keyword><keyword>RNA, Small Interfering/metabolism</keyword><keyword>Recombination, Genetic</keyword><keyword>Transcription Factors</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Tumor Suppressor Protein p53/*metabolism</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>0890-9369 (Print)</isbn><accession-num>16384933</accession-num><abstract>While Bcl-3 expression in cancer was originally thought to be limited to B-cell lymphomas with a 14;19 chromosomal translocation, more recent evidence indicates that expression of this presumptive oncoprotein is significantly more widespread in cancer. However, an oncogenic role for Bcl-3 has not been clearly identified. Experiments presented here indicate that Bcl-3 is inducible by DNA damage and is required for the induction of Hdm2 gene expression and the suppression of persistent p53 activity. Furthermore, constitutive expression of Bcl-3 suppresses DNA damage-induced p53 activation and inhibits p53-induced apoptosis through a mechanism that is at least partly dependent on the up-regulation of Hdm2. The results provide insight into a mechanism whereby altered expression of Bcl-3 leads to tumorigenic potential. Since Bcl-3 is required for germinal center formation, these results suggest functional similarities with the unrelated Bcl-6 oncoprotein in suppressing potential p53-dependent cell cycle arrest and apoptosis in response to somatic hypermutation and class switch recombination.</abstract><notes>Kashatus, David&#xD;Cogswell, Patricia&#xD;Baldwin, Albert S&#xD;Ai35098/ai/niaid&#xD;Ca73756/ca/nci&#xD;Ca75080/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Genes &amp; development&#xD;Genes Dev. 2006 Jan 15;20(2):225-35. Epub 2005 Dec 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16384933</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>14.795</custom4><electronic-resource-num>gad.1352206 [pii]&#xD;10.1101/gad.1352206</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>417</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">417</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Korngold, E. C.</author><author>Jaffer, F. A.</author><author>Weissleder, R.</author><author>Sosnovik, D. E.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th St., 5th floor, Boston, MA 02129, USA.</auth-address><titles><title>Noninvasive imaging of apoptosis in cardiovascular disease</title><secondary-title>Heart Fail Rev</secondary-title></titles><pages>163-73</pages><volume>13</volume><number>2</number><edition>2007/12/13</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1382-4147 (Print)</isbn><accession-num>18074226</accession-num><abstract>Recent advances in molecular imaging have permitted the noninvasive imaging of apoptosis, a critical process underlying the pathogenesis of many diseases of the cardiovascular system including atherosclerotic vascular disease, myocardial ischemia and reperfusion injury, chronic heart failure, myocarditis, and cardiac allograft rejection. Multiple molecular targets including phosphatidylserine, phosphatidylinositol 3-kinase, and caspases have been targeted by a variety of imaging agents and modalities such as nuclear scintigraphy, PET, MRI, and fluorescent and bioluminescent imaging. Translationally, methods utilizing radiolabeled annexin V have proven promising in several clinical trials of ischemia-reperfusion injury and cardiac allograft rejection. New approaches using novel molecular imaging agents show great potential for the ability to image apoptosis in the research and clinical setting. Ultimately the ability to detect apoptosis noninvasively would help to identify patients for emerging anti-apoptotic therapies and guide clinical management with the aim of maximal myocardial preservation.</abstract><notes>Korngold, Ethan Chauncey&#xD;Jaffer, Farouc Amin&#xD;Weissleder, Ralph&#xD;Sosnovik, David Edwin&#xD;K08 HL079984/HL/United States NHLBI&#xD;UO1-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Heart failure reviews&#xD;Heart Fail Rev. 2008 Jun;13(2):163-73.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18074226</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>2.125</custom4><electronic-resource-num>10.1007/s10741-007-9068-4</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>523</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">523</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nolan, G. P.</author></authors></contributors><auth-address>Stanford University School of Medicine, 300 Pasteur Drive, Palo Alto CA 94305, USA. gnolan@stanford.edu</auth-address><titles><title>Deeper insights into hematological oncology disorders via single-cell phospho-signaling analysis</title><secondary-title>Hematology Am Soc Hematol Educ Program</secondary-title></titles><pages>123-7, 509</pages><edition>2006/11/25</edition><keywords><keyword>Animals</keyword><keyword>Flow Cytometry</keyword><keyword>Hematologic Neoplasms/*diagnosis/metabolism</keyword><keyword>Humans</keyword><keyword>Phosphorylation</keyword><keyword>Prognosis</keyword><keyword>*Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1520-4391 (Print)</isbn><accession-num>17124050</accession-num><abstract>An understanding of hematological cancer cell signaling processes poses one of the most complex and intractable problems in modern biomedical inquiry. While we understand some of the fundamental players that contribute to oncogenic processes, significant effort is focused upon determining how these individual players relay information to each other to create the composite functions of a cancer cell. Efforts designed to understand these processes at the single cell level will undoubtedly allow for understanding of the heterogeneity of hematological tumors as well as, simultaneously, the function of the &apos;responding&apos; immune system. I will relate some of the insights our laboratory has developed over the last several years applying single-cell phospho-flow cytometry to the study of signaling in primary patient material and murine models. While it is clear that this analysis now allows us to accomplish phospho-signaling biochemistry at the single cell level with primary cell material, we are only beginning to develop some of the bioinformatics tools to appropriately display the vast amount of information collected by such approaches. These approaches, however, have already allowed us to develop approaches that prognosticate patient outcomes based on signaling status, prior to any treatment, as well as subgroup patient subtypes according to signaling states. The modest efforts to date presage a time where it should be possible to provide far more tailored therapies specific to the varied diseases represented by the hematological malignancies.</abstract><notes>Nolan, Garry P&#xD;Review&#xD;United States&#xD;Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program&#xD;Hematology Am Soc Hematol Educ Program. 2006;:123-7, 509.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17124050</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>na</custom4><electronic-resource-num>2006/1/123 [pii]&#xD;10.1182/asheducation-2006.1.123</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>112</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">112</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yin-Goen, Q.</author><author>Dale, J.</author><author>Yang, W. L.</author><author>Phan, J.</author><author>Moffitt, R.</author><author>Petros, J. A.</author><author>Datta, M. W.</author><author>Amin, M. B.</author><author>Wang, M. D.</author><author>Young, A. N.</author></authors></contributors><auth-address>Department of Pathology &amp; Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.</auth-address><titles><title>Advances in molecular classification of renal neoplasms</title><secondary-title>Histol Histopathol</secondary-title></titles><pages>325-39</pages><volume>21</volume><number>3</number><edition>2005/12/24</edition><keywords><keyword>Carcinoma, Renal Cell/*classification/diagnosis/*genetics/pathology</keyword><keyword>Cluster Analysis</keyword><keyword>DNA, Neoplasm/*analysis</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Histocytochemistry/methods</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*classification/diagnosis/*genetics/pathology</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>World Health Organization</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1699-5848 (Electronic)</isbn><accession-num>16372253</accession-num><abstract>Kidney neoplasms are classified by light microscopy using the World Health Organization (WHO) system. The WHO system defines histopathologic tumor subtypes with distinct clinical behavior and underlying genetic mutations. In adults, the common malignant subtypes are variants of renal cell carcinoma (RCC). Histopathologic classification is critical for clinical management of RCC, but is becoming more complex with recognition of novel tumor subtypes, development of procedures yielding small diagnostic biopsies, and emergence of molecular therapies directed at tumor gene activity. Therefore, classification systems based on gene expression are likely to become essential for diagnosis, prognosis and treatment of kidney tumors. Recent DNA microarray studies have shown that clinically relevant renal tumor subtypes are characterized by distinct gene expression profiles, which are useful for discovery of novel diagnostic and prognostic biomarkers. In this review, we summarize the WHO classification system for renal tumors, general applications of microarray technology in cancer research, and specific microarray studies that have advanced knowledge of renal tumor diagnosis, prognosis, therapy and pathobiology.</abstract><notes>Yin-Goen, Q&#xD;Dale, J&#xD;Yang, W-L&#xD;Phan, J&#xD;Moffitt, R&#xD;Petros, J A&#xD;Datta, M W&#xD;Amin, M B&#xD;Wang, M D&#xD;Young, A N&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Spain&#xD;Histology and histopathology&#xD;Histol Histopathol. 2006 Mar;21(3):325-39.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16372253</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.182</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>310</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">310</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H.</author><author>Liu, Y.</author><author>Westervelt, R. M.</author><author>Ham, D.</author></authors></contributors><titles><title>IC/microfluidic hybrid system for magnetic manipulation of biological cells</title><secondary-title>IEEE Journal of Solid-State Circuits</secondary-title></titles><pages>1471-1480</pages><volume>41</volume><number>6</number><edition>2006-05-30 </edition><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>0018-9200</isbn><accession-num>8935015</accession-num><abstract>This paper introduces an integrated circuit (IC)/microfluidic hybrid system for magnetic manipulation of biological cells. The hybrid system consists of an IC and a microfluidic system fabricated on top. Biological cells attached to magnetic beads are suspended inside the microfluidic system that maintains biocompatibility. The IC contains a microcoil array circuit that produces spatially-patterned microscopic magnetic fields. Programmable, rapid reconfiguration of the field pattern made possible by the IC allows an efficient simultaneous manipulation of multiple individual bead-bound cells with precise position control. Two prototypes, SiGe/microfluidic and CMOS/microfluidic hybrid systems, validate the proposed approach. </abstract><urls><related-urls><url>http://people.seas.harvard.edu/~donhee/JSSC_june2006_lee_liu_westervelt_ham.pdf</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>2.002</custom4><electronic-resource-num>10.1109/JSSC.2006.874331</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>539</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">539</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Keren, S.</author><author>Gheysens, O.</author><author>Levin, C. S.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Radiology Department, Stanford University, Standford, CA 94305, USA. shayk@stanford.edu</auth-address><titles><title>A comparison between a time domain and continuous wave small animal optical imaging system</title><secondary-title>IEEE Trans Med Imaging</secondary-title></titles><pages>58-63</pages><volume>27</volume><number>1</number><edition>2008/02/14</edition><keywords><keyword>Animals</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Image Enhancement/*instrumentation/methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Imaging, Three-Dimensional/*methods</keyword><keyword>Microscopy, Fluorescence/*instrumentation/methods/*veterinary</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tomography, Optical/*instrumentation/methods/*veterinary</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0278-0062 (Print)</isbn><accession-num>18270062</accession-num><abstract>We present a phantom study to evaluate the performance of the eXplore Optix (Advanced Research Technologies-GE Healthcare), the first commercially available time-domain tomography system for small animal fluorescence imaging, and compare its capabilities with the widely used IVIS 200 (Xenogen Corporation-Caliper) continuous wave planar imaging system. The eXplore Optix, based on point-wise illumination and collection scheme, is found to be a log order more sensitive with significantly higher detection depth and spatial resolution as compared with the wide-area illumination IVIS 200 under the conditions tested. A time-resolved detection system allows the eXplore Optix to measure the arrival time distribution of fluorescence photons. This enables fluorescence lifetime measurement, absorption mapping, and estimation of fluorescent inclusion depth, which in turn is used by a reconstruction algorithm to calculate the volumetric distribution of the fluorophore concentration. An increased acquisition time and lack of ability to image multiple animals simultaneously are the main drawbacks of the eXplore Optix as compared with the IVIS 200.</abstract><notes>Keren, S&#xD;Gheysens, O&#xD;Levin, C S&#xD;Gambhir, S S&#xD;P50 CA114747/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Comparative Study&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;IEEE transactions on medical imaging&#xD;IEEE Trans Med Imaging. 2008 Jan;27(1):58-63.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18270062</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>3.275</custom4><electronic-resource-num>10.1109/TMI.2007.902800</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>170</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">170</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soman, N. R.</author><author>Marsh, J. N.</author><author>Hughes, M. S.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA. nsoman@wustl.edu</auth-address><titles><title>Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity</title><secondary-title>IEEE Trans Nanobioscience</secondary-title></titles><pages>69-75</pages><volume>5</volume><number>2</number><edition>2006/06/30</edition><keywords><keyword>*Acoustics</keyword><keyword>Cells, Cultured</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Delivery Systems</keyword><keyword>Echocardiography/*methods</keyword><keyword>Endothelial Cells/*cytology/physiology/*radiation effects/ultrasonography</keyword><keyword>Fluorocarbons/*diagnostic use/radiation effects</keyword><keyword>Humans</keyword><keyword>*Nanostructures</keyword><keyword>Particle Size</keyword><keyword>Radiation Dosage</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1536-1241 (Print)</isbn><accession-num>16805101</accession-num><abstract>Perfluorocarbon nanoparticles consisting essentially of liquid perfluoro-octyl bromide (PFOB) core surrounded by a lipid monolayer can serve as highly specific site-targeted contrast and therapeutic agents after binding to cellular biomarkers. Based on previous findings that ultrasound applied at 2 MHz and 1.9 mechanical index (MI) for a 5-min duration dramatically enhances the cellular interaction of targeted PFOB nanoparticles with melanoma cells in vitro without inducing apoptosis or other harmful effects to cells that are targeted, we sought to define mechanisms of interaction and the safety profile of ultrasound used in conjunction with liquid perfluorocarbon nanoparticles for targeted drug delivery, as compared with conventional microbubble ultrasound contrast agents under identical insonification conditions. Cell-culture inserts were used to grow a confluent monolayer of human umbilical vein endothelial cells. Definity in conjunction with continuous wave ultrasound (2.25 MHz for 1 and 5 min) increased the permeability of monolayer by four to six times above the normal, decreased transendothelial electrical resistance (a sign of reduced membrane integrity), and decreased cell viability by approximately 50%. Histological evaluation demonstrated extensive disruptions of cell monolayers. Nanoparticles (both nontargeted and targeted) elicited no changes in these different measures under similar insonification conditions and did not disrupt cell monolayers. We hypothesize that ultrasound facilitates drug transport from the perfluorocarbon nanoparticles not by cavitation-induced effects on cell membrane but rather by direct interaction with the nanoparticles that stimulate lipid exchange and drug delivery.</abstract><notes>Soman, Neelesh R&#xD;Marsh, Jon N&#xD;Hughes, Michael S&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;IEEE transactions on nanobioscience&#xD;IEEE Trans Nanobioscience. 2006 Jun;5(2):69-75.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16805101</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>1.899</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>167</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">167</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Zhang, H.</author><author>Woodson, A. K.</author><author>Allen, J. S.</author><author>Lacy, E. K.</author><author>Carradine, C.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University School of Medicine, St Louis, MO, USA. msh@cvu.wustl.edu</auth-address><titles><title>Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo</title><secondary-title>IEEE Trans Ultrason Ferroelectr Freq Control</secondary-title></titles><pages>1609-16</pages><volume>53</volume><number>9</number><edition>2006/09/13</edition><keywords><keyword>*Algorithms</keyword><keyword>Animals</keyword><keyword>Breast Neoplasms/*ultrasonography</keyword><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>*Signal Processing, Computer-Assisted</keyword><keyword>Thermodynamics</keyword><keyword>Ultrasonography/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0885-3010 (Print)</isbn><accession-num>16964911</accession-num><abstract>We describe characterization of backscatter from tumor tissue targeted with a nanoparticle-based ultrasound contrast agent in vivo using analogs of thermodynamic quantities. We apply these waveform characteristics to detection of tumor neovasculature in tumors implanted in athymic nude mice, which were imaged using a research ultrasound scanner over a 2-hour period after injection of alpha upsilon beta3-targeted perfluorocarbon nanoparticles. Images were constructed from backscattered ultrasound using two different approaches: fundamental B-mode imaging and a signal receiver based on a thermodynamic analog (H(C)). The study shows that the thermodynamic analog is capable of detecting differences in backscattered signals that are not apparent with the B-mode approach.</abstract><notes>Hughes, Michael S&#xD;Marsh, Jon N&#xD;Zhang, Hyuing&#xD;Woodson, Adam K&#xD;Allen, John S&#xD;Lacy, Elizabeth K&#xD;Carradine, Cordelia&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Co-27031/co/nci&#xD;Hl042950/hl/nhlbi&#xD;Hl59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;IEEE transactions on ultrasonics, ferroelectrics, and frequency control&#xD;IEEE Trans Ultrason Ferroelectr Freq Control. 2006 Sep;53(9):1609-16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16964911</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>1.654</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>478</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">478</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wallace, K. D.</author><author>Marsh, J. N.</author><author>Baldwin, S. L.</author><author>Connolly, A. M.</author><author>Keeling, R.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author><author>Hughes, M. S.</author></authors></contributors><auth-address>Washington University School of Medicine, Washington University, St. Louis, MO, USA. kirk.wallace@wustl.edu</auth-address><titles><title>Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropy-based radio frequency signal processing</title><secondary-title>IEEE Trans Ultrason Ferroelectr Freq Control</secondary-title></titles><pages>2291-9</pages><volume>54</volume><number>11</number><edition>2007/12/07</edition><keywords><keyword>Algorithms</keyword><keyword>Animals</keyword><keyword>Anti-Inflammatory Agents/administration &amp; dosage</keyword><keyword>*Disease Models, Animal</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Transgenic</keyword><keyword>Muscle, Skeletal/drug effects/ultrasonography</keyword><keyword>Muscular Dystrophy, Duchenne/*drug therapy/*ultrasonography</keyword><keyword>Prednisolone/*administration &amp; dosage</keyword><keyword>Prognosis</keyword><keyword>Radio Waves</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Signal Processing, Computer-Assisted</keyword><keyword>Treatment Outcome</keyword><keyword>Ultrasonography/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 2007</date></pub-dates></dates><isbn>0885-3010 (Print)</isbn><accession-num>18051163</accession-num><abstract>Duchenne muscular dystrophy is a severe wasting disease, involving replacement of necrotic muscle tissue by fibrous material and fatty infiltrates. One primary animal model of this human disease is the X chromosome-linked mdx strain of mice. The goals of the present work were to validate and quantify the capability of both energy and entropy metrics of radio-frequency ultrasonic backscatter to differentiate among normal, dystrophic, and steroid-treated skeletal muscle in the mdx model. Thirteen 12-month-old mice were blocked into three groups: 4 treated mdx-dystrophic that received daily subcutaneous steroid (prednisolone) treatment for 14 days, 4 positive-control mdx-dystrophic that received saline injections for 14 days, and 5 negative-control animals. Biceps muscle of each animal was imaged in vivo using a 40-MHz center frequency transducer in conjunction with a Vevo-660 ultrasound system. Radio-frequency data were acquired (1 GHz, 8 bits) corresponding to a sequence of transverse images, advancing the transducer from &quot;shoulder&quot; to &quot;elbow&quot; in 100-micron steps. Data were processed to generate both &quot;integrated backscatter&quot; (log energy), and &quot;entropy&quot; (information theoretic receiver, H(f)) representations. Analyses of the integrated-backscatter values delineated both treated-and untreated-mdx biceps from normal controls (p &lt; 0.01). Complementary analyses of the entropy images differentiated the steroid-treated and positive-control mdx groups (p &lt; 0.01). To our knowledge, this study represents the first reported use of quantitative ultrasonic characterization of skeletal muscle in mdx mice. Successful differentiation among dystrophic, steroid-treated, and normal tissues suggests the potential for local noninvasive monitoring of disease severity and therapeutic effects.</abstract><notes>Wallace, Kirk D&#xD;Marsh, Jon N&#xD;Baldwin, Steven L&#xD;Connolly, Anne M&#xD;Keeling, Richard&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Hughes, Michael S&#xD;R01-HL042950/HL/United States NHLBI&#xD;R01-HL073646/HL/United States NHLBI&#xD;U54-CA119342/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;IEEE transactions on ultrasonics, ferroelectrics, and frequency control&#xD;IEEE Trans Ultrason Ferroelectr Freq Control. 2007 Nov;54(11):2291-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18051163</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>1.654</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>649</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">649</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, S.X.</author><author>Li, G.   </author></authors></contributors><auth-address>Dept. of Mater. Sci. &amp; Eng., Stanford Univ., Stanford, CA</auth-address><titles><title>Advances in Giant Magnetoresistance Biosensors With Magnetic Nanoparticle Tags: Review and Outlook</title><secondary-title>IEEE Transactions on Magnetics</secondary-title></titles><pages>1687-1702</pages><volume>44</volume><number>7</number><edition>2008/06</edition><dates><year>2008</year><pub-dates><date>Jun 17</date></pub-dates></dates><isbn>0018-9464</isbn><accession-num>10058865</accession-num><abstract>We present a review of giant magnetoresistance (GMR) spin valve sensors designed for detection of magnetic nanoparticles as biomolecular labels (nanotags) in magneto-nano biodetection technology. We discuss the intricacy of magneto-nano biosensor design and show that as few as approximately 14 monodisperse 16-nm superparamagnetic nanoparticles can be detected by submicron spin valve sensors at room temperature without resorting to lock-in (narrow band) detection. GMR biosensors and biochips have been successfully applied to the detection of biological events in the form of both protein and DNA assays with great speed, sensitivity, selectivity, and economy. The limit of molecular detection is well below 10 pM in concentration, and the protein or DNA assay time can be under two hours. The technology is highly scalable to deep multiplex detection of biomarkers in a complex disease, and amenable to integration of microfluidics and CMOS electronics for portable applications. On-chip CMOS circuitry makes a sensor density of 0.1-1 million sensors per square centimeter feasible and affordable. The theoretical and experimental results thus far suggest that magneto-nano biochip-based GMR sensor arrays and nanotags hold great promise in biomedicine, particularly for point-of-care molecular diagnostics of cancer, infectious diseases, radiation injury, cardiac diseases, and other diseases.</abstract><urls><related-urls><url>http://ieeexplore.ieee.org/xpl/freeabs_all.jsp?arnumber=4544935</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>0.953</custom4><electronic-resource-num>10.1109/TMAG.2008.920962</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>606</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">606</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lalush, D.D.S.     </author></authors></contributors><titles><title>Binary Encoding of Multiplexed Images in Mixed Noise</title><secondary-title>IEEE Transactions on Medical Imaging</secondary-title></titles><pages>1</pages><volume>PP</volume><number>99</number><edition>2008-06-10</edition><dates><year>2008</year></dates><abstract>Binary coding of multiplexed signals and images has been studied in the context of spectroscopy with models of either purely constant or purely proportional noise, and has been shown to result in improved noise performance under certain conditions. We consider the case of mixed noise in an imaging system consisting of multiple individually-controllable sources (x-ray or near-infrared, for example) shining on a single detector. We develop a mathematical model for the noise in such a system and show that the noise is dependent on the properties of the binary coding matrix and on the average number of sources used for each code. Each binary matrix has a characteristic linear relationship between the ratio of proportional-to-constant noise and the noise level in the decoded image. We introduce a criterion for noise level, which is minimized via a genetic algorithm search. The search procedure results in the discovery of matrices that outperform the Hadamard S-matrices at certain levels of mixed noise. Simulation of a seven-source radiography system demonstrates that the noise model predicts trends and rank order of performance in regions of nonuniform images and in a simple tomosynthesis reconstruction. We conclude that the model developed provides a simple framework for analysis, discovery, and optimization of binary coding patterns used in multiplexed imaging systems.</abstract><urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.275</custom4><electronic-resource-num>10.1109/TMI.2008.922697</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>519</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">519</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perez, O. D.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>The Baxter Laboratory for Genetic Pharmacology, Department of Microbiology and Immunology, Stanford University, School of Medicine, Stanford, CA 94305, USA. operez@stanford.edu</auth-address><titles><title>Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level</title><secondary-title>Immunol Rev</secondary-title></titles><pages>208-28</pages><volume>210</volume><edition>2006/04/21</edition><keywords><keyword>*Diagnostic Techniques and Procedures</keyword><keyword>Epitopes/*analysis/immunology</keyword><keyword>*Flow Cytometry</keyword><keyword>Humans</keyword><keyword>Medicine</keyword><keyword>Phosphoproteins/*analysis/immunology</keyword><keyword>Proteomics/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0105-2896 (Print)</isbn><accession-num>16623773</accession-num><abstract>Understanding a molecular basis for cellular function is a common goal of biomedicine. The complex and dynamic cellular processes underlying physiological processes become subtly or grossly perturbed in human disease. A primary objective is to demystify this complexity by creating and establishing relevant model systems to study important aspects of human disease. Although significant technological advancements over the last decade in both genomic and proteomic arenas have enabled progress, accessing the complexity of cellular interactions that occur in vivo has been a difficult arena in which to make progress. Moreover, there are extensive challenges in translating research tools to clinical applications. Flow cytometry, over the course of the last 40 years, has revolutionized the field of immunology, in both the basic science and clinical settings, as well as having been instrumental to new and exciting areas of discovery such as stem cell biology. Multiparameter machinery and systems exist now to access the heterogeneity of cellular subsets and enable phenotypic characterization and functional assays to be performed on material from both animal models and humans. This review focuses primarily on the development and application of using activation-state readouts of intracellular activity for phospho-epitopes. We present recent work on how a flow cytometric platform is used to obtain mechanistic insight into cellular processes as well as highlight the clinical applications that our laboratory has explored. Furthermore, this review discusses the challenges faced with processing high-content multidimensional and multivariate data sets. Flow cytometry, as a platform that is well situated in both the research and clinical settings, can contribute to drug discovery as well as having utility for both biomarker and patient-stratification.</abstract><notes>Perez, Omar D&#xD;Nolan, Garry P&#xD;A1/GF41520-01/GF/United States NIH&#xD;AI35304/AI/United States NIAID&#xD;AR44565/AR/United States NIAMS&#xD;N01-AR-6-2227/AR/United States NIAMS&#xD;N01-HV-28183I/HV/United States NHLBI&#xD;P01-AI39646/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;Denmark&#xD;Immunological reviews&#xD;Immunol Rev. 2006 Apr;210:208-28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16623773</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>10.536</custom4><electronic-resource-num>IMR364 [pii]&#xD;10.1111/j.0105-2896.2006.00364.x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>472</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">472</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Urbanczyk-Pearson, L. M.</author><author>Femia, F. J.</author><author>Smith, J.</author><author>Parigi, G.</author><author>Duimstra, J. A.</author><author>Eckermann, A. L.</author><author>Luchinat, C.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60201, USA.</auth-address><titles><title>Mechanistic investigation of beta-galactosidase-activated MR contrast agents</title><secondary-title>Inorg Chem</secondary-title></titles><pages>56-68</pages><volume>47</volume><number>1</number><edition>2007/12/13</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Lanthanoid Series Elements/*chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Structure</keyword><keyword>Organometallic Compounds/*chemical synthesis/chemistry</keyword><keyword>Stereoisomerism</keyword><keyword>beta-Galactosidase/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 7</date></pub-dates></dates><isbn>0020-1669 (Print)</isbn><accession-num>18072754</accession-num><abstract>We report a mechanistic investigation of an isomeric series of beta-galactosidase-activated magnetic resonance contrast agents. Our strategy focuses on the synthesis of macrocyclic caged-complexes that coordinatively saturate a chelated lanthanide. Enzyme cleavage of the complex results in an open coordination site available for water that creates a detectable MR contrast agent. The complexes consist of a DO3A Gd(III) chelator modified with a galactopyranose at the N-10 position of the macrocycle. We observed significant differences in relaxometric properties and coordination geometry that can be correlated to subtle variations of the linker between the macrocycle and the galactopyranose. After synthesis and purification of the R, S, and racemic mixtures of complexes 1 and 3 and measurement of the hydration number, water residence lifetime, and longitudinal relaxation rates, we propose mechanisms for water exclusion from the lanthanide in the precleavage state. While the stereochemistry of the linker does not influence the agents&apos; properties, the mechanism of water exclusion for each isomer is significantly influenced by the position of modification. Data for one series with a methyl group substituted on the sugar-macrocycle linker at the alpha-position suggests a steric mechanism where the galactopyranose sugar blocks water from the Gd(III) center. In contrast, our observations for a second series with methyl substitution at the beta position of the sugar-macrocycle linker are consistent with a mechanism in which a bidentate anion occupies two available coordination sites of Gd(III) in the precleavage state.</abstract><notes>Urbanczyk-Pearson, Lauren M&#xD;Femia, Frank J&#xD;Smith, Jeffrey&#xD;Parigi, Giacomo&#xD;Duimstra, Joseph A&#xD;Eckermann, Amanda L&#xD;Luchinat, Claudio&#xD;Meade, Thomas J&#xD;5 U54 CA90810/CA/United States NCI&#xD;R01 AI47003/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Inorganic chemistry&#xD;Inorg Chem. 2008 Jan 7;47(1):56-68. Epub 2007 Dec 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18072754</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.123</custom4><electronic-resource-num>10.1021/ic700888w</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>476</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">476</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, P.</author><author>Miller, J. E.</author><author>Henling, L. M.</author><author>Stern, C. L.</author><author>Frank, N. L.</author><author>Eckermann, A. L.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.</auth-address><titles><title>Synthesis and characterization of ruthenium and rhenium nucleosides</title><secondary-title>Inorg Chem</secondary-title></titles><pages>9853-62</pages><volume>46</volume><number>23</number><edition>2007/10/24</edition><keywords><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Models, Molecular</keyword><keyword>Nucleosides/*chemical synthesis/chemistry</keyword><keyword>Rhenium/*chemistry</keyword><keyword>Ruthenium/*chemistry</keyword><keyword>Spectrometry, Mass, Electrospray Ionization</keyword><keyword>Spectrophotometry, Ultraviolet</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 12</date></pub-dates></dates><isbn>0020-1669 (Print)</isbn><accession-num>17948987</accession-num><abstract>We report the synthesis and characterization of new ruthenium and rhenium nucleosides [Ru(tolyl-acac)2(IMPy)-T] (tolyl-acac=di(p-methylbenzonatemethane), IMPy=2&apos;-iminomethylpyridine, T=thymidine) (5) and [Re(CO)3(IMPy)-T]Cl (9), respectively. Structural analysis of 9 shows that the incorporation of this metal complex causes minimal perturbation to the sugar backbone and the nucleobase. Eletrochemical (5, E1/2=0.265 V vs NHE; 9, E1/2=1.67 V vs NHE), absorption (5, lambdamax=600, 486 nm; 9, lambdamax=388 nm), and emission (9, lambdamax=770 nm, pi=17 ns) data indicate that 5 and 9 are suitable probes for DNA-mediated ground-state electron-transfer studies. The separation and characterization of diastereoisomers of 5 and bipyridyl-based ruthenium nucleoside [Ru(bpy)2(IMPy)-T]2+ (7) are reported.</abstract><notes>Wang, Peijiao&#xD;Miller, Jeremiah E&#xD;Henling, Lawrence M&#xD;Stern, Charlotte L&#xD;Frank, Natia L&#xD;Eckermann, Amanda L&#xD;Meade, Thomas J&#xD;U54CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Inorganic chemistry&#xD;Inorg Chem. 2007 Nov 12;46(23):9853-62. Epub 2007 Oct 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17948987</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.123</custom4><electronic-resource-num>10.1021/ic701250r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>676</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">676</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zuo, T.</author><author>Olmstead, M. M.</author><author>Beavers, C. M.</author><author>Balch, A. L.</author><author>Wang, G.</author><author>Yee, G. T.</author><author>Shu, C.</author><author>Xu, L.</author><author>Elliott, B.</author><author>Echegoyen, L.</author><author>Duchamp, J. C.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Chemistry Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.</auth-address><titles><title>Preparation and structural characterization of the Ih and the D5h isomers of the endohedral fullerenes Tm3N@C80: icosahedral C80 cage encapsulation of a trimetallic nitride magnetic cluster with three uncoupled Tm3+ ions</title><secondary-title>Inorg Chem</secondary-title></titles><pages>5234-44</pages><volume>47</volume><number>12</number><edition>2008/05/02</edition><dates><year>2008</year><pub-dates><date>Jun 16</date></pub-dates></dates><isbn>0020-1669 (Print)</isbn><accession-num>18447327</accession-num><abstract>We report an efficient method for the preparation and purification of the Ih and the D5h isomers of Tm3N@C80. Following preparation in a Kratschmer-Huffman electric-arc generator, the Tm3N@C80 isomers were obtained by a chemical separation process followed by a one-stage isomer selective chromatographic high-performance liquid chromatography (HPLC) separation (pyrenyl, 5PYE column). The HPLC chromatographic retention behavior on a pentabromobenzyl (5PBB) column suggests a charge transfer of approximately 6 electrons; [M3N] 6+@C80(6-) and the chromatographic retention mechanisms of the Ih and the D5h isomers of Tm3N@C80 on both 5PBB and 5PYE columns are discussed. Single-crystal X-ray diffraction data demonstrate that the Tm3N cluster has a planar structure but represents a tight fit for trapping the Tm3N cluster inside the I h - and the D 5h -C 80 cages. Specifically, the Tm atoms punch out the cage carbon atoms adjacent to them. The &quot;punched out&quot; effect can be demonstrated by cage radii and pyramidal angles at cage carbon atoms near the Tm atoms. The magnetic susceptibility (chiT) for Tm3N@ Ih -C80 was found to exhibit Curie-Weiss behavior with C = 23.4 emu.K/mol, which is consistent with the calculated value for three uncoupled Tm3+ ions by considering the spin and orbital contributions with no quenching of the orbital angular momentum ( L = 5, S = 1, and J = 6; Ccalcd = 23.3 emu.K/mol). The electrochemical measurements demonstrate that both the Ih and the D5h isomers of Tm3N@C80 have a large electrochemical gap.</abstract><notes>Zuo, Tianming&#xD;Olmstead, Marilyn M&#xD;Beavers, Christine M&#xD;Balch, Alan L&#xD;Wang, Guangbin&#xD;Yee, Gordon T&#xD;Shu, Chunying&#xD;Xu, Liaosa&#xD;Elliott, Bevan&#xD;Echegoyen, Luis&#xD;Duchamp, James C&#xD;Dorn, Harry C&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Inorganic chemistry&#xD;Inorg Chem. 2008 Jun 16;47(12):5234-44. Epub 2008 Apr 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18447327</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>4.123</custom4><electronic-resource-num>10.1021/ic800227x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>351</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">351</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Duan, Z.</author><author>Seiden, M. V.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA.</auth-address><titles><title>Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer</title><secondary-title>Int J Cancer</secondary-title><alt-title>International journal of cancer</alt-title></titles><pages>1830-8</pages><volume>121</volume><number>8</number><edition>2007/10</edition><dates><year>2007</year><pub-dates><date>Oct 15</date></pub-dates></dates><isbn>0020-7136 (Print)</isbn><accession-num>17557285</accession-num><abstract>The objective of this study was to overcome drug resistance upon systemic administration of combination paclitaxel (PTX) and the apoptotic signaling molecule C(6)-ceramide (CER) in biodegradable poly(ethylene oxide)-modified poly(epsilon-caprolactone (PEO-PCL) nanoparticles. Subcutaneous sensitive (wild-type) and multidrug resistant (MDR-1 positive) SKOV-3 human ovarian adenocarcinoma xenografts were established in female Nu/Nu mice. PTX and CER were administered intravenously either as a single agent or in combination in aqueous solution and in PEO-PCL nanoparticles to the tumor-bearing mice. There was significant (p&lt; 0.05) tumor growth suppression in both wild-type SKOV-3 and multidrug resistant SKOV-3(TR) models upon single dose co-administration of PTX (20 mg/kg) and CER (100 mg/kg) in nanoparticle formulations as compared to the individual agents and administration in aqueous solutions. For instance, in SKOV-3 wild-type model, more than 4.3-fold increase (p &lt; 0.05) in tumor growth delay and 3.6-fold (p &lt; 0.05) increase in tumor volume doubling time (DT) were observed with the combination treatment in nanoparticles as compared to untreated animals. Similarly, 3-fold increase (p &lt; 0.05) in tumor growth delay and tumor volume DT was observed in SKOV-3(TR) model. Body weight changes and blood cells counts were used as measures of safety and, except for an increase in platelet counts (p &lt; 0.05) in PTX + CER treated animals, there was no difference between various treatment strategies. The results of this study show that combination of PTX and CER in biodegradable polymeric nanoparticles can serve as a very effective therapeutic strategy to overcome drug resistance in ovarian cancer. (c) 2007 Wiley-Liss, Inc.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17557285 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>4.555</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>180</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">180</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, G.</author><author>Lijowski, M.</author><author>Zhang, H.</author><author>Partlow, K. C.</author><author>Caruthers, S. D.</author><author>Kiefer, G.</author><author>Gulyas, G.</author><author>Athey, P.</author><author>Scott, M. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Division of Cardiology, Washington University Medical School, St. Louis, MO, USA.</auth-address><titles><title>Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles</title><secondary-title>Int J Cancer</secondary-title></titles><pages>1951-7</pages><volume>120</volume><number>9</number><edition>2007/02/06</edition><keywords><keyword>Animals</keyword><keyword>Indium Radioisotopes/*diagnostic use</keyword><keyword>Integrin alphaVbeta3/*analysis</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Male</keyword><keyword>*Nanoparticles</keyword><keyword>Neoplasms, Experimental/*blood supply/radionuclide imaging</keyword><keyword>Neovascularization, Pathologic/*radionuclide imaging</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0020-7136 (Print)</isbn><accession-num>17278104</accession-num><abstract>Earlier tumor detection can improve 5-year survival of patients, particularly among those presenting with cancers less than 1 cm in diameter. alpha(nu)beta(3)-Targeted (111)In nanoparticles (NP) were developed and studied for detection of tumor angiogenesis. Studies were conducted in New Zealand white rabbits implanted 12 days earlier with Vx-2 tumor. alpha(nu)beta(3)-Targeted (111)In/NP bearing approximately 10 (111)In/NP vs. approximately 1 (111)In/NP nuclide payloads were compared to nontargeted radiolabeled control particles. In vivo competitive binding studies were used to assess ligand-targeting specificity. alpha(nu)beta(3)-Integrin-targeted NP with approximately 10 (111)In/NP provided better (p &lt; 0.05) tumor-to-muscle ratio contrast (6.3 +/- 0.2) than approximately 1 (111)In/NP (5.1 +/- 0.1) or nontargeted particles with approximately 10 (111)In/NP (3.7 +/- 0.1) over the initial 2-hr postinjection. At 18 hr, mean tumor activity in rabbits receiving alpha(nu)beta(3)-integrin-targeted NP was 4-fold higher than the nontargeted control. Specificity of the NP for the tumor neovasculature was supported by in vivo competition studies and by fluorescence microscopy of alpha(nu)beta(3)-targeted fluorescent-labeled NP. Biodistribution studies revealed that the primary clearance organ in rabbits as a %ID/g tissue was the spleen. Circulatory half-life (t(1/2)beta) was estimated to be approximately 5 hr using a 2-compartment model. alpha(nu)beta(3)-Targeted (111)In perfluorocarbon NP may provide a clinically useful tool for sensitively detecting angiogenesis in nascent tumors, particularly in combination with secondary high-resolution imaging modalities, such as MRI.</abstract><notes>Hu, Grace&#xD;Lijowski, Michal&#xD;Zhang, Huiying&#xD;Partlow, Kathryn C&#xD;Caruthers, Shelton D&#xD;Kiefer, Garry&#xD;Gulyas, Gyongyi&#xD;Athey, Phillip&#xD;Scott, Michael J&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-73646/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-27031-16/co/nci&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;International journal of cancer. Journal international du cancer&#xD;Int J Cancer. 2007 May 1;120(9):1951-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17278104</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>4.555</custom4><electronic-resource-num>10.1002/ijc.22581</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>378</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">378</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bhattarai, N.</author><author>Ramay, H. R.</author><author>Chou, S. H.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Material Science and Engineering, University of Washington, Seattle,WA 98195, USA.</auth-address><titles><title>Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery</title><secondary-title>Int J Nanomedicine</secondary-title><alt-title>International journal of nanomedicine</alt-title></titles><pages>181-7</pages><volume>1</volume><number>2</number><edition>2006/06</edition><keywords><keyword>Chitosan/*chemistry</keyword><keyword>Delayed-Action Preparations/*chemical synthesis</keyword><keyword>Diffusion</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Lactic Acid/*chemistry</keyword><keyword>Materials Testing</keyword><keyword>Nanoparticles/*chemistry/*ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Pharmaceutical Preparations/administration &amp; dosage/chemistry</keyword><keyword>Serum Albumin, Bovine/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1176-9114 (Print)</isbn><accession-num>17722534</accession-num><abstract>Nanoparticles of approximately 10nm in diameter made with chitosan or lactic acid-grafted chitosan were developed for high drug loading and prolonged drug release. A drug encapsulation efficiency of 92% and a release rate of 28% from chitosan nanoparticles over a 4-week period were demonstrated with bovine serum protein. To further increase drug encapsulation, prolong drug release, and increase chitosan solubility in solution of neutral pH, chitosan was modified with lactic acid by grafting D,L-lactic acid onto amino groups in chitosan without using a catalyst. The lactic acid-grafted chitosan nanoparticles demonstrated a drug encapsulation efficiency of 96% and a protein release rate of 15% over 4 weeks. With increased protein concentration, the drug encapsulation efficiency decreased and drug release rate increased. Unlike chitosan, which is generally soluble only in acid solution, the chitosan modified with lactic acid can be prepared from solutions of neutral pH, offering an additional advantage of allowing proteins or drugs to be uniformly incorporated in the matrix structure with minimal or no denaturization.</abstract><notes>Journal Article&#xD;New Zealand</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17722534 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2006</custom3><custom4>0.618</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>684</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">684</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Swanson, S. D.</author><author>Kukowska-Latallo, J. F.</author><author>Patri, A. K.</author><author>Chen, C.</author><author>Ge, S.</author><author>Cao, Z.</author><author>Kotlyar, A.</author><author>East, A. T.</author><author>Baker, J. R.</author></authors></contributors><auth-address>Department of Radiology,The University of Michigan Medical School, The University of Michigan, USA.</auth-address><titles><title>Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement</title><secondary-title>Int J Nanomedicine</secondary-title></titles><pages>201-10</pages><volume>3</volume><number>2</number><edition>2008/08/09</edition><dates><year>2008</year></dates><isbn>1176-9114 (Print)</isbn><accession-num>18686779</accession-num><abstract>A target-specific MRI contrast agent for tumor cells expressing high affinity folate receptor was synthesized using generation five (G5) ofpolyamidoamine (PAMAM) dendrimer. Surface modified dendrimer was functionalized for targeting with folic acid (FA) and the remaining terminal primary amines of the dendrimer were conjugated with the bifunctional NCS-DOTA chelator that forms stable complexes with gadolinium (Gd III). Dendrimer-DOTA conjugates were then complexed with GdCl3 followed by ICP-OES as well as MRI measurement of their longitudinal relaxivity (T1 s(-1) mM(-1)) of water. In xenograft tumors established in immunodeficient (SCID) mice with KB human epithelial cancer cells expressing folate receptor (FAR), the 3D MRI results showed specific and statistically significant signal enhancement in tumors generated with targeted Gd(III)-DOTA-G5-FA compared with signal generated by non-targeted Gd(III)-DOTA-G5 contrast nanoparticle. The targeted dendrimer contrast nanoparticles infiltrated tumor and were retained in tumor cells up to 48 hours post-injection of targeted contrast nanoparticle. The presence of folic acid on the dendrimer resulted in specific delivery of the nanoparticle to tissues and xenograft tumor cells expressing folate receptor in vivo. We present the specificity of the dendrimer nanoparticles for targeted cancer imaging with the prolonged clearance time compared with the current clinically approved gadodiamide (Omniscan) contrast agent. Potential application of this approach may include determination of the folate receptor status of tumors and monitoring of drug therapy.</abstract><notes>Swanson, Scott D&#xD;Kukowska-Latallo, Jolanta F&#xD;Patri, Anil K&#xD;Chen, Chunyan&#xD;Ge, Song&#xD;Cao, Zhengyi&#xD;Kotlyar, Alina&#xD;East, Andrea T&#xD;Baker, James R&#xD;1 R01 EB002657/EB/United States NIBIB&#xD;N01-CO-97111/CO/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;New Zealand&#xD;International journal of nanomedicine&#xD;Int J Nanomedicine. 2008;3(2):201-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18686779</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>0.618</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>479</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">479</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tran, T. D.</author><author>Caruthers, S. D.</author><author>Hughes, M.</author><author>Marsh, J. N.</author><author>Cyrus, T.</author><author>Winter, P. M.</author><author>Neubauer, A. M.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University Medical School, 660 South Euclid Blvd, St Louis, Missouri 63110, USA.</auth-address><titles><title>Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics</title><secondary-title>Int J Nanomedicine</secondary-title></titles><pages>515-26</pages><volume>2</volume><number>4</number><edition>2008/01/22</edition><keywords><keyword>Clinical Medicine/trends</keyword><keyword>Contrast Media</keyword><keyword>Diagnostic Imaging/*trends</keyword><keyword>Drug Carriers/chemistry</keyword><keyword>Drug Delivery Systems/*trends</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Molecular Probe Techniques/*trends</keyword><keyword>Nanomedicine/trends</keyword><keyword>Nanoparticles/*diagnostic use/*therapeutic use</keyword></keywords><dates><year>2008</year></dates><isbn>1176-9114 (Print)</isbn><accession-num>18203420</accession-num><abstract>Molecular imaging is a novel tool that has allowed non-invasive diagnostic imaging to transition from gross anatomical description to identification of specific tissue epitopes and observation of biological processes at the cellular level. This technique has been confined to the field of nuclear imaging; however, recent advances in nanotechnology have extended this research to include ultrasound (US) and magnetic resonance (MR) imaging. The exploitation of nanotechnology for MR and US molecular imaging has generated several candidate contrast agents. One multimodality platform, targeted perfluorocarbon (PFC) nanoparticles, is useful for noninvasive detection with US and MR, targeted drug delivery, and quantification.</abstract><notes>Tran, Trung D&#xD;Caruthers, Shelton D&#xD;Hughes, Michael&#xD;Marsh, John N&#xD;Cyrus, Tillmann&#xD;Winter, Patrick M&#xD;Neubauer, Anne M&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Review&#xD;New Zealand&#xD;International journal of nanomedicine&#xD;Int J Nanomedicine. 2007;2(4):515-26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18203420</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>0.618</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>103</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">103</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xing, Y.</author><author>Smith, A. M.</author><author>Agrawal, A.</author><author>Ruan, G.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical, Engineering and Chemistry, Emory University and Georgia Institute of Technology, Atlanta, GA 30322, USA.</auth-address><titles><title>Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots</title><secondary-title>Int J Nanomedicine</secondary-title></titles><pages>473-81</pages><volume>1</volume><number>4</number><edition>2007/08/28</edition><keywords><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Neoplasm Proteins/*metabolism</keyword><keyword>Neoplasms/*metabolism/*pathology</keyword><keyword>*Quantum Dots</keyword><keyword>Semiconductors</keyword><keyword>Spectrometry, Fluorescence/*methods</keyword><keyword>Tumor Markers, Biological/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1176-9114 (Print)</isbn><accession-num>17722280</accession-num><abstract>Semiconductor quantum dots (QDs) are a new class of fluorescent labels with broad applications in biomedical imaging, disease diagnostics, and molecular and cell biology. In comparison with organic dyes and fluorescent proteins, quantum dots have unique optical and electronic properties such as size-tunable light emission, improved signal brightness, resistance against photobleaching, and simultaneous excitation of multiple fluorescence colors. Recent advances have led to multifunctional nanoparticle probes that are highly bright and stable under complex in vitro and in vivo conditions. New designs involve encapsulating luminescent QDs with amphiphilic block copolymers, and linking the polymer coating to tumor-targeting ligands and drug-delivery functionalities. These improved QDs have opened new possibilities for real-time imaging and tracking of molecular targets in living cells, for multiplexed analysis of biomolecular markers in clinical tissue specimens, and for ultrasensitive imaging of malignant tumors in living animal models. In this article, we briefly discuss recent developments in bioaffinity QD probes and their applications in molecular profiling of individual cancer cells and clinical tissue specimens.</abstract><notes>Xing, Yun&#xD;Smith, Andrew M&#xD;Agrawal, Amit&#xD;Ruan, Gang&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;New Zealand&#xD;International journal of nanomedicine&#xD;Int J Nanomedicine. 2006;1(4):473-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17722280</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>0.618</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>53</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">53</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rostad, K.</author><author>Mannelqvist, M.</author><author>Halvorsen, O. J.</author><author>Oyan, A. M.</author><author>Bo, T. H.</author><author>Stordrange, L.</author><author>Olsen, S.</author><author>Haukaas, S. A.</author><author>Lin, B.</author><author>Hood, L.</author><author>Jonassen, I.</author><author>Akslen, L. A.</author><author>Kalland, K. H.</author></authors></contributors><auth-address>Section for Microbiology and Immunology, The Gade Institute, Bergen, Norway.</auth-address><titles><title>ERG upregulation and related ETS transcription factors in prostate cancer</title><secondary-title>Int J Oncol</secondary-title></titles><pages>19-32</pages><volume>30</volume><number>1</number><edition>2006/12/05</edition><keywords><keyword>DNA Primers</keyword><keyword>DNA-Binding Proteins/*genetics</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization</keyword><keyword>Male</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Polymerase Chain Reaction</keyword><keyword>Prostate/physiology</keyword><keyword>Prostatectomy</keyword><keyword>Prostatic Neoplasms/*genetics/surgery</keyword><keyword>Proto-Oncogene Proteins c-ets/*genetics</keyword><keyword>Trans-Activators/*genetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1019-6439 (Print)</isbn><accession-num>17143509</accession-num><abstract>The aim of this study was to identify and validate differentially expressed genes in matched pairs of benign and malignant prostate tissue. Samples included 29 histologically verified primary tumors and 23 benign controls. Microarray analysis was initially performed using a sequence verified set of 40,000 human cDNA clones. Among the genes most consistently and highly upregulated in prostate cancer was the ETS family transcription factor ERG (ETS related gene). This finding was validated in an expanded patient series (37 tumors and 38 benign samples) using DNA oligonucleotide microarray and real-time quantitative PCR assays. ERG was 20- to more than 100-fold overexpressed in prostate cancer compared with benign prostate tissue in more than 50% of patients according to quantitative PCR. Surprisingly, ERG mRNA levels were found to be significantly higher in the endothelial cell line, HUVEC, than in the prostate cell lines PC3, DU145 and LNCaP. In situ hybridization of prostate cancer tissue revealed that ERG was abundantly expressed in both prostate cancer cells and associated endothelial cells. The consistency and magnitude of ERG overexpression in prostate cancer appeared unique, but several related ETS transcription factors were also overexpressed in matched pairs of tumor and benign samples, whereas ETS2 was significantly underexpressed. Our findings support the hypothesis that ERG overexpression and related ETS transcription factors are important for early prostate carcinogenesis.</abstract><notes>Rostad, Kari&#xD;Mannelqvist, Monica&#xD;Halvorsen, Ole Johan&#xD;Oyan, Anne Margrete&#xD;Bo, Trond Hellem&#xD;Stordrange, Laila&#xD;Olsen, Sue&#xD;Haukaas, Svein Andreas&#xD;Lin, Biaoyang&#xD;Hood, Leroy&#xD;Jonassen, Inge&#xD;Akslen, Lars Andreas&#xD;Kalland, Karl-Henning&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Greece&#xD;International journal of oncology&#xD;Int J Oncol. 2007 Jan;30(1):19-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17143509</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>2.556</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>405</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">405</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, W.</author><author>Jiang, W.</author><author>Chen, J.</author><author>Yin, M.</author><author>Wang, Z.</author><author>Jiang, X.</author></authors></contributors><auth-address>Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 200032, People&apos;s Republic of China.</auth-address><titles><title>Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride</title><secondary-title>Int J Pharm</secondary-title></titles><pages>196-205</pages><volume>349</volume><number>1-2</number><edition>2007/10/02</edition><keywords><keyword>Administration, Intranasal</keyword><keyword>Animals</keyword><keyword>Apomorphine/*administration &amp; dosage/*pharmacology/toxicity</keyword><keyword>Brain/*metabolism</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Cilia/drug effects/pathology</keyword><keyword>Copulation/*drug effects</keyword><keyword>Dopamine Agonists/*administration &amp; dosage/*pharmacology/toxicity</keyword><keyword>Drug Delivery Systems</keyword><keyword>Ejaculation/drug effects</keyword><keyword>Estrus/physiology</keyword><keyword>Female</keyword><keyword>Injections, Subcutaneous</keyword><keyword>Male</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Nasal Mucosa/pathology</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 12</date></pub-dates></dates><isbn>0378-5173 (Print)</isbn><accession-num>17904315</accession-num><abstract>Clinical studies showed apomorphine (APO) nasal spray was well tolerated, with lower dose and less side effect in treatment of erectile dysfunction compared with its sublingual formulation. The aim of this paper was to find out whether there exists any direct drug transport from nasal cavity to brain following intranasal administration to rats. Pharmacokinetic results illustrated there were no significant differences of AUC0--&gt;120 values in most brain regions and cerebrospinal fluid (CSF) through intranasal delivery route compared with subcutaneous injection, while its plasma AUC0--&gt;120 was only one-half. APO brain and CSF profiles after intranasal administration displayed faster onset compared with subcutaneous delivery. About 35-50% of APO content at 2h, by calculating brain drug direct transport percentage, were transported to different brain regions via the olfactory pathway. In addition, the similar brain drug concentration-time profiles through intranasal delivery compared with subcutaneous route had good correlation with its equivalent sexual stimulant activity on copulatory behaviour in rats. Therefore, we could conclude a nose-to-brain pathway for APO intranasal delivery, which significantly increased brain accumulation of APO. Current experiments also explained the reason why the intranasal application of APO could be an effective alternative to subcutaneous and oral formulations.</abstract><notes>Lu, Wei&#xD;Jiang, Wenming&#xD;Chen, Jun&#xD;Yin, Ming&#xD;Wang, Zejian&#xD;Jiang, Xinguo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands&#xD;International journal of pharmaceutics&#xD;Int J Pharm. 2008 Feb 12;349(1-2):196-205. Epub 2007 Aug 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17904315</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>2.408</custom4><electronic-resource-num>S0378-5173(07)00692-8 [pii]&#xD;10.1016/j.ijpharm.2007.08.012</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>169</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">169</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caruthers, S. D.</author><author>Neubauer, A. M.</author><author>Hockett, F. D.</author><author>Lamerichs, R.</author><author>Winter, P. M.</author><author>Scott, M. J.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University Medical School, St. Louis, Missouri 63110, USA. SCaruthers@cmrl.wustl.edu</auth-address><titles><title>In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla</title><secondary-title>Invest Radiol</secondary-title></titles><pages>305-12</pages><volume>41</volume><number>3</number><edition>2006/02/17</edition><keywords><keyword>Animals</keyword><keyword>Dogs</keyword><keyword>Emulsions</keyword><keyword>Fibrin/*metabolism</keyword><keyword>Fluorine</keyword><keyword>Gadolinium DTPA/*diagnostic use</keyword><keyword>Hydrocarbons, Fluorinated/*diagnostic use</keyword><keyword>*Nanostructures</keyword><keyword>*Nuclear Magnetic Resonance, Biomolecular</keyword><keyword>Phantoms, Imaging</keyword><keyword>Thrombosis/*diagnosis</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0020-9996 (Print)</isbn><accession-num>16481914</accession-num><abstract>OBJECTIVES: This study explored the use of F spectroscopy and imaging with targeted perfluorocarbon nanoparticles for the simultaneous identification of multiple bio-signatures at 1.5 T. MATERIALS AND METHODS: Two nanoparticle emulsions with perfluoro-15-crown-5-ether (CE) or perfluorooctylbromide (PFOB) cores were targeted in vitro to fibrin clot phantoms (n=12) in 4 progressive ratios using biotin-avidin interactions. The CE nanoparticles incorporated gadolinium. Fluorine images were acquired using steady-state gradient-echo techniques; spectra using volume-selective and nonselective sampling. RESULTS: On conventional T1-weighted imaging, clots with CE nanoparticles enhanced as expected, with intensity decreasing monotonically with CE concentration. All clots were visualized using wide bandwidth fluorine imaging, while restricted bandwidth excitation permitted independent imaging of CE or PFOB nanoparticles. Furthermore, F imaging and spectroscopy allowed visual and quantitative confirmation of relative perfluorocarbon nanoparticle distributions. CONCLUSIONS: F MRI/S molecular imaging of perfluorocarbon nanoparticles in vitro suggests that noninvasive phenotypic characterization of pathologic bio-signatures is feasible at clinical field strengths.</abstract><notes>Caruthers, Shelton D&#xD;Neubauer, Anne M&#xD;Hockett, Frank D&#xD;Lamerichs, Rolf&#xD;Winter, Patrick M&#xD;Scott, Michael J&#xD;Gaffney, Patrick J&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-37007/co/nci&#xD;N019co-27031/co/nci&#xD;In Vitro&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Investigative radiology&#xD;Invest Radiol. 2006 Mar;41(3):305-12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16481914</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>4.234</custom4><electronic-resource-num>10.1097/01.rli.0000199281.60135.6a&#xD;00004424-200603000-00014 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>156</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">156</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Deng, J.</author><author>Rhee, T. K.</author><author>Sato, K. T.</author><author>Salem, R.</author><author>Haines, K.</author><author>Paunesku, T.</author><author>Mulcahy, M. F.</author><author>Miller, F. H.</author><author>Omary, R. A.</author><author>Larson, A. C.</author></authors></contributors><auth-address>Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Il 60611, USA.</auth-address><titles><title>In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla</title><secondary-title>Invest Radiol</secondary-title></titles><pages>410-4</pages><volume>41</volume><number>4</number><edition>2006/03/09</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Feasibility Studies</keyword><keyword>*Image Processing, Computer-Assisted</keyword><keyword>Liver Neoplasms/*pathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Necrosis</keyword><keyword>Rabbits</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0020-9996 (Print)</isbn><accession-num>16523024</accession-num><abstract>OBJECTIVES: We sought to demonstrate the feasibility of using single-shot spin-echo echo-planar imaging for imaging liver tumor necrosis in the in vivo VX2 rabbit model at 1.5 T. MATERIALS AND METHODS: VX2 liver tumors were grown in 4 rabbits. Diffusion-weighted images (DWIs) were acquired during breath-hold using twice refocused SE-EPI (b = 0, 700, 1400 seconds/mm). Anatomic images for tumor size measurements were acquired using T2W TSE. Rabbits were euthanized for subsequent necropsy. Viable and necrotic tumor tissue ADC measurements were performed with reference to hematoxylin and eosin pathology. RESULTS: A total of 8 tumors were grown with diameters ranging from 1.2 to 5.3 cm. Viable and necrotic tumor compartments were clearly differentiated. Apparent diffusion coefficient in necrotic tumor cores, 1.26 +/- 0.11 x 10 mm/s, were significantly greater than those in surrounding viable tumor tissues, 0.74 +/- 0.06 x 10 mm/s (mean +/- SD, P &lt; 0.05). CONCLUSIONS: In vivo DWI of liver tumor necrosis in the VX2 rabbit model is feasible using a 1.5 T clinical magnetic resonance imaging scanner. DWI may permit longitudinal assessment of liver tumor therapies in both preclinical and clinical studies.</abstract><notes>Deng, Jie&#xD;Rhee, Thomas K&#xD;Sato, Kent T&#xD;Salem, Riad&#xD;Haines, Kenneth&#xD;Paunesku, Tatjana&#xD;Mulcahy, Mary F&#xD;Miller, Frank H&#xD;Omary, Reed A&#xD;Larson, Andrew C&#xD;Evaluation Studies&#xD;United States&#xD;Investigative radiology&#xD;Invest Radiol. 2006 Apr;41(4):410-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16523024</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>4.234</custom4><electronic-resource-num>10.1097/01.rli.0000201232.14903.da&#xD;00004424-200604000-00007 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>384</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">384</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Melancon, M. P.</author><author>Wang, Y.</author><author>Wen, X.</author><author>Bankson, J. A.</author><author>Stephens, L. C.</author><author>Jasser, S.</author><author>Gelovani, J. G.</author><author>Myers, J. N.</author><author>Li, C.</author></authors></contributors><auth-address>Departments of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</auth-address><titles><title>Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping</title><secondary-title>Invest Radiol</secondary-title><alt-title>Investigative radiology</alt-title></titles><pages>569-78</pages><volume>42</volume><number>8</number><edition>2007/08</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0020-9996 (Print)</isbn><accession-num>17620940</accession-num><abstract>OBJECTIVE: To evaluate the effectiveness of a dual magnetic resonance-near infrared fluorescence optical imaging agent, poly(l-glutamic acid)-DTPA-Gd-NIR813, for both preoperative and intraoperative visualization and characterization of sentinel lymph nodes (SLN) in mice. MATERIALS AND METHODS: Poly(L-glutamic acid) was conjugated with DTPA-Gd and NIR813 dye to obtain PG-DTPA-Gd-NIR813. To confirm drainage into the SLNs, this agent was injected subcutaneously into the front paw of nude mice followed by isosulfan blue (n = 6). Furthermore, PG-DTPA-Gd-NIR813 was injected subcutaneously at doses of 0.002 mmol Gd/kg (4.8 nmol eq. NIR813) and 0.02 mmol Gd/kg (48 nmol eq. NIR813) (n = 3/dose). To differentiate metastatic from nonmetastatic lymph nodes, nude mice bearing human oral squamous cell carcinoma (DM14) were injected intralingually with 0.02 mmol Gd/kg PG-DTPA-Gd-NIR813 (n = 3). Pre- and postcontrast images were taken using 4.7 T Bruker MRI scanner and Xenogen optical imaging system. The status of lymph nodes resected under the guidance of optical imaging was confirmed by histologic examinations. RESULTS: PG-DTPA-Gd-NIR813 colocalized with isosulfan blue, indicating drainage to the SLN. After subcutaneous injection, axiliary and branchial lymph nodes were clearly visualized with both T1-weighted MR and optical imaging within 3 minutes of contrast injection, even at the lowest dose tested (0.002 mmol Gd/kg). After intralingual injection in tumor-bearing mice, MR imaging identified 4 of the 6 superficial cervical lymph nodes, whereas near-infrared fluorescence (NIRF) optical imaging identified all 6 cervical nodes. The pattern of contrast enhancement of SLN visualized in MR images showed a characteristic ring-shaped appearance with a central filling defect, possibly resulting from nodal infiltration of metastatic lesions. Histopathologic examination of the SLNs resected under NIRF imaging guidance revealed micrometastases in all 6 SLNs identified by NIRF imaging. CONCLUSIONS: The dual modality imaging method demonstrated in this study represents an effective technique for localization and characterization of SLN.</abstract><notes>R01 ca119387/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17620940 </url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2007</custom3><custom4>4.234</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>332</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">332</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Hall, C. S.</author><author>Fuhrhop, R. W.</author><author>Lacy, E. K.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University School of Medicine, Cardiovascular Division, St Louis, Missouri 63110, USA. msh@cvu.wustl</auth-address><titles><title>Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging</title><secondary-title>J Acoust Soc Am</secondary-title></titles><pages>964-72</pages><volume>117</volume><number>2</number><edition>2005/03/12</edition><keywords><keyword>Animals</keyword><keyword>*Blood</keyword><keyword>Contrast Media/*pharmacokinetics</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Emulsions</keyword><keyword>Image Enhancement</keyword><keyword>Microbubbles</keyword><keyword>*Nanostructures</keyword><keyword>*Plasma</keyword><keyword>Scattering, Radiation</keyword><keyword>Signal Processing, Computer-Assisted</keyword><keyword>Swine</keyword><keyword>Transducers</keyword><keyword>*Ultrasonography</keyword></keywords><dates><year>2005</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0001-4966 (Print)</isbn><accession-num>15759715</accession-num><abstract>The ability to enhance specific molecular markers of pathology with ultrasound has been previously demonstrated by our group employing a nanoparticle contrast agent [Lanza et al., Invest. Radiol. 35, 227-234 (2000); Ultrasound Med. Biol. 23, 863-870 (1997)]. One of the advantages of this agent is very low echogenicity in the blood pool that allows increased contrast between the blood pool and the bound, site-targeted agent. We measured acoustic backscatter and attenuation coefficient as a function of the contrast agent concentration, ambient pressure, peak acoustic pressure, and as an effect of duty cycle and wave form shape. Measurements were performed while the nanoparticles were suspended in either whole porcine blood or plasma. The nanoparticles were only detectable when insonified within plasma devoid of red blood cells and were shown to exhibit backscatter levels more than 30 dB below the backscatter from whole blood. Attenuation of nanoparticles in whole porcine blood was not measurably different from that of whole blood alone over a range of concentrations up to eight times the maximum in vivo dose. The resulting data provide upper bounds on blood pool attenuation coefficient and backscatter and will be needed to more precisely define levels of molecular contrast enhancement that may be obtained in vivo.</abstract><notes>Hughes, Michael S&#xD;Marsh, Jon N&#xD;Hall, Christopher S&#xD;Fuhrhop, Ralph W&#xD;Lacy, Elizabeth K&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Hl-59865/hl/nhlbi&#xD;N01 c0-07013-32/phs&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;The Journal of the Acoustical Society of America&#xD;J Acoust Soc Am. 2005 Feb;117(2):964-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=15759715</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>1.587</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>185</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">185</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>McCarthy, J. E.</author><author>Marsh, J. N.</author><author>Arbeit, J. M.</author><author>Neumann, R. G.</author><author>Fuhrhop, R. W.</author><author>Wallace, K. D.</author><author>Znidersic, D. R.</author><author>Maurizi, B. N.</author><author>Baldwin, S. L.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>School of Medicine, Washington University, St. Louis, Missouri 63108, USA. msh@cvu.wustl.edu</auth-address><titles><title>Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging</title><secondary-title>J Acoust Soc Am</secondary-title></titles><pages>3542-57</pages><volume>121</volume><number>6</number><edition>2007/06/08</edition><keywords><keyword>Entropy</keyword><keyword>Humans</keyword><keyword>Mathematics</keyword><keyword>Models, Molecular</keyword><keyword>Nanoparticles</keyword><keyword>Neoplasms/blood supply/ultrasonography</keyword><keyword>Neovascularization, Pathologic/diagnosis</keyword><keyword>*Ultrasonography</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1520-8524 (Electronic)</isbn><accession-num>17552706</accession-num><abstract>Qualitative and quantitative properties of the finite part, H(f), of the Shannon entropy of a continuous waveform f(t) in the continuum limit are derived in order to illuminate its use for waveform characterization. Simple upper and lower bounds on H(f), based on features of f(t), are defined. Quantitative criteria for a priori estimation of the average-case variation of H(f) and log E(f), where E(f) is the signal energy of f(t) are also derived. These provide relative sensitivity estimates that could be used to prospectively choose optimal imaging strategies in real-time ultrasonic imaging machines, where system bandwidth is often pushed to its limits. To demonstrate the utility of these sensitivity relations for this application, a study designed to assess the feasibility of identification of angiogenic neovasculature targeted with perfluorocarbon nanoparticles that specifically bind to alpha(v)beta3-integrin expression in tumors was performed. The outcome of this study agrees with the prospective sensitivity estimates that were used for the two receivers. Moreover, these data demonstrate the ability of entropy-based signal receivers when used in conjunction with targeted nanoparticles to elucidate the presence of alpha(v)beta3 integrins in primordial neovasculature, particularly in acoustically unfavorable environments.</abstract><notes>Hughes, M S&#xD;McCarthy, J E&#xD;Marsh, J N&#xD;Arbeit, J M&#xD;Neumann, R G&#xD;Fuhrhop, R W&#xD;Wallace, K D&#xD;Znidersic, D R&#xD;Maurizi, B N&#xD;Baldwin, S L&#xD;Lanza, G M&#xD;Wickline, S A&#xD;Co-27031/co/nci&#xD;Eb002168/eb/nibib&#xD;Hl042950/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The Journal of the Acoustical Society of America&#xD;J Acoust Soc Am. 2007 Jun;121(6):3542-57.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17552706</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>1.587</custom4><electronic-resource-num>10.1121/1.2722050</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>392</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">392</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agrawal, A.</author><author>Sathe, T.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, Suite 2001, 101 Woodruff Circle, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Single-bead immunoassays using magnetic microparticles and spectral-shifting quantum dots</title><secondary-title>J Agric Food Chem</secondary-title></titles><pages>3778-82</pages><volume>55</volume><number>10</number><edition>2007/04/26</edition><keywords><keyword>Fluorescent Dyes</keyword><keyword>Immunoassay/*methods</keyword><keyword>*Magnetics</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Microspheres</keyword><keyword>Tumor Necrosis Factor-alpha/analysis</keyword></keywords><dates><year>2007</year><pub-dates><date>May 16</date></pub-dates></dates><isbn>0021-8561 (Print)</isbn><accession-num>17455953</accession-num><abstract>This paper reports a single-bead immunoassay method based on the combined use of magnetic microparticles (MMPs) for target capturing/enrichment and antibody-conjugated semiconductor quantum dots (QDs) for fluorescence detection. In comparison with organic dyes and fluorescent proteins, QDs exhibit unique optical properties such as size-tunable fluorescence emission (spectral shifting), large absorption coefficients, improved brightness, and superior photostability. Magnetic beads, composed of iron oxide nanoparticles embedded in polymeric matrices, provide a platform for rapid capturing and enrichment of biomolecules and pathogens in dilute biological and environmental samples. However, a major problem in using magnetic beads for fluorescence immunoassays is that the bead&apos;s autofluorescence strongly interferes with the target detection signal. This spectral overlapping problem can be overcome by using semiconductor QDs as a new class of spectral-shifting labels. By shifting the QD emission signals away from the bead autofluorescence, it is possible to detect biomolecular antigens such as tumor necrosis factor (TNF-alpha) at femtomolar (10-15 M) concentrations when the target molecules are captured and enriched on the magnetic bead surface. This sensitivity is almost 1000 times higher that that of traditional immunoabsorbent assays and more than 100 times higher than immunofluorescent assays using organic dyes.</abstract><notes>Agrawal, Amit&#xD;Sathe, Tushar&#xD;Nie, Shuming&#xD;P20 GM072069/GM/United States NIGMS&#xD;R01 CA108468-01/CA/United States NCI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of agricultural and food chemistry&#xD;J Agric Food Chem. 2007 May 16;55(10):3778-82. Epub 2007 Apr 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17455953</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>2.532</custom4><electronic-resource-num>10.1021/jf0635006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>64</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">64</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bailey, R. C.</author><author>Kwong, G. A.</author><author>Radu, C. G.</author><author>Witte, O. N.</author><author>Heath, J. R.</author></authors></contributors><auth-address>NanoSystems Biology Cancer Center: Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>1959-67</pages><volume>129</volume><number>7</number><edition>2007/01/31</edition><keywords><keyword>Animals</keyword><keyword>Antibodies/chemistry/*genetics/immunology</keyword><keyword>Cell Line</keyword><keyword>DNA/chemistry/genetics</keyword><keyword>Flow Cytometry</keyword><keyword>*Gene Library</keyword><keyword>Immunoconjugates/chemistry/genetics/immunology</keyword><keyword>Immunoglobulin G/chemistry/genetics</keyword><keyword>Mice</keyword><keyword>Microfluidic Analytical Techniques</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>*Peptide Library</keyword><keyword>T-Lymphocytes/immunology</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 21</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17260987</accession-num><abstract>Whether for pathological examination or for fundamental biology studies, different classes of biomaterials and biomolecules are each measured from a different region of a typically heterogeneous tissue sample, thus introducing unavoidable sources of noise that are hard to quantitate. We describe the method of DNA-encoded antibody libraries (DEAL) for spatially multiplexed detection of ssDNAs and proteins as well as for cell sorting, all on the same diagnostic platform. DEAL is based upon the coupling of ssDNA oligomers onto antibodies which are then combined with the biological sample of interest. Spotted DNA arrays, which are found to inhibit biofouling, are utilized to spatially stratify the biomolecules or cells of interest. We demonstrate the DEAL technique for (1) the rapid detection of multiple proteins within a single microfluidic channel, and, with the additional step of electroless amplification of gold-nanoparticle labeled secondary antibodies, we establish a detection limit of 10 fM for the protein IL-2, 150 times more sensitive than the analogue ELISA; (2) the multiplexed, on-chip sorting of both immortalized cell lines and primary immune cells with an efficiency that exceeds surface-confined panning approaches; and (3) the co-detection of ssDNAs, proteins, and cell populations on the same platform.</abstract><notes>Bailey, Ryan C&#xD;Kwong, Gabriel A&#xD;Radu, Caius G&#xD;Witte, Owen N&#xD;Heath, James R&#xD;5u54 ca119347/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Feb 21;129(7):1959-67. Epub 2007 Jan 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17260987</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja065930i</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>571</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">571</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bull, S. R.</author><author>Palmer, L. C.</author><author>Fry, N. J.</author><author>Greenfield, M. A.</author><author>Messmore, B. W.</author><author>Meade, T. J.</author><author>Stupp, S. I.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>A templating approach for monodisperse self-assembled organic nanostructures</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2742-3</pages><volume>130</volume><number>9</number><edition>2008/02/13</edition><keywords><keyword>Aluminum Silicates/chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Peptides/*chemical synthesis/chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Polymers/*chemical synthesis/chemistry</keyword><keyword>Protein Conformation</keyword><keyword>Protein Structure, Secondary</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 5</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18266371</accession-num><abstract>The precise structural control is known for self-assembly into closed spherical structures (e.g., micelles), but similar control of open structures is much more challenging. Inspired by natural tobacco mosaic virus, we present the use of a rigid-rod template to control the size of a one-dimensional self-assembly. We believe that this strategy is novel for organic self-assembly and should provide a general approach to controlling size and dimension.</abstract><notes>Bull, Steve R&#xD;Palmer, Liam C&#xD;Fry, Nathaniel J&#xD;Greenfield, Megan A&#xD;Messmore, Benjamin W&#xD;Meade, Thomas J&#xD;Stupp, Samuel I&#xD;5R01EB005866-02/EB/United States NIBIB&#xD;CA119341-02/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Mar 5;130(9):2742-3. Epub 2008 Feb 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18266371</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja710749q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>243</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">243</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bunimovich, Y. L.</author><author>Shin, Y. S.</author><author>Yeo, W. S.</author><author>Amori, M.</author><author>Kwong, G.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>Quantitative real-time measurements of DNA hybridization with alkylated nonoxidized silicon nanowires in electrolyte solution</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>16323-31</pages><volume>128</volume><number>50</number><edition>2006/12/15</edition><keywords><keyword>Alkylation</keyword><keyword>Biosensing Techniques</keyword><keyword>DNA/*analysis</keyword><keyword>Electrolytes/*chemistry</keyword><keyword>Kinetics</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Molecular Structure</keyword><keyword>Nanowires/*chemistry/ultrastructure</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>Oxidation-Reduction</keyword><keyword>Silicon/*chemistry</keyword><keyword>Solutions</keyword><keyword>Spectrum Analysis</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 20</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17165787</accession-num><abstract>The quantitative, real-time detection of single-stranded oligonucleotides with silicon nanowires (SiNWs) in physiologically relevant electrolyte solution is demonstrated. Debye screening of the hybridization event is circumvented by utilizing electrostatically adsorbed primary DNA on an amine-terminated NW surface. Two surface functionalization chemistries are compared: an amine-terminated siloxane monolayer on the native SiO2 surface of the SiNW, and an amine-terminated alkyl monolayer grown directly on a hydrogen-terminated SiNW surface. The SiNWs without the native oxide exhibit improved solution-gated field-effect transistor characteristics and a significantly enhanced sensitivity to single-stranded DNA detection, with an accompanying 2 orders of magnitude improvement in the dynamic range of sensing. A model for the detection of analyte by SiNW sensors is developed and utilized to extract DNA-binding kinetic parameters. Those values are directly compared with values obtained by the standard method of surface plasmon resonance (SPR) and demonstrated to be similar. The nanowires, however, are characterized by higher detection sensitivity. The implication is that SiNWs can be utilized to quantitate the solution-phase concentration of biomolecules at low concentrations. This work also demonstrates the importance of surface chemistry for optimizing biomolecular sensing with silicon nanowires.</abstract><notes>Bunimovich, Yuri L&#xD;Shin, Young Shik&#xD;Yeo, Woon-Seok&#xD;Amori, Michael&#xD;Kwong, Gabriel&#xD;Heath, James R&#xD;5u54 ca119347/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Dec 20;128(50):16323-31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17165787</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja065923u</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>385</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">385</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, T.</author><author>Xu, L.</author><author>Gibson, H. W.</author><author>Dorn, H. C.</author><author>Chancellor, C. J.</author><author>Olmstead, M. M.</author><author>Balch, A. L.</author></authors></contributors><auth-address>Contribution from the Departments of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, and University of California, Davis, California 95616.</auth-address><titles><title>Sc(3)N@C(78): encapsulated cluster regiocontrol of adduct docking on an ellipsoidal metallofullerene sphere</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>10795-800</pages><volume>129</volume><number>35</number><edition>2007/08/10 </edition><dates><year>2007</year><pub-dates><date>Sep 5</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17691732</accession-num><abstract>The first N-tritylpyrrolidino derivatives of D3h (78:5) Sc3N@C78 were successfully synthesized and isolated. The addition sites for the two nearly equivalent kinetic monoadducts 1a and 1b are across two different 6,6 junction sites on the Sc3N@C78 cage that are offset from the horizontal plane defined by the Sc3N cluster. The adducts were characterized by NMR experiments, DFT calculations and X-ray crystallographic analysis of Sc3N@C78 derivative 1a. A unique finding of this study is the regiocontrol of adduct docking by the internal Sc3N cluster.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17691732 </url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>7.696</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>675</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">675</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, T.</author><author>Xu, L.</author><author>Shu, C.</author><author>Champion, H. A.</author><author>Reid, J. E.</author><author>Anklin, C.</author><author>Anderson, M. R.</author><author>Gibson, H. W.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, USA.</auth-address><titles><title>Selective formation of a symmetric Sc3N@C78 bisadduct: adduct docking controlled by an internal trimetallic nitride cluster</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2136-7</pages><volume>130</volume><number>7</number><edition>2008/01/26</edition><keywords><keyword>Cyclopropanes/chemistry</keyword><keyword>Fullerenes/*chemistry</keyword><keyword>Hydrocarbons, Cyclic/*chemical synthesis/chemistry</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Malonates/chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Nitrogen Compounds/*chemical synthesis/chemistry</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry</keyword><keyword>Scandium/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 20</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18217757</accession-num><notes>Cai, Ting&#xD;Xu, Liaosa&#xD;Shu, Chunying&#xD;Champion, Hunter A&#xD;Reid, Jonathan E&#xD;Anklin, Clemens&#xD;Anderson, Mark R&#xD;Gibson, Harry W&#xD;Dorn, Harry C&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Feb 20;130(7):2136-7. Epub 2008 Jan 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18217757</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja077630m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>270</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">270</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Immobilization of ligands with precise control of density to electroactive surfaces</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15542-6</pages><volume>128</volume><number>48</number><edition>2006/11/30</edition><keywords><keyword>Aminooxyacetic Acid/*chemistry</keyword><keyword>Benzoquinones/*chemistry</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Electrochemistry</keyword><keyword>Ligands</keyword><keyword>*Models, Chemical</keyword><keyword>Oxidation-Reduction</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 6</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17132022</accession-num><abstract>We report a broadly applicable surface chemistry methodology to immobilize ligands, proteins, and cells to an electroactive substrate with precise control of ligand density. This strategy is based on the coupling of soluble aminooxy terminated ligands with an electroactive quinone terminated monolayer. The surface chemistry product oxime is also redox active but at a different potential and therefore allows for real-time monitoring of the immobilization reaction. Only the quinone form of the immobilized redox pair is reactive with soluble aminooxy groups, which allows for the determination of the yield of reaction, the ability to immobilize multiple ligands at controlled densities, and the in-situ modulation of ligand activity. We demonstrate this methodology by using cyclic voltammetry to characterize the kinetics of a model interfacial reaction with aminooxy acetic acid. We also demonstrate the synthetic flexibility and utility of this method for biospecific interactions by installing aminooxy terminated FLAG peptides and characterizing their binding to soluble anti-FLAG with surface plasmon resonance spectroscopy. We further show this methodology is compatible with microarray technology by printing rhodamine-oxyamine in various size spots and characterizing the yield within the spots by cyclic voltammetry. We also show this methodology is compatible with cell culture conditions and fluorescent microscopy technology for cell biological studies. Arraying RGD-oxyamine peptides on these substrates allows for bio-specific adhesion of Swiss 3T3 Fibroblasts.</abstract><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Dec 6;128(48):15542-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17132022</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja065828l</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>149</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">149</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, H.</author><author>MacDonald, R. C.</author><author>Li, S.</author><author>Krett, N. L.</author><author>Rosen, S. T.</author><author>O&apos;Halloran, T. V.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>13348-9</pages><volume>128</volume><number>41</number><edition>2006/10/13</edition><keywords><keyword>Antineoplastic Agents/*administration &amp; dosage/pharmacology</keyword><keyword>Arsenicals/*administration &amp; dosage/pharmacology</keyword><keyword>Capsules/*chemistry</keyword><keyword>Chemistry, Pharmaceutical/*methods</keyword><keyword>Doxorubicin/pharmacology</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Kinetics</keyword><keyword>Lipids/*chemistry</keyword><keyword>Liposomes/*chemistry</keyword><keyword>Lymphocytes/drug effects/pathology</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Oxides/*administration &amp; dosage/pharmacology</keyword><keyword>Temperature</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17031934</accession-num><notes>Chen, Haimei&#xD;MacDonald, Robert C&#xD;Li, Shuyou&#xD;Krett, Nancy L&#xD;Rosen, Steven T&#xD;O&apos;Halloran, Thomas V&#xD;Gm 054111/gm/nigms&#xD;P30 ca 060553/ca/nci&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 18;128(41):13348-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17031934</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja064864h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>314</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">314</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, J. S.</author><author>Jun, Y. W.</author><author>Yeon, S. I.</author><author>Kim, H. C.</author><author>Shin, J. S.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Chemistry, Yonsei University, Seoul 120-749, Korea.</auth-address><titles><title>Biocompatible heterostructured nanoparticles for multimodal biological detection</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15982-3</pages><volume>128</volume><number>50</number><edition>2006/12/15</edition><keywords><keyword>Biocompatible Materials/*chemistry</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Dimerization</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/*chemistry/*ultrastructure</keyword><keyword>Nanostructures/*chemistry/*ultrastructure</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 20</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17165720</accession-num><notes>Choi, Jin-sil&#xD;Jun, Young-wook&#xD;Yeon, Soo-In&#xD;Kim, Hyoung Chan&#xD;Shin, Jeon-Soo&#xD;Cheon, Jinwoo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Dec 20;128(50):15982-3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17165720</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja066547g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>100</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">100</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, H.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University, Atlanta, Georgia, USA.</auth-address><titles><title>Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>3333-8</pages><volume>129</volume><number>11</number><edition>2007/02/27</edition><keywords><keyword>Cadmium Compounds/chemistry</keyword><keyword>Cell Membrane/metabolism</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Coated Materials, Biocompatible/*chemistry/*pharmacokinetics/pharmacology</keyword><keyword>Endosomes/*metabolism</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Polyethylene Glycols/*chemistry/pharmacokinetics/pharmacology</keyword><keyword>Polyethyleneimine/*chemistry/pharmacokinetics/pharmacology</keyword><keyword>*Quantum Dots</keyword><keyword>Selenium Compounds/chemistry</keyword><keyword>Sulfides/chemistry</keyword><keyword>Surface Properties</keyword><keyword>Zinc Compounds/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 21</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17319667</accession-num><abstract>We report the development of cell-penetrating quantum dots (QDs) based on the use of multivalent and endosome-disrupting (endosomolytic) surface coatings. Hyperbranched copolymer ligands such as polyethylene glycol (PEG) grafted polyethylenimine (PEI-g-PEG) are found to encapsulate and solubilize luminescent quantum dots through direct ligand-exchange reactions. Because of the positive charges and a &quot;proton sponge effect&quot; associated with multivalent amine groups, this class of ligand-exchanged QDs is able to penetrate cell membranes and is also able to disrupt endosomal organelles in living cells. The grafted PEG segment is essential for reducing the cytotoxicity of PEI as well as for improving the overall nanoparticle stability and biocompatibility. In comparison with previous QDs encapsulated with amphiphilic polymers, the cell-penetrating QDs are smaller in size and are considerably more stable in acidic environments. Cellular uptake and imaging studies reveal that the number of PEG grafts per PEI molecule has a pronounced effect on the intracellular pathways of internalized QDs. In particular, QDs coated with PEI-g-PEG2 are rapidly internalized by endocytosis, and are initially stored in vesicles, followed by slow endosomal escape and release into the cytoplasm. These insights are important toward the design and development of nanoparticle agents for intracellular imaging and therapeutic applications.</abstract><notes>Duan, Hongwei&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468/ca/nci&#xD;U01hl080711/hl/nhlbi&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Mar 21;129(11):3333-8. Epub 2007 Feb 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17319667</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja068158s</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>101</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">101</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, H.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Atlanta, GA 30322, USA.</auth-address><titles><title>Etching colloidal gold nanocrystals with hyperbranched and multivalent polymers: a new route to fluorescent and water-soluble atomic clusters</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2412-3</pages><volume>129</volume><number>9</number><edition>2007/02/14</edition><keywords><keyword>Gold Colloid/*chemistry</keyword><keyword>Luminescent Agents/*chemistry</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>Polymers/*chemistry</keyword><keyword>Solubility</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Water/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17295485</accession-num><notes>Duan, Hongwei&#xD;Nie, Shuming&#xD;P20 gm 072069/gm/nigms&#xD;R01 ca 108468-01/ca/nci&#xD;U01 hl 080711/hl/nhlbi&#xD;U54 ca 119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Mar 7;129(9):2412-3. Epub 2007 Feb 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17295485</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja067727t</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>460</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">460</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Endres, P. J.</author><author>Paunesku, T.</author><author>Vogt, S.</author><author>Meade, T. J.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.</auth-address><titles><title>DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15760-1</pages><volume>129</volume><number>51</number><edition>2007/12/01</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>DNA/*chemistry</keyword><keyword>Gadolinium/chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>Titanium/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 26</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18047347</accession-num><abstract>Recent efforts have shown that nanoscale materials, specifically, metal-based nanoparticles, hold particular promise for the development of multifunctional imaging probes. These new materials provide the means to chaperone and concentrate both drugs and contrast agents in specific organs, tissues, and cells. Therefore, we have prepared a Gd(III)-modified DNA-TiO2 semiconducting nanoparticle that is detectable in cells by MR imaging. These labeled particles are retained at specific subcellular locations via DNA hybridization to intracellular targets, hence creating the first nanoparticle system capable of targeting specific DNA sequences while being simultaneously detected via MR imaging.</abstract><notes>Endres, Paul J&#xD;Paunesku, Tatjana&#xD;Vogt, Stefan&#xD;Meade, Thomas J&#xD;Woloschak, Gayle E&#xD;1 R01 EB005866-01/EB/United States NIBIB&#xD;1 S10 RR13880-01/RR/United States NCRR&#xD;5 U54 CA90810/CA/United States NCI&#xD;R01 CA107467/CA/United States NCI&#xD;R01 EB0021000/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 26;129(51):15760-1. Epub 2007 Nov 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18047347</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja0772389</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>593</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">593</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hall, W. P.</author><author>Anker, J. N.</author><author>Lin, Y.</author><author>Modica, J.</author><author>Mrksich, M.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.</auth-address><titles><title>A calcium-modulated plasmonic switch</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5836-7</pages><volume>130</volume><number>18</number><edition>2008/04/12</edition><keywords><keyword>Calcium/*chemistry/metabolism</keyword><keyword>Calmodulin/*chemistry/metabolism</keyword><keyword>Carboxylic Ester Hydrolases/chemistry</keyword><keyword>Metal Nanoparticles/chemistry</keyword><keyword>Nanotechnology</keyword><keyword>Protein Conformation</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Silver/chemistry</keyword><keyword>Surface Plasmon Resonance/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>May 7</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18402443</accession-num><notes>Hall, W Paige&#xD;Anker, Jeffrey N&#xD;Lin, Yao&#xD;Modica, Justin&#xD;Mrksich, Milan&#xD;Van Duyne, Richard P&#xD;1 U54 CA119341-01/CA/United States NCI&#xD;5 F32 GM077020/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 May 7;130(18):5836-7. Epub 2008 Apr 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18402443</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja7109037</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>128</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">128</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Han, M. S.</author><author>Lytton-Jean, A. K.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>A gold nanoparticle based approach for screening triplex DNA binders</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>4954-5</pages><volume>128</volume><number>15</number><edition>2006/04/13</edition><dates><year>2006</year><pub-dates><date>Apr 19</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16608320</accession-num><notes>Han, Min Su&#xD;Lytton-Jean, Abigail K R&#xD;Mirkin, Chad A&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Apr 19;128(15):4954-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16608320</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja0606475</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>492</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">492</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hodgson, L.</author><author>Chan, E. W.</author><author>Hahn, K. M.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Combining surface chemistry with a FRET-based biosensor to study the dynamics of RhoA GTPase activation in cells on patterned substrates</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9264-5</pages><volume>129</volume><number>30</number><edition>2007/07/13</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/instrumentation/*methods</keyword><keyword>Cell Adhesion/drug effects/physiology</keyword><keyword>Cell Line</keyword><keyword>Fibronectins/chemistry</keyword><keyword>Fluorescence Resonance Energy Transfer/instrumentation/*methods</keyword><keyword>Glass/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Surface Properties</keyword><keyword>rhoA GTP-Binding Protein/*analysis/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17625860</accession-num><notes>Hodgson, Louis&#xD;Chan, Eugene W L&#xD;Hahn, Klaus M&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Aug 1;129(30):9264-5. Epub 2007 Jul 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17625860</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja072900m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>597</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">597</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hoover, D. K.</author><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Asymmetric peptide nanoarray surfaces for studies of single cell polarization</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>3280-1</pages><volume>130</volume><number>11</number><edition>2008/02/23</edition><keywords><keyword>3T3 Cells</keyword><keyword>Adsorption</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Polarity</keyword><keyword>Fibroblasts/*chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Hydroquinones/chemistry</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Molecular Structure</keyword><keyword>Nanotechnology/methods</keyword><keyword>Organelles/chemistry</keyword><keyword>*Protein Array Analysis</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 19</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18290651</accession-num><notes>Hoover, Diana K&#xD;Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Mar 19;130(11):3280-1. Epub 2008 Feb 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18290651</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja711016m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>376</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">376</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kannan, R.</author><author>Rahing, V.</author><author>Cutler, C.</author><author>Pandrapragada, R.</author><author>Katti, K. K.</author><author>Kattumuri, V.</author><author>Robertson, J. D.</author><author>Casteel, S. J.</author><author>Jurisson, S.</author><author>Smith, C.</author><author>Boote, E.</author><author>Katti, K. V.</author></authors></contributors><auth-address>Department of Radiology, University of Missouri-Columbia, Columbia, Missouri 65212, USA. kannanr@health.missouri.edu</auth-address><titles><title>Nanocompatible chemistry toward fabrication of target-specific gold nanoparticles</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11342-3</pages><volume>128</volume><number>35</number><edition>2006/09</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/*chemistry/pharmacokinetics</keyword><keyword>Drug Stability</keyword><keyword>Gold/*chemistry/pharmacokinetics</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Mice</keyword><keyword>Mice, Inbred Strains</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>*Nanomedicine</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 6</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16939243</accession-num><notes>1r01ca119412-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16939243 </url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2007</custom3><custom4>7.696</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>602</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">602</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, J. Y.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Shape-specific, monodisperse nano-molding of protein particles</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5438-9</pages><volume>130</volume><number>16</number><edition>2008/04/02</edition><keywords><keyword>Adhesiveness</keyword><keyword>Albumins/*chemistry</keyword><keyword>Antineoplastic Combined Chemotherapy Protocols/*therapeutic use</keyword><keyword>Breast Neoplasms/*drug therapy</keyword><keyword>*Electronics</keyword><keyword>Female</keyword><keyword>Gold/chemistry</keyword><keyword>Humans</keyword><keyword>Industry</keyword><keyword>Microscopy, Electron, Scanning/methods</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>RNA, Small Interfering/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 23</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18376832</accession-num><notes>Kelly, Jennifer Y&#xD;DeSimone, Joseph M&#xD;5-654-CA119373-02/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Apr 23;130(16):5438-9. Epub 2008 Apr 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18376832</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja8014428</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>71</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">71</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, J. S.</author><author>Rieter, W. J.</author><author>Taylor, K. M.</author><author>An, H.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8962-3</pages><volume>129</volume><number>29</number><edition>2007/07/03</edition><keywords><keyword>HT29 Cells</keyword><keyword>Humans</keyword><keyword>Luminescence</keyword><keyword>Microscopy, Confocal</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/*chemistry/*diagnostic use</keyword><keyword>Neoplasms/*diagnosis</keyword><keyword>Particle Size</keyword><keyword>Silicon Dioxide</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 25</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17602632</accession-num><notes>Kim, Jason S&#xD;Rieter, William J&#xD;Taylor, Kathryn M L&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Lin, Wenbin&#xD;P20 rr020764/rr/ncrr&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Jul 25;129(29):8962-3. Epub 2007 Jun 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17602632</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja073062z</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>363</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">363</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, S.</author><author>Ohulchanskyy, T. Y.</author><author>Pudavar, H. E.</author><author>Pandey, R. K.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, Department of Chemistry, State University of New York, Buffalo, NY 14260-3000, USA.</auth-address><titles><title>Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2669-75</pages><volume>129</volume><number>9</number><edition>2007/03</edition><keywords><keyword>Absorption</keyword><keyword>Antineoplastic Agents/*chemistry/pharmacology</keyword><keyword>Chlorophyll/analogs &amp; derivatives/chemistry/pharmacology</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Hela Cells/drug effects/pathology</keyword><keyword>Humans</keyword><keyword>Intracellular Space/pathology</keyword><keyword>Micelles</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>*Photochemotherapy</keyword><keyword>*Photons</keyword><keyword>Photosensitizing Agents/*chemistry/pharmacology</keyword><keyword>Precipitation</keyword><keyword>Singlet Oxygen/chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17288423</accession-num><abstract>We report energy-transferring organically modified silica nanoparticles for two-photon photodynamic therapy. These nanoparticles co-encapsulate two-photon fluorescent dye nanoaggregates as an energy up-converting donor and a photosensitizing PDT drug as an acceptor. They combine two features: (i) aggregation-enhanced two-photon absorption and emission properties of a novel two-photon dye and (ii) nanoscopic fluorescence resonance energy transfer between this nanoaggregate and a photosensitizer, 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide. Stable aqueous dispersions of the co-encapsulating nanoparticles (diameter &lt; or = 30 nm) have been prepared in the nonpolar interior of micelles by coprecipitating an organically modified silica sol with the photosensitizer and an excess amount of the two-photon dye which forms fluorescent aggregates by phase separation from the particle matrix. Using a multidisciplinary nanophotonic approach, we show: (i) indirect excitation of the photosensitizer through efficient two-photon excited intraparticle energy transfer from the dye aggregates in the intracellular environment of tumor cells and (ii) generation of singlet oxygen and in vitro cytotoxic effect in tumor cells by photosensitization under two-photon irradiation.</abstract><notes>R01 ca 119358-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17288423 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>7.696</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>608</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">608</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. S.</author><author>Seferos, D. S.</author><author>Giljohann, D. A.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Thermodynamically controlled separation of polyvalent 2-nm gold nanoparticle-oligonucleotide conjugates</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5430-1</pages><volume>130</volume><number>16</number><edition>2008/03/29</edition><keywords><keyword>DNA Probes/*chemical synthesis</keyword><keyword>Gold/*chemistry</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Oligonucleotides/*chemistry</keyword><keyword>Organometallic Compounds/*chemistry</keyword><keyword>Thermodynamics</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 23</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18370386</accession-num><notes>Lee, Jae-Seung&#xD;Seferos, Dwight S&#xD;Giljohann, David A&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Apr 23;130(16):5430-1. Epub 2008 Mar 28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18370386</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja800797h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>468</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">468</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, S. M.</author><author>Chen, H.</author><author>Dettmer, C. M.</author><author>O&apos;Halloran, T. V.</author><author>Nguyen, S. T.</author></authors></contributors><auth-address>Department of Chemistry and the Center for Cancer Nanotechnology Excellence, Northwestern University, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Polymer-caged lipsomes: a pH-responsive delivery system with high stability</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15096-7</pages><volume>129</volume><number>49</number><edition>2007/11/15</edition><keywords><keyword>Acrylic Resins/*chemistry</keyword><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Cholesterol/analogs &amp; derivatives/chemistry</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Drug Stability</keyword><keyword>Fluoresceins/*chemistry</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Lipid Bilayers/chemistry</keyword><keyword>Liposomes/blood/chemical synthesis/*chemistry</keyword><keyword>Microscopy, Electron, Transmission</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 12</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>17999499</accession-num><notes>Lee, Sang-Min&#xD;Chen, Haimei&#xD;Dettmer, Christine M&#xD;O&apos;Halloran, Thomas V&#xD;Nguyen, SonBinh T&#xD;P30CA060553/CA/United States NCI&#xD;U54CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 12;129(49):15096-7. Epub 2007 Nov 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17999499</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja070748i</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>441</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">441</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, W.</author><author>Choi, H. S.</author><author>Zimmer, J. P.</author><author>Tanaka, E.</author><author>Frangioni, J. V.</author><author>Bawendi, M.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>14530-1</pages><volume>129</volume><number>47</number><edition>2007/11/07</edition><keywords><keyword>Animals</keyword><keyword>Cadmium/*chemistry/*pharmacokinetics</keyword><keyword>Cadmium Compounds/*chemistry/*pharmacokinetics</keyword><keyword>Cysteine/*chemistry</keyword><keyword>Molecular Structure</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Selenium Compounds/*chemistry/*pharmacokinetics</keyword><keyword>Sulfides/*chemistry/*pharmacokinetics</keyword><keyword>Zinc/*chemistry/*pharmacokinetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>17983223</accession-num><abstract>We have developed a versatile nanoparticle construct using a compact cysteine coating on a CdSe(ZnCdS) core(shell) nanocrystal (QD-Cys) that is biologically compatible, exceptionally compact, highly fluorescent, and easily functionalized. The small hydrodynamic diameter of QD-Cys ( approximately 6 nm) allows for renal clearance of these nanoparticles in rat models. Moreover, the ability to directly conjugate to QD-Cys opens up the possibility of functionalized nanocrystals for in vivo targeted imaging, in which small targeting molecules can be appended to QD-Cys, and unbound QDs can be rapidly cleared to achieve high signal/noise ratios and to reduce background toxicity.</abstract><notes>Liu, Wenhao&#xD;Choi, Hak Soo&#xD;Zimmer, John P&#xD;Tanaka, Eiichi&#xD;Frangioni, John V&#xD;Bawendi, Moungi&#xD;1U54-CA119349/CA/United States NCI&#xD;GM68762/GM/United States NIGMS&#xD;R01-CA-115296/CA/United States NCI&#xD;R33-EB-000673/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Nov 28;129(47):14530-1. Epub 2007 Nov 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983223</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja073790m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>614</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">614</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, W.</author><author>Howarth, M.</author><author>Greytak, A. B.</author><author>Zheng, Y.</author><author>Nocera, D. G.</author><author>Ting, A. Y.</author><author>Bawendi, M. G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139-4307, USA.</auth-address><titles><title>Compact biocompatible quantum dots functionalized for cellular imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>1274-84</pages><volume>130</volume><number>4</number><edition>2008/01/08</edition><keywords><keyword>Biocompatible Materials/*chemistry</keyword><keyword>Cell Adhesion</keyword><keyword>Epidermal Growth Factor/chemistry</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Hela Cells</keyword><keyword>Histidine/chemistry</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Micelles</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>*Quantum Dots</keyword><keyword>Receptor, Epidermal Growth Factor/chemistry</keyword><keyword>Streptavidin/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 30</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18177042</accession-num><abstract>We present a family of water-soluble quantum dots (QDs) that exhibit low nonspecific binding to cells, small hydrodynamic diameter, tunable surface charge, high quantum yield, and good solution stability across a wide pH range. These QDs are amenable to covalent modification via simple carbodiimide coupling chemistry, which is achieved by functionalizing the surface of QDs with a new class of heterobifunctional ligands incorporating dihydrolipoic acid, a short poly(ethylene glycol) (PEG) spacer, and an amine or carboxylate terminus. The covalent attachment of molecules is demonstrated by appending a rhodamine dye to form a QD-dye conjugate exhibiting fluorescence resonance energy transfer (FRET). High-affinity labeling is demonstrated by covalent attachment of streptavidin, thus enabling the tracking of biotinylated epidermal growth factor (EGF) bound to EGF receptor on live cells. In addition, QDs solubilized with the heterobifunctional ligands retain their metal-affinity driven conjugation chemistry with polyhistidine-tagged proteins. This dual functionality is demonstrated by simultaneous covalent attachment of a rhodamine FRET acceptor and binding of polyhistidine-tagged streptavidin on the same nanocrystal to create a targeted QD, which exhibits dual-wavelength emission. Such emission properties could serve as the basis for ratiometric sensing of the cellular receptor&apos;s local chemical environment.</abstract><notes>Liu, Wenhao&#xD;Howarth, Mark&#xD;Greytak, Andrew B&#xD;Zheng, Yi&#xD;Nocera, Daniel G&#xD;Ting, Alice Y&#xD;Bawendi, Moungi G&#xD;1 P20GM072029-01/GM/United States NIGMS&#xD;1U54-CA119349/CA/United States NCI&#xD;GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jan 30;130(4):1274-84. Epub 2008 Jan 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18177042</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja076069p</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>715</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">715</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, H.</author><author>Cheng, J</author></authors></contributors><titles><title>Controlled Ring-Opening Polymerization of Amino Acid N-Carboxyanhydrides and Facile End Group Functionalization of Polypeptides</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>7.885</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>616</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">616</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Matson, J. B.</author><author>Grubbs, R. H.</author></authors></contributors><auth-address>NanoSystems Biology Cancer Center, Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>Synthesis of fluorine-18 functionalized nanoparticles for use as in vivo molecular imaging agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>6731-3</pages><volume>130</volume><number>21</number><edition>2008/05/03</edition><keywords><keyword>Bicyclo Compounds/*chemistry</keyword><keyword>Catalysis</keyword><keyword>Diagnostic Imaging/methods</keyword><keyword>Electron Spin Resonance Spectroscopy</keyword><keyword>Fluorine Radioisotopes/*chemistry</keyword><keyword>Heptanes/*chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>Imides/chemical synthesis/chemistry</keyword><keyword>Isotope Labeling/methods</keyword><keyword>Mesylates/chemistry</keyword><keyword>Micelles</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Radiopharmaceuticals/*chemical synthesis/chemistry</keyword><keyword>Ruthenium/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18452296</accession-num><abstract>Nanoparticles containing fluorine-18 were prepared from block copolymers made by ring opening metathesis polymerization (ROMP). Using the fast initiating ruthenium metathesis catalyst (H2IMes)(pyr)2(Cl)2Ru=CHPh, low polydispersity amphiphilic block copolymers were prepared from a cinnamoyl-containing hydrophobic norbornene monomer and a mesyl-terminated PEG-containing hydrophilic norbornene monomer. Self-assembly into micelles and subsequent cross-linking of the micelle cores by light-activated dimerization of the cinnamoyl groups yielded stable nanoparticles. Incorporation of fluorine-18 was achieved by nucleophilic displacement of the mesylates by the radioactive fluoride ion with 31% incorporation of radioactivity. The resulting positron-emitting nanoparticles are to be used as in vivo molecular imaging agents for use in tumor imaging.</abstract><notes>Matson, John B&#xD;Grubbs, Robert H&#xD;5U54 CA119347/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 May 28;130(21):6731-3. Epub 2008 May 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18452296</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja802010d</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>227</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">227</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nakayama-Ratchford, N.</author><author>Bangsaruntip, S.</author><author>Sun, X.</author><author>Welsher, K.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Noncovalent functionalization of carbon nanotubes by fluorescein-polyethylene glycol: supramolecular conjugates with pH-dependent absorbance and fluorescence</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2448-9</pages><volume>129</volume><number>9</number><edition>2007/02/08</edition><keywords><keyword>Electrochemistry</keyword><keyword>Fluorescein/*chemistry</keyword><keyword>Fluorescence</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>*Nanotechnology</keyword><keyword>Nanotubes, Carbon/*chemistry</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Surface Properties</keyword><keyword>Surface-Active Agents/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17284037</accession-num><notes>Nakayama-Ratchford, Nozomi&#xD;Bangsaruntip, Sarunya&#xD;Sun, Xiaoming&#xD;Welsher, Kevin&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Mar 7;129(9):2448-9. Epub 2007 Feb 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17284037</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja068684j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>131</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">131</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Oh, B. K.</author><author>Park, S.</author><author>Millstone, J. E.</author><author>Lee, S. W.</author><author>Lee, K. B.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Separation of tricomponent protein mixtures with triblock nanorods</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11825-9</pages><volume>128</volume><number>36</number><edition>2006/09/07</edition><keywords><keyword>Acetic Acids/chemistry</keyword><keyword>Biotin/chemistry</keyword><keyword>Chromones/chemistry</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Histidine/chemistry</keyword><keyword>Hydrazines/chemistry</keyword><keyword>Magnetics</keyword><keyword>Nanotubes/*chemistry</keyword><keyword>Nickel/chemistry</keyword><keyword>Organic Chemicals/chemistry</keyword><keyword>Proteins/*isolation &amp; purification</keyword><keyword>Serum Albumin, Bovine/isolation &amp; purification</keyword><keyword>Staphylococcal Protein A/isolation &amp; purification</keyword><keyword>Ubiquitin/isolation &amp; purification</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 13</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16953622</accession-num><abstract>Two-component triblock magnetic nanorods with gold end blocks and nickel interior blocks have been synthesized and used as affinity templates for the simultaneous and efficient separation of a three-component protein mixture. The gold blocks were selectively functionalized with 11-amino-1-undecanethiol, and then glutaraldehyde was used to covalently attach nitrostreptavidin to them. His-tagged proteins bind to the nickel block and biotin-tagged proteins bind to the functionalized gold ends, allowing one to separate a mixture of three proteins with a single material. Each surface-bound protein can be released selectively using imidazole for the His-tagged protein and biotin for the biotinylated protein.</abstract><notes>Oh, Byung-Keun&#xD;Park, Sungho&#xD;Millstone, Jill E&#xD;Lee, Seung Woo&#xD;Lee, Ki-Bum&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Sep 13;128(36):11825-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16953622</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja057525h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>292</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">292</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Olson, D. A.</author><author>Gratton, S. E.</author><author>DeSimone, J. M.</author><author>Sheares, V. V.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Venable Hall CB 3290, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Amorphous linear aliphatic polyesters for the facile preparation of tunable rapidly degrading elastomeric devices and delivery vectors</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>13625-33</pages><volume>128</volume><number>41</number><edition>2006/10/13</edition><keywords><keyword>Biocompatible Materials/*chemical synthesis</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Elastomers/*chemical synthesis</keyword><keyword>Materials Testing</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Models, Chemical</keyword><keyword>Molecular Weight</keyword><keyword>Polyesters/*chemistry</keyword><keyword>Temperature</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17031977</accession-num><abstract>A versatile method for preparing amorphous degradable elastomers with tunable properties that can be easily fabricated into a wide variety of shape-specific devices was investigated. Completely amorphous, liquid poly(ester ether) prepolymers with number-average molecular weights between 4 and 6 x 10(3) g/mol were prepared via condensation polymerization. These liquid prepolymers were then thermally cross-linked to form degradable elastomeric structures. The ability to vary the composition of these liquid prepolymers allows for easy control of the mechanical and degradation properties of the resulting elastomeric structures. Materials can be designed to completely degrade in vitro over a range of 30 days to 6 months, while the Young&apos;s modulus can be varied over 3 orders of magnitude (G = 0.02-20 MPa). Also, the liquid nature of these prepolymers makes them amenable to a wide variety of fabrication techniques. Using traditional and modified imprint lithography techniques, we have fabricated devices that demonstrate a wide variety of biologically applicable topologies, which could easily be extended to fabricate devices with more complex geometries. Until now, no method has combined this ease and speed of fabrication with the ability to control the mechanical and degradation properties of the resulting elastomers over such a broad range.</abstract><notes>Olson, David A&#xD;Gratton, Stephanie E A&#xD;DeSimone, Joseph M&#xD;Sheares, Valerie V&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 18;128(41):13625-33.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17031977</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja063092m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>12</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">12</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. H.</author><author>Derfus, A. M.</author><author>Segal, E.</author><author>Vecchio, K. S.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358, USA.</auth-address><titles><title>Local heating of discrete droplets using magnetic porous silicon-based photonic crystals</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>7938-46</pages><volume>128</volume><number>24</number><edition>2006/06</edition><dates><year>2006</year><pub-dates><date>Jun 21</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16771508</accession-num><abstract>This paper describes a method for local heating of discrete microliter-scale liquid droplets. The droplets are covered with magnetic porous Si microparticles, and heating is achieved by application of an external alternating electromagnetic field. The magnetic porous Si microparticles consist of two layers. The top layer contains a photonic code and it is hydrophobic, with surface-grafted dodecyl moieties. The bottom layer consists of a hydrophilic silicon oxide host layer that is infused with Fe3O4 nanoparticles. The amphiphilic microparticles spontaneously align at the interface of a water droplet immersed in mineral oil, allowing manipulation of the droplets by application of a magnetic field. Application of an oscillating magnetic field (338 kHz, 18 A rms current in a coil surrounding the experiment) generates heat in the superparamagnetic particles that can raise the temperature of the enclosed water droplet to &gt;80 degrees C within 5 min. A simple microfluidics application is demonstrated: combining complementary DNA strands contained in separate droplets and then thermally inducing dehybridization of the conjugate. The complementary oligonucleotides were conjugated with the cyanine dye fluorophores Cy3 and Cy5 to quantify the melting/rebinding reaction by fluorescence resonance energy transfer (FRET). The magnetic porous Si microparticles were prepared as photonic crystals, containing spectral codes that allowed the identification of the droplets by reflectivity spectroscopy. The technique demonstrates the feasibility of tagging, manipulating, and heating small volumes of liquids without the use of conventional microfluidic channel and heating systems.</abstract><notes>N01-co-37117/co/nci&#xD;U54 ca 119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16771508 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2006</custom3><custom4>7.696</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>623</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">623</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Petros, R. A.</author><author>Ropp, P. A.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Caudill Laboratories CB 3290, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5008-9</pages><volume>130</volume><number>15</number><edition>2008/03/22</edition><keywords><keyword>Cell Survival/drug effects</keyword><keyword>Doxorubicin/*pharmacology</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Molecular Structure</keyword><keyword>Polymers/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 16</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18355010</accession-num><notes>Petros, Robby A&#xD;Ropp, Patricia A&#xD;DeSimone, Joseph M&#xD;U54-CA119343/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Apr 16;130(15):5008-9. Epub 2008 Mar 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18355010</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja801436j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>144</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">144</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Petty, R. T.</author><author>Li, H. W.</author><author>Maduram, J. H.</author><author>Ismagilov, R.</author><author>Mrksich, M.</author></authors></contributors><auth-address>Department of Chemistry and Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois 60637, USA.</auth-address><titles><title>Attachment of cells to islands presenting gradients of adhesion ligands</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8966-7</pages><volume>129</volume><number>29</number><edition>2007/07/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion/*drug effects</keyword><keyword>Coloring Agents/chemical synthesis/*chemistry</keyword><keyword>Cytological Techniques/*instrumentation</keyword><keyword>Electrochemistry</keyword><keyword>Indicators and Reagents</keyword><keyword>Ligands</keyword><keyword>Melanoma, Experimental/ultrastructure</keyword><keyword>Membranes, Artificial</keyword><keyword>Mice</keyword><keyword>Vinculin/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 25</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17602634</accession-num><notes>Petty, Rafe T&#xD;Li, Hung-Wing&#xD;Maduram, Jane H&#xD;Ismagilov, Rustem&#xD;Mrksich, Milan&#xD;T32 gm008720/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Jul 25;129(29):8966-7. Epub 2007 Jun 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17602634</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja0735709</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>628</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">628</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Pott, K. M.</author><author>Taylor, K. M.</author><author>Lin, W.</author></authors></contributors><titles><title>Nanoscale Coordination Polymers for Platinum-Based Anticancer Drug Delivery</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><volume>accepted</volume><edition>2008/08/09</edition><dates><year>2008</year></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18686947</accession-num><notes>Journal article&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Aug 8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18686947</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja803383k</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>299</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">299</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Taylor, K. M.</author><author>An, H.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9024-5</pages><volume>128</volume><number>28</number><edition>2006/07/13</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Organic Chemicals/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 19</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16834362</accession-num><notes>Rieter, William J&#xD;Taylor, Kathryn M L&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Lin, Wenbin&#xD;P20 rr020764-01/rr/ncrr&#xD;U54-ca119343-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 19;128(28):9024-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16834362</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja0627444</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>70</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">70</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Taylor, K. M.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Surface modification and functionalization of nanoscale metal-organic frameworks for controlled release and luminescence sensing</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9852-3</pages><volume>129</volume><number>32</number><edition>2007/07/25</edition><keywords><keyword>Delayed-Action Preparations</keyword><keyword>Dicarboxylic Acids/chemistry</keyword><keyword>Lanthanoid Series Elements/*chemistry</keyword><keyword>Nanocomposites/*chemistry</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry</keyword><keyword>Povidone/chemistry</keyword><keyword>Silicon Dioxide/*chemistry</keyword><keyword>Surface Properties</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17645339</accession-num><notes>Rieter, William J&#xD;Taylor, Kathryn M L&#xD;Lin, Wenbin&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Aug 15;129(32):9852-3. Epub 2007 Jul 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17645339</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja073506r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>257</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">257</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rohde, R. D.</author><author>Agnew, H. D.</author><author>Yeo, W. S.</author><author>Bailey, R. C.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>A non-oxidative approach toward chemically and electrochemically functionalizing Si(111)</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9518-25</pages><volume>128</volume><number>29</number><edition>2006/07/20</edition><keywords><keyword>Crystallization</keyword><keyword>Electrochemistry</keyword><keyword>Molecular Structure</keyword><keyword>Oxidation-Reduction</keyword><keyword>Semiconductors</keyword><keyword>Silicon/*chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 26</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16848489</accession-num><abstract>A general method for the non-oxidative functionalization of single-crystal silicon(111) surfaces is described. The silicon surface is fully acetylenylated using two-step chlorination/alkylation chemistry. A benzoquinone-masked primary amine is attached to this surface via Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition (&quot;click&quot; chemistry). The benzoquinone is electrochemically reduced, resulting in quantitative cleavage of the molecule and exposing the amine terminus. Molecules presenting a carboxylic acid have been immobilized to the exposed amine sites. X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy (FTIR), cyclic voltammetry (CV), and contact angle goniometry were utilized to characterize and quantitate each step in the functionalization process. This work represents a strategy for providing a general platform that can incorporate organic and biological molecules on Si(111) with minimal oxidation of the silicon surface.</abstract><notes>Rohde, Rosemary D&#xD;Agnew, Heather D&#xD;Yeo, Woon-Seok&#xD;Bailey, Ryan C&#xD;Heath, James R&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 26;128(29):9518-25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16848489</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja062012b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>391</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">391</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ruan, G.</author><author>Agrawal, A.</author><author>Marcus, A. I.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>14759-66</pages><volume>129</volume><number>47</number><edition>2007/11/07</edition><keywords><keyword>Biological Transport</keyword><keyword>Cell Survival</keyword><keyword>Gene Products, tat/*chemistry</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Intracellular Space/*metabolism</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Peptides/*chemistry/*metabolism</keyword><keyword>*Quantum Dots</keyword><keyword>Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>17983227</accession-num><abstract>We report the use of Tat peptide-conjugated quantum dots (Tat-QDs) to examine the complex behavior of nanoparticle probes in live cells, a topic that is of considerable current interest in developing advanced nanoparticle agents for molecular and cellular imaging. Dynamic confocal imaging studies indicate that the peptide-conjugated QDs are internalized by macropinocytosis, a fluid-phase endocytosis process triggered by Tat-QD binding to negatively charged cell membranes. The internalized Tat-QDs are tethered to the inner vesicle surfaces and are trapped in cytoplasmic organelles. The QD loaded vesicles are found to be actively transported by molecular machines (such as dyneins) along microtubule tracks. The destination of this active transport is an asymmetric perinuclear region (outside the cell nucleus) known as the microtubule organizing center (MTOC). We also find that Tat-QDs strongly bind to cellular membrane structures such as filopodia and that large QD-containing vesicles are released from the tips of filopodia by vesicle shedding. These results provide new insights into the mechanisms of Tat peptide-mediated delivery as well as toward the design of functionalized nanoparticles for molecular imaging and targeted therapy.</abstract><notes>Ruan, Gang&#xD;Agrawal, Amit&#xD;Marcus, Adam I&#xD;Nie, Shuming&#xD;P20GM072069/GM/United States NIGMS&#xD;PN2EY018244/EY/United States NEI&#xD;R01CA108468/CA/United States NCI&#xD;U01HL080711/HL/United States NHLBI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Nov 28;129(47):14759-66. Epub 2007 Nov 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983227</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja074936k</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>471</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">471</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seferos, D. S.</author><author>Giljohann, D. A.</author><author>Hill, H. D.</author><author>Prigodich, A. E.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Nano-flares: probes for transfection and mRNA detection in living cells</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15477-9</pages><volume>129</volume><number>50</number><edition>2007/11/24</edition><keywords><keyword>Base Sequence</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>DNA Probes/*chemistry/genetics</keyword><keyword>Humans</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>RNA, Messenger/*analysis/chemistry/genetics</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 19</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18034495</accession-num><notes>Seferos, Dwight S&#xD;Giljohann, David A&#xD;Hill, Haley D&#xD;Prigodich, Andrew E&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 19;129(50):15477-9. Epub 2007 Nov 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18034495</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja0776529</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>509</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">509</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, C.</author><author>Cai, T.</author><author>Xu, L.</author><author>Zuo, T.</author><author>Reid, J.</author><author>Harich, K.</author><author>Dorn, H. C.</author><author>Gibson, H. W.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, USA.</auth-address><titles><title>Manganese(III)-catalyzed free radical reactions on trimetallic nitride endohedral metallofullerenes</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15710-7</pages><volume>129</volume><number>50</number><edition>2007/11/22</edition><keywords><keyword>Catalysis</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Free Radicals/chemistry</keyword><keyword>Fullerenes/*chemistry</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Malonates/chemistry</keyword><keyword>Manganese/*chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Nitrogen/chemistry</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</keyword><keyword>Thermodynamics</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 19</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18027949</accession-num><abstract>The first reactions of trimetallic nitride templated endohedral metallofullerenes (TNT EMFs) with carbon radicals generated from diethyl malonate catalyzed by manganese(III) acetate are reported. Two methano monoadducts, Sc3N@C80-A and Sc3N@C80-B, were isolated and characterized. Sc3N@C80-A contains two ester moieties, whereas Sc3N@C80-B contains only one ester group and a hydrogen atom on the central carbon of the addend. NMR spectroscopy of the two monoadducts suggests that the addition occurs regioselectively at a 6,6-ring juncture on the surface of the icosahedrally (Ih) symmetric Sc3N@C80, forming the first 6,6-ring-bridged methano Ih Sc3N@C80 derivatives. The measured 1J(C,H) = 147 Hz for the methano carbon with its hydrogen in monoadduct Sc3N@C80-B nearly perfectly matches the data for pi-homoaromatic systems, indicating an open [6,6]-methano structure. Geometry optimization also found that the &quot;closed&quot; [6,6]-methano structures were energetically unstable and always led to the open forms. Thus, an &quot;open&quot; [6,6]-methanofulleride structure is proposed, which was induced by the norcaradiene rearrangement, resulting in the cleavage of the cyclopropane ring and the formation of energetically stable open cage fullerene derivatives. These are the first examples of thermodynamically stable adducts of the &quot;open&quot; type at the 6,6-ring juncture of Ih Sc3N@C80, differing greatly from the &quot;closed&quot; 5,6-ring juncture adducts reported previously. In addition, bis-, tri-, and up to octaadducts of Sc3N@C80 were detected by matrix-assisted laser desorption ionization time-of-flight mass spectrometry; this synthetic method was also applied to Lu3N@C80, producing adducts with up to 10 substituents on the carbon cage. These are the highest levels of substitution of TNT metallofullerenes reported so far.</abstract><notes>Shu, Chunying&#xD;Cai, Ting&#xD;Xu, Liaosa&#xD;Zuo, Tianming&#xD;Reid, Jonathan&#xD;Harich, Kim&#xD;Dorn, Harry C&#xD;Gibson, Harry W&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 19;129(50):15710-7. Epub 2007 Nov 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18027949</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja0768439</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>91</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">91</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Snee, P. T.</author><author>Somers, R. C.</author><author>Nair, G.</author><author>Zimmer, J. P.</author><author>Bawendi, M. G.</author><author>Nocera, D. G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139-4306, USA.</auth-address><titles><title>A ratiometric CdSe/ZnS nanocrystal pH sensor</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>13320-1</pages><volume>128</volume><number>41</number><edition>2006/10/13</edition><keywords><keyword>Biosensing Techniques/instrumentation/*methods</keyword><keyword>Cadmium Compounds/*chemistry</keyword><keyword>Coloring Agents/chemistry</keyword><keyword>Crystallization</keyword><keyword>Cyclobutanes/chemistry</keyword><keyword>Equipment Design</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Ligands</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oxides/chemistry</keyword><keyword>Phenols/chemistry</keyword><keyword>Phosphines/chemistry</keyword><keyword>Selenium Compounds/*chemistry</keyword><keyword>Solubility</keyword><keyword>Spectrum Analysis</keyword><keyword>Sulfides/*chemistry</keyword><keyword>Water/chemistry</keyword><keyword>Zinc Compounds/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17031920</accession-num><notes>Snee, Preston T&#xD;Somers, Rebecca C&#xD;Nair, Gautham&#xD;Zimmer, John P&#xD;Bawendi, Moungi G&#xD;Nocera, Daniel G&#xD;1u54-ca119349/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 18;128(41):13320-1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17031920</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja0618999</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>638</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">638</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Song, Y.</author><author>Kohlmeir, E. K.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Departments of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology, Radiology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Synthesis of multimeric MR contrast agents for cellular imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>6662-3</pages><volume>130</volume><number>21</number><edition>2008/05/03</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/chemical synthesis/pharmacology</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Contrast Media/*chemical synthesis/pharmacology</keyword><keyword>Gadolinium/*chemistry/pharmacology</keyword><keyword>Heterocyclic Compounds/chemistry/pharmacology</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Organometallic Compounds/*chemical synthesis/chemistry/pharmacology</keyword></keywords><dates><year>2008</year><pub-dates><date>May 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18452288</accession-num><abstract>We have prepared a series of molecular multimeric MR contrast agents for cell labeling that are easy to synthesize, relatively low molecular weight, and biocompatible. The relaxivities of the agents range from 17 to 85 mM(-1) s(-1). Cellular uptake is concentration dependent and viability is excellent. MR images of cell pellets reveal a marked increase in observed signal intensity.</abstract><notes>Song, Ying&#xD;Kohlmeir, Ellen K&#xD;Meade, Thomas J&#xD;1P50 NS054287-01/NS/United States NINDS&#xD;1R01 EB005866-01/EB/United States NIBIB&#xD;S10 RR15685-01/RR/United States NCRR&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 May 28;130(21):6662-3. Epub 2008 May 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18452288</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja0777990</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>639</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">639</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stepp, B. R.</author><author>Gibbs-Davis, J. M.</author><author>Koh, D. L.</author><author>Nguyen, S. T.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Cooperative melting in caged dimers of rigid small molecule-DNA hybrids</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9628-9</pages><volume>130</volume><number>30</number><edition>2008/07/04</edition><dates><year>2008</year><pub-dates><date>Jul 30</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18597465</accession-num><notes>Stepp, Brian R&#xD;Gibbs-Davis, Julianne M&#xD;Koh, Dorothea L F&#xD;Nguyen, SonBinh T&#xD;1U54CA11934-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jul 30;130(30):9628-9. Epub 2008 Jul 3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18597465</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja801572n</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>130</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">130</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stoeva, S. I.</author><author>Lee, J. S.</author><author>Smith, J. E.</author><author>Rosen, S. T.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8378-9</pages><volume>128</volume><number>26</number><edition>2006/06/29</edition><keywords><keyword>Biosensing Techniques/*methods</keyword><keyword>DNA/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligonucleotide Probes/chemical synthesis/*chemistry</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tumor Markers, Biological/analysis/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 5</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16802785</accession-num><notes>Stoeva, Savka I&#xD;Lee, Jae-Seung&#xD;Smith, Jennifer E&#xD;Rosen, Steven T&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 5;128(26):8378-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16802785</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja0613106</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>487</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">487</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Taylor, K. M.</author><author>Kim, J. S.</author><author>Rieter, W. J.</author><author>An, H.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Mesoporous silica nanospheres as highly efficient MRI contrast agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2154-5</pages><volume>130</volume><number>7</number><edition>2008/01/26</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Mice</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Monocytes/chemistry/cytology</keyword><keyword>Nanospheres/*chemistry</keyword><keyword>Pentetic Acid/analogs &amp; derivatives/chemistry</keyword><keyword>Silicon Dioxide/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 20</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18217764</accession-num><notes>Taylor, Kathryn M L&#xD;Kim, Jason S&#xD;Rieter, William J&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Lin, Wenbin&#xD;P20 RR020764/RR/United States NCRR&#xD;U54-CA119343/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Feb 20;130(7):2154-5. Epub 2008 Jan 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18217764</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>7.885</custom4><electronic-resource-num>10.1021/ja710193c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>722</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">722</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tong, R.</author><author>Cheng, J</author></authors></contributors><titles><title>Formulation of Conjugated Polylactide-Doxorubicin Nanoparticles through Ring-Opening Polymerization</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>7.885</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>439</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">439</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weiss, E. A.</author><author>Chiechi, R. C.</author><author>Geyer, S. M.</author><author>Porter, V. J.</author><author>Bell, D. C.</author><author>Bawendi, M. G.</author><author>Whitesides, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.</auth-address><titles><title>Size-dependent charge collection in junctions containing single-size and multi-size arrays of colloidal CdSe quantum dots</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>74-82</pages><volume>130</volume><number>1</number><edition>2007/12/13</edition><dates><year>2008</year><pub-dates><date>Jan 9</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18072773</accession-num><abstract>This paper describes the electrical characteristics of junctions composed of three-dimensional arrays of colloidal CdSe quantum dots (QDs) with tin-doped indium oxide (ITO)/poly(3,4-ethylenedioxy-thiophene):poly(styrenesulfonate) (PEDOT:PSS) and eutectic Ga-In (EGaIn) electrodes. It focuses on a comparison of junctions containing QDs of one size to those of arrays containing QDs of multiple sizes. This comparison makes it possible to estimate the relative contributions of transport across various interfaces (e.g., between the QDs and between the QDs and the electrodes) to the observed electrical characteristics of the junction and to evaluate the dependence of these contributions on the locations of various sizes of QDs within the junction. The junctions were diodes, and their turn-on voltage depended on the size of the QDs next to the PEDOT:PSS. We describe this dependence using a Marcus model to estimate the barrier for charge transfer induced by the difference in energies between the orbitals of the QDs and the valence band of PEDOT:PSS.</abstract><notes>Weiss, Emily A&#xD;Chiechi, Ryan C&#xD;Geyer, Scott M&#xD;Porter, Venda J&#xD;Bell, David C&#xD;Bawendi, Moungi G&#xD;Whitesides, George M&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jan 9;130(1):74-82. Epub 2007 Dec 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18072773</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja076438h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>438</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">438</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weiss, E. A.</author><author>Porter, V. J.</author><author>Chiechi, R. C.</author><author>Geyer, S. M.</author><author>Bell, D. C.</author><author>Bawendi, M. G.</author><author>Whitesides, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.</auth-address><titles><title>The use of size-selective excitation to study photocurrent through junctions containing single-size and multi-size arrays of colloidal CdSe quantum dots</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>83-92</pages><volume>130</volume><number>1</number><edition>2007/12/13</edition><dates><year>2008</year><pub-dates><date>Jan 9</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18072774</accession-num><abstract>This paper describes a study of the generation and flow of photocurrent through junctions containing three-dimensional arrays of colloidal CdSe quantum dots (QDs) of either a single size or multiple sizes. The electrodes were indium tin oxide (ITO) covered with a thin layer of poly(3,4-ethylenedioxy-thiophene):poly(styrenesulfonate) (PEDOT:PSS) and a eutectic alloy of Ga and In (EGaIn). We measured the current-voltage characteristics of the junctions in the dark and under illumination, with various sources and wavelengths of excitation, and their photocurrent action spectra. Size-selective photoexcitation of the arrays of multiple sizes of QDs helped to determine (i) the location of the interface at which photoinduced separation of charge occurred, (ii) whether the energy absorbed by the QDs was redistributed before separation of charge, and (iii) the dependence of the photovoltage on the locations of various sizes of QDs within the junction. This research is a step toward the use of QDs for harvesting light and for transporting energy and charge in devices-for example, solar cells and photodetectors-that operate at zero bias.</abstract><notes>Weiss, Emily A&#xD;Porter, Venda J&#xD;Chiechi, Ryan C&#xD;Geyer, Scott M&#xD;Bell, David C&#xD;Bawendi, Moungi G&#xD;Whitesides, George M&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jan 9;130(1):83-92. Epub 2007 Dec 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18072774</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.884</custom4><electronic-resource-num>10.1021/ja076439+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>135</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">135</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhao, J.</author><author>Das, A.</author><author>Zhang, X.</author><author>Schatz, G. C.</author><author>Sligar, S. G.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Resonance surface plasmon spectroscopy: low molecular weight substrate binding to cytochrome p450</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11004-5</pages><volume>128</volume><number>34</number><edition>2006/08/24</edition><keywords><keyword>Cytochrome P-450 Enzyme System/chemistry/*metabolism</keyword><keyword>Molecular Weight</keyword><keyword>Spectrophotometry, Ultraviolet</keyword><keyword>Substrate Specificity</keyword><keyword>Surface Plasmon Resonance/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 30</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16925400</accession-num><notes>Zhao, Jing&#xD;Das, Aditi&#xD;Zhang, Xiaoyu&#xD;Schatz, George C&#xD;Sligar, Stephen G&#xD;Van Duyne, Richard P&#xD;1 u54 ca119341-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Aug 30;128(34):11004-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16925400</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja0636082</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>309</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">309</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, Z.</author><author>Dominey, R. N.</author><author>Rolland, J. P.</author><author>Maynor, B. W.</author><author>Pandya, A. A.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry and the Institute for Advanced Materials, Nanoscience and Technology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Molded, high surface area polymer electrolyte membranes from cured liquid precursors</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>12963-72</pages><volume>128</volume><number>39</number><edition>2006/09/28</edition><dates><year>2006</year><pub-dates><date>Oct 4</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17002393</accession-num><abstract>Polymer electrolyte membranes (PEMs) for fuel cells have been synthesized from easily processable, 100% curable, low molecular weight reactive liquid precursors that are photochemically cured into highly proton conductive solid membranes. The liquid precursors were directly cured into membranes of desired dimensions without the need for further processing steps such as melt extrusion or solvent casting. By employing chemical cross-linking, high proton conductivities can be achieved through the incorporation of significant levels of acidic groups without rendering the material water-soluble, which plagues commonly used non-cross-linked polymers. Fabrication of membrane electrode assemblies (MEAs) from these PEMs resulted in fuel cells that outperformed those based on commercial materials. Moreover, these liquid precursors enabled the formation of three-dimensional, patterned PEMs with high fidelity, micron-scale features by using soft lithographic/micromolding techniques. The patterned membranes provided a larger interfacial area between the membrane and catalyst layer than standard flat PEMs. MEAs composed of the patterned membranes demonstrated higher power densities over that of flat ones without an increase in the macroscopic area of the fuel cells. This can potentially miniaturize fuel cells and promote their application in portable devices.</abstract><notes>Zhou, Zhilian&#xD;Dominey, Raymond N&#xD;Rolland, Jason P&#xD;Maynor, Benjamin W&#xD;Pandya, Ashish A&#xD;DeSimone, Joseph M&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 4;128(39):12963-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17002393</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.696</custom4><electronic-resource-num>10.1021/ja064391e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>31</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">31</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zimmer, J. P.</author><author>Kim, S. W.</author><author>Ohnishi, S.</author><author>Tanaka, E.</author><author>Frangioni, J. V.</author><author>Bawendi, M. G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, 02139, USA.</auth-address><titles><title>Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2526-7</pages><volume>128</volume><number>8</number><edition>2006/03/1</edition><keywords><keyword>Animals</keyword><keyword>Arsenicals/*chemistry/diagnostic use</keyword><keyword>Blood Proteins/chemistry</keyword><keyword>Cadmium/chemistry</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Indium/*chemistry/diagnostic use</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Protein Binding</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Selenium Compounds/*chemistry/diagnostic use</keyword><keyword>Semiconductors</keyword><keyword>Sentinel Lymph Node Biopsy/methods</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Thioctic Acid/analogs &amp; derivatives/chemistry</keyword><keyword>Zinc Compounds/*chemistry/diagnostic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16492023</accession-num><notes>R01-ca-115296/ca/nci&#xD;R33-eb-000673/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16492023 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>7.696</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>266</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">266</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Adli, M.</author><author>Baldwin, A. S.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center, Department of Biology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation</title><secondary-title>J Biol Chem</secondary-title></titles><pages>26976-84</pages><volume>281</volume><number>37</number><edition>2006/07/15</edition><keywords><keyword>Cell Line</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>I-kappa B Kinase/metabolism/*physiology</keyword><keyword>Inflammation</keyword><keyword>NF-kappa B/*metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Promoter Regions (Genetics)</keyword><keyword>Serine/*chemistry</keyword><keyword>Transcription Factor RelA/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 15</date></pub-dates></dates><isbn>0021-9258 (Print)</isbn><accession-num>16840782</accession-num><abstract>Nuclear factor kappaB (NF-kappaB) has been studied extensively as an inducible transcriptional regulator of the immune and inflammatory response. NF-kappaB activation downstream of lipopolysaccharide or cytokine stimulation is controlled by the IkappaB kinase complex, which contains IKKalpha and IKKbeta. Significantly, the constitutive activity of NF-kappaB has been implicated as an important aspect of many cancer cells, but mechanisms associated with this activity are poorly understood. An inducible kinase, IKK-i/IKKepsilon, related to the catalytic forms of the IkappaB kinase, has been studied as an anti-viral, innate immune regulator through its ability to control the activity of the transcription factors IRF-3 and IRF-7. Here, we demonstrate that IKK-i/IKKepsilon is expressed in a number of cancer cells and is involved in regulating NF-kappaB activity through its ability to control basal/constitutive, but not cytokine-induced, p65/RelA phosphorylation at Ser-536, a modification proposed to contribute to the transactivation function of NF-kappaB. Knockdown of IKK-i/IKKepsilon or expression of a S536A mutant form of p65 suppresses HeLa cell proliferation. The data indicate a role for IKK-i/IKKepsilon in controlling proliferation of certain cancer cells through regulation of constitutive NF-kappaB activity.</abstract><notes>Adli, Mazhar&#xD;Baldwin, Albert S&#xD;Ai35098/ai/niaid&#xD;Ca73756/ca/nci&#xD;Ca75080/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of biological chemistry&#xD;J Biol Chem. 2006 Sep 15;281(37):26976-84. Epub 2006 Jul 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16840782</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>5.808</custom4><electronic-resource-num>M603133200 [pii]&#xD;10.1074/jbc.M603133200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>242</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">242</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Berquin, I. M.</author><author>Min, Y.</author><author>Wu, R.</author><author>Wu, H.</author><author>Chen, Y. Q.</author></authors></contributors><auth-address>Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157, USA.</auth-address><titles><title>Expression signature of the mouse prostate</title><secondary-title>J Biol Chem</secondary-title></titles><pages>36442-51</pages><volume>280</volume><number>43</number><edition>2005/08/02</edition><keywords><keyword>Actins/metabolism</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cell Survival</keyword><keyword>Chemokines, CXC/metabolism</keyword><keyword>Chromosome Mapping</keyword><keyword>Collagen/metabolism</keyword><keyword>Cytoskeleton/metabolism</keyword><keyword>Epithelium/metabolism</keyword><keyword>Extracellular Matrix/metabolism</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Genetic Engineering</keyword><keyword>Genome</keyword><keyword>Immunohistochemistry</keyword><keyword>Lasers</keyword><keyword>Ligands</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Transgenic</keyword><keyword>Muscle Contraction</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prostate/*metabolism</keyword><keyword>Prostatic Neoplasms/metabolism</keyword><keyword>Receptors, CXCR4/metabolism</keyword><keyword>Sarcomeres/metabolism</keyword><keyword>Tissue Distribution</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2005</year><pub-dates><date>Oct 28</date></pub-dates></dates><isbn>0021-9258 (Print)</isbn><accession-num>16055444</accession-num><abstract>Genetically engineered mice are being used increasingly for delineating the molecular mechanisms of prostate cancer development. Epithelium-stroma interactions play a critical role in prostate development and tumorigenesis. To better understand gene expression patterns in the normal sexually mature mouse prostate, epithelium and stroma were laser-capture microdissected from ventral, dorsolateral, and anterior prostate lobes. Genome-wide expression was measured by DNA microarrays. Our analysis indicated that the gene expression pattern in the mouse dorsolateral lobe was closest to that of the human prostate peripheral zone, supporting the hypothesis that these prostate compartments are functionally equivalent. Stroma from a given lobe had closer gene expression patterns with stroma from other lobes than epithelium from the same lobe. Stroma appeared to have higher expression complexity than epithelium. Specifically, stromal cells had higher expression levels of genes implicated in cell adhesion, muscle development, and contraction, in structural constituents of cytoskeleton and actin binding, and in components such as sarcomere and extracellular matrix collagen. Among the genes that were enriched in the epithelium were secretory proteins, including seminal vesicle protein secretion 2 and 5. Surprisingly, prostate stroma expressed many osteogenic molecules, as confirmed by immunohistochemistry. A &quot;bone-like&quot; environment in the prostate may predispose prostate cells for survival in the bone. Chemokine Cxcl12 but not its receptor, Cxcr4, was expressed in normal prostate. In prostate tumors, interestingly, Cxcl12 was up-regulated in epithelial cells with a concomitant expression of Cxcr4. Expression of both the receptor and ligand may provide an autocrine mechanism for tumor cell migration and invasion.</abstract><notes>Berquin, Isabelle M&#xD;Min, Younong&#xD;Wu, Ruping&#xD;Wu, Hong&#xD;Chen, Yong Q&#xD;R01ca107668/ca/nci&#xD;R01es11124/es/niehs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;The Journal of biological chemistry&#xD;J Biol Chem. 2005 Oct 28;280(43):36442-51. Epub 2005 Jul 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16055444</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>5.808</custom4><electronic-resource-num>M504945200 [pii]&#xD;10.1074/jbc.M504945200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>470</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">470</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Reddi, A. L.</author><author>Ying, G.</author><author>Duan, L.</author><author>Chen, G.</author><author>Dimri, M.</author><author>Douillard, P.</author><author>Druker, B. J.</author><author>Naramura, M.</author><author>Band, V.</author><author>Band, H.</author></authors></contributors><auth-address>Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Northwestern University, Evanston, Illinois 60201, USA.</auth-address><titles><title>Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation</title><secondary-title>J Biol Chem</secondary-title></titles><pages>29336-47</pages><volume>282</volume><number>40</number><edition>2007/07/11</edition><keywords><keyword>Animals</keyword><keyword>Binding Sites</keyword><keyword>Cell Line, Tumor</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Phospholipase C gamma/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Proto-Oncogene Proteins c-cbl/metabolism/*physiology</keyword><keyword>Receptor, Platelet-Derived Growth Factor beta/*metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Ubiquitin/metabolism</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 5</date></pub-dates></dates><isbn>0021-9258 (Print)</isbn><accession-num>17620338</accession-num><abstract>Ubiquitin conjugation to receptor tyrosine kinases is a critical biochemical step in attenuating their signaling through lysosomal degradation. Our previous studies have established Cbl as an E3 ubiquitin ligase for ubiquitinylation and degradation of platelet-derived growth factor receptor (PDGFR) alpha and PDGFRbeta. However, the role of endogenous Cbl in PDGFR regulation and the molecular mechanisms of this regulation remain unclear. Here, we demonstrate that endogenous Cbl is essential for ligand-induced ubiquitinylation and degradation of PDGFRbeta; this involves the Cbl TKB domain binding to PDGFRbeta phosphotyrosine 1021, a known phospholipase C (PLC) gamma1 SH2 domain-binding site. Lack of Cbl or ablation of the Cbl-binding site on PDGFRbeta impedes receptor sorting to the lysosome. Cbl-deficient cells also show more PDGF-induced PLCgamma1 association with PDGFRbeta and enhanced PLC-mediated cell migration. Thus, Cbl-dependent negative regulation of PDGFRbeta involves a dual mechanism that concurrently promotes ubiquitin-dependent lysosomal sorting of the receptor and competitively reduces the recruitment of a positive mediator of receptor signaling.</abstract><notes>Reddi, Alagarsamy Lakku&#xD;Ying, GuoGuang&#xD;Duan, Lei&#xD;Chen, Gengsheng&#xD;Dimri, Manjari&#xD;Douillard, Patrice&#xD;Druker, Brian J&#xD;Naramura, Mayumi&#xD;Band, Vimla&#xD;Band, Hamid&#xD;1U54 CA119341-01/CA/United States NCI&#xD;CA 87986/CA/United States NCI&#xD;CA 99900/CA/United States NCI&#xD;CA76118/CA/United States NCI&#xD;CA81076/CA/United States NCI&#xD;CA94143/CA/United States NCI&#xD;CA96844/CA/United States NCI&#xD;CA99163/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The Journal of biological chemistry&#xD;J Biol Chem. 2007 Oct 5;282(40):29336-47. Epub 2007 Jul 9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17620338</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.808</custom4><electronic-resource-num>M701797200 [pii]&#xD;10.1074/jbc.M701797200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>461</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">461</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Frullano, L.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology, Radiology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA.</auth-address><titles><title>Multimodal MRI contrast agents</title><secondary-title>J Biol Inorg Chem</secondary-title></titles><pages>939-49</pages><volume>12</volume><number>7</number><edition>2007/07/31</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/chemistry</keyword><keyword>Iron/chemistry</keyword><keyword>Lanthanoid Series Elements/chemistry</keyword><keyword>Ligands</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Neoplasms/*diagnosis</keyword><keyword>Porphyrins/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0949-8257 (Print)</isbn><accession-num>17659368</accession-num><notes>Frullano, Luca&#xD;Meade, Thomas J&#xD;Review&#xD;Germany&#xD;Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry&#xD;J Biol Inorg Chem. 2007 Sep;12(7):939-49. Epub 2007 Jul 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17659368</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.325</custom4><electronic-resource-num>10.1007/s00775-007-0265-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>108</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">108</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Keselowsky, B. G.</author><author>Wang, L.</author><author>Schwartz, Z.</author><author>Garcia, A. J.</author><author>Boyan, B. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.</auth-address><titles><title>Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner</title><secondary-title>J Biomed Mater Res A</secondary-title></titles><pages>700-10</pages><volume>80</volume><number>3</number><edition>2006/11/30</edition><keywords><keyword>Alkaline Phosphatase/metabolism</keyword><keyword>Biocompatible Materials/*pharmacology</keyword><keyword>Cell Cycle</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Line</keyword><keyword>Cell Proliferation</keyword><keyword>DNA/biosynthesis</keyword><keyword>Fibronectins/metabolism</keyword><keyword>Focal Adhesion Kinase 1/metabolism</keyword><keyword>Humans</keyword><keyword>Integrin alpha5beta1/metabolism</keyword><keyword>Integrin alphaV/metabolism/*physiology</keyword><keyword>Osteoblasts/*cytology/drug effects</keyword><keyword>Signal Transduction</keyword><keyword>Surface Properties</keyword><keyword>Titanium/*pharmacology</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1549-3296 (Print)</isbn><accession-num>17133443</accession-num><abstract>Integrin alpha(5)beta(1) regulates osteoblast proliferation and differentiation on smooth synthetic surfaces presenting different chemistries, but it is not known whether this integrin controls osteoblast behavior on surfaces that have micron-scale rough topographies. We cultured MG63 human osteoblast-like cells on titanium substrates with three different roughness characteristics: chemically polished (PT), grit blasted and acid etched with a complex topography consisting of 20-100 mum craters and 0.5-2 mum micropits (SLA), and plasma-sprayed Ti with irregular projections (TPS). Cells spread well on PT but displayed a smaller footprint on SLA or TPS. Nuclei were larger on PT as well. alpha(5)beta(1) binding and FAK phosphorylation were greater on the rougher surfaces (TPS &gt; SLA &gt; PT). Antibodies against the alpha(5)beta(1) binding site on fibronectin had no effect on cell number at 3 days, but [(3)H]-thymidine incorporation was increased, suggesting that binding to fibronectin was necessary for cell cycle regulation. Antibodies to the alpha(5) subunit reduced cell number at 3 days on PT and TPS and reduced DNA synthesis on all substrates in a surface microstructure-independent manner. At 7 days, cell numbers were reduced on PT, and DNA synthesis was reduced by 50% on all surfaces. At 7 days, anti-alpha(5) antibodies caused a partial reduction in alkaline phosphatase enzyme activity on all surfaces, but this effect was independent of surface microstructure. These results indicate that surface micron-scale topography modulates alpha(5)beta(1) integrin binding and FAK activation. Signaling via alpha(5)-dependent mechanisms is required for DNA synthesis and regulation of alkaline phosphatase, but this effect is independent of surface microstructure.</abstract><notes>Keselowsky, B G&#xD;Wang, L&#xD;Schwartz, Z&#xD;Garcia, A J&#xD;Boyan, B D&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of biomedical materials research. Part A&#xD;J Biomed Mater Res A. 2007 Mar 1;80(3):700-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17133443</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>2.612</custom4><electronic-resource-num>10.1002/jbm.a.30898</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>380</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">380</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, C.</author><author>Sze, R.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, University of Washington, Seattle, 98195, USA.</auth-address><titles><title>Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI</title><secondary-title>J Biomed Mater Res A</secondary-title><alt-title>Journal of biomedical materials research</alt-title></titles><pages>550-7</pages><volume>78</volume><number>3</number><edition>2006/09</edition><keywords><keyword>*Drug Delivery Systems</keyword><keyword>Ferric Compounds</keyword><keyword>*Folic Acid</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Magnetics</keyword><keyword>*Nanostructures</keyword><keyword>*Polyethylene Glycols</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>1549-3296 (Print)</isbn><accession-num>16736484</accession-num><abstract>We report the development and in vitro study of a nanoconjugate serving as a targeted magnetic resonance imaging (MRI) contrast enhancement agent for detection of cancer cells overexpressing the folate receptor. The nanoconjugate was synthesized by coating superparamagnetic iron oxide nanoparticles with covalently bound bifunctional poly(ethylene glycol) (PEG), followed by conjugation with folic acid (FA). The specificity of the nanoconjugate targeting cancerous cells was demonstrated by comparative intracellular uptake of the nanoconjugate and PEG-/dextran-coated nanoparticles by human adenocarcinoma HeLa cells. Preferential targeting to cancerous cells was studied by comparing the uptake of the nanoconjugate by HeLa cells and by non-FR expressing osteosarcoma MG-63 cells. Uptake of the nanoconjugate by HeLa cells after 4 h incubation was found to be a 12-fold higher than that of PEG- or dextran-coated nanoparticles as quantified by inductively coupled plasma spectroscopy. A significant negative contrast enhancement was observed with magnetic resonance (MR) phantom imaging for HeLa cells over MG-63 cells, when both were cultured with the nanoconjugate. Specificity of the nanoconjugate for folate receptors was also verified with a competitive inhibition assay, in which HeLa cells were incubated with both NP-PEG-FA and free FA. The bifunctional PEG used has amide linkages within the PEG chains that can form interchain hydrogen bonding, leading to improved stability of the PEG coating. Self-assembled PEG can be controlled at the molecular level and are suitable for nanoscale coatings.</abstract><notes>N01-co37122/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16736484 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2007</custom3><custom4>2.612</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>696</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">696</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, S.</author><author>Zhu, L.</author><author>Minhaj, A. M.</author><author>Hinds, M. F.</author><author>Vu, D. H.</author><author>Rosen, D. I.</author><author>Davis, S. J.</author><author>Hasan, T.</author></authors></contributors><auth-address>Physical Sciences Inc., 20 New England Business Center, Andover, Massachusetts 01810-1077, USA. lee@psicorp.com</auth-address><titles><title>Pulsed diode laser-based monitor for singlet molecular oxygen</title><secondary-title>J Biomed Opt</secondary-title></titles><pages>034010</pages><volume>13</volume><number>3</number><edition>2008/07/08</edition><dates><year>2008</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1083-3668 (Print)</isbn><accession-num>18601555</accession-num><abstract>Photodynamic therapy (PDT) is a promising cancer treatment. PDT uses the affinity of photosensitizers to be selectively retained in malignant tumors. When tumors, pretreated with the photosensitizer, are irradiated with visible light, a photochemical reaction occurs and tumor cells are destroyed. Oxygen molecules in the metastable singlet delta state O2(1Delta) are believed to be the species that destroys cancerous cells during PDT. Monitoring singlet oxygen produced by PDT may lead to more precise and effective PDT treatments. Our approach uses a pulsed diode laser-based monitor with optical fibers and a fast data acquisition system to monitor singlet oxygen during PDT. We present results of in vitro singlet oxygen detection in solutions and in a rat prostate cancer cell line as well as PDT mechanism modeling.</abstract><notes>Lee, Seonkyung&#xD;Zhu, Leyun&#xD;Minhaj, Ahmed M&#xD;Hinds, Michael F&#xD;Vu, Danthu H&#xD;Rosen, David I&#xD;Davis, Steven J&#xD;Hasan, Tayyaba&#xD;1R43CA96243-01/CA/United States NCI&#xD;P01 CA484203/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of biomedical optics&#xD;J Biomed Opt. 2008 May-Jun;13(3):034010.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18601555</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>3.084</custom4><electronic-resource-num>10.1117/1.2927465</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>697</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">697</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pogue, B. W.</author><author>Sheng, C.</author><author>Benevides, J.</author><author>Forcione, D.</author><author>Puricelli, B.</author><author>Nishioka, N.</author><author>Hasan, T.</author></authors></contributors><auth-address>Dartmouth College, Thayer School of Engineering, Hanover, New Hampshire 03755, USA. pogue@dartmouth.edu</auth-address><titles><title>Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus</title><secondary-title>J Biomed Opt</secondary-title></titles><pages>034009</pages><volume>13</volume><number>3</number><edition>2008/07/08</edition><dates><year>2008</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1083-3668 (Print)</isbn><accession-num>18601554</accession-num><abstract>Fluorescence measurements have been used to track the dosimetry of photodynamic therapy (PDT) for many years, and this approach can be especially important for treatments with aminolevulinic-acid-induced protoporphyrin IX (ALA-PpIX). PpIX photobleaches rapidly, and the bleaching is known to be oxygen dependent, and at the same time, fractionation or reduced irradiance treatments have been shown to significantly increase efficacy. Thus, in vivo measurement of either the bleaching rate and/or the total bleaching yield could be used to track the deposited dose in tissue and determine the optimal treatment plans. Fluorescence in rat esophagus and human Barrett&apos;s esophagus are measured during PDT in both continuous and fractionated light delivery treatment, and the bleaching is quantified. Reducing the optical irradiance from 50 to 25 mWcm did not significantly alter photobleaching in rat esophagus, but fractionation of the light at 1-min on and off intervals did increase photobleaching up to 10% more (p value=0.02) and up to 25% more in the human Barrett&apos;s tissue (p value&lt;0.001). While two different tissues and two different dosimetry systems are used, the data support the overall hypothesis that light fractionation in ALA-PpIX PDT esophageal treatments should have a beneficial effect on the total treatment effect.</abstract><notes>Pogue, Brian W&#xD;Sheng, Chao&#xD;Benevides, Juan&#xD;Forcione, David&#xD;Puricelli, Bill&#xD;Nishioka, Norm&#xD;Hasan, Tayyaba&#xD;P01CA84203/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of biomedical optics&#xD;J Biomed Opt. 2008 May-Jun;13(3):034009.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18601554</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>3.084</custom4><electronic-resource-num>10.1117/1.2937476</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>171</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">171</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cyrus, T.</author><author>Abendschein, D. R.</author><author>Caruthers, S. D.</author><author>Harris, T. D.</author><author>Glattauer, V.</author><author>Werkmeister, J. A.</author><author>Ramshaw, J. A.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. tcyrus@cmrl.wustl.edu</auth-address><titles><title>MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles</title><secondary-title>J Cardiovasc Magn Reson</secondary-title></titles><periodical><full-title>J Cardiovasc Magn Reson</full-title></periodical><pages>535-41</pages><volume>8</volume><number>3</number><edition>2006/06/08</edition><keywords><keyword>Animals</keyword><keyword>Biological Markers/metabolism</keyword><keyword>Carotid Arteries/*metabolism</keyword><keyword>Collagen Type III/*metabolism</keyword><keyword>Emulsions</keyword><keyword>Extracellular Matrix/*metabolism</keyword><keyword>Fluorocarbons</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Imaging, Three-Dimensional</keyword><keyword>Immunohistochemistry</keyword><keyword>Integrin alphaVbeta3/*metabolism</keyword><keyword>*Magnetic Resonance Angiography</keyword><keyword>Muscle, Smooth/cytology/*metabolism</keyword><keyword>*Nanostructures</keyword><keyword>Swine</keyword><keyword>Vascular Patency</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1097-6647 (Print)</isbn><accession-num>16755843</accession-num><abstract>In this study, porcine carotid arteries were subjected to balloon overstretch injury followed by local delivery of paramagnetic nanoparticles targeted to alphavbeta3-integrin expressed by smooth muscle cells or collagen III within the extracellular matrix. Carotid T1-weighted angiography and vascular imaging was performed at 1.5T. While MR angiograms were indistinguishable between control and targeted vessel segments, alphavbeta3-integrin-and collagen Ill-targeted nanoparticles spatially delineated patterns and volumes of stretch injury. In conclusion, MR molecular imaging with alphavbeta3-integrin or collagen Ill-targeted nanoparticles enables the non-invasive, three-dimensional characterization of arterial pathology unanticipated from routine angiography.</abstract><notes>Cyrus, Tillmann&#xD;Abendschein, Dana R&#xD;Caruthers, Shelton D&#xD;Harris, Thomas D&#xD;Glattauer, Veronica&#xD;Werkmeister, Jerome A&#xD;Ramshaw, John A M&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance&#xD;J Cardiovasc Magn Reson. 2006;8(3):535-41.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16755843</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>1.867</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>178</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">178</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Neubauer, A. M.</author><author>Caruthers, S. D.</author><author>Hockett, F. D.</author><author>Cyrus, T.</author><author>Robertson, J. D.</author><author>Allen, J. S.</author><author>Williams, T. D.</author><author>Fuhrhop, R. W.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University, St. Louis, MO 63108, USA.</auth-address><titles><title>Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents</title><secondary-title>J Cardiovasc Magn Reson</secondary-title></titles><periodical><full-title>J Cardiovasc Magn Reson</full-title></periodical><pages>565-73</pages><volume>9</volume><number>3</number><edition>2007/03/17</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media</keyword><keyword>Coronary Disease/*diagnosis</keyword><keyword>Emulsions</keyword><keyword>Fluorine Radioisotopes/*diagnostic use</keyword><keyword>Fluorocarbons/*diagnostic use</keyword><keyword>Gadolinium DTPA/*analogs &amp; derivatives/diagnostic use</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Magnetic Resonance Angiography/*methods</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Oleic Acids/*diagnostic use</keyword><keyword>Phantoms, Imaging</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1097-6647 (Print)</isbn><accession-num>17365236</accession-num><abstract>While the current gold standard for coronary imaging is X-ray angiography, evidence is accumulating that it may not be the most sensitive technique for detecting unstable plaque. Other imaging modalities, such as cardiovascular magnetic resonance (CMR), can be used for plaque characterization, but suffer from long scan and reconstruction times for determining regions of stenosis. We have developed an intravascular fluorinated contrast agent that can be used for angiography with cardiovascular magnetic resosnace at clinical field strengths (1.5 T). This liquid perfluorocarbon nanoparticle contains a high concentration of fluorine atoms that can be used to generate contrast on 19F MR images without any competing background signal from surrounding tissues. By using a perfluorocarbon with 20 equivalent fluorine molecules, custom-built RF coils, a modified clinical scanner, and an efficient steady-state free procession sequence, we demonstrate the use of this agent for angiography of small vessels in vitro, ex vivo, and in vivo. The surprisingly high signal generated with very short scan times and low doses of perfluorocarbon indicates that this technique may be useful in clinical settings when coupled with advanced imaging strategies.</abstract><notes>Neubauer, Anne M&#xD;Caruthers, Shelton D&#xD;Hockett, Franklin D&#xD;Cyrus, Tillman&#xD;Robertson, J David&#xD;Allen, J Stacy&#xD;Williams, Todd D&#xD;Fuhrhop, Ralph W&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;United States&#xD;Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance&#xD;J Cardiovasc Magn Reson. 2007;9(3):565-73.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17365236</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>1.867</custom4><electronic-resource-num>772835296 [pii]&#xD;10.1080/10976640600945481</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>724</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">724</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Waters, E.A.</author><author>Chen, J.</author><author>Zhang, H.</author><author>Lanza, G.M.</author><author>Wickline, S.A.</author></authors></contributors><titles><title>Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS</title><secondary-title>J Cardiovasc Magn Reson</secondary-title></titles><periodical><full-title>J Cardiovasc Magn Reson</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>1.867</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>158</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">158</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, T.</author><author>Vogt, S.</author><author>Maser, J.</author><author>Lai, B.</author><author>Woloschak, G.</author></authors></contributors><auth-address>Department of Radiation Oncology, Northwestern University, 303 E. Chicago Avenue, Chicago, IL 60611, USA.</auth-address><titles><title>X-ray fluorescence microprobe imaging in biology and medicine</title><secondary-title>J Cell Biochem</secondary-title></titles><pages>1489-502</pages><volume>99</volume><number>6</number><edition>2006/09/29</edition><keywords><keyword>Animals</keyword><keyword>Homeostasis</keyword><keyword>Humans</keyword><keyword>Metals/metabolism</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Nanotechnology</keyword><keyword>Therapeutics</keyword><keyword>Trace Elements/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 15</date></pub-dates></dates><isbn>0730-2312 (Print)</isbn><accession-num>17006954</accession-num><abstract>Characteristic X-ray fluorescence is a technique that can be used to establish elemental concentrations for a large number of different chemical elements simultaneously in different locations in cell and tissue samples. Exposing the samples to an X-ray beam is the basis of X-ray fluorescence microscopy (XFM). This technique provides the excellent trace element sensitivity; and, due to the large penetration depth of hard X-rays, an opportunity to image whole cells and quantify elements on a per cell basis. Moreover, because specimens prepared for XFM do not require sectioning, they can be investigated close to their natural, hydrated state with cryogenic approaches. Until several years ago, XFM was not widely available to bio-medical communities, and rarely offered resolution better then several microns. This has changed drastically with the development of third-generation synchrotrons. Recent examples of elemental imaging of cells and tissues show the maturation of XFM imaging technique into an elegant and informative way to gain insight into cellular processes. Future developments of XFM-building of new XFM facilities with higher resolution, higher sensitivity or higher throughput will further advance studies of native elemental makeup of cells and provide the biological community including the budding area of bionanotechnology with a tool perfectly suited to monitor the distribution of metals including nanovectors and measure the results of interactions between the nanovectors and living cells and tissues.</abstract><notes>Paunesku, Tatjana&#xD;Vogt, Stefan&#xD;Maser, Jorg&#xD;Lai, Barry&#xD;Woloschak, Gayle&#xD;Ca 107467/ca/nci&#xD;Eb 002100/eb/nibib&#xD;P50 ca 89018/ca/nci&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Journal of cellular biochemistry&#xD;J Cell Biochem. 2006 Dec 15;99(6):1489-502.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17006954</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>3.381</custom4><electronic-resource-num>10.1002/jcb.21047</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>494</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">494</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, L.</author><author>Makhov, A. M.</author><author>Bear, J. E.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center, Department of Cell &amp; Developmental Biology, University of North Carolina at Chapel Hill, North Carolina 27599-7295, USA.</auth-address><titles><title>F-actin binding is essential for coronin 1B function in vivo</title><secondary-title>J Cell Sci</secondary-title></titles><pages>1779-90</pages><volume>120</volume><number>Pt 10</number><edition>2007/04/26</edition><keywords><keyword>Actins/*metabolism/ultrastructure</keyword><keyword>Adenosine Diphosphate/metabolism</keyword><keyword>Adenosine Triphosphate/metabolism</keyword><keyword>Amino Acid Sequence/physiology</keyword><keyword>Animals</keyword><keyword>Arginine/metabolism</keyword><keyword>Binding Sites/physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement/physiology</keyword><keyword>Drosophila melanogaster</keyword><keyword>Fibroblasts/metabolism/ultrastructure</keyword><keyword>Humans</keyword><keyword>Microfilament Proteins/chemistry/*metabolism</keyword><keyword>Microfilaments/metabolism/ultrastructure</keyword><keyword>Microscopy, Electron</keyword><keyword>Models, Molecular</keyword><keyword>Protein Binding/physiology</keyword><keyword>Protein Structure, Tertiary/physiology</keyword><keyword>Pseudopodia/metabolism/ultrastructure</keyword><keyword>Rats</keyword></keywords><dates><year>2007</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0021-9533 (Print)</isbn><accession-num>17456547</accession-num><abstract>Coronins are conserved F-actin binding proteins that have been implicated in a variety of processes including fibroblast migration, phagocytosis, and chemotaxis. Recent data from our lab indicate that coronin 1B coordinates Arp2/3-dependent actin filament nucleation and cofilin-mediated filament turnover at the leading edge of migrating fibroblasts. Analysis of coronin function has been hampered by the lack of a clear understanding of how coronin interacts with F-actin. Here, we identify a surface-exposed conserved arginine residue at position 30 (R30), which is crucial for coronin 1B binding to F-actin both in vitro and in vivo. Using actin co-sedimentation, we demonstrate that coronin 1B binds with high affinity to ATP/ADP-P(i)-F-actin (170 nM) and with 47-fold lower affinity to ADP-F-actin (8 microM). In contrast to a previous study, we find no evidence for enhanced cofilin binding to F-actin in the presence of either coronin 1B or coronin 1A. Instead, we find that coronin 1B protects actin filaments from cofilin-induced depolymerization. Consistent with an important role for interactions between coronin 1B and F-actin in vivo, an R30D coronin mutant that does not bind F-actin localizes inefficiently to the leading edge. Furthermore, our analysis indicates that F-actin binding is absolutely required for coronin 1B to exert its effects on whole-cell motility and lamellipodial dynamics.</abstract><notes>Cai, Liang&#xD;Makhov, Alexander M&#xD;Bear, James E&#xD;1U54CA119343/CA/United States NCI&#xD;CA-16086/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Journal of cell science&#xD;J Cell Sci. 2007 May 15;120(Pt 10):1779-90. Epub 2007 Apr 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17456547</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>6.383</custom4><electronic-resource-num>jcs.007641 [pii]&#xD;10.1242/jcs.007641</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>61</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">61</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Berquin, I. M.</author><author>Min, Y.</author><author>Wu, R.</author><author>Wu, J.</author><author>Perry, D.</author><author>Cline, J. M.</author><author>Thomas, M. J.</author><author>Thornburg, T.</author><author>Kulik, G.</author><author>Smith, A.</author><author>Edwards, I. J.</author><author>D&apos;Agostino, R.</author><author>Zhang, H.</author><author>Wu, H.</author><author>Kang, J. X.</author><author>Chen, Y. Q.</author></authors></contributors><auth-address>Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.</auth-address><titles><title>Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids</title><secondary-title>J Clin Invest</secondary-title></titles><pages>1866-75</pages><volume>117</volume><number>7</number><edition>2007/07/04</edition><keywords><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Disease Progression</keyword><keyword>Fatty Acids, Omega-3/metabolism/*pharmacology</keyword><keyword>Fatty Acids, Omega-6/metabolism/*pharmacology</keyword><keyword>Gene Deletion</keyword><keyword>*Genetic Predisposition to Disease</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>PTEN Phosphohydrolase/deficiency/genetics/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Prostatic Neoplasms/diet therapy/*genetics/*pathology</keyword><keyword>Survival Rate</keyword><keyword>bcl-Associated Death Protein/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0021-9738 (Print)</isbn><accession-num>17607361</accession-num><abstract>Although a causal role of genetic alterations in human cancer is well established, it is still unclear whether dietary fat can modulate cancer risk in a predisposed population. Epidemiological studies suggest that diets rich in omega-3 polyunsaturated fatty acids reduce cancer incidence. To determine the influence of fatty acids on prostate cancer risk in animals with a defined genetic lesion, we used prostate-specific Pten-knockout mice, an immune-competent, orthotopic prostate cancer model, and diets with defined polyunsaturated fatty acid levels. We found that omega-3 fatty acids reduced prostate tumor growth, slowed histopathological progression, and increased survival, whereas omega-6 fatty acids had opposite effects. Introducing an omega-3 desaturase, which converts omega-6 to omega-3 fatty acids, into the Pten-knockout mice reduced tumor growth similarly to the omega-3 diet. Tumors from mice on the omega-3 diet had lower proportions of phosphorylated Bad and higher apoptotic indexes compared with those from mice on omega-6 diet. Knockdown of Bad eliminated omega-3-induced cell death, and introduction of exogenous Bad restored the sensitivity to omega-3 fatty acids. Our data suggest that modulation of prostate cancer development by polyunsaturated fatty acids is mediated in part through Bad-dependent apoptosis. This study highlights the importance of gene-diet interactions in prostate cancer.</abstract><notes>Berquin, Isabelle M&#xD;Min, Younong&#xD;Wu, Ruping&#xD;Wu, Jiansheng&#xD;Perry, Donna&#xD;Cline, J Mark&#xD;Thomas, Mike J&#xD;Thornburg, Todd&#xD;Kulik, George&#xD;Smith, Adrienne&#xD;Edwards, Iris J&#xD;D&apos;Agostino, Ralph&#xD;Zhang, Hao&#xD;Wu, Hong&#xD;Kang, Jing X&#xD;Chen, Yong Q&#xD;P01 ca106742/ca/nci&#xD;R01 ca107668/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of clinical investigation&#xD;J Clin Invest. 2007 Jul;117(7):1866-75.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17607361</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>16.915</custom4><electronic-resource-num>10.1172/JCI31494</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>493</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">493</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Petermann, K. B.</author><author>Rozenberg, G. I.</author><author>Zedek, D.</author><author>Groben, P.</author><author>McKinnon, K.</author><author>Buehler, C.</author><author>Kim, W. Y.</author><author>Shields, J. M.</author><author>Penland, S.</author><author>Bear, J. E.</author><author>Thomas, N. E.</author><author>Serody, J. S.</author><author>Sharpless, N. E.</author></authors></contributors><auth-address>Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7295, USA.</auth-address><titles><title>CD200 is induced by ERK and is a potential therapeutic target in melanoma</title><secondary-title>J Clin Invest</secondary-title></titles><pages>3922-9</pages><volume>117</volume><number>12</number><edition>2007/11/17</edition><keywords><keyword>Acute Disease</keyword><keyword>Antigens, CD/genetics/*immunology</keyword><keyword>Antigens, Surface/genetics/immunology</keyword><keyword>Cell Movement/genetics/immunology</keyword><keyword>Cell Survival/genetics/immunology</keyword><keyword>Dendritic Cells/immunology/pathology</keyword><keyword>Extracellular Signal-Regulated MAP Kinases/genetics/*immunology</keyword><keyword>Gene Expression Regulation, Neoplastic/genetics/*immunology</keyword><keyword>Humans</keyword><keyword>Leukemia/genetics/immunology/pathology</keyword><keyword>Lymphocyte Activation/genetics/immunology</keyword><keyword>Melanoma/genetics/*immunology/pathology/therapy</keyword><keyword>Mutation</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Proto-Oncogene Proteins B-raf/genetics/immunology</keyword><keyword>Proto-Oncogene Proteins p21(ras)/genetics/immunology</keyword><keyword>Receptors, Cell Surface/genetics/immunology</keyword><keyword>T-Lymphocytes/immunology/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0021-9738 (Print)</isbn><accession-num>18008004</accession-num><abstract>Immune-mediated antitumor responses occur in patients with metastatic melanoma (MM), and therapies designed to augment such responses are clinically beneficial. Despite the immunogenicity of melanoma, immunomodulatory therapies fail in the majority of patients with MM. An inability of DCs to sufficiently activate effector cells may, in part, underlie this failure of the antitumor response seen in most patients. In this work, we show that mutation of N-RAS or B-RAF, signature genetic lesions present in most MMs, potently induced the expression of cell-surface CD200, a repressor of DC function. Employing 2 independent, genome-wide microarray analyses, we identified CD200 as a highly dynamic, downstream target of RAS/RAF/MEK/ERK activation in melanoma. CD200 protein was similarly overexpressed in human melanoma cell lines and primary tumors. CD200 mRNA expression correlated with progression and was higher in melanoma than in other solid tumors or acute leukemia. Melanoma cell lines expressing endogenous CD200 repressed primary T cell activation by DCs, while knockdown of CD200 by shRNA abrogated this immunosuppressive effect. These data indicate that in addition to its effects on growth, survival, and motility, ERK activation in MM attenuates a host antitumor immune response, implicating CD200 and its interaction with the CD200 receptor as a potential therapeutic target for MM.</abstract><notes>Petermann, Kimberly B&#xD;Rozenberg, Gabriela I&#xD;Zedek, Daniel&#xD;Groben, Pamela&#xD;McKinnon, Karen&#xD;Buehler, Christin&#xD;Kim, William Y&#xD;Shields, Janiel M&#xD;Penland, Shannon&#xD;Bear, James E&#xD;Thomas, Nancy E&#xD;Serody, Jonathan S&#xD;Sharpless, Norman E&#xD;CA105837/CA/United States NCI&#xD;CA106991/CA/United States NCI&#xD;CA90679/CA/United States NCI&#xD;ES14635/ES/United States NIEHS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of clinical investigation&#xD;J Clin Invest. 2007 Dec;117(12):3922-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18008004</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>16.915</custom4><electronic-resource-num>10.1172/JCI32163</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>421</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">421</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Swirski, F. K.</author><author>Libby, P.</author><author>Aikawa, E.</author><author>Alcaide, P.</author><author>Luscinskas, F. W.</author><author>Weissleder, R.</author><author>Pittet, M. J.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA. mpittet@hms.harvard.edu</auth-address><titles><title>Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata</title><secondary-title>J Clin Invest</secondary-title></titles><pages>195-205</pages><volume>117</volume><number>1</number><edition>2007/01/04</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal</keyword><keyword>Antigens, Ly/*immunology</keyword><keyword>Apolipoproteins E/blood/deficiency/genetics</keyword><keyword>Atherosclerosis/*blood/genetics</keyword><keyword>Disease Models, Animal</keyword><keyword>Flow Cytometry</keyword><keyword>Hypercholesterolemia/*blood</keyword><keyword>Macrophages/*cytology/*physiology</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Knockout</keyword><keyword>Monocytes/cytology/physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0021-9738 (Print)</isbn><accession-num>17200719</accession-num><abstract>Macrophage accumulation participates decisively in the development and exacerbation of atherosclerosis. Circulating monocytes, the precursors of macrophages, display heterogeneity in mice and humans, but their relative contribution to atherogenesis remains unknown. We report here that the Ly-6C(hi) monocyte subset increased dramatically in hypercholesterolemic apoE-deficient mice consuming a high-fat diet, with the number of Ly-6C(hi) cells doubling in the blood every month. Ly-6C(hi) monocytes adhered to activated endothelium, infiltrated lesions, and became lesional macrophages. Hypercholesterolemia-associated monocytosis (HAM) developed from increased survival, continued cell proliferation, and impaired Ly-6C(hi) to Ly-6C(lo) conversion and subsided upon statin-induced cholesterol reduction. Conversely, the number of Ly-6C(lo) cells remained unaffected. Thus, we believe that Ly-6C(hi) monocytes represent a newly recognized component of the inflammatory response in experimental atherosclerosis.</abstract><notes>Swirski, Filip K&#xD;Libby, Peter&#xD;Aikawa, Elena&#xD;Alcaide, Pilar&#xD;Luscinskas, F William&#xD;Weissleder, Ralph&#xD;Pittet, Mikael J&#xD;HL36028/HL/United States NHLBI&#xD;HL53393/HL/United States NHLBI&#xD;P01-A154904/United States PHS&#xD;R01HL034636/HL/United States NHLBI&#xD;R24 CA69246/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of clinical investigation&#xD;J Clin Invest. 2007 Jan;117(1):195-205.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17200719</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>16.915</custom4><electronic-resource-num>10.1172/JCI29950</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>198</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">198</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agus, D. B.</author><author>Sweeney, C. J.</author><author>Morris, M. J.</author><author>Mendelson, D. S.</author><author>McNeel, D. G.</author><author>Ahmann, F. R.</author><author>Wang, J.</author><author>Derynck, M. K.</author><author>Ng, K.</author><author>Lyons, B.</author><author>Allison, D. E.</author><author>Kattan, M. W.</author><author>Scher, H. I.</author></authors></contributors><auth-address>Cedars-Sinai Prostate Cancer Center, Los Angeles, CA 90048, USA. David.Agus@cshs.org</auth-address><titles><title>Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy</title><secondary-title>J Clin Oncol</secondary-title></titles><pages>675-81</pages><volume>25</volume><number>6</number><edition>2007/02/20</edition><keywords><keyword>Aged</keyword><keyword>Antibodies, Monoclonal/*administration &amp; dosage</keyword><keyword>Bridged Compounds/adverse effects/*therapeutic use</keyword><keyword>Disease Progression</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Administration Schedule</keyword><keyword>Drug Resistance, Neoplasm</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm Recurrence, Local/*drug therapy/pathology</keyword><keyword>Orchiectomy</keyword><keyword>Probability</keyword><keyword>Prognosis</keyword><keyword>Prostatic Neoplasms/*drug therapy/mortality/pathology/surgery</keyword><keyword>Receptor, erbB-2/administration &amp; dosage/*antagonists &amp; inhibitors</keyword><keyword>Risk Assessment</keyword><keyword>Single-Blind Method</keyword><keyword>Survival Analysis</keyword><keyword>Taxoids/adverse effects/*therapeutic use</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 20</date></pub-dates></dates><isbn>1527-7755 (Electronic)</isbn><accession-num>17308272</accession-num><abstract>PURPOSE: Pertuzumab represents a new class of targeted anticancer agents, human epidermal growth factor receptor (HER) dimerization inhibitors. The aim of this single-arm phase II clinical study was to assess the efficacy and safety of single-agent pertuzumab in castration-resistant prostate cancer (CRPC) patients who had experienced progression after prior chemotherapy. PATIENTS AND METHODS: Patients received pertuzumab every 3 weeks. All castration-resistant patients had experienced progression after at least one taxane-based regimen. Patients received a loading dose of 840 mg pertuzumab (cycle 1) followed by 420 mg for subsequent cycles. The primary end point was overall response and safety. A separate retrospective analysis of actual survival time versus predicted survival time for a patient population with comparable prognostic features was performed. RESULTS: Patients were enrolled (N = 42) and treated (n = 41). No patients had complete or partial response (as defined by Response Evaluation Criteria in Solid Tumors Group or 50% decline in prostate-specific antigen). Of 30 efficacy-assessable patients, five had stable disease (SD) for at least 23 weeks; one of five had SD for 36 weeks. Pertuzumab was well tolerated; diarrhea was the most common adverse effect (61.0%, grades 1 to 3). Retrospective analysis of survival using a validated nomogram suggested that survival was prolonged with pertuzumab treatment, compared with historic controls with similar baseline prognostic features. CONCLUSION: Pertuzumab was well tolerated and resulted in no objective responses, but several patients had SD more than 23 weeks from a heavily pretreated population. Retrospective analysis suggested prolonged median survival time with pertuzumab compared with historical controls. Thus, inhibition of HER dimerization may have clinical utility in CRPC patients.</abstract><notes>Agus, David B&#xD;Sweeney, Christopher J&#xD;Morris, Michael J&#xD;Mendelson, David S&#xD;McNeel, Douglas G&#xD;Ahmann, Frederick R&#xD;Wang, Jin&#xD;Derynck, Mika K&#xD;Ng, Kimmie&#xD;Lyons, Benjamin&#xD;Allison, David E&#xD;Kattan, Michael W&#xD;Scher, Howard I&#xD;Clinical Trial, Phase II&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of clinical oncology : official journal of the American Society of Clinical Oncology&#xD;J Clin Oncol. 2007 Feb 20;25(6):675-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17308272</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>13.598</custom4><electronic-resource-num>25/6/675 [pii]&#xD;10.1200/JCO.2006.07.0649</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>68</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">68</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S. E.</author><author>Pohlhaus, P. D.</author><author>Lee, J.</author><author>Guo, J.</author><author>Cho, M. J.</author><author>Desimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles</title><secondary-title>J Control Release</secondary-title></titles><pages>10-8</pages><volume>121</volume><number>1-2</number><edition>2007/07/24</edition><dates><year>2007</year><pub-dates><date>Aug 16</date></pub-dates></dates><isbn>1873-4995 (Electronic)</isbn><accession-num>17643544</accession-num><abstract>A novel method for the fabrication of polymeric particles on the order of tens of nanometers to several microns is described. This imprint lithographic technique called PRINT (Particle Replication In Non-wetting Templates), takes advantage of the unique properties of elastomeric molds comprised of a low surface energy perfluoropolyether network, allowing the production of monodisperse, shape-specific nanoparticles from an extensive array of organic precursors. This engineered nature of particle production has a number of advantages over the construction of traditional nanoparticles such as liposomes, dendrimers, and colloidal precipitates. The gentle &quot;top down&quot; approach of PRINT enables the simultaneous and independent control over particle size and shape, composition, and surface functionality, and permits the loading of delicate cargos such as small organic therapeutics and biological macromolecules. Thus, this single tool serves as a comprehensive platform for the rational design and investigation of new nanocarriers in medicine, having applications ranging from therapeutics to advanced diagnostics. Preliminary in vitro and in vivo studies were conducted, demonstrating the future utility of PRINT particles as delivery vectors in nanomedicine. Monodisperse 200 nm poly(ethylene glycol)-based (PEG) particles were fabricated using PRINT methodology and characterized via scanning electron microscopy and dynamic light scattering. Incubation with HeLa cells showed very little cytotoxicity, even at high concentrations. The biodistribution and pharmacokinetics of [(125)I]-labeled particles were studied in healthy mice following bolus tail vein administration. The particles were distributed mainly to the liver and the spleen with an apparent distribution t(1/2) of approximately 17 min followed by slow redistribution with a t(1/2) of 3.3 h. The volume of distribution for the central and peripheral compartments was found to be approximately 3 mL and 5 mL, respectively.</abstract><notes>Gratton, Stephanie E A&#xD;Pohlhaus, Patrick D&#xD;Lee, Jin&#xD;Guo, Ji&#xD;Cho, Moo J&#xD;Desimone, Joseph M&#xD;P01-gm59299/gm/nigms&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Journal of controlled release : official journal of the Controlled Release Society&#xD;J Control Release. 2007 Aug 16;121(1-2):10-8. Epub 2007 Jun 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17643544</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>4.756</custom4><electronic-resource-num>S0168-3659(07)00269-6 [pii]&#xD;10.1016/j.jconrel.2007.05.027</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>402</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">402</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, G. Y.</author><author>Tyler, B. M.</author><author>Tupper, M. M.</author><author>Karp, J. M.</author><author>Langer, R. S.</author><author>Brem, H.</author><author>Cima, M. J.</author></authors></contributors><auth-address>Division of Health Sciences and Technology, MIT/Harvard University, USA.</auth-address><titles><title>Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model</title><secondary-title>J Control Release</secondary-title></titles><pages>172-8</pages><volume>123</volume><number>2</number><edition>2007/09/22</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents,</keyword><keyword>Alkylating/chemistry/pharmacokinetics/*pharmacology/therapeutic use</keyword><keyword>*Biocompatible Materials</keyword><keyword>Carmustine/chemistry/pharmacokinetics/*pharmacology/therapeutic use</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Decanoic Acids/chemistry</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>*Drug Carriers</keyword><keyword>Drug Compounding</keyword><keyword>*Drug Implants</keyword><keyword>Drug Stability</keyword><keyword>Female</keyword><keyword>Gliosarcoma/pathology/*prevention &amp; control</keyword><keyword>Half-Life</keyword><keyword>Lactic Acid/chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Polyesters/chemistry</keyword><keyword>Polyglycolic Acid/chemistry</keyword><keyword>Polymers/*chemistry</keyword><keyword>Rats</keyword><keyword>Rats, Inbred F344</keyword><keyword>Reproducibility of Results</keyword><keyword>Solubility</keyword><keyword>Time Factors</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 6</date></pub-dates></dates><isbn>1873-4995 (Electronic)</isbn><accession-num>17884232</accession-num><abstract>Sustained local delivery of single agents and controlled delivery of multiple chemotherapeutic agents are sought for the treatment of brain cancer. A resorbable, multi-reservoir polymer microchip drug delivery system has been tested against a tumor model. The microchip reservoirs were loaded with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). BCNU was more stable at 37 degrees C within the microchip compared to a uniformly impregnated polymeric wafer (70% intact drug vs. 38%, at 48 h). The half-life of the intact free drug in the microchip was 11 days, which is a marked enhancement compared to its half-life in normal saline and 10% ethanol (7 and 10 min, respectively) [P. Tepe, S.J. Hassenbusch, R. Benoit, J.H. Anderson, BCNU stability as a function of ethanol concentration and temperature, J. Neurooncol. 10 (1991) 121-127; P. Kari, W.R. McConnell, J.M. Finkel, D.L. Hill, Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas, Cancer Chemother. Pharmacol. 4 (1980) 243-248]. A syngeneic Fischer 344 9L gliosarcoma rat model was used to study the tumoricidal efficacy of BCNU delivery from the microchip or homogeneous polymer wafer. A dose-dependent decrease in tumor size was found for 0.17, 0.67, and 1.24 mg BCNU-microchips. Tumors treated with 1.24 mg BCNU-microchips showed significant tumor reduction (p=0.001) compared to empty control microchips at two weeks. The treatment showed similar efficacy to a polymer wafer with the same dosage. The microchip reservoir array may enable delivery of multiple drugs with independent release kinetics and formulations.</abstract><notes>Kim, Grace Y&#xD;Tyler, Betty M&#xD;Tupper, Malinda M&#xD;Karp, Jeffrey M&#xD;Langer, Robert S&#xD;Brem, Henry&#xD;Cima, Michael J&#xD;1 R24 AI47739/AI/United States NIAID&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Journal of controlled release : official journal of the Controlled Release Society&#xD;J Control Release. 2007 Nov 6;123(2):172-8. Epub 2007 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17884232</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.756</custom4><electronic-resource-num>S0168-3659(07)00407-5 [pii]&#xD;10.1016/j.jconrel.2007.08.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>422</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">422</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Swirski, F. K.</author><author>Aikawa, E.</author><author>Stangenberg, L.</author><author>Wurdinger, T.</author><author>Figueiredo, J. L.</author><author>Libby, P.</author><author>Weissleder, R.</author><author>Pittet, M. J.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions</title><secondary-title>J Exp Med</secondary-title></titles><pages>3037-47</pages><volume>204</volume><number>12</number><edition>2007/11/21</edition><keywords><keyword>Animals</keyword><keyword>Flow Cytometry</keyword><keyword>Heart Injuries/*physiopathology</keyword><keyword>Kinetics</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Monocytes/classification/*physiology</keyword><keyword>Myocardial Infarction/*physiopathology</keyword><keyword>Neutrophils/*physiology</keyword><keyword>Time Factors</keyword><keyword>*Wound Healing</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 26</date></pub-dates></dates><isbn>1540-9538 (Electronic)</isbn><accession-num>18025128</accession-num><abstract>Healing of myocardial infarction (MI) requires monocytes/macrophages. These mononuclear phagocytes likely degrade released macromolecules and aid in scavenging of dead cardiomyocytes, while mediating aspects of granulation tissue formation and remodeling. The mechanisms that orchestrate such divergent functions remain unknown. In view of the heightened appreciation of the heterogeneity of circulating monocytes, we investigated whether distinct monocyte subsets contribute in specific ways to myocardial ischemic injury in mouse MI. We identify two distinct phases of monocyte participation after MI and propose a model that reconciles the divergent properties of these cells in healing. Infarcted hearts modulate their chemokine expression profile over time, and they sequentially and actively recruit Ly-6C(hi) and -6C(lo) monocytes via CCR2 and CX(3)CR1, respectively. Ly-6C(hi) monocytes dominate early (phase I) and exhibit phagocytic, proteolytic, and inflammatory functions. Ly-6C(lo) monocytes dominate later (phase II), have attenuated inflammatory properties, and express vascular-endothelial growth factor. Consequently, Ly-6C(hi) monocytes digest damaged tissue, whereas Ly-6C(lo) monocytes promote healing via myofibroblast accumulation, angiogenesis, and deposition of collagen. MI in atherosclerotic mice with chronic Ly-6C(hi) monocytosis results in impaired healing, underscoring the need for a balanced and coordinated response. These observations provide novel mechanistic insights into the cellular and molecular events that regulate the response to ischemic injury and identify new therapeutic targets that can influence healing and ventricular remodeling after MI.</abstract><notes>Nahrendorf, Matthias&#xD;Swirski, Filip K&#xD;Aikawa, Elena&#xD;Stangenberg, Lars&#xD;Wurdinger, Thomas&#xD;Figueiredo, Jose-Luiz&#xD;Libby, Peter&#xD;Weissleder, Ralph&#xD;Pittet, Mikael J&#xD;P01-A154904/United States PHS&#xD;R01HL34636/HL/United States NHLBI&#xD;R24 CA69246/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of experimental medicine&#xD;J Exp Med. 2007 Nov 26;204(12):3037-47. Epub 2007 Nov 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18025128</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>15.612</custom4><electronic-resource-num>jem.20070885 [pii]&#xD;10.1084/jem.20070885</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>423</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">423</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, H. J.</author><author>Sawaya, H.</author><author>Binstadt, B.</author><author>Brickelmaier, M.</author><author>Blasius, A.</author><author>Gorelik, L.</author><author>Mahmood, U.</author><author>Weissleder, R.</author><author>Carulli, J.</author><author>Benoist, C.</author><author>Mathis, D.</author></authors></contributors><auth-address>Section on Immunology and Immunogenetics, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115, USA.</auth-address><titles><title>Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk</title><secondary-title>J Exp Med</secondary-title></titles><pages>1911-22</pages><volume>204</volume><number>8</number><edition>2007/07/25</edition><keywords><keyword>Animals</keyword><keyword>Anti-Inflammatory Agents/pharmacology</keyword><keyword>Arthritis/*therapy</keyword><keyword>*CpG Islands</keyword><keyword>Dendritic Cells/*cytology/immunology</keyword><keyword>Immunotherapy/*methods</keyword><keyword>Inflammation/*therapy</keyword><keyword>Interferon Type II/metabolism</keyword><keyword>Interleukin-12/metabolism</keyword><keyword>Killer Cells, Natural/*cytology/immunology</keyword><keyword>Mice</keyword><keyword>Models, Biological</keyword><keyword>Neutrophils/metabolism</keyword><keyword>Oligonucleotides/chemistry</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 6</date></pub-dates></dates><isbn>0022-1007 (Print)</isbn><accession-num>17646407</accession-num><abstract>Unmethylated CpG-oligodeoxynucleotides (ODNs) are generally thought of as potent adjuvants with considerable therapeutic potential to enhance immune responses against microbes and tumors. Surprisingly, certain so-called stimulatory CpG-ODNs strongly inhibited the effector phase of inflammatory arthritis in the K/BxN serum transfer system, either preventively or therapeutically. Also unexpected was that the inhibitory influence did not depend on the adaptive immune system cells mobilized in an immunostimulatory context. Instead, they relied on cells of the innate immune system, specifically on cross talk between CD8 alpha(+) dendritic cells and natural killer cells, resulting in suppression of neutrophil recruitment to the joint, orchestrated through interleukin-12 and interferon-gamma. These findings highlight potential applications of CpG-ODNs and downstream molecules as antiinflammatory agents.</abstract><notes>Wu, Hsin-Jung&#xD;Sawaya, Heloisa&#xD;Binstadt, Bryce&#xD;Brickelmaier, Margot&#xD;Blasius, Amanda&#xD;Gorelik, Leonid&#xD;Mahmood, Umar&#xD;Weissleder, Ralph&#xD;Carulli, John&#xD;Benoist, Christophe&#xD;Mathis, Diane&#xD;P01 AI54904/AI/United States NIAID&#xD;R24 CA 92782/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of experimental medicine&#xD;J Exp Med. 2007 Aug 6;204(8):1911-22. Epub 2007 Jul 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17646407</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>15.612</custom4><electronic-resource-num>jem.20070285 [pii]&#xD;10.1084/jem.20070285</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>214</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">214</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Irish, J. M.</author><author>Czerwinski, D. K.</author><author>Nolan, G. P.</author><author>Levy, R.</author></authors></contributors><auth-address>Department of Medicine, Oncology Division, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry</title><secondary-title>J Immunol</secondary-title></titles><pages>1581-9</pages><volume>177</volume><number>3</number><edition>2006/07/20</edition><keywords><keyword>B-Lymphocyte Subsets/enzymology/*immunology/*metabolism</keyword><keyword>Flow Cytometry/*methods</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide/chemistry</keyword><keyword>Immunoglobulin G/biosynthesis/metabolism</keyword><keyword>Immunoglobulin M/biosynthesis/metabolism</keyword><keyword>Intracellular Signaling Peptides and Proteins/metabolism</keyword><keyword>Kinetics</keyword><keyword>MAP Kinase Signaling System/*immunology</keyword><keyword>Mitogen-Activated Protein Kinase 1/metabolism/physiology</keyword><keyword>Mitogen-Activated Protein Kinase 3/metabolism/physiology</keyword><keyword>Peptide Mapping/methods</keyword><keyword>Phosphorylation</keyword><keyword>Protein-Tyrosine Kinases/metabolism</keyword><keyword>Receptors, Antigen, B-Cell/metabolism/*physiology</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0022-1767 (Print)</isbn><accession-num>16849466</accession-num><abstract>Differences in BCR signaling may govern outcomes as diverse as proliferation and cell death. We profiled BCR signaling kinetics in subsets of primary human B cells using flow cytometry. In the predominant population expressing IgM, BCR cross-linking led to a quick burst of Syk, ERK1/2, and p38 signaling. In contrast, IgG B cells sustained higher per-cell ERK1/2 phosphorylation over time. This dichotomy suggested a mechanism for dampening signals transmitted by IgM. Regulatory phosphatase activity in IgM B cells was BCR-mediated and initiated more slowly than kinase activity. This BCR-mediated phosphatase activity was sensitive to inhibition by H(2)O(2) and required to attenuate IgM BCR signaling. These results provide the first kinetic maps of BCR signaling in primary human B cell subsets and enable new studies of signaling in B cell disorders, such as autoimmunity and cancer.</abstract><notes>Irish, Jonathan M&#xD;Czerwinski, Debra K&#xD;Nolan, Garry P&#xD;Levy, Ronald&#xD;Ca 33399/ca/nci&#xD;Ca 34233/ca/nci&#xD;N01-hv-281831/hv/nhlbi&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of immunology (Baltimore, Md. : 1950)&#xD;J Immunol. 2006 Aug 1;177(3):1581-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16849466</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>6.293</custom4><electronic-resource-num>177/3/1581 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>530</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">530</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Olafsen, T.</author><author>Gu, Z.</author><author>Sherman, M. A.</author><author>Leyton, J. V.</author><author>Witkosky, M. E.</author><author>Shively, J. E.</author><author>Raubitschek, A. A.</author><author>Morrison, S. L.</author><author>Wu, A. M.</author><author>Reiter, R. E.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA. tolafsen@mednet.ucla.edu</auth-address><titles><title>Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody</title><secondary-title>J Immunother</secondary-title></titles><pages>396-405</pages><volume>30</volume><number>4</number><edition>2007/04/26</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/chemistry</keyword><keyword>Antineoplastic Agents/pharmacology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Hybridomas/metabolism</keyword><keyword>Immunotherapy/*methods</keyword><keyword>Kinetics</keyword><keyword>Male</keyword><keyword>Membrane Glycoproteins/*immunology</keyword><keyword>Mice</keyword><keyword>Molecular Sequence Data</keyword><keyword>Neoplasm Proteins/*immunology</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Prostatic Neoplasms/metabolism/*pathology</keyword><keyword>Sequence Homology, Amino Acid</keyword></keywords><dates><year>2007</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1524-9557 (Print)</isbn><accession-num>17457214</accession-num><abstract>The murine 1G8 (micro1G8) monoclonal antibody directed against prostate stem cell antigen (PSCA) prevents prostate tumor establishment, growth, and metastasis in murine models. To further delineate in vivo targeting properties, micro1G8 was radiolabeled with In-111 and evaluated in nude mice bearing PC3-PSCA xenografts. Tumor activity ranged from 11.8% to 17.1% injected dose per gram (ID/g) at 24 to 96 hours postinjection. To extend the clinical applicability of micro1G8, a chimeric 1G8 antibody was produced that exhibited specific binding to PSCA and significant antitumor effect over micro1G8 in established LAPC-9 prostate cancer xenografts (P=0.0014). However, low expression yields and instability prompted us to humanize 1G8 by grafting the complementary determining regions onto the stable, human Fv framework of anti-p185 4D5v8 (trastuzumab). Two humanized 1G8 (hu1G8) versions (A and B) that differed in the number of murine residues present in the C-terminal half of CDR-H2, were produced. Biacore binding studies demonstrated affinities of 1.47 nM for micro1G8 and 3.74 nM for hu2B3-B, representing a 2.5-fold reduction. Tumor targeting of version B radioiodinated with I was evaluated by serial microPET imaging. Specific tumor targeting of I-hu1G8-B to PC3-PSCA [12.7 (+/-1.6)% ID/g at 94 h] and LAPC-9 [6.6 (+/-0.9)% ID/g at 168 h) xenografts was observed. Inhibition of tumor growth by hu1G8-B was demonstrated in mice bearing low-expressing SW-780-PSCA bladder carcinoma xenografts. In this model, the micro1G8 was ineffective, whereas the hu1G8-B exhibited approximately 50% inhibitory effect. These data support further development of hu1G8 anti-PSCA antibody for targeted imaging and therapy for tumors of urogenital origin.</abstract><notes>Olafsen, Tove&#xD;Gu, Zhennan&#xD;Sherman, Mark A&#xD;Leyton, Jeffrey V&#xD;Witkosky, Michael E&#xD;Shively, John E&#xD;Raubitschek, Andrew A&#xD;Morrison, Sherie L&#xD;Wu, Anna M&#xD;Reiter, Robert E&#xD;CA 16042/CA/United States NCI&#xD;CA 33572/CA/United States NCI&#xD;P01 CA 43904/CA/United States NCI&#xD;P50 CA 92131/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of immunotherapy (Hagerstown, Md. : 1997)&#xD;J Immunother. 2007 May-Jun;30(4):396-405.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17457214</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>4.837</custom4><electronic-resource-num>10.1097/CJI.0b013e318031b53b&#xD;00002371-200705000-00004 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>157</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">157</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Larson, A. C.</author><author>Rhee, T. K.</author><author>Deng, J.</author><author>Wang, D.</author><author>Sato, K. T.</author><author>Salem, R.</author><author>Paunesku, T.</author><author>Woloschak, G.</author><author>Mulcahy, M. F.</author><author>Li, D.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University, Chicago, Illinois, USA. alarson@radiology.northwestern.edu</auth-address><titles><title>Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model</title><secondary-title>J Magn Reson Imaging</secondary-title></titles><pages>242-7</pages><volume>24</volume><number>1</number><edition>2006/06/08</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media/*administration &amp; dosage/pharmacology</keyword><keyword>Disease Models, Animal</keyword><keyword>Gadolinium DTPA/*pharmacology</keyword><keyword>Infusions, Intra-Arterial/*methods</keyword><keyword>Infusions, Intravenous/*methods</keyword><keyword>Liver/pathology</keyword><keyword>Liver Neoplasms/*diagnosis/*pathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Rabbits</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1053-1807 (Print)</isbn><accession-num>16758469</accession-num><abstract>PURPOSE: To test the hypothesis that catheter-directed intraarterial (IA) contrast agent injection increases tumor enhancement and conspicuity compared to intravenous (IV) injection. MATERIALS AND METHODS: Eight VX2 liver tumors were grown in five rabbits. After positioning a catheter in the hepatic artery, we performed 3D inversion recovery GRE MRI after IA and IV gadopentetate-dimeglumine contrast injections at doses of 0.04 and 0.1 mmol/kg, respectively. Peak enhancement (signal-to-noise ratio (SNR)) and conspicuity (contrast-to-noise ratio (CNR)) were measured for each acquisition. RESULTS: The peak SNR and CNR were 21.7 +/- 5.8 and 17.0 +/- 4.8 (mean +/- SD) after IA injection, and 16.9 +/- 10.2 and 6.2 +/- 2.6 after IV injection. The IA CNR was significantly greater than the IV CNR (P &lt; 0.05), with a &gt;60% increase in CNR for each tumor. For six of the eight tumors the IA SNR was greater than the IV SNR, but statistical significance was not achieved due to the small sample size of the study (P = 0.07). CONCLUSION: We demonstrated the feasibility of using IA injection techniques to improve tumor conspicuity. This strategy could be employed to enhance the detection of small liver tumors or to conserve contrast agent in future MRI-guided transcatheter liver therapies.</abstract><notes>Larson, Andrew C&#xD;Rhee, Thomas K&#xD;Deng, Jie&#xD;Wang, Dingxin&#xD;Sato, Kent T&#xD;Salem, Riad&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle&#xD;Mulcahy, Mary F&#xD;Li, Debiao&#xD;Omary, Reed A&#xD;R01 hl70859/hl/nhlbi&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of magnetic resonance imaging : JMRI&#xD;J Magn Reson Imaging. 2006 Jul;24(1):242-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16758469</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>2.637</custom4><electronic-resource-num>10.1002/jmri.20623</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>182</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">182</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wickline, S. A.</author><author>Neubauer, A. M.</author><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Washington University, St. Louis, Missouri 63110, USA. saw@wuphys.wustl.edu</auth-address><titles><title>Molecular imaging and therapy of atherosclerosis with targeted nanoparticles</title><secondary-title>J Magn Reson Imaging</secondary-title></titles><pages>667-80</pages><volume>25</volume><number>4</number><edition>2007/03/10</edition><keywords><keyword>*Atherosclerosis/diagnosis/therapy</keyword><keyword>*Contrast Media</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>Humans</keyword><keyword>Nanomedicine/*methods</keyword><keyword>Nanoparticles/*diagnostic use/*therapeutic use</keyword><keyword>Neovascularization, Pathologic/diagnosis</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1053-1807 (Print)</isbn><accession-num>17347992</accession-num><abstract>Advances in bionanotechnology are poised to impact the field of cardiovascular diagnosis and therapy for decades to come. This review seeks to illustrate selected examples of newly developed diagnostic and therapeutic nanosystems that have been evaluated in experimental atherosclerosis, thrombosis, and vascular biology. We review a variety of nanotechnologies that are capable of detecting early cardiovascular pathology, as well as associated imaging approaches and conjunctive strategies for site-targeted treatment with nanoparticle delivery systems.</abstract><notes>Wickline, Samuel A&#xD;Neubauer, Anne M&#xD;Winter, Patrick M&#xD;Caruthers, Shelton D&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-073646/hl/nhlbi&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;N01-co-07121/co/nci&#xD;U54-ca-119342/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Journal of magnetic resonance imaging : JMRI&#xD;J Magn Reson Imaging. 2007 Apr;25(4):667-80.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17347992</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.637</custom4><electronic-resource-num>10.1002/jmri.20866</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>34</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">34</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Montet, X.</author><author>Funovics, M.</author><author>Montet-Abou, K.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Department of Radiology, Geneva Hospital, Geneva, Switzerland, and Department of Angiography and Interventional Radiology, Vienna Medical University, Vienna, Austria.</auth-address><titles><title>Multivalent effects of RGD peptides obtained by nanoparticle display</title><secondary-title>J Med Chem</secondary-title><alt-title>Journal of medicinal chemistry</alt-title></titles><pages>6087-93</pages><volume>49</volume><number>20</number><edition>2006/10</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line, Tumor</keyword><keyword>Endothelial Cells/metabolism</keyword><keyword>Endothelium, Vascular/cytology</keyword><keyword>Half-Life</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/*metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanostructures</keyword><keyword>Oligopeptides/blood/chemistry/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Conformation</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 5</date></pub-dates></dates><isbn>0022-2623 (Print)</isbn><accession-num>17004722</accession-num><abstract>The binding of RGD peptides to integrins offers an excellent system to study the multivalent mediated changes in affinity that arise when peptides, displayed on the surface of a nanoparticle carrier, bind to integrins displayed on the cell membrane. The IC50 of an RGD nanoparticle for endothelial adhesion was 1.0 nM nanoparticle or 20 nM peptide (20 peptide/nanoparticle) and was associated with strong multivalent effects, defined as a multivalent enhancement factor (MVE) of 38 (MVE=IC50 (peptide)/IC50 (peptide when displayed by nanoparticle)). The attachment of RGD peptides to nanoparticles resulted in an extension of the peptide blood half-life from 13 to 180 min. Based on the multivalent enhancement of affinity and extension of blood half-life, multivalent RGD nanoparticle-sized materials should be potent inhibitors of the alpha(V)beta(3) function on endothelial cells in vivo.</abstract><notes>P50 ca86355/ca/nci&#xD;R01 eb00662/eb/nibib&#xD;R24 ca92782/ca/nci&#xD;In Vitro&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17004722 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>5.115</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>6</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">6</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Magrini, A.</author><author>Di Venere, A.</author><author>Bellucci, S.</author><author>Dawson, M. I.</author><author>Rosato, N.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</auth-address><titles><title>Synthesis and characterization of supramolecular nanostructures of carbon nanotubes and ruthenium-complex Luminophores</title><secondary-title>J Nanosci Nanotechnol</secondary-title><alt-title>Journal of nanoscience and nanotechnology</alt-title></titles><pages>1381-6</pages><volume>6</volume><number>5</number><edition>2006/05</edition><keywords><keyword>Biosensing Techniques/instrumentation/*methods</keyword><keyword>Crystallization/*methods</keyword><keyword>Electric Power Supplies</keyword><keyword>Light</keyword><keyword>Luminescence</keyword><keyword>Luminescent Measurements/instrumentation/*methods</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Molecular Conformation</keyword><keyword>Nanotechnology/instrumentation/*methods</keyword><keyword>Nanotubes, Carbon/*chemistry/radiation effects/*ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Ruthenium/*chemistry/radiation effects</keyword><keyword>Surface Properties</keyword><keyword>Transducers</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>16792368</accession-num><abstract>We constructed and characterized supramolecular nanostructures consisting of ruthenium-complex luminophores, which were directly grafted onto short oxidized single-walled carbon nanotubes or physically entrapped in silica nanobeads, which had been covalently linked to short oxidized single-walled carbon nanotubes or hydrophobically adsorbed onto full-length multi-walled carbon nanotubes. These structures were evaluated as potential electron-acceptor complexes for use in the fabrication of photovoltaic devices, and for their properties as fluorescent nanocomposites for use in biosensors or nanoelectronics.</abstract><notes>U54 ca119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16792368 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>2.194</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>609</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">609</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Semiconductor quantum dots for in vivo imaging</title><secondary-title>J Nanosci Nanotechnol</secondary-title></titles><pages>2567-81</pages><volume>7</volume><number>8</number><edition>2007/08/10</edition><keywords><keyword>Animals</keyword><keyword>Cadmium/chemistry</keyword><keyword>Diagnostic Imaging/*instrumentation/methods</keyword><keyword>Embryo, Mammalian/pathology</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization, Fluorescence</keyword><keyword>Lymph Nodes/pathology</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Models, Chemical</keyword><keyword>Nanotechnology/*methods</keyword><keyword>*Quantum Dots</keyword><keyword>*Semiconductors</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>17685272</accession-num><abstract>Quantum dots play an important role in the in vitro, ex vivo, and in vivo optical imaging. Dramatic improvements have been achieved in the aspect of surface modification, biocompatibility, and targeting specificity, which had significant impact on the in vivo applications of quantum dots. This review summarizes the recent advances of quantum dots for in vivo imaging using both non-specific and targeted approaches. The toxicity of cadmium chalcogenide materials and alternative approaches such as the use of doped nanocrystal quantum dots were also discussed. The integration of quantum dots with other imaging techniques is also expected to give rise to a new generation of multifunctional probes for biomedical applications.</abstract><notes>Li, Zi-Bo&#xD;Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;R21 CA102123/CA/United States NCI&#xD;R21 EB001785/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Journal of nanoscience and nanotechnology&#xD;J Nanosci Nanotechnol. 2007 Aug;7(8):2567-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17685272</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>1.987</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>356</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">356</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tiwari, S. B.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Improved oral delivery of paclitaxel following administration in nanoemulsion formulations</title><secondary-title>J Nanosci Nanotechnol</secondary-title><alt-title>Journal of nanoscience and nanotechnology</alt-title></titles><pages>3215-21</pages><volume>6</volume><number>9-10</number><edition>2006/09</edition><keywords><keyword>Administration, Oral</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents, Phytogenic/administration &amp;</keyword><keyword>dosage/blood/chemistry/pharmacokinetics</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Drug Compounding/methods</keyword><keyword>Emulsions</keyword><keyword>Excipients/*chemistry</keyword><keyword>Female</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Nanostructures/*chemistry/*ultrastructure</keyword><keyword>Organ Specificity</keyword><keyword>Paclitaxel/administration &amp; dosage/blood/*chemistry/*pharmacokinetics</keyword><keyword>Particle Size</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>17048539</accession-num><abstract>Nanoemulsion formulations were designed for enhancing the oral bioavailability of hydrophobic drugs. Paclitaxel was selected as a model hydrophobic drug, which is also a substrate for the P-glycoprotein efflux system. The oil-in-water (o/w) nanoemulsions were formulated with pine nut oil as the internal oil phase, egg lecithin as the primary emulsifier, and water as the external phase. Stearylamine and deoxycholic acid were used to impart positive and negative charge to the emulsions, respectively. Nanoemulsions were prepared by sonication method and characterized for particle size and surface charge. The control and nanoemulsion formulations with tritiated [3H]-paclitaxel were administered orally to female C57BL/6 mice and the distribution of the drug was examined. The formulated nanoemulsions had a particle size range of approximately 90-120 nm (laser diffraction method) and zeta potential values ranging from -56 mV to +34 mV. Following oral administration, a significantly higher concentration of paclitaxel was observed in the systemic circulation when administered in the nanoemulsion relative to control aqueous solution. The absorbed drug was found to be distributed in the liver, kidneys, and lungs. The results of this study suggest that nanoemulsions are promising novel formulations that can enhance the oral bioavailability of hydrophobic drugs, like paclitaxel.</abstract><notes>R01-ca-095522/ca/nci&#xD;R01-ca-119617/ca/nci&#xD;Comparative Study&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17048539 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>2.194</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>365</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">365</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Klejbor, I.</author><author>Stachowiak, E. K.</author><author>Bharali, D. J.</author><author>Roy, I.</author><author>Spodnik, I.</author><author>Morys, J.</author><author>Bergey, E. J.</author><author>Prasad, P. N.</author><author>Stachowiak, M. K.</author></authors></contributors><auth-address>Institute of Lasers, Photonics and Biophotonics, Department of Chemistry, 458 NSC, State University of New York, Buffalo, NY 14260, USA; Molecular and Structural Neurobiology and Gene Therapy Program, Department of Pathology and Anatomical Sciences, State University of New York, Buffalo, NY 14214, USA; Department of Anatomy and Neurobiology, Gdansk Medical School, Poland.</auth-address><titles><title>ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology</title><secondary-title>J Neurosci Methods</secondary-title></titles><pages>230-243</pages><volume>165</volume><number>2</number><edition>2007/09</edition><dates><year>2007</year><pub-dates><date>Sep 30</date></pub-dates></dates><isbn>0165-0270 (Print)</isbn><accession-num>17655935</accession-num><abstract>Studies have shown the presence of expanded polyQ containing proteins in brain cells related to Huntington disease (HD) and other poly-glutamine disorders. We report the use of organically modified silica (ORMOSIL) nanoparticles as an efficient non-viral gene carrier in an effort to model brain pathology associated with those disorders induced by expanded polyQ peptides. In experiment 1, plasmids expressing Hemaglutinin-tagged polypeptides with 20 glutamine repeats (Q20) or with extended 127-glutamine repeats (Q127) were complexed with ORMOSIL nanoparticles and injected twice (2 weeks apart) into the lateral ventricle of the mouse brain. Fourteen days post-injection of Q127, immunocytochemistry revealed the presence of the characteristic nuclear and cytoplasmic Q127 aggregates in numerous striatal, septal and neocortical neuronal cells as well as ubiquitin-containing aggregates indicative of the neuronal pathology. The mice receiving Q127 showed a marked increase in the reactive GFAP (+) astrocytes in striatum, septum and brain cortex, further indicating the neurodegenerative changes, accompanied by motor impairments. In experiment 2, plasmids Q20 or Q127 were complexed with ORMOSIL and were injected into the brain lateral ventricle or directly into the striatum of adult rats. In both routes of transfection, Q127 induced the appearance of reactive GFAP (+) astrocytes and activated ED1 antigen expressing microglia. An increase in the size of the lateral ventricle was also observed in rats receiving Q127. In transgenic mouse polyQ models, extensive pathologies occur outside the nervous system and the observed brain pathologies could reflect developmental effects of the toxic polyQ proteins. Our experiments show that the nervous tissue restricted expression of poly Q-extended peptides in adult brain is sufficient to evoke neuropathologies associated with HD and other polyQ disorders. Thus, nanotechnology can be employed to model pathological and behavioral aspects of genetic brain diseases in mice as well as in other species, providing a novel research tool for in vivo testing of single or multi-gene therapies.</abstract><notes>Journal article</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17655935 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>1.884</custom4><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>453</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">453</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nakano, I.</author><author>Masterman-Smith, M.</author><author>Saigusa, K.</author><author>Paucar, A. A.</author><author>Horvath, S.</author><author>Shoemaker, L.</author><author>Watanabe, M.</author><author>Negro, A.</author><author>Bajpai, R.</author><author>Howes, A.</author><author>Lelievre, V.</author><author>Waschek, J. A.</author><author>Lazareff, J. A.</author><author>Freije, W. A.</author><author>Liau, L. M.</author><author>Gilbertson, R. J.</author><author>Cloughesy, T. F.</author><author>Geschwind, D. H.</author><author>Nelson, S. F.</author><author>Mischel, P. S.</author><author>Terskikh, A. V.</author><author>Kornblum, H. I.</author></authors></contributors><auth-address>Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.</auth-address><titles><title>Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells</title><secondary-title>J Neurosci Res</secondary-title></titles><pages>48-60</pages><volume>86</volume><number>1</number><edition>2007/08/28</edition><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Animals</keyword><keyword>Brain Neoplasms/*pathology</keyword><keyword>*Cell Proliferation</keyword><keyword>Cells, Cultured</keyword><keyword>Female</keyword><keyword>Flow Cytometry/methods</keyword><keyword>Gene Expression Regulation, Neoplastic/drug effects</keyword><keyword>Glioblastoma/*pathology</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mass Spectrometry/methods</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Middle Aged</keyword><keyword>Neoplastic Stem Cells/*physiology</keyword><keyword>Pituitary Adenylate Cyclase-Activating Polypeptide/deficiency</keyword><keyword>Protein-Serine-Threonine Kinases/*physiology</keyword><keyword>RNA, Small Interfering/pharmacology</keyword><keyword>Receptors, Cell Surface/deficiency</keyword><keyword>Transfection/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0360-4012 (Print)</isbn><accession-num>17722061</accession-num><abstract>Emerging evidence suggests that neural stem cells and brain tumors regulate their proliferation via similar pathways. In a previous study, we demonstrated that maternal embryonic leucine zipper kinase (Melk) is highly expressed in murine neural stem cells and regulates their proliferation. Here we describe how MELK expression is correlated with pathologic grade of brain tumors, and its expression levels are significantly correlated with shorter survival, particularly in younger glioblastoma patients. In normal human astrocytes, MELK is only faintly expressed, and MELK knockdown does not significantly influence their growth, whereas Ras and Akt overexpressing astrocytes have up-regulated MELK expression, and the effect of MELK knockdown is more prominent in these transformed astrocytes. In primary cultures from human glioblastoma and medulloblastoma, MELK knockdown by siRNA results in inhibition of the proliferation and survival of these tumors. Furthermore, we show that MELK siRNA dramatically inhibits proliferation and, to some extent, survival of stem cells isolated from glioblastoma in vitro. These results demonstrate a critical role for MELK in the proliferation of brain tumors, including their stem cells, and suggest that MELK may be a compelling molecular target for treatment of high-grade brain tumors.</abstract><notes>Nakano, Ichiro&#xD;Masterman-Smith, Michael&#xD;Saigusa, Kuniyasu&#xD;Paucar, Andres A&#xD;Horvath, Steve&#xD;Shoemaker, Lorelei&#xD;Watanabe, Momoko&#xD;Negro, Alejandra&#xD;Bajpai, Ruchi&#xD;Howes, Amy&#xD;Lelievre, Vincent&#xD;Waschek, James A&#xD;Lazareff, Jorge A&#xD;Freije, William A&#xD;Liau, Linda M&#xD;Gilbertson, Richard J&#xD;Cloughesy, Timothy F&#xD;Geschwind, Daniel H&#xD;Nelson, Stanley F&#xD;Mischel, Paul S&#xD;Terskikh, Alexey V&#xD;Kornblum, Harley I&#xD;CA108633/CA/United States NCI&#xD;CA110384/CA/United States NCI&#xD;CA88173/CA/United States NCI&#xD;HD34475/HD/United States NICHD&#xD;NS050151/NS/United States NINDS&#xD;NS43147/NS/United States NINDS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of neuroscience research&#xD;J Neurosci Res. 2008 Jan;86(1):48-60.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17722061</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>3.268</custom4><electronic-resource-num>10.1002/jnr.21471</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>202</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">202</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Olafsen, T.</author><author>Zhang, X.</author><author>Cao, Q.</author><author>Gambhir, S. S.</author><author>Williams, L. E.</author><author>Wu, A. M.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody</title><secondary-title>J Nucl Med</secondary-title></titles><pages>304-10</pages><volume>48</volume><number>2</number><edition>2007/02/03</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/*diagnostic use</keyword><keyword>Carcinoembryonic Antigen/*immunology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Colorectal Neoplasms/*radionuclide imaging</keyword><keyword>Female</keyword><keyword>Fluorine Radioisotopes/diagnostic use</keyword><keyword>Half-Life</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Immunoglobulin Fab Fragments/diagnostic use</keyword><keyword>Iodine Radioisotopes/diagnostic use</keyword><keyword>Isotope Labeling</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/*diagnostic use</keyword><keyword>Rats</keyword><keyword>Tissue Distribution</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17268029</accession-num><abstract>In this study, we investigated the 18F-labeled anti-carcinoembryonic antigen (CEA) T84.66 diabody, a genetically engineered noncovalent dimer of single-chain variable fragments, for small-animal PET imaging of CEA expression in xenograft-bearing mice. METHODS: 18F labeling of the anti-CEA T84.66 diabody (molecular mass, 55 kDa) was achieved with N-succinimidyl-4-18F-fluorobenzoate (18F-SFB). The biodistribution of the 18F-fluorobenzyl-T84.66 diabody (18F-FB-T84.66 diabody) was evaluated in athymic nude mice bearing subcutaneous LS 174T human colon carcinoma and C6 rat glioma tumors. Serial small-animal PET imaging studies were performed to further evaluate in vivo targeting efficacy and pharmacokinetics. RESULTS: Radiolabeling required 35 +/- 5 (mean +/- SD) min starting from 18F-SFB, and the tracer 18F-FB-T84.66 diabody was synthesized with a specific activity of 1.83 +/- 1.71 TBq/mmol. The decay-corrected radiochemical yield was 1.40% +/- 0.16% (n = 4), and the radiochemical purity was greater than 98%. The radioimmunoreactivity was 57.1% +/- 2.0%. The 18F-FB-T84.66 diabody showed rapid and high tumor uptake and fast clearance from the circulation in the LS 174T xenograft model, as evidenced by both small-animal PET imaging and biodistribution studies. High-contrast small-animal PET images were obtained as early as 1 h after injection of the 18F-FB-T84.66 diabody, and only a background level of activity accumulation was found in CEA-negative C6 tumors. The tracer exhibited predominantly renal clearance, with some activity in the liver and spleen at early time points. CONCLUSION: The 18F-labeled diabody represents a new class of tumor-specific probes for PET that are based on targeting cell surface antigen expression. The 18F-FB-T84.66 diabody can be used for high-contrast small-animal PET imaging of CEA-positive tumor xenografts. It may be translated to the clinic for PET of CEA-positive malignancies.</abstract><notes>Cai, Weibo&#xD;Olafsen, Tove&#xD;Zhang, Xianzhong&#xD;Cao, Qizhen&#xD;Gambhir, Sanjiv S&#xD;Williams, Lawrence E&#xD;Wu, Anna M&#xD;Chen, Xiaoyuan&#xD;Ca16042/ca/nci&#xD;P01 ca43904/ca/nci&#xD;P50 ca86306/ca/nci&#xD;P50 da114747/da/nida&#xD;R21 ca102123/ca/nci&#xD;R21 eb001785/eb/nibib&#xD;R24 ca93862/ca/nci&#xD;U54 ca119367/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Feb;48(2):304-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17268029</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>4.986</custom4><electronic-resource-num>48/2/304 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>533</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">533</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schipper, M. L.</author><author>Cheng, Z.</author><author>Lee, S. W.</author><author>Bentolila, L. A.</author><author>Iyer, G.</author><author>Rao, J.</author><author>Chen, X.</author><author>Wu, A. M.</author><author>Weiss, S.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Departments of Radiology and Bioengineering, Bio-X Program, Molecular Imaging Program at Stanford (MIPS), Stanford University, East 150 Clark Center, Palo Alto, CA 94305, USA.</auth-address><titles><title>microPET-based biodistribution of quantum dots in living mice</title><secondary-title>J Nucl Med</secondary-title></titles><pages>1511-8</pages><volume>48</volume><number>9</number><edition>2007/08/21</edition><keywords><keyword>Animals</keyword><keyword>Bone and Bones/metabolism</keyword><keyword>Cadmium Compounds/chemistry/*pharmacokinetics</keyword><keyword>*Copper Radioisotopes</keyword><keyword>Liver/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>*Quantum Dots</keyword><keyword>Selenium Compounds/chemistry/*pharmacokinetics</keyword><keyword>Spleen/metabolism</keyword><keyword>Tissue Distribution</keyword><keyword>Zinc Compounds/chemistry/pharmacokinetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17704240</accession-num><abstract>This study evaluates the quantitative biodistribution of commercially available CdSe quantum dots (QD) in mice. METHODS: (64)Cu-Labeled 800- or 525-nm emission wavelength QD (21- or 12-nm diameter), with or without 2,000 MW (molecular weight) polyethylene glycol (PEG), were injected intravenously into mice (5.55 MBq/25 pmol QD) and studied using well counting or by serial microPET and region-of-interest analysis. RESULTS: Both methods show rapid uptake by the liver (27.4-38.9 %ID/g) (%ID/g is percentage injected dose per gram tissue) and spleen (8.0-12.4 %ID/g). Size has no influence on biodistribution within the range tested here. Pegylated QD have slightly slower uptake into liver and spleen (6 vs. 2 min) and show additional low-level bone uptake (6.5-6.9 %ID/g). No evidence of clearance from these organs was observed. CONCLUSION: Rapid reticuloendothelial system clearance of QD will require modification of QD for optimal utility in imaging living subjects. Formal quantitative biodistribution/imaging studies will be helpful in studying many types of nanoparticles, including quantum dots.</abstract><notes>Schipper, Meike L&#xD;Cheng, Zhen&#xD;Lee, Sheen-Woo&#xD;Bentolila, Laurent A&#xD;Iyer, Gopal&#xD;Rao, Jianghong&#xD;Chen, Xiaoyuan&#xD;Wu, Anna M&#xD;Weiss, Shimon&#xD;Gambhir, Sanjiv S&#xD;5R01 EB 000312/EB/United States NIBIB&#xD;P50 CA 114747/CA/United States NCI&#xD;U54 CA 119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Sep;48(9):1511-8. Epub 2007 Aug 17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17704240</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>4.986</custom4><electronic-resource-num>jnumed.107.040071 [pii]&#xD;10.2967/jnumed.107.040071</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>505</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">505</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Desai, A.</author><author>Vyas, T.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, Massachusetts 02115.</auth-address><titles><title>Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations</title><secondary-title>J Pharm Sci</secondary-title></titles><pages>2745-56</pages><volume>97</volume><number>7</number><edition>2007/09/15</edition><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0022-3549 (Print)</isbn><accession-num>17854074</accession-num><abstract>The objective of this study was to examine augmentation of therapeutic activity in human glioblastoma cells with combination of paclitaxel (PTX) and the apoptotic signaling molecule, C(6)-ceramide (CER), when administered in novel oil-in-water nanoemulsions. The nanoemulsions were formulated with pine-nut oil, which has high concentrations of essential polyunsaturated fatty acid (PUFA). Drug-containing nanoemulsions were characterized for particle size, surface charge, and the particle morphology was examined with transmission electron microscopy (TEM). Epi-fluorescent microscopy was used to analyze nanoemulsion-encapsulated rhodamine-labeled PTX and NBD-labeled CER uptake and distribution in U-118 human glioblastoma cells. Cell viability was assessed with the MTS (formazan) assay, while apoptotic activity of PTX and CER was evaluated with caspase-3/7 activation and flow cytometry. Nanoemulsion formulations with the oil droplet size of approximately 200 nm in diameter were prepared with PTX, CER, and combination of the two agents. When administered to U-118 cells, significant enhancement in cytotoxicity was observed with combination of PTX and CER as compared to administration of individual agents. The increase in cytotoxicity correlated with enhancement in apoptotic activity in cells treated with combination of PTX and CER. The results of these studies show that oil-in-water nanoemulsions can be designed with combination therapy for enhancement of cytotoxic effect in brain tumor cells. In addition, PTX and CER can be used together to augment therapeutic activity, especially in aggressive tumor models such as glioblastoma. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:2745-2756, 2008.</abstract><notes>Desai, Ankita&#xD;Vyas, Tushar&#xD;Amiji, Mansoor&#xD;United States&#xD;Journal of pharmaceutical sciences&#xD;J Pharm Sci. 2008 Jul;97(7):2745-56.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17854074</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>2.942</custom4><electronic-resource-num>10.1002/jps.21182</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>350</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">350</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Chakilam, A.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, Massachusetts 02115.</auth-address><titles><title>Role of nanotechnology in pharmaceutical product development</title><secondary-title>J Pharm Sci</secondary-title><alt-title>Journal of pharmaceutical sciences</alt-title></titles><pages>2547-65</pages><volume>96</volume><number>10</number><edition>2007/10</edition><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0022-3549 (Print)</isbn><accession-num>17688284</accession-num><abstract>A number of new molecular entities (NMEs) selected for full-scale development based on their safety and pharmacological data suffer from undesirable physicochemical and biopharmaceutical properties, which lead to poor pharmacokinetics and distribution after in vivo administration. An optimization of the preformulation studies to develop a dosage form with proper drug delivery system to achieve desirable pharmacokinetic and toxicological properties can aid in the accelerated development of these NMEs into therapies. Nanoparticulate drug delivery systems show a promising approach to obtain desirable druglike properties by altering the biopharmaceutics and pharmacokinetics properties of the molecule. Apart from the advantages of enhancing potential for systemic administration, nanoparticulate drug delivery systems can also be used for site-specific delivery, thus alleviating unwanted toxicity due to nonspecific distribution, improve patient compliance, and provide favorable clinical outcomes. This review summarizes some of the parameters and approaches that can be used to evaluate nanoparticulate drug delivery systems in early stages of formulation development. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 2547-2565, 2007.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17688284 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>2.942</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>353</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">353</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kommareddy, S.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, MA 02115, USA.</auth-address><titles><title>Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice</title><secondary-title>J Pharm Sci</secondary-title><alt-title>Journal of pharmaceutical sciences</alt-title></titles><pages>397-407</pages><volume>96</volume><number>2</number><edition>2007/02</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/*metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Female</keyword><keyword>Gelatin/*chemistry/pharmacokinetics</keyword><keyword>Humans</keyword><keyword>Indium Radioisotopes</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>*Nanoparticles/chemistry/ultrastructure</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Particle Size</keyword><keyword>Polyethylene Glycols/*chemistry/pharmacokinetics</keyword><keyword>Sulfhydryl Compounds/*chemistry/pharmacokinetics</keyword><keyword>Surface Properties</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0022-3549 (Print)</isbn><accession-num>17075865</accession-num><abstract>The objective of the present study was to modify thiolated gelatin nanoparticles with poly(ethylene glycol) (PEG) chains and examine their long circulating and tumor-targeting properties in vivo in an orthotopic a human breast adenocarcinoma xenograft model. The crosslinked nanoparticle systems were characterized to have a size of 150-250 nm with rapid payload release properties in a highly reducing environment. Upon PEG modification, the nanoparticle size increased to 300-350 nm in diameter. The presence of PEG chains on the surface was confirmed by characterization with electron spectroscopy for chemical analysis. The in vivo long-circulating potential, biodistribution and passive tumor targeting of the controls, and PEG-modified thiolated gelatin nanoparticles were evaluated by injecting indium-111 (111In)-labeled nanoparticles into breast tumor (MDA-MB-435)-bearing nude mice. Upon modification with PEG, the nanoparticles were found to have longer circulation times, with the plasma and tumor half-lives of 15.3 and 37.8 h, respectively. The results also showed preferential localization of thiolated nanoparticles in the tumor mass. The resulting nanoparticulate systems with long circulation properties could be used to target encapsulated drugs and genes to tumors passively by utilizing the enhanced permeability and retention effect of the tumor vasculature.</abstract><notes>Eb-002027/eb/nibib&#xD;R01-ca095522/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17075865 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>2.942</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>499</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">499</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Toutchkine, A.</author><author>Han, W. G.</author><author>Ullmann, M.</author><author>Liu, T.</author><author>Bashford, D.</author><author>Noodleman, L.</author><author>Hahn, K. M.</author></authors></contributors><auth-address>Department of Pharmacology and Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Experimental and DFT studies: novel structural modifications greatly enhance the solvent sensitivity of live cell imaging dyes</title><secondary-title>J Phys Chem A</secondary-title></titles><pages>10849-60</pages><volume>111</volume><number>42</number><edition>2007/10/09</edition><keywords><keyword>Absorption</keyword><keyword>*Algorithms</keyword><keyword>Benzene/chemistry</keyword><keyword>Cells/cytology/*ultrastructure</keyword><keyword>Electron Transport</keyword><keyword>Energy Transfer</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Hydrogen Bonding</keyword><keyword>Isomerism</keyword><keyword>Methanol/chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Photochemistry</keyword><keyword>Quantum Theory</keyword><keyword>Solvents/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 25</date></pub-dates></dates><isbn>1089-5639 (Print)</isbn><accession-num>17918807</accession-num><abstract>Structural modifications of previously reported merocyanine dyes (Toutchkine, A.; Kraynov, V.; Hahn, K. J. Am. Chem. Soc. 2003, 125, 4132-4145) were found to greatly enhance the solvent dependence of their absorbance and fluorescence emission maxima. Density functional theory (DFT) calculations have been performed to understand the differences in optical properties between the new and previously synthesized dyes. Absorption and emission energies were calculated for several new dyes using DFT vertical self-consistent reaction field (VSCRF) methods. Geometries of ground and excited states were optimized with a conductor-like screening model (COSMO) and self-consistent field (SCF) methods. The new dyes have enhanced zwitterionic character in the ground state and much lower polarity in the excited state, as shown by the DFT-VSCRF calculations. Consistently, the position of the absorption bands are strongly blue-shifted in more polar solvent (methanol compared to benzene), as predicted by the DFT spectral calculations. Inclusion of explicit H-bonding solvent molecules within the quantum model further enhances the predicted shifts and is consistent with the observed spectral broadening. Smaller but significant spectral shifts in polar versus nonpolar solvent are predicted and observed for emission bands. The new dyes show large fluorescence quantum yields in polar hydrogen-bonding solvents; qualitatively, the longest bonds along the conjugated chain at the excited S1 state minimum are shorter in the more polar solvent, inhibiting photoisomerization. The loss of photostability of the dyes is a consequence of the reaction with and electron transfer to singlet oxygen, starting oxidative dye cleavage. The calculated vertical ionization potentials of three dyes I-SO, AI-SO(4), and AI-BA(4) in benzene and methanol are consistent with their relative photobleaching rates; the charge distributions along the conjugated chains for the three dyes are similarly predictive of higher reaction rates for AI-SO(4) and AI-BA(4) than for I-SO. Time-dependent DFT calculations were also performed on AI-BA(4); these were less accurate than the VSCRF method in predicting the absorption energy shift from benzene to methanol.</abstract><notes>Toutchkine, Alexei&#xD;Han, Wen-Ge&#xD;Ullmann, Matthias&#xD;Liu, Tiqing&#xD;Bashford, Donald&#xD;Noodleman, Louis&#xD;Hahn, Klaus M&#xD;GM057464/GM/United States NIGMS&#xD;GM064346/GM/United States NIGMS&#xD;GM43278/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The journal of physical chemistry. A&#xD;J Phys Chem A. 2007 Oct 25;111(42):10849-60. Epub 2007 Oct 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17918807</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>2.918</custom4><electronic-resource-num>10.1021/jp073197r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>154</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">154</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>Synergy in lipofection by cationic lipid mixtures: superior activity at the gel-liquid crystalline phase transition</title><secondary-title>J Phys Chem B</secondary-title></titles><pages>7786-95</pages><volume>111</volume><number>27</number><edition>2007/06/19</edition><keywords><keyword>Calorimetry, Differential Scanning</keyword><keyword>Cations/chemistry</keyword><keyword>Cells, Cultured</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Crystallization</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Gels</keyword><keyword>Humans</keyword><keyword>Lipid Bilayers</keyword><keyword>Lipids/*chemistry</keyword><keyword>Liposomes</keyword><keyword>Solutions</keyword><keyword>Temperature</keyword><keyword>Transfection</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 12</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17571876</accession-num><abstract>Some mixtures of two cationic lipids including phospholipid compounds (O-ethylphosphatidylcholines) as well as common, commercially available cationic lipids, such as dimethylammonium bromides and trimethylammonium propanes, deliver therapeutic DNA considerably more efficiently than do the separate molecules. In an effort to rationalize this widespread &quot;mixture synergism&quot;, we examined the phase behavior of the cationic lipid mixtures and constructed their binary phase diagrams. Among a group of more than 50 formulations, the compositions with maximum delivery activity resided unambiguously in the solid-liquid crystalline two-phase region at physiological temperature. Thus, the transfection efficacy of formulations exhibiting solid-liquid crystalline phase coexistence is more than 5 times higher than that of formulations in the gel (solid) phase and over twice that of liquid crystalline formulations; phase coexistence occurring at physiological temperature thus appears to contribute significantly to mixture synergism. This relationship between delivery activity and physical property can be rationalized on the basis of the known consequences of lipid-phase transitions, namely, the accumulation of defects and increased disorder at solid-liquid crystalline phase boundaries. Packing defects at the borders of coexisting solid and liquid crystalline domains, as well as large local density fluctuations, could be responsible for the enhanced fusogenicity of mixtures. This study leads to the important conclusion that manipulating the composition of the lipid carriers so that their phase transition takes place at physiological temperature can enhance their delivery efficacy.</abstract><notes>Koynova, Rumiana&#xD;Wang, Li&#xD;MacDonald, Robert C&#xD;Gm52329/gm/nigms&#xD;Gm57305/gm/nigms&#xD;Rr08630/rr/ncrr&#xD;U54ca119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2007 Jul 12;111(27):7786-95. Epub 2007 Jun 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17571876</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.115</custom4><electronic-resource-num>10.1021/jp071286y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>151</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">151</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kudlay, A.</author><author>Gibbs, J. M.</author><author>Schatz, G. C.</author><author>Nguyen, S. T.</author><author>de la Cruz, M. O.</author></authors></contributors><auth-address>Northwestern University, Department of Chemistry, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA. kudlay@umd.edu</auth-address><titles><title>Sharp melting of polymer-DNA hybrids: an associative phase separation approach</title><secondary-title>J Phys Chem B</secondary-title></titles><pages>1610-9</pages><volume>111</volume><number>7</number><edition>2007/01/30</edition><keywords><keyword>*Algorithms</keyword><keyword>DNA/*chemistry</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>Nucleic Acid Denaturation</keyword><keyword>*Nucleic Acid Hybridization</keyword><keyword>*Phase Transition</keyword><keyword>Solutions/chemistry</keyword><keyword>Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 22</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17256893</accession-num><abstract>An associative equilibrium theory describing the sharp melting behavior of polymer-DNA hybrids is developed. The theory considers linear polymers with attached DNAs on each polymer that serve as &quot;stickers&quot; and with a two-state model governing the DNA melting equilibrium. For three or more oligonucleotides on each polymer, solutions of polymer-DNA hybrids are found to undergo phase separation at sufficiently low temperatures. The dense phase dissolves as temperature increases, which leads to a sharp increase in the fraction of non-hybridized DNA near the phase transition temperature, in agreement with experimental absorbance profiles at 260 nm. The melting temperature is predicted to have the same dependence on salt concentration as a solution of unattached DNAs and be weakly sensitive to the concentration of DNA in solution. The melting temperature is predicted to be higher than that of unattached DNA in solution, with the magnitude of the increase sensitive to the DNA hybridization cooperativity. The theoretical predictions are generally in good quantitative agreement with new experimental data (also presented here), which show the effect of the polymer-DNA hybrid length and salt concentration on the melting profiles.</abstract><notes>Kudlay, Alexander&#xD;Gibbs, Julianne M&#xD;Schatz, George C&#xD;Nguyen, SonBinh T&#xD;de la Cruz, Monica Olvera&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2007 Feb 22;111(7):1610-9. Epub 2007 Jan 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17256893</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.115</custom4><electronic-resource-num>10.1021/jp0664667</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>617</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">617</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCullagh, M.</author><author>Prytkova, T.</author><author>Tonzani, S.</author><author>Winter, N. D.</author><author>Schatz, G. C.</author></authors></contributors><titles><title>Modeling Self-Assembly Processes Driven by Nonbonded Interactions in Soft Materials</title><secondary-title>J Phys Chem B</secondary-title></titles><edition>2008/07/19</edition><dates><year>2008</year><pub-dates><date>Jul 18</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>18636770</accession-num><abstract>This Centennial Feature Article provides an overview of research in the general area of self-assembly modeling, with particular emphasis on the self-assembly of molecules into soft nanoscale structures where the driving force for assembly is provided by nonbonded interactions (hydrogen bonds and electrostatics). The models have been developed at many different levels of theory, going all the way from simple analytical models of packing effects to atomistic descriptions using molecular dynamics methods. In between these limits are mean-field and coarse-grained models, including models for DNA, peptides, and lipids that can be used to describe the assembly of hybrid (amphiphilic) materials. Several recent applications to specific systems are discussed, including the description of peptide amphiphile assembly to make cylindrical micelles, the assembly and melting of DNA hairpins, the use of DNA tethers to assemble nanoparticles into aggregates and crystalline structures, and the use of coarse-grained lipid models to make lamellar and high-curvature phases. These examples demonstrate the difficulties associated with brute force atomistic methods, and they also show the opportunities (but uncertainties and ambiguities) associated with simpler models such as coarse-grained models. The examples also demonstrate the usefulness of successful modeling methods in the design of new materials, including an understanding of the relationship between structure and function.</abstract><notes>Journal article&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2008 Jul 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18636770</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.086</custom4><electronic-resource-num>10.1021/jp803192u</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>152</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">152</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, S. Y.</author><author>Gibbs-Davis, J. M.</author><author>Nguyen, S. T.</author><author>Schatz, G. C.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Sharp melting in DNA-linked nanostructure systems: thermodynamic models of DNA-linked polymers</title><secondary-title>J Phys Chem B</secondary-title></titles><pages>8785-91</pages><volume>111</volume><number>30</number><edition>2007/07/10</edition><keywords><keyword>Base Sequence</keyword><keyword>Chemistry, Physical</keyword><keyword>DNA/*chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Models, Theoretical</keyword><keyword>Molecular Sequence Data</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Polymers/*chemistry</keyword><keyword>*Thermodynamics</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 2</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17616117</accession-num><abstract>Sharp melting that has been found for DNA-linked nanostructure systems such as DNA-linked gold nanoparticles enhances the resolution of DNA sequence detection enough to distinguish between a perfect match and single base pair mismatches. One intriguing explanation of the sharp melting involves the cooperative dehybridization of DNA strands between the nanostructures. However, in the DNA-linked gold nanoparticle system, strong optical absorption by the gold nanoparticles hinders the direct observation of cooperativity. Here, with a combination of theory and experiment, we investigate a DNA-linked polymer system in which we can show that the optical profile of the system at 260 nm is directly related to the individual DNA dehybridization profile, providing a clear distinction from other possible mechanisms. We find that cooperativity plays a crucial role in determining both the value of the melting temperature and the shape of the melting profile well away from the melting temperature. Our analysis suggests that the dehybridization properties of DNA strands in confined or dense structures differ from DNA in solution.</abstract><notes>Park, Sung Yong&#xD;Gibbs-Davis, Julianne M&#xD;Nguyen, Sonbinh T&#xD;Schatz, George C&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2007 Aug 2;111(30):8785-91. Epub 2007 Jul 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17616117</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.115</custom4><electronic-resource-num>10.1021/jp071985a</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>153</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">153</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, S. Y.</author><author>Lee, J. S.</author><author>Georganopoulou, D.</author><author>Mirkin, C. A.</author><author>Schatz, G. C.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Structures of DNA-linked nanoparticle aggregates</title><secondary-title>J Phys Chem B</secondary-title></titles><pages>12673-81</pages><volume>110</volume><number>25</number><edition>2006/06/28</edition><keywords><keyword>DNA/*chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>*Nucleic Acid Conformation</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 29</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>16800601</accession-num><abstract>The room-temperature structure of DNA-linked gold nanoparticle aggregates is investigated using a combination of experiment and theory. The experiments involve extinction spectroscopy measurements and dynamic light scattering measurements of aggregates made using 60 and 80 nm gold particles and 30 base-pair DNA. The theoretical studies use calculated spectra for models of the aggregate structures to determine which structure matches the observations. These models include diffusion-limited cluster-cluster aggregation (DLCA), reaction-limited cluster-cluster aggregation (RLCA), and compact (nonfractal) cluster aggregation. The diameter of the nanoparticles used in the experiments is larger than has been considered previously, and this provides greater sensitivity of spectra to aggregate structure. We show that the best match between experiment and theory occurs for the RLCA fractal structures. This indicates that DNA hybridization takes place under irreversible conditions in the room-temperature aggregation. Some possible structural variations which might influence the result are considered, including the edge-to-edge distance between nanoparticles, variation in the diameter of the nanoparticles, underlying lattice structures of on-lattice compact clusters, and positional disorders in the lattice structures. We find that these variations do not change the conclusion that the room-temperature structure of the aggregates is fractal. We also examine the variation in extinction at 260 nm as temperature is increased, showing that the decrease in extinction at temperatures below the melting temperature is related to a morphological change from fractal toward compact structures.</abstract><notes>Park, Sung Yong&#xD;Lee, Jae-Seung&#xD;Georganopoulou, Dimitra&#xD;Mirkin, Chad A&#xD;Schatz, George C&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2006 Jun 29;110(25):12673-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16800601</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>4.115</custom4><electronic-resource-num>10.1021/jp062212+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>367</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">367</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, J.</author><author>Yong, K. T.</author><author>Roy, I.</author><author>Ohulchanskyy, T. Y.</author><author>Bergey, E. J.</author><author>Lee, H. H.</author><author>Tramposch, K. M.</author><author>He, S.</author><author>Maitra, A.</author><author>Prasad, P. N.</author></authors></contributors><titles><title>Imaging pancreatic cancer using surface-functionalized quantum dots</title><secondary-title>J Phys Chem B</secondary-title><alt-title>The journal of physical chemistry</alt-title></titles><pages>6969-72</pages><volume>111</volume><number>25</number><edition>2007/06</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>*Contrast Media</keyword><keyword>Humans</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Pancreatic Neoplasms/*diagnosis/*pathology</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun 28</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17552555</accession-num><abstract>In this study, CdSe/CdS/ZnS quantum dots (QDs) were used as optical contrast agent for imaging pancreatic cancer cells in vitro using transferrin and anti-Claudin-4 as targeting ligands. CdSe/CdS/ZnS was chosen because the CdSe/CdS/ZnS QDs have better photoluminescence (PL) efficiency and stability than those of CdSe/ZnS. The transferrin-mediated targeting is demonstrated in both a cell-free coprecipitation assay as well as using in vitro confocal microscopy. Pancreatic cancer specific uptake is also demonstrated using the monoclonal antibody anti-Claudin-4. This targeted QD platform will be further modified for the purpose of developing as an early detection imaging tool for pancreatic cancer.</abstract><notes>Ca104492/ca/nci&#xD;R01ca119397/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17552555 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>4.115</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>644</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">644</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Velichko, Y. S.</author><author>Stupp, S. I.</author><author>de la Cruz, M. O.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Molecular simulation study of peptide amphiphile self-assembly</title><secondary-title>J Phys Chem B</secondary-title></titles><pages>2326-34</pages><volume>112</volume><number>8</number><edition>2008/02/07</edition><keywords><keyword>Hydrogen Bonding</keyword><keyword>Hydrophobicity</keyword><keyword>Micelles</keyword><keyword>*Models, Chemical</keyword><keyword>Models, Molecular</keyword><keyword>Peptides/*chemistry/*metabolism</keyword><keyword>Polymers/chemistry</keyword><keyword>Protein Structure, Secondary</keyword><keyword>Thermodynamics</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 28</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>18251531</accession-num><abstract>We study the self-assembly of peptide amphiphile (PA) molecules, which is governed by hydrophobic interactions between alkyl tails and a network of hydrogen bonds between peptide blocks. We demonstrate that the interplay between these two interactions results in the formation of assemblies of different morphology, in particular, single beta-sheets connected laterally by hydrogen bonds, stacks of parallel beta-sheets, spherical micelles, micelles with beta-sheets in the corona, and long cylindrical fibers. We characterize the size distribution of the aggregates as a function of the molecular interactions. Our results suggest that the formation of nanofibers of peptide amphiphiles obeys an open association model, which resembles living polymerization.</abstract><notes>Velichko, Yuri S&#xD;Stupp, Samuel I&#xD;de la Cruz, Monica Olvera&#xD;5-R01-DE015920/DE/United States NIDCR&#xD;5-R01-EB003806/EB/United States NIBIB&#xD;5-U54-CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2008 Feb 28;112(8):2326-34. Epub 2008 Feb 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18251531</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.089</custom4><electronic-resource-num>10.1021/jp074420n</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">8</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Magrini, A.</author><author>Rosato, N.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><titles><title>Dispersion of pristine single-walled carbon nanotubes in water by a thiolated organosilane: application in supramolecular nanoassemblies</title><secondary-title>J Phys Chem B Condens Matter Mater Surf Interfaces Biophys</secondary-title><alt-title>The journal of physical chemistry</alt-title></titles><pages>13685-8</pages><volume>110</volume><number>28</number><edition>2006/06</edition><dates><year>2006</year><pub-dates><date>Jul 20</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>16836310</accession-num><abstract>We report a novel technique to disperse pristine single-walled carbon nanotubes in water by ultrasonication in the presence of a thiolated organosilane and subsequent ultracentrifugation. As revealed by the sharp features in the visible range of the absorption spectrum and by transmission electron microscopy, the collected supernatant fraction was composed of small bundles of nanotubes coated by a thin layer of organosilane molecules. We hypothesized and demonstrated that the organosilane adsorbed onto the nanotubes through the thiol group leaving the silane group extruding out. The pristine properties of the nanotubes and the versatile chemistry available for sol-gel materials make the reported dispersed nanotubes an excellent scaffold for the realization of supramolecular nanoassemblies suitable for different applications. As examples, we decorated them with silica nanobeads, by using a water-in-oil nanoemulsion system, and with gold nanoparticles, by a previous derivatization with a second layer of thiolated organosilane providing exposed thiol groups.</abstract><notes>U54 ca119335/ca/nci&#xD;Letter&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16836310 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>4.115</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>209</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">209</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Faca, V.</author><author>Coram, M.</author><author>Phanstiel, D.</author><author>Glukhova, V.</author><author>Zhang, Q.</author><author>Fitzgibbon, M.</author><author>McIntosh, M.</author><author>Hanash, S.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA 98109, USA. vfaca@fhcrc.org</auth-address><titles><title>Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS</title><secondary-title>J Proteome Res</secondary-title></titles><pages>2009-18</pages><volume>5</volume><number>8</number><edition>2006/08/08</edition><keywords><keyword>Acrylamides/*chemistry</keyword><keyword>Algorithms</keyword><keyword>Alkylation</keyword><keyword>Amino Acid Sequence</keyword><keyword>Blood Proteins/*analysis/genetics</keyword><keyword>Carbon Radioisotopes/chemistry</keyword><keyword>*Chromatography, Liquid/instrumentation/methods</keyword><keyword>Cysteine/chemistry</keyword><keyword>Deuterium/chemistry</keyword><keyword>Humans</keyword><keyword>*Mass Spectrometry/instrumentation/methods</keyword><keyword>Molecular Sequence Data</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1535-3893 (Print)</isbn><accession-num>16889424</accession-num><abstract>Isotopic labeling of cysteine residues with acrylamide was previously utilized for relative quantitation of proteins by MALDI-TOF. Here, we explored and compared the application of deuterated and (13)C isotopes of acrylamide for quantitative proteomic analysis using LC-MS/MS and high-resolution FTICR mass spectrometry. The method was applied to human serum samples that were immunodepleted of abundant proteins. Our results show reliable quantitation of proteins across an abundance range that spans 5 orders of magnitude based on ion intensities and known protein concentration in plasma. The use of (13)C isotope of acrylamide had a slightly greater advantage relative to deuterated acrylamide, because of shifts in elution of deuterated acrylamide relative to its corresponding nondeuterated compound by reversed-phase chromatography. Overall, the use of acrylamide for differentially labeling intact proteins in complex mixtures, in combination with LC-MS/MS provides a robust method for quantitative analysis of complex proteomes.</abstract><notes>Faca, Vitor&#xD;Coram, Marc&#xD;Phanstiel, Doug&#xD;Glukhova, Veronika&#xD;Zhang, Qing&#xD;Fitzgibbon, Matthew&#xD;McIntosh, Martin&#xD;Hanash, Samir&#xD;United States&#xD;Journal of proteome research&#xD;J Proteome Res. 2006 Aug;5(8):2009-18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16889424</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.151</custom4><electronic-resource-num>10.1021/pr060102+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>527</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">527</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Faca, V.</author><author>Pitteri, S. J.</author><author>Newcomb, L.</author><author>Glukhova, V.</author><author>Phanstiel, D.</author><author>Krasnoselsky, A.</author><author>Zhang, Q.</author><author>Struthers, J.</author><author>Wang, H.</author><author>Eng, J.</author><author>Fitzgibbon, M.</author><author>McIntosh, M.</author><author>Hanash, S.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109, USA. vfaca@fhcrc.org</auth-address><titles><title>Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes</title><secondary-title>J Proteome Res</secondary-title></titles><pages>3558-65</pages><volume>6</volume><number>9</number><edition>2007/08/19</edition><keywords><keyword>Anions</keyword><keyword>Blood Proteins/*chemistry</keyword><keyword>Chromatography, Ion Exchange/methods</keyword><keyword>Chromatography, Liquid/methods</keyword><keyword>Electrophoresis, Polyacrylamide Gel</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms/metabolism</keyword><keyword>Mass Spectrometry/methods</keyword><keyword>Protein Isoforms</keyword><keyword>Proteins/*chemistry</keyword><keyword>Proteome</keyword><keyword>Proteomics/*methods</keyword><keyword>Serum/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1535-3893 (Print)</isbn><accession-num>17696519</accession-num><abstract>In-depth analysis of the serum and plasma proteomes by mass spectrometry is challenged by the vast dynamic range of protein abundance and substantial complexity. There is merit in reducing complexity through fractionation to facilitate mass spectrometry analysis of low-abundance proteins. However, fractionation reduces throughput and has the potential of diluting individual proteins or inducing their loss. Here, we have investigated the contribution of extensive fractionation of intact proteins to depth of analysis. Pooled serum depleted of abundant proteins was fractionated by an orthogonal two-dimensional system consisting of anion-exchange and reversed-phase chromatography. The resulting protein fractions were aliquotted; one aliquot was analyzed by shotgun LC-MS/MS, and another was further resolved into protein bands in a third dimension using SDS-PAGE. Individual gel bands were excised and subjected to in situ digestion and mass spectrometry. We demonstrate that increased fractionation results in increased depth of analysis based on total number of proteins identified in serum and based on representation in individual fractions of specific proteins identified in gel bands following a third-dimension SDS gel analysis. An intact protein analysis system (IPAS) based on a two-dimensional plasma fractionation schema was implemented that resulted in identification of 1662 proteins with high confidence with representation of protein isoforms that differed in their chromatographic mobility. Further increase in depth of analysis was accomplished by repeat analysis of aliquots from the same set of two-dimensional fractions resulting in overall identification of 2254 proteins. We conclude that substantial depth of analysis of proteins from milliliter quantities of serum or plasma and detection of isoforms are achieved with depletion of abundant proteins followed by two-dimensional protein fractionation and MS analysis of individual fractions.</abstract><notes>Faca, Vitor&#xD;Pitteri, Sharon J&#xD;Newcomb, Lisa&#xD;Glukhova, Veronika&#xD;Phanstiel, Doug&#xD;Krasnoselsky, Alexei&#xD;Zhang, Qing&#xD;Struthers, Jason&#xD;Wang, Hong&#xD;Eng, Jimmy&#xD;Fitzgibbon, Matt&#xD;McIntosh, Martin&#xD;Hanash, Samir&#xD;United States&#xD;Journal of proteome research&#xD;J Proteome Res. 2007 Sep;6(9):3558-65. Epub 2007 Aug 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17696519</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>5.151</custom4><electronic-resource-num>10.1021/pr070233q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>230</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">230</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rauch, A.</author><author>Bellew, M.</author><author>Eng, J.</author><author>Fitzgibbon, M.</author><author>Holzman, T.</author><author>Hussey, P.</author><author>Igra, M.</author><author>Maclean, B.</author><author>Lin, C. W.</author><author>Detter, A.</author><author>Fang, R.</author><author>Faca, V.</author><author>Gafken, P.</author><author>Zhang, H.</author><author>Whiteaker, J.</author><author>States, D.</author><author>Hanash, S.</author><author>Paulovich, A.</author><author>McIntosh, M. W.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, Seattle, Washington, LabKey Software, Seattle, Washington 98109-1024, USA.</auth-address><titles><title>Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments</title><secondary-title>J Proteome Res</secondary-title></titles><pages>112-21</pages><volume>5</volume><number>1</number><edition>2006/01/07</edition><keywords><keyword>Computational Biology/*methods</keyword><keyword>*Database Management Systems</keyword><keyword>Proteomics/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1535-3893 (Print)</isbn><accession-num>16396501</accession-num><abstract>The open-source Computational Proteomics Analysis System (CPAS) contains an entire data analysis and management pipeline for Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) proteomics, including experiment annotation, protein database searching and sequence management, and mining LC-MS/MS peptide and protein identifications. CPAS architecture and features, such as a general experiment annotation component, installation software, and data security management, make it useful for collaborative projects across geographical locations and for proteomics laboratories without substantial computational support.</abstract><notes>Rauch, Adam&#xD;Bellew, Matthew&#xD;Eng, Jimmy&#xD;Fitzgibbon, Matthew&#xD;Holzman, Ted&#xD;Hussey, Peter&#xD;Igra, Mark&#xD;Maclean, Brendan&#xD;Lin, Chen Wei&#xD;Detter, Andrea&#xD;Fang, Ruihua&#xD;Faca, Vitor&#xD;Gafken, Phil&#xD;Zhang, Heidi&#xD;Whiteaker, Jeffrey&#xD;States, David&#xD;Hanash, Sam&#xD;Paulovich, Amanda&#xD;McIntosh, Martin W&#xD;23xs144a/phs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of proteome research&#xD;J Proteome Res. 2006 Jan;5(1):112-21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16396501</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.151</custom4><electronic-resource-num>10.1021/pr0503533</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>109</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">109</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, Z.</author><author>Bell, B. F.</author><author>Wang, L.</author><author>Zhao, G.</author><author>Olivares-Navarrete, R.</author><author>Boyan, B. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology, 315 Ferst Drive NW, Atlanta, GA 30332-0363, USA.</auth-address><titles><title>Beta-1 integrins mediate substrate dependent effects of 1alpha,25(OH)2D3 on osteoblasts</title><secondary-title>J Steroid Biochem Mol Biol</secondary-title></titles><pages>606-9</pages><volume>103</volume><number>3-5</number><edition>2007/02/24</edition><keywords><keyword>Calcitriol/*metabolism</keyword><keyword>Humans</keyword><keyword>Integrin beta Chains/genetics/*metabolism</keyword><keyword>Osteoblasts/*metabolism</keyword><keyword>Substrate Specificity</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0960-0760 (Print)</isbn><accession-num>17317155</accession-num><abstract>Surface micron-scale and submicron scale features increase osteoblast differentiation and enhance responses of osteoblasts to 1,25-dihydroxyvitamin D(3) [1alpha,25(OH)(2)D(3)]. beta(1) integrin expression is increased in osteoblasts grown on Ti substrates with rough microarchitecture, and it is regulated by 1alpha,25(OH)(2)D(3) in a surface-dependent manner. To determine if beta(1) has a role in mediating osteoblast response, we silenced beta(1) expression in MG63 human osteoblast-like cells using small interfering RNA (siRNA). In addition, MG63 cells were treated with two different monoclonal antibodies to human beta(1) to block ligand binding. beta(1)-silenced MG63 cells grown on a tissue culture plastic had reduced alkaline phosphatase activity and levels of osteocalcin, transforming growth factor beta(1), prostaglandin E(2), and osteoprotegerin in comparison with control cells. Moreover, beta(1)-silencing inhibited the effects of surface roughness on these parameters and partially inhibited effects of 1alpha,25(OH)(2)D(3). Anti beta(1) antibodies decreased alkaline phosphatase but increase osteocalcin; effects of 1alpha,25(OH)(2)D(3) on cell number and alkaline phosphatase were reduced and effects on osteocalcin were increased. These findings indicate that beta(1) plays a major and complex role in osteoblastic differentiation modulated by either surface microarchitecture or 1alpha,25(OH)(2)D(3). The results also show that beta(1) mediates, in part, the synergistic effects of surface roughness and 1alpha,25(OH)(2)D(3).</abstract><notes>Schwartz, Zvi&#xD;Bell, Bryan F&#xD;Wang, Liping&#xD;Zhao, Ge&#xD;Olivares-Navarrete, Rene&#xD;Boyan, Barbara D&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;The Journal of steroid biochemistry and molecular biology&#xD;J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):606-9. Epub 2006 Dec 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17317155</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>2.799</custom4><electronic-resource-num>S0960-0760(06)00449-3 [pii]&#xD;10.1016/j.jsbmb.2006.12.083</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>444</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">444</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Norville, J. E.</author><author>Kelly, D. F.</author><author>Knight, T. F., Jr.</author><author>Belcher, A. M.</author><author>Walz, T.</author></authors></contributors><auth-address>MIT Computer Science and Artificial Intelligence Laboratory, 32 Vassar Street, Cambridge, MA 02139, USA.</auth-address><titles><title>7A projection map of the S-layer protein sbpA obtained with trehalose-embedded monolayer crystals</title><secondary-title>J Struct Biol</secondary-title></titles><pages>313-23</pages><volume>160</volume><number>3</number><edition>2007/07/20</edition><keywords><keyword>Bacillus/*chemistry</keyword><keyword>Bacterial Proteins/chemistry/isolation &amp; purification/*ultrastructure</keyword><keyword>Carbon</keyword><keyword>Cryoelectron Microscopy/instrumentation/*methods</keyword><keyword>Crystallization/*methods</keyword><keyword>Crystallography/instrumentation/*methods</keyword><keyword>Dimyristoylphosphatidylcholine</keyword><keyword>Ethane</keyword><keyword>Monosaccharide Transport Proteins/chemistry/isolation &amp;</keyword><keyword>purification/*ultrastructure</keyword><keyword>Negative Staining/methods</keyword><keyword>Porosity</keyword><keyword>Protein Conformation</keyword><keyword>Quaternary Ammonium Compounds</keyword><keyword>Specimen Handling/instrumentation/*methods</keyword><keyword>Trehalose</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1095-8657 (Electronic)</isbn><accession-num>17638580</accession-num><abstract>Two-dimensional crystallization on lipid monolayers is a versatile tool to obtain structural information of proteins by electron microscopy. An inherent problem with this approach is to prepare samples in a way that preserves the crystalline order of the protein array and produces specimens that are sufficiently flat for high-resolution data collection at high tilt angles. As a test specimen to optimize the preparation of lipid monolayer crystals for electron microscopy imaging, we used the S-layer protein sbpA, a protein with potential for designing arrays of both biological and inorganic materials with engineered properties for a variety of nanotechnology applications. Sugar embedding is currently considered the best method to prepare two-dimensional crystals of membrane proteins reconstituted into lipid bilayers. We found that using a loop to transfer lipid monolayer crystals to an electron microscopy grid followed by embedding in trehalose and quick-freezing in liquid ethane also yielded the highest resolution images for sbpA lipid monolayer crystals. Using images of specimens prepared in this way we could calculate a projection map of sbpA at 7A resolution, one of the highest resolution projection structures obtained with lipid monolayer crystals to date.</abstract><notes>Norville, Julie E&#xD;Kelly, Deborah F&#xD;Knight, Thomas F Jr&#xD;Belcher, Angela M&#xD;Walz, Thomas&#xD;GM62580/GM/United States NIGMS&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of structural biology&#xD;J Struct Biol. 2007 Dec;160(3):313-23. Epub 2007 Jun 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17638580</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>3.677</custom4><electronic-resource-num>S1047-8477(07)00140-2 [pii]&#xD;10.1016/j.jsb.2007.06.002</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">4</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Li, L.</author><author>Tsuji, K.</author><author>Moossa, A. R.</author><author>Katsuoka, K.</author><author>Hoffman, R. M.</author><author>Bouvet, M.</author></authors></contributors><auth-address>Department of Surgery, University of California San Diego, San Diego, California, USA.</auth-address><titles><title>Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine</title><secondary-title>J Surg Res</secondary-title><alt-title>The Journal of surgical research</alt-title></titles><pages>164-9</pages><volume>132</volume><number>2</number><edition>2006/05</edition><keywords><keyword>Angiogenesis Inhibitors/*therapeutic use</keyword><keyword>Animals</keyword><keyword>Antigens, CD31/analysis</keyword><keyword>Antimetabolites, Antineoplastic/therapeutic use</keyword><keyword>Deoxycytidine/*analogs &amp; derivatives/therapeutic use</keyword><keyword>Endothelium, Vascular/chemistry</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Intermediate Filament Proteins/analysis/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neovascularization, Pathologic/*drug therapy</keyword><keyword>Nerve Tissue Proteins/analysis/genetics</keyword><keyword>Pancreatic Neoplasms/*blood supply/drug therapy</keyword><keyword>Transfection</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0022-4804 (Print)</isbn><accession-num>16500746</accession-num><abstract>BACKGROUND: The stem cell marker nestin recently has been shown to be expressed in nascent blood vessels in nestin-driven green fluorescent protein (ND-GFP) transgenic nude mice. MATERIALS AND METHODS: In the present study, we visualized by dual-color fluorescence imaging tumor angiogenesis in the ND-GFP transgenic nude mice after orthotopic transplantation of the MIA PaCa-2 human pancreatic cancer line expressing red fluorescent protein. Mice were treated with gemcitabine at 150 mg/kg/dose on days 3, 6, 10, and 13 after tumor implantation. At day 14, mice were sacrificed and mean nascent blood vessel density and tumor volume were calculated and compared to control mice. RESULTS: Nestin was highly expressed in proliferating endothelial cells and nascent blood vessels in the growing tumor. Results of immunohistochemical staining showed that CD31 co-localized in ND-GFP-expressing nascent blood vessels. The density of nascent blood vessels in the tumor was readily quantitated. Gemcitabine significantly decreased the mean nascent blood vessel density in the tumor as well as decreased tumor volume. CONCLUSION: The dual-color model of the ND-GFP nude mouse orthotopically implanted with RFP-expressing pancreatic tumor cells enabled the simultaneous visualization and quantitation of tumor angiogenesis and tumor volume. These results demonstrated for the first time that gemcitabine is an inhibitor of angiogenesis as well as tumor growth in pancreatic cancer. The results have important implications for the clinical application of gemcitabine in this disease.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16500746 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>2.038</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>84</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">84</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hayashi, K.</author><author>Yamauchi, K.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Amoh, Y.</author><author>Hoffman, R. M.</author><author>Bouvet, M.</author></authors></contributors><auth-address>Department of Surgery, University of California San Diego, San Diego, California, USA.</auth-address><titles><title>Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma</title><secondary-title>J Surg Res</secondary-title></titles><pages>165-70</pages><volume>140</volume><number>2</number><edition>2007/04/10</edition><keywords><keyword>Animals</keyword><keyword>Antibiotics, Antineoplastic/therapeutic use</keyword><keyword>Bone Neoplasms/*blood supply/drug therapy/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Doxorubicin/therapeutic use</keyword><keyword>Endothelium, Vascular/metabolism/pathology</keyword><keyword>Fibrosarcoma/*blood supply/drug therapy/metabolism</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Humans</keyword><keyword>Intermediate Filament Proteins/genetics/metabolism</keyword><keyword>Luminescent Proteins/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Neovascularization, Pathologic/metabolism/*pathology/*prevention &amp; control</keyword><keyword>Nerve Tissue Proteins/genetics/metabolism</keyword><keyword>Regional Blood Flow</keyword><keyword>Sarcoma/*blood supply/drug therapy/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0022-4804 (Print)</isbn><accession-num>17418866</accession-num><abstract>BACKGROUND: Angiogenesis is a critical step in tumor growth, progression, and metastasis. Soft tissue and bone sarcoma are resistant to most therapeutic approaches. Angiogenesis of these tumors may be an effective target. We hypothesized that we could inhibit tumor growth by targeting angiogenesis in a mouse model of sarcoma. We demonstrate in this report, using powerful color-coded fluorescent imageable tumor-host models, the onset of angiogenesis of these sarcomas and its inhibition. MATERIALS AND METHODS: Transgenic mice were used as the host in which green fluorescent protein (GFP) is driven by a regulatory element of the stem cell marker nestin (ND-GFP). Nascent blood vessels express ND-GFP in this model. We visualized, by dual-color fluorescence imaging, angiogenesis of sarcoma formed by the HT-1080 human fibrosarcoma cell line expressing red fluorescent protein (RFP) in the ND-GFP mice. Tumor cells were injected into either the muscle or the bone. RESULTS: Nestin was highly expressed in proliferating endothelial cells and nascent blood vessels in the growing tumors, including the surrounding tissues. Immunohistochemical staining showed that CD31 colocalized in ND-GFP-expressing nascent blood vessels. The density of nascent blood vessels in the tumor was readily quantitated. The mice were given daily i.p. injections of 5 mg/kg of doxorubicin after implantation of tumor cells. Doxorubicin significantly decreased the mean nascent blood vessel density in the tumors as well as decreased tumor volume. CONCLUSION: The dual-color model of the ND-GFP nude mouse and RFP sarcoma cells is useful for the visualization and quantitation of bone and soft tissue tumor angiogenesis and evaluation of angiogenic inhibitors for such tumors. These data suggest targeting angiogenesis of sarcomas as a promising clinical approach.</abstract><notes>Hayashi, Katsuhiro&#xD;Yamauchi, Kensuke&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Amoh, Yasuyuki&#xD;Hoffman, Robert M&#xD;Bouvet, Michael&#xD;Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of surgical research&#xD;J Surg Res. 2007 Jun 15;140(2):165-70. Epub 2007 Apr 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17418866</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>2.038</custom4><electronic-resource-num>S0022-4804(06)00611-1 [pii]&#xD;10.1016/j.jss.2006.11.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>159</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">159</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhee, T. K.</author><author>Ryu, R. K.</author><author>Bangash, A. K.</author><author>Wang, D.</author><author>Szolc-Kowalska, B.</author><author>Harris, K. R.</author><author>Sato, K. T.</author><author>Chrisman, H. B.</author><author>Vogelzang, R. L.</author><author>Paunesku, T.</author><author>Woloschak, G. E.</author><author>Larson, A. C.</author><author>Omary, R. A.</author></authors></contributors><auth-address>aDepartment of Radiology, Northwestern University Feinberg School of Medicine, 676 North St Clair St, Ste 800, Chicago, IL 60611.</auth-address><titles><title>Rabbit VX2 Tumors as an Animal Model of Uterine Fibroids and for Uterine Artery Embolization</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><pages>411-8</pages><volume>18</volume><number>3</number><edition>2007/03/23</edition><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>17377188</accession-num><abstract>Purpose To determine the suitability of the rabbit VX2 tumor animal model for uterine fibroids and uterine artery embolization (UAE). Materials and Methods The authors implanted and grew one uterine VX2 tumor per rabbit in six rabbits. UAE was performed by using 100-300 mum embolic particles and confirmed with x-ray digital subtraction angiography, magnetic resonance (MR) imaging, and necropsy. Unenhanced and contrast medium-enhanced MR images of VX2 tumors were obtained before and after UAE. Relative MR signal-to noise-ratio (SNR) was measured in the uterine VX2 tumor and in normal uterine tissue before and after UAE and compared by using a paired t-test (P = .05). Results VX2 uterine tumors were successfully grown, and both VX2 tumor presence in the uterus and UAE were seen angiographically and confirmed with necropsy in all six rabbits. Statistically significant reductions in relative SNRs were measured in tumors (SNR before UAE, 15.3 +/- 5.15; SNR after UAE, 3.84 +/- 3.94; P &lt; .0001). No statistically significant decrease in SNR was measured in normal uterine tissue before and after UAE (P = .63 for the right uterine horn and P = .93 for the left uterine horn). Conclusion Rabbit VX2 uterine tumors may be a suitable animal model of uterine fibroids and UAE.</abstract><notes>Rhee, Thomas K&#xD;Ryu, Robert K&#xD;Bangash, Affaan K&#xD;Wang, Dingxin&#xD;Szolc-Kowalska, Barbara&#xD;Harris, Kathleen R&#xD;Sato, Kent T&#xD;Chrisman, Howard B&#xD;Vogelzang, Robert L&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle E&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2007 Mar;18(3):411-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17377188</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>1.597</custom4><electronic-resource-num>18/3/411 [pii]&#xD;10.1016/j.jvir.2007.01.013</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>160</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">160</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhee, T. K.</author><author>Young, J. Y.</author><author>Larson, A. C.</author><author>Haines, G. K., 3rd</author><author>Sato, K. T.</author><author>Salem, R.</author><author>Mulcahy, M. F.</author><author>Kulik, L. M.</author><author>Paunesku, T.</author><author>Woloschak, G. E.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University Feinberg School of Medicine, 448 E Ontario St, Ste 700, Chicago, IL 60611, USA.</auth-address><titles><title>Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><pages>639-45</pages><volume>18</volume><number>5</number><edition>2007/05/15</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>*Chemoembolization, Therapeutic</keyword><keyword>Disease Models, Animal</keyword><keyword>Feasibility Studies</keyword><keyword>Hypoxia-Inducible Factor 1, alpha Subunit/*biosynthesis</keyword><keyword>Liver Neoplasms, Experimental/*genetics/*therapy</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>17494846</accession-num><abstract>PURPOSE: To test the hypothesis that transcatheter arterial embolization (TAE) of VX2 rabbit liver tumors increases the expression of hypoxia-inducible factor-1alpha (HIF-1alpha), a transcription factor that regulates the expression of pro-angiogenic genes. MATERIALS AND METHODS: VX2 tumors were implanted in the livers of eight New Zealand white rabbits. Once tumor growth was seen at T2-weighted turbo spin-echo magnetic resonance (MR) imaging, four of the eight rabbits underwent TAE with 45-150-mum polyvinyl alcohol particles. The remaining four rabbits served as non-TAE controls. The TAE end point was stasis of antegrade blood flow. All rabbits were sacrificed for tumor harvest 2 hours after TAE. Tumor tissue and corresponding normal liver tissue in each rabbit liver were stained with anti-human HIF-1alpha monoclonal antibody and reviewed with light microscopy. Percentages of stained viable tumor and normal liver cells were compared by using the Mann-Whitney U test (alpha=0.05). RESULTS: In eight rabbits with 24 discrete liver tumors, the mean percentage (+/-standard deviation) of positive HIF-1alpha-stained cells in the TAE group was greater than that in the control group (19%+/-7.0 vs 12%+/-8.0, respectively) (P=.05). Normal liver tissue in both the TAE and control groups showed no HIF-1alpha staining. CONCLUSION: Although HIF-1alpha is not expressed in normal rabbit liver parenchyma-even after TAE-HIF-1alpha expression is present in implanted VX2 rabbit liver tumors and significantly increased in lesions that have undergone embolization.</abstract><notes>Rhee, Thomas K&#xD;Young, Joseph Y&#xD;Larson, Andrew C&#xD;Haines, G Kenneth 3rd&#xD;Sato, Kent T&#xD;Salem, Riad&#xD;Mulcahy, Mary F&#xD;Kulik, Laura M&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle E&#xD;Omary, Reed A&#xD;Ca73042/ca/nci&#xD;Ca81375/ca/nci&#xD;K08 dk60020/dk/niddk&#xD;Ns 21442/ns/ninds&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2007 May;18(5):639-45.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17494846</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>1.597</custom4><electronic-resource-num>18/5/639 [pii]&#xD;10.1016/j.jvir.2007.02.031</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>645</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">645</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Virmani, S.</author><author>Harris, K. R.</author><author>Szolc-Kowalska, B.</author><author>Paunesku, T.</author><author>Woloschak, G. E.</author><author>Lee, F. T.</author><author>Lewandowski, R. J.</author><author>Sato, K. T.</author><author>Ryu, R. K.</author><author>Salem, R.</author><author>Larson, A. C.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University, 737 N Michigan Ave, Ste 1600, Chicago, IL 60611, USA.</auth-address><titles><title>Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><pages>931-6</pages><volume>19</volume><number>6</number><edition>2008/05/28</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>18503910</accession-num><abstract>PURPOSE: To compare two methods to (a) propagate VX2 cell strain in rabbit hind limbs and (b) inoculate liver parenchymal tumors in rabbits. MATERIALS AND METHODS: One hundred forty-two New Zealand white rabbits were used for this study (60 with hind limb tumor [donors] and 82 with liver tumors [recipients]). In the donor group, nine rabbits received frozen VX2 cell suspension and 51 were injected with freshly prepared VX2 cell suspension. In the recipient group, 32 rabbits were injected with VX2 tumor cells and 50 were implanted with a small tumor fragment in the liver parenchyma. Success rates in terms of tumor growth were compared by using chi(2) or Fisher exact tests, with alpha = .05. RESULTS: Hind limb and liver tumors were successfully grown in 48 of the 60 rabbits in the donor group (80%) and 57 of the 82 rabbits in the recipient group (70%). The success rate of growing hind limb tumors increased from 33% (three of nine rabbits) to 88% (45 of 51 rabbits) when fresh VX2 cells instead of frozen were injected percutaneously (P &lt; .0011). Similarly, the success rate for VX2 liver tumors almost doubled from 47% (15 of 32 rabbits) to 84% (42 of 50 rabbits) when a tumor fragment instead of VX2 cell suspension was used (P &lt; .00036). This also significantly reduced the frequency of metastasis (P &lt; .005). CONCLUSIONS: The authors recommend (a) the use of fresh VX2 cell suspension for percutaneous injection in the hind limbs of rabbits to maintain the VX2 cell strain and (b) the surgical implantation of freshly harvested VX2 tumor fragment into the liver parenchyma to establish liver tumors.</abstract><notes>Virmani, Sumeet&#xD;Harris, Kathleen R&#xD;Szolc-Kowalska, Barbara&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle E&#xD;Lee, Fred T&#xD;Lewandowski, Robert J&#xD;Sato, Kent T&#xD;Ryu, Robert K&#xD;Salem, Riad&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;CA107467/CA/United States NCI&#xD;EB002100/EB/United States NIBIB&#xD;P50 CA89018/CA/United States NCI&#xD;U54 CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2008 Jun;19(6):931-6. Epub 2008 Apr 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18503910</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>2.207</custom4><electronic-resource-num>S1051-0443(08)00231-5 [pii]&#xD;10.1016/j.jvir.2008.02.019</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>473</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">473</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Virmani, S.</author><author>Wang, D.</author><author>Harris, K. R.</author><author>Ryu, R. K.</author><author>Sato, K. T.</author><author>Lewandowski, R. J.</author><author>Nemcek, A. A., Jr.</author><author>Szolc-Kowalska, B.</author><author>Woloschak, G.</author><author>Salem, R.</author><author>Larson, A. C.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University, 448 E Ontario St, Suite 700, Chicago, Illinois 60611, USA.</auth-address><titles><title>Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><pages>1280-6</pages><volume>18</volume><number>10</number><edition>2007/10/04</edition><keywords><keyword>Angiography, Digital Subtraction</keyword><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media/administration &amp; dosage</keyword><keyword>*Embolization, Therapeutic</keyword><keyword>Fluorescent Dyes/*administration &amp; dosage</keyword><keyword>Gadolinium DTPA/administration &amp; dosage</keyword><keyword>Hepatic Artery/radiography</keyword><keyword>Injections, Intra-Arterial</keyword><keyword>Linear Models</keyword><keyword>*Liver Circulation</keyword><keyword>Liver Neoplasms, Experimental/*blood supply/pathology/*therapy</keyword><keyword>*Magnetic Resonance Angiography</keyword><keyword>*Microspheres</keyword><keyword>Rabbits</keyword><keyword>Reproducibility of Results</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>17911519</accession-num><abstract>PURPOSE: Transcatheter intraarterial perfusion (TRIP) magnetic resonance (MR) imaging is clinically used in the interventional MR imaging setting to verify distribution of injected embolic or chemoembolic material during liver-directed transcatheter therapies and to monitor reductions in perfusion. The accuracy of this technique remains unknown. In the present study, rabbit VX2 liver tumors were used to test the hypothesis that TRIP MR imaging accurately measures changes in tumor perfusion during transcatheter arterial embolization (TAE), with injection of fluorescent microspheres used as the gold-standard technique. MATERIALS AND METHODS: Five New Zealand White rabbits were used for this study (two donor rabbits and three with VX2 liver tumors). In three rabbits with implanted VX2 liver tumors, catheters were superselectively placed under digital subtraction angiographic guidance into the left hepatic artery supplying the targeted tumor. Fluorescent microspheres were injected into each rabbit&apos;s left ventricle before and after TAE. TRIP MR images were obtained at baseline and after embolizations for all rabbits with intraarterial injections of 2.5% gadopentetate dimeglumine solution. Linear regression was used to compare relative reductions in tumor perfusion between TRIP MR imaging and fluorescent microspheres. Results were considered statistically significant at a P value less than .05. RESULTS: There was good correlation between TRIP MR imaging and fluorescent microsphere measurements of reduction in tumor perfusion (r = 0.722, P &lt; .012). CONCLUSIONS: TRIP MR imaging provides accurate semiquantitative measurement of perfusion reduction during TAE in rabbit liver tumors.</abstract><notes>Virmani, Sumeet&#xD;Wang, Dingxin&#xD;Harris, Kathleen R&#xD;Ryu, Robert K&#xD;Sato, Kent T&#xD;Lewandowski, Robert J&#xD;Nemcek, Albert A Jr&#xD;Szolc-Kowalska, Barbara&#xD;Woloschak, Gayle&#xD;Salem, Riad&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;CA81375/CA/United States NCI&#xD;EB002100/EB/United States NIBIB&#xD;U54 CA119341/CA/United States NCI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Validation Studies&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2007 Oct;18(10):1280-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17911519</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>2.207</custom4><electronic-resource-num>18/10/1280 [pii]&#xD;10.1016/j.jvir.2007.07.008</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>522</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">522</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, A. W.</author><author>Sharp, E. R.</author><author>O&apos;Mahony, A.</author><author>Rosenberg, M. G.</author><author>Israelski, D. M.</author><author>Nolan, G. P.</author><author>Nixon, D. F.</author></authors></contributors><auth-address>Division of Experimental Medicine, University of California at San Francisco, 1001 Potrero Ave., Bldg. 3, UCSF Box 1234, San Francisco, CA 94143-1234, USA.</auth-address><titles><title>Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection</title><secondary-title>J Virol</secondary-title></titles><pages>3702-12</pages><volume>82</volume><number>7</number><edition>2008/01/25</edition><keywords><keyword>Adolescent</keyword><keyword>Antigens, Surface/analysis</keyword><keyword>CD4 Lymphocyte Count</keyword><keyword>Cells, Cultured</keyword><keyword>Child</keyword><keyword>Child, Preschool</keyword><keyword>*Extracellular Signal-Regulated MAP Kinases</keyword><keyword>Female</keyword><keyword>Flow Cytometry</keyword><keyword>HIV Infections/*immunology/metabolism</keyword><keyword>HIV-1/*immunology</keyword><keyword>Humans</keyword><keyword>Infant</keyword><keyword>Male</keyword><keyword>Monocytes/chemistry</keyword><keyword>Phosphorylation</keyword><keyword>Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/analysis</keyword><keyword>STAT5 Transcription Factor/*metabolism</keyword><keyword>*Signal Transduction</keyword><keyword>Viral Load</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1098-5514 (Electronic)</isbn><accession-num>18216116</accession-num><abstract>Despite extensive evidence of cell signaling alterations induced by human immunodeficiency virus type 1 (HIV-1) in vitro, the relevance of these changes to the clinical and/or immunologic status of HIV-1-infected individuals is often unclear. As such, mapping the details of cell type-specific degradation of immune function as a consequence of changes to signaling network responses has not been readily accessible. We used a flow cytometric-based assay of signaling to determine Janus kinase/signal transducers and activators of transcription (Jak/STAT) signaling changes at the single-cell level within distinct cell subsets from the primary immune cells of HIV-1-infected donors. We identified a specific defect in granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven Stat5 phosphorylation in the monocytes of HIV-1+ donors. This inhibition was statistically significant in a cohort of treated and untreated individuals. Ex vivo Stat5 phosphorylation levels varied among HIV-1+ donors but did not correlate with CD4(+) T-cell counts or HIV-1 plasma viral load. Low Stat5 activation occurred in HIV-1-infected donors despite normal GM-CSF receptor levels. Investigation of mitogen-activated protein kinase (MAPK) pathways, also stimulated by GM-CSF, led to the observation that lipopolysaccharide-stimulated extracellular signal-regulated kinase phosphorylation is enhanced in monocytes. Thus, we have identified a specific, imbalanced monocyte signaling profile, with inhibition of STAT and enhancement of MAPK signaling, associated with HIV-1 infection. This understanding of altered monocyte signaling responses that contribute to defective antigen presentation during HIV-1 infection could lead to immunotherapeutic approaches that compensate for the deficiency.</abstract><notes>Lee, Andrew W&#xD;Sharp, Elizabeth R&#xD;O&apos;Mahony, Alison&#xD;Rosenberg, Michael G&#xD;Israelski, Dennis M&#xD;Nolan, Garry P&#xD;Nixon, Douglas F&#xD;AI060379/AI/United States NIAID&#xD;K08 AI067064/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of virology&#xD;J Virol. 2008 Apr;82(7):3702-12. Epub 2008 Jan 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18216116</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>5.332</custom4><electronic-resource-num>JVI.01582-07 [pii]&#xD;10.1128/JVI.01582-07</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>164</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">164</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aslam, M.</author><author>Li, S.</author><author>Dravid, V.P.</author></authors></contributors><titles><title>Controlled synthesis and stability of Co@SiO2 aqueous colloids</title><secondary-title>J. Am. Ceram. Soc.</secondary-title></titles><pages>950-956</pages><volume>90</volume><number>3</number><edition>2007/05</edition><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><urls><related-urls><url>http://vpd.ms.northwestern.edu/Publications_files/2007/Cobalt_silica_Published2007.pdf</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>583</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">583</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, Hongwei</author><author>Kuang, Min</author><author>Wang, Xiaoxia</author><author>Wang, Y. Andrew</author><author>Mao, Hui</author><author>Nie, Shuming</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle Suite 2001, Atlanta, Georgia 30322, Department of Radiology and Center for MR Research, Emory University School of Medicine, 1364 Clifton Road, Atlanta, Georgia 30322, and Ocean Nanotech, LLC, 700 Research Center Blvd., Fayetteville, Arkansas 72701</auth-address><titles><title>Reexamining the Effects of Particle Size and Surface Chemistry on the Magnetic Properties of Iron Oxide Nanocrystals: New Insights into Spin Disorder and Proton Relaxivity</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><pages>8127-8131</pages><volume>112</volume><number>22</number><edition>2008/07</edition><dates><year>2008</year></dates><isbn>1932-7447</isbn><abstract>Abstract: Superparamagnetic iron oxide nanocrystals are a class of nontoxic and biodegradable nanomaterials with broad applications in science, engineering, and medicine, but there is still considerable debate on how crystalline domain size and surface chemistry influence their properties for magnetic resonance imaging (MRI). Here we examine the effects of particle size and surface chemistry by comparing proton relaxivity data for two particle sizes and three surface coatings (6 combinations). These combinations are achieved by using both direct ligand exchange and indirect encapsulation methods to solubilize oleic-acid capped iron oxide nanocrystals. The results indicate that proton relaxivity depends on the particle size, the surface coating thickness and hydrophilicity, and the coordination chemistry of inner capping ligands. Nanocrystals coated with the hydrophilic ligand polyethylenimine (PEI) yield the highest proton relaxivity, whereas nanocrystals capped with oleic acid and amphiphilic polymers exhibit the strongest dependence on particle size. These effects arise from intrinsic surface spin disorders as well as from rapid exchange (diffusion) of water molecules between the bulk phase and the adjacent layer surrounding the particle surface.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp8029083</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>545</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">545</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hasan, W.</author><author>Lee, J.</author><author>Henzie, J.</author><author>Odom, T. W.</author></authors></contributors><auth-address>Department of Chemistry and Department of Materials Science and Engineering, Northwestern University, 2145 Sheridan Rd., Evanston, Illinois 60208-3113</auth-address><titles><title>Selective Functionalization and Spectral Identification of Gold Nanopyramids</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><pages>17176-17179</pages><volume>111</volume><number>46</number><edition>2007/10/25  </edition><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1932-7447</isbn><abstract>Abstract: This paper reports the selective functionalization of gold nanopyramids and spectral identification of their orientation on a surface. Facile asymmetric functionalization of the nanopyramids with different thiol-terminated ligands was achieved by controlling the etching conditions of the nanopyramidal template. We confirmed this differential modification by attaching gold colloids to either the inner or outer surfaces of the Au nanopyramids using hybridized DNA. Significantly, we have also demonstrated that the relative orientation of the nanopyramids can be identified by measuring their scattering spectra only. This unique capability of these three-dimensional, asymmetric particles enables their orientation to be determined in condensed media without the need for direct and destructive imaging tools.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp709607s</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>542</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">542</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>He, J. H.</author><author>Zhang, Y. Y.</author><author>Liu, J.</author><author>Moore, D.</author><author>Bao, G.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>Graduate Institute of Electro-Optical Engineering and Department of Electrical Engineering, National Taiwan University, Taipei, 106 Taiwan, School of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0245, and School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245</auth-address><titles><title>ZnS/Silica Nanocable Field Effect Transistors as Biological and Chemical Nanosensors</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><pages>12152-12156</pages><volume>111</volume><number>33</number><edition>2007/07/27 </edition><dates><year>2007</year><pub-dates><date>July </date></pub-dates></dates><isbn>1932-7447</isbn><abstract>Abstract: Compound semiconductor/isolator (ZnS/silica) core/shell nanocables have been used to fabricate single nanowire-based field effect transistors. Using the surface-adsorbed charged molecules as the gate, the nanocable-based devices show potential for label-free, real-time, and sensitive detection of biological species. After chemical modification, amine- and oxide-functionalized nanocables exhibit linear pH-dependent conductance, which could be elucidated in terms of the changes of surface charge during protonation and deprotonation. Selective biological recognition of nanocable sensors has been demonstrated using biotinylation.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp074772u</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>586</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">586</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Moore, D.</author><author>Morber, J. R.</author><author>Snyder, R. L.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245</auth-address><titles><title>Growth of Ultralong ZnS/SiO2 Core-Shell Nanowires by Volume and Surface Diffusion VLS Process</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><pages>2895-2903</pages><volume>112</volume><number>8</number><edition>2008/07</edition><dates><year>2008</year></dates><isbn>1932-7447</isbn><abstract>Abstract: Nanowires of up to 1 cm in length and approximately 30 nm in diameter were synthesized through a simple chemical vapor deposition process. Scanning electron microscopy (SEM) data showed that these nanowires were well-aligned and grew in the direction along the flow of the carrier gas. Through transmission electron microscopy (TEM) and X-ray diffraction (XRD) analysis, the nanowires were found to be composed of a single-crystalline ZnS core and amorphous SiO2 shell. Gold catalyst particles were found at the tips of the nanowires and completely encased by a silica shell. Photoluminescence (PL) measurements were performed on nanowire samples in which the synthesis time was systematically varied to provide information regarding growth dynamics. After a systematic study on the structure, we propose that the core-shell nanowires were formed via a distinct volume and surface diffusion process occurring simultaneously for different chemical species in and on the gold catalyst particle.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp709903b</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>634</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">634</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shuford, K. L.</author><author>Lee, J.</author><author>Odom, T. W.</author><author>Schatz, G. C.</author></authors></contributors><auth-address>Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831-6142, Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, and Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208-3113</auth-address><titles><title>Optical Properties of Gold Pyramidal Shells</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><pages>6662-6666</pages><volume>112</volume><number>17</number><edition>2008/04/08</edition><dates><year>2008</year></dates><isbn>1932-7447</isbn><abstract>Abstract: We present an investigation of the optical properties of gold pyramidal shell nanoparticles. Theory shows a multiresonance spectrum at near-infrared wavelengths that is consistent with the measured extinction spectra of particles that are fabricated using a soft-lithography technique. In addition to electric dipole and electric quadrupole resonances, the calculations identify an unusual plasmon mode, which involves oscillation of the polarization perpendicular to the direction of both the incident polarization and wave vector. We show that this TE-like resonance can be suppressed by truncating the tip of the pyramid or by increasing the shell thickness without adversely affecting the in-plane dipole and quadrupole resonances.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp8004844</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1021/jp8004844 </electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>336</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">336</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, G. X.</author><author>Sun, S. H.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Li, Gx&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA&#xD;Western Digital Corp, Fremont, CA 94539 USA&#xD;Brown Univ, Dept Chem, Providence, RI 02912 USA</auth-address><titles><title>Spin valve biosensors: Signal dependence on nanoparticle position</title><secondary-title>Journal of Applied Physics</secondary-title></titles><pages>-</pages><volume>99</volume><number>8</number><edition>2006/04</edition><keywords><keyword>magnetic nanoparticles</keyword><keyword>biological applications</keyword><keyword>sensitive diagnostics</keyword><keyword>sensors</keyword><keyword>biochips</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0021-8979</isbn><accession-num>ISI:000237404200633</accession-num><abstract>Experimental and theoretical studies have been carried out on the spin valve sensor signal dependence on the spatial locations of magnetic nanoparticles as potential biomolecular labels in the magnetic biodetection technology. Superparamagnetic 16 nm magnetite (Fe3O4) nanoparticles were site specifically deposited at different positions relative to a submicron-wide spin valve sensor. The spin valve sensor signal showed both polarity and magnitude differences with the particles at different positions. A theoretical model including magnetic sensor-particle interaction confirms the experimental results and provides a design guide to the sensing area. Moreover, the theoretical calculations reveal a nonmonotonic signal dependence on the vertical particle-to-sensor distance due to the sensor-particle interaction, and show that an optimum distance exists for signal strength and quantification. (C) 2006 American Institute of Physics.</abstract><notes>040TV&#xD;Times Cited:2&#xD;Cited References Count:11</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000237404200633</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>2.316</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>387</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">387</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, M. C.</author><author>Khanna, S. N.</author></authors></contributors><auth-address>Qian, MC&#xD;Virginia Commonwealth Univ, Dept Phys, Med Coll Virginia Campus, Richmond, VA 23284 USA&#xD;Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA</auth-address><titles><title>An ab initio investigation on the endohedral metallofullerene Gd3N-C-80</title><secondary-title>Journal of Applied Physics</secondary-title></titles><pages>-</pages><volume>101</volume><number>9</number><edition>2007/05</edition><keywords><keyword>gd3n-at-c-80</keyword><keyword>gd3n</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0021-8979</isbn><accession-num>ISI:000246567900217</accession-num><abstract>First-principles electronic structure studies on the ground state geometry and electronic and magnetic properties of bare and hydrogen coated metallofullerene Gd3N-C-80 have been carried out within a density functional formalism. The correlation effects are incorporated either through a generalized gradient corrected functional or through an on-site Coulomb interaction (LDA+U). It is shown that the bare Gd3N-C-80 possess a ferromagnetic ground state with a large spin moment of 21 mu(B) that is highly stable against spin fluctuations. The simulated Raman spectrum shows that the low-energy peaks are contributed by the floppy movement of N atom. As to the effect of addition of hydrogens, it is shown that the most favorable site for the hydrogen adsorption is an on-top site where the H atom is located above a five-member carbon ring with a binding energy of 1.92 eV, while the least stable site corresponds to an on-top absorption above a six-member ring. A study of the energetics upon multiple adsorption of H shows that the binding energy of the H to metallofullerene drops after 11 H atoms. This shows that it should be possible to attach multiple ligands offering the potential that the Gd3N-C-80 can be functionalized with ligands or assembled in cluster assemblies.</abstract><notes>169BO&#xD;Times Cited:0&#xD;Cited References Count:14</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246567900217</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2007</custom3><custom4>2.316</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>343</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">343</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Etgar, L.</author><author>Lifshitz, E.</author><author>Tannenbaum, R.</author></authors></contributors><auth-address>Tannenbaum, R&#xD;Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel&#xD;Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel&#xD;Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel&#xD;Technion Israel Inst Technol, Schulich Fac Chem, Nanosci &amp; Nanotechnol Program, IL-32000 Haifa, Israel&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA USA</auth-address><titles><title>Hierarchical conjugate structure of gamma-Fe2O3 nanoparticles and PbSe quantum dots for biological applications</title><secondary-title>Journal of Physical Chemistry C</secondary-title></titles><pages>6238-6244</pages><volume>111</volume><number>17</number><edition>2007/05</edition><keywords><keyword>iron-oxide nanoparticles</keyword><keyword>magnetic nanoparticles</keyword><keyword>semiconductor nanocrystals</keyword><keyword>colloidal pbse</keyword><keyword>optical gain</keyword><keyword>biomolecules</keyword><keyword>superlattices</keyword><keyword>nanoclusters</keyword><keyword>separation</keyword><keyword>emission</keyword></keywords><dates><year>2007</year><pub-dates><date>May 3</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000245954900015</accession-num><abstract>The development and characterization of a unique conjugated structure comprised of gamma-Fe2O3 nanoparticles (NPs) and PbSe nanocrystal quantum dots (NQDs), bonded via chemical functional groups, are discussed. Compatibility with an aqueous environment was rendered by exchanging the traditional organic surfactants (oleic acid) of the PbSe NQDs and gamma-Fe2O3 NPs with 2-aminoethanethiol and polyhedral silsesquioxane hydrate octakis ligands, respectively. Comparison of the transmission electron microscopy (TEM) images of the PbSe NQDs and gamma-Fe2O3 NPs capped with either organic or water-soluble ligands highlights the preservation of the morphology and size of both types of nanoclusters upon ligand exchange. Furthermore, the absorbance, photoluminescence (PL), and Fourier transform infrared spectra of the PbSe QDs revealed that the optical properties of the NQDs were retained during the surfactant exchange. High-resolution TEM images of the complete conjugated structure validate the presence of the coupling between the PbSe NQDs and the gamma-Fe2O3 NPs. This unique system has substantial advantages for biological applications such as bio-sensing, detection of cancer cells, and drug delivery.</abstract><notes>160PN&#xD;Times Cited:0&#xD;Cited References Count:54</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245954900015</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>na</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>382</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">382</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, X. J.</author><author>Shao, R. P.</author><author>Elliott, A. M.</author><author>Stafford, R. J.</author><author>Esparza-Coss, E.</author><author>Bankson, J. A.</author><author>Liang, G.</author><author>Luo, Z. P.</author><author>Park, K.</author><author>Markert, J. T.</author><author>Li, C.</author></authors></contributors><auth-address>Li, C&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Box 57,1515 Holcombe Blvd, Houston, TX 77030 USA&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA&#xD;Sam Houston State Univ, Dept Phys, Huntsville, TX 77341 USA&#xD;Texas A&amp;M Univ, Coll Stn, Microscopy &amp; Imaging Ctr, College Stn, TX 77843 USA&#xD;Univ Texas, Dept Phys, Austin, TX 78712 USA</auth-address><titles><title>Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy</title><secondary-title>Journal of Physical Chemistry C</secondary-title></titles><pages>6245-6251</pages><volume>111</volume><number>17</number><edition>2007/05</edition><keywords><keyword>atherosclerotic plaques</keyword><keyword>surface modification</keyword><keyword>contrast agents</keyword><keyword>nanoparticles</keyword><keyword>particles</keyword><keyword>growth</keyword><keyword>cancer</keyword><keyword>scattering</keyword></keywords><dates><year>2007</year><pub-dates><date>May 3</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000245954900016</accession-num><abstract>We describe the synthesis, characterization, and use of hybrid nanoparticles with a superparamagnetic iron oxide (SPIO)-silica core and a gold nanoshell. These multifunctional nanoparticles, designated SPIO-Au nanoshells, displayed superparamagnetic characteristics and a significant absorbance in the near-infrared (NIR) region of the electromagnetic spectrum. In addition, they exhibited high transverse relaxivities, R-2, and a large R-2/R-1 ratio, and therefore, they could be imaged by MRI to obtain T-2-weighted images. Moreover, the SPIO-Au nanoshells showed efficient photothermal effects when exposed to NIR light. The use of SPIO-Au nanoshells, with their combination of unique magnetic and optical properties, should enhance the efficacy of nanoshell-mediated photothermal therapy by making it possible to direct more nanoparticles to tumors through the application of external magnetic field and by permitting real-time in vivo MRI imaging of the distribution of the nanoparticles before, during, and after photothermal therapy.</abstract><notes>160PN&#xD;Times Cited:0&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245954900016</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2007</custom3><custom4>na</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>582</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">582</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Deshpande, V.S.</author><author>Mrksichb, M.</author><author>McMeeking, R.M.</author><author>Evans, A.G.</author></authors></contributors><titles><title>A bio-mechanical model for coupling cell contractility with focal adhesion formation</title><secondary-title>Journal of the Mechanics and Physics of Solids</secondary-title></titles><pages>1484-1510</pages><volume>56</volume><number>4</number><edition>2007/09/01</edition><keywords><keyword>Mechano-sensitivity</keyword><keyword>Self-assembly</keyword><keyword>Focal adhesions</keyword><keyword>Stress fibers</keyword><keyword>Myosin</keyword></keywords><dates><year>2008</year><pub-dates><date>04/2008</date></pub-dates></dates><abstract>Focal adhesions (FAs) are large, multi-protein complexes that provide a mechanical link between the cytoskeletal contractile machinery and the extracellular matrix. They exhibit mechanosensitive properties; they self-assemble upon application of pulling forces and dissociate when these forces are decreased. We rationalize this mechano-sensitivity from thermodynamic considerations and develop a continuum framework in which the cytoskeletal contractile forces generated by stress fibers drive the assembly of the FA multi-protein complexes. The FA model has three essential features: (i) the low and high affinity integrins co-exist in thermodynamic equilibrium, (ii) the low affinity integrins within the plasma membrane are mobile, and (iii) the contractile forces generated by the stress fibers are in mechanical equilibrium and change the free energies of the integrins. A general two-dimensional framework is presented and the essential features of the model illustrated using one-dimensional examples. Consistent with observations, the coupled stress fiber and FA model predict that (a) the FAs concentrate around the periphery of the cell; (b) the fraction of the cell covered by FAs increases with decreasing cell size while the total FA intensity increases with increasing cell size; and (c) the FA intensity decreases substantially when cell contractility is curtailed.</abstract><urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.542</custom4><electronic-resource-num>10.1016/j.jmps.2007.08.006</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>341</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">341</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, W.</author><author>Wilson, R. J.</author><author>Xu, L.</author><author>Han, S. J.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Hu, W&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA</auth-address><titles><title>Patterning of high density magnetic nanodot arrays by nanoimprint lithography</title><secondary-title>Journal of Vacuum Science &amp; Technology A</secondary-title></titles><pages>1294-1297</pages><volume>25</volume><number>4</number><edition>2007/07</edition><keywords><keyword>single-domain</keyword><keyword>fabrication</keyword><keyword>islands</keyword><keyword>media</keyword><keyword>mold</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>0734-2101</isbn><accession-num>ISI:000248491700112</accession-num><abstract>In this work the authors present results from thermal nanoimprint lithography patterning of high density arrays of circular holes with 100 nm diameters at 300 nm pitch, or with 50 nm diameters at 100 nm pitch, throughout an area of 1 cm(2). They demonstrate the fabrication of dense gigabit magnetic nanodot arrays using polymethyl methacrylate and polymethyl glutarimide resist bilayers and a lift-off process. The magnetic properties of these nanodot arrays are shown to be readily characterized by alternating gradient magnetometry. Several issues are addressed which arise during patterning and characterization, such as template damage induced by Au metallization, metal residue control, and nanodot diameter tuning by oxygen plasma etching. (c) 2007 American Vacuum Society.</abstract><notes>196OK&#xD;Times Cited:0&#xD;Cited References Count:18</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000248491700112</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>1.597</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>437</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">437</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Daniel, K. D.</author><author>Kim, G. Y.</author><author>Vassiliou, C. C.</author><author>Jalali-Yazdi, F.</author><author>Langer, R.</author><author>Cima, M. J.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.</auth-address><titles><title>Multi-reservoir device for detecting a soluble cancer biomarker</title><secondary-title>Lab Chip</secondary-title></titles><pages>1288-93</pages><volume>7</volume><number>10</number><edition>2007/09/27</edition><keywords><keyword>Biosensing Techniques/*instrumentation/methods</keyword><keyword>Blood Chemical Analysis/*instrumentation/methods</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Flow Injection Analysis/*instrumentation/methods</keyword><keyword>Humans</keyword><keyword>Magnetics/diagnostic use/*instrumentation</keyword><keyword>Microfluidic Analytical Techniques/*instrumentation/methods</keyword><keyword>Neoplasms/*blood</keyword><keyword>Tumor Markers, Biological/*blood</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>17896012</accession-num><abstract>By combining the sensing capabilities of nanoscale magnetic relaxation switches (MRS) within multi-reservoir structures, a potentially powerful implantable multiplexed sensor has been developed. MRS are magnetic nanoparticles that decrease the transverse relaxation time (T(2)) of water in the presence of an analyte. The switches encased in polydimethylsiloxane (PDMS) devices with polycarbonate membranes (10 nm pores) have demonstrated in vitro sensing of the beta subunit of human chorionic gonadotrophin (hCG-beta), which is elevated in testicular and ovarian cancer. Devices showed transverse relaxation time (T(2)) shortening by magnetic resonance imaging (MRI) when incubated in analyte solutions of 0.5 to 5 microg hCG-beta mL(-1). The decrease in T(2) was between 9% and 27% (compared to control devices) after approximately 28 h. This prototype device is an important first step in developing an implantable sensor for detecting soluble cancer biomarkers in vivo.</abstract><notes>Daniel, Karen D&#xD;Kim, Grace Y&#xD;Vassiliou, Christophoros C&#xD;Jalali-Yazdi, Farzad&#xD;Langer, Robert&#xD;Cima, Michael J&#xD;5 U54 CA119349-12/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2007 Oct;7(10):1288-93. Epub 2007 Jul 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17896012</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>5.068</custom4><electronic-resource-num>10.1039/b705143c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>133</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">133</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Goluch, E. D.</author><author>Nam, J. M.</author><author>Georganopoulou, D. G.</author><author>Chiesl, T. N.</author><author>Shaikh, K. A.</author><author>Ryu, K. S.</author><author>Barron, A. E.</author><author>Mirkin, C. A.</author><author>Liu, C.</author></authors></contributors><auth-address>Micro and Nanotechnology Laboratory, Bioengineering Department, University of Illinois at Urbana-Champaign, 208 N. Wright Street, Urbana, IL 61801, USA.</auth-address><titles><title>A bio-barcode assay for on-chip attomolar-sensitivity protein detection</title><secondary-title>Lab Chip</secondary-title></titles><pages>1293-9</pages><volume>6</volume><number>10</number><edition>2006/11/15</edition><keywords><keyword>Animals</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Goats</keyword><keyword>*Microfluidic Analytical Techniques</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Prostate-Specific Antigen/*blood</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>17102842</accession-num><abstract>Functionalized nanoparticles hold great promise in realizing highly sensitive and selective biodetection. We report a single disposable chip which is capable of carrying out a multi-step process that employs nanoparticles--a bio-barcode assay (BCA) for single protein marker detection. To illustrate the capability of the system, we tested for the presence of prostate specific antigen (PSA) in buffer solution and goat serum. Detection was accomplished at PSA concentrations as low as 500 aM. This corresponds to only 300 copies of protein analytes using 1 microL total sample volume. We established that the on-chip BCA for PSA detection offers four orders of magnitude higher sensitivity compared to commercially available ELISA-based PSA tests.</abstract><notes>Goluch, Edgar D&#xD;Nam, Jwa-Min&#xD;Georganopoulou, Dimitra G&#xD;Chiesl, Thomas N&#xD;Shaikh, Kashan A&#xD;Ryu, Kee S&#xD;Barron, Annelise E&#xD;Mirkin, Chad A&#xD;Liu, Chang&#xD;5 r01 hg-0197002s1/hg/nhgri&#xD;Ai-03-017/ai/niaid&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2006 Oct;6(10):1293-9. Epub 2006 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17102842</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>5.068</custom4><electronic-resource-num>10.1039/b606294f</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>670</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">670</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Grover, W. H.</author><author>von Muhlen, M. G.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Teflon films for chemically-inert microfluidic valves and pumps</title><secondary-title>Lab Chip</secondary-title></titles><pages>913-8</pages><volume>8</volume><number>6</number><edition>2008/05/24</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>18497911</accession-num><abstract>We present a simple method for fabricating chemically-inert Teflon microfluidic valves and pumps in glass microfluidic devices. These structures are modeled after monolithic membrane valves and pumps that utilize a featureless polydimethylsiloxane (PDMS) membrane bonded between two etched glass wafers. The limited chemical compatibility of PDMS has necessitated research into alternative materials for microfluidic devices. Previous work has shown that spin-coated amorphous fluoropolymers and Teflon-fluoropolymer laminates can be fabricated and substituted for PDMS in monolithic membrane valves and pumps for space flight applications. However, the complex process for fabricating these spin-coated Teflon films and laminates may preclude their use in many research and manufacturing contexts. As an alternative, we show that commercially-available fluorinated ethylene-propylene (FEP) Teflon films can be used to fabricate chemically-inert monolithic membrane valves and pumps in glass microfluidic devices. The FEP Teflon valves and pumps presented here are simple to fabricate, function similarly to their PDMS counterparts, maintain their performance over extended use, and are resistant to virtually all chemicals. These structures should facilitate lab-on-a-chip research involving a vast array of chemistries that are incompatible with native PDMS microfluidic devices.</abstract><notes>Grover, William H&#xD;von Muhlen, Marcio G&#xD;Manalis, Scott R&#xD;P50-GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2008 Jun;8(6):913-8. Epub 2008 Apr 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18497911</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>5.068</custom4><electronic-resource-num>10.1039/b800600h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>448</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">448</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hunt, T. P.</author><author>Issadore, D.</author><author>Westervelt, R. M.</author></authors></contributors><auth-address>Department of Physics, Harvard University, 29 Oxford Street, Cambridge, MA 02138, USA.</auth-address><titles><title>Integrated circuit/microfluidic chip to programmably trap and move cells and droplets with dielectrophoresis</title><secondary-title>Lab Chip</secondary-title></titles><pages>81-7</pages><volume>8</volume><number>1</number><edition>2007/12/21</edition><keywords><keyword>Animals</keyword><keyword>Computer Simulation</keyword><keyword>Electronics/instrumentation/*methods</keyword><keyword>Electrophoresis/instrumentation/*methods</keyword><keyword>Macrophages, Alveolar/chemistry</keyword><keyword>Microfluidics/instrumentation/*methods</keyword><keyword>Models, Chemical</keyword><keyword>Motion</keyword><keyword>Rats</keyword><keyword>*Software</keyword><keyword>Yeasts/*cytology</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>18094765</accession-num><abstract>We present an integrated circuit/microfluidic chip that traps and moves individual living biological cells and chemical droplets along programmable paths using dielectrophoresis (DEP). Our chip combines the biocompatibility of microfluidics with the programmability and complexity of integrated circuits (ICs). The chip is capable of simultaneously and independently controlling the location of thousands of dielectric objects, such as cells and chemical droplets. The chip consists of an array of 128 x 256 pixels, 11 x 11 microm(2) in size, controlled by built-in SRAM memory; each pixel can be energized by a radio frequency (RF) voltage of up to 5 V(pp). The IC was built in a commercial foundry and the microfluidic chamber was fabricated on its top surface at Harvard. Using this hybrid chip, we have moved yeast and mammalian cells through a microfluidic chamber at speeds up to 30 microm sec(-1). Thousands of cells can be individually trapped and simultaneously positioned in controlled patterns. The chip can trap and move pL droplets of water in oil, split one droplet into two, and mix two droplets into one. Our IC/microfluidic chip provides a versatile platform to trap and move large numbers of cells and fluid droplets individually for lab-on-a-chip applications.</abstract><notes>Hunt, Thomas P&#xD;Issadore, David&#xD;Westervelt, R M&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2008 Jan;8(1):81-7. Epub 2007 Nov 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18094765</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>5.068</custom4><electronic-resource-num>10.1039/b710928h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>30</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">30</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H.</author><author>Liu, Y.</author><author>Ham, D.</author><author>Westervelt, R. M.</author></authors></contributors><auth-address>Department of Physics, Harvard University, Cambridge, MA 02138, USA.</auth-address><titles><title>Integrated cell manipulation system--CMOS/microfluidic hybrid</title><secondary-title>Lab Chip</secondary-title><alt-title>Lab on a chip</alt-title></titles><pages>331-7</pages><volume>7</volume><number>3</number><edition>2007/03</edition><keywords><keyword>Catalysis</keyword><keyword>Microfluidics/*instrumentation</keyword><keyword>Miniaturization</keyword><keyword>*Systems Integration</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>17330164</accession-num><abstract>Manipulation of biological cells using a CMOS/microfluidic hybrid system is demonstrated. The hybrid system starts with a custom-designed CMOS (complementary metal-oxide semiconductor) chip fabricated in a semiconductor foundry. A microfluidic channel is post-fabricated on top of the CMOS chip to provide biocompatible environments. The motion of individual biological cells that are tagged with magnetic beads is directly controlled by the CMOS chip that generates microscopic magnetic field patterns using an on-chip array of micro-electromagnets. Furthermore, the CMOS chip allows high-speed and programmable reconfiguration of the magnetic fields, substantially increasing the manipulation capability of the hybrid system. Extending from previous work that verified the concept of the hybrid system, this paper reports a set of manipulation experiments with biological cells, which further confirms the advantage of the hybrid approach. To enhance the biocompatibility of the system, the microfluidic channel is redesigned and the temperature of the device is monitored by on-chip sensors. Combining microelectronics and microfluidics, the CMOS/microfluidic hybrid system presents a new model for a cell manipulation platform in biological and biomedical applications.</abstract><notes>Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17330164 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>5.068</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>510</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">510</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Y. C.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Pre-binding dynamic range and sensitivity enhancement for immuno-sensors using nanofluidic preconcentrator</title><secondary-title>Lab Chip</secondary-title></titles><pages>392-4</pages><volume>8</volume><number>3</number><edition>2008/02/29</edition><keywords><keyword>Binding Sites</keyword><keyword>Immunoassay/*instrumentation</keyword><keyword>Kinetics</keyword><keyword>Microfluidics/*instrumentation</keyword><keyword>*Nanotechnology</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>18305855</accession-num><abstract>Almost all immuno-biosensors are inherently limited by the quality of antibodies available for the target molecule, and obtaining a highly sensitive antibody for a given target molecule is a challenge. We describe a highly efficient and flexible way to enhance immunoassay detection sensitivity and binding kinetics using a nanofluidic based electrokinetic preconcentrator. The device is a microfluidic integration of charge-based biomolecule concentrator and a bead-based immunoassay. Because the preconcentrator can increase the local biomolecule concentration by many orders of magnitude, it gives the immuno-sensor better sensitivity and faster binding kinetics. With a 30 min preconcentration, we were able to enhance the immunoassay sensitivity (with molecular background) by more than 500 fold from higher 50 pM to the sub 100 fM range. Moreover, by adjusting the preconcentration time, we can switch the detection range of the given bead-based assay (from 10-10 000 ng ml(-1) to 0.01-10 000 ng ml(-1)) to have a broader dynamic range of detection. As the system can enhance both detection sensitivity and dynamic range, it can be used to address the most critical detection issues in the detection of common disease biomarkers.</abstract><notes>Wang, Ying-Chih&#xD;Han, Jongyoon&#xD;CA119402/CA/United States NCI&#xD;EB005743/EB/United States NIBIB&#xD;GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2008 Mar;8(3):392-4. Epub 2008 Jan 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18305855</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2008</custom3><custom4>5.068</custom4><electronic-resource-num>10.1039/b717220f</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>324</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">324</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yezhelyev, M. V.</author><author>Gao, X.</author><author>Xing, Y.</author><author>Al-Hajj, A.</author><author>Nie, S.</author><author>O&apos;Regan, R. M.</author></authors></contributors><auth-address>Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.</auth-address><titles><title>Emerging use of nanoparticles in diagnosis and treatment of breast cancer</title><secondary-title>Lancet Oncol</secondary-title></titles><pages>657-67</pages><volume>7</volume><number>8</number><edition>2006/08/05</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>Breast Neoplasms/*diagnosis/*drug therapy</keyword><keyword>Diagnostic Imaging</keyword><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization, Fluorescence</keyword><keyword>Liposomes</keyword><keyword>*Nanostructures</keyword><keyword>Tumor Markers, Biological/analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1470-2045 (Print)</isbn><accession-num>16887483</accession-num><abstract>The biological application of nanoparticles is a rapidly developing area of nanotechnology that raises new possibilities in the diagnosis and treatment of human cancers. In cancer diagnostics, fluorescent nanoparticles can be used for multiplex simultaneous profiling of tumour biomarkers and for detection of multiple genes and matrix RNA with fluorescent in-situ hybridisation. In breast cancer, three crucial biomarkers can be detected and accurately quantified in single tumour sections by use of nanoparticles conjugated to antibodies. In the near future, the use of conjugated nanoparticles will allow at least ten cancer-related proteins to be detected on tiny tumour sections, providing a new method of analysing the proteome of an individual tumour. Supermagnetic nanoparticles have exciting possibilities as contrast agents for cancer detection in vivo, and for monitoring the response to treatment. Several chemotherapy agents are available as nanoparticle formulations, and have at least equivalent efficacy and fewer toxic effects compared with conventional formulations. Ultimately, the use of nanoparticles will allow simultaneous tumour targeting and drug delivery in a unique manner. In this review, we give an overview of the use of clinically applicable nanoparticles in oncology, with particular focus on the diagnosis and treatment of breast cancer.</abstract><notes>Yezhelyev, Maksym V&#xD;Gao, Xiaohu&#xD;Xing, Yun&#xD;Al-Hajj, Ahmad&#xD;Nie, Shuming&#xD;O&apos;Regan, Ruth M&#xD;1 u54 ca119338-0/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;The lancet oncology&#xD;Lancet Oncol. 2006 Aug;7(8):657-67.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16887483</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>10.119</custom4><electronic-resource-num>S1470-2045(06)70793-8 [pii]&#xD;10.1016/S1470-2045(06)70793-8</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>595</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">595</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Herlihy, K. P.</author><author>Nunes, J.</author><author>Desimone, J. M.</author></authors></contributors><auth-address>desimone@unc.edu.</auth-address><titles><title>Electrically Driven Alignment and Crystallization of Unique Anisotropic Polymer Particles</title><secondary-title>Langmuir</secondary-title></titles><edition>2008/07/24</edition><dates><year>2008</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>18646784</accession-num><abstract>Micrometer-sized monodisperse anisotropic polymer particles, with disk, rod, fenestrated hexagon (hexnut), and boomerang shapes, were synthesized using the particle replication in nonwetting templates (PRINT) process, and investigations were conducted on aqueous suspensions of these particles when subjected to alternating electric fields. A coplanar electrode configuration, with 1 to 2 mm electrode gaps (20-50 V ac, 0.5-5.0 kHz) was used, and the experiments were monitored with fluorescence microscopy. For all particle suspensions, the field brought about significant changes in the packing and orientation. Extensive particle chaining and packing were observed for the disk, rod, and hexnut suspensions. Because of the size and geometry of the boomerang particles, limited chaining was observed; however, the field triggered a change from random to a more ordered packing arrangement.</abstract><notes>Journal article&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2008 Jul 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18646784</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>4.009</custom4><electronic-resource-num>10.1021/la801250g</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>141</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">141</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kowalczyk, J.</author><author>Barski, P.</author><author>Witt, D.</author><author>Grzybowski, B. A.</author></authors></contributors><auth-address>ProChimia Surfaces, ul. Zacisze 2, 81-823 Sopot, Poland.</auth-address><titles><title>Versatile and efficient synthesis of omega-functionalized asymmetric disulfides via sulfenyl bromide adducts</title><secondary-title>Langmuir</secondary-title></titles><pages>2318-21</pages><volume>23</volume><number>5</number><edition>2007/01/26</edition><keywords><keyword>Bromides/*chemistry</keyword><keyword>Catalysis</keyword><keyword>Chemistry, Physical/*methods</keyword><keyword>Disulfides/*chemistry</keyword><keyword>Electrochemistry/methods</keyword><keyword>Models, Chemical</keyword><keyword>Molecular Structure</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 27</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>17249705</accession-num><abstract>Various types of asymmetric disulfides can be synthesized under mild conditions and in excellent yields by a method involving dialkoxylthiophosphoranesulfenyl halide precursors. This straightforward, rapid procedure is used to prepare a series of disulfides bearing neutral, acidic, and basic terminal groups as well as groups commonly used in biospecific self-assembled monolayers.</abstract><notes>Kowalczyk, Janusz&#xD;Barski, Piotr&#xD;Witt, Dariusz&#xD;Grzybowski, Bartosz A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2007 Feb 27;23(5):2318-21. Epub 2007 Jan 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17249705</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>3.902</custom4><electronic-resource-num>10.1021/la063013k</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>20</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">20</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, M. P.</author><author>Derfus, A. M.</author><author>Alvarez, S. D.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California-San Diego, 9500 Gilman Drive, Department 0358, La Jolla, CA 92093-0358, USA.</auth-address><titles><title>The smart Petri dish: a nanostructured photonic crystal for real-time monitoring of living cells</title><secondary-title>Langmuir</secondary-title></titles><pages>7084-90</pages><volume>22</volume><number>16</number><edition>2006/08</edition><keywords><keyword>Animals</keyword><keyword>*Cell Culture Techniques/instrumentation</keyword><keyword>Cell Survival</keyword><keyword>Cells, Cultured</keyword><keyword>Hepatocytes/*cytology</keyword><keyword>Oxygen</keyword><keyword>*Photons</keyword><keyword>Rats</keyword><keyword>Rats, Inbred Lew</keyword><keyword>Spectrophotometry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>16863264</accession-num><abstract>The intensity of light scattered from a porous Si photonic crystal is used to monitor physiological changes in primary rat hepatocytes. The cells are seeded on the surface of a porous Si photonic crystal that has been filled with polystyrene and treated with an O2 plasma. Light resonant with the photonic crystal is scattered by the cell layer and detected as an optical peak with a charge-coupled-device spectrometer. It is demonstrated that exposure of hepatocytes to the toxins cadmium chloride or acetaminophen leads to morphology changes that cause a measurable increase in scattered intensity. The increase in signal occurs before traditional assays are able to detect a decrease in viability, demonstrating the potential of the technique as a complementary tool for cell viability studies. The scattering method presented here is noninvasive and can be performed in real time, representing a significant advantage compared to other techniques for in vitro monitoring of cell morphology.</abstract><notes>N01 co 37117/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;the ACS journal of surfaces and colloids</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16863264 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2006</custom3><custom4>3.902</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>398</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">398</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tison, C. K.</author><author>Milam, V. T.</author></authors></contributors><auth-address>School of Materials Science &amp; Engineering, Georgia Institute of Technology, 771 Ferst Dr. NW, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Reversing DNA-mediated adhesion at a fixed temperature</title><secondary-title>Langmuir</secondary-title></titles><pages>9728-36</pages><volume>23</volume><number>19</number><edition>2007/08/19</edition><keywords><keyword>Colloids/*chemistry</keyword><keyword>DNA/*chemistry</keyword><keyword>Microscopy, Confocal</keyword><keyword>Microspheres</keyword><keyword>Models, Biological</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>*Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 11</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>17696456</accession-num><abstract>Recognition-based assembly of micron- to nano-sized colloidal particles functionalized with DNA has generated great interest in the past decade; however, reversing the assembly process is typically achieved by thermal denaturation of the oligonucleotide duplexes. Here, we report an alternative disassembly approach at a fixed temperature using competitive hybridization events between immobilized and soluble oligonucleotide strands. Microspheres are first aggregated via primary hybridization events between immobilized DNA strands with a weak, but sufficient, affinity for partner strands to link complementary surfaces together. To reverse the aggregation process, soluble oligonucleotides are then added to competitively displace the original hybridization partners through secondary hybridization events. Using flow cytometry to quantify hybridization events and microscopy to examine DNA-mediated aggregation and redispersion, we found that the efficiency of competitive displacement is based upon (1) the difference in base pair matches between the primary and secondary target for the same probe sequence and (2) the concentration of hybridizing oligonucleotides participating in microsphere aggregation. To the best of our knowledge, this study is the first to employ DNA hybridization events to mediate reversible adhesion between colloidal particles at a fixed temperature.</abstract><notes>Tison, Christopher K&#xD;Milam, Valeria T&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2007 Sep 11;23(19):9728-36. Epub 2007 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17696456</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>4.009</custom4><electronic-resource-num>10.1021/la700601j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>654</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">654</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westcott, N. P.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Synergistic microfluidic and electrochemical strategy to activate and pattern surfaces selectively with ligands and cells</title><secondary-title>Langmuir</secondary-title></titles><pages>2261-5</pages><volume>24</volume><number>6</number><edition>2008/02/19</edition><keywords><keyword>3T3 Cells</keyword><keyword>Amines/chemical synthesis/*chemistry</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cells, Cultured</keyword><keyword>Electrochemistry</keyword><keyword>Electrolytes/chemistry</keyword><keyword>Fibroblasts/*chemistry</keyword><keyword>Hydroquinones/chemical synthesis/*chemistry</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Microfluidics/instrumentation/*methods</keyword><keyword>Particle Size</keyword><keyword>Quinones/*chemistry</keyword><keyword>Solutions/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 18</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>18278968</accession-num><abstract>We show a straightforward, flexible synergistic approach that combines microfluidics, electrochemistry, and a general immobilization strategy to activate regions of a substrate selectively for the precise immobilization of ligands and cells in patterns for a variety of cell-based assays and cell migration and cell adhesion studies. We develop microfluidic microchips to control the delivery of electrolyte solution to select regions of an electroactive hydroquinone SAM. Once an electrical potential is applied to the substrate, only the hydroquinone exposed to electrolyte solution within the microfluidic channels oxidizes to the corresponding quinone. The quinone form can then react chemoselectively with oxyamine-tethered ligands to pattern the surface. Therefore, this microfluidic/electrochemistry strategy selectively activates the surface for ligand patterning that exactly matches the channel design of the microfluidic channel. We demonstrate the ease of this system by first quantitatively characterizing the electrochemical activation and immobilization of ligands on the surface. Second, we immobilize a fluorescent dye to show the fidelity of the methodology, and third, we show the immobilization of biospecific cell adhesive peptide ligands to pattern cells. This is the first report that combines microfluidics/electrochemistry and a general electroactive immobilization strategy to pattern ligands and cells. We believe that this strategy will be of broad utility for applications ranging from fundamental studies of cell behavior to patterning molecules on a variety of materials for molecular electronic devices.</abstract><notes>Westcott, Nathan P&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2008 Mar 18;24(6):2261-5. Epub 2008 Feb 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18278968</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>4.009</custom4><electronic-resource-num>10.1021/la703744v</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>143</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yeo, W. S.</author><author>Mrksich, M.</author></authors></contributors><auth-address>Department of Chemistry and Howard Hughes Medical Institute, The University of Chicago, 929 East 57th Street, Chicago, Illinois 60637, USA.</auth-address><titles><title>Electroactive self-assembled monolayers that permit orthogonal control over the adhesion of cells to patterned substrates</title><secondary-title>Langmuir</secondary-title></titles><pages>10816-20</pages><volume>22</volume><number>25</number><edition>2006/11/30</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion/physiology</keyword><keyword>Electrochemistry</keyword><keyword>Esters/chemical synthesis/*chemistry</keyword><keyword>Fibroblasts/*chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Ligands</keyword><keyword>*Membranes, Artificial</keyword><keyword>Mice</keyword><keyword>Molecular Structure</keyword><keyword>Particle Size</keyword><keyword>Quinones/chemical synthesis/*chemistry</keyword><keyword>Structure-Activity Relationship</keyword><keyword>Surface Properties</keyword><keyword>Swiss 3T3 Cells</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 5</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>17129065</accession-num><abstract>This article describes an electroactive substrate that displays two independent dynamic functions for controlling the adhesion of cells. The approach is based on self-assembled monolayers on gold that are patterned into regions presenting the Arg-Gly-Asp peptide cell adhesion ligand. The patterned regions differ in the electrochemical properties of the linkers that tether the peptides to the monolayer. In this work, three distinct chemistries are employed that provide for release of the ligand on application of a negative potential, release of the ligand on application of a positive potential, and no change in response to a potential. Cells were allowed to attach to a monolayer patterned into circular regions comprising the three chemistries. Treatment with electric potentials of 650 or -650 mV resulted in the selective release of adherent cells only from regions that display the relevant electroactive groups. This example establishes the preparation of dynamic substrates with multiple functions and will be important to preparing model cultures derived from multiple cell types, with control over the temporal interactions of each cell population.</abstract><notes>Yeo, Woon-Seok&#xD;Mrksich, Milan&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2006 Dec 5;22(25):10816-20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17129065</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>3.902</custom4><electronic-resource-num>10.1021/la061212y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>308</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">308</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, L.</author><author>Zhou, Z.</author><author>Cheng, B.</author><author>Desimone, J. M.</author><author>Samulski, E. T.</author></authors></contributors><auth-address>Curriculum in Applied and Materials Sciences and Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Superhydrophobic behavior of a perfluoropolyether lotus-leaf-like topography</title><secondary-title>Langmuir</secondary-title></titles><pages>8576-80</pages><volume>22</volume><number>20</number><edition>2006/09/20</edition><keywords><keyword>Aluminum Oxide/*chemistry</keyword><keyword>Ethers/*chemistry</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>*Membranes, Artificial</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 26</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>16981778</accession-num><abstract>We demonstrate the fabrication of 2-D arrays of nanopillars made from perfluoropolyether derivatives using a porous anodic aluminum oxide membrane as a template. Pretexturing the aluminum prior to anodization enables one to engineer multiple morphological length scales and thereby synthesize a lotus-leaf-like topography. Both nanopillars on a flat surface and on a lotus-leaf-like topology exhibit superhydrophobicity, low contact angle hysteresis, and self-cleaning.</abstract><notes>Zhang, Lei&#xD;Zhou, Zhilian&#xD;Cheng, Bin&#xD;Desimone, Joseph M&#xD;Samulski, Edward T&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2006 Sep 26;22(20):8576-80.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16981778</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>3.902</custom4><electronic-resource-num>10.1021/la061400o</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>659</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">659</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, X.</author><author>Jain, P. K.</author><author>El-Sayed, I. H.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, 30332-0400, USA.</auth-address><titles><title>Plasmonic photothermal therapy (PPTT) using gold nanoparticles</title><secondary-title>Lasers Med Sci</secondary-title></titles><pages>217-28</pages><volume>23</volume><number>3</number><edition>2007/08/04</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0268-8921 (Print)</isbn><accession-num>17674122</accession-num><abstract>The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy modalities, most commonly the photothermal therapy method, which employs light absorbing dyes for achieving the photothermal damage of tumors, and the photodynamic therapy, which employs chemical photosensitizers that generate singlet oxygen that is capable of tumor destruction. However, recent advances in the field of nanoscience have seen the emergence of noble metal nanostructures with unique photophysical properties, well suited for applications in cancer phototherapy. Noble metal nanoparticles, on account of the phenomenon of surface plasmon resonance, possess strongly enhanced visible and near-infrared light absorption, several orders of magnitude more intense compared to conventional laser phototherapy agents. The use of plasmonic nanoparticles as highly enhanced photoabsorbing agents has thus introduced a much more selective and efficient cancer therapy strategy, viz. plasmonic photothermal therapy (PPTT). The synthetic tunability of the optothermal properties and the bio-targeting abilities of the plasmonic gold nanostructures make the PPTT method furthermore promising. In this review, we discuss the development of the PPTT method with special emphasis on the recent in vitro and in vivo success using gold nanospheres coupled with visible lasers and gold nanorods and silica-gold nanoshells coupled with near-infrared lasers.</abstract><notes>Huang, Xiaohua&#xD;Jain, Prashant K&#xD;El-Sayed, Ivan H&#xD;El-Sayed, Mostafa A&#xD;England&#xD;Lasers in medical science&#xD;Lasers Med Sci. 2008 Jul;23(3):217-28. Epub 2007 Aug 3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17674122</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>0.827</custom4><electronic-resource-num>10.1007/s10103-007-0470-x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>575</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">575</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, J.</author><author>Wang, Q.</author><author>Zhang, H.</author><author>Yang, X.</author><author>Wang, J.</author><author>Berkowitz, B. A.</author><author>Wickline, S. A.</author><author>Song, S. K.</author></authors></contributors><auth-address>Department of Medicine, Washington University, St. Louis, Missouri, USA.</auth-address><titles><title>In vivo quantification of T1, T2, and apparent diffusion coefficient in the mouse retina at 11.74T</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>731-8</pages><volume>59</volume><number>4</number><edition>2008/04/03</edition><keywords><keyword>*Algorithms</keyword><keyword>Animals</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Reproducibility of Results</keyword><keyword>Retina/*cytology</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>18383302</accession-num><abstract>MRI has recently been used for noninvasive examination of retinal structure and function in rats and cats. However, the advantages of quantitative high-resolution MRI of retina from mice have not yet been explored. In the present study, T(1) and T(2) relaxation time constants and the directional apparent diffusion coefficient (ADC) in the retina of C57/BL6 mice were measured. Three MR-detected retina layers and a MR-detected choroid layer were observed on both T(1)- and T(2)-weighted images at an image resolution of 47 x 47 x 400 microm(3). The significantly higher ADC parallel to than that perpendicular to the optic nerve in the MR-detected outer retina layer at the central retina reflects the known cellular organization of the photoreceptor cells. This study establishes, for the first time, normative metrics of T(1), T(2), and ADC of the mouse retina. These MR parameters are expected to be useful in future evaluation of developmental and pathological alterations of retinal cell layers in mice.</abstract><notes>Chen, Junjie&#xD;Wang, Qing&#xD;Zhang, Huiying&#xD;Yang, Xiaoxia&#xD;Wang, Jian&#xD;Berkowitz, Bruce A&#xD;Wickline, Samuel A&#xD;Song, Sheng-Kwei&#xD;CA 119342/CA/United States NCI&#xD;EY018109/EY/United States NEI&#xD;HL073646/HL/United States NHLBI&#xD;R24-CA83060/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2008 Apr;59(4):731-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18383302</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>3.427</custom4><electronic-resource-num>10.1002/mrm.21570</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>458</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">458</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cilliers, R.</author><author>Song, Y.</author><author>Kohlmeir, E. K.</author><author>Larson, A. C.</author><author>Omary, R. A.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois, USA.</auth-address><titles><title>Modification of embolic-PVA particles with MR contrast agents</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>898-902</pages><volume>59</volume><number>4</number><edition>2008/04/03</edition><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>18383280</accession-num><abstract>We report the synthesis and characterization of polyvinyl alcohol (PVA) embolic particles modified with a clinically approved magnetic resonance (MR) contrast agent. PVA particles are used during transcatheter arterial embolization (TAE) procedures and this minimally invasive technique is a widely employed treatment for inoperable tumors. The PVA particles are injected into tumor vessels and prevent blood flow which results in tumor attenuation. An accurate assessment of the endpoint of embolization is critical to successful TAE procedures. Recent reports suggest that 20% of endpoint determination of TAE procedures by angiographic techniques are erroneous. Real time, in vivo imaging of the embolic particles would overcome this limitation. The contrast-modified PVA particles described here show an 80% decrease in T(1) relaxation times compared to unmodified particles. Images of particles in capillary tubes of similar size to catheters used in TAE procedures are clearly visible by MRI.</abstract><notes>Cilliers, Renee&#xD;Song, Ying&#xD;Kohlmeir, Ellen K&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;Meade, Thomas J&#xD;CA119341/CA/United States NCI&#xD;R01 EB005866/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2008 Apr;59(4):898-902.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18383280</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.427</custom4><electronic-resource-num>10.1002/mrm.21518</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>629</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">629</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hong, R.</author><author>Cima, M. J.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Harvard Medical School, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.</auth-address><titles><title>Magnetic microparticle aggregation for viscosity determination by MR</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>515-20</pages><volume>59</volume><number>3</number><edition>2008/02/29</edition><keywords><keyword>Contrast Media/chemistry</keyword><keyword>Ferrosoferric Oxide/chemistry</keyword><keyword>Iron/*chemistry</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oxides/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Viscosity</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>18306403</accession-num><abstract>Micron-sized magnetic particles were induced to aggregate when placed in homogeneous magnetic fields, like those of MR imagers and relaxometers, and then spontaneously returned to their dispersed state when removed from the field. Associated with the aggregation and dispersion of the magnetic particles were time-dependent increases and decreases in the spin-spin relaxation time (T2) of the water. Magnetic nanoparticles, with far smaller magnetic moments per particle, did not undergo magnetically induced aggregation and exhibited time-independent values of T2. The rate of T2 change associated with magnetic microparticle aggregation was used to determine the viscosity of liquid samples, providing a method that can be of particular advantage for determining the viscosity of small volumes of potentially biohazardous samples of blood or blood plasma.</abstract><notes>Hong, Rui&#xD;Cima, Michael J&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;R01-EB004626/EB/United States NIBIB&#xD;R01-EB00662/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2008 Mar;59(3):515-20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18306403</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>3.427</custom4><electronic-resource-num>10.1002/mrm.21526</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>716</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">716</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Neubauer, M.</author><author>Caruthers, S.D.</author><author>Hockett, F.D.</author><author>Winter, P.M.</author><author>Chen J, </author><author>Gaffney PJ, </author><author>Robertson JD, </author><author>Lanza GM, </author><author>Wickline SA. </author></authors></contributors><titles><title>Tunable perfluorocarbon nanoparticles for molecular imaging using gadolinium-modulated 19F signals</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>3.427</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>717</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">717</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ruiz-Cabello, J.</author><author>Walczak P, </author><author>Kedziorek DA, </author><author>Chacko VP, </author><author>Schmieder AH, </author><author>Wickline SA, </author><author>Lanza GM, </author><author>Bulte JWM</author></authors></contributors><titles><title>In Vivo “Hot Spot” MR Imaging of Neural Stem Cells using Fluorinated Nanoparticles</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>3.427</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>719</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">719</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seo, S.I.</author><author>Gera, L.</author><author>Zhau, H.E.</author><author>Qian, W.P.</author><author>Iqbal, S.</author><author>Johnson, N.A.</author><author>Zhang, S.</author><author>Zayzafoon, M.</author><author>Stewart, J.</author><author>Chung, L.W.K.</author><author>Wu, D.</author></authors></contributors><titles><title>BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells through the inhibition of survivin expression</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>3.427</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>723</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">723</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, D.</author><author>Bangash, A.</author><author>Rhee, T.</author><author>Woloschak, G.</author><author>Paunesku, T.</author><author>Salem, R.</author><author>Omary, R.</author><author>Larson, A</author></authors></contributors><titles><title>Fourdimensional Transcatheter Intra-arterial Perfusion (TRIP)-MRI for Monitoring Liver Tumor Embolization in VX2 Rabbits</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.427</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>175</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">175</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Cai, K.</author><author>Chen, J.</author><author>Adair, C. R.</author><author>Kiefer, G. E.</author><author>Athey, P. S.</author><author>Gaffney, P. J.</author><author>Buff, C. E.</author><author>Robertson, J. D.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Cardiovascular Division, Washington University, St. Louis, Missouri 63108, USA. patrick@cvu.wustl.edu</auth-address><titles><title>Targeted PARACEST nanoparticle contrast agent for the detection of fibrin</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>1384-8</pages><volume>56</volume><number>6</number><edition>2006/11/08</edition><keywords><keyword>Contrast Media/analysis/*chemistry</keyword><keyword>Fibrin/*analysis/*chemistry</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Magnetic Resonance Spectroscopy/*methods</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Particle Size</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>17089356</accession-num><abstract>A lipid-encapsulated perfluorocarbon nanoparticle molecular imaging contrast agent that utilizes a paramagnetic chemical exchange saturation transfer (PARACEST) chelate is presented. PARACEST agents are ideally suited for molecular imaging applications because one can switch the contrast on and off at will simply by adjusting the pulse sequence parameters. This obviates the need for pre- and postinjection images to define contrast agent binding. Spectroscopy (4.7T) of PARACEST nanoparticles revealed a bound water peak at 52 ppm, in agreement with results from the water-soluble chelate. Imaging of control nanoparticles showed no appreciable contrast, while PARACEST nanoparticles produced &gt;10% signal enhancement. PARACEST nanoparticles were targeted to clots via antifibrin antibodies and produced a contrast-to-noise ratio (CNR) of 10 at the clot surface.</abstract><notes>Winter, Patrick M&#xD;Cai, Kejia&#xD;Chen, Junjie&#xD;Adair, Christopher R&#xD;Kiefer, Garry E&#xD;Athey, Phillip S&#xD;Gaffney, Patrick J&#xD;Buff, Carolyn E&#xD;Robertson, J David&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Co-07121/co/nci&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2006 Dec;56(6):1384-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17089356</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>3.427</custom4><electronic-resource-num>10.1002/mrm.21093</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>495</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">495</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hodgson, L.</author><author>Pertz, O.</author><author>Hahn, K. M.</author></authors></contributors><auth-address>Department of Pharmacology, Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Design and optimization of genetically encoded fluorescent biosensors: GTPase biosensors</title><secondary-title>Methods Cell Biol</secondary-title></titles><pages>63-81</pages><volume>85</volume><edition>2007/12/25</edition><keywords><keyword>Base Sequence</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Cell Line</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>*GTP Phosphohydrolases</keyword><keyword>*Green Fluorescent Proteins</keyword><keyword>Humans</keyword><keyword>Molecular Sequence Data</keyword><keyword>Protein Engineering</keyword><keyword>Recombinant Fusion Proteins</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0091-679X (Print)</isbn><accession-num>18155459</accession-num><abstract>This chapter details the design and optimization of biosensors based on a design used successfully to study nucleotide loading of small GTPase proteins in living cells. This design can be generalized to study many other protein activities, using a single, genetically encoded chain incorporating the protein to be studied, an &quot;affinity reagent&quot; which binds only to the activated form of the targeted protein, and mutants of the green fluorescent protein (GFP) that undergo fluorescence resonance energy transfer (FRET). Specific topics include procedures and caveats in the design and cloning of single-chain FRET sensors, in vitro and in vivo validation, expression in living cell systems for biological studies, and some general considerations in quantitative fluorescence imaging.</abstract><notes>Hodgson, Louis&#xD;Pertz, Olivier&#xD;Hahn, Klaus M&#xD;United States&#xD;Methods in cell biology&#xD;Methods Cell Biol. 2008;85:63-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18155459</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>1.582</custom4><electronic-resource-num>S0091-679X(08)85004-2 [pii]&#xD;10.1016/S0091-679X(08)85004-2</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>277</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">277</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hodgson, L.</author><author>Nalbant, P.</author><author>Shen, F.</author><author>Hahn, K.</author></authors></contributors><auth-address>Department of Pharmacology, University of North Carolina, Chapel Hill, USA.</auth-address><titles><title>Imaging and photobleach correction of Mero-CBD, sensor of endogenous Cdc42 activation</title><secondary-title>Methods Enzymol</secondary-title></titles><pages>140-56</pages><volume>406</volume><edition>2006/02/14</edition><keywords><keyword>Biosensing Techniques/*methods</keyword><keyword>*Cell Movement</keyword><keyword>Fluorescence Recovery After Photobleaching/*methods</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Peptide Fragments/chemistry</keyword><keyword>Pyrimidinones/chemistry</keyword><keyword>Software</keyword><keyword>Wiskott-Aldrich Syndrome Protein/chemistry</keyword><keyword>cdc42 GTP-Binding Protein/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0076-6879 (Print)</isbn><accession-num>16472656</accession-num><abstract>This chapter details quantitative imaging of the Mero-CBD biosensor, which reports activation of endogenous Cdc42 in living cells. The procedures described are appropriate for imaging any biosensor that uses two different fluorophores on a single molecule, including FRET biosensors. Of particular interest is an algorithm to correct for fluorophore photobleaching, useful when quantitating activity changes over time. Specific topics include procedures and caveats in production of the Mero-CBD sensor, image acquisition, motion artifacts, shading correction, background subtraction, registration, and ratio imaging.</abstract><notes>Hodgson, Louis&#xD;Nalbant, Perihan&#xD;Shen, Feimo&#xD;Hahn, Klaus&#xD;United States&#xD;Methods in enzymology&#xD;Methods Enzymol. 2006;406:140-56.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16472656</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>1.64</custom4><electronic-resource-num>S0076-6879(06)06012-5 [pii]&#xD;10.1016/S0076-6879(06)06012-5</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>302</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">302</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shen, F.</author><author>Hodgson, L.</author><author>Hahn, K.</author></authors></contributors><auth-address>Department of Pharmacology, Linebarger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</auth-address><titles><title>Digital autofocus methods for automated microscopy</title><secondary-title>Methods Enzymol</secondary-title></titles><pages>620-32</pages><volume>414</volume><edition>2006/11/18</edition><keywords><keyword>Algorithms</keyword><keyword>Automation</keyword><keyword>Computational Biology/methods</keyword><keyword>Computers</keyword><keyword>Image Processing, Computer-Assisted/instrumentation/*methods</keyword><keyword>Microscopy/methods</keyword><keyword>Microscopy, Fluorescence/*instrumentation/*methods</keyword><keyword>Models, Statistical</keyword><keyword>Programming Languages</keyword><keyword>Software</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0076-6879 (Print)</isbn><accession-num>17110214</accession-num><abstract>Automatic focusing of microscope images is an essential part of modern high-throughput microscopy. This chapter describes implementation of a robust autofocus system appropriate for using either air or oil immersion objectives in robotic imaging. Both hardware and software algorithms are described, and caveats of using viscous immersion media with multifield scanning are detailed.</abstract><notes>Shen, Feimo&#xD;Hodgson, Louis&#xD;Hahn, Klaus&#xD;Review&#xD;United States&#xD;Methods in enzymology&#xD;Methods Enzymol. 2006;414:620-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17110214</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>1.64</custom4><electronic-resource-num>S0076-6879(06)14032-X [pii]&#xD;10.1016/S0076-6879(06)14032-X</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>165</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">165</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caruthers, S. D.</author><author>Winter, P. M.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Cardiovascular MR Labs, Division of Cardiology, Washington University, St. Louis, Missouri, USA.</auth-address><titles><title>Targeted magnetic resonance imaging contrast agents</title><secondary-title>Methods Mol Med</secondary-title></titles><pages>387-400</pages><volume>124</volume><edition>2006/03/02</edition><keywords><keyword>Contrast Media/*administration &amp; dosage</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>March</date></pub-dates></dates><isbn>1543-1894 (Print)</isbn><accession-num>16506431</accession-num><abstract>The era of personalized medicine is emerging as physicians attempt to diagnose disease in asymptomatic individuals and treat pathology early in its natural history. A novel tool in an emerging armamentarium, molecular imaging will allow noninvasive characterization and segmentation of patients for delivering custom-tailored therapy. Nanoparticulate agents, such as superparamagnetic agents, liposomes, perfluorocarbon nanoparticle emulsions, and dendrimers, are being intensively researched as formulation platforms for various targeted clinical applications. As exemplified by perfluorocarbon nanoparticles, these new agents, in combination with the rapid innovations in imaging hardware and software, will allow the emergence of new medical diagnostic and therapeutic paradigms.</abstract><notes>Caruthers, Shelton D&#xD;Winter, Patrick M&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Review&#xD;United States&#xD;Methods in molecular medicine&#xD;Methods Mol Med. 2006;124:387-400.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16506431</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>na</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>615</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">615</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Y.</author><author>Boukhelifa, M.</author><author>Tribble, E.</author><author>Morin-Kensicki, E.</author><author>Uetrecht, A.</author><author>Bear, J. E.</author><author>Bankaitis, V. A.</author></authors></contributors><auth-address>Department of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7090.</auth-address><titles><title>The sac1 phosphoinositide phosphatase regulates Golgi membrane morphology and mitotic spindle organization in mammals</title><secondary-title>Mol Biol Cell</secondary-title></titles><pages>3080-96</pages><volume>19</volume><number>7</number><edition>2008/05/16</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1059-1524 (Print)</isbn><accession-num>18480408</accession-num><abstract>Phosphoinositides (PIPs) are ubiquitous regulators of signal transduction events in eukaryotic cells. PIPs are degraded by various enzymes, including PIP phosphatases. The integral membrane Sac1 phosphatases represent a major class of such enzymes. The central role of lipid phosphatases in regulating PIP homeostasis notwithstanding, the biological functions of Sac1-phosphatases remain poorly characterized. Herein, we demonstrate that functional ablation of the single murine Sac1 results in preimplantation lethality in the mouse and that Sac1 insufficiencies result in disorganization of mammalian Golgi membranes and mitotic defects characterized by multiple mechanically active spindles. Complementation experiments demonstrate mutant mammalian Sac1 proteins individually defective in either phosphoinositide phosphatase activity, or in recycling of the enzyme from the Golgi system back to the endoplasmic reticulum, are nonfunctional proteins in vivo. The data indicate Sac1 executes an essential household function in mammals that involves organization of both Golgi membranes and mitotic spindles and that both enzymatic activity and endoplasmic reticulum localization are important Sac1 functional properties.</abstract><notes>Liu, Yang&#xD;Boukhelifa, Malika&#xD;Tribble, Emily&#xD;Morin-Kensicki, Elizabeth&#xD;Uetrecht, Andrea&#xD;Bear, James E&#xD;Bankaitis, Vytas A&#xD;United States&#xD;Molecular biology of the cell&#xD;Mol Biol Cell. 2008 Jul;19(7):3080-96. Epub 2008 May 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18480408</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>6.420</custom4><electronic-resource-num>E07-12-1290 [pii]&#xD;10.1091/mbc.E07-12-1290</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>573</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">573</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>A photo-electroactive surface strategy for immobilizing ligands in patterns and gradients for studies of cell polarization</title><secondary-title>Mol Biosyst</secondary-title></titles><pages>746-53</pages><volume>4</volume><number>7</number><edition>2008/06/20</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1742-2051 (Electronic)</isbn><accession-num>18563249</accession-num><abstract>We report a combined photochemical and electrochemical method to pattern ligands and cells in complex geometries and gradients on inert surfaces. This work demonstrates: (1) the control of density of immobilized ligands within overlapping photopatterns, and (2) the attached cell culture patterned onto ligand defined gradients for studies of directional cell polarity. Our approach is based on the photochemical activation of benzoquinonealkanethiols. Immobilization of aminooxy terminated ligands in selected region of the quinone monolayer resulted in patterns on the surface. This approach is unique in that the extent of photochemical deprotection, as well as ligand immobilization can be monitored and quantified by cyclic voltammetry in situ. Furthermore, complex photochemical patterns of single or multiple ligands can be routinely generated using photolithographic masks. Finally, this methodology is completely compatible with attached cell culture and we show how the subtle interplay between cell-cell interactions and underlying peptide gradient influences cell polarization. The combined use of photochemistry, electrochemistry and well defined surface chemistry provides molecular level control of patterned ligands and gradients on surfaces.</abstract><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Molecular bioSystems&#xD;Mol Biosyst. 2008 Jul;4(7):746-53. Epub 2008 May 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18563249</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>4.121</custom4><electronic-resource-num>10.1039/b801394b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>200</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">200</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Rao, J.</author><author>Gambhir, S. S.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Road, P095, Stanford, CA 94305-5484, USA.</auth-address><titles><title>How molecular imaging is speeding up antiangiogenic drug development</title><secondary-title>Mol Cancer Ther</secondary-title></titles><pages>2624-33</pages><volume>5</volume><number>11</number><edition>2006/11/24</edition><keywords><keyword>Angiogenesis Inhibitors/*therapeutic use</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents/*therapeutic use</keyword><keyword>Drug Design</keyword><keyword>Integrin alphaVbeta3/metabolism</keyword><keyword>Intracellular Signaling Peptides and Proteins/metabolism</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms/*blood supply/metabolism/radionuclide imaging</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/metabolism</keyword><keyword>*Tomography, Emission-Computed/trends</keyword><keyword>Vascular Endothelial Growth Factor A/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1535-7163 (Print)</isbn><accession-num>17121909</accession-num><abstract>Drug development is a long process that generally spans about 10 to 15 years. The shift in recent drug discovery to novel agents against specific molecular targets highlights the need for more robust molecular imaging platforms. Using molecular probes, molecular imaging can aid in many steps of the drug development process, such as providing whole body readout in an intact system, decreasing the workload and speeding up drug development/validation, and facilitating individualized anticancer treatment monitoring and dose optimization. The main focus of this review is the recent advances in tumor angiogenesis imaging, and the targets include vascular endothelial growth factor and vascular endothelial growth factor receptor, integrin alpha(v)beta(3), matrix metalloproteinase, endoglin (CD105), and E-selectin. Through tumor angiogenesis imaging, it is expected that a robust platform for understanding the mechanisms of tumor angiogenesis and evaluating the efficacy of novel antiangiogenic therapies will be developed, which can help antiangiogenic drug development in both the preclinical stage and the clinical settings. Molecular imaging has enormous potential in improving the efficiency of the drug development process, including the specific area of antiangiogenic drugs.</abstract><notes>Cai, Weibo&#xD;Rao, Jianghong&#xD;Gambhir, Sanjiv S&#xD;Chen, Xiaoyuan&#xD;P50 ca114747/ca/nci&#xD;R21 ca102123/ca/nci&#xD;R21 eb001785/eb/nibib&#xD;R24 ca93862/ca/nci&#xD;U54 ca119367/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2006 Nov;5(11):2624-33.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17121909</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>5.137</custom4><electronic-resource-num>5/11/2624 [pii]&#xD;10.1158/1535-7163.MCT-06-0395</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>679</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">679</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Melancon, M. P.</author><author>Lu, W.</author><author>Yang, Z.</author><author>Zhang, R.</author><author>Cheng, Z.</author><author>Elliot, A. M.</author><author>Stafford, J.</author><author>Olson, T.</author><author>Zhang, J. Z.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</auth-address><titles><title>In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy</title><secondary-title>Mol Cancer Ther</secondary-title></titles><pages>1730-9</pages><volume>7</volume><number>6</number><edition>2008/06/21</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1535-7163 (Print)</isbn><accession-num>18566244</accession-num><abstract>Laser-induced phototherapy is a new therapeutic use of electromagnetic radiation for cancer treatment. The use of targeted plasmonic gold nanoparticles can reduce the laser energy necessary for selective tumor cell destruction. However, the ability for targeted delivery of the currently used gold nanoparticles to tumor cells is limited. Here, we describe a new class of molecular specific photothermal coupling agents based on hollow gold nanoshells (HAuNS; average diameter, approximately 30 nm) covalently attached to monoclonal antibody directed at epidermal growth factor receptor (EGFR). The resulting anti-EGFR-HAuNS exhibited excellent colloidal stability and efficient photothermal effect in the near-infrared region. EGFR-mediated selective uptake of anti-EGFR-HAuNS in EGFR-positive A431 tumor cells but not IgG-HAuNS control was shown in vitro by imaging scattered light from the nanoshells. Irradiation of A431 cells treated with anti-EGFR-HAuNS with near-infrared laser resulted in selective destruction of these cells. In contrast, cells treated with anti-EGFR-HAuNS alone, laser alone, or IgG-HAuNS plus laser did not show observable effect on cell viability. Using 111In-labeled HAuNS, we showed that anti-EGFR-HAuNS could be delivered to EGFR-positive tumors at 6.8% ID/g, and the microscopic image of excised tumor with scattering signal from nanoshells confirmed preferential delivery to A431 tumor of anti-EGFR-HAuNS compared with IgG-HAuNS. The absence of silica core, the relatively small particle size and high tumor uptake, and the absence of cytotoxic surfactant required to stabilize other gold nanoparticles suggest that immuno-HAuNS have the potential to extend to in vivo molecular therapy.</abstract><notes>Melancon, Marites P&#xD;Lu, Wei&#xD;Yang, Zhi&#xD;Zhang, Rui&#xD;Cheng, Zhi&#xD;Elliot, Andrew M&#xD;Stafford, Jason&#xD;Olson, Tammy&#xD;Zhang, Jin Z&#xD;Li, Chun&#xD;CA16672/CA/United States NCI&#xD;R01 CA119387/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2008 Jun;7(6):1730-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18566244</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2008</custom3><custom4>5.137</custom4><electronic-resource-num>7/6/1730 [pii]&#xD;10.1158/1535-7163.MCT-08-0016</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>117</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">117</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sinha, R.</author><author>Kim, G. J.</author><author>Nie, S.</author><author>Shin, D. M.</author></authors></contributors><auth-address>Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365-C Clifton Road, Room 3090, Atlanta, GA 30322, USA.</auth-address><titles><title>Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery</title><secondary-title>Mol Cancer Ther</secondary-title></titles><pages>1909-17</pages><volume>5</volume><number>8</number><edition>2006/08/25</edition><keywords><keyword>Animals</keyword><keyword>Antigens/drug effects/metabolism</keyword><keyword>Carbohydrates</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nanostructures</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Neoplasms/*drug therapy/therapy</keyword><keyword>Receptors, Cell Surface/drug effects/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1535-7163 (Print)</isbn><accession-num>16928810</accession-num><abstract>Nanotechnology refers to the interactions of cellular and molecular components and engineered materials-typically, clusters of atoms, molecules, and molecular fragments into incredibly small particles-between 1 and 100 nm. Nanometer-sized particles have novel optical, electronic, and structural properties that are not available either in individual molecules or bulk solids. The concept of nanoscale devices has led to the development of biodegradable self-assembled nanoparticles, which are being engineered for the targeted delivery of anticancer drugs and imaging contrast agents. Nanoconstructs such as these should serve as customizable, targeted drug delivery vehicles capable of ferrying large doses of chemotherapeutic agents or therapeutic genes into malignant cells while sparing healthy cells. Such &quot;smart&quot; multifunctional nanodevices hold out the possibility of radically changing the practice of oncology, allowing easy detection and then followed by effective targeted therapeutics at the earliest stages of the disease. In this article, we briefly discuss the use of bioconjugated nanoparticles for the delivery and targeting of anticancer drugs.</abstract><notes>Sinha, Rajni&#xD;Kim, Gloria J&#xD;Nie, Shuming&#xD;Shin, Dong M&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2006 Aug;5(8):1909-17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16928810</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>5.137</custom4><electronic-resource-num>5/8/1909 [pii]&#xD;10.1158/1535-7163.MCT-06-0141</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>498</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">498</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Healy, K. D.</author><author>Hodgson, L.</author><author>Kim, T. Y.</author><author>Shutes, A.</author><author>Maddileti, S.</author><author>Juliano, R. L.</author><author>Hahn, K. M.</author><author>Harden, T. K.</author><author>Bang, Y. J.</author><author>Der, C. J.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC 27599-7295, USA.</auth-address><titles><title>DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms</title><secondary-title>Mol Carcinog</secondary-title></titles><pages>326-37</pages><volume>47</volume><number>5</number><edition>2007/10/13</edition><keywords><keyword>Carcinoma, Non-Small-Cell Lung/metabolism/pathology/*prevention &amp; control</keyword><keyword>Cell Movement</keyword><keyword>Collagen/metabolism</keyword><keyword>DNA Primers</keyword><keyword>Drug Combinations</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Genes, Tumor Suppressor/physiology</keyword><keyword>Guanosine Triphosphate/metabolism</keyword><keyword>Humans</keyword><keyword>Hydrolysis</keyword><keyword>Laminin/metabolism</keyword><keyword>Lung Neoplasms/metabolism/pathology/*prevention &amp; control</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Phospholipase C delta/metabolism</keyword><keyword>Polymerase Chain Reaction</keyword><keyword>Proteoglycans/metabolism</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Tumor Stem Cell Assay</keyword><keyword>Tumor Suppressor Proteins/*physiology</keyword><keyword>rho GTP-Binding Proteins/genetics/*metabolism</keyword><keyword>rhoA GTP-Binding Protein/genetics/*metabolism</keyword><keyword>rhoB GTP-Binding Protein/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1098-2744 (Electronic)</isbn><accession-num>17932950</accession-num><abstract>Expression of the tumor suppressor deleted in liver cancer-1 (DLC-1) is lost in non-small cell lung (NSCLC) and other human carcinomas, and ectopic DLC-1 expression dramatically reduces proliferation and tumorigenicity. DLC-1 is a multi-domain protein that includes a Rho GTPase activating protein (RhoGAP) domain which has been hypothesized to be the basis of its tumor suppressive actions. To address the importance of the RhoGAP function of DLC-1 in tumor suppression, we performed biochemical and biological studies evaluating DLC-1 in NSCLC. Full-length DLC-1 exhibited strong GAP activity for RhoA as well as RhoB and RhoC, but only very limited activity for Cdc42 in vitro. In contrast, the isolated RhoGAP domain showed 5- to 20-fold enhanced activity for RhoA, RhoB, RhoC, and Cdc42. DLC-1 protein expression was absent in six of nine NSCLC cell lines. Restoration of DLC-1 expression in DLC-1-deficient NSCLC cell lines reduced RhoA activity, and experiments with a RhoA biosensor demonstrated that DLC-1 dramatically reduces RhoA activity at the leading edge of cellular protrusions. Furthermore, DLC-1 expression in NSCLC cell lines impaired both anchorage-dependent and -independent growth, as well as invasion in vitro. Surprisingly, we found that the anti-tumor activity of DLC-1 was due to both RhoGAP-dependent and -independent activities. Unlike the rat homologue p122RhoGAP, DLC-1 was not capable of activating the phospholipid hydrolysis activity of phospholipase C-delta1. Combined, these studies provide information on the mechanism of DLC-1 function and regulation, and further support the role of DLC-1 tumor suppression in NSCLC.</abstract><notes>Healy, Kevin D&#xD;Hodgson, Louis&#xD;Kim, Tai-Young&#xD;Shutes, Adam&#xD;Maddileti, Savitri&#xD;Juliano, Rudolph L&#xD;Hahn, Klaus M&#xD;Harden, T Kendall&#xD;Bang, Yung-Jue&#xD;Der, Channing J&#xD;CA063071/CA/United States NCI&#xD;CA67771/CA/United States NCI&#xD;GM57391/GM/United States NIGMS&#xD;GM57464/GM/United States NIGMS&#xD;GM64346/GM/United States NIGMS&#xD;P01HL4500/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular carcinogenesis&#xD;Mol Carcinog. 2008 May;47(5):326-37.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17932950</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>2.743</custom4><electronic-resource-num>10.1002/mc.20389</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>497</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">497</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, X.</author><author>Lietha, D.</author><author>Ceccarelli, D. F.</author><author>Karginov, A. V.</author><author>Rajfur, Z.</author><author>Jacobson, K.</author><author>Hahn, K. M.</author><author>Eck, M. J.</author><author>Schaller, M. D.</author></authors></contributors><auth-address>Department of Cell &amp; Developmental Biology, 534 Taylor Hall, CB 7090, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Spatial and temporal regulation of focal adhesion kinase activity in living cells</title><secondary-title>Mol Cell Biol</secondary-title></titles><pages>201-14</pages><volume>28</volume><number>1</number><edition>2007/10/31</edition><keywords><keyword>Acids</keyword><keyword>Amino Acid Motifs</keyword><keyword>Amino Acid Sequence</keyword><keyword>Biosensing Techniques</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases/chemistry/genetics/*metabolism</keyword><keyword>Humans</keyword><keyword>Models, Molecular</keyword><keyword>Phosphatidylinositol 4,5-Diphosphate/metabolism</keyword><keyword>Phospholipids/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Protein Binding</keyword><keyword>Protein Structure, Tertiary</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1098-5549 (Electronic)</isbn><accession-num>17967873</accession-num><abstract>Focal adhesion kinase (FAK) is an essential kinase that regulates developmental processes and functions in the pathology of human disease. An intramolecular autoinhibitory interaction between the FERM and catalytic domains is a major mechanism of regulation. Based upon structural studies, a fluorescence resonance energy transfer (FRET)-based FAK biosensor that discriminates between autoinhibited and active conformations of the kinase was developed. This biosensor was used to probe FAK conformational change in live cells and the mechanism of regulation. The biosensor demonstrates directly that FAK undergoes conformational change in vivo in response to activating stimuli. A conserved FERM domain basic patch is required for this conformational change and for interaction with a novel ligand for FAK, acidic phospholipids. Binding to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing phospholipid vesicles activated and induced conformational change in FAK in vitro, and alteration of PIP2 levels in vivo changed the level of activation of the conformational biosensor. These findings provide direct evidence of conformational regulation of FAK in living cells and novel insight into the mechanism regulating FAK conformation.</abstract><notes>Cai, Xinming&#xD;Lietha, Daniel&#xD;Ceccarelli, Derek F&#xD;Karginov, Andrei V&#xD;Rajfur, Zenon&#xD;Jacobson, Ken&#xD;Hahn, Klaus M&#xD;Eck, Michael J&#xD;Schaller, Michael D&#xD;GM0064346/GM/United States NIGMS&#xD;HL45100/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular and cellular biology&#xD;Mol Cell Biol. 2008 Jan;28(1):201-14. Epub 2007 Oct 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17967873</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>6.773</custom4><electronic-resource-num>MCB.01324-07 [pii]&#xD;10.1128/MCB.01324-07</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>291</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">291</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nakamura, K.</author><author>Uhlik, M. T.</author><author>Johnson, N. L.</author><author>Hahn, K. M.</author><author>Johnson, G. L.</author></authors></contributors><auth-address>Department of Pharmacology, CB#7365, 1108 Mary Ellen Jones Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.</auth-address><titles><title>PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation</title><secondary-title>Mol Cell Biol</secondary-title></titles><pages>2065-79</pages><volume>26</volume><number>6</number><edition>2006/03/02</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Bacterial Proteins/genetics/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Dimerization</keyword><keyword>Enzyme Activation</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Green Fluorescent Proteins/genetics/metabolism</keyword><keyword>Luminescent Proteins/genetics/metabolism</keyword><keyword>MAP Kinase Kinase 5/drug effects/genetics/*metabolism</keyword><keyword>MAP Kinase Kinase Kinase 2/genetics/metabolism</keyword><keyword>Mitogen-Activated Protein Kinase 7/drug effects/genetics/*metabolism</keyword><keyword>Molecular Sequence Data</keyword><keyword>Multiprotein Complexes</keyword><keyword>Mutation</keyword><keyword>Protein Interaction Mapping</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Recombinant Proteins/genetics/metabolism</keyword><keyword>*Signal Transduction</keyword><keyword>Sorbitol/pharmacology</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0270-7306 (Print)</isbn><accession-num>16507987</accession-num><abstract>MEKK2, MEK5, and extracellular signal-regulated kinase 5 (ERK5) are members of a three-kinase cascade for the activation of ERK5. MEK5 is the only MAP2K to express a PB1 domain, and we have shown that it heterodimerizes with the PB1 domain of MEKK2. Here we demonstrate the MEK5 PB1 domain is a scaffold that also binds ERK5, functionally forming a MEKK2-MEK5-ERK5 complex. Reconstitution assays and CFP/YFP imaging (fluorescence resonance energy transfer [FRET]) measuring YFP-MEKK2/CFP-MEK5 and CFP-MEK5/YFP-ERK5 interactions define distinct MEK5 PB1 domain binding sites for MEKK2 and ERK5, with a C-terminal extension of the PB1 domain contributing to ERK5 binding. Stimulus-dependent CFP/YFP FRET in combination with mutational analysis was used to define MEK5 PB1 domain residues critical for the interaction of MEKK2/MEK5 and MEK5/ERK5 required for activation of the ERK5 pathway in living cells. Fusion of the MEK5 PB1 domain to the N terminus of MEK1 confers ERK5 regulation by a MAP2K normally regulating only ERK1/2. The MEK5 PB1 domain confers stringent MAP3K regulation of ERK5 relative to more promiscuous MAP3K control of ERK1/2, JNK, and p38.</abstract><notes>Nakamura, Kazuhiro&#xD;Uhlik, Mark T&#xD;Johnson, Nancy L&#xD;Hahn, Klaus M&#xD;Johnson, Gary L&#xD;Gm30324/gm/nigms&#xD;Gm68820/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular and cellular biology&#xD;Mol Cell Biol. 2006 Mar;26(6):2065-79.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16507987</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>6.773</custom4><electronic-resource-num>26/6/2065 [pii]&#xD;10.1128/MCB.26.6.2065-2079.2006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>293</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">293</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paliwal, S.</author><author>Pande, S.</author><author>Kovi, R. C.</author><author>Sharpless, N. E.</author><author>Bardeesy, N.</author><author>Grossman, S. R.</author></authors></contributors><auth-address>Department of Cancer Biology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA.</auth-address><titles><title>Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis</title><secondary-title>Mol Cell Biol</secondary-title></titles><pages>2360-72</pages><volume>26</volume><number>6</number><edition>2006/03/02</edition><keywords><keyword>ADP-Ribosylation Factors/genetics/*metabolism</keyword><keyword>Alcohol Oxidoreductases</keyword><keyword>Animals</keyword><keyword>Apoptosis/*physiology</keyword><keyword>Cell Nucleolus/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Colonic Neoplasms/genetics/pathology</keyword><keyword>DNA-Binding Proteins/genetics/*metabolism/radiation effects</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Phosphoproteins/genetics/*metabolism/radiation effects</keyword><keyword>Proteasome Endopeptidase Complex/metabolism/radiation effects</keyword><keyword>Protein Transport</keyword><keyword>RNA, Small Interfering</keyword><keyword>Tumor Suppressor Protein p53/genetics/*metabolism</keyword><keyword>Two-Hybrid System Techniques</keyword><keyword>Ubiquitin/metabolism</keyword><keyword>Ultraviolet Rays</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0270-7306 (Print)</isbn><accession-num>16508011</accession-num><abstract>ARF encodes a potent tumor suppressor that antagonizes MDM2, a negative regulator of p53. ARF also suppresses the proliferation of cells lacking p53, and loss of ARF in p53-null mice, compared with ARF or p53 singly null mice, results in a broadened tumor spectrum and decreased tumor latency. To investigate the mechanism of p53-independent tumor suppression by ARF, potential interacting proteins were identified by yeast two-hybrid screen. The antiapoptotic transcriptional corepressor C-terminal binding protein 2 (CtBP2) was identified, and ARF interactions with both CtBP1 and CtBP2 were confirmed in vitro and in vivo. Interaction with ARF resulted in proteasome-dependent CtBP degradation. Both ARF-induced CtBP degradation and CtBP small interfering RNA led to p53-independent apoptosis in colon cancer cells. ARF induction of apoptosis was dependent on its ability to interact with CtBP, and reversal of ARF-induced CtBP depletion by CtBP overexpression abrogated ARF-induced apoptosis. CtBP proteins represent putative targets for p53-independent tumor suppression by ARF.</abstract><notes>Paliwal, Seema&#xD;Pande, Sandhya&#xD;Kovi, Ramesh C&#xD;Sharpless, Norman E&#xD;Bardeesy, Nabeel&#xD;Grossman, Steven R&#xD;5ko1-ca89548/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular and cellular biology&#xD;Mol Cell Biol. 2006 Mar;26(6):2360-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16508011</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>6.773</custom4><electronic-resource-num>26/6/2360 [pii]&#xD;10.1128/MCB.26.6.2360-2372.2006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>525</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">525</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Madoz-Gurpide, J.</author><author>Kuick, R.</author><author>Wang, H.</author><author>Misek, D. E.</author><author>Hanash, S. M.</author></authors></contributors><auth-address>Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA. juanmg@usal.es</auth-address><titles><title>Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><pages>268-81</pages><volume>7</volume><number>2</number><edition>2007/10/06</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Antibodies, Neoplasm/immunology</keyword><keyword>Antibody Formation/*immunology</keyword><keyword>Antigens, Neoplasm/*blood/chemistry/*immunology</keyword><keyword>Autoantibodies/blood</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemical Fractionation</keyword><keyword>Chromatography, Liquid</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms/*blood/genetics/*immunology</keyword><keyword>Mass Spectrometry</keyword><keyword>Molecular Sequence Data</keyword><keyword>Protein Array Analysis/*methods</keyword><keyword>Ubiquitin Thiolesterase/chemistry/genetics/immunology/isolation &amp;</keyword><keyword>purification</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1535-9484 (Electronic)</isbn><accession-num>17916591</accession-num><abstract>The identification of biomarkers (both molecules and profiles) in patient sera offers enormous interest for the diagnosis of cancers. In this context, the detection of antibodies to tumor cell autologous antigens possesses great potential. The humoral immune response represents a form of biological amplification of signals that are otherwise weak because of very low concentrations of antigen, especially in the early stages of cancers. Herein we present the use of integral microarrays spotted with tumor-derived proteins to investigate the antibody repertoire in the sera of lung cancer patients and controls. The use of two-dimensional liquid chromatography allowed us to separate proteins from the lung adenocarcinoma cell line A549 into 1760 fractions, which were printed in duplicate, along with various controls, onto nitrocellulose coated slides. The sensitivity and specificity of the microarrays to detect singular antibodies in fluids were first validated through the recognition of fractions containing a lung marker antigen by antibody probing. Twenty fractions were initially selected as highly reactive against the anti-PGP9.5 antibody, and subsequent mass spectrometry analyses confirmed the identity of PGP9.5 protein in four of them. As a result, the importance of neighboring fractions in microarray detection was revealed due to the spreading of proteins during the separation process. Next, the microarrays were individually incubated with 14 serum samples from patients with lung cancer patients, 14 sera from colon cancer patients, and 14 control sera from normal subjects. The reactivity of the selected fractions was analyzed, and the level of immunoglobulin bound to each fraction by each serum sample was quantified. Eight of the 20 fractions offered p values &lt; 0.01 and were recognized by an average of four reacting patients, whereas no serum from normal individuals was positive for those fractions. Protein microarrays from tumor-derived fractions hold the diagnostic potential of uncovering antigens that induce an immune response in patients with certain types of cancers.</abstract><notes>Madoz-Gurpide, Juan&#xD;Kuick, Rork&#xD;Wang, Hong&#xD;Misek, David E&#xD;Hanash, Sam M&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2008 Feb;7(2):268-81. Epub 2007 Oct 4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17916591</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>9.62</custom4><electronic-resource-num>M700366-MCP200 [pii]&#xD;10.1074/mcp.M700366-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>226</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">226</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mannova, P.</author><author>Fang, R.</author><author>Wang, H.</author><author>Deng, B.</author><author>McIntosh, M. W.</author><author>Hanash, S. M.</author><author>Beretta, L.</author></authors></contributors><auth-address>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.</auth-address><titles><title>Modification of host lipid raft proteome upon hepatitis C virus replication</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><pages>2319-25</pages><volume>5</volume><number>12</number><edition>2006/09/01</edition><keywords><keyword>Cell Extracts/chemistry</keyword><keyword>Cell Fractionation/methods</keyword><keyword>Electrophoresis, Gel, Two-Dimensional</keyword><keyword>Hepacivirus/*physiology</keyword><keyword>Host-Parasite Relations</keyword><keyword>Humans</keyword><keyword>Membrane Microdomains/*chemistry/metabolism/virology</keyword><keyword>Proteome/*analysis/metabolism</keyword><keyword>Proteomics/methods</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>*Virus Replication</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>16943187</accession-num><abstract>Hepatitis C virus (HCV) replication complex resides in detergent-insoluble subcellular domains or lipid rafts. We used two proteomics approaches to characterize the protein content of lipid rafts isolated from Huh7 cells and its modification upon HCV replication. Using two-dimensional electrophoresis and mass spectrometry, we identified approximately 100 protein spots in the isolated lipid rafts; among them, 39 were reproducibly modified in HCV replicon cell lines as compared with control cell lines. We also used stable isotope labeling by amino acids in cell culture (SILAC) combined with one-dimensional electrophoresis separation and mass spectrometry. Using this approach, we identified 1036 individual proteins based on peptides selected with at least 95% confidence; among them, 413 proteins were identified with at least two peptides. Quantification analysis identified 150 proteins modified by at least 2.5-fold (110 up-regulated and 40 down-regulated) in HCV-replicating cells compared with controls. Protein identifications and quantifications obtained by both proteomics approaches were largely concordant. Modulated proteins included a majority of proteins involved in vesicular and protein trafficking and in cell signaling. Remarkably for a large number of proteins, their up-regulation in lipid rafts of HCV replicon cells was due to their relocalization. By using small interfering RNAs directed to the modulated small GTPases Cdc42 and RhoA, we observed an increase in HCV replication, whereas reduction of syntaxin 7 expression resulted in decreased replication of HCV. Our findings indicate that protein subcellular relocalization occurs in HCV-containing cells that can directly affect HCV replication.</abstract><notes>Mannova, Petra&#xD;Fang, Ruihua&#xD;Wang, Hong&#xD;Deng, Bin&#xD;McIntosh, Martin W&#xD;Hanash, Samir M&#xD;Beretta, Laura&#xD;Comparative Study&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2006 Dec;5(12):2319-25. Epub 2006 Aug 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16943187</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>9.62</custom4><electronic-resource-num>M600121-MCP200 [pii]&#xD;10.1074/mcp.M600121-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>52</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">52</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stewart, J. J.</author><author>White, J. T.</author><author>Yan, X.</author><author>Collins, S.</author><author>Drescher, C. W.</author><author>Urban, N. D.</author><author>Hood, L.</author><author>Lin, B.</author></authors></contributors><auth-address>The Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><pages>433-43</pages><volume>5</volume><number>3</number><edition>2005/12/02</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Cisplatin/*pharmacology</keyword><keyword>*Drug Resistance, Neoplasm</keyword><keyword>Drug Therapy</keyword><keyword>Female</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Genes, Neoplasm/genetics</keyword><keyword>Humans</keyword><keyword>Neoplasm Proteins/analysis/genetics/*metabolism</keyword><keyword>Ovarian Neoplasms/*genetics/*metabolism/pathology</keyword><keyword>Protein Array Analysis</keyword><keyword>*Proteomics</keyword><keyword>RNA, Messenger/analysis/genetics/metabolism</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>16319398</accession-num><abstract>Nearly all women diagnosed with ovarian cancer receive combination chemotherapy including cis- or carboplatin. Despite high initial response rates, resistance to cisplatin develops in roughly one-third of women during primary treatment and in all women treated for recurrent disease. ICAT coupled with tandem MS is a quantitative proteomic technique for high throughput protein expression profiling of complex protein mixtures. Using ICAT/MS/MS we profiled the nuclear, cytosolic, and microsomal fractions obtained from IGROV-1 [corrected] (cisplatin-sensitive) and IGROV-1/CP [corrected] (cisplatin-resistant) ovarian cancer cell lines. The proteomes of cisplatin-sensitive and -resistant ovarian cancer cells were compared, and protein expression was correlated with mRNA expression profiles. A total of 1117 proteins were identified and quantified. The relative expression of 121 of these varied between the two cell lines. Sixty-three proteins were overexpressed in cisplatin-sensitive, and 58 were over expressed in cisplatin-resistant cells. Examples of proteins at least 5-fold overexpressed in resistant cells and with biological relevance to cancer include cell recognition molecule CASPR3 (13.3-fold), S100 protein family members (8.7-fold), junction adhesion molecule Claudin 4 (7.2-fold), and CDC42-binding protein kinase beta (5.4-fold). Examples of cancer-related proteins at least 5-fold overexpressed in sensitive cells include hepatocyte growth factor inhibitor 1B (13.3-fold) and programmed cell death 6-interacting protein (12.7-fold). The direction of changes in expression levels between proteins and mRNAs were not always in the same direction, possibly reflecting posttranscriptional control of protein expression. We identified proteins whose expression profiles correlate with cisplatin resistance in ovarian cancer cells. Several proteins may be involved in modulating response to cisplatin and have potential as markers of treatment response or treatment targets.</abstract><notes>Stewart, Jennifer J&#xD;White, James T&#xD;Yan, Xiaowei&#xD;Collins, Steven&#xD;Drescher, Charles W&#xD;Urban, Nicole D&#xD;Hood, Leroy&#xD;Lin, Biaoyang&#xD;2p50ca083636-06/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2006 Mar;5(3):433-43. Epub 2005 Nov 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16319398</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>9.62</custom4><electronic-resource-num>M500140-MCP200 [pii]&#xD;10.1074/mcp.M500140-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>54</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">54</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, B.</author><author>Ranish, J. A.</author><author>Utleg, A. G.</author><author>White, J. T.</author><author>Yan, X.</author><author>Lin, B.</author><author>Hood, L.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><pages>141-9</pages><volume>6</volume><number>1</number><edition>2006/11/01</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Avidin/chemistry</keyword><keyword>Cattle</keyword><keyword>Chickens</keyword><keyword>Glycopeptides/*analysis/chemistry</keyword><keyword>Glycoproteins/chemistry</keyword><keyword>Glycosylation</keyword><keyword>Humans</keyword><keyword>Microsomes</keyword><keyword>Molecular Sequence Data</keyword><keyword>Neoplasm Proteins/chemistry</keyword><keyword>Proteomics/*methods</keyword><keyword>Spectrometry, Mass, Electrospray Ionization/*methods</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>17074749</accession-num><abstract>We present a robust and general shotgun glycoproteomics approach to comprehensively profile glycoproteins in complex biological mixtures. In this approach, glycopeptides derived from glycoproteins are enriched by selective capture onto a solid support using hydrazide chemistry followed by enzymatic release of the peptides and subsequent analysis by tandem mass spectrometry. The approach was validated using standard protein mixtures that resulted in a close to 100% capture efficiency. Our capture approach was then applied to microsomal fractions of the cisplatin-resistant ovarian cancer cell line IGROV-1/CP. With a Protein Prophet probability value greater than 0.9, we identified a total of 302 proteins with an average protein identification rate of 136 +/- 19 (n = 4) in a single linear quadrupole ion trap (LTQ) mass spectrometer nano-LC-MS experiment and a selectivity of 91 +/- 1.6% (n = 4) for the N-linked glycoconsensus sequence. Our method has several advantages. 1) Digestion of proteins initially into peptides improves the solubility of large membrane proteins and exposes all of the glycosylation sites to ensure equal accessibility to capture reagents. 2) Capturing glycosylated peptides can effectively reduce sample complexity and at the same time increase the confidence of MS-based protein identifications (more potential peptide identifications per protein). 3) The utility of sodium sulfite as a quencher in our capture approach to replace the solid phase extraction step in an earlier glycoprotein chemical capture approach for removing excess sodium periodate allows the overall capture procedure to be completed in a single vessel. This improvement minimizes sample loss, increases sensitivity, and makes our protocol amenable for high throughput implementation, a feature that is essential for biomarker identification and validation of a large number of clinical samples. 4) The approach is demonstrated here on the analysis of N-linked glycopeptides; however, it can be applied equally well to O-glycoprotein analysis.</abstract><notes>Sun, Bingyun&#xD;Ranish, Jeffrey A&#xD;Utleg, Angelita G&#xD;White, James T&#xD;Yan, Xiaowei&#xD;Lin, Biaoyang&#xD;Hood, Leroy&#xD;1p50gm076547/gm/nigms&#xD;1u54ca119347/ca/nci&#xD;1u54da021519/da/nida&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2007 Jan;6(1):141-9. Epub 2006 Oct 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17074749</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>9.62</custom4><electronic-resource-num>T600046-MCP200 [pii]&#xD;10.1074/mcp.T600046-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>55</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">55</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tu, L. C.</author><author>Yan, X.</author><author>Hood, L.</author><author>Lin, B.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><pages>575-88</pages><volume>6</volume><number>4</number><edition>2007/01/16</edition><keywords><keyword>Androgens/*metabolism/pharmacology</keyword><keyword>Cadherins/metabolism</keyword><keyword>Cell Cycle Proteins/chemistry/genetics/*metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Endoplasmic Reticulum/metabolism</keyword><keyword>Humans</keyword><keyword>Immunoprecipitation</keyword><keyword>Intracellular Signaling Peptides and</keyword><keyword>Proteins/chemistry/genetics/*metabolism</keyword><keyword>Male</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms, Hormone-Dependent/etiology/genetics/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Prostatic Neoplasms/etiology/genetics/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Interaction Mapping</keyword><keyword>Proteomics</keyword><keyword>Tandem Mass Spectrometry</keyword><keyword>beta Catenin/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>17220478</accession-num><abstract>NDRG1 is known to play important roles in both androgen-induced cell differentiation and inhibition of prostate cancer metastasis. However, the proteins associated with NDRG1 function are not fully enumerated. Using coimmunoprecipitation and mass spectrometry analysis, we identified 58 proteins that interact with NDRG1 in prostate cancer cells. These proteins include nuclear proteins, adhesion molecules, endoplasmic reticulum (ER) chaperons, proteasome subunits, and signaling proteins. Integration of our data with protein-protein interaction data from the Human Proteome Reference Database allowed us to build a comprehensive interactome map of NDRG1. This interactome map consists of several modules such as a nuclear module and a cell membrane module; these modules explain the reported versatile functions of NDRG1. We also determined that serine 330 and threonine 366 of NDRG1 were phosphorylated and demonstrated that the phosphorylation of NDRG1 was prominently mediated by protein kinase A (PKA). Further, we showed that NDRG1 directly binds to beta-catenin and E-cadherin. However, the phosphorylation of NDRG1 did not interrupt the binding of NDRG1 to E-cadherin and beta-catenin. Finally, we showed that the inhibition of NDRG1 expression by RNA interference decreased the ER inducible chaperon GRP94 expression, directly proving that NDRG1 is involved in the ER stress response. Intriguingly, we observed that many members of the NDRG1 interactome are androgen-regulated and that the NDRG1 interactome links to the androgen response network through common interactions with beta-catenin and heat shock protein 90. Therefore we overlaid the transcriptomic expression changes in the NDRG1 interactome in response to androgen treatment and built a dual dynamic picture of the NDRG1 interactome in response to androgen. This interactome map provides the first road map for understanding the functions of NDRG1 in cells and its roles in human diseases, such as prostate cancer, which can progress from androgen-dependent curable stages to androgen-independent incurable stages.</abstract><notes>Tu, Lan Chun&#xD;Yan, Xiaowei&#xD;Hood, Leroy&#xD;Lin, Biaoyang&#xD;1p50gm076547/gm/nigms&#xD;1u54ca119347/ca/nci&#xD;1u54da021519/da/nida&#xD;5p01ca085859/ca/nci&#xD;5p50ca097186/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2007 Apr;6(4):575-88. Epub 2007 Jan 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17220478</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>9.62</custom4><electronic-resource-num>M600249-MCP200 [pii]&#xD;10.1074/mcp.M600249-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>146</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Endres, P. J.</author><author>Macrenaris, K. W.</author><author>Vogt, S.</author><author>Allen, M. J.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence</title><secondary-title>Mol Imaging</secondary-title></titles><pages>485-97</pages><volume>5</volume><number>4</number><edition>2006/12/08</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Chelating Agents/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>*Contrast Media/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Dogs</keyword><keyword>Gadolinium DTPA/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Heterocyclic Compounds/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Spectrometry, X-Ray Emission</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct-Dec</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>17150161</accession-num><abstract>The inability to transduce cellular membranes is a limitation of current magnetic resonance imaging probes used in biologic and clinical settings. This constraint confines contrast agents to extracellular and vascular regions of the body, drastically reducing their viability for investigating processes and cycles in developmental biology. Conversely, a contrast agent with the ability to permeate cell membranes could be used in visualizing cell patterning, cell fate mapping, gene therapy, and, eventually, noninvasive cancer diagnosis. Therefore, we describe the synthesis and quantitative imaging of four contrast agents with the capability to cross cell membranes in sufficient quantity for detection. Each agent is based on the conjugation of a Gd(III) chelator with a cellular transduction moiety. Specifically, we coupled Gd(III)-diethylenetriaminepentaacetic acid DTPA and Gd(III)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid with an 8-amino acid polyarginine oligomer and an amphipathic stilbene molecule, 4-amino-4&apos;-(N,N-dimethylamino)stilbene. The imaging modality that provided the best sensitivity and spatial resolution for direct detection of the contrast agents is synchrotron radiation x-ray fluorescence (SR-XRF). Unlike optical microscopy, SR-XRF provides two-dimensional images with resolution 10(3) better than (153)Gd gamma counting, without altering the agent by organic fluorophore conjugation. The transduction efficiency of the intracellular agents was evaluated by T(1) analysis and inductively coupled plasma mass spectrometry to determine the efficacy of each chelate-transporter combination.</abstract><notes>Endres, Paul J&#xD;Macrenaris, Keith W&#xD;Vogt, Stefan&#xD;Allen, Matthew J&#xD;Meade, Thomas J&#xD;1r01 eb005866-01/eb/nibib&#xD;5u54 ca90810/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2006 Oct-Dec;5(4):485-97.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17150161</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>2.961</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>32</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">32</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, K. A.</author><author>Clemons, P. A.</author><author>Yu, A. M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA. kkelly9@partners.org</auth-address><titles><title>High-throughput identification of phage-derived imaging agents</title><secondary-title>Mol Imaging</secondary-title></titles><pages>24-30</pages><volume>5</volume><number>1</number><edition>2006/01</edition><keywords><keyword>Affinity Labels/chemistry</keyword><keyword>Bacteriophages/*chemistry/genetics</keyword><keyword>Enzyme-Linked Immunosorbent Assay/methods</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry/methods</keyword><keyword>Lipopolysaccharides/pharmacology</keyword><keyword>Macrophages/*chemistry/drug effects/metabolism</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Monocytes/chemistry/drug effects/metabolism</keyword><keyword>*Peptide Library</keyword><keyword>Peptides/*chemistry/genetics/metabolism</keyword><keyword>Protein Binding</keyword><keyword>U937 Cells</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan-Mar</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>16779967</accession-num><abstract>The use of phage-displayed peptide libraries is a powerful method for selecting peptides with desired binding properties. However, the validation and prioritization of &quot;hits&quot; obtained from this screening approach remains challenging. Here, we describe the development and testing of a new analysis method to identify and display hits from phage-display experiments and high-throughput enzyme-linked immunosorbent assay screens. We test the method using a phage screen against activated macrophages to develop imaging agents with higher specificity for active disease processes. The new methodology should be useful in identifying phage hits and is extendable to other library screening methods such as small-molecule and nanoparticle libraries.</abstract><notes>P50 ca86355/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;official journal of the Society for Molecular Imaging</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16779967 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>2.961</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>94</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">94</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Montet-Abou, K.</author><author>Montet, X.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><titles><title>Cell internalization of magnetic nanoparticles using transfection agents</title><secondary-title>Mol Imaging</secondary-title></titles><pages>1-9</pages><volume>6</volume><number>1</number><edition>2007/02/22</edition><dates><year>2007</year><pub-dates><date>Jan-Mar</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>17311760</accession-num><abstract>Transfection agent (TFA)-induced magnetic cell labeling with Feridex IV is an attractive method of loading cells because it employs a pharmaceutical source of iron oxide. Although attractive, the method has two significant drawbacks. First, it requires mixing positively charged transfection agents and negatively charged magnetic nanoparticles, and the resulting loss of nanoparticle surface charge causes nanoparticle precipitation. Second, it can result in nanoparticle adsorption to the cell surface rather than internalization. Internalization of Feridex (and associated dextran) is important since dextran cell exterior can react with the antidextran antibodies, commonly present in human populations, and trigger an antibody-mediated cytotoxicity. Here we employed three assays for selecting Feridex/TFA mixtures to minimize nanoparticle precipitation and surface adsorption: (1) an assay for precipitation or stability (light scattering), (2) an assay for labeled cells (percentage of cells retained by a magnetic filter), and (3) an antidextran-based assay for nanoparticle internalization. Cells loaded with Feridex/protamine had internalized iron, whereas cells loaded with Feridex/Lipofectamine had surface-adsorbed iron. Optimal conditions for loading cells were 10 mug/Feridex and 3 mug/mL protamine sulfate. Conditions for loading cells with Feridex and a TFA need to be carefully selected to minimize nanoparticle precipitation and dextran adsorption to the cell surface.</abstract><notes>Montet-Abou, Karin&#xD;Montet, Xavier&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2007 Jan-Mar;6(1):1-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17311760</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>2.961</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>95</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">95</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, E. Y.</author><author>Josephson, L.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>&quot;Clickable&quot; nanoparticles for targeted imaging</title><secondary-title>Mol Imaging</secondary-title></titles><pages>122-8</pages><volume>5</volume><number>2</number><edition>2006/09/07</edition><keywords><keyword>*Alkynes</keyword><keyword>Animals</keyword><keyword>*Azides</keyword><keyword>Cell Line</keyword><keyword>*Coated Materials, Biocompatible/administration &amp; dosage</keyword><keyword>*Drug Delivery Systems/methods</keyword><keyword>Fluorescein/administration &amp; dosage</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>*Nanostructures</keyword><keyword>Paclitaxel/administration &amp; dosage</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr-Jun</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>16954026</accession-num><abstract>Nanomaterials functionalized with targeting ligands are increasingly recognized as useful materials for molecular imaging and drug delivery. Here we describe the development and validation of azide-alkyne reactions (&quot;click chemistry&quot;) for the rapid, site-specific modification of nanoparticles with small molecules. The facile preparation of stable nanoparticles bearing azido or alkyne groups capable of reaction with their corresponding counterpart functionalized small molecules is demonstrated. The Cu(I)-catalyzed cycloaddition of azides and alkynes is shown to be a highly efficient and selective method for point functionalization of magnetic nanoparticles. Derivatized nanoparticles bearing biotin, fluorochrome, or steroid moieties are stable for several months. Nanoparticle click chemistry will be useful for other nanomaterials, design of novel sensors, and drug delivery vehicles.</abstract><notes>Sun, Eric Yi&#xD;Josephson, Lee&#xD;Weissleder, Ralph&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2006 Apr-Jun;5(2):122-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16954026</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>2.961</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>531</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">531</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Venisnik, K. M.</author><author>Olafsen, T.</author><author>Gambhir, S. S.</author><author>Wu, A. M.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular &amp; Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.</auth-address><titles><title>Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging</title><secondary-title>Mol Imaging Biol</secondary-title></titles><pages>267-77</pages><volume>9</volume><number>5</number><edition>2007/06/20</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Antibodies, Neoplasm/*diagnostic use/genetics</keyword><keyword>Base Sequence</keyword><keyword>Carcinoembryonic Antigen/*immunology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copepoda/enzymology/genetics</keyword><keyword>DNA Primers/genetics</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunoglobulin Fragments/diagnostic use/genetics</keyword><keyword>Iodine Radioisotopes/diagnostic use</keyword><keyword>Luciferases/*diagnostic use/genetics</keyword><keyword>Luminescent Measurements</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Molecular Sequence Data</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms, Experimental/*diagnosis/radionuclide imaging</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Protein Engineering</keyword><keyword>Radiopharmaceuticals/diagnostic use</keyword><keyword>Rats</keyword><keyword>Recombinant Fusion Proteins/diagnostic use/genetics</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>1536-1632 (Print)</isbn><accession-num>17577599</accession-num><abstract>The bioluminescent protein Gaussia luciferase (GLuc) was fused to an anti-carcinoembryonic antigen (CEA) antibody fragment, the diabody, for in vivo optical tumor imaging. A 15-amino acid N-terminal truncation (GLDelta15) resulted in a brighter protein. Fusions of the anti-CEA diabody to full-length GLuc and GLDelta15 retained high affinity for the antigen, emitted light, and exhibited excellent enzymatic stability. In vivo optical imaging of tumor-bearing mice demonstrated specific targeting of diabody-GLDelta15 to CEA-positive xenografts, with a tumor/background ratio of 3.8 +/- 0.4 at four hours after tail-vein injection, compared to antigen-negative tumors at 1.3 +/- 0.1 (p = 0.001). MicroPET imaging using (124)I-diabody-GLDelta15 demonstrated specific uptake in the CEA-positive tumor (2.6% ID [injected dose]/g) compared to the CEA-negative tumor (0.4% ID/g) at 21 hours. Although further optimization of this fusion protein may be needed to improve in vivo performance, the diabody-GLDelta15 is a promising optical imaging probe for tumor detection in vivo.</abstract><notes>Venisnik, Katy M&#xD;Olafsen, Tove&#xD;Gambhir, Sanjiv S&#xD;Wu, Anna M&#xD;P01 CA43904/CA/United States NCI&#xD;P30 CA16042/CA/United States NCI&#xD;R01 CA082214/CA/United States NCI&#xD;R24 CA92865/CA/United States NCI&#xD;T32 GM08652/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging&#xD;Mol Imaging Biol. 2007 Sep-Oct;9(5):267-77.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17577599</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>2.951</custom4><electronic-resource-num>10.1007/s11307-007-0101-8</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>361</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">361</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Baba, K.</author><author>Pudavar, H. E.</author><author>Roy, I.</author><author>Ohulchanskyy, T. Y.</author><author>Chen, Y.</author><author>Pandey, R. K.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, SUNY at Buffalo, Buffalo, NY 14260, USA.</auth-address><titles><title>New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug</title><secondary-title>Mol Pharm</secondary-title><alt-title>Molecular pharmaceutics</alt-title></titles><pages>289-97</pages><volume>4</volume><number>2</number><edition>2007/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>*Hydrophobicity</keyword><keyword>Light</keyword><keyword>Mice</keyword><keyword>Microscopy, Confocal</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Photochemotherapy/*methods</keyword><keyword>Photosensitizing Agents/*administration &amp; dosage/pharmacokinetics</keyword><keyword>Solubility</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>17266331</accession-num><abstract>A carrier-free method for delivery of a hydrophobic drug in its pure form, using nanocrystals (nanosized crystals), is proposed. To demonstrate this technique, nanocrystals of a hydrophobic photosensitizing anticancer drug, 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide (HPPH), have been synthesized using the reprecipitation method. The resulting drug nanocrystals were monodispersed and stable in aqueous dispersion, without the necessity of an additional stabilizer (surfactant). As shown by confocal microscopy, these pure drug nanocrystals were taken up by the cancer cells with high avidity. Though the fluorescence and photodynamic activity of the drug were substantially quenched in the form of nanocrystals in aqueous suspension, both these characteristics were recovered under in vitro and in vivo conditions. This recovery of drug activity and fluorescence is possibly due to the interaction of nanocrystals with serum albumin, resulting in conversion of the drug nanocrystals into the molecular form. This was confirmed by demonstrating similar recovery in presence of fetal bovine serum (FBS) or bovine serum albumin (BSA). Under similar treatment conditions, the HPPH in nanocrystal form or in 1% Tween-80/water formulation showed comparable in vitro and in vivo efficacy.</abstract><notes>P30 ca16056/ca/nci&#xD;R01 ca119358/ca/nci&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17266331 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>11.03</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>362</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">362</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cinteza, L. O.</author><author>Ohulchanskyy, T. Y.</author><author>Sahoo, Y.</author><author>Bergey, E. J.</author><author>Pandey, R. K.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, SUNY at Buffalo, Buffalo, New York 14260, USA.</auth-address><titles><title>Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy</title><secondary-title>Mol Pharm</secondary-title><alt-title>Molecular pharmaceutics</alt-title></titles><pages>415-23</pages><volume>3</volume><number>4</number><edition>2006/07</edition><keywords><keyword>Chlorophyll/analogs &amp; derivatives/chemistry</keyword><keyword>Drug Carriers/*chemical synthesis/*chemistry</keyword><keyword>Drug Delivery Systems</keyword><keyword>Drug Design</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Magnetics/*therapeutic use</keyword><keyword>Micelles</keyword><keyword>Nanostructures</keyword><keyword>Nanotechnology</keyword><keyword>Phosphatidylethanolamines/chemistry</keyword><keyword>Photochemistry</keyword><keyword>Photochemotherapy/*methods</keyword><keyword>Polyethylene Glycols/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>16889435</accession-num><abstract>We report the design, synthesis using nanochemistry, and characterization of a novel multifunctional polymeric micelle-based nanocarrier system, which demonstrates combined function of magnetophoretically guided drug delivery together with light-activated photodynamic therapy. Specifically, the nanocarrier consists of polymeric micelles of diacylphospholipid-poly(ethylene glycol) (PE-PEG) coloaded with the photosensitizer drug 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH), and magnetic Fe3O4 nanoparticles. The nanocarrier shows excellent stability and activity over several weeks. The physicochemical characterizations have been carried out by transmission electron micrography and optical spectroscopy. An efficient cellular uptake has been confirmed with confocal laser scanning microscopy. The loading efficiency of HPPH is practically unaffected upon coloading with the magnetic nanoparticles, and its phototoxicity is retained. The magnetic response of the nanocarriers was demonstrated by their magnetically directed delivery to tumor cells in vitro. The magnetophoretic control on the cellular uptake provides enhanced imaging and phototoxicity. These multifunctional nanocarriers demonstrate the exciting prospect offered by nanochemistry for targeting photodynamic therapy.</abstract><notes>Ca104492/ca/nci&#xD;Ca55791/ca/nci&#xD;In Vitro&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16889435 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2006</custom3><custom4>11.03</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>604</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">604</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Wang, L.</author><author>Macdonald, R. C.</author></authors></contributors><auth-address>rkoynova@gmail.com.</auth-address><titles><title>Cationic Phospholipids Forming Cubic Phases: Lipoplex Structure and Transfection Efficiency</title><secondary-title>Mol Pharm</secondary-title></titles><edition>2008/06/20</edition><dates><year>2008</year><pub-dates><date>Jun 19</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>18563910</accession-num><abstract>The transfection activity and the phase behavior of two novel cationic O-alkyl-phosphatidylcholines, 1,2-dioleoyl- sn-glycero-3-hexylphosphocholine (C6-DOPC) and 1,2-dierucoyl- sn-glycero-3-ethylphosphocholine (di22:1-EPC), have been examined with the aim of more completely understanding the mechanism of lipid-mediated DNA delivery. Both lipids form cubic phases: C6-DOPC in the entire temperature range from -10 to 90 degrees C, while di22:1-EPC exhibits an irreversible lamellar-cubic transition between 50 and 70 degrees C on heating. The lipoplexes formed by C6-DOPC arrange into hexagonal phase, while the lipoplexes of di22:1-EPC are lamellar. Both lipids exhibit lower transfection activity than the lamellar-forming 1,2-dioleoyl- sn-glycero-3-ethylphosphocholine (EDOPC). Thus, for the studied cationic phospholipid-DNA systems, the lipoplex phase state is a factor that does not seem to correlate with transfection activity. The parameter that exhibits better correlation with the transfection activity within the present data set is the phase state of the lipid dispersion prior to the addition of DNA. Thus, the lamellar lipid dispersion (EDOPC) produces more efficient lipoplexes than the dispersion with coexisting lamellar and cubic aggregates (diC22:1-EPC), which is even more efficient than the purely cubic dispersions (C6-DOPC; diC22:1-EPC after heating). It could be inferred from these data and from previous research that cubic phase lipid aggregates are unlikely to be beneficial to transfection. The lack of correlation between the phase state of lipoplexes and their transfection activity observed within the present data set does not mean that lipid phase state is generally unimportant for lipofection: a viewpoint now emerging from our previous studies is that the critical factor in lipid-mediated transfection is the structural evolution of lipoplexes within the cell, upon interacting and mixing with cellular lipids.</abstract><notes>Journal article&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2008 Jun 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18563910</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>11.030</custom4><electronic-resource-num>10.1021/mp800011e</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>475</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">475</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Synergistic effect between components of mixtures of cationic amphipaths in transfection of primary endothelial cells</title><secondary-title>Mol Pharm</secondary-title></titles><pages>615-23</pages><volume>4</volume><number>4</number><edition>2007/04/06</edition><keywords><keyword>Cations/chemistry</keyword><keyword>Cells, Cultured</keyword><keyword>Endothelial Cells/*metabolism</keyword><keyword>Endothelium, Vascular/cytology</keyword><keyword>Humans</keyword><keyword>Lipids/*chemistry</keyword><keyword>Membrane Fusion</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Models, Structural</keyword><keyword>Phosphatidylcholines/*chemistry</keyword><keyword>Solubility</keyword><keyword>*Transfection</keyword><keyword>Umbilical Arteries/cytology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>17408283</accession-num><abstract>To date, the primary approach to improving the transfection properties of cationic lipids has been the synthesis of new kinds of cationic amphipaths. Recently, however, it was found that combining two cationic lipid derivatives having the same head group but tails of different chain lengths can provide another, and often superior, approach to higher transfection efficiency. For example, the combination of medium-chain and long-chain homologues of O-ethylphosphatidylcholine transfected DNA into primary human umbilical artery endothelial cells (HUAECs) more than 30-fold more efficiently than did either compound separately. Here it is reported that this synergism of mixtures is not limited to O-ethylphosphatidylcholine homologues, but is also exhibited by other common cationic amphipathic transfection reagents; for example, combining DC-Chol (3beta-[N&apos;,N&apos;-dimethylaminoethane)-carbamol] cholesterol), dimethylditetradecylammonium bromide, or DMTAP (1,2-dimyristoyl-3-trimethylammonium-propane) with EDOPC increased transfection significantly both in the absence and in the presence of serum. Furthermore, combining a poorer transfection agent-dimethyldioctadecylammonium bromide-with dimethylditetradecylammonium bromide increased transfection by about an order of magnitude with a maximum at an intermediate composition. Lack of synergy occurred with some mixtures, such as DMTAP and DOTAP (1,2-dioleoyl-3-trimethylammonium-propane), in which case transfection activity was a linear function of composition both in the absence and presence of serum. Although the mechanism of enhanced transfection by mixtures is not fully understood, the existence of a number of optimal mixtures with diverse cationic compounds indicates that attention to mixture formulations can lead to greatly improved transfection by cationic amphipathic carriers.</abstract><notes>Wang, Li&#xD;MacDonald, Robert C&#xD;GM074429/GM/United States NIGMS&#xD;GM52329/GM/United States NIGMS&#xD;GM57305/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2007 Jul-Aug;4(4):615-23. Epub 2007 Apr 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17408283</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>11.03</custom4><electronic-resource-num>10.1021/mp0601291</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>694</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">694</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zheng, Q.</author><author>Bonoiu, A.</author><author>Ohulchanskyy, T. Y.</author><author>He, G. S.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Department of Chemistry, Institute for Lasers, Photonics, and Biophotonics, State University of New York at Buffalo, Buffalo, New York 14260, USA.</auth-address><titles><title>Water-soluble two-photon absorbing nitrosyl complex for light-activated therapy through nitric oxide release</title><secondary-title>Mol Pharm</secondary-title></titles><pages>389-98</pages><volume>5</volume><number>3</number><edition>2008/02/20</edition><dates><year>2008</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>18281943</accession-num><abstract>A water-soluble nitrosyl complex with large two-photon absorption was synthesized by incorporating a two-photon absorbing chromophore with tetra(ethylene glycol) units, into the Roussin&apos;s red salt. The nitrosyl complex exhibits quenched emission due to energy transfer from the two-photon chromophore to the Roussin&apos;s red salt. The nitric oxide (NO) release induced by one- or two-photon irradiation was detected by EPR spectroscopy with a chemical probe, the Fe(II)- N-(dithiocarbamoyl)- N-methyl- d-glucamine (Fe-MGD) complex. Increased one- or two-photon excited fluorescence, with a concomitant photochemical release of NO, was observed upon one- or two-photon light irradiation. With the observed light-dependent cytotoxicity against cancer cells of the water-soluble nitrosyl complex, it was demonstrated that two-photon-functionalized nitrosyl complexes can be effective NO donors for light-activated treatment.</abstract><notes>Zheng, Qingdong&#xD;Bonoiu, Adela&#xD;Ohulchanskyy, Tymish Y&#xD;He, Guang S&#xD;Prasad, Paras N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2008 May-Jun;5(3):389-98. Epub 2008 Feb 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18281943</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>11.03</custom4><electronic-resource-num>10.1021/mp700117s</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>657</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">657</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, A.</author><author>Paunesku, T.</author><author>Brown, E.M.B.</author><author>Babbo, A.</author><author>Cruz, C.</author><author>Aslam, M.</author><author>Dravid, V.</author><author>Woloschak, G.E</author></authors></contributors><titles><title>Titanium Dioxide Nanoparticles Assembled by DNA Molecules Hybridization and Loading of DNA Interacting Proteins</title><secondary-title>Nano</secondary-title></titles><pages>27-36</pages><volume>3</volume><number>1</number><edition>2008/07</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>443</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">443</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Anikeeva, P. O.</author><author>Halpert, J. E.</author><author>Bawendi, M. G.</author><author>Bulovic, V.</author></authors></contributors><auth-address>Laboratory of Organic Optics and Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Electroluminescence from a mixed red-green-blue colloidal quantum dot monolayer</title><secondary-title>Nano Lett</secondary-title></titles><pages>2196-200</pages><volume>7</volume><number>8</number><edition>2007/07/10</edition><keywords><keyword>Colloids/chemistry</keyword><keyword>Color</keyword><keyword>Crystallization/*methods</keyword><keyword>Electrochemistry/*instrumentation/methods</keyword><keyword>Light</keyword><keyword>Lighting/instrumentation/*methods</keyword><keyword>Luminescent Measurements/*instrumentation/methods</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Molecular Conformation</keyword><keyword>Nanostructures/*chemistry/radiation effects/ultrastructure</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17616230</accession-num><abstract>We demonstrate light emitting devices (LEDs) with a broad spectral emission generated by electroluminescence from a mixed-monolayer of red, green, and blue emitting colloidal quantum dots (QDs) in a hybrid organic/inorganic structure. The colloidal QDs are reproducibly synthesized and yield high luminescence efficiency materials suitable for LED applications. Independent processing of the organic charge transport layers and the QD luminescent layer allows for precise tuning of the emission spectrum without changing the device structure, simply by changing the ratio of different color QDs in the active layer. Spectral tuning is demonstrated through fabrication of white QD-LEDs that exhibit external quantum efficiencies of 0.36% (Commission Internationale de l&apos;Eclairage) coordinates of (0.35, 0.41) at video brightness, and color rendering index of 86 as compared to a 5500 K blackbody reference.</abstract><notes>Anikeeva, Polina O&#xD;Halpert, Jonathan E&#xD;Bawendi, Moungi G&#xD;Bulovic, Vladimir&#xD;Evaluation Studies&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Aug;7(8):2196-200. Epub 2007 Jul 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17616230</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl0703424</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>445</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">445</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bhaviripudi, S.</author><author>Qi, J.</author><author>Hu, E. L.</author><author>Belcher, A. M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Synthesis, characterization, and optical properties of ordered arrays of III-nitride nanocrystals</title><secondary-title>Nano Lett</secondary-title></titles><pages>3512-7</pages><volume>7</volume><number>11</number><edition>2007/10/24</edition><keywords><keyword>Crystallization</keyword><keyword>Gallium/*chemistry</keyword><keyword>Luminescence</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Micelles</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Models, Chemical</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Nitrogen/*chemistry</keyword><keyword>Oxygen/chemistry</keyword><keyword>Photochemistry/methods</keyword><keyword>Polymers/chemistry</keyword><keyword>Silicon/chemistry</keyword><keyword>Spectrophotometry/methods</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17949047</accession-num><abstract>A new approach involving self-assembling block copolymer micellar templates and gas-phase reactions to synthesize arrays of monodisperse III-nitrides nanocrystals in the size range of 1-5 nm with uniform spacings between the nanoparticles is demonstrated. The photoluminescence emission spectra revealed the GaN nanocrystals are in the quantum-confined regime. This method not only offers great promise for the controlled synthesis of arrays of ternary III-nitride nanocrystals but may also enable doping in binary nitrides.</abstract><notes>Bhaviripudi, Sreekar&#xD;Qi, Jifa&#xD;Hu, Evelyn L&#xD;Belcher, Angela M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Nov;7(11):3512-7. Epub 2007 Oct 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17949047</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl072129d</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>449</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">449</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bleszynski, A. C.</author><author>Zwanenburg, F. A.</author><author>Westervelt, R. M.</author><author>Roest, A. L.</author><author>Bakkers, E. P.</author><author>Kouwenhoven, L. P.</author></authors></contributors><auth-address>Department of Physics and School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, USA.</auth-address><titles><title>Scanned probe imaging of quantum dots inside InAs nanowires</title><secondary-title>Nano Lett</secondary-title></titles><pages>2559-62</pages><volume>7</volume><number>9</number><edition>2007/08/19</edition><keywords><keyword>Arsenicals/*chemistry</keyword><keyword>Electron Transport</keyword><keyword>Indium/*chemistry</keyword><keyword>Materials Testing</keyword><keyword>Microscopy, Scanning Probe/*methods</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Nanotubes/*chemistry/*ultrastructure</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17691848</accession-num><abstract>We show how a scanning probe microscope (SPM) can be used to image electron flow through InAs nanowires, elucidating the physics of nanowire devices on a local scale. A charged SPM tip is used as a movable gate. Images of nanowire conductance versus tip position spatially map the conductance of InAs nanowires at liquid-He temperatures. Plots of conductance versus backgate voltage without the tip present show complex patterns of Coulomb-blockade peaks. Images of nanowire conductance identify their source as multiple quantum dots formed by disorder along the nanowire--each dot is surrounded by a series of concentric rings corresponding to Coulomb blockade peaks. An SPM image locates the dots and provides information about their size. In this way, SPM images can be used to understand the features that control transport through nanowires. The nanowires were grown from metal catalyst particles and have diameters approximately 80 nm and lengths 2-3 microm.</abstract><notes>Bleszynski, Ania C&#xD;Zwanenburg, Floris A&#xD;Westervelt, R M&#xD;Roest, Aarnoud L&#xD;Bakkers, Erik P A M&#xD;Kouwenhoven, Leo P&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Sep;7(9):2559-62. Epub 2007 Aug 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17691848</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl0621037</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>201</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">201</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Shin, D. W.</author><author>Chen, K.</author><author>Gheysens, O.</author><author>Cao, Q.</author><author>Wang, S. X.</author><author>Gambhir, S. S.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, USA.</auth-address><titles><title>Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects</title><secondary-title>Nano Lett</secondary-title></titles><pages>669-76</pages><volume>6</volume><number>4</number><edition>2006/04/13</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Coated Materials, Biocompatible/analysis/chemical synthesis</keyword><keyword>Glioblastoma/*blood supply/metabolism/*pathology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Neovascularization, Pathologic/metabolism/*pathology</keyword><keyword>Oligopeptides/chemistry/*diagnostic use/pharmacokinetics</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword><keyword>Spectrophotometry, Infrared/*methods</keyword><keyword>Whole Body Imaging/methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16608262</accession-num><abstract>We report the in vivo targeting and imaging of tumor vasculature using arginine-glycine-aspartic acid (RGD) peptide-labeled quantum dots (QDs). Athymic nude mice bearing subcutaneous U87MG human glioblastoma tumors were administered QD705-RGD intravenously. The tumor fluorescence intensity reached maximum at 6 h postinjection with good contrast. The results reported here open up new perspectives for integrin-targeted near-infrared optical imaging and may aid in cancer detection and management including imaging-guided surgery.</abstract><notes>Cai, Weibo&#xD;Shin, Dong-Woon&#xD;Chen, Kai&#xD;Gheysens, Olivier&#xD;Cao, Qizhen&#xD;Wang, Shan X&#xD;Gambhir, Sanjiv S&#xD;Chen, Xiaoyuan&#xD;1u54ca119367-01/ca/nci&#xD;P50 ca114747/ca/nci&#xD;R21 ca102123/ca/nci&#xD;R21 eb001785/eb/nibib&#xD;R24 ca93862/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Apr;6(4):669-76.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16608262</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>9.96</custom4><electronic-resource-num>10.1021/nl052405t</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>581</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">581</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dennis, A. M.</author><author>Bao, G.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, Georgia 30332, USA.</auth-address><titles><title>Quantum dot-fluorescent protein pairs as novel fluorescence resonance energy transfer probes</title><secondary-title>Nano Lett</secondary-title></titles><pages>1439-45</pages><volume>8</volume><number>5</number><edition>2008/04/17</edition><keywords><keyword>Crystallization/*methods</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>Histidine/*chemistry</keyword><keyword>Materials Testing</keyword><keyword>Molecular Conformation</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18412403</accession-num><abstract>Fluorescence resonance energy transfer (FRET) characteristics, including the efficiency, donor-acceptor distance, and binding strength of six fluorescent protein (FP)-quantum dot (QD) pairs were quantified, demonstrating that FPs are efficient acceptors for QD donors with up to 90% quenching of QD fluorescence and that polyhistidine coordination to QD core-shell surface is a straightforward and effective means of conjugating proteins to commercially available QDs. This provides a novel approach to developing QD-based FRET probes for biomedical applications.</abstract><notes>Dennis, Allison M&#xD;Bao, Gang&#xD;CA119338/CA/United States NCI&#xD;HL-80711/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 May;8(5):1439-45. Epub 2008 Apr 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18412403</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl080358+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>397</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">397</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gao, Y.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Electrostatic potential in a bent piezoelectric nanowire. The fundamental theory of nanogenerator and nanopiezotronics</title><secondary-title>Nano Lett</secondary-title></titles><pages>2499-505</pages><volume>7</volume><number>8</number><edition>2007/07/25</edition><keywords><keyword>Computer Simulation</keyword><keyword>Elasticity</keyword><keyword>*Electric Power Supplies</keyword><keyword>Electromagnetic Fields</keyword><keyword>Electronics/*instrumentation</keyword><keyword>Electrostatics</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>*Models, Chemical</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Nanotubes/*chemistry</keyword><keyword>*Transducers</keyword><keyword>Vibration</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17645367</accession-num><abstract>We have applied the perturbation theory for calculating the piezoelectric potential distribution in a nanowire (NW) as pushed by a lateral force at the tip. The analytical solution given under the first-order approximation produces a result that is within 6% from the full numerically calculated result using the finite element method. The calculation shows that the piezoelectric potential in the NW almost does not depend on the z-coordinate along the NW unless very close to the two ends, meaning that the NW can be approximately taken as a &quot;parallel plated capacitor&quot;. This is entirely consistent to the model established for nanopiezotronics, in which the potential drop across the nanowire serves as the gate voltage for the piezoelectric field effect transistor. The maximum potential at the surface of the NW is directly proportional to the lateral displacement of the NW and inversely proportional to the cube of its length-to-diameter aspect ratio. The magnitude of piezoelectric potential for a NW of diameter 50 nm and length 600 nm is approximately 0.3 V. This voltage is much larger than the thermal voltage ( approximately 25 mV) and is high enough to drive the metal-semiconductor Schottky diode at the interface between atomic force microscope tip and the ZnO NW, as assumed in our original mechanism for the nanogenerators.</abstract><notes>Gao, Yifan&#xD;Wang, Zhong Lin&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Aug;7(8):2499-505. Epub 2007 Jul 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17645367</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl071310j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>463</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">463</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Giljohann, D. A.</author><author>Seferos, D. S.</author><author>Patel, P. C.</author><author>Millstone, J. E.</author><author>Rosi, N. L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles</title><secondary-title>Nano Lett</secondary-title></titles><pages>3818-21</pages><volume>7</volume><number>12</number><edition>2007/11/14</edition><keywords><keyword>Biological Transport</keyword><keyword>DNA/*chemistry/pharmacokinetics</keyword><keyword>Gold/*chemistry</keyword><keyword>Hela Cells/metabolism</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligodeoxyribonucleotides/*chemistry/pharmacokinetics</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17997588</accession-num><abstract>The cellular internalization of oligonucleotide-modified nanoparticles is investigated. Uptake is dependent on the density of the oligonucleotide loading on the surface of the particles, where higher densities lead to greater uptake. Densely functionalized nanoparticles adsorb a large number of proteins on the nanoparticle surface. Nanoparticle uptake is greatest where a large number of proteins are associated with the particle.</abstract><notes>Giljohann, David A&#xD;Seferos, Dwight S&#xD;Patel, Pinal C&#xD;Millstone, Jill E&#xD;Rosi, Nathaniel L&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Dec;7(12):3818-21. Epub 2007 Nov 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17997588</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl072471q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>596</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">596</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hill, H. D.</author><author>Macfarlane, R. J.</author><author>Senesi, A. J.</author><author>Lee, B.</author><author>Park, S. Y.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>chadnano@northwestern.edu.</auth-address><titles><title>Controlling the Lattice Parameters of Gold Nanoparticle FCC Crystals with Duplex DNA Linkers</title><secondary-title>Nano Lett</secondary-title></titles><edition>2008/06/25</edition><dates><year>2008</year><pub-dates><date>Jun 24</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18572967</accession-num><abstract>DNA-functionalized gold nanoparticles can be used to induce the formation and control the unit cell parameters of highly ordered face-centered cubic crystal lattices. Nanoparticle spacing increases linearly with longer DNA interconnect length, yielding maximum unit cell parameters of 77 nm and 0.52% inorganic-filled space for the DNA constructs studied. In general, we show that longer DNA connections result in a decrease in the overall crystallinity and order of the lattice due to greater conformational flexibility.</abstract><notes>Journal article&#xD;Nano letters&#xD;Nano Lett. 2008 Jun 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18572967</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl8011787</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>440</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">440</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, H.</author><author>Dorn, A.</author><author>Nair, G. P.</author><author>Bulovic, V.</author><author>Bawendi, M. G.</author></authors></contributors><auth-address>Department of Chemistry, Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Bias-induced photoluminescence quenching of single colloidal quantum dots embedded in organic semiconductors</title><secondary-title>Nano Lett</secondary-title></titles><pages>3781-6</pages><volume>7</volume><number>12</number><edition>2007/11/24</edition><keywords><keyword>Colloids/*chemistry</keyword><keyword>Diamines/chemistry</keyword><keyword>Luminescence</keyword><keyword>Organic Chemicals/*chemistry</keyword><keyword>Quantum Theory</keyword><keyword>*Semiconductors</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18034504</accession-num><abstract>We demonstrate reversible quenching of the photoluminescence from single CdSe/ZnS colloidal quantum dots embedded in thin films of the molecular organic semiconductor N,N&apos;-diphenyl-N,N&apos;-bis(3-methylphenyl)-(1,1&apos;-biphenyl)-4,4&apos;-diamine (TPD) in a layered device structure. Our analysis, based on current and charge carrier density, points toward field ionization as the dominant photoluminescence quenching mechanism. Blinking traces from individual quantum dots reveal that the photoluminescence amplitude decreases continuously as a function of increasing forward bias even at the single quantum dot level. In addition, we show that quantum dot photoluminescence is quenched by aluminum tris(8-hydroxyquinoline) (Alq3) in chloroform solutions as well as in thin solid films of Alq3 whereas TPD has little effect. This highlights the importance of chemical compatibility between semiconductor nanocrystals and surrounding organic semiconductors. Our study helps elucidate elementary interactions between quantum dots and organic semiconductors, knowledge needed for designing efficient quantum dot organic optoelectronic devices.</abstract><notes>Huang, Hao&#xD;Dorn, August&#xD;Nair, Gautham P&#xD;Bulovic, Vladimir&#xD;Bawendi, Moungi G&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Dec;7(12):3781-6. Epub 2007 Nov 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18034504</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl072263y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>139</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">139</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. S.</author><author>Lytton-Jean, A. K.</author><author>Hurst, S. J.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Silver nanoparticle-oligonucleotide conjugates based on DNA with triple cyclic disulfide moieties</title><secondary-title>Nano Lett</secondary-title></titles><pages>2112-5</pages><volume>7</volume><number>7</number><edition>2007/06/19</edition><keywords><keyword>*Dna</keyword><keyword>*Disulfides</keyword><keyword>*Metal Nanoparticles</keyword><keyword>*Oligonucleotides</keyword><keyword>*Phosphoric Acid Esters</keyword><keyword>*Silver</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17571909</accession-num><abstract>We report a new strategy for preparing silver nanoparticle-oligonucleotide conjugates that are based upon DNA with cyclic disulfide-anchoring groups. These particles are extremely stable and can withstand NaCl concentrations up to 1.0 M. When silver nanoparticles functionalized with complementary sequences are combined, they assemble to form DNA-linked nanoparticle networks. This assembly process is reversible with heating and is associated with a red shifting of the particle surface plasmon resonance and a concomitant color change from yellow to pale red. Analogous to the oligonucleotide-functionalized gold nanoparticles, these particles also exhibit highly cooperative binding properties with extremely sharp melting transitions. This work is an important step toward using silver nanoparticle-oligonucleotide conjugates for a variety of purposes, including molecular diagnostic labels, synthons in programmable materials synthesis approaches, and functional components for nanoelectronic and plasmonic devices.</abstract><notes>Lee, Jae-Seung&#xD;Lytton-Jean, Abigail K R&#xD;Hurst, Sarah J&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Jul;7(7):2112-5. Epub 2007 Jun 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17571909</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>9.96</custom4><electronic-resource-num>10.1021/nl071108g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>366</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">366</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ohulchanskyy, T. Y.</author><author>Roy, I.</author><author>Goswami, L. N.</author><author>Chen, Y.</author><author>Bergey, E. J.</author><author>Pandey, R. K.</author><author>Oseroff, A. R.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute of Lasers, Photonics and Biophotonics, Department of Chemistry, State University of New York, Buffalo, New York, and PDT Center, Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, New York.</auth-address><titles><title>Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><pages>2835-42</pages><volume>7</volume><number>9</number><edition>2007/09</edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17718587</accession-num><abstract>We report a novel nanoformulation of a photosensitizer (PS), for photodynamic therapy (PDT) of cancer, where the PS molecules are covalently incorporated into organically modified silica (ORMOSIL) nanoparticles. We found that the covalently incorporated PS molecules retained their spectroscopic and functional properties and could robustly generate cytotoxic singlet oxygen molecules upon photoirradiation. The synthesized nanoparticles are of ultralow size ( approximately 20 nm) and are highly monodispersed and stable in aqueous suspension. The advantage offered by this covalently linked nanofabrication is that the drug is not released during systemic circulation, which is often a problem with physical encapsulation. These nanoparticles are also avidly uptaken by tumor cells in vitro and demonstrate phototoxic action, thereby highlighting their potential in diagnosis and PDT of cancer.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17718587 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom2>Yes- Prasad and Oseroff CNPPs</custom2><custom3>2007</custom3><custom4>9.96</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>161</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">161</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, T.</author><author>Vogt, S.</author><author>Lai, B.</author><author>Maser, J.</author><author>Stojicevic, N.</author><author>Thurn, K. T.</author><author>Osipo, C.</author><author>Liu, H.</author><author>Legnini, D.</author><author>Wang, Z.</author><author>Lee, C.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology, Northwestern University, Chicago, Illinois 60611, USA.</auth-address><titles><title>Intracellular distribution of TiO2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity</title><secondary-title>Nano Lett</secondary-title></titles><pages>596-601</pages><volume>7</volume><number>3</number><edition>2007/02/06</edition><keywords><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>Cell Line</keyword><keyword>Cell Nucleolus/*metabolism/ultrastructure</keyword><keyword>DNA, Mitochondrial/metabolism</keyword><keyword>Humans</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Microscopy, Electron</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Mitochondria/*metabolism/ultrastructure</keyword><keyword>Nanotechnology</keyword><keyword>Oligodeoxyribonucleotides/*chemistry/*metabolism</keyword><keyword>PC12 Cells</keyword><keyword>Rats</keyword><keyword>Titanium/*chemistry/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17274661</accession-num><abstract>Deoxyribonucleic acid (DNA) oligonucleotides hybridize to matching DNA sequences in cells, as established in the literature, depending on active transcription of the target sequence and local molarity of the oligonucleotide. We investigated the intracellular distribution of nanoconjugates composed of DNA oligonucleotides attached to TiO2 nanoparticles, thus creating a locally increased concentration of the oligonucleotide. Two types of nanoconjugates, with oligonucleotides matching mitochondrial or nucleolar DNA, were specifically retained in mitochondria or nucleoli.</abstract><notes>Paunesku, Tatjana&#xD;Vogt, Stefan&#xD;Lai, Barry&#xD;Maser, Jorg&#xD;Stojicevic, Natasa&#xD;Thurn, Kenneth T&#xD;Osipo, Clodia&#xD;Liu, Hong&#xD;Legnini, Daniel&#xD;Wang, Zhou&#xD;Lee, Chung&#xD;Woloschak, Gayle E&#xD;Ca107467/ca/nci&#xD;Eb002100/eb/nibib&#xD;P50 ca89018/ca/nci&#xD;U54ca119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Mar;7(3):596-601. Epub 2007 Feb 3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17274661</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>9.96</custom4><electronic-resource-num>10.1021/nl0624723</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>37</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">37</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Quinti, L.</author><author>Weissleder, R.</author><author>Tung, C. H.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, 02129, USA.</auth-address><titles><title>A fluorescent nanosensor for apoptotic cells</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><pages>488-90</pages><volume>6</volume><number>3</number><edition>2006/03</edition><keywords><keyword>*Apoptosis</keyword><keyword>Biosensing Techniques/*instrumentation/*methods</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescence</keyword><keyword>Fluorescent Dyes/*analysis</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Molecular Structure</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Nanotechnology/*instrumentation/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16522048</accession-num><abstract>A biocompatible surface-functionalized nanoparticle was designed to sense phosphatidylserine exposed on apoptotic cells. We conjugated synthetic artificial phosphatidylserine binding ligands in a multivalent fashion onto magnetofluorescent nanoparticles. Our results show that (1) the synthetic nanoparticles bind to apoptotic cells, (2) there is excellent correlation with annexin V staining by microscopy, and (3) FACS analysis with nanoparticles allows the measurement of therapeutic apoptosis induction. The described nanomaterials should be useful for a variety of biomedical applications including in vivo imaging of apoptosis.</abstract><notes>P50-ca86355/ca/nci&#xD;R01 ca99385/ca/nci&#xD;R21 ca114149/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16522048 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>9.96</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>325</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">325</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seleverstov, O.</author><author>Zabirnyk, O.</author><author>Zscharnack, M.</author><author>Bulavina, L.</author><author>Nowicki, M.</author><author>Heinrich, J. M.</author><author>Yezhelyev, M.</author><author>Emmrich, F.</author><author>O&apos;Regan, R.</author><author>Bader, A.</author></authors></contributors><auth-address>Center for Biotechnology and Biomedicine (BBZ), University of Leipzig, D-04103 Leipzig, Germany. alex_seleverstov@yahoo.de</auth-address><titles><title>Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation</title><secondary-title>Nano Lett</secondary-title></titles><pages>2826-32</pages><volume>6</volume><number>12</number><edition>2006/12/14</edition><keywords><keyword>*Autophagy</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Membrane/metabolism/ultrastructure</keyword><keyword>Cell Survival</keyword><keyword>Cells, Cultured</keyword><keyword>Coculture Techniques</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Mesenchymal Stem Cells/metabolism/*physiology/ultrastructure</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Microtubule-Associated Proteins/metabolism</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17163713</accession-num><abstract>Lately certain cytotoxicity of quantum dots (QDs) and some deleterious effects of labeling procedure on stem cells differentiation abilities were shown. In the present study we compared cytotoxicity and intracellular processing of two different-sized protein-conjugated QDs after labeling of the human mesenchymal stem cells (hMSC). An asymmetrical intracellular uptake of red (605 nm) and green (525 nm) quantum dots was observed. We describe for the first time a size-dependent activation of autophagy, caused by nanoparticles.</abstract><notes>Seleverstov, Oleksandr&#xD;Zabirnyk, Olga&#xD;Zscharnack, Matthias&#xD;Bulavina, Larysa&#xD;Nowicki, Marcin&#xD;Heinrich, Jan-Michael&#xD;Yezhelyev, Maksym&#xD;Emmrich, Frank&#xD;O&apos;Regan, Ruth&#xD;Bader, Augustinus&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Dec;6(12):2826-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17163713</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>9.96</custom4><electronic-resource-num>10.1021/nl0619711</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>541</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">541</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, B. R.</author><author>Cheng, Z.</author><author>De, A.</author><author>Koh, A. L.</author><author>Sinclair, R.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, and Department of Materials Science and Engineering, Stanford University, Stanford, California 94305, and Department of Bioengineering, Stanford University School of Medicine, Stanford, California 94305 sgambhir@stanford.edu.</auth-address><titles><title>Real-Time Intravital Imaging of RGD-Quantum Dot Binding to Luminal Endothelium in Mouse Tumor Neovasculature</title><secondary-title>Nano Lett</secondary-title></titles><edition>2008/04/05</edition><dates><year>2008</year><pub-dates><date>Apr 4</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18386933</accession-num><abstract>Nanoscale materials have increasingly become subject to intense investigation for use in cancer diagnosis and therapy. However, there is a fundamental dearth in cellular-level understanding of how nanoparticles interact within the tumor environment in living subjects. Adopting quantum dots (qdots) for their excellent brightness, photostability, monodispersity, and fluorescent yield, we link arginine-glycine-aspartic acid (RGD) peptides to target qdots specifically to newly formed/forming blood vessels expressing alpha vbeta 3 integrins. Using this model nanoparticle system, we exploit intravital microscopy with subcellular ( approximately 0.5 microm) resolution to directly observe and record, for the first time, the binding of nanoparticle conjugates to tumor blood vessels in living subjects. This generalizable method enabled us to show that in this model qdots do not extravasate and, unexpectedly, that they only bind as aggregates rather than individually. This level of understanding is critical on the path toward ensuring regulatory approval of nanoparticles in humans for disease diagnostics and therapeutics. Equally vital, the work provides a platform by which to design and optimize molecularly targeted nanoparticles including quantum dots for applications in living subjects.</abstract><notes>Journal article&#xD;Nano letters&#xD;Nano Lett. 2008 Apr 4;.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18386933</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl080141f</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>636</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">636</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soman, N. R.</author><author>Lanza, G. M.</author><author>Heuser, J. M.</author><author>Schlesinger, P. H.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, MI 63110, USA.</auth-address><titles><title>Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides</title><secondary-title>Nano Lett</secondary-title></titles><pages>1131-6</pages><volume>8</volume><number>4</number><edition>2008/02/28</edition><keywords><keyword>Antineoplastic Agents/*administration &amp; dosage/pharmacology</keyword><keyword>Circular Dichroism</keyword><keyword>*Drug Carriers</keyword><keyword>Fluorescence</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Melitten/*administration &amp; dosage/pharmacology</keyword><keyword>*Nanostructures</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18302330</accession-num><abstract>The therapeutic potential of cytolytic peptides is plagued by nonspecificity and enzymatic degradation. We report the first stable incorporation of melittin (a 26 amino acid amphipathic peptide) into an outer lipid monolayer of perfluorocarbon nanoparticles. Melittin binds avidly to the nanoparticles (dissociation constant approximately 3.27 nM) and retains its pore-forming activity after contact-mediated delivery to model bilayer membrane (liposomes) thereby demonstrating the effectiveness of perfluorocarbon nanoparticles as unique nanocarriers for cytolytic peptides.</abstract><notes>Soman, Neelesh R&#xD;Lanza, Gregory M&#xD;Heuser, John M&#xD;Schlesinger, Paul H&#xD;Wickline, Samuel A&#xD;R01 HL 073646/HL/United States NHLBI&#xD;U54 CA119342/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 Apr;8(4):1131-6. Epub 2008 Feb 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18302330</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl073290r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>322</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">322</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Song, J.</author><author>Zhou, J.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Piezoelectric and semiconducting coupled power generating process of a single ZnO belt/wire. A technology for harvesting electricity from the environment</title><secondary-title>Nano Lett</secondary-title></titles><pages>1656-62</pages><volume>6</volume><number>8</number><edition>2006/08/10</edition><keywords><keyword>Electric Conductivity</keyword><keyword>*Electric Power Supplies</keyword><keyword>*Electricity</keyword><keyword>Electrochemistry/*instrumentation/methods</keyword><keyword>Energy Transfer</keyword><keyword>Environment</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Mechanics</keyword><keyword>Motion</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Nanotubes/*chemistry</keyword><keyword>Semiconductors</keyword><keyword>Technology</keyword><keyword>*Transducers</keyword><keyword>Vibration</keyword><keyword>Zinc Oxide/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16895352</accession-num><abstract>This paper presents the experimental observation of piezoelectric generation from a single ZnO wire/belt for illustrating a fundamental process of converting mechanical energy into electricity at nanoscale. By deflecting a wire/belt using a conductive atomic force microscope tip in contact mode, the energy is first created by the deflection force and stored by piezoelectric potential, and later converts into piezoelectric energy. The mechanism of the generator is a result of coupled semiconducting and piezoelectric properties of ZnO. A piezoelectric effect is required to create electric potential of ionic charges from elastic deformation; semiconducting property is necessary to separate and maintain the charges and then release the potential via the rectifying behavior of the Schottky barrier at the metal-ZnO interface, which serves as a switch in the entire process. The good conductivity of ZnO is rather unique because it makes the current flow possible. This paper demonstrates a principle for harvesting energy from the environment. The technology has the potential of converting mechanical movement energy (such as body movement, muscle stretching, blood pressure), vibration energy (such as acoustic/ultrasonic wave), and hydraulic energy (such as flow of body fluid, blood flow, contraction of blood vessels) into electric energy that may be sufficient for self-powering nanodevices and nanosystems in applications such as in situ, real-time, and implantable biosensing, biomedical monitoring, and biodetection.</abstract><notes>Song, Jinhui&#xD;Zhou, Jun&#xD;Wang, Zhong Lin&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Aug;6(8):1656-62.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16895352</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>9.96</custom4><electronic-resource-num>10.1021/nl060820v</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>46</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">46</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sullivan, B. D.</author><author>Dehlinger, D. A.</author><author>Zlatanovic, S.</author><author>Esener, S. A.</author><author>Heller, M. J.</author></authors></contributors><auth-address>Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.</auth-address><titles><title>Low-frequency electrophoretic actuation of nanoscale optoentropic transduction mechanisms</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><pages>950-5</pages><volume>7</volume><number>4</number><edition>2007/04</edition><keywords><keyword>Biosensing Techniques/*methods</keyword><keyword>DNA/*chemistry</keyword><keyword>Electrophoresis/*methods</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>In Situ Hybridization/*methods</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Sequence Analysis, DNA/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17355161</accession-num><abstract>Inherent bistabilities within DNA-assembled fluorescent resonant energy transfer systems demonstrated time-varying optical signals in response to an electrophoretic driving force. Frequency responses of electrophoretically driven FRET systems were shown to be sequence specific. Integration of these signals over time gave near single-molecule sensitivity within a high background of autofluorescence. This research suggests that externally driven nanoscale mechanical systems may help improve information flow within morphologically intact specimens.</abstract><notes>U54 ca119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17355161 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>9.96</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>396</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">396</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Liu, J.</author><author>Song, J.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Integrated nanogenerators in biofluid</title><secondary-title>Nano Lett</secondary-title></titles><pages>2475-9</pages><volume>7</volume><number>8</number><edition>2007/07/03</edition><keywords><keyword>Body Fluids/*chemistry</keyword><keyword>*Electricity</keyword><keyword>Electrochemistry/*instrumentation/methods</keyword><keyword>Energy Transfer</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Microfluidic Analytical Techniques/*instrumentation</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Systems Integration</keyword><keyword>*Transducers</keyword><keyword>Zinc Oxide/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17604406</accession-num><abstract>We have demonstrated a prototype ZnO nanowire based nanogenerator (NG) that can effectively generate electricity inside biofluid when stimulated by ultrasonic waves. The potential of increasing output current and voltage was illustrated by connecting multiple NGs in parallel and serial, respectively, clearly demonstrating the possibility of raising output power by three-dimensional integration and architecture. The output current was increased by 20-30 times and reached as high as 35 nA when a 2 mm2 size NG was placed at a region where the ultrasonic waves were focused. This work unambiguously shows the feasibility of NGs for power conversion inside biofluid. It sets a solid foundation for self-powering implantable and wireless nanodevices and nanosystems in biofluid and any other type of liquid.</abstract><notes>Wang, Xudong&#xD;Liu, Jin&#xD;Song, Jinhui&#xD;Wang, Zhong Lin&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Aug;7(8):2475-9. Epub 2007 Jun 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17604406</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl0712567</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>326</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">326</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Zhou, J.</author><author>Song, J.</author><author>Liu, J.</author><author>Xu, N.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Piezoelectric field effect transistor and nanoforce sensor based on a single ZnO nanowire</title><secondary-title>Nano Lett</secondary-title></titles><pages>2768-72</pages><volume>6</volume><number>12</number><edition>2006/12/14</edition><keywords><keyword>Elasticity</keyword><keyword>Nanowires/*chemistry</keyword><keyword>Semiconductors</keyword><keyword>Stress, Mechanical</keyword><keyword>Surface Properties</keyword><keyword>Transistors</keyword><keyword>Zinc Oxide/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17163703</accession-num><abstract>Utilizing the coupled piezoelectric and semiconducting dual properties of ZnO, we demonstrate a piezoelectric field effect transistor (PE-FET) that is composed of a ZnO nanowire (NW) (or nanobelt) bridging across two Ohmic contacts, in which the source to drain current is controlled by the bending of the NW. A possible mechanism for the PE-FET is suggested to be associated with the carrier trapping effect and the creation of a charge depletion zone under elastic deformatioin. This PE-FET has been applied as a force/pressure sensor for measuring forces in the nanonewton range and even smaller with the use of smaller NWs. An almost linear relationship between the bending force and the conductance was found at small bending regions, demonstrating the principle of nanowire-based nanoforce and nanopressure sensors.</abstract><notes>Wang, Xudong&#xD;Zhou, Jun&#xD;Song, Jinhui&#xD;Liu, Jin&#xD;Xu, Ningsheng&#xD;Wang, Zhong L&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Dec;6(12):2768-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17163703</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>9.96</custom4><electronic-resource-num>10.1021/nl061802g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>514</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">514</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Welsher, K.</author><author>Liu, Z.</author><author>Daranciang, D.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules</title><secondary-title>Nano Lett</secondary-title></titles><pages>586-90</pages><volume>8</volume><number>2</number><edition>2008/01/17</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media/chemistry</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Lymphoma/*pathology</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Nanotubes, Carbon/*analysis</keyword><keyword>Spectrophotometry, Infrared/*methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18197719</accession-num><abstract>Fluorescent molecules emitting in the near-infrared (NIR, wavelength approximately 0.8-2 microm) are relatively scarce and have been actively sought for biological applications because cells and tissues exhibit little auto-fluorescence in this region. Here, we report the use of semiconducting single-walled carbon nanotubes (SWNTs) as near-infrared fluorescent tags for selective probing of cell surface receptors and cell imaging. Biologically inert SWNTs with polyethyleneglycol functionalization are conjugated to antibodies such as Rituxan to selectively recognize CD20 cell surface receptor on B-cells with little nonspecific binding to negative T-cells and Herceptin to recognize HER2/neu positive breast cancer cells. We image selective SWNT-antibody binding to cells by detecting the intrinsic NIR photoluminescence of nanotubes. We observe ultralow NIR autofluorescence for various cells, an advantageous feature over high autofluorescence and large variations between cells lines in the visible. This establishes SWNTs as novel NIR fluorophors for sensitive and selective biological detections and imaging in vitro and potentially in vivo. Further, our results clearly show that the interactions between carbon nanotubes and living cells are strongly dependent on surface functionalization of nanotubes.</abstract><notes>Welsher, Kevin&#xD;Liu, Zhuang&#xD;Daranciang, Dan&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 Feb;8(2):586-90. Epub 2008 Jan 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18197719</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>9.627</custom4><electronic-resource-num>10.1021/nl072949q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>368</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">368</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yong, K. T.</author><author>Qian, J.</author><author>Roy, I.</author><author>Lee, H. H.</author><author>Bergey, E. J.</author><author>Tramposch, K. M.</author><author>He, S.</author><author>Swihart, M. T.</author><author>Maitra, A.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, University at Buffalo, The State University of New York, Buffalo, New York 14260-4200, USA.</auth-address><titles><title>Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><pages>761-5</pages><volume>7</volume><number>3</number><edition>2007/03</edition><keywords><keyword>Fluorescent Dyes</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Microscopy, Confocal</keyword><keyword>Microscopy, Electron</keyword><keyword>Microscopy, Fluorescence, Multiphoton</keyword><keyword>Molecular Probes/chemistry</keyword><keyword>Nanotechnology</keyword><keyword>Nanotubes/*chemistry/ultrastructure</keyword><keyword>*Quantum Dots</keyword><keyword>Transferrin/pharmacokinetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17288490</accession-num><abstract>Live cell imaging using CdSe/CdS/ZnS quantum rods (QRs) as targeted optical probes is reported. The QRs, synthesized in organic media using a binary surfactant mixture, were dispersed in aqueous media using mercaptoundecanoic acid (MUA) and lysine. Transferrin (Tf) was linked to the QRs to produce QR-Tf bioconjugates that were used for targeted in vitro delivery to a human cancer cell line. Confocal and two-photon imaging were used to confirm receptor-mediated uptake of QR-Tf conjugates into the HeLa cells, which overexpress the transferrin receptor (TfR). Uptake was not observed with QRs that lacked Tf functionalization or with cells that were presaturated with free Tf and then treated with Tf-functionalized QRs.</abstract><notes>Ca104492/ca/nci&#xD;R01ca119397/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17288490 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>9.96</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>239</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">239</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, Y.</author><author>So, M. K.</author><author>Rao, J.</author></authors></contributors><auth-address>Biophysics, Cancer Biology, and Molecular Imaging Programs, Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, Stanford, California 94305-5484, USA.</auth-address><titles><title>Protease-modulated cellular uptake of quantum dots</title><secondary-title>Nano Lett</secondary-title></titles><pages>1988-92</pages><volume>6</volume><number>9</number><edition>2006/09/14</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Coated Materials, Biocompatible/chemistry/*pharmacokinetics</keyword><keyword>Fibrosarcoma/*metabolism/*pathology</keyword><keyword>Humans</keyword><keyword>Materials Testing</keyword><keyword>Matrix Metalloproteinase 2/chemistry/*pharmacokinetics</keyword><keyword>Matrix Metalloproteinase 7/chemistry/*pharmacokinetics</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16968013</accession-num><abstract>Quantum dots (QDs) are often cell-impermeable and require transporters to facilitate crossing over cell membranes. Here we present a simple and versatile method that utilizes enzymes, matrix metalloprotease 2 (MMP-2) and MMP-7, to modulate the cellular uptake of QDs. QD-peptide conjugates could be efficiently taken up into cells after the MMP treatment. This enzyme-modulated cellular uptake of QDs may be applied to other nanoparticles for biological imaging and selective drug delivery into tumor cells.</abstract><notes>Zhang, Yan&#xD;So, Min Kyung&#xD;Rao, Jianghong&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Sep;6(9):1988-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16968013</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>9.96</custom4><electronic-resource-num>10.1021/nl0611586</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>342</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">342</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gu, F. X.</author><author>Karnik, R.</author><author>Wang, A. Z.</author><author>Alexis, F.</author><author>Levy-Nissenbaum, E.</author><author>Hong, S.</author><author>Langer, R. S.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Gu, Fx&#xD;MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA&#xD;MIT, Dept Chem Engn, Cambridge, MA 02139 USA&#xD;Harvard MIT Ctr Canc Nanotechnol, Cambridge, MA 02139 USA&#xD;MIT, Dept Mech Engn, Cambridge, MA 02139 USA&#xD;Harvard Univ, Sch Med, Brigham &amp; Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA&#xD;Harvard Univ, Sch Med, Brigham &amp; Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA</auth-address><titles><title>Targeted nanoparticles for cancer therapy</title><secondary-title>Nano Today</secondary-title></titles><pages>14-21</pages><volume>2</volume><number>3</number><edition>2007/06</edition><keywords><keyword>chronic lymphocytic-leukemia</keyword><keyword>pegylated liposomal doxorubicin</keyword><keyword>her2-positive breast-cancer</keyword><keyword>consolidative 1st-line chemotherapy</keyword><keyword>monoclonal-antibody therapy</keyword><keyword>stem-cell transplantation</keyword><keyword>chemical-analysis systems</keyword><keyword>ph-sensitive liposomes</keyword><keyword>human tumor xenograft</keyword><keyword>non-hodgkins-lymphoma</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1748-0132</isbn><accession-num>ISI:000246853500014</accession-num><abstract>Over the past decade, there has been an increasing interest in using nanotechnology for cancer therapy. The development of smart targeted nanoparticles (NPs) that can deliver drugs at a sustained rate directly to cancer cells may provide better efficacy and lower toxicity for treating primary and advanced metastatic tumors. We highlight some of the promising classes of targeting molecules that are under development for the delivery of NPs. We also review the emerging technologies for the fabrication of targeted NPs using microfluidic devices.</abstract><notes>173DK&#xD;Times Cited:0&#xD;Cited References Count:139</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246853500014</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>5.929</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>172</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">172</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lanza, G. M.</author><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Hughes, M. S.</author><author>Cyrus, T.</author><author>Marsh, J. N.</author><author>Neubauer, A. M.</author><author>Partlow, K. C.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Division of Cardiology, Washington University Medical School, Cortex Building, St Louis, MO 63108, USA. greg@cvu.wustl.edu</auth-address><titles><title>Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles</title><secondary-title>Nanomed</secondary-title></titles><pages>321-9</pages><volume>1</volume><number>3</number><edition>2007/08/25</edition><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17716162</accession-num><abstract>Nanomedicine promises to enhance the ability of clinicians to address some of the serious challenges responsible for cardiovascular mortality, morbidity and numerous societal consequences. Targeted imaging and therapy applications with perfluorocarbon nanoparticles are relevant to a broad spectrum of cardiovascular diseases, ranging from asymptomatic atherosclerotic disease to acute myocardial infarction or stroke. As illustrated in this article, perfluorocarbon nanoparticles offer new tools to recognize and characterize pathology, to identify and segment high-risk patients and to treat chronic and acute disease.</abstract><notes>Lanza, Gregory M&#xD;Winter, Patrick M&#xD;Caruthers, Shelton D&#xD;Hughes, Michael S&#xD;Cyrus, Tillmann&#xD;Marsh, Jon N&#xD;Neubauer, Anne M&#xD;Partlow, Kathy C&#xD;Wickline, Samuel A&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2006 Oct;1(3):321-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17716162</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>2.818</custom4><electronic-resource-num>10.2217/17435889.1.3.321</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>186</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">186</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Marsh, J. N.</author><author>Senpan, A.</author><author>Hu, G.</author><author>Scott, M. J.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Washington University School of Medicine, Cardiovascular Division, St Louis, MO 63108, USA. jnm@cvu.wustl.edu</auth-address><titles><title>Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis</title><secondary-title>Nanomed</secondary-title></titles><pages>533-43</pages><volume>2</volume><number>4</number><edition>2007/08/25</edition><keywords><keyword>Blood Coagulation/*drug effects/physiology</keyword><keyword>Drug Carriers/chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Fibrin/*drug effects</keyword><keyword>Fibrinolytic Agents/administration &amp; dosage/chemistry</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Streptokinase/*administration &amp; dosage/chemistry</keyword><keyword>Thrombolytic Therapy/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17716136</accession-num><abstract>BACKGROUND: Reperfusion of the ischemic brain is the most effective therapy for acute stroke, restoring blood flow to threatened tissues. Thrombolytics, such as recombinant tissue plasminogen activator, administered within 3 h of symptom onset can improve neurologic outcome, although the potential for adverse hemorrhagic events limits its use to less than 3% of acute ischemic stroke patients. Targeting of clot-dissolving therapeutics has the potential to decrease the frequency of complications while simultaneously increasing treatment effectiveness, by concentrating the available drug at the desired site and permitting a lower systemic dose. OBJECTIVES: We aimed to develop a fibrin-specific, liquid perfluorocarbon nanoparticle that is surface modified to deliver the plasminogen activator streptokinase. We also aimed to evaluate its effectiveness for targeted thrombolysis in vitro using quantitative acoustic microscopy. METHODS: Human plasma clots were formed in vitro and targeted with streptokinase-loaded nanoparticles, control nanoparticles or a mixture of both. Depending on the treatment group, clots were then exposed to either phosphate-buffered saline (PBS), PBS with plasminogen or PBS with plasminogen and free streptokinase. Spatially registered ultrasound scans were performed at 15-min intervals for 1 h to quantify changes in clot morphology and backscatter. RESULTS: Nanoparticles bound to the clot significantly increased the acoustic contrast of the targeted clot surface, permitting volumetric estimates. Profile plots of detected clot surfaces demonstrated that streptokinase-loaded, fibrin-targeted perfluoro-octylbromide nanoparticles in the presence of plasminogen induced rapid fibrinolysis (&lt;60 min) without concurrent microbubble production and cavitation. Streptokinase-loaded or fibrin-targeted control nanoparticles insonified in PBS did not induce clot lysis. Morphologic changes in the treated group were accompanied by temporal and spatial changes in backscatter. Ultrasound exposure had no effect on the digestion process. Effective concentrations of targeted streptokinase were orders of magnitude lower than equivalently efficacious levels of free drug. Moreover, increasing competitive inhibition of fibrin-bound streptokinase nanoparticles reduced clot lysis in a monotonic fashion. As little as 1% surface targeting of streptokinase nanoparticles produced significant decreases in clot volumes (approximately 30%) in 1 h. CONCLUSION: This new nanoparticle-based thrombolytic agent provides specific and rapid fibrinolysis in vitro and may have a clinical role in early reperfusion during acute ischemic stroke.</abstract><notes>Marsh, J N&#xD;Senpan, A&#xD;Hu, G&#xD;Scott, M J&#xD;Gaffney, P J&#xD;Wickline, S A&#xD;Lanza, G M&#xD;Eb-01704/eb/nibib&#xD;Hl-73646/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-27031/co/nci&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Aug;2(4):533-43.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17716136</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.818</custom4><electronic-resource-num>10.2217/17435889.2.4.533</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>93</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">93</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Kelly, K. A.</author><author>Sun, E. Y.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Harvard Medical School and Massachusetts General Hospital, 149 13th St, Rm 5406, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>Targeted delivery of multifunctional magnetic nanoparticles</title><secondary-title>Nanomed</secondary-title></titles><pages>153-67</pages><volume>2</volume><number>2</number><edition>2007/08/25</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Magnetics/*diagnostic use/*therapeutic use</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanoparticles/*chemistry/*diagnostic use/*therapeutic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17716118</accession-num><abstract>Magnetic nanoparticles and their magnetofluorescent analogues have become important tools for in vivo imaging using magnetic resonance imaging and fluorescent optical methods. A number of monodisperse magnetic nanoparticle preparations have been developed over the last decade for angiogenesis imaging, cancer staging, tracking of immune cells (monocyte/macrophage, T cells) and for molecular and cellular targeting. Phage display and data mining have enabled the procurement of novel tissue- or receptor-specific peptides, while high-throughput screening of diversity-oriented synthesis libraries has identified small molecules that permit or prevent uptake by specific cell types. Next-generation magnetic nanoparticles are expected to be truly multifunctional, incorporating therapeutic functionalities and further enhancing an already diverse repertoire of capabilities.</abstract><notes>McCarthy, Jason R&#xD;Kelly, Kimberly A&#xD;Sun, Eric Y&#xD;Weissleder, Ralph&#xD;U54-ca119349/ca/nci&#xD;U54-ca126515/ca/nci&#xD;Uo1-hl080731/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Apr;2(2):153-67.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17716118</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>2.818</custom4><electronic-resource-num>10.2217/17435889.2.2.153</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>481</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">481</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perelman, L. A.</author><author>Pacholski, C.</author><author>Li, Y. Y.</author><author>Vannieuwenhz, M. S.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Nitto Denko Technical Corp, Carlsbad, CA, USA. loren.perelman@gmail.com</auth-address><titles><title>pH-triggered release of vancomycin from protein-capped porous silicon films</title><secondary-title>Nanomed</secondary-title></titles><pages>31-43</pages><volume>3</volume><number>1</number><edition>2008/04/09</edition><keywords><keyword>Absorption</keyword><keyword>Coated Materials, Biocompatible/*chemistry</keyword><keyword>Diffusion</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>*Hydrogen-Ion Concentration</keyword><keyword>Materials Testing</keyword><keyword>*Membranes, Artificial</keyword><keyword>Protein Binding</keyword><keyword>Serum Albumin, Bovine/*chemistry</keyword><keyword>Silicon/*chemistry</keyword><keyword>Vancomycin/administration &amp; dosage/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>18393665</accession-num><abstract>OBJECTIVE: An in vitro model system for pH-triggered release of the antibiotic vancomycin from porous Si films is studied. METHOD: Vancomycin is infused into a mesoporous Si film from a mixed aqueous/acetonitrile solution and trapped by a capping layer containing the protein bovine serum albumin (BSA). The protein effectively traps vancomycin in the porous nanostructure at pH 4.0; the protein dissolves and vancomycin is released into solution when the pH increases to 7.4. The surface chemistry of porous Si exerts a substantial effect on the efficacy of drug loading. The amount of drug loading is larger in freshly-etched (hydrophobic, hydrogen-terminated) porous Si and smaller in methyl-modified, undecylenic acid-modified and thermally oxidized samples. The quantity of drug loaded in a freshly etched porous Si chip is proportional to the thickness of the porous layer, which exhibits a constant volume loading efficiency of 31% (v/v). Flow-cell experiments designed to mimic the transition from pH 4 to 7 that occurs when material moves from the stomach to the upper intestinal tract were performed on the freshly etched films and vancomycin- and BSA-release rates were quantified from the effluent of the flow cell by high-pressure liquid chromatography analysis. RESULTS &amp; CONCLUSION: There is a small, constant rate of vancomycin release at pH 4 that is independent of the amount of drug loaded in the pores. This is attributed to diffusion of vancomycin from the BSA-capping layer. The release rate increases five- to tenfold when the pH of the solution in the flow cell increases to 7.4; 100% of the drug is released within 3 h of this increase.</abstract><notes>Perelman, Loren A&#xD;Pacholski, Claudia&#xD;Li, Yang Yang&#xD;Vannieuwenhz, Michael S&#xD;Sailor, Michael J&#xD;U54 CA 119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2008 Feb;3(1):31-43.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18393665</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>2.818</custom4><electronic-resource-num>10.2217/17435889.3.1.31</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>105</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">105</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhyner, M. N.</author><author>Smith, A. M.</author><author>Gao, X.</author><author>Mao, H.</author><author>Yang, L.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Chemistry, Hematology and Oncology, and the Winship Cancer Institute, Emory University and Georgia Institute of Technology, Atlanta, GA 30322, USA.</auth-address><titles><title>Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging</title><secondary-title>Nanomed</secondary-title></titles><pages>209-17</pages><volume>1</volume><number>2</number><edition>2007/08/25</edition><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17716110</accession-num><abstract>Nanometer-sized particles, such as semiconductor quantum dots and iron oxide nanocrystals, have novel optical, electronic, magnetic or structural properties that are not available from either molecules or bulk solids. When linked with tumor-targeting ligands, such as monoclonal antibodies, peptide fragments of tumor-specific proteins or small molecules, these nanoparticles can be used to target tumor antigens (biomarkers) and tumor vasculatures with high affinity and specificity. In the mesoscopic size range of 5-100 nm diameter, quantum dots and related nanoparticles have large surface areas and functional groups that can be linked to multiple diagnostic (e.g., optical, radioisotopic or magnetic) and therapeutic (e.g., anticancer) agents. In this review, recent advances in the development and applications of bioconjugated quantum dots and multifunctional nanoparticles for in vivo tumor imaging and targeting are discussed.</abstract><notes>Rhyner, Matthew N&#xD;Smith, Andrew M&#xD;Gao, Xiaohu&#xD;Mao, Hui&#xD;Yang, Lily&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468â€“01/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2006 Aug;1(2):209-17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17716110</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.818</custom4><electronic-resource-num>10.2217/17435889.1.2.209</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>393</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">393</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sha, M. Y.</author><author>Xu, H.</author><author>Penn, S. G.</author><author>Cromer, R.</author></authors></contributors><auth-address>Oxonica Inc, 665 Clyde Avenue, Suite A, Mountain View, CA 94043, USA.</auth-address><titles><title>SERS nanoparticles: a new optical detection modality for cancer diagnosis</title><secondary-title>Nanomed</secondary-title></titles><pages>725-34</pages><volume>2</volume><number>5</number><edition>2007/11/03</edition><keywords><keyword>Contrast Media</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Neoplasms/*diagnosis</keyword><keyword>Surface Plasmon Resonance/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17976033</accession-num><abstract>Surface-enhanced Raman scattering (SERS) is an optical detection technique that offers advantages over traditional assay detection technologies, such as fluorescence and chemiluminescence. These advantages include sensitivity, high levels of multiplexing, robustness and ability to perform detection in blood and other biological matrices. Here, we report on the growing field of SERS-active nanoparticles as a novel method for detection, with special emphasis on their use in the field of oncology. We discuss examples of SERS-active nanoparticles used in an assay for PSA, BRCA1 and Her-2, along with examples of nucleic-acid detection. We present data on a novel homogeneous, single-tube, rapid assay for nucleic acid detection and show how it will benefit the oncology community.</abstract><notes>Sha, Michael Y&#xD;Xu, Hongxia&#xD;Penn, Sharron G&#xD;Cromer, Remy&#xD;U54 CA 119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Oct;2(5):725-34.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17976033</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>2.818</custom4><electronic-resource-num>10.2217/17435889.2.5.725</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>355</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">355</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kommareddy, S.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery</title><secondary-title>Nanomedicine</secondary-title></titles><pages>32-42</pages><volume>3</volume><number>1</number><edition>2007/03</edition><keywords><keyword>Animals</keyword><keyword>DNA/*metabolism</keyword><keyword>Disulfides/*chemistry/metabolism</keyword><keyword>Electrostatics</keyword><keyword>Gelatin/*chemistry/metabolism</keyword><keyword>Glutathione/*metabolism</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Plasmids/metabolism</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1549-9642 (Electronic)</isbn><accession-num>17379167</accession-num><abstract>Poly(ethylene glycol) (PEG)-modified thiolated gelatin (PEG-SHGel) anoparticles were developed as a long-circulating passively targeted delivery system that responds to intracellular glutathione concentrations to enhance DNA delivery and transfection. Reporter plasmid expressing enhanced green fluorescent protein (EGFP-N1) was encapsulated in the nanoparticles. DNA-containing gelatin (Gel) and thiolated gelatin (SHGel) nanoparticles were found to have a size range of 220 to 250 nm, whereas surface modification with PEG resulted in particles with a slightly larger size range of 310 to 350 nm. PEG modification was confirmed by electron spectroscopy for chemical analysis (ESCA), where an increase in the ether peak intensities of the C1s spectra corresponds to the surface presence of ethylene oxide residues. In addition, the PEG-SHGel nanoparticles released encapsulate plasmid DNA in response to varying concentrations of glutathione (up to 5.0 mM GSH in phosphate-buffered saline, or PBS). The stability of the encapsulated DNA was confirmed by agarose gel electrophoresis. Finally, from the qualitative and quantitative results of in vitro transfection studies in murine fibroblast cells (NIH3T3), PEG-Gel and PEG-SHGel nanoparticles afforded the highest transfection efficiency of the reporter plasmid. The results of these studies show that PEG-modified thiolated gelatin nanoparticles could serve as a very efficient nanoparticulate vector for systemic DNA delivery to solid tumors where the cells are known to have significantly higher intracellular GSH concentrations.</abstract><notes>Eb-002027/eb/nibib&#xD;R01-ca095522/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;nanotechnology, biology, and medicine</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17379167 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>2.818</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>620</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">620</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, T.</author><author>Ke, T.</author><author>Dharmakumar, R.</author><author>Mascheri, N.</author><author>Wu, A.</author><author>Lai, B.</author><author>Vogt, S.</author><author>Maser, J.</author><author>Thurn, K.</author><author>Szolc-Kowalska, B.</author><author>Larson, A.</author><author>Bergan, R. C.</author><author>Omary, R.</author><author>Li, D.</author><author>Lu, Z. R.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</auth-address><titles><title>Gadolinium-conjugated TiO(2)-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images</title><secondary-title>Nanomedicine</secondary-title></titles><edition>2008/06/24</edition><dates><year>2008</year><pub-dates><date>Jun 20</date></pub-dates></dates><isbn>1549-9642 (Electronic)</isbn><accession-num>18567541</accession-num><abstract>Nanoconjugates composed of titanium dioxide (TiO(2)) nanoparticles, DNA oligonucleotides, and a gadolinium (Gd) contrast agent were synthesized for use in magnetic resonance imaging. Transfection of cultured cancer cells with these nanoconjugates showed them to be superior to the free contrast agent of the same formulation with regard to intracellular accumulation, retention, and subcellular localization. Our results have shown that 48 hours after treatment, the concentration of Gd in nanoconjugate-treated cells was 1000-fold higher than in cells treated with contrast agent alone. Consequently, T1-weighted contrast enhancements were observed in cells treated with nanoconjugates but not in cells treated by the contrast agent alone. This type of nanoconjugate with increased retention time, Gd accumulation, and intracellular delivery may find its use in Gd neutron-capture cancer therapy.</abstract><notes>Journal article&#xD;Nanomedicine : nanotechnology, biology, and medicine&#xD;Nanomedicine. 2008 Jun 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18567541</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>2.818</custom4><electronic-resource-num>S1549-9634(08)00046-4 [pii]&#xD;10.1016/j.nano.2008.04.004</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>552</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">552</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thurn, K.</author><author>Brown, E.</author><author>Wu, A. </author><author>Vogt, S. </author><author>Lai, B. </author><author>Maser, J.</author><author>Paunesku, T.</author><author>Woloschak, G.</author></authors></contributors><titles><title>Nanoparticles for Applications in Cellular Imaging</title><secondary-title>Nanoscale Research Letters</secondary-title></titles><pages>430-441</pages><volume>2</volume><number>9</number><edition>2007/09</edition><keywords><keyword>Nanoparticle</keyword><keyword>Cellular uptake</keyword><keyword>Quantum dots</keyword><keyword>Titanium dioxide</keyword></keywords><dates><year>2007</year><pub-dates><date>September 2007</date></pub-dates></dates><abstract>In the following review we discuss several types of nanoparticles (such as TiO2, quantum dots, and gold nanoparticles) and their impact on the ability to image biological components in fixed cells. The review also discusses factors influencing nanoparticle imaging and uptake in live cells in vitro. Due to their unique size-dependent properties nanoparticles offer numerous advantages over traditional dyes and proteins. For example, the photostability, narrow emission peak, and ability to rationally modify both the size and surface chemistry of Quantum Dots allow for simultaneous analyses of multiple targets within the same cell. On the other hand, the surface characteristics of nanometer sized TiO2 allow efficient conjugation to nucleic acids which enables their retention in specific subcellular compartments. We discuss cellular uptake mechanisms for the internalization of nanoparticles and studies showing the influence of nanoparticle size and charge and the cell type targeted on nanoparticle uptake. The predominant nanoparticle uptake mechanisms include clathrin-dependent mechanisms, macropinocytosis, and phagocytosis.</abstract><notes>[1]&#xD;[2]&#xD;[3]&#xD;[4]&#xD;doi:10.1007/s11671-007-9081-5</notes><urls><related-urls><url>http://www.ingentaconnect.com/content/klu/11671/2007/00000002/00000009/00009081</url><url>http://dx.doi.org/10.1007/s11671-007-9081-5</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1007/s11671-007-9081-5</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>650</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">650</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, J.</author><author>Wang, X.</author><author>Wang, Z.L.</author></authors></contributors><titles><title>Bio-inspired fabrication of antireflection nanostructures by replicating fly eyes</title><secondary-title>Nanotechnology</secondary-title></titles><pages>6 pp</pages><volume>19</volume><number>2</number><edition>2007/12/6 </edition><section>025602</section><dates><year>2008</year><pub-dates><date>16 January 2008</date></pub-dates></dates><abstract>In this study, we examined the fine structure of the compound eyes of a household fly and precisely replicated its entire structure using a low-temperature atomic layer deposition technique. The surface of the fly eye is found to be covered by highly packed protuberances, which potentially increases visual efficiency through increased photon capture for a given stimulus. The alumina replica was achieved by removing the fly compound eye template at high temperature, and the alumina coating was crystallized simultaneously. Besides the morphology, the unique antireflection property was also inherited by the alumina replica. By measuring the reflective spectra of the replica, we demonstrated that the alumina replica of a fly eye was an efficient antireflection structure of visible light at an incident angle up to 80°. Such a grating would be particularly useful on a cured corneal surface since it could increase the transmission of incident light through the cornea compared with a smooth surface.</abstract><urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.310</custom4><electronic-resource-num> 10.1088/0957-4484/19/02/025602</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>543</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">543</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kirkham, M.</author><author>Wang, X.</author><author>Wang, Z.L.</author><author>Snyder, R.L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0245, USA</auth-address><titles><title>Solid Au nanoparticles as a catalyst for growing aligned ZnO nanowires: a new understanding of the vapour–liquid–solid process</title><secondary-title>Nanotechnology</secondary-title></titles><pages>365304</pages><volume>18</volume><number>36</number><edition>2007/08</edition><dates><year>2007</year><pub-dates><date>14 August 2007</date></pub-dates></dates><abstract>X-ray diffraction techniques have been applied to characterize the Au-catalysed growth of aligned ZnO nanowire arrays on an AlGaN/AlN/Al2O3 substrate. The orientation relationships between the AlN layer, AlGaN layer, ZnO nanowires and Au particles were determined using x-ray texture analysis. Two orientations of the Au nanoparticles, related by a 30° rotation about the sample normal, were observed. The gold lattice parameter of the ZnO nanowire sample was determined to be the same as that of a control sample never exposed to vaporized ZnO, indicating the absence of Zn in the Au catalyst particles. Our results indicate that the Au catalyst particles were solid during growth, and that growth proceeded by a surface diffusion process, rather than a bulk diffusion process.</abstract><work-type>Journal Article</work-type><urls><related-urls><url>http://www.nanoscience.gatech.edu/zlwang/paper/2007/07_NT_3.pdf</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.310</custom4><electronic-resource-num>10.1088/0957-4484/18/36/365304</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>607</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">607</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H.Y.</author><author>Lee, S.H.</author><author>Chenjie, X.</author><author>Xie, J.</author><author>Lee, J.H.</author><author>Wu, B.</author><author>Koh, A.L.</author><author>Wang, X.</author><author>Sinclair, R.</author><author>Wang, S.X.</author><author>Nishimura, D.G.</author><author>Biswal, S.</author><author>Sun, S.</author><author>Cho, S.H.</author><author>Chen, X.</author></authors></contributors><titles><title>Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent</title><secondary-title>Nanotechnology</secondary-title></titles><volume>19</volume><edition>2008/04</edition><section>165101</section><dates><year>2008</year><pub-dates><date>23 April 2008</date></pub-dates></dates><abstract>The purpose of this study was to synthesize biocompatible polyvinylpyrrolidone (PVP)-coated iron oxide (PVP-IO) nanoparticles and to evaluate their efficacy as a magnetic resonance imaging (MRI) contrast agent. The PVP-IO nanoparticles were synthesized by a thermal decomposition method and characterized by x-ray diffraction (XRD), transmission electron microscopy (TEM), dynamic light scattering (DLS), and a superconducting quantum interface device (SQUID). The core size of the particles is about 8–10 nm and the overall size is around 20–30 nm. The measured r2 (reciprocal of T2 relaxation time) and r2* (reciprocal of T2* relaxation time) are 141.2 and 338.1 (s mM)-1, respectively. The particles are highly soluble and stable in various buffers and in serum. The macrophage uptake of PVP-IO is comparable to that of Feridex as measured by a Prussian blue iron stain and phantom study. The signal intensity of a rabbit liver was effectively reduced after intravenous administration of PVP-IO. Therefore PVP-IO nanoparticles are potentially useful for T2-weighted MR imaging.</abstract><urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>3.310</custom4><electronic-resource-num>10.1088/0957-4484/19/16/165101</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>637</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">637</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soman, N.R.</author><author>Marsh, J.N.</author><author>Lanza, G.M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University School of Medicine, Consortium for Translational Research in Advanced Imaging and Nanomedicine, CTRAIN, Campus Box 8215, St Louis, MO 63110, USA</auth-address><titles><title>New mechanisms for non-porative ultrasound stimulation of cargo delivery to cell cytosol with targeted perfluorocarbon nanoparticles</title><secondary-title>Nanotechnology</secondary-title></titles><pages>185102-185109</pages><volume>19</volume><number>18</number><edition>2008/04/01</edition><section>185102</section><dates><year>2008</year><pub-dates><date>7 May 2008</date></pub-dates></dates><abstract>The cell membrane constitutes a major barrier for non-endocytotic intracellular delivery of therapeutic molecules from drug delivery vehicles. Existing approaches to breaching the cell membrane include cavitational ultrasound (with microbubbles), electroporation and cell-penetrating peptides. We report the use of diagnostic ultrasound for intracellular delivery of therapeutic bulky cargo with the use of molecularly targeted liquid perfluorocarbon (PFC) nanoparticles. To demonstrate the concept, we used a lipid with a surrogate polar head group, nanogold-DPPE, incorporated into the nanoparticle lipid monolayer. Melanoma cells were incubated with nanogold particles and this was followed by insonication with continuous wave ultrasound (2.25 MHz, 5 min, 0.6 MPa). Cells not exposed to ultrasound showed gold particles partitioned only in the outer bilayer of the cell membrane with no evidence of the intracellular transit of nanogold. However, the cells exposed to ultrasound exhibited numerous nanogold-DPPE components inside the cell that appeared polarized inside intracellular vesicles demonstrating cellular uptake and trafficking. Further, ultrasound-exposed cells manifested no incorporation of calcein or the release of lactate dehydrogenase. These observations are consistent with a mechanism that suggests that ultrasound is capable of stimulating the intracellular delivery of therapeutic molecules via non-porative mechanisms. Therefore, non-cavitational adjunctive ultrasound offers a novel paradigm in intracellular cargo delivery from PFC nanoparticles.</abstract><urls><related-urls><url>http://www.iop.org/EJ/abstract/0957-4484/19/18/185102</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>3.310</custom4><electronic-resource-num>10.1088/0957-4484/19/18/185102</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>442</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">442</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, H. S.</author><author>Liu, W.</author><author>Misra, P.</author><author>Tanaka, E.</author><author>Zimmer, J. P.</author><author>Itty Ipe, B.</author><author>Bawendi, M. G.</author><author>Frangioni, J. V.</author></authors></contributors><auth-address>Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Room SL-B05, Boston, Massachusetts 02215, USA.</auth-address><titles><title>Renal clearance of quantum dots</title><secondary-title>Nat Biotechnol</secondary-title></titles><pages>1165-70</pages><volume>25</volume><number>10</number><edition>2007/09/25</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media</keyword><keyword>Diagnostic Imaging</keyword><keyword>Drug Stability</keyword><keyword>Kidney/*metabolism</keyword><keyword>Male</keyword><keyword>Nanotechnology</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17891134</accession-num><abstract>The field of nanotechnology holds great promise for the diagnosis and treatment of human disease. However, the size and charge of most nanoparticles preclude their efficient clearance from the body as intact nanoparticles. Without such clearance or their biodegradation into biologically benign components, toxicity is potentially amplified and radiological imaging is hindered. Using intravenously administered quantum dots in rodents as a model system, we have precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles. Zwitterionic or neutral organic coatings prevented adsorption of serum proteins, which otherwise increased hydrodynamic diameter by &gt;15 nm and prevented renal excretion. A final hydrodynamic diameter &lt;5.5 nm resulted in rapid and efficient urinary excretion and elimination of quantum dots from the body. This study provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.</abstract><notes>Choi, Hak Soo&#xD;Liu, Wenhao&#xD;Misra, Preeti&#xD;Tanaka, Eiichi&#xD;Zimmer, John P&#xD;Itty Ipe, Binil&#xD;Bawendi, Moungi G&#xD;Frangioni, John V&#xD;1U54-CA119349/CA/United States NCI&#xD;GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2007 Oct;25(10):1165-70. Epub 2007 Sep 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17891134</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>22.67</custom4><electronic-resource-num>nbt1340 [pii]&#xD;10.1038/nbt1340</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>225</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">225</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mallick, P.</author><author>Schirle, M.</author><author>Chen, S. S.</author><author>Flory, M. R.</author><author>Lee, H.</author><author>Martin, D.</author><author>Ranish, J.</author><author>Raught, B.</author><author>Schmitt, R.</author><author>Werner, T.</author><author>Kuster, B.</author><author>Aebersold, R.</author></authors></contributors><auth-address>Institute for Systems Biology, 1441 N. 34th Street, Seattle, Washington 98103, USA.</auth-address><titles><title>Computational prediction of proteotypic peptides for quantitative proteomics</title><secondary-title>Nat Biotechnol</secondary-title></titles><pages>125-31</pages><volume>25</volume><number>1</number><edition>2007/01/02</edition><keywords><keyword>*Algorithms</keyword><keyword>Gene Expression Profiling/*methods</keyword><keyword>Mass Spectrometry/*methods</keyword><keyword>Peptide Mapping/*methods</keyword><keyword>Peptides/analysis/*chemistry</keyword><keyword>Proteome/analysis/*chemistry</keyword><keyword>Sequence Analysis, Protein/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17195840</accession-num><abstract>Mass spectrometry-based quantitative proteomics has become an important component of biological and clinical research. Although such analyses typically assume that a protein&apos;s peptide fragments are observed with equal likelihood, only a few so-called &apos;proteotypic&apos; peptides are repeatedly and consistently identified for any given protein present in a mixture. Using &gt;600,000 peptide identifications generated by four proteomic platforms, we empirically identified &gt;16,000 proteotypic peptides for 4,030 distinct yeast proteins. Characteristic physicochemical properties of these peptides were used to develop a computational tool that can predict proteotypic peptides for any protein from any organism, for a given platform, with &gt;85% cumulative accuracy. Possible applications of proteotypic peptides include validation of protein identifications, absolute quantification of proteins, annotation of coding sequences in genomes, and characterization of the physical principles governing key elements of mass spectrometric workflows (e.g., digestion, chromatography, ionization and fragmentation).</abstract><notes>Mallick, Parag&#xD;Schirle, Markus&#xD;Chen, Sharon S&#xD;Flory, Mark R&#xD;Lee, Hookeun&#xD;Martin, Daniel&#xD;Ranish, Jeffrey&#xD;Raught, Brian&#xD;Schmitt, Robert&#xD;Werner, Thilo&#xD;Kuster, Bernhard&#xD;Aebersold, Ruedi&#xD;N01-hv-28179/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2007 Jan;25(1):125-31. Epub 2006 Dec 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17195840</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>22.67</custom4><electronic-resource-num>nbt1275 [pii]&#xD;10.1038/nbt1275</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>360</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">360</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Oh, P.</author><author>Borgstrom, P.</author><author>Witkiewicz, H.</author><author>Li, Y.</author><author>Borgstrom, B. J.</author><author>Chrastina, A.</author><author>Iwata, K.</author><author>Zinn, K. R.</author><author>Baldwin, R.</author><author>Testa, J. E.</author><author>Schnitzer, J. E.</author></authors></contributors><auth-address>Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, California 92121, USA.</auth-address><titles><title>Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung</title><secondary-title>Nat Biotechnol</secondary-title><alt-title>Nature biotechnology</alt-title></titles><pages>327-37</pages><volume>25</volume><number>3</number><edition>2007/03</edition><keywords><keyword>Aminopeptidases/*immunology</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/biosynthesis/*pharmacokinetics</keyword><keyword>Caveolae/*immunology/physiology</keyword><keyword>Caveolin 1/metabolism</keyword><keyword>Drug Carriers</keyword><keyword>Drug Delivery Systems</keyword><keyword>*Endocytosis</keyword><keyword>Endothelium, Vascular/*immunology/physiology</keyword><keyword>Lung/blood supply/*immunology/physiology</keyword><keyword>Mice</keyword><keyword>Nanoparticles</keyword><keyword>Proteomics/methods</keyword><keyword>Radionuclide Imaging</keyword><keyword>Rats</keyword><keyword>Tomography, Emission-Computed, Single-Photon</keyword><keyword>*Video Recording</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17334358</accession-num><abstract>How effectively and quickly endothelial caveolae can transcytose in vivo is unknown, yet critical for understanding their function and potential clinical utility. Here we use quantitative proteomics to identify aminopeptidase P (APP) concentrated in caveolae of lung endothelium. Electron microscopy confirms this and shows that APP antibody targets nanoparticles to caveolae. Dynamic intravital fluorescence microscopy reveals that targeted caveolae operate effectively as pumps, moving antibody within seconds from blood across endothelium into lung tissue, even against a concentration gradient. This active transcytosis requires normal caveolin-1 expression. Whole body gamma-scintigraphic imaging shows rapid, specific delivery into lung well beyond that achieved by standard vascular targeting. This caveolar trafficking in vivo may underscore a key physiological mechanism for selective transvascular exchange and may provide an enhanced delivery system for imaging agents, drugs, gene-therapy vectors and nanomedicines. &apos;In vivo proteomic imaging&apos; as described here integrates organellar proteomics with multiple imaging techniques to identify an accessible target space that includes the transvascular pumping space of the caveola.</abstract><notes>R01 hl074063/hl/nhlbi&#xD;R01 hl52766/hl/nhlbi&#xD;R01 hl58216/hl/nhlbi&#xD;R01ca104898/ca/nci&#xD;R24ca95893/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17334358 </url></related-urls></urls><custom1>CNPP - S.K.C.C.</custom1><custom3>2007</custom3><custom4>22.67</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>394</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">394</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, X.</author><author>Peng, X. H.</author><author>Ansari, D. O.</author><author>Yin-Goen, Q.</author><author>Chen, G. Z.</author><author>Shin, D. M.</author><author>Yang, L.</author><author>Young, A. N.</author><author>Wang, M. D.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags</title><secondary-title>Nat Biotechnol</secondary-title></titles><pages>83-90</pages><volume>26</volume><number>1</number><edition>2007/12/25</edition><keywords><keyword>Animals</keyword><keyword>Carcinoma, Squamous Cell/*diagnosis</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Particle Size</keyword><keyword>Spectrum Analysis, Raman/*methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1546-1696 (Electronic)</isbn><accession-num>18157119</accession-num><abstract>We describe biocompatible and nontoxic nanoparticles for in vivo tumor targeting and detection based on pegylated gold nanoparticles and surface-enhanced Raman scattering (SERS). Colloidal gold has been safely used to treat rheumatoid arthritis for 50 years, and has recently been found to amplify the efficiency of Raman scattering by 14-15 orders of magnitude. Here we show that large optical enhancements can be achieved under in vivo conditions for tumor detection in live animals. An important finding is that small-molecule Raman reporters such as organic dyes were not displaced but were stabilized by thiol-modified polyethylene glycols. These pegylated SERS nanoparticles were considerably brighter than semiconductor quantum dots with light emission in the near-infrared window. When conjugated to tumor-targeting ligands such as single-chain variable fragment (ScFv) antibodies, the conjugated nanoparticles were able to target tumor biomarkers such as epidermal growth factor receptors on human cancer cells and in xenograft tumor models.</abstract><notes>Qian, Ximei&#xD;Peng, Xiang-Hong&#xD;Ansari, Dominic O&#xD;Yin-Goen, Qiqin&#xD;Chen, Georgia Z&#xD;Shin, Dong M&#xD;Yang, Lily&#xD;Young, Andrew N&#xD;Wang, May D&#xD;Nie, Shuming&#xD;P50CA128613/CA/United States NCI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2008 Jan;26(1):83-90. Epub 2007 Dec 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18157119</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>22.67</custom4><electronic-resource-num>nbt1377 [pii]&#xD;10.1038/nbt1377</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>700</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">700</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Red-Horse, K.</author><author>Ferrara, N.</author></authors></contributors><titles><title>Vascular targeting via caveolae</title><secondary-title>Nat Biotechnol</secondary-title></titles><pages>431-2</pages><volume>25</volume><number>4</number><edition>2007/04/11</edition><keywords><keyword>Aminopeptidases/immunology</keyword><keyword>Animals</keyword><keyword>Antibodies/immunology</keyword><keyword>Biological Transport</keyword><keyword>Blood Vessels/*metabolism</keyword><keyword>Caveolae/*metabolism</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Neoplasms/therapy</keyword><keyword>Rats</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17420750</accession-num><notes>Red-Horse, Kristy&#xD;Ferrara, Napoleone&#xD;Comment&#xD;News&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2007 Apr;25(4):431-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17420750</url></related-urls></urls><custom1>CNPP - S.K.C.C.</custom1><custom3>2007</custom3><custom4>22.67</custom4><electronic-resource-num>nbt0407-431 [pii]&#xD;10.1038/nbt0407-431</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>234</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">234</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>So, M. K.</author><author>Xu, C.</author><author>Loening, A. M.</author><author>Gambhir, S. S.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program, Department of Radiology, Stanford University, 1201 Welch Road, Stanford, California 94305-5484, USA.</auth-address><titles><title>Self-illuminating quantum dot conjugates for in vivo imaging</title><secondary-title>Nat Biotechnol</secondary-title></titles><pages>339-43</pages><volume>24</volume><number>3</number><edition>2006/02/28</edition><keywords><keyword>Animals</keyword><keyword>Diagnostic Imaging</keyword><keyword>Energy Transfer</keyword><keyword>Fluorescence</keyword><keyword>Luciferases/genetics/metabolism</keyword><keyword>Luminescent Measurements/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Quantum Dots</keyword><keyword>Semiconductors</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>16501578</accession-num><abstract>Fluorescent semiconductor quantum dots hold great potential for molecular imaging in vivo. However, the utility of existing quantum dots for in vivo imaging is limited because they require excitation from external illumination sources to fluoresce, which results in a strong autofluorescence background and a paucity of excitation light at nonsuperficial locations. Here we present quantum dot conjugates that luminesce by bioluminescence resonance energy transfer in the absence of external excitation. The conjugates are prepared by coupling carboxylate-presenting quantum dots to a mutant of the bioluminescent protein Renilla reniformis luciferase. We show that the conjugates emit long-wavelength (from red to near-infrared) bioluminescent light in cells and in animals, even in deep tissues, and are suitable for multiplexed in vivo imaging. Compared with existing quantum dots, self-illuminating quantum dot conjugates have greatly enhanced sensitivity in small animal imaging, with an in vivo signal-to-background ratio of &gt; 10(3) for 5 pmol of conjugate.</abstract><notes>So, Min-Kyung&#xD;Xu, Chenjie&#xD;Loening, Andreas M&#xD;Gambhir, Sanjiv S&#xD;Rao, Jianghong&#xD;5r01ca82214-7/ca/nci&#xD;P50 ca114747/ca/nci&#xD;R24ca92862/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2006 Mar;24(3):339-43. Epub 2006 Feb 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16501578</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>22.67</custom4><electronic-resource-num>nbt1188 [pii]&#xD;10.1038/nbt1188</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>669</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">669</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Squires, T. M.</author><author>Messinger, R. J.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Chemical Engineering, University of California, Santa Barbara, California 93106, USA. squires@engineering.ucsb.edu</auth-address><titles><title>Making it stick: convection, reaction and diffusion in surface-based biosensors</title><secondary-title>Nat Biotechnol</secondary-title></titles><pages>417-26</pages><volume>26</volume><number>4</number><edition>2008/04/09</edition><keywords><keyword>Adhesiveness</keyword><keyword>Biosensing Techniques/*instrumentation/*methods</keyword><keyword>Computer Simulation</keyword><keyword>Diffusion</keyword><keyword>*Equipment Failure Analysis</keyword><keyword>Microfluidics/*methods</keyword><keyword>*Models, Chemical</keyword><keyword>*Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1546-1696 (Electronic)</isbn><accession-num>18392027</accession-num><abstract>The past decade has seen researchers develop and apply novel technologies for biomolecular detection, at times approaching hard limits imposed by physics and chemistry. In nearly all sensors, the transport of target molecules to the sensor can play as critical a role as the chemical reaction itself in governing binding kinetics, and ultimately performance. Yet rarely does an analysis of the interplay between diffusion, convection and reaction motivate experimental design or interpretation. Here we develop a physically intuitive and practical understanding of analyte transport for researchers who develop and employ biosensors based on surface capture. We explore the qualitatively distinct behaviors that result, develop rules of thumb to quickly determine how a given system will behave, and derive order-of-magnitude estimates for fundamental quantities of interest, such as fluxes, collection rates and equilibration times. We pay particular attention to collection limits for micro- and nanoscale sensors, and highlight unexplained discrepancies between reported values and theoretical limits.</abstract><notes>Squires, Todd M&#xD;Messinger, Robert J&#xD;Manalis, Scott R&#xD;P50-GM68762/GM/United States NIGMS&#xD;R01-CA119402/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2008 Apr;26(4):417-26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18392027</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>22.67</custom4><electronic-resource-num>nbt1388 [pii]&#xD;10.1038/nbt1388</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>297</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">297</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ramsey, M. R.</author><author>Sharpless, N. E.</author></authors></contributors><titles><title>ROS as a tumour suppressor?</title><secondary-title>Nat Cell Biol</secondary-title></titles><pages>1213-5</pages><volume>8</volume><number>11</number><edition>2006/11/02</edition><keywords><keyword>Cell Aging/*physiology</keyword><keyword>Cell Division/physiology</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/metabolism/physiology</keyword><keyword>E2F Transcription Factors/metabolism/physiology</keyword><keyword>Humans</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms/*metabolism/physiopathology</keyword><keyword>Reactive Oxygen Species/*metabolism</keyword><keyword>Retinoblastoma Protein/metabolism/physiology</keyword><keyword>Signal Transduction/physiology</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1465-7392 (Print)</isbn><accession-num>17077852</accession-num><notes>Ramsey, Matthew R&#xD;Sharpless, Norman E&#xD;Comment&#xD;News&#xD;England&#xD;Nature cell biology&#xD;Nat Cell Biol. 2006 Nov;8(11):1213-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17077852</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>18.49</custom4><electronic-resource-num>ncb1106-1213 [pii]&#xD;10.1038/ncb1106-1213</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>205</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">205</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Davidson, E. A.</author><author>Ellington, A. D.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, Institute for Cell and Molecular Biology, 1 University Station/A4800, University of Texas at Austin, Austin, Texas 78712, USA.</auth-address><titles><title>Synthetic RNA circuits</title><secondary-title>Nat Chem Biol</secondary-title></titles><pages>23-8</pages><volume>3</volume><number>1</number><edition>2006/12/19</edition><keywords><keyword>Catalysis</keyword><keyword>Codon/genetics</keyword><keyword>*Gene Expression Regulation</keyword><keyword>*Genetic Engineering/methods</keyword><keyword>Models, Biological</keyword><keyword>RNA/chemistry/genetics/*physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1552-4450 (Print)</isbn><accession-num>17173026</accession-num><abstract>Natural and engineered RNA &apos;parts&apos; can perform a variety of functions, including hybridizing to targets, binding ligands and undergoing programmed conformational changes, and catalyzing reactions. These RNA parts can in turn be assembled into synthetic genetic circuits that regulate gene expression by acting either in cis or in trans on mRNAs. As more parts are discovered and engineered, it should be increasingly possible to create synthetic RNA circuits that are able to carry out complex logical operations in cells, either superimposed on or autonomous to extant gene regulation.</abstract><notes>Davidson, Eric A&#xD;Ellington, Andrew D&#xD;Review&#xD;United States&#xD;Nature chemical biology&#xD;Nat Chem Biol. 2007 Jan;3(1):23-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17173026</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>13.683</custom4><electronic-resource-num>nchembio846 [pii]&#xD;10.1038/nchembio846</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>521</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">521</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krutzik, P. O.</author><author>Crane, J. M.</author><author>Clutter, M. R.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford University, 269 Campus Drive, Stanford, California 94305, USA.</auth-address><titles><title>High-content single-cell drug screening with phosphospecific flow cytometry</title><secondary-title>Nat Chem Biol</secondary-title></titles><pages>132-42</pages><volume>4</volume><number>2</number><edition>2007/12/25</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Evaluation, Preclinical</keyword><keyword>Flow Cytometry/*methods</keyword><keyword>Humans</keyword><keyword>Janus Kinases/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mitogen-Activated Protein Kinases/metabolism</keyword><keyword>Phosphorus/*analysis</keyword><keyword>STAT Transcription Factors/metabolism</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1552-4469 (Electronic)</isbn><accession-num>18157122</accession-num><abstract>Drug screening is often limited to cell-free assays involving purified enzymes, but it is arguably best applied against systems that represent disease states or complex physiological cellular networks. Here, we describe a high-content, cell-based drug discovery platform based on phosphospecific flow cytometry, or phosphoflow, that enabled screening for inhibitors against multiple endogenous kinase signaling pathways in heterogeneous primary cell populations at the single-cell level. From a library of small-molecule natural products, we identified pathway-selective inhibitors of Jak-Stat and MAP kinase signaling. Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds. Lead compound selectivity was confirmed in vivo in mice. Phosphoflow therefore provides a unique platform that can be applied throughout the drug discovery process, from early compound screening to in vivo testing and clinical monitoring of drug efficacy.</abstract><notes>Krutzik, Peter O&#xD;Crane, Janelle M&#xD;Clutter, Matthew R&#xD;Nolan, Garry P&#xD;AI35304/AI/United States NIAID&#xD;N01-HV-28183/HV/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature chemical biology&#xD;Nat Chem Biol. 2008 Feb;4(2):132-42. Epub 2007 Dec 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18157122</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>13.683</custom4><electronic-resource-num>nchembio.2007.59 [pii]&#xD;10.1038/nchembio.2007.59</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>256</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">256</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mischel, P. S.</author><author>Cloughesy, T.</author></authors></contributors><auth-address>Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095-1732, USA. pmischel@mednet.ucla.edu</auth-address><titles><title>Using molecular information to guide brain tumor therapy</title><secondary-title>Nat Clin Pract Neurol</secondary-title></titles><pages>232-3</pages><volume>2</volume><number>5</number><edition>2006/08/26</edition><keywords><keyword>Brain Neoplasms/*genetics/*therapy</keyword><keyword>Glioma/*genetics/*therapy</keyword><keyword>Humans</keyword><keyword>Molecular Biology/*trends</keyword><keyword>Oncogenes/genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1745-834X (Print)</isbn><accession-num>16932555</accession-num><notes>Mischel, Paul S&#xD;Cloughesy, Timothy&#xD;Review&#xD;England&#xD;Nature clinical practice. Neurology&#xD;Nat Clin Pract Neurol. 2006 May;2(5):232-3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16932555</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>0.625</custom4><electronic-resource-num>ncpneuro0145 [pii]&#xD;10.1038/ncpneuro0145</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>58</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">58</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>He, X. C.</author><author>Yin, T.</author><author>Grindley, J. C.</author><author>Tian, Q.</author><author>Sato, T.</author><author>Tao, W. A.</author><author>Dirisina, R.</author><author>Porter-Westpfahl, K. S.</author><author>Hembree, M.</author><author>Johnson, T.</author><author>Wiedemann, L. M.</author><author>Barrett, T. A.</author><author>Hood, L.</author><author>Wu, H.</author><author>Li, L.</author></authors></contributors><auth-address>Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA.</auth-address><titles><title>PTEN-deficient intestinal stem cells initiate intestinal polyposis</title><secondary-title>Nat Genet</secondary-title></titles><pages>189-98</pages><volume>39</volume><number>2</number><edition>2007/01/24</edition><keywords><keyword>Animals</keyword><keyword>Cell Count</keyword><keyword>Cell Cycle</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Intestinal Polyps/*genetics</keyword><keyword>Intestines/*metabolism</keyword><keyword>Mice</keyword><keyword>PTEN Phosphohydrolase/genetics/metabolism/*physiology</keyword><keyword>Phosphorylation</keyword><keyword>Proto-Oncogene Proteins c-akt/metabolism</keyword><keyword>Stem Cells/*metabolism</keyword><keyword>beta Catenin/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1061-4036 (Print)</isbn><accession-num>17237784</accession-num><abstract>Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells (ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog (PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector beta-catenin. Akt phosphorylates beta-catenin at Ser552, resulting in a nuclear-localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN-deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of beta-catenin.</abstract><notes>He, Xi C&#xD;Yin, Tong&#xD;Grindley, Justin C&#xD;Tian, Qiang&#xD;Sato, Toshiro&#xD;Tao, W Andy&#xD;Dirisina, Raminarao&#xD;Porter-Westpfahl, Kimberly S&#xD;Hembree, Mark&#xD;Johnson, Teri&#xD;Wiedemann, Leanne M&#xD;Barrett, Terrence A&#xD;Hood, Leroy&#xD;Wu, Hong&#xD;Li, Linheng&#xD;R01 dk070001/dk/niddk&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature genetics&#xD;Nat Genet. 2007 Feb;39(2):189-98. Epub 2007 Jan 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17237784</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>25.556</custom4><electronic-resource-num>ng1928 [pii]&#xD;10.1038/ng1928</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>66</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">66</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, R. K.</author><author>Baker, A. C.</author><author>Debiasi, R. M.</author><author>Winckler, W.</author><author>Laframboise, T.</author><author>Lin, W. M.</author><author>Wang, M.</author><author>Feng, W.</author><author>Zander, T.</author><author>MacConaill, L.</author><author>Lee, J. C.</author><author>Nicoletti, R.</author><author>Hatton, C.</author><author>Goyette, M.</author><author>Girard, L.</author><author>Majmudar, K.</author><author>Ziaugra, L.</author><author>Wong, K. K.</author><author>Gabriel, S.</author><author>Beroukhim, R.</author><author>Peyton, M.</author><author>Barretina, J.</author><author>Dutt, A.</author><author>Emery, C.</author><author>Greulich, H.</author><author>Shah, K.</author><author>Sasaki, H.</author><author>Gazdar, A.</author><author>Minna, J.</author><author>Armstrong, S. A.</author><author>Mellinghoff, I. K.</author><author>Hodi, F. S.</author><author>Dranoff, G.</author><author>Mischel, P. S.</author><author>Cloughesy, T. F.</author><author>Nelson, S. F.</author><author>Liau, L. M.</author><author>Mertz, K.</author><author>Rubin, M. A.</author><author>Moch, H.</author><author>Loda, M.</author><author>Catalona, W.</author><author>Fletcher, J.</author><author>Signoretti, S.</author><author>Kaye, F.</author><author>Anderson, K. C.</author><author>Demetri, G. D.</author><author>Dummer, R.</author><author>Wagner, S.</author><author>Herlyn, M.</author><author>Sellers, W. R.</author><author>Meyerson, M.</author><author>Garraway, L. A.</author></authors></contributors><auth-address>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA.</auth-address><titles><title>High-throughput oncogene mutation profiling in human cancer</title><secondary-title>Nat Genet</secondary-title></titles><pages>347-51</pages><volume>39</volume><number>3</number><edition>2007/02/13</edition><keywords><keyword>DNA Mutational Analysis/*methods</keyword><keyword>Gene Expression Profiling</keyword><keyword>Genome, Human</keyword><keyword>Genotype</keyword><keyword>Humans</keyword><keyword>*Mutation</keyword><keyword>Neoplasms/*genetics</keyword><keyword>*Oncogenes</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1061-4036 (Print)</isbn><accession-num>17293865</accession-num><abstract>Systematic efforts are underway to decipher the genetic changes associated with tumor initiation and progression. However, widespread clinical application of this information is hampered by an inability to identify critical genetic events across the spectrum of human tumors with adequate sensitivity and scalability. Here, we have adapted high-throughput genotyping to query 238 known oncogene mutations across 1,000 human tumor samples. This approach established robust mutation distributions spanning 17 cancer types. Of 17 oncogenes analyzed, we found 14 to be mutated at least once, and 298 (30%) samples carried at least one mutation. Moreover, we identified previously unrecognized oncogene mutations in several tumor types and observed an unexpectedly high number of co-occurring mutations. These results offer a new dimension in tumor genetics, where mutations involving multiple cancer genes may be interrogated simultaneously and in &apos;real time&apos; to guide cancer classification and rational therapeutic intervention.</abstract><notes>Thomas, Roman K&#xD;Baker, Alissa C&#xD;Debiasi, Ralph M&#xD;Winckler, Wendy&#xD;Laframboise, Thomas&#xD;Lin, William M&#xD;Wang, Meng&#xD;Feng, Whei&#xD;Zander, Thomas&#xD;MacConaill, Laura&#xD;Lee, Jeffrey C&#xD;Nicoletti, Rick&#xD;Hatton, Charlie&#xD;Goyette, Mary&#xD;Girard, Luc&#xD;Majmudar, Kuntal&#xD;Ziaugra, Liuda&#xD;Wong, Kwok-Kin&#xD;Gabriel, Stacey&#xD;Beroukhim, Rameen&#xD;Peyton, Michael&#xD;Barretina, Jordi&#xD;Dutt, Amit&#xD;Emery, Caroline&#xD;Greulich, Heidi&#xD;Shah, Kinjal&#xD;Sasaki, Hidefumi&#xD;Gazdar, Adi&#xD;Minna, John&#xD;Armstrong, Scott A&#xD;Mellinghoff, Ingo K&#xD;Hodi, F Stephen&#xD;Dranoff, Glenn&#xD;Mischel, Paul S&#xD;Cloughesy, Tim F&#xD;Nelson, Stan F&#xD;Liau, Linda M&#xD;Mertz, Kirsten&#xD;Rubin, Mark A&#xD;Moch, Holger&#xD;Loda, Massimo&#xD;Catalona, William&#xD;Fletcher, Jonathan&#xD;Signoretti, Sabina&#xD;Kaye, Frederic&#xD;Anderson, Kenneth C&#xD;Demetri, George D&#xD;Dummer, Reinhard&#xD;Wagner, Stephan&#xD;Herlyn, Meenhard&#xD;Sellers, William R&#xD;Meyerson, Matthew&#xD;Garraway, Levi A&#xD;P50ca70907/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature genetics&#xD;Nat Genet. 2007 Mar;39(3):347-51. Epub 2007 Feb 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17293865</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>25.556</custom4><electronic-resource-num>ng1975 [pii]&#xD;10.1038/ng1975</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>566</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">566</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Anker, J. N.</author><author>Hall, W. P.</author><author>Lyandres, O.</author><author>Shah, N. C.</author><author>Zhao, J.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Chemistry Department, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Biosensing with plasmonic nanosensors</title><secondary-title>Nat Mater</secondary-title></titles><pages>442-53</pages><volume>7</volume><number>6</number><edition>2008/05/24</edition><keywords><keyword>*Biosensing Techniques</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Surface Plasmon Resonance/*instrumentation</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>18497851</accession-num><abstract>Recent developments have greatly improved the sensitivity of optical sensors based on metal nanoparticle arrays and single nanoparticles. We introduce the localized surface plasmon resonance (LSPR) sensor and describe how its exquisite sensitivity to size, shape and environment can be harnessed to detect molecular binding events and changes in molecular conformation. We then describe recent progress in three areas representing the most significant challenges: pushing sensitivity towards the single-molecule detection limit, combining LSPR with complementary molecular identification techniques such as surface-enhanced Raman spectroscopy, and practical development of sensors and instrumentation for routine use and high-throughput detection. This review highlights several exceptionally promising research directions and discusses how diverse applications of plasmonic nanoparticles can be integrated in the near future.</abstract><notes>Anker, Jeffrey N&#xD;Hall, W Paige&#xD;Lyandres, Olga&#xD;Shah, Nilam C&#xD;Zhao, Jing&#xD;Van Duyne, Richard P&#xD;1 U54 CA119341-01/CA/United States NCI&#xD;5 F32 GM077020/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2008 Jun;7(6):442-53.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18497851</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>19.194</custom4><electronic-resource-num>nmat2162 [pii]&#xD;10.1038/nmat2162</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>56</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">56</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McAlpine, M. C.</author><author>Ahmad, H.</author><author>Wang, D.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>Highly ordered nanowire arrays on plastic substrates for ultrasensitive flexible chemical sensors</title><secondary-title>Nat Mater</secondary-title></titles><pages>379-84</pages><volume>6</volume><number>5</number><edition>2007/04/24</edition><keywords><keyword>Biosensing Techniques/*instrumentation/*trends</keyword><keyword>Chemistry, Analytical/instrumentation/trends</keyword><keyword>*Nanowires/ultrastructure</keyword><keyword>*Plastics</keyword><keyword>Semiconductors/trends</keyword><keyword>Silicon</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>17450146</accession-num><abstract>The development of a robust method for integrating high-performance semiconductors on flexible plastics could enable exciting avenues in fundamental research and novel applications. One area of vital relevance is chemical and biological sensing, which if implemented on biocompatible substrates, could yield breakthroughs in implantable or wearable monitoring systems. Semiconducting nanowires (and nanotubes) are particularly sensitive chemical sensors because of their high surface-to-volume ratios. Here, we present a scalable and parallel process for transferring hundreds of pre-aligned silicon nanowires onto plastic to yield highly ordered films for low-power sensor chips. The nanowires are excellent field-effect transistors, and, as sensors, exhibit parts-per-billion sensitivity to NO2, a hazardous pollutant. We also use SiO2 surface chemistries to construct a &apos;nano-electronic nose&apos; library, which can distinguish acetone and hexane vapours via distributed responses. The excellent sensing performance coupled with bendable plastic could open up opportunities in portable, wearable or even implantable sensors.</abstract><notes>McAlpine, Michael C&#xD;Ahmad, Habib&#xD;Wang, Dunwei&#xD;Heath, James R&#xD;5u54 ca119347/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2007 May;6(5):379-84. Epub 2007 Apr 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17450146</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>19.194</custom4><electronic-resource-num>nmat1891 [pii]&#xD;10.1038/nmat1891</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>311</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">311</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rabin, O.</author><author>Manuel Perez, J.</author><author>Grimm, J.</author><author>Wojtkiewicz, G.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.</auth-address><titles><title>An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles</title><secondary-title>Nat Mater</secondary-title></titles><pages>118-22</pages><volume>5</volume><number>2</number><edition>2006/01/31</edition><keywords><keyword>Animals</keyword><keyword>Bismuth/adverse effects/*analysis/*chemistry</keyword><keyword>Blood Vessels</keyword><keyword>Contrast Media/adverse effects/*analysis/*chemistry</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Stability</keyword><keyword>Liver</keyword><keyword>Lymph Nodes</keyword><keyword>Mice</keyword><keyword>Nanostructures/adverse effects/analysis/*chemistry</keyword><keyword>Sulfides/adverse effects/*analysis/*chemistry</keyword><keyword>Tomography, X-Ray Computed/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>16444262</accession-num><abstract>Nanomaterials have become increasingly important in the development of new molecular probes for in vivo imaging, both experimentally and clinically. Nanoparticulate imaging probes have included semiconductor quantum dots, magnetic and magnetofluorescent nanoparticles, gold nanoparticles and nanoshells, among others. However, the use of nanomaterials for one of the most common imaging techniques, computed tomography (CT), has remained unexplored. Current CT contrast agents are based on small iodinated molecules. They are effective in absorbing X-rays, but non-specific distribution and rapid pharmacokinetics have rather limited their microvascular and targeting performance. Here we propose the use of a polymer-coated Bi(2)S(3) nanoparticle preparation as an injectable CT imaging agent. This preparation demonstrates excellent stability at high concentrations (0.25 M Bi(3+)), high X-ray absorption (fivefold better than iodine), very long circulation times (&gt;2 h) in vivo and an efficacy/safety profile comparable to or better than iodinated imaging agents. We show the utility of these polymer-coated Bi(2)S(3) nanoparticles for enhanced in vivo imaging of the vasculature, the liver and lymph nodes in mice. These nanoparticles and their bioconjugates are expected to become an important adjunct to in vivo imaging of molecular targets and pathological conditions.</abstract><notes>Rabin, Oded&#xD;Manuel Perez, J&#xD;Grimm, Jan&#xD;Wojtkiewicz, Gregory&#xD;Weissleder, Ralph&#xD;P50 ca86355/ca/nci&#xD;R01-eb004626a01/eb/nibib&#xD;R24 ca92782/ca/nci&#xD;U54 ca119349/ca/nci&#xD;Uo1 hl080731/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2006 Feb;5(2):118-22. Epub 2006 Jan 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16444262</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>19.194</custom4><electronic-resource-num>nmat1571 [pii]&#xD;10.1038/nmat1571</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>231</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">231</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seo, W. S.</author><author>Lee, J. H.</author><author>Sun, X.</author><author>Suzuki, Y.</author><author>Mann, D.</author><author>Liu, Z.</author><author>Terashima, M.</author><author>Yang, P. C.</author><author>McConnell, M. V.</author><author>Nishimura, D. G.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry and Laboratory for Advanced Materials, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents</title><secondary-title>Nat Mater</secondary-title></titles><pages>971-6</pages><volume>5</volume><number>12</number><edition>2006/11/23</edition><keywords><keyword>Animals</keyword><keyword>Cobalt/*chemistry/*diagnostic use</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Crystallization/methods</keyword><keyword>Ferrous Compounds/*chemistry/*diagnostic use</keyword><keyword>Graphite/*chemistry</keyword><keyword>Image Enhancement/methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Materials Testing</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Rabbits</keyword><keyword>Spectrophotometry, Infrared/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>17115025</accession-num><abstract>Nanocrystals with advanced magnetic or optical properties have been actively pursued for potential biological applications, including integrated imaging, diagnosis and therapy. Among various magnetic nanocrystals, FeCo has superior magnetic properties, but it has yet to be explored owing to the problems of easy oxidation and potential toxicity. Previously, FeCo nanocrystals with multilayered graphitic carbon, pyrolytic carbon or inert metals have been obtained, but not in the single-shelled, discrete, chemically functionalized and water-soluble forms desired for biological applications. Here, we present a scalable chemical vapour deposition method to synthesize FeCo/single-graphitic-shell nanocrystals that are soluble and stable in water solutions. We explore the multiple functionalities of these core-shell materials by characterizing the magnetic properties of the FeCo core and near-infrared optical absorbance of the single-layered graphitic shell. The nanocrystals exhibit ultra-high saturation magnetization, r1 and r2 relaxivities and high optical absorbance in the near-infrared region. Mesenchymal stem cells are able to internalize these nanoparticles, showing high negative-contrast enhancement in magnetic-resonance imaging (MRI). Preliminary in vivo experiments achieve long-lasting positive-contrast enhancement for vascular MRI in rabbits. These results point to the potential of using these nanocrystals for integrated diagnosis and therapeutic (photothermal-ablation) applications.</abstract><notes>Seo, Won Seok&#xD;Lee, Jin Hyung&#xD;Sun, Xiaoming&#xD;Suzuki, Yoriyasu&#xD;Mann, David&#xD;Liu, Zhuang&#xD;Terashima, Masahiro&#xD;Yang, Philip C&#xD;McConnell, Michael V&#xD;Nishimura, Dwight G&#xD;Dai, Hongjie&#xD;1 u54 ca119367-01/ca/nci&#xD;R01 hlo78678/phs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2006 Dec;5(12):971-6. Epub 2006 Nov 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17115025</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>19.194</custom4><electronic-resource-num>nmat1775 [pii]&#xD;10.1038/nmat1775</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>419</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">419</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kirsch, D. G.</author><author>Dinulescu, D. M.</author><author>Miller, J. B.</author><author>Grimm, J.</author><author>Santiago, P. M.</author><author>Young, N. P.</author><author>Nielsen, G. P.</author><author>Quade, B. J.</author><author>Chaber, C. J.</author><author>Schultz, C. P.</author><author>Takeuchi, O.</author><author>Bronson, R. T.</author><author>Crowley, D.</author><author>Korsmeyer, S. J.</author><author>Yoon, S. S.</author><author>Hornicek, F. J.</author><author>Weissleder, R.</author><author>Jacks, T.</author></authors></contributors><auth-address>Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>A spatially and temporally restricted mouse model of soft tissue sarcoma</title><secondary-title>Nat Med</secondary-title></titles><pages>992-7</pages><volume>13</volume><number>8</number><edition>2007/08/07</edition><keywords><keyword>Animals</keyword><keyword>Cell Transformation, Neoplastic</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/genetics</keyword><keyword>*Disease Models, Animal</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Lung Neoplasms/secondary</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Sarcoma/genetics/metabolism/*pathology</keyword><keyword>Time Factors</keyword><keyword>Tumor Suppressor Protein p14ARF/genetics</keyword><keyword>Tumor Suppressor Protein p53/deficiency/genetics/metabolism</keyword><keyword>Up-Regulation/genetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1078-8956 (Print)</isbn><accession-num>17676052</accession-num><abstract>Soft tissue sarcomas are mesenchymal tumors that are fatal in approximately one-third of patients. To explore mechanisms of sarcoma pathogenesis, we have generated a mouse model of soft tissue sarcoma. Intramuscular delivery of an adenovirus expressing Cre recombinase in mice with conditional mutations in Kras and Trp53 was sufficient to initiate high-grade sarcomas with myofibroblastic differentiation. Like human sarcomas, these tumors show a predilection for lung rather than lymph node metastasis. Using this model, we showed that a prototype handheld imaging device can identify residual tumor during intraoperative molecular imaging. Deletion of the Ink4a-Arf locus (Cdkn2a), but not Bak1 and Bax, could substitute for mutation of Trp53 in this model. Deletion of Bak1 and Bax, however, was able to substitute for mutation of Trp53 in the development of sinonasal adenocarcinoma. Therefore, the intrinsic pathway of apoptosis seems sufficient to mediate p53 tumor suppression in an epithelial cancer, but not in this model of soft tissue sarcoma.</abstract><notes>Kirsch, David G&#xD;Dinulescu, Daniela M&#xD;Miller, John B&#xD;Grimm, Jan&#xD;Santiago, Philip M&#xD;Young, Nathan P&#xD;Nielsen, G Petur&#xD;Quade, Bradley J&#xD;Chaber, Christopher J&#xD;Schultz, Christian P&#xD;Takeuchi, Osamu&#xD;Bronson, Roderick T&#xD;Crowley, Denise&#xD;Korsmeyer, Stanley J&#xD;Yoon, Sam S&#xD;Hornicek, Francis J&#xD;Weissleder, Ralph&#xD;Jacks, Tyler&#xD;K08 CA 114176/CA/United States NCI&#xD;P30-CA14051/CA/United States NCI&#xD;P50 CA86355/CA/United States NCI&#xD;R24 CA92782/CA/United States NCI&#xD;U54 CA119349/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature medicine&#xD;Nat Med. 2007 Aug;13(8):992-7. Epub 2007 Aug 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17676052</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>26.380</custom4><electronic-resource-num>nm1602 [pii]&#xD;10.1038/nm1602</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>626</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">626</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Radu, C. G.</author><author>Shu, C. J.</author><author>Nair-Gill, E.</author><author>Shelly, S. M.</author><author>Barrio, J. R.</author><author>Satyamurthy, N.</author><author>Phelps, M. E.</author><author>Witte, O. N.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, 23-120 Center for Health Sciences, Los Angeles, California 90095, USA.</auth-address><titles><title>Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2&apos;-deoxycytidine analog</title><secondary-title>Nat Med</secondary-title></titles><pages>783-8</pages><volume>14</volume><number>7</number><edition>2008/06/11</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1546-170X (Electronic)</isbn><accession-num>18542051</accession-num><abstract>Monitoring immune function with molecular imaging could have a considerable impact on the diagnosis and treatment evaluation of immunological disorders and therapeutic immune responses. Positron emission tomography (PET) is a molecular imaging modality with applications in cancer and other diseases. PET studies of immune function have been limited by a lack of specialized probes. We identified [(18)F]FAC (1-(2&apos;-deoxy-2&apos;-[(18)F]fluoroarabinofuranosyl) cytosine) by differential screening as a new PET probe for the deoxyribonucleotide salvage pathway. [(18)F]FAC enabled visualization of lymphoid organs and was sensitive to localized immune activation in a mouse model of antitumor immunity. [(18)F]FAC microPET also detected early changes in lymphoid mass in systemic autoimmunity and allowed evaluation of immunosuppressive therapy. These data support the use of [(18)F]FAC PET for immune monitoring and suggest a wide range of clinical applications in immune disorders and in certain types of cancer.</abstract><notes>Radu, Caius G&#xD;Shu, Chengyi J&#xD;Nair-Gill, Evan&#xD;Shelly, Stephanie M&#xD;Barrio, Jorge R&#xD;Satyamurthy, Nagichettiar&#xD;Phelps, Michael E&#xD;Witte, Owen N&#xD;5U54 CA119347/CA/United States NCI&#xD;P50 CA86306/CA/United States NCI&#xD;R24 CA92865/CA/United States NCI&#xD;T32 GM08042/GM/United States NIGMS&#xD;United States Howard Hughes Medical Institute&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature medicine&#xD;Nat Med. 2008 Jul;14(7):783-8. Epub 2008 Jun 8.</notes><reviewed-item>internal</reviewed-item><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18542051</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>26.380</custom4><electronic-resource-num>nm1724 [pii]&#xD;10.1038/nm1724</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>408</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">408</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ebert, M. S.</author><author>Neilson, J. R.</author><author>Sharp, P. A.</author></authors></contributors><auth-address>Center for Cancer Research, E17-529B Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells</title><secondary-title>Nat Methods</secondary-title></titles><pages>721-6</pages><volume>4</volume><number>9</number><edition>2007/08/19</edition><keywords><keyword>3&apos; Untranslated Regions</keyword><keyword>Animals</keyword><keyword>Blotting, Northern</keyword><keyword>Blotting, Western</keyword><keyword>Genes, Reporter</keyword><keyword>*Genetic Vectors</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Luciferases, Firefly/genetics</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>Oligonucleotides, Antisense/genetics</keyword><keyword>Plasmids</keyword><keyword>*RNA Interference</keyword><keyword>RNA Polymerase III/genetics</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>17694064</accession-num><abstract>MicroRNAs are predicted to regulate thousands of mammalian genes, but relatively few targets have been experimentally validated and few microRNA loss-of-function phenotypes have been assigned. As an alternative to chemically modified antisense oligonucleotides, we developed microRNA inhibitors that can be expressed in cells, as RNAs produced from transgenes. Termed &apos;microRNA sponges&apos;, these competitive inhibitors are transcripts expressed from strong promoters, containing multiple, tandem binding sites to a microRNA of interest. When vectors encoding these sponges are transiently transfected into cultured cells, sponges derepress microRNA targets at least as strongly as chemically modified antisense oligonucleotides. They specifically inhibit microRNAs with a complementary heptameric seed, such that a single sponge can be used to block an entire microRNA seed family. RNA polymerase II promoter (Pol II)-driven sponges contain a fluorescence reporter gene for identification and sorting of sponge-treated cells. We envision the use of stably expressed sponges in animal models of disease and development.</abstract><notes>Ebert, Margaret S&#xD;Neilson, Joel R&#xD;Sharp, Phillip A&#xD;P30-CA14051/CA/United States NCI&#xD;U19-AI056900/AI/United States NIAID&#xD;U54 CA112967/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2007 Sep;4(9):721-6. Epub 2007 Aug 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17694064</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>15.471</custom4><electronic-resource-num>nmeth1079 [pii]&#xD;10.1038/nmeth1079</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>598</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">598</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Howarth, M.</author><author>Liu, W.</author><author>Puthenveetil, S.</author><author>Zheng, Y.</author><author>Marshall, L. F.</author><author>Schmidt, M. M.</author><author>Wittrup, K. D.</author><author>Bawendi, M. G.</author><author>Ting, A. Y.</author></authors></contributors><auth-address>Department of Chemistry, 77 Massachusetts Avenue, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Monovalent, reduced-size quantum dots for imaging receptors on living cells</title><secondary-title>Nat Methods</secondary-title></titles><pages>397-9</pages><volume>5</volume><number>5</number><edition>2008/04/22</edition><keywords><keyword>Animals</keyword><keyword>Carcinoembryonic Antigen</keyword><keyword>Cell Survival</keyword><keyword>Cells/*cytology/*metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Electrophoresis, Agar Gel</keyword><keyword>Fluorescent Dyes</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Ligands</keyword><keyword>Nanotechnology/methods</keyword><keyword>Polyethylene Glycols</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Receptors, Cell Surface/*analysis</keyword><keyword>Receptors, Glutamate/metabolism</keyword><keyword>Staining and Labeling/methods</keyword><keyword>Streptavidin</keyword><keyword>Synapses/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1548-7105 (Electronic)</isbn><accession-num>18425138</accession-num><abstract>We describe a method to generate monovalent quantum dots (QDs) using agarose gel electrophoresis. We passivated QDs with a carboxy-terminated polyethylene-glycol ligand, yielding particles with half the diameter of commercial QDs, which we conjugated to a single copy of a high-affinity targeting moiety (monovalent streptavidin or antibody to carcinoembryonic antigen) to label cell-surface proteins. The small size improved access of QD-labeled glutamate receptors to neuronal synapses, and monovalency prevented EphA3 tyrosine kinase activation.</abstract><notes>Howarth, Mark&#xD;Liu, Wenhao&#xD;Puthenveetil, Sujiet&#xD;Zheng, Yi&#xD;Marshall, Lisa F&#xD;Schmidt, Michael M&#xD;Wittrup, K Dane&#xD;Bawendi, Moungi G&#xD;Ting, Alice Y&#xD;CA101830/CA/United States NCI&#xD;P20GM072029-01/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2008 May;5(5):397-9. Epub 2008 Apr 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18425138</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>15.471</custom4><electronic-resource-num>nmeth.1206 [pii]&#xD;10.1038/nmeth.1206</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>318</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">318</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kandere-Grzybowska, K.</author><author>Campbell, C.</author><author>Komarova, Y.</author><author>Grzybowski, B. A.</author><author>Borisy, G. G.</author></authors></contributors><auth-address>Department of Cell and Molecular Biology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611-3008, USA.</auth-address><titles><title>Molecular dynamics imaging in micropatterned living cells</title><secondary-title>Nat Methods</secondary-title></titles><pages>739-41</pages><volume>2</volume><number>10</number><edition>2005/09/24</edition><keywords><keyword>Animals</keyword><keyword>Cytoskeleton/*ultrastructure</keyword><keyword>Gold/*chemistry</keyword><keyword>*Microscopy, Electron</keyword><keyword>*Microscopy, Fluorescence</keyword><keyword>Platinum/*chemistry</keyword><keyword>*Replica Techniques</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword></keywords><dates><year>2005</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>16179919</accession-num><abstract>Micropatterning approaches using self-assembled monolayers of alkyl thiols on gold are not optimal for important imaging modalities in cell biology because of absorption of light and scattering of electrons by the gold layer. We report here an anisotropic solid microetching (ASOMIC) procedure that overcomes these limitations. The method allows molecular dynamics imaging by wide-field and total internal reflection fluorescence (TIRF) microscopy of living mammalian cells and correlative platinum replica electron microscopy.</abstract><notes>Kandere-Grzybowska, Kristiana&#xD;Campbell, Christopher&#xD;Komarova, Yulia&#xD;Grzybowski, Bartosz A&#xD;Borisy, Gary G&#xD;Gm 25062/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2005 Oct;2(10):739-41.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16179919</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>15.471</custom4><electronic-resource-num>nmeth796 [pii]&#xD;10.1038/nmeth796</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>218</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">218</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krutzik, P. O.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling</title><secondary-title>Nat Methods</secondary-title></titles><pages>361-8</pages><volume>3</volume><number>5</number><edition>2006/04/22</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD11b/metabolism</keyword><keyword>B-Lymphocytes/cytology/metabolism</keyword><keyword>CD4-Positive T-Lymphocytes/cytology/metabolism</keyword><keyword>*Cell Physiology</keyword><keyword>Cytokines/metabolism</keyword><keyword>Drug Evaluation, Preclinical/*methods</keyword><keyword>Flow Cytometry/*methods</keyword><keyword>Fluorescent Dyes</keyword><keyword>Interferon Type II/metabolism</keyword><keyword>Kinetics</keyword><keyword>Mice</keyword><keyword>Receptors, Antigen, T-Cell/antagonists &amp; inhibitors/metabolism</keyword><keyword>Receptors, Cell Surface/antagonists &amp; inhibitors/*metabolism</keyword><keyword>Signal Transduction/*physiology</keyword><keyword>Spleen/cytology/pathology</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>16628206</accession-num><abstract>Flow cytometry allows high-content, multiparameter analysis of single cells, making it a promising tool for drug discovery and profiling of intracellular signaling. To add high-throughput capacity to flow cytometry, we developed a cell-based multiplexing technique called fluorescent cell barcoding (FCB). In FCB, each sample is labeled with a different signature, or barcode, of fluorescence intensity and emission wavelengths, and mixed with other samples before antibody staining and analysis by flow cytometry. Using three FCB fluorophores, we were able to barcode and combine entire 96-well plates, reducing antibody consumption 100-fold and acquisition time to 5-15 min per plate. Using FCB and phospho-specific flow cytometry, we screened a small-molecule library for inhibitors of T cell-receptor and cytokine signaling, simultaneously determining compound efficacy and selectivity. We also analyzed IFN-gamma signaling in multiple cell types from primary mouse splenocytes, revealing differences in sensitivity and kinetics between B cells, CD4+ and CD4- T cells and CD11b-hi cells.</abstract><notes>Krutzik, Peter O&#xD;Nolan, Garry P&#xD;Ai35304/ai/niaid&#xD;N01-hv-28183/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2006 May;3(5):361-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16628206</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>15.471</custom4><electronic-resource-num>nmeth872 [pii]&#xD;10.1038/nmeth872</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>532</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">532</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Loening, A. M.</author><author>Wu, A. M.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Departments of Radiology and Bioengineering, Bio-X Program, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Red-shifted Renilla reniformis luciferase variants for imaging in living subjects</title><secondary-title>Nat Methods</secondary-title></titles><pages>641-3</pages><volume>4</volume><number>8</number><edition>2007/07/10</edition><keywords><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Luciferases, Renilla/genetics/*metabolism</keyword><keyword>Luminescence</keyword><keyword>Mice</keyword><keyword>Mutagenesis, Site-Directed</keyword><keyword>Renilla/*enzymology</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>17618292</accession-num><abstract>The use of R. reniformis luciferase (RLuc) as a reporter gene in small-animal imaging has been hampered by its 481 nm peaked emission spectrum, as blue wavelengths are strongly attenuated in biological tissues. To overcome this, we generated variants of RLuc with bathochromic (red) shifts of up to 66 nm (547 nm peak) that also had greater stability and higher light emission than native RLuc.</abstract><notes>Loening, Andreas Markus&#xD;Wu, Anna M&#xD;Gambhir, Sanjiv Sam&#xD;CA114747 ICMIC P50/CA/United States NCI&#xD;CA119367 CCNE U54/CA/United States NCI&#xD;R01 CA082214/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2007 Aug;4(8):641-3. Epub 2007 Jul 8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17618292</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>15.471</custom4><electronic-resource-num>nmeth1070 [pii]&#xD;10.1038/nmeth1070</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>97</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">97</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tannous, B. A.</author><author>Grimm, J.</author><author>Perry, K. F.</author><author>Chen, J. W.</author><author>Weissleder, R.</author><author>Breakefield, X. O.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital-East, Building 149, 13th Street, Charlestown, Massachusetts 02129, USA.</auth-address><titles><title>Metabolic biotinylation of cell surface receptors for in vivo imaging</title><secondary-title>Nat Methods</secondary-title></titles><pages>391-6</pages><volume>3</volume><number>5</number><edition>2006/04/22</edition><keywords><keyword>Base Sequence</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Biotin/*metabolism</keyword><keyword>*Biotinylation</keyword><keyword>Cell Membrane/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Genes, Reporter</keyword><keyword>Green Fluorescent Proteins/analysis</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Peptides/chemistry</keyword><keyword>Receptors, Cell Surface/chemistry/*metabolism</keyword><keyword>Streptavidin/chemistry</keyword><keyword>Transduction, Genetic</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>16628210</accession-num><abstract>We have developed a versatile, potent technique for imaging cells in culture and in vivo by expressing a metabolically biotinylated cell-surface receptor and visualizing it with labeled streptavidin moieties. The recombinant reporter protein, which incorporates a biotin acceptor peptide (BAP) between an N-terminal signal sequence and a transmembrane domain, (BAP-TM) was efficiently biotinylated by endogenous biotin ligase in mammalian cells with the biotin displayed on the cell surface. Tumors expressing the BAP-TM have high sensitivity for magnetic resonance and fluorescence tomographic imaging in vivo after intravascular injection of streptavidin conjugated to magnetic nanoparticles or fluorochromes, respectively. Moreover, streptavidin-horseradish peroxidase conjugates in conjunction with a peroxidase-sensitive gadolinium agent further increased and prolonged the magnetic resonance signal. This BAP-TM allows noninvasive real-time imaging of any cell type transduced to express this reporter protein in culture or in vivo.</abstract><notes>Tannous, Bakhos A&#xD;Grimm, Jan&#xD;Perry, Katherine F&#xD;Chen, John W&#xD;Weissleder, Ralph&#xD;Breakefield, Xandra O&#xD;Ca69246/ca/nci&#xD;Ca86355/ca/nci&#xD;Ca92782/ca/nci&#xD;R01 hl078641/hl/nhlbi&#xD;U01 hl080731/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2006 May;3(5):391-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16628210</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>15.471</custom4><electronic-resource-num>nmeth875 [pii]&#xD;10.1038/nmeth875</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>337</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">337</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Cai, W. B.</author><author>He, L. N.</author><author>Nakayama, N.</author><author>Chen, K.</author><author>Sun, X. M.</author><author>Chen, X. Y.</author><author>Dai, H. J.</author></authors></contributors><auth-address>Dai, HJ&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford MIPS, Stanford, CA 94305 USA&#xD;Stanford Univ, Sch Med, BioX Program, Stanford, CA 94305 USA</auth-address><titles><title>In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>47-52</pages><volume>2</volume><number>1</number><edition>2007/01</edition><keywords><keyword>rgd peptide</keyword><keyword>cells</keyword><keyword>expression</keyword><keyword>functionalization</keyword><keyword>transporters</keyword><keyword>delivery</keyword><keyword>cancer</keyword><keyword>alpha(v)beta(3)</keyword><keyword>integrins</keyword><keyword>agents</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1748-3387</isbn><accession-num>ISI:000243902900015</accession-num><abstract>Single-walled carbon nanotubes (SWNTs) exhibit unique size, shape and physical properties(1-3) that make them promising candidates for biological applications. Here, we investigate the biodistribution of radio-labelled SWNTs in mice by in vivo positron emission tomography (PET), ex vivo biodistribution and Raman spectroscopy. It is found that SWNTs that are functionalized with phospholipids bearing polyethylene-glycol (PEG) are surprisingly stable in vivo. The effect of PEG chain length on the biodistribution and circulation of the SWNTs is studied. Effectively PEGylated SWNTs exhibit relatively long blood circulation times and low uptake by the reticuloendothelial system ( RES). Efficient targeting of integrin positive tumour in mice is achieved with SWNTs coated with PEG chains linked to an arginine-glycine-aspartic acid (RGD) peptide. A high tumour accumulation is attributed to the multivalent effect of the SWNTs. The Raman signatures of SWNTs are used to directly probe the presence of nanotubes in mice tissues and confirm the radio-label-based results.</abstract><notes>131WQ&#xD;Times Cited:4&#xD;Cited References Count:30</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000243902900015</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>na</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>618</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">618</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schipper, M. L.</author><author>Nakayama-Ratchford, N.</author><author>Davis, C. R.</author><author>Kam, N. W.</author><author>Chu, P.</author><author>Liu, Z.</author><author>Sun, X.</author><author>Dai, H.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Palo Alto, California 94305-5427, USA.</auth-address><titles><title>A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>216-21</pages><volume>3</volume><number>4</number><edition>2008/07/26</edition><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1748-3395 (Electronic)</isbn><accession-num>18654506</accession-num><abstract>Single-walled carbon nanotubes are currently under evaluation in biomedical applications, including in vivo delivery of drugs, proteins, peptides and nucleic acids (for gene transfer or gene silencing), in vivo tumour imaging and tumour targeting of single-walled carbon nanotubes as an anti-neoplastic treatment. However, concerns about the potential toxicity of single-walled carbon nanotubes have been raised. Here we examine the acute and chronic toxicity of functionalized single-walled carbon nanotubes when injected into the bloodstream of mice. Survival, clinical and laboratory parameters reveal no evidence of toxicity over 4 months. Upon killing, careful necropsy and tissue histology show age-related changes only. Histology and Raman microscopic mapping demonstrate that functionalized single-walled carbon nanotubes persisted within liver and spleen macrophages for 4 months without apparent toxicity. Although this is a preliminary study with a small group of animals, our results encourage further confirmation studies with larger groups of animals.</abstract><notes>Schipper, Meike L&#xD;Nakayama-Ratchford, Nozomi&#xD;Davis, Corrine R&#xD;Kam, Nadine Wong Shi&#xD;Chu, Pauline&#xD;Liu, Zhuang&#xD;Sun, Xiaoming&#xD;Dai, Hongjie&#xD;Gambhir, Sanjiv S&#xD;P50 CA114747/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nature nanotechnology&#xD;Nat Nanotechnol. 2008 Apr;3(4):216-21. Epub 2008 Mar 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18654506</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>nnano.2008.68 [pii]&#xD;10.1038/nnano.2008.68</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>534</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">534</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305, USA.</auth-address><titles><title>Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging</title><secondary-title>Nat Protoc</secondary-title></titles><pages>89-96</pages><volume>3</volume><number>1</number><edition>2008/01/15</edition><keywords><keyword>Biological Markers/analysis/chemistry</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Humans</keyword><keyword>Iodine Radioisotopes</keyword><keyword>Neoplasms/*blood supply/pathology</keyword><keyword>Oligopeptides/*analysis/chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>Spectrometry, Fluorescence/*methods</keyword><keyword>Spectroscopy, Near-Infrared/*methods</keyword></keywords><dates><year>2008</year></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>18193025</accession-num><abstract>To take full advantage of the unique optical properties of quantum dots (QDs) and expedite future near-infrared fluorescence (NIRF) imaging applications, QDs need to be effectively, specifically and reliably directed to a specific organ or disease site after systemic administration. Recently, we reported the use of peptide-conjugated QDs for non-invasive NIRF imaging of tumor vasculature markers in small animal models. In this protocol, we describe the detailed procedure for the preparation of such peptide-conjugated QDs using commercially available PEG-coated QDs and arginine-glycine-aspartic acid (RGD) peptides. Conjugation of the thiolated RGD peptide to the QDs was achieved through a heterobifunctional linker, 4-maleimidobutyric acid N-succinimidyl ester. Competitive cell binding assay, using (125)I-echistatin as the radioligand, and live cell staining were carried out to confirm the successful attachment of the RGD peptides to the QD surface before in vivo imaging of tumor-bearing mice. In general, QD conjugation and in vitro validation of the peptide-conjugated QDs can be accomplished within 1-2 d; in vivo imaging will take another 1-2 d depending on the experimental design.</abstract><notes>Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;R21 CA121842/CA/United States NCI&#xD;U54CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2008;3(1):89-96.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18193025</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>1.671</custom4><electronic-resource-num>nprot.2007.478 [pii]&#xD;10.1038/nprot.2007.478</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>99</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">99</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pittet, M. J.</author><author>Swirski, F. K.</author><author>Reynolds, F.</author><author>Josephson, L.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. mpittet@hms.harvard.edu</auth-address><titles><title>Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles</title><secondary-title>Nat Protoc</secondary-title></titles><pages>73-9</pages><volume>1</volume><number>1</number><edition>2007/04/05</edition><keywords><keyword>Animals</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Magnetics</keyword><keyword>Mice</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Staining and Labeling/*methods</keyword><keyword>T-Lymphocytes/*chemistry/cytology</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>17406214</accession-num><abstract>Observation of immune and stem cells in their native microenvironments requires the development of imaging agents to allow their in vivo tracking. We describe here the synthesis of magnetofluorescent nanoparticles for cell labeling in vitro and for multimodality imaging of administered cells in vivo. MION-47, a prototype monocrystalline iron oxide nanoparticle, was first converted to an intermediate bearing a fluorochrome and amine groups, then reacted with either HIV-Tat peptide or protamine to yield a nanoparticle with membrane-translocating properties. We describe how to assess optimal cell labeling with tests of cell phenotype and function. Synthesis of magnetofluorescent nanoparticles and cell-labeling optimization can be realized in 48 h, whereas nanoparticle uptakes and retention studies may generally take up to 120 h. Labeled cells can be detected by magnetic resonance imaging, fluorescence reflectance imaging, fluorescence-mediated tomography, confocal microscopy and flow cytometry, and can be purified based on their fluorescent or magnetic properties. The present protocol focuses on T-cell labeling but can be used for labeling a variety of circulating cells.</abstract><notes>Pittet, Mikael J&#xD;Swirski, Filip K&#xD;Reynolds, Frederick&#xD;Josephson, Lee&#xD;Weissleder, Ralph&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2006;1(1):73-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17406214</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>1.671</custom4><electronic-resource-num>nprot.2006.11 [pii]&#xD;10.1038/nprot.2006.11</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>233</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">233</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>So, M. K.</author><author>Loening, A. M.</author><author>Gambhir, S. S.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, Stanford, California 94305-5484, USA.</auth-address><titles><title>Creating self-illuminating quantum dot conjugates</title><secondary-title>Nat Protoc</secondary-title></titles><pages>1160-4</pages><volume>1</volume><number>3</number><edition>2007/04/05</edition><keywords><keyword>Energy Transfer</keyword><keyword>Imidazoles</keyword><keyword>Luciferases, Renilla</keyword><keyword>*Luminescence</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Pyrazines</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>17406398</accession-num><abstract>Semiconductor quantum dots are inorganic fluorescent nanocrystals that, because of their unique optical properties compared with those of organic fluorophores, have become popular as fluorescent imaging probes. Although external light excitation is typically required for imaging with quantum dots, a new type of quantum dot conjugate has been reported that can luminesce with no need for external excitation. These self-illuminating quantum dot conjugates can be prepared by coupling of commercially available carboxylate-presenting quantum dots to the light-emitting protein Renilla luciferase. When the conjugates are exposed to the luciferase&apos;s substrate coelenterazine, the energy released by substrate catabolism is transferred to the quantum dots through bioluminescence resonance energy transfer, leading to quantum dot light emission. This protocol describes step-by-step procedures for the preparation and characterization of these self-illuminating quantum dot conjugates. The preparation process is relatively simple and can be done in less than 2 hours. The availability of self-illuminating quantum dot conjugates will provide many new possibilities for in vivo imaging and detection, such as monitoring of in vivo cell trafficking, multiplex bioluminescence imaging and new quantum dot-based biosensors.</abstract><notes>So, Min-Kyung&#xD;Loening, Andreas M&#xD;Gambhir, Sanjiv S&#xD;Rao, Jianghong&#xD;1u54ca119367-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2006;1(3):1160-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17406398</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>1.671</custom4><electronic-resource-num>nprot.2006.162 [pii]&#xD;10.1038/nprot.2006.162</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>643</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">643</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Urbanczyk-Pearson, L. M.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Department of Biochemistry and Molecular and Cell Biology, Department of Neurobiology and Physiology, Department of Radiology, Northwestern University, Evanston, Illinois 60201, USA.</auth-address><titles><title>Preparation of magnetic resonance contrast agents activated by beta-galactosidase</title><secondary-title>Nat Protoc</secondary-title></titles><pages>341-50</pages><volume>3</volume><number>3</number><edition>2008/03/08</edition><dates><year>2008</year></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>18323804</accession-num><abstract>The preparation of beta-EgadMe and alpha-EgadMe, magnetic resonance (MR) contrast agents that can be used for in vivo detection of beta-galactosidase, is described. Diastereomerically pure beta-EgadMe can be synthesized by kinetically resolving the starting material as described in Step 1. The total time for the preparation of the racemic mixture of beta-EgadMe is about 8 d, and the total time for an diastereomerically resolved agent is about 9 d. The final metallated agent is stable at room temperature as a solid or in aqueous buffer (pH 5.5-10) indefinitely. Diastereomerically pure alpha-EgadMe can be prepared by beginning the synthesis with enantiomerically pure bromopropionic acid. The total time for the preparation of racemic alpha-EgadMe or diastereomerically pure alpha-EgadMe is about 8 d. The final metallated agent is stable at room temperature as a solid or in aqueous buffer (pH 5.5-10) indefinitely.</abstract><notes>Urbanczyk-Pearson, Lauren M&#xD;Meade, Thomas J&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2008;3(3):341-50. Epub 2008 Feb 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18323804</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>1.671</custom4><electronic-resource-num>nprot.2007.529 [pii]&#xD;10.1038/nprot.2007.529</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>110</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">110</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xing, Y.</author><author>Chaudry, Q.</author><author>Shen, C.</author><author>Kong, K. Y.</author><author>Zhau, H. E.</author><author>Chung, L. W.</author><author>Petros, J. A.</author><author>O&apos;Regan, R. M.</author><author>Yezhelyev, M. V.</author><author>Simons, J. W.</author><author>Wang, M. D.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, 101 Woodruff Circle Suite 1001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry</title><secondary-title>Nat Protoc</secondary-title></titles><pages>1152-65</pages><volume>2</volume><number>5</number><edition>2007/06/05</edition><dates><year>2007</year></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>17546006</accession-num><abstract>Bioconjugated quantum dots (QDs) provide a new class of biological labels for evaluating biomolecular signatures (biomarkers) on intact cells and tissue specimens. In particular, the use of multicolor QD probes in immunohistochemistry is considered one of the most important and clinically relevant applications. At present, however, clinical applications of QD-based immunohistochemistry have achieved only limited success. A major bottleneck is the lack of robust protocols to define the key parameters and steps. Here, we describe our recent experience, preliminary results and detailed protocols for QD-antibody conjugation, tissue specimen preparation, multicolor QD staining, image processing and biomarker quantification. The results demonstrate that bioconjugated QDs can be used for multiplexed profiling of molecular biomarkers, and ultimately for correlation with disease progression and response to therapy. In general, QD bioconjugation is completed within 1 day, and multiplexed molecular profiling takes 1-3 days depending on the number of biomarkers and QD probes used.</abstract><notes>Xing, Yun&#xD;Chaudry, Qaiser&#xD;Shen, Christopher&#xD;Kong, Koon Yin&#xD;Zhau, Haiyen E&#xD;Chung, Leland W&#xD;Petros, John A&#xD;O&apos;Regan, Ruth M&#xD;Yezhelyev, Maksym V&#xD;Simons, Jonathan W&#xD;Wang, May D&#xD;Nie, Shuming&#xD;R01 ca108468/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2007;2(5):1152-65.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17546006</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>1.671</custom4><electronic-resource-num>nprot.2007.107 [pii]&#xD;10.1038/nprot.2007.107</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>216</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">216</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Irish, J. M.</author><author>Kotecha, N.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>Department of Medicine, Oncology Division, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Mapping normal and cancer cell signalling networks: towards single-cell proteomics</title><secondary-title>Nat Rev Cancer</secondary-title></titles><pages>146-55</pages><volume>6</volume><number>2</number><edition>2006/02/24</edition><keywords><keyword>*Cell Communication</keyword><keyword>Cell Transformation, Neoplastic/*genetics</keyword><keyword>Flow Cytometry</keyword><keyword>Humans</keyword><keyword>Neoplasms/diagnosis/genetics/pathology</keyword><keyword>Prognosis</keyword><keyword>*Proteomics</keyword><keyword>*Signal Transduction</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1474-175X (Print)</isbn><accession-num>16491074</accession-num><abstract>Oncogenesis and tumour progression are supported by alterations in cell signalling. Using flow cytometry, it is now possible to track and analyse signalling events in individual cancer cells. Data from this type of analysis can be used to create a network map of signalling in each cell and to link specific signalling profiles with clinical outcomes. This form of &apos;single-cell proteomics&apos; can identify pathways that are activated in therapy-resistant cells and can provide biomarkers for cancer diagnosis and for determining patient prognosis.</abstract><notes>Irish, Jonathan M&#xD;Kotecha, Nikesh&#xD;Nolan, Garry P&#xD;Review&#xD;England&#xD;Nature reviews. Cancer&#xD;Nat Rev Cancer. 2006 Feb;6(2):146-55.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16491074</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>31.58</custom4><electronic-resource-num>nrc1804 [pii]&#xD;10.1038/nrc1804</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>348</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">348</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Burg, T. P.</author><author>Godin, M.</author><author>Knudsen, S. M.</author><author>Shen, W.</author><author>Carlson, G.</author><author>Foster, J. S.</author><author>Babcock, K.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Weighing of biomolecules, single cells and single nanoparticles in fluid</title><secondary-title>Nature</secondary-title><alt-title>Nature</alt-title></titles><pages>1066-9</pages><volume>446</volume><number>7139</number><edition>2007/04</edition><keywords><keyword>Bacteria/chemistry/isolation &amp; purification</keyword><keyword>Biological Products/analysis/*chemistry</keyword><keyword>Cells/*chemistry</keyword><keyword>Colloids/analysis/chemistry</keyword><keyword>Microfluidics/*instrumentation/*methods</keyword><keyword>Molecular Weight</keyword><keyword>Nanoparticles/analysis/*chemistry</keyword><keyword>Proteins/analysis/chemistry</keyword><keyword>Quartz</keyword><keyword>Solutions/chemistry</keyword><keyword>Vacuum</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 26</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>17460669</accession-num><abstract>Nanomechanical resonators enable the measurement of mass with extraordinary sensitivity. Previously, samples as light as 7 zeptograms (1 zg = 10(-21) g) have been weighed in vacuum, and proton-level resolution seems to be within reach. Resolving small mass changes requires the resonator to be light and to ring at a very pure tone-that is, with a high quality factor. In solution, viscosity severely degrades both of these characteristics, thus preventing many applications in nanotechnology and the life sciences where fluid is required. Although the resonant structure can be designed to minimize viscous loss, resolution is still substantially degraded when compared to measurements made in air or vacuum. An entirely different approach eliminates viscous damping by placing the solution inside a hollow resonator that is surrounded by vacuum. Here we demonstrate that suspended microchannel resonators can weigh single nanoparticles, single bacterial cells and sub-monolayers of adsorbed proteins in water with sub-femtogram resolution (1 Hz bandwidth). Central to these results is our observation that viscous loss due to the fluid is negligible compared to the intrinsic damping of our silicon crystal resonator. The combination of the low resonator mass (100 ng) and high quality factor (15,000) enables an improvement in mass resolution of six orders of magnitude over a high-end commercial quartz crystal microbalance. This gives access to intriguing applications, such as mass-based flow cytometry, the direct detection of pathogens, or the non-optical sizing and mass density measurement of colloidal particles.</abstract><notes>Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17460669 </url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2007</custom3><custom4>26.68</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>524</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">524</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hanash, S. M.</author><author>Pitteri, S. J.</author><author>Faca, V. M.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109, USA.</auth-address><titles><title>Mining the plasma proteome for cancer biomarkers</title><secondary-title>Nature</secondary-title></titles><pages>571-9</pages><volume>452</volume><number>7187</number><edition>2008/04/04</edition><keywords><keyword>Body Fluids/metabolism</keyword><keyword>Humans</keyword><keyword>Neoplasms/*blood/diagnosis/pathology</keyword><keyword>Plasma/*metabolism</keyword><keyword>Proteome/*metabolism</keyword><keyword>*Proteomics</keyword><keyword>Tumor Markers, Biological/analysis/*blood</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 3</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>18385731</accession-num><abstract>Systematic searches for plasma proteins that are biological indicators, or biomarkers, for cancer are underway. The difficulties caused by the complexity of biological-fluid proteomes and tissue proteomes (which contribute proteins to plasma) and by the extensive heterogeneity among diseases, subjects and levels of sample procurement are gradually being overcome. This is being achieved through rigorous experimental design and in-depth quantitative studies. The expected outcome is the development of panels of biomarkers that will allow early detection of cancer and prediction of the probable response to therapy. Achieving these objectives requires high-quality specimens with well-matched controls, reagent resources, and an efficient process to confirm discoveries through independent validation studies.</abstract><notes>Hanash, Samir M&#xD;Pitteri, Sharon J&#xD;Faca, Vitor M&#xD;Review&#xD;England&#xD;Nature&#xD;Nature. 2008 Apr 3;452(7187):571-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18385731</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>26.681</custom4><electronic-resource-num>nature06916 [pii]&#xD;10.1038/nature06916</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>272</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">272</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Janzen, V.</author><author>Forkert, R.</author><author>Fleming, H. E.</author><author>Saito, Y.</author><author>Waring, M. T.</author><author>Dombkowski, D. M.</author><author>Cheng, T.</author><author>DePinho, R. A.</author><author>Sharpless, N. E.</author><author>Scadden, D. T.</author></authors></contributors><auth-address>Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114, USA.</auth-address><titles><title>Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a</title><secondary-title>Nature</secondary-title></titles><pages>421-6</pages><volume>443</volume><number>7110</number><edition>2006/09/08</edition><keywords><keyword>Aging</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Basic Helix-Loop-Helix Transcription Factors/genetics/metabolism</keyword><keyword>Bone Marrow Transplantation</keyword><keyword>*Cell Aging</keyword><keyword>Cell Count</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/genetics/*metabolism</keyword><keyword>Hematopoietic Stem Cells/*cytology/*metabolism</keyword><keyword>Homeodomain Proteins/genetics/metabolism</keyword><keyword>Mice</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 28</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16957735</accession-num><abstract>Stem-cell ageing is thought to contribute to altered tissue maintenance and repair. Older humans experience increased bone marrow failure and poorer haematologic tolerance of cytotoxic injury. Haematopoietic stem cells (HSCs) in older mice have decreased per-cell repopulating activity, self-renewal and homing abilities, myeloid skewing of differentiation, and increased apoptosis with stress. Here we report that the cyclin-dependent kinase inhibitor p16INK4a, the level of which was previously noted to increase in other cell types with age, accumulates and modulates specific age-associated HSC functions. Notably, in the absence of p16INK4a, HSC repopulating defects and apoptosis were mitigated, improving the stress tolerance of cells and the survival of animals in successive transplants, a stem-cell-autonomous tissue regeneration model. Inhibition of p16INK4a may ameliorate the physiological impact of ageing on stem cells and thereby improve injury repair in aged tissue.</abstract><notes>Janzen, Viktor&#xD;Forkert, Randolf&#xD;Fleming, Heather E&#xD;Saito, Yoriko&#xD;Waring, Michael T&#xD;Dombkowski, David M&#xD;Cheng, Tao&#xD;DePinho, Ronald A&#xD;Sharpless, Norman E&#xD;Scadden, David T&#xD;England&#xD;Nature&#xD;Nature. 2006 Sep 28;443(7110):421-6. Epub 2006 Sep 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16957735</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>26.68</custom4><electronic-resource-num>nature05159 [pii]&#xD;10.1038/nature05159</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>286</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">286</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krishnamurthy, J.</author><author>Ramsey, M. R.</author><author>Ligon, K. L.</author><author>Torrice, C.</author><author>Koh, A.</author><author>Bonner-Weir, S.</author><author>Sharpless, N. E.</author></authors></contributors><auth-address>Department of Medicine, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>p16INK4a induces an age-dependent decline in islet regenerative potential</title><secondary-title>Nature</secondary-title></titles><pages>453-7</pages><volume>443</volume><number>7110</number><edition>2006/09/08</edition><keywords><keyword>Aging/*physiology</keyword><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/genetics/*metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Islets of Langerhans/*cytology/drug effects/pathology</keyword><keyword>Mice</keyword><keyword>Regeneration/*physiology</keyword><keyword>Streptozocin/pharmacology</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 28</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16957737</accession-num><abstract>The p16INK4a tumour suppressor accumulates in many tissues as a function of advancing age. p16INK4a is an effector of senescence and a potent inhibitor of the proliferative kinase Cdk4 (ref. 6), which is essential for pancreatic beta-cell proliferation in adult mammals. Here we show that p16INK4a constrains islet proliferation and regeneration in an age-dependent manner. Expression of the p16INK4a transcript is enriched in purified islets compared with the exocrine pancreas, and islet-specific expression of p16INK4a, but not other cyclin-dependent kinase inhibitors, increases markedly with ageing. To determine the physiological significance of p16INK4a accumulation on islet function, we assessed the impact of p16INK4a deficiency and overexpression with increasing age and in the regenerative response after exposure to a specific beta-cell toxin. Transgenic mice that overexpress p16INK4a to a degree seen with ageing demonstrated decreased islet proliferation. Similarly, islet proliferation was unaffected by p16INK4a deficiency in young mice, but was relatively increased in p16(INK4a)-deficient old mice. Survival after toxin-mediated ablation of beta-cells, which requires islet proliferation, declined with advancing age; however, mice lacking p16INK4a demonstrated enhanced islet proliferation and survival after beta-cell ablation. These genetic data support the view that an age-induced increase of p16INK4a expression limits the regenerative capacity of beta-cells with ageing.</abstract><notes>Krishnamurthy, Janakiraman&#xD;Ramsey, Matthew R&#xD;Ligon, Keith L&#xD;Torrice, Chad&#xD;Koh, Angela&#xD;Bonner-Weir, Susan&#xD;Sharpless, Norman E&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature&#xD;Nature. 2006 Sep 28;443(7110):453-7. Epub 2006 Sep 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16957737</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>26.68</custom4><electronic-resource-num>nature05092 [pii]&#xD;10.1038/nature05092</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>290</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">290</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Molofsky, A. V.</author><author>Slutsky, S. G.</author><author>Joseph, N. M.</author><author>He, S.</author><author>Pardal, R.</author><author>Krishnamurthy, J.</author><author>Sharpless, N. E.</author><author>Morrison, S. J.</author></authors></contributors><auth-address>Howard Hughes Medical Institute, Department of Internal Medicine, and Center for Stem Cell Biology, University of Michigan, Ann Arbor, Michigan 48109-2216, USA.</auth-address><titles><title>Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing</title><secondary-title>Nature</secondary-title></titles><pages>448-52</pages><volume>443</volume><number>7110</number><edition>2006/09/08</edition><keywords><keyword>Aging/*physiology</keyword><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclin-Dependent Kinase Inhibitor</keyword><keyword>p16/biosynthesis/deficiency/genetics/*metabolism</keyword><keyword>Mice</keyword><keyword>Neurons/*cytology</keyword><keyword>Olfactory Bulb/cytology/physiology</keyword><keyword>Prosencephalon/*cytology/metabolism</keyword><keyword>Regeneration/*physiology</keyword><keyword>Stem Cells/cytology</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 28</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16957738</accession-num><abstract>Mammalian ageing is associated with reduced regenerative capacity in tissues that contain stem cells. It has been proposed that this is at least partially caused by the senescence of progenitors with age; however, it has not yet been tested whether genes associated with senescence functionally contribute to physiological declines in progenitor activity. Here we show that progenitor proliferation in the subventricular zone and neurogenesis in the olfactory bulb, as well as multipotent progenitor frequency and self-renewal potential, all decline with age in the mouse forebrain. These declines in progenitor frequency and function correlate with increased expression of p16INK4a, which encodes a cyclin-dependent kinase inhibitor linked to senescence. Ageing p16INK4a-deficient mice showed a significantly smaller decline in subventricular zone proliferation, olfactory bulb neurogenesis, and the frequency and self-renewal potential of multipotent progenitors. p16INK4a deficiency did not detectably affect progenitor function in the dentate gyrus or enteric nervous system, indicating regional differences in the response of neural progenitors to increased p16INK4a expression during ageing. Declining subventricular zone progenitor function and olfactory bulb neurogenesis during ageing are thus caused partly by increasing p16INK4a expression.</abstract><notes>Molofsky, Anna V&#xD;Slutsky, Shalom G&#xD;Joseph, Nancy M&#xD;He, Shenghui&#xD;Pardal, Ricardo&#xD;Krishnamurthy, Janakiraman&#xD;Sharpless, Norman E&#xD;Morrison, Sean J&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature&#xD;Nature. 2006 Sep 28;443(7110):448-52. Epub 2006 Sep 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16957738</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>26.68</custom4><electronic-resource-num>nature05091 [pii]&#xD;10.1038/nature05091</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>296</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">296</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pertz, O.</author><author>Hodgson, L.</author><author>Klemke, R. L.</author><author>Hahn, K. M.</author></authors></contributors><auth-address>University of North Carolina at Chapel Hill, Department of Pharmacology and Lineberger Cancer Center, Chapel Hill, North Carolina 27599, USA. khahn@med.unc.edu</auth-address><titles><title>Spatiotemporal dynamics of RhoA activity in migrating cells</title><secondary-title>Nature</secondary-title></titles><pages>1069-72</pages><volume>440</volume><number>7087</number><edition>2006/03/21</edition><keywords><keyword>3T3 Cells</keyword><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>*Cell Movement</keyword><keyword>Cell Surface Extensions/drug effects/*metabolism</keyword><keyword>Fibroblasts</keyword><keyword>Mice</keyword><keyword>Pinocytosis</keyword><keyword>Platelet-Derived Growth Factor/pharmacology</keyword><keyword>Time Factors</keyword><keyword>rac GTP-Binding Proteins/metabolism</keyword><keyword>rhoA GTP-Binding Protein/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 20</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16547516</accession-num><abstract>Rho family GTPases regulate the actin and adhesion dynamics that control cell migration. Current models postulate that Rac promotes membrane protrusion at the leading edge and that RhoA regulates contractility in the cell body. However, there is evidence that RhoA also regulates membrane protrusion. Here we use a fluorescent biosensor, based on a novel design preserving reversible membrane interactions, to visualize the spatiotemporal dynamics of RhoA activity during cell migration. In randomly migrating cells, RhoA activity is concentrated in a sharp band directly at the edge of protrusions. It is observed sporadically in retracting tails, and is low in the cell body. RhoA activity is also associated with peripheral ruffles and pinocytic vesicles, but not with dorsal ruffles induced by platelet-derived growth factor (PDGF). In contrast to randomly migrating cells, PDGF-induced membrane protrusions have low RhoA activity, potentially because PDGF strongly activates Rac, which has previously been shown to antagonize RhoA activity. Our data therefore show that different extracellular cues induce distinct patterns of RhoA signalling during membrane protrusion.</abstract><notes>Pertz, Olivier&#xD;Hodgson, Louis&#xD;Klemke, Richard L&#xD;Hahn, Klaus M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature&#xD;Nature. 2006 Apr 20;440(7087):1069-72. Epub 2006 Mar 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16547516</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>26.68</custom4><electronic-resource-num>nature04665 [pii]&#xD;10.1038/nature04665</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>624</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">624</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qin, Y.</author><author>Wang, X.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Microfibre-nanowire hybrid structure for energy scavenging</title><secondary-title>Nature</secondary-title></titles><pages>809-13</pages><volume>451</volume><number>7180</number><edition>2008/02/15</edition><dates><year>2008</year><pub-dates><date>Feb 14</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>18273015</accession-num><abstract>A self-powering nanosystem that harvests its operating energy from the environment is an attractive proposition for sensing, personal electronics and defence technologies. This is in principle feasible for nanodevices owing to their extremely low power consumption. Solar, thermal and mechanical (wind, friction, body movement) energies are common and may be scavenged from the environment, but the type of energy source to be chosen has to be decided on the basis of specific applications. Military sensing/surveillance node placement, for example, may involve difficult-to-reach locations, may need to be hidden, and may be in environments that are dusty, rainy, dark and/or in deep forest. In a moving vehicle or aeroplane, harvesting energy from a rotating tyre or wind blowing on the body is a possible choice to power wireless devices implanted in the surface of the vehicle. Nanowire nanogenerators built on hard substrates were demonstrated for harvesting local mechanical energy produced by high-frequency ultrasonic waves. To harvest the energy from vibration or disturbance originating from footsteps, heartbeats, ambient noise and air flow, it is important to explore innovative technologies that work at low frequencies (such as &lt;10 Hz) and that are based on flexible soft materials. Here we present a simple, low-cost approach that converts low-frequency vibration/friction energy into electricity using piezoelectric zinc oxide nanowires grown radially around textile fibres. By entangling two fibres and brushing the nanowires rooted on them with respect to each other, mechanical energy is converted into electricity owing to a coupled piezoelectric-semiconductor process. This work establishes a methodology for scavenging light-wind energy and body-movement energy using fabrics.</abstract><notes>Qin, Yong&#xD;Wang, Xudong&#xD;Wang, Zhong Lin&#xD;England&#xD;Nature&#xD;Nature. 2008 Feb 14;451(7180):809-13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18273015</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>26.681</custom4><electronic-resource-num>nature06601 [pii]&#xD;10.1038/nature06601</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>418</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">418</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ventura, A.</author><author>Kirsch, D. G.</author><author>McLaughlin, M. E.</author><author>Tuveson, D. A.</author><author>Grimm, J.</author><author>Lintault, L.</author><author>Newman, J.</author><author>Reczek, E. E.</author><author>Weissleder, R.</author><author>Jacks, T.</author></authors></contributors><auth-address>Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.</auth-address><titles><title>Restoration of p53 function leads to tumour regression in vivo</title><secondary-title>Nature</secondary-title></titles><pages>661-5</pages><volume>445</volume><number>7128</number><edition>2007/01/26</edition><keywords><keyword>Alleles</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Cell Aging</keyword><keyword>Cell Division</keyword><keyword>Disease Models, Animal</keyword><keyword>Humans</keyword><keyword>Lymphoma/metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Neoplasms/drug therapy/*metabolism/*pathology</keyword><keyword>Organ Specificity</keyword><keyword>Sarcoma/metabolism/pathology</keyword><keyword>Tumor Suppressor Protein p53/deficiency/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 8</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>17251932</accession-num><abstract>Tumorigenesis is a multi-step process that requires activation of oncogenes and inactivation of tumour suppressor genes. Mouse models of human cancers have recently demonstrated that continuous expression of a dominantly acting oncogene (for example, Hras, Kras and Myc) is often required for tumour maintenance; this phenotype is referred to as oncogene addiction. This concept has received clinical validation by the development of active anticancer drugs that specifically inhibit the function of oncoproteins such as BCR-ABL, c-KIT and EGFR. Identifying additional gene mutations that are required for tumour maintenance may therefore yield clinically useful targets for new cancer therapies. Although loss of p53 function is a common feature of human cancers, it is not known whether sustained inactivation of this or other tumour suppressor pathways is required for tumour maintenance. To explore this issue, we developed a Cre-loxP-based strategy to temporally control tumour suppressor gene expression in vivo. Here we show that restoring endogenous p53 expression leads to regression of autochthonous lymphomas and sarcomas in mice without affecting normal tissues. The mechanism responsible for tumour regression is dependent on the tumour type, with the main consequence of p53 restoration being apoptosis in lymphomas and suppression of cell growth with features of cellular senescence in sarcomas. These results support efforts to treat human cancers by way of pharmacological reactivation of p53.</abstract><notes>Ventura, Andrea&#xD;Kirsch, David G&#xD;McLaughlin, Margaret E&#xD;Tuveson, David A&#xD;Grimm, Jan&#xD;Lintault, Laura&#xD;Newman, Jamie&#xD;Reczek, Elizabeth E&#xD;Weissleder, Ralph&#xD;Jacks, Tyler&#xD;England&#xD;Nature&#xD;Nature. 2007 Feb 8;445(7128):661-5. Epub 2007 Jan 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17251932</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>26.681</custom4><electronic-resource-num>nature05541 [pii]&#xD;10.1038/nature05541</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>653</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">653</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weissleder, R.</author><author>Pittet, M. J.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, USA.</auth-address><titles><title>Imaging in the era of molecular oncology</title><secondary-title>Nature</secondary-title></titles><pages>580-9</pages><volume>452</volume><number>7187</number><edition>2008/04/04</edition><keywords><keyword>Diagnostic Imaging/methods/*trends</keyword><keyword>Fluorescence</keyword><keyword>Genes, Reporter</keyword><keyword>Humans</keyword><keyword>Microscopy</keyword><keyword>Molecular Diagnostic Techniques/methods/*trends</keyword><keyword>Neoplasms/*diagnosis/genetics/*metabolism/pathology</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 3</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>18385732</accession-num><abstract>New technologies for imaging molecules, particularly optical technologies, are increasingly being used to understand the complexity, diversity and in vivo behaviour of cancers. &apos;Omic&apos; approaches are providing comprehensive &apos;snapshots&apos; of biological indicators, or biomarkers, of cancer, but imaging can take this information a step further, showing the activity of these markers in vivo and how their location changes over time. Advances in experimental and clinical imaging are likely to improve how cancer is understood at a systems level and, ultimately, should enable doctors not only to locate tumours but also to assess the activity of the biological processes within these tumours and to provide &apos;on the spot&apos; treatment.</abstract><notes>Weissleder, Ralph&#xD;Pittet, Mikael J&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nature&#xD;Nature. 2008 Apr 3;452(7187):580-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18385732</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>26.681</custom4><electronic-resource-num>nature06917 [pii]&#xD;10.1038/nature06917</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>346</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">346</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yelin, D.</author><author>Rizvi, I.</author><author>White, W. M.</author><author>Motz, J. T.</author><author>Hasan, T.</author><author>Bouma, B. E.</author><author>Tearney, G. J.</author></authors></contributors><auth-address>Harvard Medical School and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.</auth-address><titles><title>Three-dimensional miniature endoscopy</title><secondary-title>Nature</secondary-title><alt-title>Nature</alt-title></titles><pages>765</pages><volume>443</volume><number>7113</number><edition>2006/10</edition><keywords><keyword>Animals</keyword><keyword>Endoscopy/*methods</keyword><keyword>Female</keyword><keyword>Mice</keyword><keyword>Ovarian Neoplasms/pathology</keyword><keyword>Peritoneal Neoplasms/diagnosis/pathology/secondary</keyword><keyword>Peritoneum/pathology</keyword><keyword>Pliability</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 19</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>17051200</accession-num><notes>Journal Article&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17051200 </url></related-urls></urls><custom1>CNPP - Mass. Gen. Hosp.</custom1><custom3>2007</custom3><custom4>26.68</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>718</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">718</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schipper, M. </author><author>Nakayama-Ratchford, N. </author><author>Davis, C.</author><author>Kam, N. W. S. </author><author>Chu, P. </author><author>Liu, Z. </author><author>Sun, X. </author><author>Cork, L. </author><author>Dai, H. </author><author>Gambhir, S. </author></authors></contributors><titles><title>Initial Toxicology Studies of Single Walled Carbon Nanotubes in Mice</title><secondary-title>Nature Nanotechnology</secondary-title></titles><periodical><full-title>Nature Nanotechnology</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom4>14.917</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>416</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">416</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harisinghani, M.</author><author>Ross, R. W.</author><author>Guimaraes, A. R.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, MA 02129-2060, USA. mharisinghani@partners.org</auth-address><titles><title>Utility of a new bolus-injectable nanoparticle for clinical cancer staging</title><secondary-title>Neoplasia</secondary-title></titles><pages>1160-5</pages><volume>9</volume><number>12</number><edition>2007/12/18</edition><keywords><keyword>Adenocarcinoma/diagnosis/pathology/*secondary</keyword><keyword>Contrast Media/*administration &amp; dosage/analysis</keyword><keyword>Dextrans/*administration &amp; dosage</keyword><keyword>Ferrosoferric Oxide/administration &amp; dosage/analysis/*diagnostic use</keyword><keyword>Humans</keyword><keyword>Imaging, Three-Dimensional</keyword><keyword>Injections, Intravenous</keyword><keyword>Lymph Node Excision</keyword><keyword>Lymphatic Metastasis/*diagnosis/pathology</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Male</keyword><keyword>Nanoparticles/administration &amp; dosage/analysis/*diagnostic use</keyword><keyword>Neoplasm Staging/*methods</keyword><keyword>Pelvis</keyword><keyword>Pilot Projects</keyword><keyword>Prospective Studies</keyword><keyword>Prostatic Neoplasms/*pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1476-5586 (Electronic)</isbn><accession-num>18084623</accession-num><abstract>BACKGROUND: In this study, we report on the use of a new, bolus-injectable, carboxymethyl dextran-based magnetic nanoparticle (MNP), ferumoxytol, to improve detection in loco-regional lymph nodes by magnetic resonance imaging (MRI). METHODS: This preliminary study was performed as a prospective, single-center, open label pilot study to determine the magnitude of nodal MRI signal changes and to determine the optimal time points for imaging following intravenous (IV) bolus injection of the MNP. The study group consisted of 10 patients, all of whom were diagnosed with prostate cancer before any systemic therapy. RESULTS: All 10 patients had lymph nodes evaluated by histopathology. Of the evaluated 26 lymph nodes, 20 were benign and 6 were malignant. The mean short-axis diameter of benign lymph nodes was 6 mm and the mean short-axis diameter of malignant lymph nodes was 7 mm. Following IV administration, there was a significant change in mean signal-to-noise ratio (SNR) of benign lymph nodes (P &lt; .0001) whereas there was little change in the mean SNR of malignant nodes (P = .1624). No adverse events were encountered. CONCLUSION: Ferumoxytol is safe and, at the appropriate circulation interval, modulates nodal signal intensity, allowing for identification of malignant nodal involvement by MRI.</abstract><notes>Harisinghani, Mukesh&#xD;Ross, Robert W&#xD;Guimaraes, Alexander R&#xD;Weissleder, Ralph&#xD;N01-CO-12400/CO/United States NCI&#xD;Clinical Trial&#xD;Research Support, N.I.H., Extramural&#xD;Canada&#xD;Neoplasia (New York, N.Y.)&#xD;Neoplasia. 2007 Dec;9(12):1160-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18084623</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.913</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>35</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">35</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Montet, X.</author><author>Montet-Abou, K.</author><author>Reynolds, F.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>Nanoparticle imaging of integrins on tumor cells</title><secondary-title>Neoplasia</secondary-title><alt-title>Neoplasia (New York, N.Y</alt-title></titles><pages>214-22</pages><volume>8</volume><number>3</number><edition>2006/03</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/blood supply/chemistry/*pathology</keyword><keyword>Carcinoma/blood supply/chemistry/*pathology</keyword><keyword>Cell Line, Tumor/chemistry/ultrastructure</keyword><keyword>Diagnostic Imaging/methods</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Delivery Systems</keyword><keyword>Feasibility Studies</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/analysis</keyword><keyword>Fluorometry/*methods</keyword><keyword>Gliosarcoma/chemistry/*pathology</keyword><keyword>Half-Life</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/*analysis</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Nanostructures/analysis</keyword><keyword>Neoplasm Proteins/*analysis</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Oligopeptides/analysis</keyword><keyword>Particle Size</keyword><keyword>Rats</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1476-5586 (Electronic)</isbn><accession-num>16611415</accession-num><abstract>Nanoparticles 10 to 100 nm in size can deliver large payloads to molecular targets, but undergo slow diffusion and/or slow transport through delivery barriers. To examine the feasibility of nanoparticles targeting a marker expressed in tumor cells, we used the binding of cyclic arginine-glycine-aspartic acid (RGD) nanoparticle targeting integrins on BT-20 tumor as a model system. The goals of this study were: 1) to use nanoparticles to image alpha(V)beta3 integrins expressed in BT-20 tumor cells by fluorescence-based imaging and magnetic resonance imaging, and, 2) to identify factors associated with the ability of nanoparticles to target tumor cell integrins. Three factors were identified: 1) tumor cell integrin expression (the alpha(V)beta3 integrin was expressed in BT-20 cells, but not in 9L cells); 2) nanoparticle pharmacokinetics (the cyclic RGD peptide cross-linked iron oxide had a blood half-life of 180 minutes and was able to escape from the vasculature over its long circulation time); and 3) tumor vascularization (the tumor had a dense capillary bed, with distances of &lt;100 microm between capillaries). These results suggest that nanoparticles could be targeted to the cell surface markers expressed in tumor cells, at least in the case wherein the nanoparticles and the tumor model have characteristics similar to those of the BT-20 tumor employed here.</abstract><notes>P50 ca86355/ca/nci&#xD;R01 eb00662/eb/nibib&#xD;R24 ca92782/ca/nci&#xD;Comparative Study&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Canada</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16611415 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>4.913</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>98</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">98</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Trehin, R.</author><author>Figueiredo, J. L.</author><author>Pittet, M. J.</author><author>Weissleder, R.</author><author>Josephson, L.</author><author>Mahmood, U.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>Fluorescent nanoparticle uptake for brain tumor visualization</title><secondary-title>Neoplasia</secondary-title></titles><pages>302-11</pages><volume>8</volume><number>4</number><edition>2006/06/08</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD11b/biosynthesis</keyword><keyword>Brain Neoplasms/*diagnosis/*pathology</keyword><keyword>Carbocyanines/pharmacology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/*pharmacology</keyword><keyword>Gliosarcoma/*diagnosis/pathology</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Fluorescence/instrumentation</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Rats</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1476-5586 (Electronic)</isbn><accession-num>16756722</accession-num><abstract>Accurate delineation of tumor margins is vital to the successful surgical resection of brain tumors. We have previously developed a multimodal nanoparticle CLIO-Cy5.5, which is detectable by both magnetic resonance imaging and fluorescence, to assist in intraoperatively visualizing tumor boundaries. Here we examined the accuracy of tumor margin determination of orthotopic tumors implanted in hosts with differing immune responses to the tumor. Using a nonuser-based signal intensity method applied to fluorescent micrographs of 9L gliosarcoma green fluorescent protein (GFP) tumors, mean overestimations of 2 and 24 microm were obtained using Cy5.5 fluorescence, compared to the true tumor margin determined by GFP fluorescence, in nude mice and rats, respectively. To resolve which cells internalized the nanoparticle and to quantitate degree of uptake, tumors were disaggregated and cells were analyzed by flow cytometry and fluorescence microscopy. Nanoparticle uptake was seen in both CD11b+ cells (representing activated microglia and macrophages) and tumor cells in both animal models by both methods. CD11b+ cells were predominantly found at the tumor margin in both hosts, but were more pronounced at the margin in the rat model. Additional metastatic (CT26 colon) and primary (Gli36 glioma) brain tumor models likewise demonstrated that the nanoparticle was internalized both by tumor cells and by host cells. Together, these observations suggest that fluorescent nanoparticles provide an accurate method of tumor margin estimation based on a combination of tumor cell and host cell uptake for primary and metastatic tumors in animal model systems and offer potential for clinical translation.</abstract><notes>Trehin, Rachel&#xD;Figueiredo, Jose-Luiz&#xD;Pittet, Mikael J&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;Mahmood, Umar&#xD;Eb001872/eb/nibib&#xD;P50 c 86355/phs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Canada&#xD;Neoplasia (New York, N.Y.)&#xD;Neoplasia. 2006 Apr;8(4):302-11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16756722</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>4.913</custom4><electronic-resource-num>10.1593/neo.05751</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>147</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">147</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Brekke, C.</author><author>Morgan, S. C.</author><author>Lowe, A. S.</author><author>Meade, T. J.</author><author>Price, J.</author><author>Williams, S. C.</author><author>Modo, M.</author></authors></contributors><auth-address>NeuroImaging Research Group - Department of Neurology, Institute of Psychiatry, King&apos;s College London, UK.</auth-address><titles><title>The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry</title><secondary-title>NMR Biomed</secondary-title></titles><pages>77-89</pages><volume>20</volume><number>2</number><edition>2006/09/05</edition><keywords><keyword>Animals</keyword><keyword>Cell Differentiation/drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement/drug effects</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Contrast Media/*pharmacology</keyword><keyword>Dextrans/*pharmacology</keyword><keyword>Gadolinium/*pharmacology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>Neurons/cytology</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Rhodamines/*pharmacology</keyword><keyword>Stem Cells/cytology</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0952-3480 (Print)</isbn><accession-num>16952123</accession-num><abstract>The in vivo monitoring of cell survival and migration will be essential to the translation of cell-based therapies from the laboratory to clinical studies. The pre-labeling of cells with magnetic resonance imaging (MRI) contrast agents renders them visible in vivo for serial cellular imaging. However, little is known about the impact of the presence of these metal particles inside transplanted cells. The use of the bimodal contrast agent GRID made it possible to demonstrate by means of fluorescent microscopy and inductively coupled plasma mass spectrometry (ICP-MS) that, after 16 h of incubation (without the use of a transfection agent), neural stem cells (NSCs) were saturated and no longer incorporated particles. With this maximal uptake, no significant effect on cell viability was observed. However, a significant decrease in proliferation was evident in cells that underwent 24 h of labeling. A significant increase in reactive oxygen species was observed for all GRID labeling, with a very significant increase with 24 h of labeling. GRID labeling did not affect cell motility in comparison with PKH26-labeled NSCs in a glioma-based migration assay and also allowed differentiation into all major cell types of the brain. GRID-labeled cells induced a signal change of 47% on T(2) measurements and allows a detection of cell clusters of approximately 220 cells/microl. Further in vivo testing will be required to ensure that cell labeling with gadolinium-based MRI contrast agents does not impair their ability to repair.</abstract><notes>Brekke, Cecilie&#xD;Morgan, Sarah C&#xD;Lowe, Andrew S&#xD;Meade, Thomas J&#xD;Price, Jack&#xD;Williams, Steve C R&#xD;Modo, Michel&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;NMR in biomedicine&#xD;NMR Biomed. 2007 Apr;20(2):77-89.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16952123</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>3.626</custom4><electronic-resource-num>10.1002/nbm.1077</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>23</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">23</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, A. A.</author><author>Derfus, A. M.</author><author>Khetani, S. R.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Harvard-M.I.T. Division of Health Sciences and Technology/Electrical Engineering and Computer Science, Massachusetts Institute of Technology, MA, USA.</auth-address><titles><title>Quantum dots to monitor RNAi delivery and improve gene silencing</title><secondary-title>Nucleic Acids Res</secondary-title><alt-title>Nucleic acids research</alt-title></titles><pages>e190</pages><volume>33</volume><number>22</number><edition>2005/12</edition><keywords><keyword>Animals</keyword><keyword>Cadherins/genetics</keyword><keyword>Coculture Techniques</keyword><keyword>Female</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Small Interfering/*analysis</keyword><keyword>Rats</keyword><keyword>Rats, Inbred Lew</keyword><keyword>Transfection</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>16352864</accession-num><abstract>A critical issue in using RNA interference for identifying genotype/phenotype correlations is the uniformity of gene silencing within a cell population. Variations in transfection efficiency, delivery-induced cytotoxicity and &apos;off target&apos; effects at high siRNA concentrations can confound the interpretation of functional studies. To address this problem, we have developed a novel method of monitoring siRNA delivery that combines unmodified siRNA with seminconductor quantum dots (QDs) as multi color biological probes. We co-transfected siRNA with QDs using standard transfection techniques, thereby leveraging the photostable fluorescent nanoparticles to track delivery of nucleic acid, sort cells by degree of transfection and purify homogenously-silenced subpopulations. Compared to alternative RNAi tracking methods (co-delivery of reporter plasmids and end-labeling the siRNA), QDs exhibit superior photostability and tunable optical properties for an extensive selection of non-overlapping colors. Thus this simple, modular system can be extended toward multiplexed gene knockdown studies, as demonstrated in a two color proof-of-principle study with two biological targets. When the method was applied to investigate the functional role of T-cadherin (T-cad) in cell-cell communication, a subpopulation of highly silenced cells obtained by QD labeling was required to observe significant downstream effects of gene knockdown.</abstract><notes>N01 co37117/co/nci&#xD;R01 dk065152/dk/niddk&#xD;R01 dk56966/dk/niddk&#xD;U54 ca119349/ca/nci&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16352864 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>6.317</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>529</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">529</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T. C.</author><author>Twu, K. Y.</author><author>Ellington, A. D.</author><author>Levy, M.</author></authors></contributors><auth-address>Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA.</auth-address><titles><title>Aptamer mediated siRNA delivery</title><secondary-title>Nucleic Acids Res</secondary-title></titles><pages>e73</pages><volume>34</volume><number>10</number><edition>2006/06/03</edition><keywords><keyword>Aptamers, Nucleotide/*chemistry</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Lamins/metabolism</keyword><keyword>Prostate-Specific Antigen/metabolism</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage/chemistry</keyword><keyword>Streptavidin/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>16740739</accession-num><abstract>Nucleic acids that bind to cells and are subsequently internalized could prove to be novel delivery reagents. An anti-prostate specific membrane antigen aptamer that has previously been shown to bind to prostate tumor cells was coupled to siRNAs via a modular streptavidin bridge. The resulting conjugates could be simply added onto cells without any further preparation, and were taken up within 30 min. The siRNA-mediated inhibition of gene expression was as efficient as observed with conventional lipid-based reagents, and was dependent upon conjugation to the aptamer. These results suggest new venues for the therapeutic delivery of siRNAs and for the development of reagents that can be used to probe cellular physiology.</abstract><notes>Chu, Ted C&#xD;Twu, Karen Y&#xD;Ellington, Andrew D&#xD;Levy, Matthew&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2006 Jun 1;34(10):e73.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16740739</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>6.317</custom4><electronic-resource-num>34/10/e73 [pii]&#xD;10.1093/nar/gkl388</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>207</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">207</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Desiere, F.</author><author>Deutsch, E. W.</author><author>King, N. L.</author><author>Nesvizhskii, A. I.</author><author>Mallick, P.</author><author>Eng, J.</author><author>Chen, S.</author><author>Eddes, J.</author><author>Loevenich, S. N.</author><author>Aebersold, R.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, WA, USA. fdesiere@yahoo.com</auth-address><titles><title>The PeptideAtlas project</title><secondary-title>Nucleic Acids Res</secondary-title></titles><pages>D655-8</pages><volume>34</volume><number>Database issue</number><edition>2005/12/31</edition><keywords><keyword>Animals</keyword><keyword>Chromosome Mapping</keyword><keyword>*Databases, Protein/statistics &amp; numerical data</keyword><keyword>Drosophila Proteins/chemistry/genetics</keyword><keyword>Humans</keyword><keyword>Internet</keyword><keyword>Mass Spectrometry</keyword><keyword>Peptide Fragments/*analysis/chemistry</keyword><keyword>Proteome/chemistry/*genetics</keyword><keyword>Proteomics</keyword><keyword>Saccharomyces cerevisiae Proteins/chemistry/genetics</keyword><keyword>Sequence Analysis, Protein</keyword><keyword>User-Computer Interface</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 1</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>16381952</accession-num><abstract>The completion of the sequencing of the human genome and the concurrent, rapid development of high-throughput proteomic methods have resulted in an increasing need for automated approaches to archive proteomic data in a repository that enables the exchange of data among researchers and also accurate integration with genomic data. PeptideAtlas (http://www.peptideatlas.org/) addresses these needs by identifying peptides by tandem mass spectrometry (MS/MS), statistically validating those identifications and then mapping identified sequences to the genomes of eukaryotic organisms. A meaningful comparison of data across different experiments generated by different groups using different types of instruments is enabled by the implementation of a uniform analytic process. This uniform statistical validation ensures a consistent and high-quality set of peptide and protein identifications. The raw data from many diverse proteomic experiments are made available in the associated PeptideAtlas repository in several formats. Here we present a summary of our process and details about the Human, Drosophila and Yeast PeptideAtlas builds.</abstract><notes>Desiere, Frank&#xD;Deutsch, Eric W&#xD;King, Nichole L&#xD;Nesvizhskii, Alexey I&#xD;Mallick, Parag&#xD;Eng, Jimmy&#xD;Chen, Sharon&#xD;Eddes, James&#xD;Loevenich, Sandra N&#xD;Aebersold, Ruedi&#xD;N01-hv-28179/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2006 Jan 1;34(Database issue):D655-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16381952</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>6.317</custom4><electronic-resource-num>34/suppl_1/D655 [pii]&#xD;10.1093/nar/gkj040</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>288</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">288</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fisher, M.</author><author>Abramov, M.</author><author>Van Aerschot, A.</author><author>Xu, D.</author><author>Juliano, R. L.</author><author>Herdewijn, P.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina Chapel Hill NC 27599, USA.</auth-address><titles><title>Inhibition of MDR1 expression with altritol-modified siRNAs</title><secondary-title>Nucleic Acids Res</secondary-title></titles><pages>1064-74</pages><volume>35</volume><number>4</number><edition>2007/02/01</edition><keywords><keyword>Animals</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>P-Glycoprotein/*genetics/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Polymerase Chain Reaction</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Messenger/metabolism</keyword><keyword>RNA, Small Interfering/*chemistry/pharmacology</keyword><keyword>Rhodamine 123/analysis</keyword><keyword>Sugar Alcohols/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>17264131</accession-num><abstract>Altritol-modified nucleic acids (ANAs) support RNA-like A-form structures when included in oligonucleotide duplexes. Thus altritol residues seem suitable as candidates for the chemical modification of siRNAs. Here we report that ANA-modified siRNAs targeting the MDR1 gene can exhibit improved efficacy as compared to unmodified controls. This was particularly true of ANA modifications at or near the 3&apos; end of the sense or antisense strands, while modification at the 5&apos; end of the antisense strand resulted in complete loss of activity. Multiple ANA modifications within the sense strand were also well tolerated. Duplexes with ANA modifications at appropriate positions in both strands were generally more effective than duplexes with one modified and one unmodified strand. Initial evidence suggests that the loss of activity associated with ANA modification of the 5&apos;-antisense strand may be due to reduced phosphorylation at this site by cellular kinases. Treatment of drug resistant cells with MDR1-targeted siRNAs resulted in reduction of P-glycoprotein (Pgp) expression, parallel reduction in MDR1 message levels, increased accumulation of the Pgp substrate rhodamine 123, and reduced resistance to anti-tumor drugs. Interestingly, the duration of action of some of the ANA-modified siRNAs was substantially greater than that of unmodified controls. These observations suggest that altritol modifications may be helpful in developing siRNAs with enhanced pharmacological effectiveness.</abstract><notes>Fisher, Michael&#xD;Abramov, Mikhail&#xD;Van Aerschot, Arthur&#xD;Xu, Dong&#xD;Juliano, Rudolph L&#xD;Herdewijn, Piet&#xD;P01 gm59299/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2007;35(4):1064-74. Epub 2007 Jan 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17264131</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>6.317</custom4><custom7>Jan</custom7><electronic-resource-num>gkl1126 [pii]&#xD;10.1093/nar/gkl1126</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>627</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">627</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhee, W. J.</author><author>Santangelo, P. J.</author><author>Jo, H.</author><author>Bao, G.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.</auth-address><titles><title>Target accessibility and signal specificity in live-cell detection of BMP-4 mRNA using molecular beacons</title><secondary-title>Nucleic Acids Res</secondary-title></titles><pages>e30</pages><volume>36</volume><number>5</number><edition>2008/02/16</edition><keywords><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>Bone Morphogenetic Proteins/*genetics/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization, Fluorescence</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Molecular Sequence Data</keyword><keyword>Oligonucleotide Probes/*chemistry</keyword><keyword>RNA, Messenger/*analysis/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>18276638</accession-num><abstract>The ability to visualize mRNA in single living cells and monitor in real-time the changes of mRNA level and localization can provide unprecedented opportunities for biological and disease studies. However, the mRNA detection specificity and sensitivity are critically dependent on the selection of target sequences and their accessibility. We carried out an extensive study of the target accessibility of BMP-4 mRNA using 10 different designs of molecular beacons (MBs), and identified the optimal beacon design. Specifically, for MB design 1 and 8 (MB1 and MB8), the fluorescent intensities from BMP-4 mRNA correlated well with the GFP signal after upregulating BMP-4 and co-expressing GFP using adenovirus, and the knockdown of BMP-4 mRNA using siRNA significantly reduced the beacon signals, demonstrating detection specificity. The beacon specificity was further confirmed using blocking RNA and in situ hybridization. We found that fluorescence signal from MBs depends critically on target sequences; the target sequences corresponding to siRNA sites may not be good sites for beacon-based mRNA detection, and vice versa. Possible beacon design rules are identified and approaches for enhancing target accessibility are discussed. This has significant implications to MB design for live cell mRNA detection.</abstract><notes>Rhee, Won Jong&#xD;Santangelo, Philip J&#xD;Jo, Hanjoong&#xD;Bao, Gang&#xD;CA119338/CA/United States NCI&#xD;HL70531/HL/United States NHLBI&#xD;HL80711/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2008 Mar;36(5):e30. Epub 2008 Feb 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18276638</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>6.954</custom4><electronic-resource-num>gkn039 [pii]&#xD;10.1093/nar/gkn039</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>692</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">692</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, A. P.</author><author>Burzynski, R.</author><author>Yoon, Y. K.</author><author>Prasad, P. N.</author><author>He, S.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, State University of New York at Buffalo, Buffalo, NY 14260, USA.</auth-address><titles><title>Double-layer fabrication scheme for large-area polymeric photonic crystal membrane on silicon surface by multibeam interference lithography</title><secondary-title>Opt Lett</secondary-title></titles><pages>1303-5</pages><volume>33</volume><number>12</number><edition>2008/06/17</edition><dates><year>2008</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0146-9592 (Print)</isbn><accession-num>18552939</accession-num><abstract>We report on the fabrication of two-dimensional polymeric photonic crystal membranes on the surface of silicon using visible-light multibeam interference lithography. The structures are created by the interference of three beams of a green laser. A polymer buffer layer doped with a Rhodamine B laser dye, interlaid between the lithography layer and the silicon substrate, suppresses the effects of strong reflection and nonradiative absorption of silicon on the interference pattern. Large-area defect-free photonic crystal membranes are experimentally realized on silicon surface.</abstract><notes>Zhang, A Ping&#xD;Burzynski, Ryszard&#xD;Yoon, Yong-Kyu&#xD;Prasad, Paras N&#xD;He, Sailing&#xD;United States&#xD;Optics letters&#xD;Opt Lett. 2008 Jun 15;33(12):1303-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18552939</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>3.711</custom4><electronic-resource-num>163298 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>415</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">415</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bouffard, J.</author><author>Kim, Y.</author><author>Swager, T. M.</author><author>Weissleder, R.</author><author>Hilderbrand, S. A.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>A highly selective fluorescent probe for thiol bioimaging</title><secondary-title>Org Lett</secondary-title></titles><pages>37-40</pages><volume>10</volume><number>1</number><edition>2007/12/08</edition><keywords><keyword>Colorimetry/methods</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>*Fluorescent Dyes</keyword><keyword>Molecular Structure</keyword><keyword>Nitrobenzenes/*chemistry</keyword><keyword>Nitrogen/chemistry</keyword><keyword>Oxygen/chemistry</keyword><keyword>Sulfhydryl Compounds/*analysis</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 3</date></pub-dates></dates><isbn>1523-7060 (Print)</isbn><accession-num>18062694</accession-num><abstract>A new fluorescent turn-on probe (3) for the selective sensing and bioimaging of thiols is reported. In aqueous buffer solutions at physiological pH, thiols cleave the 2,4-dinitrobenzenesulfonyl group to release the red-emissive donor-acceptor fluorophore (4). The probe displays excellent immunity to interference from nitrogen and oxygen nucleophiles and the imaging of thiols in living cells is demonstrated.</abstract><notes>Bouffard, Jean&#xD;Kim, Youngmi&#xD;Swager, Timothy M&#xD;Weissleder, Ralph&#xD;Hilderbrand, Scott A&#xD;1-U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Organic letters&#xD;Org Lett. 2008 Jan 3;10(1):37-40. Epub 2007 Dec 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18062694</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/ol702539v</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>710</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">710</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Guimaraes, A.</author><author>Rakhlin, E.</author><author>Long, D.</author><author>Weissleder, R.</author><author>Thayer S</author></authors></contributors><titles><title>MRI monitors physiologic changes with anti-hedgehog therapy in pancreatic adenocarcinoma xenograft model</title><secondary-title>Pancreas</secondary-title></titles><periodical><full-title>Pancreas</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom4>2.300</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>682</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">682</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Deshpande, D.</author><author>Devalapally, H.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, MA, 02115, USA.</auth-address><titles><title>Enhancement in Anti-proliferative Effects of Paclitaxel in Aortic Smooth Muscle Cells upon Co-administration with Ceramide using Biodegradable Polymeric Nanoparticles</title><secondary-title>Pharm Res</secondary-title></titles><pages>1936-47</pages><volume>25</volume><number>8</number><edition>2008/05/16</edition><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>18480968</accession-num><abstract>PURPOSE: Using a combination of paclitaxel (PTX), and the apoptotic signaling molecule, C(6)-ceramide (CER), the enhancement in anti-proliferative effect of human aortic smooth muscle cells (SMC) was examined by administering in polymeric nanoparticles. METHODS: PTX- and CER-loaded poly(ethylene oxide)-modified poly(epsilon caprolactone) (PEO-PCL) nanoparticles were formulated by solvent displacement and characterized. The uptake and intracellular localization of the nanoparticle in SMC was examined using Z-stack fluorescent confocal microscopy. Anti-proliferative and pro-apoptotic effects of SMC were determined upon administration of PTX and CER, either as single agent or in combination, in aqueous solution and in PEO-PCL nanoparticle formulations. RESULTS: High encapsulation efficiencies (i.e., &gt;95%) of PTX and CER at 10% (w/w) loading were attained in the PEO-PCL nanoparticles of around 270 nm in diameter. Fluorescence confocal analysis showed that nanoparticle delivery did facilitate cellular uptake and internalization. Additionally, combination of PTX and CER delivery in PEO-PCL nanoparticles was significantly more effective in decreasing the proliferation of SMC, probably by enhancing the apoptotic response. CONCLUSIONS: The results of this study show that combination of PTX and CER when administered in PEO-PCL nanoparticles can significantly augment the anti-proliferative effect in SMC. This strategy may potentially be useful in the treatment of coronary restenosis.</abstract><notes>Deshpande, Dipti&#xD;Devalapally, Harikrishna&#xD;Amiji, Mansoor&#xD;United States&#xD;Pharmaceutical research&#xD;Pharm Res. 2008 Aug;25(8):1936-47. Epub 2008 May 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18480968</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>2.848</custom4><electronic-resource-num>10.1007/s11095-008-9614-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>585</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">585</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S. E.</author><author>Napier, M. E.</author><author>Ropp, P. A.</author><author>Tian, S.</author><author>Desimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA.</auth-address><titles><title>Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles</title><secondary-title>Pharm Res</secondary-title></titles><volume>accepted</volume><edition>2008/07/02</edition><dates><year>2008</year></dates><isbn>0724-8741 (Print)</isbn><accession-num>18592353</accession-num><abstract>PURPOSE: To investigate the cellular internalization pathways of shape- and size-specific particles as a function of zeta potential in different cell types. METHODS: A top-down particle fabrication technique called PRINT was utilized to fabricate monodisperse 1 mum cylindrical particles. Cellular internalization of these PRINT particles was monitored using confocal microscopy, flow cytometry, and transmission electron microscopy. The endocytic pathway used by 1 mum cationic PRINT particles was evaluated using different inhibitory strategies. Cytotoxicity assays were used to determine the toxicity of both cationic and anionic PRINT particles in multiple cell types. RESULTS: Particle internalization was confirmed using confocal microscopy, flow cytometry and transmission electron microscopy. The mechanism of internalization of positively charged PRINT particles was found to be predominantly clathrin-mediated endocytosis and macropinocytosis with very few particles utilizing a caveolae-mediated endocytic pathway. The exposed charge on the surface of the particles had a significant effect on the rate of endocytosis in all cell types tested, except for the macrophage cells. No significant cytotoxicity was observed for all PRINT particles used in the present study. CONCLUSIONS: Cylindrical 1 mum PRINT particles were readily internalized into HeLa, NIH 3T3, OVCAR-3, MCF-7, and RAW 264.7 cells. Particles with a positive zeta potential exhibited an enhanced rate of endocytosis compared to negatively charged particles with identical sizes and shapes. It was found that PRINT particles with a positive zeta potential were endocytosed into HeLa cells using predominantely clathrin-mediated and macropinocytotic pathways.</abstract><notes>Journal article&#xD;Pharmaceutical research&#xD;Pharm Res. 2008 Jul 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18592353</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>2.848</custom4><electronic-resource-num>10.1007/s11095-008-9654-8</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>284</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">284</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kang, H.</author><author>DeLong, R.</author><author>Fisher, M. H.</author><author>Juliano, R. L.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides</title><secondary-title>Pharm Res</secondary-title></titles><pages>2099-106</pages><volume>22</volume><number>12</number><edition>2005/09/27</edition><keywords><keyword>3T3 Cells</keyword><keyword>Animals</keyword><keyword>Boron Compounds</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Chromatography, Gel</keyword><keyword>*Dendrimers</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Fluorescent Dyes</keyword><keyword>Gene Products, tat/*chemistry</keyword><keyword>Genes, MDR/genetics</keyword><keyword>Mice</keyword><keyword>Microscopy, Confocal</keyword><keyword>Oligonucleotides/*administration &amp; dosage</keyword><keyword>P-Glycoprotein/metabolism</keyword><keyword>Polyamines/*chemistry</keyword><keyword>RNA, Antisense/*administration &amp; dosage</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage</keyword><keyword>Ribonucleases/metabolism</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>16184444</accession-num><abstract>PURPOSE: PAMAM G5 dendrimer (P) was conjugated to Tat peptide (T), a cell penetrating peptide, in search of an efficient cellular delivery vehicle for antisense and siRNA oligonucleotides. METHODS: PAMAM G5 dendrimer was reacted with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid, sulfosuccinimidyl ester, sodium salt (BODIPY) for visualization to yield the conjugate BP. Bifunctional sulfosuccinimidyl 6-[alpha-methyl-alpha-(2-pyridyldithio)toluamido]hexanoate (sulfo-LC-SMPT) was then used to conjugate primary amino groups of BP to cysteine derivatized Tat peptide to give the designed conjugate, BPT. This conjugate was complexed with antisense and siRNA oligonucleotides designed to inhibit MDR1 gene expression. NIH 3T3 MDR cells were used for the evaluation of biological activity of the conjugate. RESULTS: Both antisense and siRNA readily formed complexes with the synthesized BPT, introduced into NIH 3T3 MDR cells, and primarily accumulated in intracellular vesicles. MDR1 gene expression was partially inhibited by the antisense-BPT complex and weakly inhibited by the siRNA-BPT complex when both were tested at nontoxic levels of dendrimer. Conjugation with Tat peptide did not improve the delivery efficiency of the dendrimer. CONCLUSIONS: Dendrimer-oligonucleotide complexes were moderately effective for delivery of antisense and only poorly effective for delivery of siRNA. Conjugation of the dendrimer with the Tat cell penetrating peptide failed to further enhance the effectiveness of the dendrimer.</abstract><notes>Kang, Hyunmin&#xD;DeLong, Robert&#xD;Fisher, Michael H&#xD;Juliano, Rudolph L&#xD;P01 gm59299/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Pharmaceutical research&#xD;Pharm Res. 2005 Dec;22(12):2099-106. Epub 2005 Oct 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16184444</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>2.848</custom4><electronic-resource-num>10.1007/s11095-005-8330-5</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>88</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">88</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, M.</author><author>Lu, J. J.</author><author>Zhang, C.</author><author>Chen, J.</author><author>Klibanov, A. M.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Building 56-579, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library</title><secondary-title>Pharm Res</secondary-title></titles><pages>1564-71</pages><volume>24</volume><number>8</number><edition>2007/03/27</edition><keywords><keyword>Acrylates/chemistry</keyword><keyword>Animals</keyword><keyword>COS Cells</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>Cercopithecus aethiops</keyword><keyword>*Combinatorial Chemistry Techniques</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Genetic Vectors/*chemistry/genetics</keyword><keyword>Humans</keyword><keyword>Imines/*chemistry</keyword><keyword>Luciferases/genetics/metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Molecular Structure</keyword><keyword>Polyamines/*chemistry</keyword><keyword>Polyethylenes/*chemistry</keyword><keyword>Transfection/methods</keyword><keyword>beta-Galactosidase/genetics/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>17385014</accession-num><abstract>PURPOSE: Low efficiency and toxicity are two major drawbacks of current non-viral gene delivery vectors. Since DNA delivery to mammalian cells is a multi-step process, generating and searching combinatorial libraries of vectors employing high-throughput synthesis and screening methods is an attractive strategy for the development of new improved vectors because it increases the chance of identifying the most overall optimized vectors. MATERIALS AND METHODS: Based on the rationale that increasing the effective molecular weight of small PEIs, which are poor vectors compared to the higher molecular weight homologues but less toxic, raises their transfection efficiency due to better DNA binding, we synthesized a library of 144 biodegradable derivatives from two small PEIs and 24 bi- and oligo-acrylate esters. A 423-Da linear PEI and its 1:1 (w/w) mixture with a 1.8-kDa branched PEI were cross-linked with the acrylates at three molar ratios in DMSO. The resulting polymers were screened for their efficiency in delivering a beta-galactosidase expressing plasmid to COS-7 monkey kidney cells. Selected most potent polymers from the initial screen were tested for toxicity in A549 human lung cancer cells, and in vivo in a systemic gene delivery model in mice employing a firefly luciferase expressing plasmid. RESULTS: Several polycations that exhibited high potency and low toxicity in vitro were identified from the library. The most potent derivative of the linear 423-Da PEI was that cross-linked with tricycle-[5.2.1.0]-decane-dimethanol diacrylate (diacrylate 14), which exhibited an over 3,600-fold enhancement in efficiency over the parent. The most potent mixed PEI was that cross-linked with ethylene glycol diacrylate (diacrylate 4) which was over 850-fold more efficient than the physically mixed parent PEIs. The relative efficiencies of these polymers were even up to over twice as high as that of the linear 22-kDa PEI, considered the &quot;gold standard&quot; for in vitro and systemic gene delivery. The potent cross-linked polycations identified were also less toxic than the 22-kDa PEI. The optimal vector in vivo was the mixed PEI cross-linked with propylene glycol glycerolate diacrylate (diacrylate 7); it mediated the highest gene expression in the lungs, followed by the spleen, with the expression in the former being 53-fold higher compared to the latter. In contrast, the parent PEIs mediated no gene expression at all under similar conditions, and injection of the polyplexes of the 22-kDa PEI at its optimal N/P of 10 prepared under identical conditions killed half of the mice injected. CONCLUSIONS: High-throughput synthesis and transfection assay of a cross-linked library of biodegradable PEIs was proven effective in identifying highly transfecting vectors. The identified vectors exhibited dramatically superior efficiency compared to their parents both in vitro and in an in vivo systemic gene delivery model. The majority of these vectors mediated preferential gene delivery to the lung, and their in vivo toxicity paralleled that in vitro.</abstract><notes>Thomas, Mini&#xD;Lu, James J&#xD;Zhang, Chengcheng&#xD;Chen, Jianzhu&#xD;Klibanov, Alexander M&#xD;Ai56267/ai/niaid&#xD;Gm26698/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Pharmaceutical research&#xD;Pharm Res. 2007 Aug;24(8):1564-71. Epub 2007 Mar 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17385014</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>2.848</custom4><electronic-resource-num>10.1007/s11095-007-9279-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>359</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">359</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>van Vlerken, L. E.</author><author>Vyas, T. K.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery</title><secondary-title>Pharm Res</secondary-title><alt-title>Pharmaceutical research</alt-title></titles><pages>1405-14</pages><volume>24</volume><number>8</number><edition>2007/08</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage/therapeutic use</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Gene Therapy/*methods</keyword><keyword>Humans</keyword><keyword>Models, Biological</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Neoplasms/drug therapy/*therapy</keyword><keyword>Polyethylene Glycols/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>17393074</accession-num><abstract>The success of anti-cancer therapies largely depends on the ability of the therapeutics to reach their designated cellular and intracellular target sites, while minimizing accumulation and action at non-specific sites. Surface modification of nanoparticulate carriers with poly(ethylene glycol) (PEG)/poly(ethylene oxide) (PEO) has emerged as a strategy to enhance solubility of hydrophobic drugs, prolong circulation time, minimize non-specific uptake, and allow for specific tumor-targeting through the enhanced permeability and retention effect. Furthermore, PEG/PEO modification has emerged as a platform for incorporation of active targeting ligands, thereby providing the drug and gene carriers with specific tumor-targeting properties through a flexible tether. This review focuses on the recent developments surrounding such PEG/PEO-surface modification of polymeric nanocarriers to promote tumor-targeting capabilities, thereby enhancing efficacy of anti-cancer therapeutic strategies.</abstract><notes>Journal Article&#xD;Review&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17393074 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>2.848</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>383</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">383</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Melancon, M. P.</author><author>Wang, W.</author><author>Wang, Y. T.</author><author>Shao, R. P.</author><author>Ji, X. J.</author><author>Gelovani, J. G.</author><author>Li, C.</author></authors></contributors><auth-address>Li, C&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Imaging Box 57,1515 Holcombe Blvd, Houston, TX 77030 USA&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA</auth-address><titles><title>A novel method for Imaging in vivo degradation of poly(L-glutamic acid), a biodegradable drug carrier</title><secondary-title>Pharmaceutical Research</secondary-title></titles><pages>1217-1224</pages><volume>24</volume><number>6</number><edition>2007/06</edition><keywords><keyword>biodegradation</keyword><keyword>cathepsin b</keyword><keyword>molecular imaging</keyword><keyword>near-infrared optical imaging</keyword><keyword>poly(l-glutamic acid)</keyword><keyword>cathepsin-b</keyword><keyword>fluorescent</keyword><keyword>paclitaxel</keyword><keyword>assay</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0724-8741</isbn><accession-num>ISI:000246619700021</accession-num><abstract>Purpose. To develop an L-PG-based imaging probe suitable for assessing the degradation of L-PG in vivo.&#xD;Materials and Methods. Conjugates of L-PG and a near-infrared fluorescence (NIRF) dye, NIR813, were characterized with regard to quenching efficiency and degradability by cathepsin B (CB) and other proteases. The kinetics of L-PG-NIR813&apos;s degradation and its degradation in orthotopic human U87/TGL glioma in nude mice after intravenous injection was assessed using NIRF optical imaging (n = 3).&#xD;Results. The fluorescence signal from L-PG-NIR813 was efficiently quenched and activated at NIR813 loadings of 8-10%. Upon exposure to CB, the fluorescence intensity of L-PG-NIR813 increased 10-fold. L-PG-NIR813 was also degraded by another cysteine protease cathepsin L, but not by MMP-2, cathepsin E, cathepsin D, and plasmin. A selective CB inhibitor blocked the fluorescence activation. After intravenous injection, the degradation of L-PG-NIR813 was visualized primarily in the liver, which peaked at 4 h postinjection. Activation of L-PG-NIR813 but not D-PG-NIR813 was clearly seen in U87/TGL tumors.&#xD;Conclusion. Our results indicate that L-PG-NIR813 may be used to monitor the in vivo degradation of L-PG-based polymeric drugs, and that this agent may prove useful in noninvasive imaging of protease activity, particularly that of cysteine proteases.</abstract><notes>169VH&#xD;Times Cited:0&#xD;Cited References Count:24</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246619700021</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2007</custom3><custom4>2.848</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>695</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">695</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Verma, S.</author><author>Sallum, U. W.</author><author>Athar, H.</author><author>Rosenblum, L.</author><author>Foley, J. W.</author><author>Hasan, T.</author></authors></contributors><auth-address>Wellman Center for Photomedicine, Massachusetts General Hospital; and Department of Dermatology, Harvard Medical School, Boston, MA, USA.</auth-address><titles><title>Antimicrobial Photodynamic Efficacy of Side-chain Functionalized Benzo[a]phenothiazinium Dyes</title><secondary-title>Photochem Photobiol</secondary-title></titles><edition>2008/07/29</edition><dates><year>2008</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>0031-8655 (Print)</isbn><accession-num>18657053</accession-num><abstract>5-(Ethylamino)-9-diethylaminobenzo[a]phenothiazinium chloride (EtNBS) is a photosensitizer (PS) with broad antimicrobial photodynamic activity. The objective of this study was to determine the antimicrobial photodynamic effect of side chain/end group modifications of EtNBS on two representative bacterial Gram-type-specific strains. Two EtNBS derivatives were synthesized, each functionalized with a different side-chain end-group, alcohol or carboxylic acid. In solution, both exhibited photochemical properties consistent with those of the EtNBS parent molecule. In vitro photodynamic therapy experiments revealed an initial Gram-type-specificity with two representative strains; both derivatives were phototoxic to Staphylococcus aureus 29213 but the carboxylic acid derivative was nontoxic to Escherichia coli 25922. This difference in photodynamic efficacy was not due to a difference in the binding of the two molecules to the bacteria as the amount of both derivatives bound by bacteria was identical. Interestingly, the carboxylic acid derivative produced no fluorescence emission when observed in cultures of E. coli via fluorescence microscopy. These early findings suggest that the addition of small functional groups could achieve Gram-type-specific phototoxicity through altering the photodynamic activity of PSs and deserve further exploration in a larger number of representative strains of each Gram type.</abstract><notes>Journal article&#xD;Photochemistry and photobiology&#xD;Photochem Photobiol. 2008 Jul 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18657053</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>2.172</custom4><electronic-resource-num>PHP403 [pii]&#xD;10.1111/j.1751-1097.2008.00403.x</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>506</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">506</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Thomas, T. P.</author><author>Myc, L. A.</author><author>Kotlyar, A.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109-0533, USA.</auth-address><titles><title>Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles</title><secondary-title>Phys Chem Chem Phys</secondary-title></titles><pages>5712-20</pages><volume>9</volume><number>42</number><edition>2007/10/26</edition><keywords><keyword>Electrophoresis, Polyacrylamide Gel</keyword><keyword>Ferric Compounds/*chemical synthesis/chemistry</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Polyamines/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 14</date></pub-dates></dates><isbn>1463-9076 (Print)</isbn><accession-num>17960261</accession-num><abstract>We report the synthesis and characterization of a group of carboxyl-functionalized poly(amidoamine) (PAMAM) dendrimers of generation 3 (G3) that were used for the stabilization of superparamagnetic iron oxide (Fe(3)O(4)) nanoparticles (NPs). Folic acid (FA) molecules were conjugated onto the dendrimer surfaces in an attempt to achieve specific targeted imaging of tumor cells that overexpress FA receptors using dendrimer-stabilized Fe(3)O(4) NPs. Fe(3)O(4) NPs were synthesized using controlled co-precipitation of Fe(ii) and Fe(iii) ions and the formed dendrimer-stabilized Fe(3)O(4) NPs were characterized using transmission electron microscopy (TEM) and polyacrylamide gel electrophoresis (PAGE). The intracellular uptake of dendrimer-stabilized Fe(3)O(4) NPs was tested in vitro using KB cells (a human epithelial carcinoma cell line) that overexpress FA receptors. It appears that carboxyl-terminated PAMAM dendrimer-stabilized Fe(3)O(4) NPs can be uptaken by KB cells regardless of the repelling force between the negatively charged cells and the negatively charged particles. In the presence of a large amount of carboxyl terminal groups on the dendrimer surface, the receptor-mediated endocytosis of Fe(3)O(4) NPs stabilized by FA-modified dendrimers was not facilitated. It implies that the surface charge of dendrimer-stabilized magnetic iron oxide NPs in biological medium is an important factor influencing their biological performance.</abstract><notes>Shi, Xiangyang&#xD;Thomas, Thommey P&#xD;Myc, Lukasz A&#xD;Kotlyar, Alina&#xD;Baker, James R Jr&#xD;1 R01 CA119409/CA/United States NCI&#xD;1 RO1 EB002657/EB/United States NIBIB&#xD;N0I-CO-97111/CO/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Physical chemistry chemical physics : PCCP&#xD;Phys Chem Chem Phys. 2007 Nov 14;9(42):5712-20. Epub 2007 Sep 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17960261</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>3.343</custom4><electronic-resource-num>10.1039/b709147h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>162</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">162</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Subramanian, H.</author><author>Pradhan, P.</author><author>Kim, Y. L.</author><author>Backman, V.</author></authors></contributors><auth-address>Biomedical Engineering Department, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Penetration depth of low-coherence enhanced backscattered light in subdiffusion regime</title><secondary-title>Phys Rev E Stat Nonlin Soft Matter Phys</secondary-title></titles><pages>041914</pages><volume>75</volume><number>4 Pt 1</number><edition>2007/05/16</edition><keywords><keyword>Anisotropy</keyword><keyword>Biophysics/*methods</keyword><keyword>Computer Simulation</keyword><keyword>Diffusion</keyword><keyword>Light</keyword><keyword>Models, Statistical</keyword><keyword>Models, Theoretical</keyword><keyword>Monte Carlo Method</keyword><keyword>Photons</keyword><keyword>Refractometry</keyword><keyword>*Scattering, Radiation</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1539-3755 (Print)</isbn><accession-num>17500928</accession-num><abstract>The mechanisms of photon propagation in random media in the diffusive multiple scattering regime have been previously studied using diffusion approximation. However, similar understanding in the low-order (subdiffusion) scattering regime is not complete due to difficulties in tracking photons that undergo very few scatterings events. Recent developments in low-coherence enhanced backscattering (LEBS) overcome these difficulties and enable probing photons that travel very short distances and undergo only a few scattering events. In LEBS, enhanced backscattering is observed under illumination with spatial coherence length L{sc} less than the scattering mean free path l{s}. In order to understand the mechanisms of photon propagation in LEBS in the subdiffusion regime, it is imperative to develop analytical and numerical models that describe the statistical properties of photon trajectories. Here we derive the probability distribution of penetration depth of LEBS photons and report Monte Carlo numerical simulations to support our analytical results. Our results demonstrate that, surprisingly, the transport of photons that undergo low-order scattering events has only weak dependence on the optical properties of the medium (l{s} and anisotropy factor g) and strong dependence on the spatial coherence length of illumination, L{sc} relative to those in the diffusion regime. More importantly, these low-order scattering photons typically penetrate less than l{s} into the medium due to the low spatial coherence length of illumination and their penetration depth is proportional to the one-third power of the coherence volume (i.e., [l{s}piL{s}{2}]1/3) .</abstract><notes>Subramanian, Hariharan&#xD;Pradhan, Prabhakar&#xD;Kim, Young L&#xD;Backman, Vadim&#xD;R01 ca 112315/ca/nci&#xD;R01eb 003682/eb/nibib&#xD;R25 ca 100600-01a1/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Physical review. E, Statistical, nonlinear, and soft matter physics&#xD;Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Apr;75(4 Pt 1):041914. Epub 2007 Apr 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17500928</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>2.483</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>276</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">276</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hall, A. R.</author><author>An, L.</author><author>Liu, J.</author><author>Vicci, L.</author><author>Falvo, M. R.</author><author>Superfine, R.</author><author>Washburn, S.</author></authors></contributors><auth-address>Curriculum in Applied and Materials Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Experimental measurement of single-wall carbon nanotube torsional properties</title><secondary-title>Phys Rev Lett</secondary-title></titles><pages>256102</pages><volume>96</volume><number>25</number><edition>2006/08/16</edition><dates><year>2006</year><pub-dates><date>Jun 30</date></pub-dates></dates><isbn>0031-9007 (Print)</isbn><accession-num>16907325</accession-num><abstract>We report on the characterization of nanometer-scale torsional devices based on individual single-walled carbon nanotubes as the spring elements. The axial shear moduli of the nanotubes are obtained through modeling of device reaction to various amounts of applied electrostatic force and are compared to theoretical values.</abstract><notes>Hall, A R&#xD;An, L&#xD;Liu, J&#xD;Vicci, L&#xD;Falvo, M R&#xD;Superfine, R&#xD;Washburn, S&#xD;United States&#xD;Physical review letters&#xD;Phys Rev Lett. 2006 Jun 30;96(25):256102. Epub 2006 Jun 28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16907325</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.072</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>295</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">295</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pau, S.</author><author>Pai, C. S.</author><author>Low, Y. L.</author><author>Moxom, J.</author><author>Reilly, P. T.</author><author>Whitten, W. B.</author><author>Ramsey, J. M.</author></authors></contributors><auth-address>The University of Arizona, Tucson, Arizona 85721, USA.</auth-address><titles><title>Microfabricated quadrupole ion trap for mass spectrometer applications</title><secondary-title>Phys Rev Lett</secondary-title></titles><pages>120801</pages><volume>96</volume><number>12</number><edition>2006/04/12</edition><dates><year>2006</year><pub-dates><date>Mar 31</date></pub-dates></dates><isbn>0031-9007 (Print)</isbn><accession-num>16605890</accession-num><abstract>An array of miniaturized cylindrical quadrupole ion traps, with a radius of 20 microm, is fabricated using silicon micromachining using phosphorus doped polysilicon and silicon dioxide for the purpose of creating a mass spectrometer on a chip. We have operated the array for mass-selective ion ejection and mass analysis using Xe ions at a pressure of 10(-4). The scaling rules for the ion trap in relation to operating pressure, voltage, and frequency are examined.</abstract><notes>Pau, S&#xD;Pai, C S&#xD;Low, Y L&#xD;Moxom, J&#xD;Reilly, P T A&#xD;Whitten, W B&#xD;Ramsey, J M&#xD;United States&#xD;Physical review letters&#xD;Phys Rev Lett. 2006 Mar 31;96(12):120801. Epub 2006 Mar 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16605890</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.072</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>39</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">39</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alvarez, S. D.</author><author>Schwartz, M. P.</author><author>Migliori, B.</author><author>Rang, C. U.</author><author>Chao, L.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA</auth-address><titles><title>Using a porous silicon photonic crystal for bacterial cell-based biosensing</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><pages>1439-1443</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>immobilization</keyword><keyword>microcavities</keyword><keyword>bacteriophage</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300040</accession-num><abstract>This work demonstrates a method for non-invasively monitoring the growth and 06 virus infection of Pseudomonas syringae bacteria using a 1-D porous silicon photonic crystal and a white-light source coupled to a CCD spectrometer. Bacteria growth on porous Si leads to increased scattering efficiency that can be measured as a change in intensity of light reflected from a 1-D porous Si photonic crystal. A linear relationship between bacteria concentration and intensity of light at the photonic resonance is observed, and detection limits are similar to those obtained from optical density measurements. Upon infection with virus, decreases in scattered light intensity are observed at times that correlate with cell lysis caused by viral replication and subsequent bursting of bacteria cells. It is shown that measurements can be performed in real-time and in an incubator where cells remain in their ideal environment throughout the experiment. This method is well-suited for cell-based biosensing, because bacteria cells can be monitored remotely without the need for sampling cells for plating or optical density measurements. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:0&#xD;Cited References Count:16</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300040</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.214</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>42</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">42</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. S.</author><author>Meade, S. O.</author><author>Segal, E.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Jacobs Sch Engn, Dept Bioengn, La Jolla, CA 92093 USA</auth-address><titles><title>Porous silicon-based polymer replicas formed by bead patterning</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><pages>1383-1387</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>photonic crystals</keyword><keyword>smart dust</keyword><keyword>biosensor</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300029</accession-num><abstract>Monodisperse, micrometer-sized polymer beads can be imparted with a porous nanostructure by softening them into a porous silicon photonic crystal template. Infiltration of the polymer and replication of the photonic spectral properties is verified by optical reflectivity measurements of the beads as they infuse into the nanostructure. The polymer beads can be removed from the porous Si template by dissolution of the template with a basic solution. This treatment destroys the photonic properties, although scanning electron microscopy (SEM) reveals that some nanotexturing remains in the polymer beads. This simple, solvent-free process provides a means to produce nanotextured particles of controllable size and shape. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:0&#xD;Cited References Count:16</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300029</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.214</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>43</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">43</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perelman, L. A.</author><author>Schwartz, M. P.</author><author>Wohlrab, A. M.</author><author>VanNieuwenhze, M. S.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Mat Sci &amp; Engn Program, La Jolla, CA 92093 USA</auth-address><titles><title>A simplified biomolecule attachment strategy for biosensing using a porous Si oxide interferometer</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><pages>1394-1398</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>surface-plasmon resonance</keyword><keyword>fourier-transform spectroscopy</keyword><keyword>ala-d-ala</keyword><keyword>trivalent system</keyword><keyword>silicon</keyword><keyword>chemistry</keyword><keyword>vancomycin</keyword><keyword>affinity</keyword><keyword>sensors</keyword><keyword>layers</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300031</accession-num><abstract>A simple strategy for linking biomolecules to porous Si surfaces and detecting peptide/drug binding is described. Porous Si is prepared using an electrochemical etch and then thermally oxidized by heating in ambient atmosphere. Bovine serum albumin (BSA) is then non-covalently adsorbed to the inner pore walls of the porous Si oxide (PSiO2) matrix. The BSA layer is used as a linker for covalent attachment of the peptide Ac-L-Lysine-D-Alanine-D-Alanine (KAA) using published bioconjugation chemistry. BSA-coated surfaces functionalized with KAA display specificity for the glycopeptide vancomycin while resisting adsorption of non-specific reagents. While the biomolecule attachment strategy reported here is used to bind peptides, the scheme can be generalized to the linking of any primary amine-containing molecule to PSiO2 surfaces. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:0&#xD;Cited References Count:28</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300031</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.214</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>41</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">41</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, M. P.</author><author>Yu, C.</author><author>Alvarez, S. D.</author><author>Migliori, B.</author><author>Godin, D.</author><author>Chao, L.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA&#xD;NSERC, CRSNG, Ottawa, ON K1A 1H5, Canada</auth-address><titles><title>Using an oxidized porous silicon interferometer for determination of relative protein binding affinity through non-covalent capture probe immobilization</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><pages>1444-1448</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>surface-plasmon resonance</keyword><keyword>grating couplers</keyword><keyword>microcavities</keyword><keyword>chemistry</keyword><keyword>biosensor</keyword><keyword>sensors</keyword><keyword>immunoassays</keyword><keyword>crystals</keyword><keyword>sera</keyword><keyword>size</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300041</accession-num><abstract>An oxidized porous Si interferometer was used to measure binding of immunoglobulin G (IgG) to an immobilized protein A capture probe. Protein A was non-covalently immobilized on a thermally oxidized porous Si (PSiO2) sample and exposed to IgG originating from different species. The resulting order of IgG affinity toward the protein A-coated surface (human &gt; rabbit &gt;&gt; sheep IgG) agrees with previous inhibition studies for protein A/IgG binding. No signal change was observed when a protein A coated sample was exposed to bovine serum albumin (BSA), demonstrating that the adsorbed sensing layer sufficiently coats the PSiO2 surface to prevent non-specific binding. This strategy is excellent for qualitative measurements of protein binding affinity because it is label-free, requires minimal sample preparation, and can be implemented using an inexpensive CCD-based spectrometer coupled to a tungsten lamp. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:1&#xD;Cited References Count:36</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300041</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.214</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>45</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">45</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Meade, S. O.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA</auth-address><titles><title>Microfabrication of freestanding porous silicon particles containing spectral barcodes</title><secondary-title>Physica Status Solidi-Rapid Research Letters</secondary-title></titles><pages>R71-R73</pages><volume>1</volume><number>2</number><edition>2007/03</edition><keywords><keyword>photonic crystals</keyword><keyword>microcarriers</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1862-6254</isbn><accession-num>ISI:000244882400013</accession-num><abstract>A method to microfabricate micron-scale freestanding porous silicon photonic crystal particles is described. An electrochemically prepared film of porous silicon on a crystalline silicon substrate is patterned with an SU8-25 photoresist, and the unmasked porous silicon is removed with a chlorine plasma reactive ion etch. Porous microparticles are then removed from the substrate by electropolishing. Scanning electron microscopy and microscopic reflection spectroscopy are used to characterize the geometry and optical properties of the freestanding particles.</abstract><notes>145RO&#xD;Times Cited:0&#xD;Cited References Count:7</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000244882400013</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>na</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>339</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">339</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Duan, H. W.</author><author>Rhyner, M. N.</author><author>Ruan, G.</author><author>Nie, S. M.</author></authors></contributors><auth-address>Nie, SM&#xD;Georgia Tech, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA&#xD;Georgia Tech, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA</auth-address><titles><title>A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots</title><secondary-title>Physical Chemistry Chemical Physics</secondary-title></titles><pages>3895-3903</pages><volume>8</volume><number>33</number><edition>2006</edition><keywords><keyword>cdse/cds core/shell nanocrystals</keyword><keyword>acid</keyword><keyword>photoluminescence</keyword><keyword>nanoparticles</keyword><keyword>fluorescence</keyword><keyword>thiols</keyword><keyword>growth</keyword><keyword>shell</keyword></keywords><dates><year>2006</year></dates><isbn>1463-9076</isbn><accession-num>ISI:000239937900018</accession-num><abstract>A number of procedures are currently available to encapsulate and solubilize hydrophobic semiconductor Quantum Dots (QDs) for biological applications. Most of these procedures are based on the use of small-molecule coordinating ligands, amphiphilic polymers, or amphiphilic lipids. However, it is still not clear how these different surface coating molecules affect the optical, colloidal, and chemical properties of the solubilized QDs. Here we report a systematic study to examine the effects of surface coating chemistry on the hydrodynamic size, fluorescence quantum yield, photostability, chemical stability, and biocompatibility of water-soluble QDs. The results indicate that quantum dots with the smallest hydrodynamic sizes are best prepared by direct ligand exchange with hydrophilic molecules, but the resulting particles are less stable than those encapsulated in amphiphilic polymers. For stability against chemical oxidation, QDs should be protected with a hydrophobic bilayer. For high stability under acidic conditions, the best QDs are prepared by using hyperbranched polyethylenimine. For stability in high salt buffers, it is preferable to have uncharged, sterically-stabilized QDs, like those coated with polyethylene glycol ( PEG). These insights are expected to benefit the development of quantum dots and related nanoparticle probes for molecular and cellular imaging applications.</abstract><notes>076DT&#xD;Times Cited:5&#xD;Cited References Count:36</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000239937900018</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.892</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>388</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">388</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, M. C.</author><author>Ong, S. V.</author><author>Khanna, S. N.</author><author>Knickelbein, M. B.</author></authors></contributors><titles><title>Magnetic endohedral metallofullerenes with floppy interiors (vol 75, art no 104424, 2007)</title><secondary-title>Physical Review B</secondary-title></titles><pages>-</pages><volume>75</volume><number>22</number><edition>2007/06</edition><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1098-0121</isbn><accession-num>ISI:000247624800097</accession-num><notes>184EV&#xD;Times Cited:0&#xD;Cited References Count:1</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000247624800097</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2007</custom3><custom4>3.172</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>389</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">389</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, M. C.</author><author>Ong, S. V.</author><author>Khanna, S. N.</author><author>Knickelbein, M. B.</author></authors></contributors><auth-address>Khanna, SN&#xD;Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA&#xD;Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA&#xD;Argonne Natl Lab, Div Chem, Argonne, IL 60439 USA</auth-address><titles><title>Magnetic endohedral metallofullerenes with floppy interiors</title><secondary-title>Physical Review B</secondary-title></titles><pages>-</pages><volume>75</volume><number>10</number><edition>2007/03</edition><keywords><keyword>mri contrast agents</keyword><keyword>nickel clusters</keyword><keyword>transition-metal</keyword><keyword>molecular-beam</keyword><keyword>gd3n-at-c-80</keyword><keyword>temperature</keyword><keyword>gd3n</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1098-0121</isbn><accession-num>ISI:000245329100069</accession-num><abstract>It is shown that Gd3N@C-80 is a highly magnetic and very stable motif that allows enhanced contrast magnetic resonance imaging and electric dipole moment with potential for cancer treatment. Using a synergistic approach combining Stern-Gerlach experiments in beams and first-principles electronic structure studies, it is demonstrated that an isolated Gd3N has a ground state spin moment of 23 mu(B) followed by a noncollinear state of 17.2 mu(B) only 88 meV above the ground state. The large moment is largely due to localized f electrons. As a Gd3N is embedded inside a C-80 cage, the localized f electrons maintain the magnetic character while the hybridization between the s, d states of isolated Gd3N and p states of C-80 leads to a strongly bound motif with an interaction energy of 13.63 eV and a large highest-occupied-molecular-orbital-lowest-unoccupied-molecular-orbital gap of 1.48 eV. Gd3N@C-80 is further shown to possess two isomers corresponding to the location of the N atom on either side of the Gd-3 triangle with an appreciable electric dipole moment and a low barrier of 91 meV for transition between them offering potential for a fluctuating dipole.</abstract><notes>151ZF&#xD;Times Cited:1&#xD;Cited References Count:40</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245329100069</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2007</custom3><custom4>3.172</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>334</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">334</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wieland, K. A.</author><author>Wang, Y.</author><author>Solin, S. A.</author><author>Girgis, A. M.</author><author>Ram-Mohan, L. R.</author></authors></contributors><auth-address>Wieland, KA&#xD;Washington Univ, Dept Phys, CB 1105,1 Brookings Dr, St Louis, MO 63130 USA&#xD;Washington Univ, Dept Phys, St Louis, MO 63130 USA&#xD;Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA&#xD;Worcester Polytech Inst, Dept Phys, Worcester, MA 01609 USA</auth-address><titles><title>Experimental measurement and finite-element modeling of extraordinary optoconductance in GaAs-In metal-semiconductor hybrid structures</title><secondary-title>Physical Review B</secondary-title></titles><pages>-</pages><volume>73</volume><number>15</number><edition>2006/04</edition><keywords><keyword>read-head sensors</keyword><keyword>gap semiconductors</keyword><keyword>magnetoresistance</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1098-0121</isbn><accession-num>ISI:000237155100055</accession-num><abstract>We present a detailed discussion of extraordinary optoconductance (EOC). (Here optoconductance is synonymous with photoconductance.) Experimental data were acquired via macroscopic metal-semiconductor hybrid structures composed of GaAs and In and subjected to illumination from an Ar ion laser. A drift diffusion model using the finite element method (FEM) provided a reasonable fit to the data. EOC is explored as a function of laser position, bias current, laser power density, and temperature. The positional dependence of the voltage is accounted for by the Dember effect, with the model incorporating the excess hole distribution based on the carrier mobility, and thus the mean free path. The bias current is found to produce a linear voltage offset and does not influence the EOC. A linear relationship is found between the laser power density and the voltage in the bare and hybrid devices. This dependence is reproduced in the model by a generation rate parameter which is related to the power density. Incorporating the mobility and diffusion temperature dependence, the model directly parallels the temperature dependence of the EOC without the use of fitting parameters.</abstract><notes>037OA&#xD;Times Cited:1&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000237155100055</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>3.172</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>704</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">704</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bashir, A.</author><author>Volik, S.</author><author>Collins, C.</author><author>Bafna, V.</author><author>Raphael, B. J.</author></authors></contributors><auth-address>Bioinformatics Graduate Program, University of California San Diego, San Diego, California, United States of America. abashir@ucsd.edu</auth-address><titles><title>Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer</title><secondary-title>PLoS Comput Biol</secondary-title></titles><pages>e1000051</pages><volume>4</volume><number>4</number><edition>2008/04/12</edition><keywords><keyword>*Algorithms</keyword><keyword>Base Sequence</keyword><keyword>Breast Neoplasms/*genetics</keyword><keyword>Chromosome Mapping/*methods</keyword><keyword>Female</keyword><keyword>Gene Rearrangement/*genetics</keyword><keyword>Humans</keyword><keyword>Molecular Sequence Data</keyword><keyword>Sequence Analysis, DNA/*methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1553-7358 (Electronic)</isbn><accession-num>18404202</accession-num><abstract>Paired-end sequencing is emerging as a key technique for assessing genome rearrangements and structural variation on a genome-wide scale. This technique is particularly useful for detecting copy-neutral rearrangements, such as inversions and translocations, which are common in cancer and can produce novel fusion genes. We address the question of how much sequencing is required to detect rearrangement breakpoints and to localize them precisely using both theoretical models and simulation. We derive a formula for the probability that a fusion gene exists in a cancer genome given a collection of paired-end sequences from this genome. We use this formula to compute fusion gene probabilities in several breast cancer samples, and we find that we are able to accurately predict fusion genes in these samples with a relatively small number of fragments of large size. We further demonstrate how the ability to detect fusion genes depends on the distribution of gene lengths, and we evaluate how different parameters of a sequencing strategy impact breakpoint detection, breakpoint localization, and fusion gene detection, even in the presence of errors that suggest false rearrangements. These results will be useful in calibrating future cancer sequencing efforts, particularly large-scale studies of many cancer genomes that are enabled by next-generation sequencing technologies.</abstract><notes>Bashir, Ali&#xD;Volik, Stanislav&#xD;Collins, Colin&#xD;Bafna, Vineet&#xD;Raphael, Benjamin J&#xD;5 U54 CA119335-02/CA/United States NCI&#xD;CA58207/CA/United States NCI&#xD;R33 CA103068/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;PLoS computational biology&#xD;PLoS Comput Biol. 2008 Apr 25;4(4):e1000051.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18404202</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>6.236</custom4><electronic-resource-num>10.1371/journal.pcbi.1000051</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>600</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">600</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, K. A.</author><author>Bardeesy, N.</author><author>Anbazhagan, R.</author><author>Gurumurthy, S.</author><author>Berger, J.</author><author>Alencar, H.</author><author>Depinho, R. A.</author><author>Mahmood, U.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America. kkelly9@partners.org</auth-address><titles><title>Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma</title><secondary-title>PLoS Med</secondary-title></titles><pages>e85</pages><volume>5</volume><number>4</number><edition>2008/04/18</edition><keywords><keyword>Adenocarcinoma/*diagnosis</keyword><keyword>Animals</keyword><keyword>Carcinoma, Pancreatic Ductal/*diagnosis</keyword><keyword>Cell Line, Tumor</keyword><keyword>Disease Models, Animal</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Microscopy, Confocal</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Pancreatic Neoplasms/*diagnosis</keyword><keyword>Peptide Library</keyword><keyword>Peptides/*metabolism</keyword><keyword>Plectin/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1549-1676 (Electronic)</isbn><accession-num>18416599</accession-num><abstract>BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, typically presenting with metastasis at the time of diagnosis and exhibiting profound resistance to existing therapies. The development of molecular markers and imaging probes for incipient PDAC would enable earlier detection and guide the development of interventive therapies. Here we sought to identify novel molecular markers and to test their potential as targeted imaging agents. METHODS AND FINDINGS: Here, a phage display approach was used in a mouse model of PDAC to screen for peptides that specifically bind to cell surface antigens on PDAC cells. These screens yielded a motif that distinguishes PDAC cells from normal pancreatic duct cells in vitro, which, upon proteomics analysis, identified plectin-1 as a novel biomarker of PDAC. To assess their utility for in vivo imaging, the plectin-1 targeted peptides (PTP) were conjugated to magnetofluorescent nanoparticles. In conjunction with intravital confocal microscopy and MRI, these nanoparticles enabled detection of small PDAC and precursor lesions in engineered mouse models. CONCLUSIONS: Our approach exploited a well-defined model of PDAC, enabling rapid identification and validation of PTP. The developed specific imaging probe, along with the discovery of plectin-1 as a novel biomarker, may have clinical utility in the diagnosis and management of PDAC in humans.</abstract><notes>Kelly, Kimberly A&#xD;Bardeesy, Nabeel&#xD;Anbazhagan, Rajesh&#xD;Gurumurthy, Sushma&#xD;Berger, Justin&#xD;Alencar, Herlen&#xD;Depinho, Ronald A&#xD;Mahmood, Umar&#xD;Weissleder, Ralph&#xD;K01 CA104647â€“03/CA/United States NCI&#xD;P01-CA117969â€“01/CA/United States NCI&#xD;P50-CA86355/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;PLoS medicine&#xD;PLoS Med. 2008 Apr 15;5(4):e85.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18416599</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>12.601</custom4><electronic-resource-num>07-PLME-RA-1015 [pii]&#xD;10.1371/journal.pmed.0050085</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>80</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">80</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Y. T.</author><author>Carson, D. A.</author></authors></contributors><auth-address>Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, United States of America. ytliu@ucsd.edu</auth-address><titles><title>A novel approach for determining cancer genomic breakpoints in the presence of normal DNA</title><secondary-title>PLoS ONE</secondary-title></titles><pages>e380</pages><volume>2</volume><number>4</number><edition>2007/04/19</edition><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1932-6203 (Electronic)</isbn><accession-num>17440616</accession-num><abstract>CDKN2A (encodes p16(INK4A) and p14(ARF)) deletion, which results in both Rb and p53 inactivation, is the most common chromosomal anomaly in human cancers. To precisely map the deletion breakpoints is important to understanding the molecular mechanism of genomic rearrangement and may also be useful for clinical applications. However, current methods for determining the breakpoint are either of low resolution or require the isolation of relatively pure cancer cells, which can be difficult for clinical samples that are typically contaminated with various amounts of normal host cells. To overcome this hurdle, we have developed a novel approach, designated Primer Approximation Multiplex PCR (PAMP), for enriching breakpoint sequences followed by genomic tiling array hybridization to locate the breakpoints. In a series of proof-of-concept experiments, we were able to identify cancer-derived CDKN2A genomic breakpoints when more than 99.9% of wild type genome was present in a model system. This design can be scaled up with bioinformatics support and can be applied to validate other candidate cancer-associated loci that are revealed by other more systemic but lower throughput assays.</abstract><notes>Liu, Yu-Tsueng&#xD;Carson, Dennis A&#xD;United States&#xD;PLoS ONE&#xD;PLoS ONE. 2007 Apr 18;2(4):e380.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17440616</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>na</custom4><electronic-resource-num>10.1371/journal.pone.0000380</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>407</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">407</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, H.</author><author>Neilson, J. R.</author><author>Kumar, P.</author><author>Manocha, M.</author><author>Shankar, P.</author><author>Sharp, P. A.</author><author>Manjunath, N.</author></authors></contributors><auth-address>The CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America.</auth-address><titles><title>miRNA profiling of naive, effector and memory CD8 T cells</title><secondary-title>PLoS ONE</secondary-title></titles><pages>e1020</pages><volume>2</volume><number>10</number><edition>2007/10/11</edition><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1932-6203 (Electronic)</isbn><accession-num>17925868</accession-num><abstract>microRNAs have recently emerged as master regulators of gene expression during development and cell differentiation. Although profound changes in gene expression also occur during antigen-induced T cell differentiation, the role of miRNAs in the process is not known. We compared the miRNA expression profiles between antigen-specific naive, effector and memory CD8+ T cells using 3 different methods--small RNA cloning, miRNA microarray analysis and real-time PCR. Although many miRNAs were expressed in all the T cell subsets, the frequency of 7 miRNAs (miR-16, miR-21, miR-142-3p, miR-142-5p, miR-150, miR-15b and let-7f) alone accounted for approximately 60% of all miRNAs, and their expression was several fold higher than the other expressed miRNAs. Global downregulation of miRNAs (including 6/7 dominantly expressed miRNAs) was observed in effector T cells compared to naive cells and the miRNA expression levels tended to come back up in memory T cells. However, a few miRNAs, notably miR-21 were higher in effector and memory T cells compared to naive T cells. These results suggest that concomitant with profound changes in gene expression, miRNA profile also changes dynamically during T cell differentiation. Sequence analysis of the cloned mature miRNAs revealed an extensive degree of end polymorphism. While 3&apos;end polymorphisms dominated, heterogeneity at both ends, resembling drosha/dicer processing shift was also seen in miR-142, suggesting a possible novel mechanism to generate new miRNA and/or to diversify miRNA target selection. Overall, our results suggest that dynamic changes in the expression of miRNAs may be important for the regulation of gene expression during antigen-induced T cell differentiation. Our study also suggests possible novel mechanisms for miRNA biogenesis and function.</abstract><notes>Wu, Haoquan&#xD;Neilson, Joel R&#xD;Kumar, Priti&#xD;Manocha, Monika&#xD;Shankar, Premlata&#xD;Sharp, Phillip A&#xD;Manjunath, N&#xD;R21 AI 066197/AI/United States NIAID&#xD;U19 AI 056900/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;PLoS ONE&#xD;PLoS ONE. 2007 Oct 10;2(10):e1020.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17925868</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1371/journal.pone.0001020</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>709</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">709</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S.E.A.</author><author>Ropp, P.A. </author><author>Pohlhaus, P.D. </author><author>Luft, J.C. </author><author>Madden, V.J. </author><author>Napier, M.E. </author><author>DeSimone J.M. </author></authors></contributors><titles><title>The Effect of Particle Design on Cellular Internalization Pathways</title><secondary-title>PNAS</secondary-title></titles><periodical><full-title>PNAS</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - UNC</custom1><custom4>9.598</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>551</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">551</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, D. </author><author>Pentzer, E. B.</author><author>Nguyen, S. T.</author></authors></contributors><titles><title>Bioactive and Therapeutic ROMP Polymers</title><secondary-title>Polymer Reviews</secondary-title></titles><pages>419 - 459</pages><volume>47</volume><number>3</number><edition>2007/07</edition><dates><year>2007</year><pub-dates><date>July 2007</date></pub-dates></dates><isbn>1558-3724</isbn><abstract>This review summarizes the developments in the area of ROMP-based polymer carriers as well as side-chain and main-chain polymer therapeutics during the period of 1993â€“2007. The promising emergence of ROMP-derived amphiphilic block copolymers containing therapeutic agents, their assembly into polymer nanoparticles, together with their modification for the targeting group attachment is outlined. Recent application of ROMP-based side-chain polymer therapeutics as multivalent scaffolds and the synthesis of DIVEMA-type main-chain polymers from ROMP-active monomers are also discussed. Finally, an outlook on the opportunities and the future directions in the use of ROMP towards the development of the next generation of polymer therapeutics is provided.</abstract><urls><related-urls><url>http://www.informaworld.com/10.1080/15583720701455186</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>3.158</custom4><electronic-resource-num>10.1080/15583720701455186</electronic-resource-num><access-date>June 09, 2008</access-date></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>564</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">564</key></foreign-keys><ref-type name="Hearing">14</ref-type><contributors><authors><author>Agrawal, A.</author><author>Deo, R.</author><author>Wang, G. D.</author><author>Wang, M. D.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, GA 30322, USA.</auth-address><titles><title>Nanometer-scale mapping and single-molecule detection with color-coded nanoparticle probes</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>3298-303</pages><volume>105</volume><number>9</number><edition>2008/02/29</edition><keywords><keyword>Algorithms</keyword><keyword>Color</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Molecular Probes/*chemistry/diagnostic use</keyword><keyword>Nanoparticles/*chemistry/diagnostic use</keyword><keyword>Nanotechnology/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 4</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18305159</accession-num><abstract>We report a method for single-molecule detection and biomolecular structural mapping based on dual-color imaging and automated colocalization of bioconjugated nanoparticle probes at nanometer precision. In comparison with organic dyes and fluorescent proteins, nanoparticle probes such as fluorescence energy-transfer nanobeads and quantum dots provide significant advantages in signal brightness, photostability, and multicolor-light emission. As a result, we have achieved routine two-color superresolution imaging and single-molecule detection with standard fluorescence microscopes and inexpensive digital color cameras. By using green and red nanoparticles to simultaneously recognize two binding sites on a single target, individual biomolecules such as nucleic acids are detected and identified without target amplification or probe/target separation. We also demonstrate that a powerful astrophysical method (originally developed to analyze crowded stellar fields) can be used for automated and rapid statistical analysis of nanoparticle colocalization signals. The ability to rapidly localize bright nanoparticle probes at nanometer precision has implications not only for ultrasensitive medical detection but also for structural mapping of molecular complexes in which individual components are tagged with color-coded nanoparticles.</abstract><notes>Agrawal, Amit&#xD;Deo, Rajesh&#xD;Wang, Geoffrey D&#xD;Wang, May D&#xD;Nie, Shuming&#xD;P20 GM072069/GM/United States NIGMS&#xD;R01 CA108468/CA/United States NCI&#xD;R01 GM60562/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3298-303. Epub 2008 Feb 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18305159</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0712351105 [pii]&#xD;10.1073/pnas.0712351105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>451</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">451</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bartlett, D. W.</author><author>Su, H.</author><author>Hildebrandt, I. J.</author><author>Weber, W. A.</author><author>Davis, M. E.</author></authors></contributors><auth-address>Chemical Engineering, California Institute of Technology, 1200 East California Boulevard, MC 210-41, Pasadena, CA 91125, USA.</auth-address><titles><title>Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>15549-54</pages><volume>104</volume><number>39</number><edition>2007/09/19</edition><keywords><keyword>Animals</keyword><keyword>Chemistry, Pharmaceutical/methods</keyword><keyword>Cyclodextrins/*administration &amp; dosage/chemistry</keyword><keyword>Drug Carriers</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Heterocyclic Compounds, 1-Ring/chemistry</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, SCID</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms/*therapy</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>RNA, Small Interfering/*metabolism</keyword><keyword>Technology, Pharmaceutical/methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 25</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17875985</accession-num><abstract>Targeted delivery represents a promising approach for the development of safer and more effective therapeutics for oncology applications. Although macromolecules accumulate nonspecifically in tumors through the enhanced permeability and retention (EPR) effect, previous studies using nanoparticles to deliver chemotherapeutics or siRNA demonstrated that attachment of cell-specific targeting ligands to the surface of nanoparticles leads to enhanced potency relative to nontargeted formulations. Here, we use positron emission tomography (PET) and bioluminescent imaging to quantify the in vivo biodistribution and function of nanoparticles formed with cyclodextrin-containing polycations and siRNA. Conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid to the 5&apos; end of the siRNA molecules allows labeling with (64)Cu for PET imaging. Bioluminescent imaging of mice bearing luciferase-expressing Neuro2A s.c. tumors before and after PET imaging enables correlation of functional efficacy with biodistribution data. Although both nontargeted and transferrin-targeted siRNA nanoparticles exhibit similar biodistribution and tumor localization by PET, transferrin-targeted siRNA nanoparticles reduce tumor luciferase activity by approximately 50% relative to nontargeted siRNA nanoparticles 1 d after injection. Compartmental modeling is used to show that the primary advantage of targeted nanoparticles is associated with processes involved in cellular uptake in tumor cells rather than overall tumor localization. Optimization of internalization may therefore be key for the development of effective nanoparticle-based targeted therapeutics.</abstract><notes>Bartlett, Derek W&#xD;Su, Helen&#xD;Hildebrandt, Isabel J&#xD;Weber, Wolfgang A&#xD;Davis, Mark E&#xD;CA119347/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54. Epub 2007 Sep 17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17875985</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0707461104 [pii]&#xD;10.1073/pnas.0707461104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>454</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">454</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Beroukhim, R.</author><author>Getz, G.</author><author>Nghiemphu, L.</author><author>Barretina, J.</author><author>Hsueh, T.</author><author>Linhart, D.</author><author>Vivanco, I.</author><author>Lee, J. C.</author><author>Huang, J. H.</author><author>Alexander, S.</author><author>Du, J.</author><author>Kau, T.</author><author>Thomas, R. K.</author><author>Shah, K.</author><author>Soto, H.</author><author>Perner, S.</author><author>Prensner, J.</author><author>Debiasi, R. M.</author><author>Demichelis, F.</author><author>Hatton, C.</author><author>Rubin, M. A.</author><author>Garraway, L. A.</author><author>Nelson, S. F.</author><author>Liau, L.</author><author>Mischel, P. S.</author><author>Cloughesy, T. F.</author><author>Meyerson, M.</author><author>Golub, T. A.</author><author>Lander, E. S.</author><author>Mellinghoff, I. K.</author><author>Sellers, W. R.</author></authors></contributors><auth-address>Broad Institute, Massachusetts Institute of Technology and Harvard University, 7 Cambridge Center, Cambridge, MA 02142, USA.</auth-address><titles><title>Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>20007-12</pages><volume>104</volume><number>50</number><edition>2007/12/14</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Chromosome Aberrations/*statistics &amp; numerical data</keyword><keyword>Data Interpretation, Statistical</keyword><keyword>Glioma/*genetics/pathology</keyword><keyword>Humans</keyword><keyword>Polymorphism, Single Nucleotide</keyword><keyword>Probability</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18077431</accession-num><abstract>Comprehensive knowledge of the genomic alterations that underlie cancer is a critical foundation for diagnostics, prognostics, and targeted therapeutics. Systematic efforts to analyze cancer genomes are underway, but the analysis is hampered by the lack of a statistical framework to distinguish meaningful events from random background aberrations. Here we describe a systematic method, called Genomic Identification of Significant Targets in Cancer (GISTIC), designed for analyzing chromosomal aberrations in cancer. We use it to study chromosomal aberrations in 141 gliomas and compare the results with two prior studies. Traditional methods highlight hundreds of altered regions with little concordance between studies. The new approach reveals a highly concordant picture involving approximately 35 significant events, including 16-18 broad events near chromosome-arm size and 16-21 focal events. Approximately half of these events correspond to known cancer-related genes, only some of which have been previously tied to glioma. We also show that superimposed broad and focal events may have different biological consequences. Specifically, gliomas with broad amplification of chromosome 7 have properties different from those with overlapping focalEGFR amplification: the broad events act in part through effects on MET and its ligand HGF and correlate with MET dependence in vitro. Our results support the feasibility and utility of systematic characterization of the cancer genome.</abstract><notes>Beroukhim, Rameen&#xD;Getz, Gad&#xD;Nghiemphu, Leia&#xD;Barretina, Jordi&#xD;Hsueh, Teli&#xD;Linhart, David&#xD;Vivanco, Igor&#xD;Lee, Jeffrey C&#xD;Huang, Julie H&#xD;Alexander, Sethu&#xD;Du, Jinyan&#xD;Kau, Tweeny&#xD;Thomas, Roman K&#xD;Shah, Kinjal&#xD;Soto, Horacio&#xD;Perner, Sven&#xD;Prensner, John&#xD;Debiasi, Ralph M&#xD;Demichelis, Francesca&#xD;Hatton, Charlie&#xD;Rubin, Mark A&#xD;Garraway, Levi A&#xD;Nelson, Stan F&#xD;Liau, Linda&#xD;Mischel, Paul S&#xD;Cloughesy, Tim F&#xD;Meyerson, Matthew&#xD;Golub, Todd A&#xD;Lander, Eric S&#xD;Mellinghoff, Ingo K&#xD;Sellers, William R&#xD;CA109038/CA/United States NCI&#xD;CA126546/CA/United States NCI&#xD;K08 CA122833-01A1/CA/United States NCI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12. Epub 2007 Dec 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18077431</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0710052104 [pii]&#xD;10.1073/pnas.0710052104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>406</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">406</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Calabrese, J. M.</author><author>Seila, A. C.</author><author>Yeo, G. W.</author><author>Sharp, P. A.</author></authors></contributors><auth-address>Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>RNA sequence analysis defines Dicer&apos;s role in mouse embryonic stem cells</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>18097-102</pages><volume>104</volume><number>46</number><edition>2007/11/09</edition><keywords><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>DNA, Complementary</keyword><keyword>Embryonic Stem Cells/*metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>RNA Interference</keyword><keyword>Repetitive Sequences, Nucleic Acid</keyword><keyword>Ribonuclease III/genetics/*physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 13</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>17989215</accession-num><abstract>Short RNA expression was analyzed from Dicer-positive and Dicer-knockout mouse embryonic [corrected] stem (ES) cells, using high-throughput pyrosequencing. A correlation of miRNA quantification with sequencing frequency estimates that there are 110,000 miRNAs per ES cell, the majority of which can be accounted for by six distinct miRNA loci. Four of these miRNA loci or their human homologues have demonstrated roles in cell cycle regulation or oncogenesis, suggesting that a major function of the miRNA pathway in ES cells may be to shape their distinct cell cycle. Forty-six previously uncharacterized miRNAs were identified, most of which are expressed at low levels and are less conserved than the set of known miRNAs. Low-abundance short RNAs matching all classes of repetitive elements were present in cells lacking Dicer, although the production of some SINE- and simple repeat-associated short RNAs appeared to be Dicer-dependent. These and other Dicer-dependent sequences resembled miRNAs. At a depth of sequencing that approaches the total number of 5&apos; phosphorylated short RNAs per cell, miRNAs appeared to be Dicer&apos;s only substrate. The results presented suggest a model in which repeat-associated miRNAs serve as host defenses against repetitive elements, a function canonically ascribed to other classes of short RNA.</abstract><notes>Calabrese, J Mauro&#xD;Seila, Amy C&#xD;Yeo, Gene W&#xD;Sharp, Phillip A&#xD;5-F32-HD051190/HD/United States NICHD&#xD;P01-CA42063/CA/United States NCI&#xD;P30-CA14051/CA/United States NCI&#xD;R01-GM34277/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18097-102. Epub 2007 Nov 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17989215</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0709193104 [pii]&#xD;10.1073/pnas.0709193104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>317</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">317</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheon, J.</author><author>Park, J. I.</author><author>Choi, J. S.</author><author>Jun, Y. W.</author><author>Kim, S.</author><author>Kim, M. G.</author><author>Kim, Y. M.</author><author>Kim, Y. J.</author></authors></contributors><auth-address>Department of Chemistry and Nano-Medical National Core Research Center, Yonsei University, Seoul, Korea. jcheon@yonsei.ac.kr</auth-address><titles><title>Magnetic superlattices and their nanoscale phase transition effects</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>3023-7</pages><volume>103</volume><number>9</number><edition>2006/02/24</edition><dates><year>2006</year><pub-dates><date>Feb 28</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16492783</accession-num><abstract>The systematic assembly of nanoscale constituents into highly ordered superlattices is of significant interest because of the potential of their multifunctionalities and the discovery of new collective properties. However, successful observations of such superlattice-associated nanoscale phenomena are still elusive. Here, we present magnetic superlattices of Co and Fe(3)O(4) nanoparticles with multidimensional symmetry of either AB (NaCl) or AB(2) (AlB(2)). The discovery of significant enhancement (approximately 25 times) of ferrimagnetism is further revealed by forming previously undescribed superlattices of magnetically soft-hard Fe(3)O(4)@CoFe(2)O(4) through the confined geometrical effect of thermally driven intrasuperlattice phase transition between the nanoparticulate components.</abstract><notes>Cheon, Jinwoo&#xD;Park, Jong-Il&#xD;Choi, Jin-sil&#xD;Jun, Young-wook&#xD;Kim, Sehun&#xD;Kim, Min Gyu&#xD;Kim, Young-Min&#xD;Kim, Youn Joong&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3023-7. Epub 2006 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16492783</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>9.643</custom4><electronic-resource-num>0508877103 [pii]&#xD;10.1073/pnas.0508877103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>142</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">142</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Collier, J. H.</author><author>Mrksich, M.</author></authors></contributors><auth-address>Department of Chemistry and Institute for Biophysical Dynamics, University of Chicago, 5735 South Ellis Avenue, Chicago, IL 60637, USA.</auth-address><titles><title>Engineering a biospecific communication pathway between cells and electrodes</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>2021-5</pages><volume>103</volume><number>7</number><edition>2006/02/08</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>*Biosensing Techniques/instrumentation</keyword><keyword>CHO Cells</keyword><keyword>Carboxylic Ester Hydrolases/chemistry/genetics/*metabolism</keyword><keyword>Cricetinae</keyword><keyword>Cricetulus</keyword><keyword>Electricity</keyword><keyword>*Electrodes</keyword><keyword>Fusarium/enzymology</keyword><keyword>Molecular Sequence Data</keyword><keyword>Protein Engineering</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb 14</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16461913</accession-num><abstract>Methods for transducing the cellular activities of mammalian cells into measurable electronic signals are important in many biotechnical applications, including biosensors, cell arrays, and other cell-based devices. This manuscript describes an approach for functionally integrating cellular activities and electrical processes in an underlying substrate. The cells are engineered with a cell-surface chimeric receptor that presents the nonmammalian enzyme cutinase. Action of this cell-surface cutinase on enzyme substrate self-assembled monolayers switches a nonelectroactive hydroxyphenyl ester to an electroactive hydroquinone, providing an electrical activity that can be identified with cyclic voltammetry. In this way, cell-surface enzymatic activity is transduced into electronic signals. The development of strategies to directly interface the activities of cells with materials will be important to enabling a broad class of hybrid microsystems that combine living and nonliving components.</abstract><notes>Collier, Joel H&#xD;Mrksich, Milan&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2021-5. Epub 2006 Feb 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16461913</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>9.643</custom4><electronic-resource-num>0504349103 [pii]&#xD;10.1073/pnas.0504349103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>27</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">27</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farokhzad, O. C.</author><author>Cheng, J.</author><author>Teply, B. A.</author><author>Sherifi, I.</author><author>Jon, S.</author><author>Kantoff, P. W.</author><author>Richie, J. P.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesiology, Brigham and Women&apos;s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.</auth-address><titles><title>Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><pages>6315-20</pages><volume>103</volume><number>16</number><edition>2006/04</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents, Phytogenic/*administration &amp; dosage/therapeutic use</keyword><keyword>Aptamers, Nucleotide/*administration &amp; dosage/chemistry/therapeutic use</keyword><keyword>Capsules</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Polyglactin 910/chemistry</keyword><keyword>Prostatic Neoplasms/*drug therapy/pathology</keyword><keyword>Taxoids/*administration &amp; dosage/therapeutic use</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 18</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16606824</accession-num><abstract>Targeted uptake of therapeutic nanoparticles in a cell-, tissue-, or disease-specific manner represents a potentially powerful technology. Using prostate cancer as a model, we report docetaxel (Dtxl)-encapsulated nanoparticles formulated with biocompatible and biodegradable poly(D,L-lactic-co-glycolic acid)-block-poly(ethylene glycol) (PLGA-b-PEG) copolymer and surface functionalized with the A10 2&apos;-fluoropyrimidine RNA aptamers that recognize the extracellular domain of the prostate-specific membrane antigen (PSMA), a well characterized antigen expressed on the surface of prostate cancer cells. These Dtxl-encapsulated nanoparticle-aptamer bioconjugates (Dtxl-NP-Apt) bind to the PSMA protein expressed on the surface of LNCaP prostate epithelial cells and get taken up by these cells resulting in significantly enhanced in vitro cellular toxicity as compared with nontargeted nanoparticles that lack the PSMA aptamer (Dtxl-NP) (P &lt; 0.0004). The Dtxl-NP-Apt bioconjugates also exhibit remarkable efficacy and reduced toxicity as measured by mean body weight loss (BWL) in vivo [body weight loss of 7.7 +/- 4% vs. 18 +/- 5% for Dtxl-NP-Apt vs. Dtxl-NP at nadir, respectively (mean +/- SD); n = 7]. After a single intratumoral injection of Dtxl-NP-Apt bioconjugates, complete tumor reduction was observed in five of seven LNCaP xenograft nude mice (initial tumor volume of approximately 300 mm3), and 100% of these animals survived our 109-day study. In contrast, two of seven mice in the Dtxl-NP group had complete tumor reduction with 109-day survivability of only 57%. Dtxl alone had a survivability of only 14%. Saline and nanoparticles without drug were similarly nonefficacious. This report demonstrates the potential utility of nanoparticle-aptamer bioconjugates for a therapeutic application.</abstract><notes>Ca 119349/ca/nci&#xD;Eb003647/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16606824 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>9.643</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>29</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">29</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fulci, G.</author><author>Breymann, L.</author><author>Gianni, D.</author><author>Kurozomi, K.</author><author>Rhee, S. S.</author><author>Yu, J.</author><author>Kaur, B.</author><author>Louis, D. N.</author><author>Weissleder, R.</author><author>Caligiuri, M. A.</author><author>Chiocca, E. A.</author></authors></contributors><auth-address>Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, James Cancer Hospital and Solove Research Institute, Ohio State University Medical Center, Columbus, OH 43210, USA.</auth-address><titles><title>Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><pages>12873-8</pages><volume>103</volume><number>34</number><edition>2006/08</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/pathology/therapy/virology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclophosphamide/administration &amp; dosage/*pharmacology/therapeutic use</keyword><keyword>Glioma/*immunology/pathology/*therapy/virology</keyword><keyword>Immunity, Natural/*drug effects/*immunology</keyword><keyword>Interferon Type II/metabolism</keyword><keyword>Male</keyword><keyword>Neoplasm Transplantation</keyword><keyword>*Oncolytic Virotherapy</keyword><keyword>Phagocytes</keyword><keyword>Rats</keyword><keyword>Simplexvirus/drug effects/*immunology</keyword><keyword>Virion/drug effects</keyword><keyword>Virus Replication/drug effects</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 22</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16908838</accession-num><abstract>Clinical trials are testing oncolytic viruses (OVs) as therapies for cancer. We have shown that animals that have brain tumors and are treated with a herpes simplex virus (HSV)-derived OV live significantly longer when cyclophosphamide (CPA) is preadministered. Here, we explore the mechanisms behind this finding. In a syngeneic rat glioma model, intratumoral HSV administration is associated with rapid increase of natural killer cells, microglia/macrophages (CD68+ and CD163+), and IFN-gamma. Pretreatment with CPA enhances HSV replication and oncolysis and reduces an HSV-mediated increase in CD68+ and CD163+ cells and intratumoral IFN-gamma. Molecular imaging shows CPA pretreatment to inhibit HSV-induced infiltration of tumor-associated phagocytic cells. Our results reveal molecular and cellular mechanisms that inhibit intratumoral spread of HSV and suggest a therapeutic path for improving the efficacy of virotherapy as a treatment for cancer.</abstract><notes>Ca16058/ca/nci&#xD;Ca68458/ca/nci&#xD;Ca95426/ca/nci&#xD;Ns41571/ns/ninds&#xD;P01 ca69246/ca/nci&#xD;R01 ca85139/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16908838 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>9.643</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>413</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">413</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gounaris, E.</author><author>Erdman, S. E.</author><author>Restaino, C.</author><author>Gurish, M. F.</author><author>Friend, D. S.</author><author>Gounari, F.</author><author>Lee, D. M.</author><author>Zhang, G.</author><author>Glickman, J. N.</author><author>Shin, K.</author><author>Rao, V. P.</author><author>Poutahidis, T.</author><author>Weissleder, R.</author><author>McNagny, K. M.</author><author>Khazaie, K.</author></authors></contributors><auth-address>Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Mast cells are an essential hematopoietic component for polyp development</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>19977-82</pages><volume>104</volume><number>50</number><edition>2007/12/14</edition><keywords><keyword>Adenomatous Polyposis Coli/genetics/metabolism/pathology</keyword><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Colorectal Neoplasms/genetics/*pathology</keyword><keyword>Hematopoietic System/*metabolism/*pathology</keyword><keyword>Humans</keyword><keyword>Mast Cells/metabolism/*pathology</keyword><keyword>Mastocytosis/genetics/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Mice, Mutant Strains</keyword><keyword>Mice, Transgenic</keyword><keyword>Neoplasm Recurrence, Local/genetics/pathology</keyword><keyword>Polyps/genetics/*pathology</keyword><keyword>Precancerous Conditions/genetics/pathology</keyword><keyword>Radiation Chimera</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18077429</accession-num><abstract>It is generally agreed that most colon cancers develop from adenomatous polyps, and it is this fact on which screening strategies are based. Although there is overwhelming evidence to link intrinsic genetic lesions with the formation of these preneoplastic lesions, recent data suggest that the tumor stromal environment also plays an essential role in this disease. In particular, it has been suggested that CD34(+) immature myeloid precursor cells are required for tumor development and invasion. Here we have used mice conditional for the stabilization of beta-catenin or defective for the adenomatous polyposis coli (APC) gene to reinvestigated the identity and importance of tumor-infiltrating hematopoietic cells in polyposis. We show that, from the onset, polyps are infiltrated with proinflammatory mast cells (MC) and their precursors. Depletion of MC either pharmacologically or through the generation of chimeric mice with genetic lesions in MC development leads to a profound remission of existing polyps. Our data suggest that MC are an essential hematopoietic component for preneoplastic polyp development and are a novel target for therapeutic intervention.</abstract><notes>Gounaris, Elias&#xD;Erdman, Susan E&#xD;Restaino, Clifford&#xD;Gurish, Michael F&#xD;Friend, Daniel S&#xD;Gounari, Fotini&#xD;Lee, David M&#xD;Zhang, Guoying&#xD;Glickman, Jonathan N&#xD;Shin, Kichul&#xD;Rao, Varada P&#xD;Poutahidis, Theofilos&#xD;Weissleder, Ralph&#xD;McNagny, Kelly M&#xD;Khazaie, Khashayarsha&#xD;R01-AI059676/AI/United States NIAID&#xD;R01-CA104547/CA/United States NCI&#xD;R01-CA108854/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Validation Studies&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19977-82. Epub 2007 Dec 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18077429</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0704620104 [pii]&#xD;10.1073/pnas.0704620104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>587</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">587</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gu, F.</author><author>Zhang, L.</author><author>Teply, B. A.</author><author>Mann, N.</author><author>Wang, A.</author><author>Radovic-Moreno, A. F.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Chemical Engineering, Harvard-MIT Center of Cancer Nanotechnology Excellence, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.</auth-address><titles><title>Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>2586-91</pages><volume>105</volume><number>7</number><edition>2008/02/15</edition><keywords><keyword>Animals</keyword><keyword>Benzeneacetamides/chemistry</keyword><keyword>Biophysics</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemistry, Physical</keyword><keyword>Endocytosis</keyword><keyword>Glycolates/*chemistry</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Nude</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Piperidones/chemistry</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Prostate-Specific Antigen/*chemistry</keyword><keyword>Surface Properties</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 19</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18272481</accession-num><abstract>There has been progressively heightened interest in the development of targeted nanoparticles (NPs) for differential delivery and controlled release of drugs. Despite nearly three decades of research, approaches to reproducibly formulate targeted NPs with the optimal biophysicochemical properties have remained elusive. A central challenge has been defining the optimal interplay of parameters that confer molecular targeting, immune evasion, and drug release to overcome the physiological barriers in vivo. Here, we report a strategy for narrowly changing the biophysicochemical properties of NPs in a reproducible manner, thereby enabling systematic screening of optimally formulated drug-encapsulated targeted NPs. NPs were formulated by the self-assembly of an amphiphilic triblock copolymer composed of end-to-end linkage of poly(lactic-co-glycolic-acid) (PLGA), polyethyleneglycol (PEG), and the A10 aptamer (Apt), which binds to the prostate-specific membrane antigen (PSMA) on the surface of prostate cancer (PCa) cells, enabling, respectively, controlled drug release, &quot;stealth&quot; properties for immune evasion, and cell-specific targeting. Fine-tuning of NP size and drug release kinetics was further accomplished by controlling the copolymer composition. By using distinct ratios of PLGA-b-PEG-b-Apt triblock copolymer with PLGA-b-PEG diblock copolymer lacking the A10 Apt, we developed a series of targeted NPs with increasing Apt densities that inversely affected the amount of PEG exposure on NP surface and identified the narrow range of Apt density when the NPs were maximally targeted and maximally stealth, resulting in most efficient PCa cell uptake in vitro and in vivo. This approach may contribute to further development of targeted NPs as highly selective and effective therapeutic modalities.</abstract><notes>Gu, Frank&#xD;Zhang, Liangfang&#xD;Teply, Benjamin A&#xD;Mann, Nina&#xD;Wang, Andrew&#xD;Radovic-Moreno, Aleksandar F&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/United States NCI&#xD;EB003647/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2586-91. Epub 2008 Feb 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18272481</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0711714105 [pii]&#xD;10.1073/pnas.0711714105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>248</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">248</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Horvath, S.</author><author>Zhang, B.</author><author>Carlson, M.</author><author>Lu, K. V.</author><author>Zhu, S.</author><author>Felciano, R. M.</author><author>Laurance, M. F.</author><author>Zhao, W.</author><author>Qi, S.</author><author>Chen, Z.</author><author>Lee, Y.</author><author>Scheck, A. C.</author><author>Liau, L. M.</author><author>Wu, H.</author><author>Geschwind, D. H.</author><author>Febbo, P. G.</author><author>Kornblum, H. I.</author><author>Cloughesy, T. F.</author><author>Nelson, S. F.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Department of Human Genetics, University of California, Los Angeles, CA 90095, USA. shorvath@mednet.ucla.edu</auth-address><titles><title>Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>17402-7</pages><volume>103,</volume><number>46</number><edition>Nov 9, 2006.</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/genetics</keyword><keyword>Cells, Cultured</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Glioblastoma/*genetics</keyword><keyword>Hu Paraneoplastic Encephalomyelitis Antigens/genetics</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Nerve Tissue Proteins/*genetics</keyword><keyword>Oncogene Proteins/*genetics</keyword><keyword>RNA Interference</keyword><keyword>*Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov 14</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17090670</accession-num><abstract>Glioblastoma is the most common primary malignant brain tumor of adults and one of the most lethal of all cancers. Patients with this disease have a median survival of 15 months from the time of diagnosis despite surgery, radiation, and chemotherapy. New treatment approaches are needed. Recent works suggest that glioblastoma patients may benefit from molecularly targeted therapies. Here, we address the compelling need for identification of new molecular targets. Leveraging global gene expression data from two independent sets of clinical tumor samples (n = 55 and n = 65), we identify a gene coexpression module in glioblastoma that is also present in breast cancer and significantly overlaps with the &quot;metasignature&quot; for undifferentiated cancer. Studies in an isogenic model system demonstrate that this module is downstream of the mutant epidermal growth factor receptor, EGFRvIII, and that it can be inhibited by the epidermal growth factor receptor tyrosine kinase inhibitor Erlotinib. We identify ASPM (abnormal spindle-like microcephaly associated) as a key gene within this module and demonstrate its overexpression in glioblastoma relative to normal brain (or body tissues). Finally, we show that ASPM inhibition by siRNA-mediated knockdown inhibits tumor cell proliferation and neural stem cell proliferation, supporting ASPM as a potential molecular target in glioblastoma. Our weighted gene coexpression network analysis provides a blueprint for leveraging genomic data to identify key control networks and molecular targets for glioblastoma, and the principle eluted from our work can be applied to other cancers.</abstract><notes>Horvath, S&#xD;Zhang, B&#xD;Carlson, M&#xD;Lu, K V&#xD;Zhu, S&#xD;Felciano, R M&#xD;Laurance, M F&#xD;Zhao, W&#xD;Qi, S&#xD;Chen, Z&#xD;Lee, Y&#xD;Scheck, A C&#xD;Liau, L M&#xD;Wu, H&#xD;Geschwind, D H&#xD;Febbo, P G&#xD;Kornblum, H I&#xD;Cloughesy, T F&#xD;Nelson, S F&#xD;Mischel, P S&#xD;Ca108633/ca/nci&#xD;Ca119347/ca/nci&#xD;Ns050151/ns/ninds&#xD;Ns43137/ns/ninds&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17402-7. Epub 2006 Nov 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17090670</url></related-urls></urls><custom1>CCNE-Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>9.643</custom4><electronic-resource-num>0608396103 [pii]&#xD;10.1073/pnas.0608396103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>540</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">540</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Keren, S.</author><author>Zavaleta, C.</author><author>Cheng, Z.</author><author>de la Zerda, A.</author><author>Gheysens, O.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Departments of Radiology and Bioengineering, Bio-X Program, Stanford University, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Noninvasive molecular imaging of small living subjects using Raman spectroscopy</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>5844-9</pages><volume>105</volume><number>15</number><edition>2008/04/02</edition><dates><year>2008</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18378895</accession-num><abstract>Molecular imaging of living subjects continues to rapidly evolve with bioluminescence and fluorescence strategies, in particular being frequently used for small-animal models. This article presents noninvasive deep-tissue molecular images in a living subject with the use of Raman spectroscopy. We describe a strategy for small-animal optical imaging based on Raman spectroscopy and Raman nanoparticles. Surface-enhanced Raman scattering nanoparticles and single-wall carbon nanotubes were used to demonstrate whole-body Raman imaging, nanoparticle pharmacokinetics, multiplexing, and in vivo tumor targeting, using an imaging system adapted for small-animal Raman imaging. The imaging modality reported here holds significant potential as a strategy for biomedical imaging of living subjects.</abstract><notes>Keren, S&#xD;Zavaleta, C&#xD;Cheng, Z&#xD;de la Zerda, A&#xD;Gheysens, O&#xD;Gambhir, S S&#xD;5-RO1-EBB000312/United States PHS&#xD;P50 CA114747/CA/United States NCI&#xD;T32 CA09695-15/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5844-9. Epub 2008 Mar 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18378895</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0710575105 [pii]&#xD;10.1073/pnas.0710575105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>319</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">319</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, Evanston, IL 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>14373-8</pages><volume>103</volume><number>39</number><edition>2006/09/20</edition><keywords><keyword>Animals</keyword><keyword>Cations/*metabolism</keyword><keyword>Cell Surface Extensions/*chemistry</keyword><keyword>Cells, Cultured</keyword><keyword>DNA/metabolism</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>*Phase Transition</keyword><keyword>Phosphatidylcholines/chemistry/*metabolism</keyword><keyword>Phosphatidylglycerols/chemistry/metabolism</keyword><keyword>Transfection/*methods</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 26</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16983097</accession-num><abstract>Two cationic phospholipid derivatives with asymmetric hydrocarbon chains were synthesized: ethyl esters of oleoyldecanoyl-ethylphosphatidylcholine (C18:1/C10-EPC) and stearoyldecanoyl-ethylphosphatidylcholine (C18:0/C10-EPC). The former was 50 times more effective as a DNA transfection agent (human umbilical artery endothelial cells) than the latter, despite their similar chemical structure and virtually identical lipoplex organization. A likely reason for the superior effectiveness of C18:1/C10-EPC relative to C18:0/C10-EPC (and to many other cationic lipoids) was suggested by the phases that evolved when these lipoids were mixed with negatively charged membrane lipid formulations. The saturated C18:0/C10-EPC remained lamellar in mixtures with biomembrane-mimicking lipid formulations [e.g., dioleoyl-phosphatidylcholine/dioleoyl-phosphatidylethanolamine/dioleoyl-ph osphatidylserine/cholesterol at 45:20:20:15 (wt/wt)]; in contrast, the unsaturated C18:1/C10-EPC exhibited a lamellar-nonlamellar phase transition in such mixtures, which took place at physiological temperatures, approximately 37 degrees C. As is well known, lipid vehicles exhibit maximum leakiness and contents release in the vicinity of phase transitions, especially those involving nonlamellar phase formation. Moreover, nonlamellar phase-forming compositions are frequently highly fusogenic. Indeed, FRET experiments showed that C18:1/C10-EPC exhibits lipid mixing with negatively charged membranes that is several times more extensive than that of C18:0/C10-EPC. Thus, C18:1/C10-EPC lipoplexes are likely to easily fuse with membranes, and, as a result of lipid mixing, the resultant aggregates should exhibit extensive phase coexistence and heterogeneity, thereby facilitating DNA release and leading to superior transfection efficiency. These results highlight the phase properties of the carrier lipid/cellular lipid mixtures as a decisive factor for transfection success and suggest a strategy for the rational design of superior cationic lipid carriers.</abstract><notes>Koynova, Rumiana&#xD;Wang, Li&#xD;MacDonald, Robert C&#xD;Gm 52329/gm/nigms&#xD;Gm 57305/gm/nigms&#xD;Gm 74429/gm/nigms&#xD;Rr 08630/rr/ncrr&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14373-8. Epub 2006 Sep 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16983097</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>9.643</custom4><electronic-resource-num>0603085103 [pii]&#xD;10.1073/pnas.0603085103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>515</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">515</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Davis, C.</author><author>Cai, W.</author><author>He, L.</author><author>Chen, X.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>1410-5</pages><volume>105</volume><number>5</number><edition>2008/01/31</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/analysis/*pharmacokinetics/*toxicity</keyword><keyword>Blood Circulation</keyword><keyword>Injections, Intravenous</keyword><keyword>Materials Testing</keyword><keyword>Mice</keyword><keyword>Mice, Inbred Strains</keyword><keyword>Nanotubes, Carbon/analysis/*toxicity</keyword><keyword>Polyethylene Glycols/chemistry/pharmacokinetics/toxicity</keyword><keyword>Spectrum Analysis, Raman</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 5</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18230737</accession-num><abstract>Carbon nanotubes are promising new materials for molecular delivery in biological systems. The long-term fate of nanotubes intravenously injected into animals in vivo is currently unknown, an issue critical to potential clinical applications of these materials. Here, using the intrinsic Raman spectroscopic signatures of single-walled carbon nanotubes (SWNTs), we measured the blood circulation of intravenously injected SWNTs and detect SWNTs in various organs and tissues of mice ex vivo over a period of three months. Functionalization of SWNTs by branched polyethylene-glycol (PEG) chains was developed, enabling thus far the longest SWNT blood circulation up to 1 day, relatively low uptake in the reticuloendothelial system (RES), and near-complete clearance from the main organs in approximately 2 months. Raman spectroscopy detected SWNT in the intestine, feces, kidney, and bladder of mice, suggesting excretion and clearance of SWNTs from mice via the biliary and renal pathways. No toxic side effect of SWNTs to mice was observed in necropsy, histology, and blood chemistry measurements. These findings pave the way to future biomedical applications of carbon nanotubes.</abstract><notes>Liu, Zhuang&#xD;Davis, Corrine&#xD;Cai, Weibo&#xD;He, Lina&#xD;Chen, Xiaoyuan&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1410-5. Epub 2008 Jan 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18230737</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0707654105 [pii]&#xD;10.1073/pnas.0707654105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>145</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">145</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Major, J. L.</author><author>Parigi, G.</author><author>Luchinat, C.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA.</auth-address><titles><title>The synthesis and in vitro testing of a zinc-activated MRI contrast agent</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>13881-6</pages><volume>104</volume><number>35</number><edition>2007/08/29</edition><dates><year>2007</year><pub-dates><date>Aug 28</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17724345</accession-num><abstract>Zinc(II) plays a vital role in normal cellular function as an essential component of numerous enzymes, transcription factors, and synaptic vesicles. While zinc can be linked to a variety of physiological processes, the mechanisms of its cellular actions are less discernible. Here, we have synthesized and tested a Zn(II)-activated magnetic resonance imaging (MRI) contrast agent in which the coordination geometry of the complex rearranges upon binding of Zn(II). In the absence of Zn(II) water is restricted from binding to a chelated Gd(III) ion by coordinating acetate arms resulting in a low relaxivity of 2.33 mM(-1) x s(-1) at 60 MHz. Upon addition of Zn(II) the relaxivity of the Gd(III)-Zn(II) complex increases to 5.07 mM(-1) x s(-1) and is consistent with one water molecule bound to Gd(III). These results were confirmed by nuclear magnetic relaxation dispersion analysis. There was no observed change in relaxivity of the Gd(III) complex when physiologically competing cations Ca(II) and Mg(II) were added. A competitive binding assay gave a dissociation constant of 2.38 x 10(-4) M for the Gd(III)-Zn(II) complex. In vitro magnetic resonance images confirm that Zn(II) concentrations as low as 100 microM can be detected by using this contrast agent.</abstract><notes>Major, Jody L&#xD;Parigi, Giacomo&#xD;Luchinat, Claudio&#xD;Meade, Thomas J&#xD;1 r01 eb005866-01/eb/nibib&#xD;5 u54 ca90810/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13881-6. Epub 2007 Aug 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17724345</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>9.643</custom4><electronic-resource-num>0706247104 [pii]&#xD;10.1073/pnas.0706247104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>705</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">705</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Murphy, E. A.</author><author>Majeti, B. K.</author><author>Barnes, L. A.</author><author>Makale, M.</author><author>Weis, S. M.</author><author>Lutu-Fuga, K.</author><author>Wrasidlo, W.</author><author>Cheresh, D. A.</author></authors></contributors><auth-address>Department of Pathology, Moores Cancer Center, University of California at San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA.</auth-address><titles><title>Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>9343-8</pages><volume>105</volume><number>27</number><edition>2008/07/09</edition><keywords><keyword>Angiogenesis Inhibitors/pharmacology</keyword><keyword>Animals</keyword><keyword>Carcinoma, Renal Cell/pathology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Disease Models, Animal</keyword><keyword>Doxorubicin/*administration &amp; dosage/pharmacology/*therapeutic use</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Endothelium/drug effects/pathology</keyword><keyword>Integrin alphaVbeta3/metabolism</keyword><keyword>Kidney Neoplasms/pathology</keyword><keyword>Mice</keyword><keyword>*Nanoparticles</keyword><keyword>Neoplasm Metastasis/*drug therapy</keyword><keyword>Neoplasms/*blood supply/*pathology</keyword><keyword>Neovascularization, Pathologic/pathology</keyword><keyword>Oligopeptides/pharmacology</keyword><keyword>Pancreatic Neoplasms/blood supply/pathology</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 8</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18607000</accession-num><abstract>Integrin alphanubeta3 is found on a subset of tumor blood vessels where it is associated with angiogenesis and malignant tumor growth. We designed an alphanubeta3-targeted nanoparticle (NP) encapsulating the cytotoxic drug doxorubicin (Dox) for targeted drug delivery to the alphanubeta3-expressing tumor vasculature. We observed real-time targeting of this NP to tumor vessels and noted selective apoptosis in regions of the alphanubeta3-expressing tumor vasculature. In clinically relevant pancreatic and renal cell orthotopic models of spontaneous metastasis, targeted delivery of Dox produced an antimetastatic effect. In fact, alphanubeta3-mediated delivery of this drug to the tumor vasculature resulted in a 15-fold increase in antimetastatic activity without producing drug-associated weight loss as observed with systemic administration of the free drug. These findings reveal that NP-based delivery of cytotoxic drugs to the alphanubeta3-positive tumor vasculature represents an approach for treating metastatic disease.</abstract><notes>Murphy, Eric A&#xD;Majeti, Bharat K&#xD;Barnes, Leo A&#xD;Makale, Milan&#xD;Weis, Sara M&#xD;Lutu-Fuga, Kimberly&#xD;Wrasidlo, Wolfgang&#xD;Cheresh, David A&#xD;P01-CA078045/CA/United States NCI&#xD;P01-CA104898/CA/United States NCI&#xD;U54-CA119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9343-8. Epub 2008 Jul 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18607000</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0803728105 [pii]&#xD;10.1073/pnas.0803728105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>430</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">430</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pittet, M. J.</author><author>Grimm, J.</author><author>Berger, C. R.</author><author>Tamura, T.</author><author>Wojtkiewicz, G.</author><author>Nahrendorf, M.</author><author>Romero, P.</author><author>Swirski, F. K.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, 185 Cambridge Street, Boston, MA 02114, USA. mpittet@mgh.harvard.edu</auth-address><titles><title>In vivo imaging of T cell delivery to tumors after adoptive transfer therapy</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>12457-61</pages><volume>104</volume><number>30</number><edition>2007/07/21</edition><keywords><keyword>*Adoptive Transfer</keyword><keyword>Animals</keyword><keyword>Antigens/immunology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Movement</keyword><keyword>*Immunotherapy, Adoptive</keyword><keyword>Lymphopenia/immunology/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Neoplasms/*immunology/*pathology/therapy</keyword><keyword>T-Lymphocytes/*cytology/*immunology</keyword><keyword>Tomography Scanners, X-Ray Computed</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 24</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17640914</accession-num><abstract>Adoptive transfer therapy of in vitro-expanded tumor-specific cytolytic T lymphocytes (CTLs) can mediate objective cancer regression in patients. Yet, technical limitations hamper precise monitoring of posttherapy T cell responses. Here we show in a mouse model that fused single photon emission computed tomography and x-ray computed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumor sites. Assessment of CTL localization is rapid, noninvasive, three-dimensional, and can be repeated for longitudinal analyses. We compared the effects of lymphodepletion before adoptive transfer on CTL recruitment and report that combined treatment increased intratumoral delivery of CTLs and improved antitumor efficacy. Because (111)In-oxine is a Food and Drug Administration-approved clinical agent, and human SPECT-CT systems are available, this approach should be clinically translatable, insofar as it may assess the efficacy of immunization procedures in individual patients and lead to development of more effective therapies.</abstract><notes>Pittet, Mikael J&#xD;Grimm, Jan&#xD;Berger, Cedric R&#xD;Tamura, Takahiko&#xD;Wojtkiewicz, Gregory&#xD;Nahrendorf, Matthias&#xD;Romero, Pedro&#xD;Swirski, Filip K&#xD;Weissleder, Ralph&#xD;P50-CA086355/CA/United States NCI&#xD;R24-CA92782/CA/United States NCI&#xD;U54-CA126515-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12457-61. Epub 2007 Jul 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17640914</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>9.643</custom4><electronic-resource-num>0704460104 [pii]&#xD;10.1073/pnas.0704460104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>228</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">228</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pourmand, N.</author><author>Caramuta, S.</author><author>Villablanca, A.</author><author>Mori, S.</author><author>Karhanek, M.</author><author>Wang, S. X.</author><author>Davis, R. W.</author></authors></contributors><auth-address>Stanford Genome Technology Center, Palo Alto, CA 94304, USA. pourmand@stanford.edu</auth-address><titles><title>Branch migration displacement assay with automated heuristic analysis for discrete DNA length measurement using DNA microarrays</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>6146-51</pages><volume>104</volume><number>15</number><edition>2007/03/29</edition><dates><year>2007</year><pub-dates><date>Apr 10</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17389407</accession-num><abstract>The analysis of short tandem repeats (STRs) plays an important role in forensic science, human identification, genetic mapping, and disease diagnostics. Traditional STR analysis utilizes gel- or column-based approaches to analyze DNA repeats. Individual STR alleles are separated and distinguished according to fragment length; thus the assay is generally hampered by its low multiplex capacity. However, use of DNA microarray would employ a simple hybridization and detection for field forensics and biology. Here we demonstrate a rapid, highly sensitive method for STR analysis that utilizes DNA microarray technology. We describe two adaptations to accomplish this: the use of competitive hybridization to remove unpaired ssDNA from an array and the use of neural network classification to automate the analysis. The competitive displacement technique mimics the branch migration process that occurs during DNA recombination. Our technique will facilitate the rapid deduction of identity, length, and number of repeats for the multiple STRs in an unknown DNA sample.</abstract><notes>Pourmand, Nader&#xD;Caramuta, Stefano&#xD;Villablanca, Andrea&#xD;Mori, Silvia&#xD;Karhanek, Miloslav&#xD;Wang, Shan X&#xD;Davis, Ronald W&#xD;P01-hg000205/hg/nhgri&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6146-51. Epub 2007 Mar 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17389407</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>9.643</custom4><electronic-resource-num>0700921104 [pii]&#xD;10.1073/pnas.0700921104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>63</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">63</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Price, N. D.</author><author>Trent, J.</author><author>El-Naggar, A. K.</author><author>Cogdell, D.</author><author>Taylor, E.</author><author>Hunt, K. K.</author><author>Pollock, R. E.</author><author>Hood, L.</author><author>Shmulevich, I.</author><author>Zhang, W.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, WA 98103, USA.</auth-address><titles><title>Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>3414-9</pages><volume>104</volume><number>9</number><edition>2007/03/16</edition><keywords><keyword>Algorithms</keyword><keyword>Blotting, Western</keyword><keyword>Chromosomes, Human, Pair 9/*genetics</keyword><keyword>Computational Biology/methods</keyword><keyword>Diagnosis, Differential</keyword><keyword>Evaluation Studies</keyword><keyword>Gastrointestinal Stromal Tumors/classification/*genetics</keyword><keyword>Genetic Markers/genetics</keyword><keyword>Genomics/methods</keyword><keyword>Guanine Nucleotide Exchange Factors/*genetics</keyword><keyword>Humans</keyword><keyword>Leiomyosarcoma/classification/*genetics</keyword><keyword>Muscle Proteins/*genetics</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Open Reading Frames/*genetics</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 27</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17360660</accession-num><abstract>Gastrointestinal stromal tumor (GIST) has emerged as a clinically distinct type of sarcoma with frequent overexpression and mutation of the c-Kit oncogene and a favorable response to imatinib mesylate [also known as STI571 (Gleevec)] therapy. However, a significant diagnostic challenge remains in the differentiation of GIST from leiomyosarcomas (LMSs). To improve on the diagnostic evaluation and to complement the immunohistochemical evaluation of these tumors, we performed a whole-genome gene expression study on 68 well characterized tumor samples. Using bioinformatic approaches, we devised a two-gene relative expression classifier that distinguishes between GIST and LMS with an accuracy of 99.3% on the microarray samples and an estimated accuracy of 97.8% on future cases. We validated this classifier by using RT-PCR on 20 samples in the microarray study and on an additional 19 independent samples, with 100% accuracy. Thus, our two-gene relative expression classifier is a highly accurate diagnostic method to distinguish between GIST and LMS and has the potential to be rapidly implemented in a clinical setting. The success of this classifier is likely due to two general traits, namely that the classifier is independent of data normalization and that it uses as simple an approach as possible to achieve this independence to avoid overfitting. We expect that the use of simple marker pairs that exhibit these traits will be of significant clinical use in a variety of contexts.</abstract><notes>Price, Nathan D&#xD;Trent, Jonathan&#xD;El-Naggar, Adel K&#xD;Cogdell, David&#xD;Taylor, Ellen&#xD;Hunt, Kelly K&#xD;Pollock, Raphael E&#xD;Hood, Leroy&#xD;Shmulevich, Ilya&#xD;Zhang, Wei&#xD;1k23ca109060-01/ca/nci&#xD;Ca-16672/ca/nci&#xD;P50 gm076547/gm/nigms&#xD;R01 ca098570-01/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3414-9. Epub 2007 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17360660</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>9.643</custom4><electronic-resource-num>0611373104 [pii]&#xD;10.1073/pnas.0611373104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>631</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">631</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shaw, S. Y.</author><author>Westly, E. C.</author><author>Pittet, M. J.</author><author>Subramanian, A.</author><author>Schreiber, S. L.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142, USA.</auth-address><titles><title>Perturbational profiling of nanomaterial biologic activity</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>7387-92</pages><volume>105</volume><number>21</number><edition>2008/05/22</edition><keywords><keyword>Animals</keyword><keyword>Biological Assay</keyword><keyword>Cell Line</keyword><keyword>Cluster Analysis</keyword><keyword>Humans</keyword><keyword>Materials Testing/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Nanoparticles/chemistry/*toxicity</keyword><keyword>Structure-Activity Relationship</keyword></keywords><dates><year>2008</year><pub-dates><date>May 27</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18492802</accession-num><abstract>Our understanding of the biologic effects (including toxicity) of nanomaterials is incomplete. In vivo animal studies remain the gold standard; however, widespread testing remains impractical, and the development of in vitro assays that correlate with in vivo activity has proven challenging. Here, we demonstrate the feasibility of analyzing in vitro nanomaterial activity in a generalizable, systematic fashion. We assessed nanoparticle effects in a multidimensional manner, using multiple cell types and multiple assays that reflect different aspects of cellular physiology. Hierarchical clustering of these data identifies nanomaterials with similar patterns of biologic activity across a broad sampling of cellular contexts, as opposed to extrapolating from results of a single in vitro assay. We show that this approach yields robust and detailed structure-activity relationships. Furthermore, a subset of nanoparticles were tested in mice, and nanoparticles with similar activity profiles in vitro exert similar effects on monocyte number in vivo. These data suggest a strategy of multidimensional characterization of nanomaterials in vitro that can inform the design of novel nanomaterials and guide studies of in vivo activity.</abstract><notes>Shaw, Stanley Y&#xD;Westly, Elizabeth C&#xD;Pittet, Mikael J&#xD;Subramanian, Aravind&#xD;Schreiber, Stuart L&#xD;Weissleder, Ralph&#xD;K08HL077186/HL/United States NHLBI&#xD;N01-CO-12400/CO/United States NCI&#xD;P50CA086355/CA/United States NCI&#xD;U01HL080731/HL/United States NHLBI&#xD;U54CA119349/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 May 27;105(21):7387-92. Epub 2008 May 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18492802</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>9.643</custom4><electronic-resource-num>0802878105 [pii]&#xD;10.1073/pnas.0802878105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">19</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Simberg, D.</author><author>Duza, T.</author><author>Park, J. H.</author><author>Essler, M.</author><author>Pilch, J.</author><author>Zhang, L.</author><author>Derfus, A. M.</author><author>Yang, M.</author><author>Hoffman, R. M.</author><author>Bhatia, S.</author><author>Sailor, M. J.</author><author>Ruoslahti, E.</author></authors></contributors><auth-address>Cancer Research Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</auth-address><titles><title>Biomimetic amplification of nanoparticle homing to tumors</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><pages>932-6</pages><volume>104</volume><number>3</number><edition>2007/01</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Biomimetics/*methods</keyword><keyword>Cell Line, Tumor</keyword><keyword>Liver/drug effects</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>*Nanoparticles/chemistry/diagnostic use</keyword><keyword>Neoplasms/blood supply/*diagnosis</keyword><keyword>Neovascularization, Pathologic</keyword><keyword>Peptides/chemistry/diagnostic use/pharmacology</keyword><keyword>Thrombosis/chemically induced/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 16</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17215365</accession-num><abstract>Nanoparticle-based diagnostics and therapeutics hold great promise because multiple functions can be built into the particles. One such function is an ability to home to specific sites in the body. We describe here biomimetic particles that not only home to tumors, but also amplify their own homing. The system is based on a peptide that recognizes clotted plasma proteins and selectively homes to tumors, where it binds to vessel walls and tumor stroma. Iron oxide nanoparticles and liposomes coated with this tumor-homing peptide accumulate in tumor vessels, where they induce additional local clotting, thereby producing new binding sites for more particles. The system mimics platelets, which also circulate freely but accumulate at a diseased site and amplify their own accumulation at that site. The self-amplifying homing is a novel function for nanoparticles. The clotting-based amplification greatly enhances tumor imaging, and the addition of a drug carrier function to the particles is envisioned.</abstract><notes>Ca 099258/ca/nci&#xD;Ca 119335/ca/nci&#xD;N01 co 37117/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17215365 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2007</custom3><custom4>9.643</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>48</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">48</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>True, L.</author><author>Coleman, I.</author><author>Hawley, S.</author><author>Huang, C. Y.</author><author>Gifford, D.</author><author>Coleman, R.</author><author>Beer, T. M.</author><author>Gelmann, E.</author><author>Datta, M.</author><author>Mostaghel, E.</author><author>Knudsen, B.</author><author>Lange, P.</author><author>Vessella, R.</author><author>Lin, D.</author><author>Hood, L.</author><author>Nelson, P. S.</author></authors></contributors><auth-address>Department of Pathology, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>A molecular correlate to the Gleason grading system for prostate adenocarcinoma</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>10991-6</pages><volume>103</volume><number>29</number><edition>2006/07/11</edition><keywords><keyword>Adenocarcinoma/classification/*genetics/metabolism/*pathology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Male</keyword><keyword>Neoplasm Staging</keyword><keyword>Prostatic Neoplasms/classification/*genetics/metabolism/*pathology</keyword><keyword>Tumor Markers, Biological/*genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 18</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16829574</accession-num><abstract>Adenocarcinomas of the prostate can be categorized into tumor grades based on the extent to which the cancers histologically resemble normal prostate glands. Because grades are surrogates of intrinsic tumor behavior, characterizing the molecular phenotype of grade is of potential clinical importance. To identify molecular alterations underlying prostate cancer grades, we used microdissection to obtain specific cohorts of cancer cells corresponding to the most common Gleason patterns (patterns 3, 4, and 5) from 29 radical prostatectomy samples. We paired each cancer sample with matched benign lumenal prostate epithelial cells and profiled transcript abundance levels by microarray analysis. We identified an 86-gene model capable of distinguishing low-grade (pattern 3) from high-grade (patterns 4 and 5) cancers. This model performed with 76% accuracy when applied to an independent set of 30 primary prostate carcinomas. Using tissue microarrays comprising &gt;800 prostate samples, we confirmed a significant association between high levels of monoamine oxidase A expression and poorly differentiated cancers by immunohistochemistry. We also confirmed grade-associated levels of defender against death (DAD1) protein and HSD17 beta4 transcripts by immunohistochemistry and quantitative RT-PCR, respectively. The altered expression of these genes provides functional insights into grade-associated features of therapy resistance and tissue invasion. Furthermore, in identifying a profile of 86 genes that distinguish high- from low-grade carcinomas, we have generated a set of potential targets for modulating the development and progression of the lethal prostate cancer phenotype.</abstract><notes>True, Lawrence&#xD;Coleman, Ilsa&#xD;Hawley, Sarah&#xD;Huang, Ching-Ying&#xD;Gifford, David&#xD;Coleman, Roger&#xD;Beer, Tomasz M&#xD;Gelmann, Edward&#xD;Datta, Milton&#xD;Mostaghel, Elahe&#xD;Knudsen, Beatrice&#xD;Lange, Paul&#xD;Vessella, Robert&#xD;Lin, Daniel&#xD;Hood, Leroy&#xD;Nelson, Peter S&#xD;Dk65204/dk/niddk&#xD;P01ca85859/ca/nci&#xD;P50ca97186/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10991-6. Epub 2006 Jul 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16829574</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>9.643</custom4><electronic-resource-num>0603678103 [pii]&#xD;10.1073/pnas.0603678103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>263</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">263</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, S.</author><author>Garcia, A. J.</author><author>Wu, M.</author><author>Lawson, D. A.</author><author>Witte, O. N.</author><author>Wu, H.</author></authors></contributors><auth-address>Departments of Molecular and Medical Pharmacology and Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California-Los Angeles, 650 Charles E. Young Drive South, Los Angeles, CA 90095, USA.</auth-address><titles><title>Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><pages>1480-5</pages><volume>103</volume><number>5</number><edition>2006/01/25</edition><keywords><keyword>Animals</keyword><keyword>Bromodeoxyuridine/pharmacology</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Separation</keyword><keyword>DNA-Binding Proteins</keyword><keyword>Disease Models, Animal</keyword><keyword>Disease Progression</keyword><keyword>Flow Cytometry</keyword><keyword>Gene Deletion</keyword><keyword>Genes, Tumor Suppressor</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Ki-67 Antigen/biosynthesis</keyword><keyword>Kinetics</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neoplasms/metabolism</keyword><keyword>PTEN Phosphohydrolase/metabolism/*physiology</keyword><keyword>Phosphoproteins/metabolism</keyword><keyword>Prostatic Neoplasms/*genetics/pathology</keyword><keyword>Stem Cells/*cytology</keyword><keyword>Time Factors</keyword><keyword>Trans-Activators/metabolism</keyword><keyword>Tumor Suppressor Proteins</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 31</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16432235</accession-num><abstract>PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a potent tumor suppressor gene frequently mutated in human prostate cancers. Deletion of Pten in a murine model of prostate cancer recapitulates the disease progression seen in humans. Using defined cell lineage markers, we demonstrate that PTEN negatively regulates p63-positive prostatic basal cell proliferation without blocking differentiation. Concomitant with basal cell proliferation is the expansion of a prostate stem/progenitor-like subpopulation as evidenced by the progressive increase of stem cell antigen-1 (Sca-1)- and BCL-2-positive cells. This observation provides strong evidence that basal cell proliferation can be an initiating event for precancerous lesions. Sca-1(+) and BCL-2(+) progenitors may serve as cancer-initiating cells in this model.</abstract><notes>Wang, Shunyou&#xD;Garcia, Alejandro J&#xD;Wu, Michelle&#xD;Lawson, Devon A&#xD;Witte, Owen N&#xD;Wu, Hong&#xD;P50 ca 092131/ca/nci&#xD;P50 ca 86306/ca/nci&#xD;R01 ca 107166/ca/nci&#xD;R01 ca 107166-01s1/ca/nci&#xD;T32 ca 09056/ca/nci&#xD;U01 ca 84128/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1480-5. Epub 2006 Jan 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16432235</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>9.643</custom4><electronic-resource-num>0510652103 [pii]&#xD;10.1073/pnas.0510652103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>120</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">120</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hsieh, C. L.</author><author>Xie, Z.</author><author>Yu, J.</author><author>Martin, W. D.</author><author>Datta, M. W.</author><author>Wu, G. J.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutic Program, Department of Urology, Emory University School of Medicine, Atlanta, Georgia 30322, USA. chsieh2@emory.edu</auth-address><titles><title>Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model</title><secondary-title>Prostate</secondary-title></titles><pages>685-91</pages><volume>67</volume><number>7</number><edition>2007/03/08</edition><keywords><keyword>Animals</keyword><keyword>Antigens, Viral, Tumor/genetics/metabolism</keyword><keyword>Bone Neoplasms/diagnosis/genetics/secondary</keyword><keyword>Disease Models, Animal</keyword><keyword>Disease Progression</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Luciferases/genetics/*metabolism</keyword><keyword>Luminescent Proteins/genetics/*metabolism</keyword><keyword>Lymphatic Metastasis/diagnosis/genetics/pathology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Neoplasm Metastasis/diagnosis/genetics/*pathology</keyword><keyword>Prostate-Specific Antigen/genetics/metabolism</keyword><keyword>Prostatic Neoplasms/genetics/*metabolism/pathology</keyword><keyword>Receptors, Androgen/genetics/*metabolism</keyword><keyword>Receptors, Tumor Necrosis Factor, Member 25/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0270-4137 (Print)</isbn><accession-num>17342752</accession-num><abstract>BACKGROUND: We previously established a bioluminescent transgenic mouse model, sPSA-Luc, with luciferase gene expression restricted to the prostate under the control of the supra prostate-specific antigen (sPSA) promoter. We now assess the feasibility of generating bigenic mice, TRAMP-Luc, with the sPSA-Luc as the founder strain crossbred with TRAMP (transgenic adenocarcinoma mouse prostate) mice, to evaluate non-invasively the metastatic potential of prostate tumors. METHODS: TRAMP-Luc mice were obtained as [C57BL/6 TRAMP x FVB sPSA-Luc] F1 offspring. Tumor development in 10 TRAMP-Luc males was followed by bioluminescence imaging from 8 to 24 weeks of age. Immunohistochemical (IHC) staining for T antigen (Tg), androgen receptor (AR), luciferase and/or pathological analysis verified the tumor distribution in the imaged tissues including prostate gland, lymph node and bone. RESULTS: Group I animals that presented with no grossly visible tumors showed prostate-confined bioluminescence with slightly increased signal intensity with age. Group II animals that developed large tumors displayed a widely distributed and biphasic bioluminescence pattern. The peak was reached between 10 and 14 weeks of age, then markedly decreased or even disappeared beyond week 16, except for one mouse that showed an increased bioluminescence signal at the jaw bone and hind limbs at week 22. These tumors were shown by IHC to contain Tg but lost AR and luciferase beyond week 16 in poorly differentiated prostate tumors. CONCLUSION: A direct correlation between bioluminescence emission and AR expression was found in TRAMP-Luc tumor progression model. This model allows non-invasive imaging of prostate cancer metastases to bone and soft tissues.</abstract><notes>Hsieh, Chia-Ling&#xD;Xie, Zhihui&#xD;Yu, Jie&#xD;Martin, W David&#xD;Datta, Milton W&#xD;Wu, Guang-Jer&#xD;Chung, Leland W K&#xD;1p01ca098912-01/ca/nci&#xD;1u54ca119338/ca/nci&#xD;5p20gm072069/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The Prostate&#xD;Prostate. 2007 May 15;67(7):685-91.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17342752</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.724</custom4><electronic-resource-num>10.1002/pros.20510</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>47</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">47</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, W.</author><author>Zhou, D.</author><author>Glusman, G.</author><author>Utleg, A. G.</author><author>White, J. T.</author><author>Nelson, P. S.</author><author>Vasicek, T. J.</author><author>Hood, L.</author><author>Lin, B.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells</title><secondary-title>Prostate</secondary-title></titles><pages>936-44</pages><volume>66</volume><number>9</number><edition>2006/03/17</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Androgens/*physiology</keyword><keyword>Blotting, Northern</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chromosomes, Human, Pair 19/genetics</keyword><keyword>Cloning, Organism</keyword><keyword>DNA/analysis/genetics</keyword><keyword>DNA, Complementary/genetics</keyword><keyword>DNA, Neoplasm/analysis/genetics</keyword><keyword>Exons/genetics</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Kidney/chemistry</keyword><keyword>Male</keyword><keyword>Molecular Sequence Data</keyword><keyword>Multigene Family</keyword><keyword>Prostate/*chemistry/physiology</keyword><keyword>Prostatic Neoplasms/*chemistry/genetics/physiopathology</keyword><keyword>*Pseudogenes</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Tissue Kallikreins/*analysis/*genetics/physiology</keyword><keyword>Transcription, Genetic</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0270-4137 (Print)</isbn><accession-num>16541416</accession-num><abstract>BACKGROUND: Fifteen human tissue kallikrein (KLK) genes have been identified as a cluster on chromosome 19. KLK expression is associated with various human diseases including cancers. Noncoding RNAs such as PCA3/DD3 and PCGEM1 have been identified in prostate cancer cells. METHODS: Using massively parallel signature sequencing (MPSS) technology, RT-PCR, and 5&apos; rapid amplification of cDNA ends (RACE), we identified and cloned a novel gene that maps to the KLK locus. RESULTS: We have characterized this gene, named as KLK31P by the HUGO Gene Nomenclature Committee, as an unprocessed KLK pseudogene. It contains five exons, two of which are KLK-derived while the rest are &quot;exonized&quot; interspersed repeats. KLK31P is expressed abundantly in prostate tissues and is androgen regulated. KLK31P is expressed at lower levels in localized and metastatic prostate cancer cells than in normal prostate cells. CONCLUSIONS: KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that may play a role in prostate carcinogenesis or maintenance.</abstract><notes>Lu, Wei&#xD;Zhou, Daixing&#xD;Glusman, Gustavo&#xD;Utleg, Angelita G&#xD;White, James T&#xD;Nelson, Peter S&#xD;Vasicek, Thomas J&#xD;Hood, Leroy&#xD;Lin, Biaoyang&#xD;5p01ca085859-02/ca/nci&#xD;5p50ca097186-02/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Prostate&#xD;Prostate. 2006 Jun 15;66(9):936-44.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16541416</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>3.724</custom4><electronic-resource-num>10.1002/pros.20382</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>224</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">224</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Loening, A. M.</author><author>Fenn, T. D.</author><author>Wu, A. M.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>The CRUMP Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.</auth-address><titles><title>Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output</title><secondary-title>Protein Eng Des Sel</secondary-title></titles><pages>391-400</pages><volume>19</volume><number>9</number><edition>2006/07/22</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>DNA Mutational Analysis</keyword><keyword>Luciferases, Renilla/*biosynthesis/blood/genetics</keyword><keyword>*Luminescence</keyword><keyword>Models, Genetic</keyword><keyword>*Models, Molecular</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Molecular Sequence Data</keyword><keyword>Recombinant Proteins/*biosynthesis/blood/genetics</keyword><keyword>Renilla/*enzymology/genetics</keyword><keyword>Sequence Alignment</keyword><keyword>Sequence Analysis, DNA</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1741-0126 (Print)</isbn><accession-num>16857694</accession-num><abstract>Luciferases, which have seen expansive employment as reporter genes in biological research, could also be used in applications where the protein itself is conjugated to ligands to create probes that are appropriate for use in small animal imaging. As the bioluminescence activity of commonly used luciferases is too labile in serum to permit this application, specific mutations of Renilla luciferase, selected using a consensus sequence driven strategy, were screened for their ability to confer stability of activity in serum as well as their light output. Using this information, a total of eight favorable mutations were combined to generate a mutant Renilla luciferase (RLuc8) that, compared with the parental enzyme, is 200-fold more resistant to inactivation in murine serum and exhibits a 4-fold improvement in light output. Results of the mutational analysis were also used to generate a double mutant optimized for use as a reporter gene. The double mutant had half the resistance to inactivation in serum of the native enzyme while yielding a 5-fold improvement in light output. These variants of Renilla luciferase, which exhibit significantly improved properties compared with the native enzyme, will allow enhanced sensitivity in existing luciferase-based assays as well as enable the development of novel probes labeled with the luciferase protein.</abstract><notes>Loening, Andreas Markus&#xD;Fenn, Timothy David&#xD;Wu, Anna M&#xD;Gambhir, Sanjiv Sam&#xD;5 r01 ca082214-06/ca/nci&#xD;P50 ca114747/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Protein engineering, design &amp; selection : PEDS&#xD;Protein Eng Des Sel. 2006 Sep;19(9):391-400. Epub 2006 Jul 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16857694</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>3</custom4><electronic-resource-num>gzl023 [pii]&#xD;10.1093/protein/gzl023</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>210</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Flory, M. R.</author><author>Lee, H.</author><author>Bonneau, R.</author><author>Mallick, P.</author><author>Serikawa, K.</author><author>Morris, D. R.</author><author>Aebersold, R.</author></authors></contributors><auth-address>Department of Molecular Biology and Biochemistry, Wesleyan University, Middletown, CT 06459, USA. mflory@wesleyan.edu</auth-address><titles><title>Quantitative proteomic analysis of the budding yeast cell cycle using acid-cleavable isotope-coded affinity tag reagents</title><secondary-title>Proteomics</secondary-title></titles><pages>6146-57</pages><volume>6</volume><number>23</number><edition>2006/11/30</edition><keywords><keyword>Carbon Isotopes</keyword><keyword>Cell Cycle/*physiology</keyword><keyword>Genes, Fungal/genetics</keyword><keyword>Isotope Labeling/*methods</keyword><keyword>Proteomics/*methods</keyword><keyword>Saccharomyces cerevisiae/*cytology</keyword><keyword>Saccharomyces cerevisiae Proteins/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1615-9853 (Print)</isbn><accession-num>17133367</accession-num><abstract>Quantitative profiling of proteins, the direct effectors of nearly all biological functions, will undoubtedly complement technologies for the measurement of mRNA. Systematic proteomic measurement of the cell cycle is now possible by using stable isotopic labeling with isotope-coded affinity tag reagents and software tools for high-throughput analysis of LC-MS/MS data. We provide here the first such study achieving quantitative, global proteomic measurement of a time-course gene expression experiment in a model eukaryote, the budding yeast Saccharomyces cerevisiae, during the cell cycle. We sampled 48% of all predicted ORFs, and provide the data, including identifications, quantitations, and statistical measures of certainty, to the community in a sortable matrix. We do not detect significant concordance in the dynamics of the system over the time-course tested between our proteomic measurements and microarray measures collected from similarly treated yeast cultures. Our proteomic dataset therefore provides a necessary and complementary measure of eukaryotic gene expression, establishes a rich database for the functional analysis of S. cerevisiae proteins, and will enable further development of technologies for global proteomic analysis of higher eukaryotes.</abstract><notes>Flory, Mark R&#xD;Lee, Hookeun&#xD;Bonneau, Richard&#xD;Mallick, Parag&#xD;Serikawa, Kyle&#xD;Morris, David R&#xD;Aebersold, Ruedi&#xD;1r33-ca-93302/ca/nci&#xD;N01-hv-28179/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Proteomics&#xD;Proteomics. 2006 Dec;6(23):6146-57.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17133367</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.735</custom4><electronic-resource-num>10.1002/pmic.200600159</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>611</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">611</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, R.</author><author>Guo, Y.</author><author>Han, B.M.</author><author>Yan, X.</author><author>Utleg, A.G.</author><author>Li, W.</author><author>Tu, L.C.</author><author>Wang, J.</author><author>Hood, L.</author><author>Xia, S.</author><author>Lin, B.</author></authors></contributors><auth-address>Shanghai Institute of Planned Parenthood Research, Shanghai, China; Systems Biomedicine Center, Shanghai Jiaotong University, Shanghai, China; Department of Urology, Shanghai 1st People&apos;s Hospital, Shanghai, China; The Institute for Systems Biology, Seattle, WA, USA</auth-address><titles><title>Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates</title><secondary-title>PROTEOMICS - CLINICAL APPLICATIONS</secondary-title></titles><pages>543-555</pages><volume>2</volume><number>4</number><edition>2008/03/7</edition><keywords><keyword>Biomarker</keyword><keyword>Expressed prostatic secretions</keyword><keyword>Mass spectrometry</keyword><keyword>Prostate cancer</keyword></keywords><dates><year>2008</year></dates><isbn>1862-8354</isbn><abstract>Expressed prostatic secretions (EPS) contain proteins of prostate origin that may reflect the health status of the prostate and be used as diagnostic markers for prostate diseases including prostatitis, benign prostatic hyperplasia, and prostate cancer. Despite their importance and potential applications, a complete catalog of EPS proteins is not yet available. We, therefore, undertook a comprehensive analysis of the EPS proteome using 2-D micro-LC combined with MS/MS. Using stringent filtering criteria, we identified a list of 114 proteins with at least two unique-peptide hits and an additional 75 proteins with only a single unique-peptide hit. The proteins identified include kallikrein 2 (KLK2), KLK3 (prostate-specific antigen), KLK11, and nine cluster of differentiation (CD) molecules including CD10, CD13, CD14, CD26, CD66a, CD66c, CD 143, CD177, and CD224. To our knowledge, this list represents the first comprehensive characterization of the EPS proteome, and it provides a candidate biomarker list for targeted quantitative proteomics analysis using a multiple reaction monitoring (MRM) approach. To help prioritize candidate biomarkers, we constructed a protein-protein interaction network of the EPS proteins using Cytoscape (www.cytoscape.org), and overlaid the expression level changes from the Oncomine database onto the network.</abstract><notes>10.1002/prca.200780159</notes><urls><related-urls><url>http://dx.doi.org/10.1002/prca.200780159</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1002/prca.200780159 </electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>707</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">707</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schreiber, E. C.</author><author>Chang, S. X. </author></authors></contributors><titles><title>Monte Carlo simulation of x-ray pixel beam array micro-RT dosimetry</title><secondary-title>Radiation Research</secondary-title></titles><periodical><full-title>Radiation Research</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - UNC</custom1><custom4>2.599</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>386</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">386</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fatouros, P. P.</author><author>Corwin, F. D.</author><author>Chen, Z. J.</author><author>Broaddus, W. C.</author><author>Tatum, J. L.</author><author>Kettenmann, B.</author><author>Ge, Z.</author><author>Gibson, H. W.</author><author>Russ, J. L.</author><author>Leonard, A. P.</author><author>Duchamp, J. C.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Department of Radiology, Virginia Commonwealth University, Sanger Hall, B3-021, 1101 E Marshall St, PO Box 980072, Richmond, VA 23298-0072, USA. ppfatouros@vcu.edu</auth-address><titles><title>In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle</title><secondary-title>Radiology</secondary-title><alt-title>Radiology</alt-title></titles><periodical><full-title>Radiology</full-title></periodical><alt-periodical><full-title>Radiology</full-title></alt-periodical><pages>756-64</pages><volume>240</volume><number>3</number><edition>2006/09</edition><keywords><keyword>Animals</keyword><keyword>Brain/*anatomy &amp; histology</keyword><keyword>Female</keyword><keyword>Fullerenes/*diagnostic use</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>*Nanostructures</keyword><keyword>Rats</keyword><keyword>Rats, Inbred F344</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0033-8419 (Print)</isbn><accession-num>16837672</accession-num><abstract>PURPOSE: To evaluate the effectiveness of a functionalized trimetallic nitride endohedral metallofullerene nanoparticle as a magnetic resonance (MR) imaging proton relaxation agent and to follow its distribution for in vitro agarose gel infusions and in vivo infusions in rat brain. MATERIALS AND METHODS: The animal study was approved by the animal care and use committee. Gd(3)N@C(80) was functionalized with poly(ethylene glycol) units, and the carbon cage was hydroxylated to provide improved water solubility and biodistribution. Relaxation rate measurements (R1 = 1/T1 and R2 = 1/T2) of water solutions of this contrast agent were conducted at 0.35-, 2.4-, and 9.4-T MR imaging. Images of contrast agent distributions were produced following infusions in six agarose gel samples at 2.4 T and from direct brain infusions into normal and tumor-bearing rat brain at 2.4 T. The relaxivity of a control functionalized lutetium agent, Lu(3)N@C(80), was also determined. RESULTS: Water hydrogen MR imaging relaxivity (r1) for this metallofullerene nanoparticle was markedly higher than that for commercial agents (eg, gadodiamide); r1 values of 102, 143, and 32 L . mmol(-1) . sec(-1) were measured at 0.35, 2.4, and 9.4 T, respectively. In studies of in vitro agarose gel infusion, the use of functionalized Gd(3)N@C(80) at concentrations an order of magnitude lower resulted in equivalent visualization in comparison with commercial agents. Comparable contrast enhancement was obtained with direct infusions of 0.013 mmol/L of Gd(3)N@C(80) and 0.50 mmol/L of gadodiamide in live normal rat brain. Elapsed-time studies demonstrated lower diffusion rates for Gd(3)N@C(80) relative to gadodiamide in live normal rat brain tissue. Functionalized metallofullerenes directly infused into a tumor-bearing brain provided an improved tumor delineation in comparison with the intravenously injected conventional Gd(3+) chelate. A control lutetium functionalized Lu(3)N@C(80) nanoparticle exhibited very low MR imaging relaxivity. CONCLUSION: The new functionalized trimetallic nitride endohedral metallofullerene species Gd(3)N@C(80)[DiPEG5000(OH)(x)] is an effective proton relaxation agent, as demonstrated with in vitro relaxivity and MR imaging studies, in infusion experiments with agarose gel and in vivo rat brain studies simulating clinical conditions of direct intraparenchymal drug delivery for the treatment of brain tumors.</abstract><notes>R01 ca119371-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16837672 </url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2006</custom3><custom4>5.251</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>711</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">711</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gupta, T.</author><author>Virmani, S.</author><author>Neidt, T.M.</author><author>Szolc-Kowalska, B.</author><author>Woloschak, G.E.</author><author>Ryu, R.K.</author><author>Sato, K.T.</author><author>Gates, V.</author><author>Lewandowski, R.J.</author><author>Salem, R.</author><author>Omary, R.A.</author><author>Larson, A.C</author></authors></contributors><titles><title>MRI Tracking of Iron-labeled Glass Radioembolization Microspheres During Transcatheter Intra-arterial Delivery to Liver Tumors in VX2 Rabbits</title><secondary-title>Radiology</secondary-title></titles><periodical><full-title>Radiology</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.561</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>474</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">474</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, D.</author><author>Bangash, A. K.</author><author>Rhee, T. K.</author><author>Woloschak, G. E.</author><author>Paunesku, T.</author><author>Salem, R.</author><author>Omary, R. A.</author><author>Larson, A. C.</author></authors></contributors><auth-address>Department of Radiology, Feinberg School of Medicine, and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 448 E Ontario St, Suite 700, Chicago, IL 60611, USA.</auth-address><titles><title>Liver tumors: monitoring embolization in rabbits with VX2 tumors--transcatheter intraarterial first-pass perfusion MR imaging</title><secondary-title>Radiology</secondary-title></titles><periodical><full-title>Radiology</full-title></periodical><pages>130-9</pages><volume>245</volume><number>1</number><edition>2007/09/22</edition><keywords><keyword>Angiography, Digital Subtraction</keyword><keyword>Animals</keyword><keyword>*Embolization, Therapeutic</keyword><keyword>Liver Neoplasms, Experimental/*therapy</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0033-8419 (Print)</isbn><accession-num>17885186</accession-num><abstract>PURPOSE: To prospectively test the hypothesis that transcatheter intraarterial first-pass perfusion (TRIP) magnetic resonance (MR) imaging can depict serial reductions in rabbit liver tumor perfusion during transcatheter arterial embolization (TAE). MATERIALS AND METHODS: All experiments had institutional animal care and use committee approval. In four rabbits implanted with eight VX2 liver tumors, catheters were positioned in the hepatic arteries with conventional angiographic guidance. After transfer to the MR imaging suite, serial TAE was performed, with approximately 0.5 million 40-120-microm embolic particles injected at each embolic stage. TRIP MR imaging was performed at baseline and after each subsequent embolic stage (10 minutes between stages). Serial TAE and TRIP MR imaging were repeated until stasis. The first-pass time course of signal enhancement was measured in both tumors and hepatic arteries. Tumor area under the curve (AUC) and maximum upslope (MUS) values, each normalized by arterial input, were measured to assess iterative perfusion reduction. Perfusion measurements across TAE stages were compared with paired t tests and linear regression. RESULTS: AUC decreased from a pre-TAE baseline of 0.408 (95% confidence interval [CI]: 0.330, 0.486) to 0.065 (95% CI: 0.046, 0.085) (P&lt;.001) after TAE. MUS decreased from a pre-TAE baseline of 0.151 (95% CI: 0.121, 0.181) to 0.027 (95% CI: 0.022, 0.031) (P&lt;.001) after TAE. Reductions to AUC and MUS after each embolic stage were statistically significant (P&lt;.006 for each group of paired comparisons). AUC strongly correlated with MUS (r=0.966, P&lt;.001). CONCLUSION: TRIP MR imaging can depict serial reductions in liver tumor perfusion during TAE. TRIP MR imaging offers the potential to target functional embolic end points during TAE.</abstract><notes>Wang, Dingxin&#xD;Bangash, Affaan K&#xD;Rhee, Thomas K&#xD;Woloschak, Gayle E&#xD;Paunesku, Tatjana&#xD;Salem, Riad&#xD;Omary, Reed A&#xD;Larson, Andrew C&#xD;United States&#xD;Radiology&#xD;Radiology. 2007 Oct;245(1):130-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17885186</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.251</custom4><electronic-resource-num>245/1/130 [pii]&#xD;10.1148/radiol.2451061689</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>244</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">244</key></foreign-keys><ref-type name="Government Document">46</ref-type><contributors><authors><author>Lee, C. C.</author><author>Sui, G.</author><author>Elizarov, A.</author><author>Shu, C. J.</author><author>Shin, Y. S.</author><author>Dooley, A. N.</author><author>Huang, J.</author><author>Daridon, A.</author><author>Wyatt, P.</author><author>Stout, D.</author><author>Kolb, H. C.</author><author>Witte, O. N.</author><author>Satyamurthy, N.</author><author>Heath, J. R.</author><author>Phelps, M. E.</author><author>Quake, S. R.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Department of Bioengineering, California Institute of Technology, Pasadena, CA 91125, USA.</auth-address><titles><title>Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics</title><secondary-title>Science</secondary-title></titles><pages>1793-6</pages><volume>310</volume><number>5755</number><edition>2005/12/17</edition><keywords><keyword>Animals</keyword><keyword>Automation</keyword><keyword>Fluorides</keyword><keyword>Fluorodeoxyglucose F18/*chemical synthesis</keyword><keyword>Gas Chromatography-Mass Spectrometry</keyword><keyword>Mice</keyword><keyword>*Microfluidics</keyword><keyword>Miniaturization</keyword><keyword>Molecular Probes/*chemical synthesis</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/*chemical synthesis</keyword><keyword>Rhabdomyosarcoma/radionuclide imaging</keyword><keyword>Solvents</keyword><keyword>Tomography, Emission-Computed</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec 16</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16357255</accession-num><abstract>Microreactor technology has shown potential for optimizing synthetic efficiency, particularly in preparing sensitive compounds. We achieved the synthesis of an [(18)F]fluoride-radiolabeled molecular imaging probe, 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG), in an integrated microfluidic device. Five sequential processes-[18F]fluoride concentration, water evaporation, radiofluorination, solvent exchange, and hydrolytic deprotection-proceeded with high radio-chemical yield and purity and with shorter synthesis time relative to conventional automated synthesis. Multiple doses of [18F]FDG for positron emission tomography imaging studies in mice were prepared. These results, which constitute a proof of principle for automated multistep syntheses at the nanogram to microgram scale, could be generalized to a range of radiolabeled substrates.</abstract><notes>Lee, Chung-Cheng&#xD;Sui, Guodong&#xD;Elizarov, Arkadij&#xD;Shu, Chengyi Jenny&#xD;Shin, Young-Shik&#xD;Dooley, Alek N&#xD;Huang, Jiang&#xD;Daridon, Antoine&#xD;Wyatt, Paul&#xD;Stout, David&#xD;Kolb, Hartmuth C&#xD;Witte, Owen N&#xD;Satyamurthy, Nagichettiar&#xD;Heath, James R&#xD;Phelps, Michael E&#xD;Quake, Stephen R&#xD;Tseng, Hsian-Rong&#xD;5t32-gm07616/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2005 Dec 16;310(5755):1793-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16357255</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>30.03</custom4><electronic-resource-num>310/5755/1793 [pii]&#xD;10.1126/science.1118919</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>127</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">127</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rosi, N. L.</author><author>Giljohann, D. A.</author><author>Thaxton, C. S.</author><author>Lytton-Jean, A. K.</author><author>Han, M. S.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113 USA.</auth-address><titles><title>Oligonucleotide-modified gold nanoparticles for intracellular gene regulation</title><secondary-title>Science</secondary-title></titles><pages>1027-30</pages><volume>312</volume><number>5776</number><edition>2006/05/20</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Deoxyribonucleases/metabolism</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Glutathione/metabolism</keyword><keyword>*Gold</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>*Nanostructures</keyword><keyword>*Oligodeoxyribonucleotides, Antisense/metabolism</keyword><keyword>RNA, Messenger</keyword></keywords><dates><year>2006</year><pub-dates><date>May 19</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16709779</accession-num><abstract>We describe the use of gold nanoparticle-oligonucleotide complexes as intracellular gene regulation agents for the control of protein expression in cells. These oligonucleotide-modified nanoparticles have affinity constants for complementary nucleic acids that are higher than their unmodified oligonucleotide counterparts, are less susceptible to degradation by nuclease activity, exhibit greater than 99% cellular uptake, can introduce oligonucleotides at a higher effective concentration than conventional transfection agents, and are nontoxic to the cells under the conditions studied. By chemically tailoring the density of DNA bound to the surface of gold nanoparticles, we demonstrated a tunable gene knockdown.</abstract><notes>Rosi, Nathaniel L&#xD;Giljohann, David A&#xD;Thaxton, C Shad&#xD;Lytton-Jean, Abigail K R&#xD;Han, Min Su&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2006 May 19;312(5776):1027-30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16709779</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>30.03</custom4><electronic-resource-num>312/5776/1027 [pii]&#xD;10.1126/science.1125559</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>123</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">123</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Song, J.</author><author>Liu, J.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0245, USA.</auth-address><titles><title>Direct-current nanogenerator driven by ultrasonic waves</title><secondary-title>Science</secondary-title></titles><pages>102-5</pages><volume>316</volume><number>5821</number><edition>2007/04/07</edition><keywords><keyword>Electric Conductivity</keyword><keyword>*Electricity</keyword><keyword>Microelectrodes</keyword><keyword>Nanotechnology</keyword><keyword>*Nanowires</keyword><keyword>*Ultrasonics</keyword><keyword>Zinc Oxide</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 6</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>17412957</accession-num><abstract>We have developed a nanowire nanogenerator that is driven by an ultrasonic wave to produce continuous direct-current output. The nanogenerator was fabricated with vertically aligned zinc oxide nanowire arrays that were placed beneath a zigzag metal electrode with a small gap. The wave drives the electrode up and down to bend and/or vibrate the nanowires. A piezoelectric-semiconducting coupling process converts mechanical energy into electricity. The zigzag electrode acts as an array of parallel integrated metal tips that simultaneously and continuously create, collect, and output electricity from all of the nanowires. The approach presents an adaptable, mobile, and cost-effective technology for harvesting energy from the environment, and it offers a potential solution for powering nanodevices and nanosystems.</abstract><notes>Wang, Xudong&#xD;Song, Jinhui&#xD;Liu, Jin&#xD;Wang, Zhong Lin&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2007 Apr 6;316(5821):102-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17412957</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>30.03</custom4><electronic-resource-num>316/5821/102 [pii]&#xD;10.1126/science.1139366</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>122</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">122</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Z. L.</author><author>Song, J.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. zhong.wang@mse.gatech.edu</auth-address><titles><title>Piezoelectric nanogenerators based on zinc oxide nanowire arrays</title><secondary-title>Science</secondary-title></titles><pages>242-6</pages><volume>312</volume><number>5771</number><edition>2006/04/15</edition><dates><year>2006</year><pub-dates><date>Apr 14</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16614215</accession-num><abstract>We have converted nanoscale mechanical energy into electrical energy by means of piezoelectric zinc oxide nanowire (NW) arrays. The aligned NWs are deflected with a conductive atomic force microscope tip in contact mode. The coupling of piezoelectric and semiconducting properties in zinc oxide creates a strain field and charge separation across the NW as a result of its bending. The rectifying characteristic of the Schottky barrier formed between the metal tip and the NW leads to electrical current generation. The efficiency of the NW-based piezoelectric power generator is estimated to be 17 to 30%. This approach has the potential of converting mechanical, vibrational, and/or hydraulic energy into electricity for powering nanodevices.</abstract><notes>Wang, Zhong Lin&#xD;Song, Jinhui&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2006 Apr 14;312(5771):242-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16614215</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>30.03</custom4><electronic-resource-num>312/5771/242 [pii]&#xD;10.1126/science.1124005</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>313</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">313</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. weissleder@helix.mgh.harvard.edu</auth-address><titles><title>Molecular imaging in cancer</title><secondary-title>Science</secondary-title></titles><pages>1168-71</pages><volume>312</volume><number>5777</number><edition>2006/05/27</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/therapeutic use</keyword><keyword>*Diagnostic Imaging</keyword><keyword>Drug Evaluation, Preclinical</keyword><keyword>Humans</keyword><keyword>Indicators and Reagents</keyword><keyword>*Molecular Diagnostic Techniques</keyword><keyword>Neoplasms/chemistry/*diagnosis/*therapy</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/*diagnostic use</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2006</year><pub-dates><date>May 26</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16728630</accession-num><abstract>Medical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targeted imaging agents expected to broadly expand the capabilities of conventional anatomical imaging methods. Molecular imaging will allow clinicians to not only see where a tumor is located in the body, but also to visualize the expression and activity of specific molecules (e.g., proteases and protein kinases) and biological processes (e.g., apoptosis, angiogenesis, and metastasis) that influence tumor behavior and/or response to therapy. This information is expected to have a major impact on cancer detection, individualized treatment, and drug development, as well as our understanding of how cancer arises.</abstract><notes>Weissleder, Ralph&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2006 May 26;312(5777):1168-71.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16728630</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>30.03</custom4><electronic-resource-num>312/5777/1168 [pii]&#xD;10.1126/science.1125949</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>191</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">191</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Young, A. N.</author><author>Master, V. A.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. andrew.n.young@emory.edu</auth-address><titles><title>Current trends in the molecular classification of renal neoplasms</title><secondary-title>ScientificWorldJournal</secondary-title><alt-title>TSW Urology</alt-title></titles><pages>2505-18</pages><volume>6</volume><edition>2007/07/11</edition><keywords><keyword>Carcinoma, Renal Cell/*diagnosis/*pathology</keyword><keyword>Computational Biology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*diagnosis/*genetics/*pathology</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>Software</keyword><keyword>Treatment Outcome</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2006</year><pub-dates><date>July</date></pub-dates></dates><isbn>1537-744X (Electronic)</isbn><accession-num>17619725</accession-num><abstract>Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. RCC is a significant challenge for pathologic diagnosis and clinical management. The primary approach to diagnosis is by light microscopy, using the World Health Organization (WHO) classification system, which defines histopathologic tumor subtypes with distinct clinical behavior and underlying genetic mutations. However, light microscopic diagnosis of RCC subtypes is often difficult due to variable histology. In addition, the clinical behavior of RCC is highly variable and therapeutic response rates are poor. Few clinical assays are available to predict outcome in RCC or correlate behavior with histology. Therefore, novel RCC classification systems based on gene expression should be useful for diagnosis, prognosis, and treatment. Recent microarray studies have shown that renal tumors are characterized by distinct gene expression profiles, which can be used to discover novel diagnostic and prognostic biomarkers. Here, we review clinical features of kidney cancer, the WHO classification system, and the growing role of molecular classification for diagnosis, prognosis, and therapy of this disease.</abstract><notes>Young, Andrew N&#xD;Master, Viraj A&#xD;Amin, Mahul B&#xD;1 u54 ca119338-02/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;TheScientificWorldJournal&#xD;ScientificWorldJournal. 2006 Dec 15;6:2505-18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17619725</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>0.877</custom4><electronic-resource-num>10.1100/tsw.2006.390</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>535</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">535</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Nanoplatforms for targeted molecular imaging in living subjects</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1840-54</pages><volume>3</volume><number>11</number><edition>2007/10/19</edition><keywords><keyword>*Contrast Media</keyword><keyword>Diagnostic Imaging/*trends</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Molecular Probe Techniques/*trends</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanostructures/*diagnostic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17943716</accession-num><abstract>Molecular or personalized medicine is the future of patient management and molecular imaging plays a key role towards this goal. Recently, nanoplatform-based molecular imaging has emerged as an interdisciplinary field, which involves chemistry, engineering, biology, and medicine. Possessing unprecedented potential for early detection, accurate diagnosis, and personalized treatment of diseases, nanoplatforms have been employed in every single biomedical imaging modality, namely, optical imaging, computed tomography, ultrasound, magnetic resonance imaging, single-photon-emission computed tomography, and positron emission tomography. Multifunctionality is the key advantage of nanoplatforms over traditional approaches. Targeting ligands, imaging labels, therapeutic drugs, and many other agents can all be integrated into the nanoplatform to allow for targeted molecular imaging and molecular therapy by encompassing many biological and biophysical barriers. In this Review, we will summarize the current state-of-the-art of nanoplatforms for targeted molecular imaging in living subjects.</abstract><notes>Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/United States NCI&#xD;R21 CA102123/CA/United States NCI&#xD;R21 EB001785/EB/United States NIBIB&#xD;R24 CA93862/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2007 Nov;3(11):1840-54.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17943716</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>6.024</custom4><electronic-resource-num>10.1002/smll.200700351</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>712</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">712</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hadjipanayis, C.G.</author><author>Bonder, M.J.</author><author>Balakrishnan, S.</author><author>Wang, X.</author><author>Mao, H.</author><author>Hadjipanayis, G.C.</author></authors></contributors><titles><title>Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>6.024</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>713</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">713</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harris, T.</author><author>von Maltzhahn, G </author><author>Lord, M.E.</author><author>Park, J.</author><author>Agarwal, A.</author><author>Min, D.</author><author>Sailor, M.J. </author><author>Bhatia, S.N.</author></authors></contributors><titles><title>Protease-Triggered Unveiling of Bioactive Nanoparticles</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>internal</custom2><custom4>6.024</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>377</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">377</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kattumuri, V.</author><author>Katti, K.</author><author>Bhaskaran, S.</author><author>Boote, E. J.</author><author>Casteel, S. W.</author><author>Fent, G. M.</author><author>Robertson, D. J.</author><author>Chandrasekhar, M.</author><author>Kannan, R.</author><author>Katti, K. V.</author></authors></contributors><auth-address>Department of Physics, Alton Building Laboratories, University of Missouri-Columbia, Columbia, MO 65211 USA.</auth-address><titles><title>Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>333-41</pages><volume>3</volume><number>2</number><edition>2007/02</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media</keyword><keyword>Crystallization/methods</keyword><keyword>Excipients/chemistry</keyword><keyword>Gold/*chemistry/*pharmacokinetics</keyword><keyword>Gum Arabic/*chemistry/*pharmacokinetics</keyword><keyword>Kinetics</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Molecular Conformation</keyword><keyword>Nanoparticles/*chemistry/*ultrastructure</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Swine</keyword><keyword>Tissue Distribution</keyword><keyword>Tomography, X-Ray Computed</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17262759</accession-num><abstract>Gold nanoparticles (AuNPs) have exceptional stability against oxidation and therefore will play a significant role in the advancement of clinically useful diagnostic and therapeutic nanomedicines. Despite the huge potential for a new generation of AuNP-based nanomedicinal products, nontoxic AuNP constructs and formulations that can be readily administered site-specifically through the intravenous mode, for diagnostic imaging by computed tomography (CT) or for therapy via various modalities, are still rare. Herein, we report results encompassing: 1) the synthesis and stabilization of AuNPs within the nontoxic phytochemical gum-arabic matrix (GA-AuNPs); 2) detailed in vitro analysis and in vivo pharmacokinetics studies of GA-AuNPs in pigs to gain insight into the organ-specific localization of this new generation of AuNP vector, and 3) X-ray CT contrast measurements of GA-AuNP vectors for potential utility in molecular imaging. Our results demonstrate that naturally occurring GA can be used as a nontoxic phytochemical construct in the production of readily administrable biocompatible AuNPs for diagnostic and therapeutic applications in nanomedicine.</abstract><notes>1r01a119412-01/phs&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17262759 </url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2007</custom3><custom4>6.024</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>379</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">379</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kohler, N.</author><author>Sun, C.</author><author>Fichtenholtz, A.</author><author>Gunn, J.</author><author>Fang, C.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science &amp; Engineering, University of Washington, Seattle, WA98195, USA.</auth-address><titles><title>Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>785-92</pages><volume>2</volume><number>6</number><edition>2006/06</edition><keywords><keyword>Adsorption</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage/diagnostic use</keyword><keyword>Brain Neoplasms/radionuclide imaging</keyword><keyword>Cell Line, Tumor</keyword><keyword>Coated Materials, Biocompatible/chemistry/diagnostic use/therapeutic use</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Glioma/drug therapy/*radionuclide imaging</keyword><keyword>Image Enhancement/methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Magnetics/diagnostic use/therapeutic use</keyword><keyword>Methotrexate/*chemistry</keyword><keyword>Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Rats</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17193123</accession-num><abstract>We report the development of a biostable methotrexate-immobilized iron oxide nanoparticle drug carrier that may potentially be used for real-time monitoring of drug delivery through magnetic resonance imaging. Methotrexate (MTX) was immobilized on the nanoparticle surface via a poly(ethylene glycol) self-assembled monolayer (PEG SAM). The cytotoxicity of the nanoparticle-drug conjugate (NP-PEG-MTX) to target cells was studied with 9L glioma cells. Cellular uptake experiments showed that the uptake of NP-PEG-MTX conjugates by glioma cells was considerably higher than that of control nanoparticles. Magnetic resonance imaging in 9L cells cultured with NP-PEG-MTX of various concentrations showed significant contrast enhancement. NP-PEG-MTX demonstrated higher cytotoxicity in 9L cells to free MTX in vitro. Leucovorin, an MTX antidote, was used to rescue the cells that had been exposed to NP-PEG-MTX or free MTX, and the experiment verified the biocompatibility of NP-PEG-MTX conjugates and the MTX on NP-PEG-MTX conjugates to be the true source of the cytotoxicity to the target cells. TEM results showed that NP-PEG-MTX conjugates were internalized into the 9L cellular cytoplasm and retained its crystal structure therein for up to 144 h, as identified by electron diffraction. This prolonged particle retention may allow physicians to image tumor cells exposed to the NP-PEG-MTX conjugate over an extended therapeutic time course.</abstract><notes>Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17193123 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2006</custom3><custom4>6.024</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>69</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">69</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Maynor, B. W.</author><author>LaRue, I.</author><author>Hu, Z.</author><author>Rolland, J. P.</author><author>Pandya, A.</author><author>Fu, Q.</author><author>Liu, J.</author><author>Spontak, R. J.</author><author>Sheiko, S. S.</author><author>Samulski, R. J.</author><author>Samulski, E. T.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Supramolecular nanomimetics: replication of micelles, viruses, and other naturally occurring nanoscale objects</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>845-9</pages><volume>3</volume><number>5</number><edition>2007/03/30</edition><keywords><keyword>Biomimetic Materials/*chemistry</keyword><keyword>Biomimetics/*methods</keyword><keyword>Crystallization/*methods</keyword><keyword>Ethers/*chemistry</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Micelles</keyword><keyword>Molecular Conformation</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Viruses/*chemistry/ultrastructure</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17393549</accession-num><notes>Maynor, Benjamin W&#xD;LaRue, Isaac&#xD;Hu, Zhaokang&#xD;Rolland, Jason P&#xD;Pandya, Ashish&#xD;Fu, Qiang&#xD;Liu, Jie&#xD;Spontak, Richard J&#xD;Sheiko, Sergei S&#xD;Samulski, Richard J&#xD;Samulski, Edward T&#xD;DeSimone, Joseph M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2007 May;3(5):845-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17393549</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>6.024</custom4><electronic-resource-num>10.1002/smll.200600507</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>33</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">33</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Jaffer, F. A.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Room 5406, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>A macrophage-targeted theranostic nanoparticle for biomedical applications</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>983-7</pages><volume>2</volume><number>8-9</number><edition>2007/08</edition><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17193154</accession-num><notes>P50 ca86355/ca/nci&#xD;R01 hl080731/hl/nhlbi&#xD;T32 ca79443/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17193154 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>6.024</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>630</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">630</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sanedrin, R. G.</author><author>Huang, L.</author><author>Jang, J. W.</author><author>Kakkassery, J.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Polyethylene glycol as a novel resist and sacrificial material for generating positive and negative nanostructures</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>920-4</pages><volume>4</volume><number>7</number><edition>2008/06/20</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18563746</accession-num><notes>Sanedrin, Raymond G&#xD;Huang, Ling&#xD;Jang, Jae-Won&#xD;Kakkassery, Joseph&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2008 Jul;4(7):920-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18563746</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>6.024</custom4><electronic-resource-num>10.1002/smll.200701089</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>374</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">374</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Wang, S.</author><author>Meshinchi, S.</author><author>Van Antwerp, M. E.</author><author>Bi, X.</author><author>Lee, I.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA. xshi@umich.edu</auth-address><titles><title>Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>1245-52</pages><volume>3</volume><number>7</number><edition>2007/07</edition><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17523182</accession-num><abstract>We present a general approach for the targeting and imaging of cancer cells using dendrimer-entrapped gold nanoparticles (Au DENPs). Au DENPs were found to be able to covalently link with targeting and imaging ligands for subsequent cancer-cell targeting and imaging. The Au DENPs linked with defined numbers of folic acid (FA) and fluorescein isothiocyanate (FI) molecules are water soluble, stable, and biocompatible. In vitro studies show that the FA- and FI-modified Au DENPs can specifically bind to KB cells (a human epithelial carcinoma cell line) that overexpress high-affinity folate receptors and they are internalized dominantly into lysosomes of target cells within 2 h. These findings demonstrate that Au DENPs may serve as a general platform for cancer imaging and therapeutics.</abstract><notes>N0i-co-97111/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17523182 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>6.024</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>678</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">678</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shukla, R.</author><author>Nune, S. K.</author><author>Chanda, N.</author><author>Katti, K.</author><author>Mekapothula, S.</author><author>Kulkarni, R. R.</author><author>Welshons, W. V.</author><author>Kannan, R.</author><author>Katti, K. V.</author></authors></contributors><auth-address>Department of Radiology, 301, Business Loop 70W University of Missouri-Columbia Columbia, MO 65212 (USA).</auth-address><titles><title>Soybeans as a Phytochemical Reservoir for the Production and Stabilization of Biocompatible Gold Nanoparticles</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><edition>2008/07/22</edition><dates><year>2008</year><pub-dates><date>Jul 18</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18642250</accession-num><abstract>The present study demonstrates an unprecedented green process for the production of gold nanoparticles by simple treatment of gold salts with soybean extracts. Reduction capabilities of antioxidant phytochemicals present in soybean and their ability to reduce gold salts chemically to nanoparticles with subsequent coating of proteins and a host of other phytochemicals present in soybean on the freshly generated gold nanoparticles are discussed. The new genre of green nanoparticles exhibit remarkable in vitro stability in various buffers including saline, histidine, HSA, and cysteine solutions. MTT assays reveal that the green gold nanoparticles are nontoxic and thus provide excellent opportunities for their applications in nanomedicine for molecular imaging and therapy. The overall strategy described herein for the generation of gold nanoparticles meets all 12 principles of green chemistry, as no &quot;man-made&quot; chemicals, other than the gold salts, are used in the green nanotechnological process.</abstract><notes>Journal article&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2008 Jul 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18642250</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2008</custom3><custom4>6.024</custom4><electronic-resource-num>10.1002/smll.200800525</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>511</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">511</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, C.</author><author>Veiseh, O.</author><author>Gunn, J.</author><author>Fang, C.</author><author>Hansen, S.</author><author>Lee, D.</author><author>Sze, R.</author><author>Ellenbogen, R. G.</author><author>Olson, J.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science &amp; Engineering, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>372-9</pages><volume>4</volume><number>3</number><edition>2008/01/31</edition><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18232053</accession-num><abstract>Converging advances in the development of nanoparticle-based imaging probes and improved understanding of the molecular biology of brain tumors offer the potential to provide physicians with new tools for the diagnosis and treatment of these deadly diseases. However, the effectiveness of promising nanoparticle technologies is currently limited by insufficient accumulation of these contrast agents within tumors. Here a biocompatible nanoprobe composed of a poly(ethylene glycol) (PEG) coated iron oxide nanoparticle that is capable of specifically targeting glioma tumors via the surface-bound targeting peptide, chlorotoxin (CTX), is presented. The preferential accumulation of the nanoprobe within gliomas and subsequent magnetic resonance imaging (MRI) contrast enhancement are demonstrated in vitro in 9L cells and in vivo in tumors of a xenograft mouse model. TEM imaging reveals that the nanoprobes are internalized into the cytoplasm of 9L cells and histological analysis of selected tissues indicates that there are no acute toxic effects of these nanoprobes. High targeting specificity and benign biological response establish this nanoprobe as a potential platform to aid in the diagnosis and treatment of gliomas and other tumors of neuroectodermal origin.</abstract><notes>Sun, Conroy&#xD;Veiseh, Omid&#xD;Gunn, Jonathan&#xD;Fang, Chen&#xD;Hansen, Stacey&#xD;Lee, Donghoon&#xD;Sze, Raymond&#xD;Ellenbogen, Richard G&#xD;Olson, Jim&#xD;Zhang, Miqin&#xD;N01CO37122/CO/United States NCI&#xD;R01CA119408/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2008 Mar;4(3):372-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18232053</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2008</custom3><custom4>6.024</custom4><electronic-resource-num>10.1002/smll.200700784</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>96</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">96</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, E. Y.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Building 149, 13th St., Room 5410, Charlestown, MA 02129, USA.</auth-address><titles><title>Continuous analyte sensing with magnetic nanoswitches</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1144-7</pages><volume>2</volume><number>10</number><edition>2006/12/29</edition><keywords><keyword>Biosensing Techniques</keyword><keyword>Fiber Optics</keyword><keyword>Glucose/chemistry</keyword><keyword>Immunoassay/instrumentation/methods</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Magnetic Resonance Spectroscopy/methods</keyword><keyword>Models, Chemical</keyword><keyword>Nanomedicine/*methods</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Protein Binding</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword><keyword>Water</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17193579</accession-num><notes>Sun, Eric Yi&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;P50 ca86355/ca/nci&#xD;R01 00662/phs&#xD;R01 eb004626/eb/nibib&#xD;U01 hl 080731/hl/nhlbi&#xD;U54 ca119349/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2006 Oct;2(10):1144-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17193579</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>6.024</custom4><electronic-resource-num>10.1002/smll.200600204</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>140</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">140</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Vega, R. A.</author><author>Shen, C. K.</author><author>Maspoch, D.</author><author>Robach, J. G.</author><author>Lamb, R. A.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Monitoring single-cell infectivity from virus-particle nanoarrays fabricated by parallel dip-pen nanolithography</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1482-5</pages><volume>3</volume><number>9</number><edition>2007/08/19</edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17694589</accession-num><notes>Vega, Rafael A&#xD;Shen, Clifton K-F&#xD;Maspoch, Daniel&#xD;Robach, Jessica G&#xD;Lamb, Robert A&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2007 Sep;3(9):1482-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17694589</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>6.024</custom4><electronic-resource-num>10.1002/smll.200700244</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>340</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">340</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kandere-Grzybowska, K.</author><author>Campbell, C. J.</author><author>Mahmud, G.</author><author>Komarova, Y.</author><author>Soh, S.</author><author>Grzybowski, B. A.</author></authors></contributors><auth-address>Grzybowski, BA&#xD;Northwestern Univ, Dept Biol &amp; Chem Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Biol &amp; Chem Engn, Evanston, IL 60208 USA</auth-address><titles><title>Cell motility on micropatterned treadmills and tracks</title><secondary-title>Soft Matter</secondary-title></titles><pages>672-679</pages><volume>3</volume><number>6</number><edition>2007</edition><keywords><keyword>drop shape-analysis</keyword><keyword>soft lithography</keyword><keyword>migration</keyword><keyword>surfaces</keyword><keyword>growth</keyword><keyword>fibroblasts</keyword><keyword>polarity</keyword><keyword>microtubules</keyword><keyword>orientation</keyword><keyword>monolayers</keyword></keywords><dates><year>2007</year></dates><isbn>1744-683X</isbn><accession-num>ISI:000246696700002</accession-num><abstract>Surfaces micropatterned with disjointed cell adhesive/non-adhesive regions allow for precise control of cell shape, internal organization and function. In particular, substrates prepared by the reaction - diffusion ASoMic ( Anisotropic So lid Microetching) method localize cells onto transparent micro-islands or tracks surrounded by an opaque, adhesion-resistant background. ASoMic is compatible with several important imaging modalities ( e. g. wide-field, fluorescent, TIRF and confocal microscopies), and can be used to study and quantify various intracellular and cellular processes related to cell motility. For cells constrained on the islands, the imposed geometry controls spatial organization of the cytoskeleton, while the transparency of the islands allows for real-time analysis of cytoskeletal dynamics. For cells on transparent, linear tracks, the high optical contrast between these adhesive regions and the surrounding non-adhesive background allows for straightforward quantification of the key parameters describing cell motility. Both types of systems provide analytical-quality data that can assist fundamental studies of cell locomotion and can provide a technological basis for cell motility microassays.</abstract><notes>170WK&#xD;Times Cited:0&#xD;Cited References Count:49</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246696700002</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.703</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>548</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">548</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, Hyung-Kun</author><author>Soukasene, Stephen</author><author>Jiang, Hongzhou</author><author>Zhang, Shuming</author><author>Feng, Wenchun</author><author>Stupp, Samuel I.</author></authors></contributors><titles><title>Light-induced self-assembly of nanofibers inside liposomes</title><secondary-title>Soft Matter</secondary-title></titles><pages>962-964</pages><volume>4</volume><number>5</number><edition>2008/03/4</edition><dates><year>2008</year></dates><abstract>Spatially confined self-assembly of peptide amphiphile nanofibers inside liposomes is triggered by light.</abstract><notes>10.1039/b719486b</notes><urls><related-urls><url>http://dx.doi.org/10.1039/b719486b</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.703</custom4><electronic-resource-num>10.1039/b719486b</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>655</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">655</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wieland, K.A.</author><author>Solin, S.A.</author></authors></contributors><auth-address>Department of Physics and Center for Materials Innovation, Washington University in St. Louis, CB 1105, 1 Brookings Drive, St. Louis, MO 63130, United States</auth-address><titles><title>Analytical modeling of symmetry breaking in extraordinary optoconductance</title><secondary-title>Solid State Commun</secondary-title></titles><pages>1-6</pages><volume>146</volume><number>1-2</number><edition>2008/02/9</edition><keywords><keyword>Semiconductors</keyword><keyword>Metal</keyword><keyword>Photoconductivity and photovoltaics</keyword><keyword>Electronic transport</keyword></keywords><dates><year>2008</year><pub-dates><date>April</date></pub-dates></dates><abstract>Extraordinary optoconductance (EOC) devices with symmetric leads have been shown to have a symmetric positional dependence when exposed to focused illumination. While advantageous for a position sensitive detector (PSD), this symmetric positional dependence, when the device is uniformly illuminated, leads to a minimization of the output voltage. Here, with the aid of a previously employed point charge model, we address two ways to break the symmetry and recover the output signal. The first is to impose uniform illumination but only on half the sample. This method has practical limitations as the device is miniaturized to the nanoscale. The second is via asymmetric placement of the voltage probes in a four-probe measurement. Crucial to the discussion is the effect of the surface charge density. Several ways of modeling the induced surface charge density are presented. Utilizing the above-described approach, optimal asymmetric lead positions are found.</abstract><urls><related-urls><url>http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6TVW-4RSYCBV-3&amp;_user=10&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_sort=d&amp;view=c&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=2fcc089df58dcf8ee6b66b14fb01f338</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>1.535</custom4><electronic-resource-num>doi:10.1016/j.ssc.2008.02.002</electronic-resource-num></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>338</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">338</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>David, K.</author><author>Dan, N.</author><author>Tannenbaum, R.</author></authors></contributors><auth-address>Tannenbaum, R&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, 771 Ferst Dr NW, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Drexel Univ, Dept Chem &amp; Biol Engn, Philadelphia, PA 19104 USA&#xD;Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel</auth-address><titles><title>Competitive adsorption of polymers on metal nanoparticles</title><secondary-title>Surface Science</secondary-title></titles><pages>1781-1788</pages><volume>601</volume><number>8</number><edition>2007/04</edition><keywords><keyword>polymer adsorption</keyword><keyword>competitive adsorption</keyword><keyword>metal nanoparticles</keyword><keyword>thermal properties</keyword><keyword>diblock co-polymers</keyword><keyword>thermal-properties</keyword><keyword>colloidal particle</keyword><keyword>oxide nanoclusters</keyword><keyword>surfaces</keyword><keyword>polystyrene</keyword><keyword>matrix</keyword><keyword>kinetics</keyword><keyword>decomposition</keyword><keyword>interfaces</keyword><keyword>silica</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0039-6028</isbn><accession-num>ISI:000246313900002</accession-num><abstract>We investigate the effect of system properties and adsorption sequence on competitive adsorption of poly(methyl methacrylate) (PMMA) and polystyrene (PS) on narrowly polydispersed cobalt (Co) nanoparticles (D similar to 27 nm). The adsorbed layer composition is studied using thermo-gravimetric analysis (TGA). We find that adsorbed layers of PS are completely displaced by PMMA when the solvent is a common good solvent. An adsorbed layer of only PMMA is also obtained through competitive adsorption from a common good solvent. However, in a selective solvent that is poor for PS, sequential adsorption leads to the formation of mixed layers. (c) 2007 Elsevier B.V. All rights reserved.</abstract><notes>165OD&#xD;Times Cited:0&#xD;Cited References Count:46</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246313900002</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>1.855</custom4><language>English</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>403</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">403</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, H.</author><author>Cannizzaro, C.</author><author>Vunjak-Novakovic, G.</author><author>Langer, R.</author><author>Vacanti, C. A.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Division of Health Sciences and Technology, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. hpark@mit.edu</auth-address><titles><title>Nanofabrication and microfabrication of functional materials for tissue engineering</title><secondary-title>Tissue Eng</secondary-title></titles><pages>1867-77</pages><volume>13</volume><number>8</number><edition>2007/05/24</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/*chemical synthesis</keyword><keyword>Humans</keyword><keyword>*Nanostructures</keyword><keyword>*Nanotechnology</keyword><keyword>Tissue Engineering/*instrumentation/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1076-3279 (Print)</isbn><accession-num>17518744</accession-num><abstract>The burgeoning field of regenerative medicine promises significant progress in the treatment of cardiac ischemia, liver disease, and spinal cord injury. Key to its success will be the ability to engineer tissue safely and reliably. Tissue functionality must be recapitulated in the laboratory and then integrated into surrounding tissue upon transfer to the patient. Scaffolding materials must be chosen such that the microenvironment surrounding the cells is a close analog of the native environment. In the early days of tissue engineering, these materials were largely borrowed from other fields, with much of the focus on biocompatibility and biodegradation. However, attention has shifted recently to cell-cell and cell-surface interactions, largely because of enabling technologies at the nanoscale and microscale. Studies on cellular behavior in response to various stimuli are now easily realized by using microfabrication techniques and devices (e.g., biomedical microelectromechanical systems). These experiments are reproducible and moderate in cost, and often can be accomplished at high throughput, providing the fundamental knowledge required to design biomaterials that closely mimic the biological system. It is our opinion that these novel materials and technologies will bring engineered tissues one step closer to practical application in the clinic. This review discusses their application to cardiac, liver, and nerve tissue engineering.</abstract><notes>Park, Hyoungshin&#xD;Cannizzaro, Christopher&#xD;Vunjak-Novakovic, Gordana&#xD;Langer, Robert&#xD;Vacanti, Charles A&#xD;Farokhzad, Omid C&#xD;CA119349/CA/United States NCI&#xD;DE13023/DE/United States NIDCR&#xD;DE16516/DE/United States NIDCR&#xD;EB002520-01/EB/United States NIBIB&#xD;EB003647/EB/United States NIBIB&#xD;HL060435/HL/United States NHLBI&#xD;HL076485-01/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Tissue engineering&#xD;Tissue Eng. 2007 Aug;13(8):1867-77.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17518744</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>4.409</custom4><electronic-resource-num>10.1089/ten.2006.0198</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>9</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">9</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Bruckner, S.</author><author>Nika, K.</author><author>Bottini, N.</author><author>Bellucci, S.</author><author>Magrini, A.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Infectious and Inflammatory Disease Center, The Burnham Institute, La Jolla, CA 92037, USA.</auth-address><titles><title>Multi-walled carbon nanotubes induce T lymphocyte apoptosis</title><secondary-title>Toxicol Lett</secondary-title><alt-title>Toxicology letters</alt-title></titles><pages>121-6</pages><volume>160</volume><number>2</number><edition>2006/01</edition><keywords><keyword>*Apoptosis</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Nanotubes, Carbon/chemistry/*toxicity/ultrastructure</keyword><keyword>Oxidation-Reduction</keyword><keyword>Receptors, Antigen, T-Cell/chemistry/metabolism</keyword><keyword>T-Lymphocytes/*drug effects</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 5</date></pub-dates></dates><isbn>0378-4274 (Print)</isbn><accession-num>16125885</accession-num><abstract>Carbon nanotubes are a man-made form of carbon that did not exist in our environment until very recently. Due to their unique chemical, physical, optical, and magnetic properties, carbon nanotubes have found many uses in industrial products and in the field of nanotechnology, including in nanomedicine. However, very little is yet known about the toxicity of carbon nanotubes. Here, we compare the toxicity of pristine and oxidized multi-walled carbon nanotubes on human T cells and find that the latter are more toxic and induce massive loss of cell viability through programmed cell death at doses of 400 microg/ml, which corresponds to approximately 10 million carbon nanotubes per cell. Pristine, hydrophobic, carbon nanotubes were less toxic and a 10-fold lower concentration of either carbon nanotube type were not nearly as toxic. Our results suggest that carbon nanotubes indeed can be very toxic at sufficiently high concentrations and that careful toxicity studies need to be undertaken particularly in conjunction with nanomedical applications of carbon nanotubes.</abstract><notes>Comparative Study&#xD;Journal Article&#xD;Netherlands</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16125885 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>2.826</custom4><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>399</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">399</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Merrill, A. H., Jr.</author><author>Wang, M. D.</author><author>Park, M.</author><author>Sullards, M. C.</author></authors></contributors><auth-address>School of Biology, Chemistry and Biochemistry, The Wallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. al.merrill@biology.gatech.edu</auth-address><titles><title>(Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology</title><secondary-title>Trends Biochem Sci</secondary-title></titles><pages>457-68</pages><volume>32</volume><number>10</number><edition>2007/10/12</edition><keywords><keyword>Eukaryotic Cells/chemistry/metabolism</keyword><keyword>Extracellular Matrix/*metabolism</keyword><keyword>Glycolipids/chemistry/metabolism</keyword><keyword>Mass Spectrometry</keyword><keyword>Molecular Structure</keyword><keyword>Phospholipids/chemistry/metabolism</keyword><keyword>Prokaryotic Cells/chemistry/metabolism</keyword><keyword>Sphingolipids/chemistry/*metabolism</keyword><keyword>Systems Biology/*methods/trends</keyword><keyword>Viruses/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0968-0004 (Print)</isbn><accession-num>17928229</accession-num><abstract>Sphingolipids are found in essentially all eukaryotes and in some prokaryotes and viruses, where they influence cell structure, signaling and interactions with the extracellular environment. Because of the combinatorial nature of their biosynthesis, the sphingolipidome comprises untold thousands of species that encompass bioactive backbones and complex phospho- and glycolipids. Mass spectrometry is able to analyze a growing fraction of the sphingolipidome and is beginning to provide information about localization. Use of these structure specific, quantitative methods is producing insights, and surprises, regarding sphingolipid structure, metabolism, function and disease. Dealing with such large data sets poses special challenges for systems biology, but the intrinsic and elegant interrelationships among these compounds might provide a key to dealing with the complexity of the sphingolipidome.</abstract><notes>Merrill, Alfred H Jr&#xD;Wang, May Dongmei&#xD;Park, Meeyoung&#xD;Sullards, M Cameron&#xD;GM069338/GM/United States NIGMS&#xD;PA02132/United States PHS&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Trends in biochemical sciences&#xD;Trends Biochem Sci. 2007 Oct;32(10):457-68.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17928229</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>14.994</custom4><electronic-resource-num>S0968-0004(07)00214-9 [pii]&#xD;10.1016/j.tibs.2007.09.004</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>331</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">331</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Crowder, K. C.</author><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Barbieri, A. M.</author><author>Fuhrhop, R. W.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Medicine, Washington University in St. Louis, School of Medicine, St. Louis, MO 63110, USA.</auth-address><titles><title>Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery</title><secondary-title>Ultrasound Med Biol</secondary-title></titles><pages>1693-700</pages><volume>31</volume><number>12</number><edition>2005/12/14</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Cytosol/metabolism</keyword><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Lipids/*administration &amp; dosage</keyword><keyword>Melanoma/*drug therapy/metabolism</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Nanostructures</keyword><keyword>Nanotechnology</keyword><keyword>*Ultrasonics</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0301-5629 (Print)</isbn><accession-num>16344131</accession-num><abstract>Liquid perfluorocarbon nanoparticles serve as sensitive and specific targeted contrast and drug delivery vehicles by binding to specific cell surface markers. We hypothesized that application of acoustic energy at diagnostic power levels could promote nanoparticle-associated drug delivery by stimulating increased interaction between the nanoparticle&apos;s lipid layer and the targeted cell&apos;s plasma membrane. Ultrasound (mechanical index = 1.9) applied with a conventional ultrasound imaging system to nanoparticles targeted to alpha(v)beta3-integrins on C32 melanoma cancer cells in vitro produced no untoward effects. Within 5 min, lipid delivery from nanoparticles into cell cytoplasm was dramatically augmented. We also demonstrate the operation of a potential physical mechanism for this effect, the acoustic radiation force on the nanoparticles, which may contribute to the enhanced lipid delivery. Accordingly, we propose that local delivery of lipophilic substances (e.g., drugs) from targeted nanoparticles directly into cell cytoplasm can be augmented rapidly and safely with conventional ultrasound imaging devices through nondestructive mechanisms.</abstract><notes>Crowder, Kathryn C&#xD;Hughes, Michael S&#xD;Marsh, Jon N&#xD;Barbieri, Alejandro M&#xD;Fuhrhop, Ralph W&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Co-37007/co/nci&#xD;Hl-42950/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Ultrasound in medicine &amp; biology&#xD;Ultrasound Med Biol. 2005 Dec;31(12):1693-700.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16344131</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>2.011</custom4><electronic-resource-num>S0301-5629(05)00308-X [pii]&#xD;10.1016/j.ultrasmedbio.2005.07.022</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>184</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">184</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Wallace, K. D.</author><author>Donahue, T. A.</author><author>Connolly, A. M.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University, School of Medicine, St Louis, MO 63108, USA. msh@cvu.wust.edu</auth-address><titles><title>Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver</title><secondary-title>Ultrasound Med Biol</secondary-title></titles><pages>1236-43</pages><volume>33</volume><number>8</number><edition>2007/05/01</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0301-5629 (Print)</isbn><accession-num>17467153</accession-num><abstract>The dystrophinopathies comprise a group of X-linked genetic diseases that feature dystrophin deficiency. Duchenne and Becker muscular dystrophy are characterized by progressive weakness and wasting of skeletal, smooth, and/or cardiac muscle. Duchenne muscular dystrophy (DMD) is the most severe dystrophinopathy, with an incidence of 1:3500 male births. Despite understanding the structural and genetic basis for DMD, the pathogenesis and clinical basis for more severe involvement in specific skeletal muscle groups and the heart are poorly understood. Current techniques, such as strength testing for monitoring progress of disease and therapy in DMD patients, are imprecise and physically demanding for test subjects. Ultrasound is well-suited to detect changes in structure and organization in muscle tissue in a manner that makes low demands on the patient. Therefore, we investigated the use of ultrasound to quantitatively phenotype the remodeling process in patients with DMD. Beam-formed radio-frequency (RF) data were acquired from the skeletal muscles of nine DMD and five normal subjects imaged with a clinical imaging system (HDI5000 w/7 MHz probe applied above left biceps muscle). From these data, images were reconstructed using B-mode (log of analytic signal magnitude) and information-theoretic receivers (H(f)-receiver). H(f) images obtained from dystrophic muscle contained extensive &quot;mottled&quot; regions (i.e., areas with heterogeneous image contrast) that were not readily apparent from the B-Mode images. The 2-D autocorrelation of DMD H(f) images have broader peaks than those of normal subjects, which is indicative of larger scatterer sizes, consistent with pathologic changes of fibers, edema and fatty infiltration. Comparison of the relative peak widths (full width measured at 60% maximum) of the autocorrelation of the DMD and normal H(f) images shows a quantitative difference between the two groups (p &lt; 0.005, student two-tailed paired t-test). Consequently, these imaging techniques may prove useful for longitudinal monitoring of disease progression and therapy.</abstract><notes>Hughes, Michael S&#xD;Marsh, Jon N&#xD;Wallace, Kirk D&#xD;Donahue, Tamara A&#xD;Connolly, Anne M&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;5r01hl042950-17/hl/nhlbi&#xD;5r01hl073646-02/hl/nhlbi&#xD;Iu54ca119342-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Ultrasound in medicine &amp; biology&#xD;Ultrasound Med Biol. 2007 Aug;33(8):1236-43. Epub 2007 Apr 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17467153</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.011</custom4><electronic-resource-num>S0301-5629(07)00086-5 [pii]&#xD;10.1016/j.ultrasmedbio.2007.02.007</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>181</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">181</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Marsh, J. N.</author><author>Partlow, K. C.</author><author>Abendschein, D. R.</author><author>Scott, M. J.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Center for Applied Nanomedicine, Department of Internal Medicine, Washington University, St. Louis, MO 63108, USA. jnm@cvu.wustl.edu</auth-address><titles><title>Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes</title><secondary-title>Ultrasound Med Biol</secondary-title></titles><pages>950-8</pages><volume>33</volume><number>6</number><edition>2007/04/17</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>*Contrast Media</keyword><keyword>Emulsions</keyword><keyword>*Epitopes</keyword><keyword>Female</keyword><keyword>Fluorocarbons/*diagnostic use</keyword><keyword>Image Enhancement/methods</keyword><keyword>Light</keyword><keyword>Microscopy, Acoustic/methods</keyword><keyword>Microscopy, Electron, Scanning/methods</keyword><keyword>Muscle, Smooth, Vascular/cytology/ultrasonography</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Nanotechnology/methods</keyword><keyword>Scattering, Radiation</keyword><keyword>Swine</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0301-5629 (Print)</isbn><accession-num>17434667</accession-num><abstract>Targeted, liquid perfluorocarbon nanoparticles are effective agents for acoustic contrast enhancement of abundant cellular epitopes (e.g., fibrin in thrombi) and for lower prevalence binding sites, such as integrins associated with tumor neovasculature. In this study, we sought to delineate the quantitative relationship between the extent of contrast enhancement of targeted surfaces and the density (and concentration) of bound perfluorocarbon (PFC) nanoparticles. Two dramatically different substrates were utilized for targeting. In one set of experiments, the surfaces of smooth, flat, avidin-coated agar disks were exposed to biotinylated nanoparticles to yield a thin layer of targeted contrast. For the second set of measurements, we targeted PFC nanoparticles applied in thicker layers to cultured smooth muscle cells expressing the transmembrane glycoprotein &quot;tissue factor&quot; at the cell surface. An acoustic microscope was used to characterize reflectivity for all samples as a function of bound PFC (determined via gas chromatography). We utilized a formulation of low-scattering nanoparticles having oil-based cores to compete against high-scattering PFC nanoparticles for binding, to elucidate the dependence of contrast enhancement on PFC concentration. The relationship between reflectivity enhancement and bound PFC content varied in a curvilinear fashion and exhibited an apparent asymptote (approximately 16 dB and 9 dB enhancement for agar and cell samples, respectively) at the maximum concentrations (approximately 150 microg and approximately 1000 microg PFOB for agar and cell samples, respectively). Samples targeted with only oil-based nanoparticles exhibited mean backscatter values that were nearly identical to untreated samples (&lt;1 dB difference), confirming the oil particles&apos; low-scattering behavior. The results of this study indicate that substantial contrast enhancement with liquid perfluorocarbon nanoparticles can be realized even in cases of partial surface coverage (as might be encountered when targeting sparsely populated epitopes) or when targeting surfaces with locally irregular topography. Furthermore, it may be possible to assess the quantity of bound cellular epitopes through acoustic means.</abstract><notes>Marsh, Jon N&#xD;Partlow, Kathryn C&#xD;Abendschein, Dana R&#xD;Scott, Michael J&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Ca119342/ca/nci&#xD;Eb002168/eb/nibib&#xD;Hl042950/hl/nhlbi&#xD;R01 eb002168-06/eb/nibib&#xD;R01 hl042950-15/hl/nhlbi&#xD;R01 hl042950-16/hl/nhlbi&#xD;R01 hl042950-17/hl/nhlbi&#xD;U54 ca119342-01/ca/nci&#xD;U54 ca119342-02/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Ultrasound in medicine &amp; biology&#xD;Ultrasound Med Biol. 2007 Jun;33(6):950-8. Epub 2007 Apr 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17434667</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.011</custom4><electronic-resource-num>S0301-5629(07)00010-5 [pii]&#xD;10.1016/j.ultrasmedbio.2006.12.007</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>565</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">565</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alexis, F.</author><author>Rhee, J. W.</author><author>Richie, J. P.</author><author>Radovic-Moreno, A. F.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Anesthesiology, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA 02115, USA.</auth-address><titles><title>New frontiers in nanotechnology for cancer treatment</title><secondary-title>Urol Oncol</secondary-title></titles><pages>74-85</pages><volume>26</volume><number>1</number><edition>2008/01/15</edition><keywords><keyword>Dendrimers/diagnostic use</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Drug Design</keyword><keyword>Humans</keyword><keyword>Nanotechnology/*trends</keyword><keyword>Urologic Neoplasms/*diagnosis/*pathology</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1078-1439 (Print)</isbn><accession-num>18190835</accession-num><abstract>Nanotechnology is a field of research at the crossroads of biology, chemistry, physics, engineering, and medicine. Design of multifunctional nanoparticles capable of targeting cancer cells, delivering and releasing drugs in a regulated manner, and detecting cancer cells with enormous specificity and sensitivity are just some examples of the potential application of nanotechnology to oncological diseases. In this review we discuss the recent advances of cancer nanotechnology with particular attention to nanoparticle systems that are in clinical practice or in various stages of development for cancer imaging and therapy.</abstract><notes>Alexis, Frank&#xD;Rhee, June-Wha&#xD;Richie, Jerome P&#xD;Radovic-Moreno, Aleksandar F&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/United States NCI&#xD;EB003647/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Urologic oncology&#xD;Urol Oncol. 2008 Jan-Feb;26(1):74-85.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18190835</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>2.561</custom4><electronic-resource-num>S1078-1439(07)00092-0 [pii]&#xD;10.1016/j.urolonc.2007.03.017</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>395</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">395</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C.</author><author>Zhu, Y.</author><author>Cerwinka, W. H.</author><author>Zhau, H. E.</author><author>Marshall, F. F.</author><author>Simons, J. W.</author><author>Nie, S.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology, Emory University School of Medicine, Atlanta, GA 30322, USA.</auth-address><titles><title>Quantum dots: emerging applications in urologic oncology</title><secondary-title>Urol Oncol</secondary-title></titles><pages>86-92</pages><volume>26</volume><number>1</number><edition>2008/01/15</edition><keywords><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Prognosis</keyword><keyword>Prostatic Neoplasms/diagnosis/genetics</keyword><keyword>Quantum Theory</keyword><keyword>Tumor Markers, Biological/analysis</keyword><keyword>Urologic Neoplasms/*diagnosis/therapy</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1078-1439 (Print)</isbn><accession-num>18190836</accession-num><abstract>Quantum dots (QDs), nanometer-sized fluorescent probes with unique optical and electronic properties, offer a promising and powerful tool for cancer imaging and diagnostics. For the past few years, QDs were actively developed for biomolecular profiling of cancer biomarkers, in vivo tumor imaging, and even targeted drug delivery. These emerging applications are currently being improved and integrated into clinical practice. In this article, we describe the development of multifunctional QDs and their potential applications in oncology, with a particular emphasis on the diagnosis, prognosis, and treatment of urologic cancers.</abstract><notes>Shi, Chunmeng&#xD;Zhu, Ying&#xD;Cerwinka, Wolfgang H&#xD;Zhau, Haiyen E&#xD;Marshall, Fray F&#xD;Simons, Jonathan W&#xD;Nie, Shuming&#xD;Chung, Leland W K&#xD;P01 CA098912/CA/United States NCI&#xD;R01 CA 108468/CA/United States NCI&#xD;R01 GM60562/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Urologic oncology&#xD;Urol Oncol. 2008 Jan-Feb;26(1):86-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18190836</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>2.561</custom4><electronic-resource-num>S1078-1439(07)00093-2 [pii]&#xD;10.1016/j.urolonc.2007.03.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>588</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">588</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Guimaraes, A.R.</author><author>Tabatabei, S.</author><author>Dahl, D.</author><author>McDougal, W.S.</author><author>Weissleder, R.</author><author>Harisinghani, M.G.</author></authors></contributors><titles><title>Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer.</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><pages>708-12</pages><volume>71</volume><number>4</number><edition>2008 Mar 4</edition><dates><year>2008</year></dates><abstract>OBJECTIVE: To assess lymphotrophic nanoparticle-enhanced magnetic resonance imaging (LNMRI) in identifying malignant nodal involvement in patients with renal neoplasms. METHODS: MRI was performed in 9 patients with renal masses. All patients were imaged on a GE 1.5T system with phased array body coil. Protocols included T2 and T2* weighted imaging before and after administration of ferumoxtran-10 (Combidex) for the evaluation of lymph node (LN) involvement. All 9 patients underwent nephrectomy. Lymph node dissection (LND) was performed in patients with stage 2 renal cell cancer (RCC), or transitional cell cancer (TCC), per routine clinical practice. Data analysis was performed by 2 radiologists, who were blinded to pathologic results. Nodes that lacked contrast uptake were deemed malignant, and those with homogeneous uptake were deemed benign. Quantitative, retrospective analysis was performed on primary tumors by quantifying T2* with a monoexponential fitting algorithm (Osirix). T2* was quantified before, immediately after, and 24 hours after the administration of ferumoxtran-10. RESULTS: MRI demonstrated 26 lymph nodes within the 9 patients imaged (24 benign and 2 malignant). Pathologic results allowed comparison in 22 of the 26 lymph nodes and demonstrated high sensitivity (100%) and specificity (95.7%). CONCLUSIONS: LNMRI demonstrated high sensitivity (100%) and specificity (95.7%) in patients with renal neoplasms. Although in a relatively small sample size, the results are encouraging and warrant a larger, prospective trial.</abstract><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>2.134</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>720</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">720</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C.</author><author>Zhu, Y.</author><author>Xie, Z. </author><author>Qian, W.</author><author>Hsieh, C.L.</author><author>Nie, S.</author><author>Su, Y.</author><author>Zhau, H.E.</author><author>Chung, L.W.K.</author></authors></contributors><titles><title>Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>2.134</custom4></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>115</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">115</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Young, A. N.</author><author>Dale, J.</author><author>Yin-Goen, Q.</author><author>Harris, W. B.</author><author>Petros, J. A.</author><author>Datta, M. W.</author><author>Wang, M. D.</author><author>Marshall, F. F.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. andrew.n.young@emory.edu</auth-address><titles><title>Current trends in molecular classification of adult renal tumors</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><pages>873-80</pages><volume>67</volume><number>5</number><edition>2006/05/16</edition><keywords><keyword>Adult</keyword><keyword>Gene Expression Profiling</keyword><keyword>Genetic Markers</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*classification/diagnosis/*genetics</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1527-9995 (Electronic)</isbn><accession-num>16698345</accession-num><notes>Young, Andrew N&#xD;Dale, Jennifer&#xD;Yin-Goen, Qiqin&#xD;Harris, Wayne B&#xD;Petros, John A&#xD;Datta, Milton W&#xD;Wang, May D&#xD;Marshall, Fray F&#xD;Amin, Mahul B&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Urology&#xD;Urology. 2006 May;67(5):873-80.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16698345</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.13</custom4><electronic-resource-num>S0090-4295(05)01695-X [pii]&#xD;10.1016/j.urology.2005.11.042</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers final Aug 21.enl" path="T:\caNanoLab\Alliance papers final Aug 21.enl">Alliance papers final Aug 21.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>401</rec-number><foreign-keys><key app="EN" db-id="x2wt595vxzdad8ezazppsttpd2zxsva5ptve">401</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lim, S. D.</author><author>Young, A. N.</author><author>Paner, G. P.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology, Konkuk University School of Medicine, Gwangjin-Gu, Seoul, Republic of Korea.</auth-address><titles><title>Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases</title><secondary-title>Virchows Arch</secondary-title></titles><pages>49-55</pages><volume>452</volume><number>1</number><edition>2007/11/21</edition><keywords><keyword>Antigens, CD44/*metabolism</keyword><keyword>Carcinoma, Renal Cell/*metabolism/mortality/secondary</keyword><keyword>Disease-Free Survival</keyword><keyword>Female</keyword><keyword>Fluorescent Antibody Technique, Indirect</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Kidney Neoplasms/*metabolism/mortality/pathology</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm Staging</keyword><keyword>Prognosis</keyword><keyword>Survival Rate</keyword><keyword>Tumor Markers, Biological/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0945-6317 (Print)</isbn><accession-num>18026989</accession-num><abstract>Possible prognostic utility of CD44 in renal cell carcinoma (RCC) prompted a comparison of its expression in primary and metastatic RCC. A total of 164 paraffin-embedded tissues of primary RCC and metastatic RCCs from 125 patients were immunostained with CD44 (standard form) antibody. It consisted of 86 primary RCCs (50 with subsequent metastasis [MET+] and 36 with no known metastasis [MET-]) during follow up and 78 metastatic RCCs (39 metastatic RCCs only and 39 with matched RCC primary from RCC MET + category). Immunoreactivity for CD44 was scored semiquantitatively as 0, 1, or 2 (0, &lt;5%; 1, 5-50%; 2, &gt; or =50%). Expression of CD44 was significantly higher in metastatic RCCs compared to primary RCCs (p = 0.036). CD44 immunoreactivity in the primary RCC (MET- and MET+) correlated with progression-free survival (p = 0.027). In metastatic RCCs, CD44 immunoreactivity also correlated with survival after detection of first metastasis (p = 0.011). In multivariate analysis, stage (p = 0.0001) and CD44 immunoreactivity (p = 0.03) in primary RCC were independent predictors of progression-free survival. Our study suggests that CD44 status in RCC provides useful prognostic information both in primary and metastatic RCCs and may have applicability in stratifying patients for therapeutic decisions.</abstract><notes>Lim, So Dug&#xD;Young, Andrew N&#xD;Paner, Gladell P&#xD;Amin, Mahul B&#xD;Comparative Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Virchows Archiv : an international journal of pathology&#xD;Virchows Arch. 2008 Jan;452(1):49-55. Epub 2007 Nov 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18026989</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>2.029</custom4><electronic-resource-num>10.1007/s00428-007-0530-4</electronic-resource-num><language>eng</language></record></records></xml>
